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NOTICE TO READERS
This AICPA Audit and Accounting Guide has been prepared by the AICPA 
Health Care Committee to assist preparers of financial statements in preparing 
financial statements in conformity with generally accepted accounting princi­
ples and to assist auditors in auditing and reporting on such financial state­
ments in accordance with generally accepted auditing standards.
Descriptions of accounting principles and financial reporting practices in Audit 
and Accounting Guides are approved by the affirmative vote of at least two- 
thirds of the members of the Accounting Standards Executive Committee, 
which is the senior technical body of the AICPA authorized to speak for the 
AICPA in the areas of financial accounting and reporting. SAS No. 69, The 
Meaning o f Present Fairly in Conformity With Generally Accepted Accounting 
Principles, identifies AICPA Audit and Accounting Guides that have been 
cleared by the Financial Accounting Standards Board (for financial statements 
of entities other than governmental entities) or Governmental Accounting 
Standards Board (for financial statements of Governmental entities) as sources 
of established accounting principles in category b of the hierarchy of generally 
accepted accounting principles that it establishes. This Audit and Accounting 
Guide has been cleared by the Financial Accounting Standards Board and the 
Governmental Accounting Standards Board. AICPA members should consider 
the accounting principles described in this Audit and Accounting Guide if  the 
accounting treatment of a transaction or event is not specified by a pronounce­
ment covered by rule 203 of the AICPA Code of Professional Conduct. In such 
circumstances, the accounting treatments specified by this Audit and Account­
ing Guide should be used, or the member should be prepared to justify another 
treatment, as discussed in paragraph 7 of SAS No. 69.
Auditing guidance included in an AICPA Audit and Accounting Guide is an 
interpretive publication pursuant to SAS No. 95, Generally Accepted Auditing 
Standards. Interpretive publications are recommendations on the application 
of SASs in specific circumstances, including engagements for entities in spe­
cialized industries. Interpretive publications are issued under the authority of 
the Auditing Standards Board.
The auditor should identify interpretive publications applicable to his or her 
audit. I f  the auditor does not apply the auditing guidance included in an 
applicable interpretive publication, the auditor should be prepared to explain 
how he or she complied with the SAS provisions addressed by such auditing 
guidance.
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VThis edition of the Audit and Accounting Guide Health Care Organizations, 
has been modified by the AICPA staff to include certain changes necessary 
due to the issuance of authoritative pronouncements since the Guide was 
originally issued. This Guide reflects relevant guidance contained in 
authoritative pronouncements through January 1, 2003:
• FASB Statement No. 148, Accounting for Stock-Based Compensation— 
Transition and Disclosure
• FASB Interpretations through Interpretation No. 45, Guarantor’s 
Accounting and Disclosure Requirements for Guarantees, Including 
Indirect Guarantees o f Indebtedness of Others
• FASB Technical Bulletins (TB) through TB 01-1, Effective Date for 
Certain Financial Institutions of Certain Provisions of Statement 140 
Related to the Isolation o f Transferred Financial Assets
• FASB Emerging Issues Task Force (EITF) consensus positions 
adopted at meetings of the EITF held through October 2002
• GASB Statements through Statement No. 39, Determining Whether 
Certain Organizations Are Component Units
• GASB Interpretations through Interpretation No. 6, Recognition and 
Measurement of Certain Liabilities and Expenditures in Governmental 
Fund Financial Statements
• GASB Technical Bulletins (TB) 2000-1, Disclosures about Year 2000 
Issues—a rescission o f Technical Bulletins 98-1 and 99-1
• Statements of Position (SOP) through SOP 02-2, Accounting for Deriva­
tive Instruments and Hedging Activities by Not-for-Profit Health Care 
Organizations, and Clarification of the Performance Indicator
• Practice Bulletins (PB) through PB No. 15, Accounting by the Issuer 
of Surplus Notes
• Statements on Auditing Standards (SAS) through SAS No. 100, 
Interim Financial Information
Users of this Guide should consider pronouncements issued subsequent to 
those listed above to determine their effect on entities covered by this Guide.
The changes made for the current year are identified in a schedule in 
appendix H of the Guide. The changes do not include all those that might 
be considered necessary if  the Guide were subjected to a comprehensive 
review and revision.
The chapters and illustrative financial statements for a sample 
governmental hospital authority in appendix A  of this Guide have not been 
modified to conform to the requirements of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for State 
and Local Governments, and related pronouncements because of the phased-in 
effective dates of GASB Statement No. 34. The provisions of GASB Statement 
No. 34 and related pronouncements concerning governmental health care 
entities that are included in the scope of this Guide are discussed in 
appendix F of this Guide. The chapters and illustrative financial 
statements for a governmental hospital authority in appendix A  of this 
Guide will be modified to conform to the requirements of GASB Statement 
No. 34 and related pronouncements in a future edition of this Guide.
(continued)
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This edition includes Statement of Position 98-2, Accounting for Costs of 
Activities o f Not-for-Profit Organizations and State and Local Governmental 
Entities That Include Fund Raising (appendix C), Statement of Position 
99-1, Guidance to Practitioners in Conducting and Reporting on an Agreed- 
Upon Procedures Engagement to Assist Management in Evaluating the 
Effectiveness of Its Corporate Compliance Program (appendix D), and 
Statement of Position 00-1, Auditing Health Care Third-Party Revenues and 
Related Receivables (appendix E). In using this Guide, readers should refer 
to the material in these Statements of Position.
vii
Preface
Purpose
This Guide has been prepared to assist providers of health care services in 
preparing financial statements in conformity with generally accepted account­
ing principles (GAAP) and to assist independent auditors in auditing and 
reporting on those financial statements.
Applicability
This Guide applies to health care organizations that are either (a) inves­
tor-owned businesses or (b) not-for-profit enterprises that have no owner­
ship interest and are essentially self-sustaining from fees charged for goods 
and services, as defined in Financial Accounting Standards Board (FASB) 
Statement of Financial Accounting Concepts No. 4, Objectives o f Financial 
Reporting by Nonbusiness Organizations, paragraph 8,1 or (c) governmen­
tal. This Guide applies to organizations whose principal operations consist 
of providing or agreeing to provide health care services and that derive all 
or almost all of their revenues from the sale of goods or services; it also 
applies to organizations whose primary activities are the planning, organi­
zation, and oversight of such organizations, such as parent or holding 
companies of health care providers.
This Guide applies to the following types of health care organizations:
•  Clinics, medical group practices, individual practice associations, in­
dividual practitioners, emergency care facilities, laboratories, surgery 
centers, and other ambulatory care organizations
•  Continuing care retirement communities (CCRCs)
•  Health maintenance organizations (HMOs) and similar prepaid 
health care plans
•  Home health agencies
•  Hospitals
•  Nursing homes that provide skilled, intermediate, and less intensive’ 
levels of health care
•  Drug and alcohol rehabilitation centers and other rehabilitation facilities
This Guide also applies to integrated delivery systems that include one or 
more of the above types of organizations.
This Guide does not apply to voluntary health and welfare organizations, as 
defined in FASB Statement No. 117, Financial Statements of Not-for-Profit 
Organizations. These organizations should follow the American Institute of 
Certified Public Accountants (AICPA) Audit and Accounting Guide Not-for- 
Profit Organizations. Related fund-raising foundations that meet the definition 
of a not-for-profit organization given in FASB Statement No. 117 also should 
follow the AICPA Audit and Accounting Guide Not-for-Profit Organizations.
1 See paragraph 1.03 of this Guide.
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When separate financial statements are issued for a state or local governmen­
tal health care organization that uses enterprise fund accounting and report­
ing, the accounting, reporting, and disclosure requirements set forth in this 
Guide and by pronouncements of the Governmental Accounting Standards 
Board (GASB) apply. (See chapter 1 for a discussion of the application of GAAP.) 
GASB Statement No. 34, Basic Financial Statements—and Management’s 
Discussion and Analysis—for State and Local Governments, replaces the pre­
vious definition with a new definition of enterprise funds. Governmental health 
care organizations that are required to adopt, or that have elected early 
implementation of GASB Statement No. 34, as amended, should refer to 
appendix F of this Guide. See paragraph 1.11 of this Guide for a discussion of 
the effective dates of GASB Statement No. 34.
Limitations
This Guide does not discuss the application of all GAAP and all generally 
accepted auditing standards (GAAS) that are relevant to the preparation and 
audit of financial statements of health care organizations. The Guide is directed 
primarily to those aspects of the preparation and audit of health care organi­
zations’ financial statements that are unique to those organizations or areas 
considered particularly significant to them.
Other Literature
This Guide incorporates certain provisions of FASB Statements No. 116, 
Accounting for Contributions Received and Contributions Made, No. 117, No. 
124, Accounting for Certain Investments Held by Not-for-Profit Organizations, 
No. 136, Transfers of Assets to a Not-for-Profit Organization or Charitable Trust 
That Raises or Holds Contributions for Others, and GASB Statement No. 33, 
Accounting and Financial Reporting for Nonexchange Transactions, as 
amended. The provisions of GASB Statement No. 34 and related pronounce­
ments are discussed in appendix F of this Guide. The chapters and illustrative 
financial statements for a governmental hospital authority in appendix A of 
this Guide have not been modified to conform to the requirements of GASB 
Statement No. 34 and related pronouncements because of the phased-in effec­
tive dates of GASB Statement No. 34. The chapters and illustrative financial 
statements for a governmental hospital authority in appendix A  of this Guide 
will be modified to conform to the requirements of GASB Statement No. 34 and 
related pronouncements in a future edition of this Guide. Not all guidance 
included in those Statements, however, is incorporated, repeated, or summa­
rized in this Guide. Accordingly, those Statements, and all authoritative 
guidance,2 should be read in conjunction with this Guide.
This Guide supersedes the AICPA Audit and Accounting Guide Audits of 
Providers of Health Care Services. This Guide also incorporates and supersedes 
AICPA Statements of Position (SOP) 89-5, Financial Accounting and Reporting 
by Providers of Prepaid Health Care Services, 90-8, Financial Accounting and 
Reporting by Continuing Care Retirement Communities, and 94-2, The Appli­
cation of the Requirements o f Accounting Research Bulletins, Opinions of the
2 Other professional literature and authoritative guidance includes statements issued by the 
AICPA Accounting Standards Executive Committee (AcSEC) and the FASB—including its Emerging 
Issues Task Force (EITF). Authoritative literature for governmental health care entities includes 
GASB pronouncements, FASB and AICPA pronouncements specifically made applicable to state and 
local governmental entities by the GASB, and AICPA Audit and Accounting Guides, Industry Audit 
Guides, Statements of Position, and Practice Bulletins made applicable to governmental entities and 
cleared by the GASB.
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Accounting Principles Board, and Statements and Interpretations o f the Finan­
cial Accounting Standards Board to Not-for-Profit Organizations.
Office of Management and Budget (OMB) Circular A-133, Audits of States, 
Local Governments, and Non-Profit Organizations, sets forth audit require­
ments for health care organizations expending federal awards. Institutions 
covered by OMB Circular A-133 include not-for-profit hospitals, public hospi­
tals and institutions of higher education, and their affiliated hospitals, volun­
tary health and welfare organizations and other community-based 
organizations.3 Auditors of health care organizations that are subject to the 
audit requirements of OMB Circular A-133 should refer to SOP 98-3, Audits of 
States, Local Governments, and Not-for-Profit Organizations Receiving Federal 
Awards for further assistance.4
Effective Date and Transition
The provisions of this Guide, other than those included in paragraphs 1.27 
through 1.38, which are discussed below, are effective for financial statements 
for periods beginning after June 15, 1996.5 Earlier application is permitted.
The provisions included in paragraphs 1.27 through 1.38 are effective for 
financial statements issued for fiscal years beginning after December 15, 1994, 
except for organizations with less than $5 million in total assets and less than 
$1 million in annual expenses. For those organizations, the effective date is fiscal 
years beginning after December 15, 1995. Earlier application is permitted.
Unless the provisions of this Guide, other than those included in paragraphs
1.27 through 1.38, are applied retroactively under the provisions of the follow­
ing paragraph, the effect of initially applying this Guide shall be reported as 
the effect of a change in accounting principle, in a manner similar to the 
cumulative effect of a change in accounting principle (Accounting Principles 
Board [APB] Opinion No. 20, Accounting Changes, paragraph 19). The amount 
of the cumulative effect should be based on a retroactive computation. A 
not-for-profit organization should report the cumulative effect of a change in 
accounting on each class of net assets in the statement of activities between the 
captions extraordinary items, i f  any, and change in unrestricted net assets, 
change in temporarily restricted net assets, and change in permanently re­
stricted net assets. The cumulative effect on temporary and permanently 
restricted net assets should be reflected in the statement of changes in net 
assets. An investor-owned business should report the amount of the cumulative 
effect in the income statement between the captions extraordinary items and 
net income (APB Opinion No. 20, paragraph 20).
3 The Codification of Office of Management and Budget (OMB) Circular A-133 by the U.S. 
Department of Health and Human Services (HHS) also includes audit requirements for commercial 
organizations (including for-profit hospitals) that receive federal awards under HHS programs. 
Generally, the organization has two options regarding audits: (1) a financial-related audit of a 
particular award in accordance with Government Auditing Standards, or (2) an audit that meets the 
requirements of OMB Circular A-133. See title 45 of the Code of Federal Regulations section 74.26(d) 
for further information.
4 SOP 98-3, Audits of States, Local Governments, and Not-for-Profit Organizations Receiving 
Federal Awards, is updated annually with conforming changes. SOP 98-3 is available in the AICPA 
publication Technical Practice Aids, and is also included as an appendix to the AICPA Audit and 
Accounting Guides Audits of State and Local Governmental Units (Non-GASB 34 Edition), Audits of 
State and Local Governments (GASB 34 Edition), and Not-for-Profit Organizations. In 2003, SOP 98-3 
will be removed from those industry Guides and will be available in a separate Audit Guide Audits of 
States, Local Governments, and Not-for-Profit Organizations Receiving Federal Awards. SOP 98-3 will 
also be removed from Technical Practice Aids when it is removed from those Industry Guides.
5 This Guide does not defer the effective date of any pronouncements that cover not-for-profit 
organizations.
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be applied retroactively by restating the opening net assets for the earliest year 
presented or for the year this Guide is first applied if  no prior years are 
presented. In the period in which this Guide is first applied, that organization 
should disclose the nature of any restatement and its effect on the change in 
net assets for each period presented. An investor-owned business should 
account for any restatement as a change in accounting principle applied 
retroactively (APB Opinion No. 20, paragraphs 27 and 28).
In implementing the guidance in paragraphs 1.27 through 1.38, which incor­
porates the provisions of SOP 94-2 into this Guide, the transition rules of the 
APB Opinions and FASB Statements adopted, other than their effective dates, 
should be followed. However, i f  there is more than one change in accounting 
principle as a result of applying the guidance in paragraphs 1.27 through 1.38, 
organizations have the option of including the cumulative effect of adopting 
those accounting principles in the statement of activity or similar statement in 
the year this Guide is adopted, regardless of the transition rules of the APB 
Opinions and FASB Statements adopted,6 and the financial statements should 
disclose the nature of the cumulative adjustment. (Paragraphs 19 and 20 of 
APB Opinion No. 20 discuss reporting the cumulative effects of changes in 
accounting principles.) In circumstances in which there is more than one 
change in accounting principle resulting from applying this Guide and the 
cumulative effect of adopting those accounting principles is included in the 
statement of activity or similar statement in the year the guidance in para­
graphs 1.27 through 1.38 is adopted, this Guide does not require the pro forma 
disclosures required by paragraphs 19(d) and 21 of APB Opinion No. 20.
6 Organizations that adopt the guidance in paragraphs 1.27 through 1.38 of this Guide in the 
same year in which they adopt FASB Statement No. 116 are permitted to apply the provisions of 
paragraph 17 of that Statement, concerning recognition of expirations of restrictions, prospectively, 
as specified in that Statement, regardless of whether they report the cumulative effect of adopting 
other accounting principles as a result of applying the guidance in paragraphs 1.27 through 1.38 of 
this Guide.
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Unique Considerations of Health Care Organizations 1
Chapter 1 
Unique Considerations of Health 
Care Organizations
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
Overview
1.01 Financial statements of health care organizations should be prepared 
in conformity with generally accepted accounting principles (GAAP). AICPA 
Statement on Auditing Standards (SAS) No. 69, The Meaning of Present Fairly in 
Conformity With Generally Accepted Accounting Principles (AICPA, Professional 
Standards, vol. 1, AU sec. 411), provides the GAAP hierarchy summary for both 
nongovernmental and governmental organizations.1
Classification of Health Care Organizations
1.02 Health care enterprises usually can be classified into the following 
categories on the basis of their operating characteristics:
a. Investor-Owned Health Care Enterprises. These are owned by in­
vestors or others with a private equity interest and provide goods or 
services with the objective of making a profit.
1 Governmental Accounting Standards Board (GASB) Statement No. 20, Accounting and Finan­
cial Reporting for Proprietary Funds and Other Governmental Entities That Use Proprietary Fund 
Accounting, paragraph 6, provides interim guidance for governmental proprietary activities, such as 
governmental health care enterprises. Governmental proprietary activities should apply all applica­
ble GASB pronouncements as well as any Financial Accounting Standards Board (FASB) Statements 
and Interpretations, Accounting Principles Board (APB) Opinions, and Accounting Research Bulle­
tins (ARBs) issued on or before November 30, 1989, that do not conflict with or contradict GASB 
pronouncements. Furthermore, paragraph 7 of GASB Statement No. 20 provides that governmental 
proprietary activities may apply all FASB Statements and Interpretations issued after November 30, 
1989, that do not conflict with or contradict GASB pronouncements. Entities that choose to apply 
these “new” FASB pronouncements must apply them on an “all or none” basis (that is, they may not 
select which pronouncements to apply). In addition, GASB Statement No. 29, The Use of Not-for- 
Profit Accounting and Financial Reporting Principles by Governmental Entities, provides that pro­
prietary activities that apply the provisions of paragraph 7 of GASB Statement No. 20 should apply 
only those FASB Statements and Interpretations issued after November 30, 1989 that are developed 
for business enterprises (see paragraph 1.40 in this Guide). They should not apply FASB Statements 
and Interpretations whose provisions are limited to not-for-profit organizations, such as FASB 
Statement No. 117, Financial Statements of Not-for-Profit Organizations, or address issues concern­
ing primarily such organizations, such as FASB Statement No. 116, Accounting for Contributions 
Received and Contributions Made. The requirements set forth in this Guide for governmental health 
care enterprises generally apply to such enterprises that apply paragraph 7 of GASB Statement No. 
20. Governmental health care entities that are required to adopt, or that have elected early imple­
mentation of GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion 
and Analysis—for State and Local Governments, and related pronouncements should refer to appen­
dix F of this Guide.
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b. Not-for-Profit, Business-Oriented Organizations. These are charac­
terized by no ownership interests and essentially are self-sustaining 
from fees charged for goods and services. The fees charged by such 
organizations generally are intended to help the organization main­
tain its self-sustaining status rather than to maximize profits for the 
owner’s benefit. Such organizations often are exempt from federal 
income taxes and may receive contributions of relatively small 
amounts from resource providers that do not expect commensurate 
or proportionate pecuniary return.
c. Governmental Health Care Organizations. These are public corpo­
rations2 and bodies corporate and politic. Other organizations are 
governmental organizations if  they have one or more of the following 
characteristics:
•  Popular election of officers or appointment (or approval) of a 
controlling majority of the members of the organization’s gov­
erning body by officials of one or more state or local governments;
•  The potential for unilateral dissolution by a government with 
the net assets reverting to a government; or
•  The power to enact and enforce a tax levy.
Furthermore, organizations are presumed to be governmental if they 
have the ability to issue directly (rather than through a state or 
municipal authority) debt that pays interest exempt from federal 
taxation. However, organizations possessing only that ability (to 
issue tax-exempt debt) and none of the other governmental charac­
teristics may rebut the presumption that they are governmental if 
their determination is supported by compelling, relevant evidence.
d. Not-for-Profit, Nonbusiness-Oriented Organizations. These are vol­
untary health and welfare organizations (see the Glossary) as de­
fined in FASB Statement No. 117, Financial Statements o f 
Not-for-Profit Organizations. Such organizations are within the 
scope of the AICPA Audit and Accounting Guide Not-for-Profit Or­
ganizations rather than this Guide.
Financial Reporting of Health Care Organizations
1.03 The nature of the organization and its operating structure have a 
significant effect on the needs of financial statement users. According to FASB 
Statement of Financial Accounting Concepts (Concepts Statement) No. 4, Ob­
jectives of Financial Reporting by Nonbusiness Organizations, paragraph 8:
Some organizations have no ownership interests but are essentially self-sustain­
ing from fees they charge for goods and services. Examples are those private 
nonprofit hospitals . . .  that may receive relatively small amounts of contributions 
and grants but finance their capital needs largely from the proceeds of debt issues 
and their operating needs largely from service charges rather than from private 
philanthropy or governmental grants. As a result, assessment of amounts, timing,
2 Black’s Law Dictionary defines a public corporation as: An artificial person (e.g., [a] municipal­
ity or a governmental corporation) created for the administration of public affairs. Unlike a private 
corporation it has no protection against legislative acts altering or even repealing its charter. 
Instrumentalities created by [the] state, formed and owned by it in [the] public interest, supported in 
whole or part by public funds, and governed by managers deriving their authority from [the] state. 
Sharon Realty Co. v. Westlake, Ohio Com.Pl., 188 N.E.2d 318, 323, 25, 0.0.2d 322. A public 
corporation is an instrumentality of the state, founded and owned in the public interest, supported by 
public funds and governed by those deriving their authority from the state. York County Fair Ass’n v. 
South Carolina Tax Commission, 249 S.C. 337, 154 S.E.2d 361, 362.
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and uncertainty of cash flows becomes the dominant interest of their creditors 
and other resource providers and profitability becomes an important indicator 
of performance. Consequently, the objectives of FASB Concepts Statement No.
1 [Objectives of Financial Reporting by Business Enterprises] may be more 
appropriate for those organizations. [Footnote reference omitted.]
1.04 The financial reporting for not-for-profit, business-oriented organi­
zations and investor-owned health care enterprises generally is consistent 
except for transactions that clearly are not applicable. For example, not-for- 
profit, business organizations would have nothing to report for shareholders’ 
equity. On the other hand, investor-owned health care enterprises typically 
would not have anything to report for contributions. Reporting for governmen­
tal health care organizations that use enterprise fund accounting and report­
ing also is consistent except for matters unique to governmental entities.
1.05 The basic financial statements of health care organizations generally 
consist of a balance sheet, a statement of operations, a statement of changes in 
equity (or net assets/fund balance), a statement of cash flows, and notes to the 
financial statements.3 The statement of operations for not-for-profit organiza­
tions should report a performance indicator (see paragraph 10.17) as well as all 
other changes in unrestricted net assets for the period. The statement of opera­
tions may be combined with the statement of changes in equity (net assets). 
Illustrative financial statements are included in the appendix A  of this Guide.
1.06 FASB Statement No. 1174 requires not-for-profit organizations to 
provide information about the liquidity of assets and liabilities in the balance 
sheet. Health care organizations should classify assets and liabilities as cur­
rent and noncurrent. However, rather than presenting a classified balance 
sheet, a continuing care retirement community (CCRC) instead may sequence 
assets according to their nearness of conversion to cash and may sequence 
liabilities according to the nearness of the maturity and resulting use of cash.
1.07 FASB Statement No. 95, Statement o f Cash Flows, and GASB State­
ment No. 9, Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds 
and Governmental Entities That Use Proprietary Fund Accounting, established 
standards for cash flow reporting for investor-owned organizations and govern­
mental entities, respectively. FASB Statement No. 95 was amended by FASB 
Statement No. 117 to include not-for-profit organizations. The statement of 
cash flows may be prepared using the direct or indirect method of reporting 
cash flows.
1.08 A  health care organization may be a part of another organization, such 
as a general-purpose government, a medical school or a university, or a subsidiary 
of a corporation. The recommendations in this Guide apply to the separate 
financial statements of these organizations as defined above. Therefore, when 
separate financial statements are prepared for a governmental health care organi­
zation that uses enterprise fund accounting and reporting, the accounting and 
disclosure requirements set forth by GASB pronouncements and this Guide apply. 
The requirements in this Guide presume that governmental health care organiza­
tions apply paragraph 7 of GASB Statement No. 20. (See footnote 1.)
3 The terms balance sheet and statement of operations indicate the content and purpose of the 
respective statements and serve as possible titles for those statements. Other appropriately descrip­
tive titles may also be used. For example, a statement reporting financial position could be called a 
statement of financial position as well as a balance sheet. Current practice and purpose suggest, 
however, that a statement of cash flows only be titled “Statement of Cash Flows.”
4 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1.)
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GASB Statement No. 34—New Financial Reporting 
Requirements for State and Local Governments, and 
Related Statements
1.09 GASB Statement No. 34, Basic Financial Statements—and Manage­
ment’s Discussion and Analysis—for State and Local Governments, was issued 
in June 1999. That Statement establishes a new financial reporting model for 
general-purpose governments and makes other changes to the financial report­
ing standards for state and local governments. GASB Statement No. 34 was 
amended by GASB Statement No. 35, Basic Financial Statements and Man­
agement’s Discussion and Analysis—for Public Colleges and Universities, to 
include public colleges and universities in the scope of GASB Statement No. 
34. GASB Statement No. 37, Basic Financial Statements—and Management’s 
Discussion and Analysis—for State and Local Governments: Omnibus, clarifies 
certain provisions of GASB Statement No. 34. GASB Statement No. 38, Certain 
Financial Statement Note Disclosures, modifies certain financial statement 
note disclosure requirements and adds new requirements.
1.10 Most of the governmental health care organizations included within 
the scope of this Guide are considered special-purpose governments engaged 
in business-type activities for purposes of applying GASB Statement No. 34. 
Because GASB Statement No. 34 is written from the perspective of general- 
purpose governments, paragraph 138 of GASB Statement No. 34 discusses how 
those requirements apply to special-purpose governments engaged only in 
business-type activities, such as certain governmental health care entities. 
Among its requirements, GASB Statement No. 34 requires that special-purpose 
governments that are engaged only in business-type activities should present 
financial statements required for enterprise funds, including required supple­
mentary information (RSI), which consist of:
•  Management’s Discussion and Analysis (MD&A)
•  Enterprise Fund Financial Statements, consisting of:
— Statement of net assets or balance sheet
— Statement of revenues, expenses, and changes in net assets
— Statement of cash flows
•  Notes to financial statements
•  RSI other than MD&A, if applicable
In addition, paragraph 94 of GASB Statement No. 34 states that enterprise 
funds may elect to apply all FASB Statements and Interpretations issued after 
November 30, 1989, except those that conflict with or contradict GASB pro­
nouncements, based on the provisions of paragraph 7 of GASB Statement No. 
20, as amended by GASB Statement No. 34.
1.11 GASB Statement No. 34 amends or supersedes various existing 
GASB and National Council on Governmental Accounting (NCGA) Statements 
and Interpretations, and the requirements of GASB Statement No. 34 are 
effective in three phases based on a government’s total annual revenues in the 
first fiscal year ending after June 15, 1999. Governments with total annual 
revenues (excluding extraordinary items) of $100 million or more (phase 1) 
should apply that Statement for periods beginning after June 15, 2001. Gov­
ernments with at least $10 million but less than $100 million in revenues 
(phase 2) should apply that Statement for periods beginning after June 15, 
2002. Governments with less than $10 million in revenues (phase 3) should 
apply that Statement for periods beginning after June 15, 2003. Earlier appli­
cation is encouraged. All component units should implement the requirements
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of GASB Statement No. 34 no later than the same year as their primary 
government, regardless of the amount of each component unit’s total revenues. 
I f  a primary government chooses early implementation of that Statement, all 
of its component units also should implement this standard early to provide 
the financial information required for the government-wide financial state­
ments. GASB Statement No. 38 generally has the same effective dates as 
GASB Statement No. 34 and its amendments. Simultaneous implementation 
of GASB Statement No. 34, as amended, and GASB Statement No. 38, how­
ever, is not required, and portions of GASB Statement No. 38 may be adopted 
before GASB Statement No. 34. Because of its effective dates, the provisions of 
GASB Statement No. 34 and related pronouncements are not yet effective for 
certain governmental entities, and have not been integrated into the chapters 
and the illustrative financial statements for a governmental hospital authority 
in appendix A  of this Guide, but are discussed in appendix F of this Guide. The 
chapters and the illustrative financial statements for a governmental hospital 
authority in appendix A  of this Guide will be modified in a future edition to 
conform to the requirements of GASB Statement No. 34 and related pro­
nouncements.
Revenue From Health Care Services
1.12 In general, gross service revenue is recorded in the accounting 
records on an accrual basis at the provider’s established rates, regardless of 
whether the health care organization expects to collect that amount. Provisions 
recognizing contractual adjustments and other adjustments (see examples in 
paragraph 5.02) are recorded on an accrual basis and deducted from gross 
service revenue to determine net service revenue. For financial reporting 
purposes, gross revenue does not include charity care (see discussion in para­
graph 10.03) and service revenue is reported net of contractual and other 
adjustments in the statement of operations. Accounting and auditing issues 
related to receivables and revenue from health care services are discussed in 
chapters 5 and 10.
1.13 In many cases, revenues are generated as a result of an agreement 
to provide health care rather than from the actual provision of services. For 
example, an integrated delivery system may agree to provide all health-related 
services for a specified group residing within its primary service area for an 
agreed-upon amount per member per month (PMPM). These revenues are 
premium revenues, not patient service revenues, since they are earned by 
agreeing to provide care, regardless of whether services actually are rendered.
Third-Party Payor Considerations
1.14 Some third-party payors retrospectively determine final amounts 
reimbursable for services rendered to their beneficiaries based on allowable 
costs. These payors reimburse the health care organization on the basis of 
interim payment rates until the retrospective determination of allowable costs 
can be made. In most instances, the accumulation and allocation of allowable 
costs and other factors result in final settlements different from the interim 
payment rates. Final settlements are determined after the close of the fiscal 
periods to which they apply and may affect materially the health care organi­
zation’s financial position and results of operations. Consequently, a reason­
able estimate of the amount receivable from or payable to these payors should 
be made in the same period that the related services are rendered. Accounting 
and auditing issues related to receivables from third parties are discussed in 
chapter 5.
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Classification and Reporting of Net Assets
1.15 Currently, many not-for-profit health care organizations use fund 
accounting for purposes of internal recordkeeping and managerial control. 
Many individual funds may be established by an organization to help in 
monitoring compliance with donor or grantor restrictions due to the fiduciary 
accountability associated with these resources. Each fund consists of a self- 
balancing group of accounts composed of assets, liabilities, and net assets. 
Consistent with FASB Concepts Statement No. 6, Elements o f Financial State­
ments, FASB Statement No. 117 concluded that although some not-for-profit 
organizations may choose to classify assets and liabilities into fund groups, 
information about those groupings is not a necessary part of general-purpose 
external financial reporting. Although FASB Statement No. 117 does not 
preclude not-for-profit organizations from using fund accounting for internal 
recordkeeping and reporting, for purposes of external financial reporting each 
of the individual internal funds must be classified into one or more of the three 
broad classes of net assets: unrestricted net assets, temporarily restricted net 
assets, and permanently restricted net assets. These classifications are related 
to the existence or absence of donor-imposed restrictions and are discussed in 
more detail in paragraphs 1.16 through 1.20 and also chapter 9.
1.16 Unrestricted Net Assets. These represent the part of net assets that 
have not been externally restricted for identified purposes by donors and 
grantors. Unrestricted net assets also include assets whose use is contractually 
limited, such as—
•  Proceeds of debt issues and funds of the health care organization 
deposited with a trustee and limited to use in accordance with the 
requirements of an indenture or a similar agreement. (See paragraph 
7.17.)
•  Other assets limited to use for identified purposes through an agree­
ment between the health care organization and an outside party other 
than a donor or grantor. Examples include assets set aside under debt 
agreements, assets set aside under self-insurance (risk-retention) 
funding arrangements, and assets set aside to meet statutory reserve 
requirements (such as those required under state law for many health 
maintenance organizations [HMOs]). (See paragraph 8.20.)
1.17 Information about significant contractual limits (for example, debt 
covenants and self-insurance trusts) generally is disclosed in the notes to the 
financial statements. Similarly, internally designated funds should be re­
ported separately from externally designated funds either on the face of the 
balance sheet or in the notes to the financial statements.
1.18 Temporarily Restricted and Permanently Restricted Net Assets. 
FASB Statement No. 117 defines two classes of donor-restricted net assets: 
temporarily restricted and permanently restricted. The distinction between 
these two types of restricted net assets is based on the nature of the donor’s 
restriction. Temporarily restricted net assets are those donor-restricted net 
assets that can be used by the not-for-profit organization for their specified 
purpose once the donor’s restriction is met. Generally, these restrictions are 
met either by the passage of time or by actions taken by the entity, such as use 
of the funds for the purpose intended. Permanently restricted net assets (for 
example, endowment funds) are those with donor restrictions that do not 
expire with the passage of time and cannot be removed by any actions taken 
by the entity. All donor-restricted net assets must be classified into one of these 
two broad categories for external reporting. Not-for-profit organizations may 
want to further classify temporarily and permanently restricted net assets into
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distinct groups that distinguish the nature or purpose of the donor’s restriction. 
Accounting and reporting considerations pertaining to gifts and grants that are 
externally restricted for identified purposes by donors and grantors are dis­
cussed in paragraphs 9.04 through 9.06 and 10.08 through 10.14.
1.19 It should be noted that donor restrictions generally relate to limita­
tions on the use of net assets rather than the use of specific assets. According 
to FASB Concepts Statement No. 6, paragraphs 101 and 102:
Restrictions impose responsibilities on management to ensure that the organi­
zation uses donated resources in the manner stipulated by resource providers. 
Sometimes donor-imposed restrictions limit an organization’s ability to sell or 
exchange the particular asset received. For example, a donor may give a 
painting to a museum stipulating that it must be publicly displayed, properly 
maintained, and never sold.
More commonly, donors’ stipulations permit the organization to pool the 
donated assets with other assets and to sell or exchange the donated assets for 
other suitable assets as long as the economic benefits of the donated assets are 
not consumed or used for a purpose that does not comply with the stipulation.
For example, a donor may contribute 100 shares of Security A  to an organiza­
tion’s endowment, thereby requiring that the amount of the gift be retained 
permanently but not requiring that the specified shares be held indefinitely. 
Thus, permanently restricted net assets and temporarily restricted net assets 
generally refer to amounts of net assets that are restricted by donor-imposed 
limits, not to specific assets.
1.20 A  not-for-profit organization can report separate line items within 
any of the three classes of net assets either on the face of the balance sheet or 
in the notes to the financial statements to further distinguish the nature of 
donor restrictions within that category of net assets. For example, a health care 
organization may want to disclose the amount of temporarily restricted net 
assets restricted for a specific purpose such as indigent care. Further examples 
are provided in paragraph 15 of FASB Statement No. 117. An organization’s 
internal fund accounting can be used to account for these different types of 
resources within a specific class of net assets.
Health Care Contracting
1.21 Contracts between a health care provider and a payor based on 
anything other than full charges requires the provider to accept some financial 
risk. The nature and degree of risk for the provider varies depending on the 
contract terms (for example, the definition of the unit of service or the basis for 
payment). In planning the audit of the health care provider, the auditor 
considers the audit risk associated with the entity’s health care contracts. For 
example, contracts with payments for services based on a discount from the 
provider’s established rates may have different risks than contracts with 
payments for services based on a capitated arrangement.
1.22 Generally, capitation payments are made at the beginning of each 
month and obligate the provider to render covered services during the month. 
Revenue is earned as a result of agreeing to provide services to qualified 
beneficiaries and not as a result of actually providing the care. I f  the provider’s 
accounting system records patient charges and establishes patient receivables 
as services are rendered, appropriate valuation allowances or adjustments 
should be recorded so only the amount of contract revenue is recorded.
1.23 A  capitation contract may obligate the provider to assume the risk of 
physician referrals and other outside services. In this case, a liability for 
unpaid claims, including incurred but not reported claims, should be estab­
lished. A  lag analysis may be helpful in estimating the liability.
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1.24 In addition to the capitation payments, the amount of contract 
revenue may be affected by factors such as reinsurance recoveries, deductibles, 
coinsurance, and risk pool adjustments. Risk pool adjustments may be based 
on factors such as utilization or cost targets.
1.25 Sometimes health care providers enter preferred provider arrange­
ments with self-insured employers whereby the provider guarantees that the 
employer’s health care cost will not increase over a specified amount or 
percentage. In substance, these providers may have provided aggregate stop­
loss insurance to the self-insured employer, and a material liability to the 
provider may exist. FASB Statement No. 5, Accounting for Contingencies, 
provides guidance on accounting for these contingencies. GASB Statement No. 
10, Accounting and Financial Reporting for Risk Financing and Related Insurance 
Issues, provides guidance on accounting for contingencies by governmental 
enterprises.
GAAP Hierarchy for Not-for-Profit Organizations
1.26 SAS No. 69 states that the guidance provided by FASB Statements 
and Interpretations, Opinions of the APB, and ARBs shall be considered 
established accounting principles pursuant to Rule 203 of the AICPA Code of 
Professional Conduct. (Appendix G [paragraph 1.48] of this chapter discusses 
SAS No. 69 and the hierarchy of sources of GAAP.)
1.27 Not-for-profit organizations should follow the guidance in effective 
provisions of ARBs, APB Opinions, and FASB Statements and Interpretations 
unless the specific pronouncement explicitly exempts not-for-profit organiza­
tions or their subject matter precludes such applicability. (As noted in para­
graphs 1.32 and 1.33, not-for-profit organizations should follow the guidance 
in FASB Statements No. 116, Accounting for Contributions Received and 
Contributions Made, No. 117, No. 124, Accounting for Certain Investments Held 
by Not-for-Profit Organizations, and No. 136, Transfers of Assets to a Not-for- 
Profit Organization or Charitable Trust That Raises or Holds Contributions for 
Others, and this Guide in applying the guidance in pronouncements listed in 
appendixes C and D [paragraphs 1.44 and 1.45] of this chapter.)
1.28 The appendixes [paragraphs 1.42 through 1.48] of this chapter are 
aids to the implementation of the guidance in this chapter.
1.29 Pronouncements issued by the FASB subsequent to this Guide’s 
effective date apply to not-for-profit organizations unless those pronounce­
ments explicitly exempt not-for-profit organizations or their subject matter 
precludes such applicability.5
1.30 Not-for-profit organizations may follow and are not prohibited from 
following the guidance in effective provisions of the APB Opinions and the 
FASB Statements and Interpretations listed in appendix A  [paragraph 1.42] of 
this chapter, which specifically exempt not-for-profit organizations from their 
application, unless FASB Statements No. 116 or No. 117 or this Guide provide 
different guidance. (However, the guidance included in the effective provisions 
of pronouncements listed in appendix A  [paragraph 1.42] applies to all for- 
profit entities owned, whether owned all or in part, by not-for-profit entities.)
5 The guidance in paragraphs 1.26 through 1.38 addresses only the pronouncements listed in 
paragraph 1.27. However, not-for-profit organizations are also subject to other pronouncements 
included in categories (b)-(d) of paragraph 5 of SAS No. 69 and should apply AICPA Audit and 
Accounting Guides, Statements of Position (SOPs), and Practice Bulletins and FASB Technical 
Bulletins and the consensus positions of the FASB Emerging Issues Task Force (EITF) that apply to 
them. (Appendix G [paragraph 1.48] of this chapter discusses SAS No. 69 and the GAAP hierarchy.)
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The discussion in paragraphs 1.32 through 1.38 should be considered in 
determining the hierarchy of such guidance and of guidance issued by the 
AICPA.
1.31 Certain financial reporting guidance listed in appendix B [para­
graph 1.43] of this chapter, such as that concerning common stock and convertible 
debt, generally does not apply to the kinds of not-for-profit entities covered by 
this Guide, because such entities do not enter into the kinds of transactions 
covered by that guidance. (However, the guidance included in the effective 
provisions of pronouncements included in appendix B [paragraph 1.43] applies 
to all for-profit entities owned, whether owned all or in part, by not-for-profit 
entities. Also, not-for-profit organizations should follow the effective provisions 
of pronouncements in appendix B [paragraph 1.43] if they enter into the kinds 
of transactions covered by that guidance.)
1.32 Other pronouncements, which are listed in appendix C [paragraph 1.44] 
of this chapter (ARB No. 51, Consolidated Financial Statements, and APB Opinion 
No. 29, Accounting for Nonmonetary Transactions), do not exempt not-for-profit 
organizations from their scope, but the transactions they contemplate also are 
covered by FASB Statement No. 116 and this Guide. FASB Statement Nos. 116, 
117, 124, and 136 and this Guide provide guidance for applying the pronounce­
ments to circumstances unique to not-for-profit organizations and not contem­
plated by the pronouncements and therefore should be followed to apply the 
guidance in those pronouncements to not-for-profit organizations. (However, the 
guidance included in the effective provisions of pronouncements included in 
appendix C [paragraph 1.44] should be followed by all for-profit entities owned, 
whether owned all or in part, by not-for-profit entities.)
1.33 Some pronouncements (listed in appendix D [paragraph 1.45] of this 
chapter), which may include guidance concerning the recognition and measure­
ment of assets, liabilities, revenues, expenses, gains and losses, and financial 
statement display, state that their provisions apply only to entities operating 
in certain industries. Such entities generally are business enterprises. An 
example of such guidance is FASB Statement No. 63, Financial Reporting by 
Broadcasters. However, some not-for-profit organizations conduct activities6 in 
some of those industries and should apply the guidance in the pronouncements 
concerning the recognition and measurement of assets, liabilities, revenues, 
expenses, and gains and losses to the transactions unique to those industries. 
However, such not-for-profit organizations should follow the financial state­
ment display guidance in FASB Statement No. 117 and this Guide, even 
though it may conflict with display that would result from applying the 
guidance in the pronouncements listed in appendix D [paragraph 1.45].
1.34 Financial reporting pronouncements that have not been superseded 
and are not included in appendixes A  through D [paragraphs 1.42 through 
1.45] of this chapter are listed in appendix E [paragraph 1.46] of this chapter. 
Not-for-profit organizations should follow the effective provisions of the pro­
nouncements listed in appendix E [paragraph 1.46].7
1.35 Certain other pronouncements, although they do not exempt not- 
for-profit organizations and do cover transactions conducted by not-for-profit 
organizations, include some provisions whose application by not-for-profit 
organizations may be unclear. Nevertheless, not-for-profit organizations are 
required to follow the effective provisions of those pronouncements. These 
provisions and their applicability are discussed below.
6 Such activities may be conducted by (a) for-profit entities owned and consolidated by not-for-profit 
organizations, (b) divisions of not-for-profit organizations, or (c) entire not-for-profit organizations.
7 See footnote 5.
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APB Opinion No. 16, Business Combinations*
1.36 Because the conditions for applying the pooling of interests method of 
accounting for a business combination generally include an exchange of common 
stock of the combining entities, not-for-profit organizations generally would not 
meet the conditions for applying that method. The AICPA Accounting Standards 
Executive Committee (AcSEC) believes that circumstances exist under which 
reporting on the combination of two or more not-for-profit organizations (or that of 
a not-for-profit organization with a formerly for-profit entity) by the pooling of 
interests method better reflects the substance of the transaction than reporting by 
the purchase method. Therefore, not-for-profit organizations are, under certain 
circumstances, permitted to report by the pooling of interests method, even though 
they generally do not issue common stock. Such circumstances include the combi­
nation of two or more entities to form a new entity without the exchange of 
consideration. See paragraph 11.37 for further guidance.
1.37 An example of acceptable practice, in some circumstances, for report­
ing business combinations by not-for-profit organizations if there has been no 
exchange of consideration is to report the (a) assets, (b) liabilities, and (c) net 
asset balances of the combined entities as of the beginning of the year and 
disclose the information that would be required to be disclosed for a pooling of 
interests under APB Opinion No. 16.
Provisions of Certain Pronouncements Concerning Financial 
Statement Display
1.38 The following pronouncements include provisions specifying the fi­
nancial statement display of certain financial statement elements or items 
such as gains and losses, extraordinary items, translation adjustments, income 
tax expense, and prepaid or deferred income taxes:
•  APB Opinion No. 9, Reporting the Results o f Operations
•  APB Opinion No. 26, Early Extinguishment o f Debt, as amended by 
APB Opinion No. 30, Reporting the Results of Operations—Reporting 
the Effects of Disposal o f a Segment of a Business, and Extraordinary, 
Unusual and Infrequently Occurring Events and Transactions; FASB 
Statement No. 4, Reporting Gains and Losses from Extinguishment of
* In June 2001, the FASB issued FASB Statement No. 141, Business Combinations, which 
supersedes several pronouncements including APB Opinion No. 16, Business Combinations. 
However, FASB Statement No. 141 does not apply to certain combinations, including a combination 
involving two or more not-for-profit organizations or the acquisition of a for-profit business entity by 
a not-for-profit organization. For those combinations, the guidance in APB Opinion No. 16 still 
applies. Thus, GAAP does not change for those types of combinations. Not-for-profit health care 
organizations should continue to follow the guidance in this Guide and in APB Opinion No. 16, as 
amended by pronouncements prior to the issuance of FASB Statement No. 141. Pronouncements that 
were amended by FASB Statement No. 141 should be applied by those entities as though that 
Statement had not amended them. In addition, in applying the guidance included in APB Opinion No. 
16, not-for-profit health care organizations should continue to apply the amendments to that Opinion 
that were included in FASB Statement No. 121, Accounting for the Impairment of Long-Lived Assets 
and for Long-Lived Assets to Be Disposed Of, even though FASB Statement No. 121 was superseded 
by FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets. (FASB 
Statement No. 144 did not carry forward those amendments to APB Opinion No. 16 because APB 
Opinion No. 16 had been superseded.) The FASB has on its agenda a project on accounting for 
combinations of not-for-profit organizations, the scope of which also will include the acquisition of a 
for-profit business entity by a not-for-profit organization. Readers should be alert to the issuance of a 
final standard. Also, FASB Statement No. 142, Goodwill and Other Intangible Assets, is not 
applicable to goodwill and other intangible assets arising from combinations between not-for-profit 
organizations or arising from the acquisition of a for-profit business entity by a not-for-profit 
organization until the FASB completes its deliberation with respect to application of the purchase 
method by those entities.
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Debt; (rescinded by FASB Statement No. 145, Rescission of FASB 
Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, 
and Technical Corrections) and FASB Statement No. 140, Accounting 
for Transfers and Servicing of Financial Assets and Extinguishments 
of Liabilities*
•  APB Opinion No. 30, as amended by FASB Statement No. 128, Earn­
ings per Share, FASB Statement No. 144, Accounting for the Impair­
ment or Disposal o f Long-Lived Assets, and FASB Statement No. 145*
•  FASB Statement No. 52, Foreign Currency Translation
•  FASB Statement No. 109, Accounting for Income Taxes
None of the preceding pronouncements considers the net asset reporting 
model included in FASB Statement No. 117 and this Guide. Therefore, 
preparers of financial statements of not-for-profit organizations should 
consider the reporting objectives of these APB Opinions and FASB State­
ments when exercising judgment about how to best display elements, such 
as in which net asset class.
GAAP Hierarchy for Governmental Organizations ***
1.39 SAS No. 69 provides that, for state or local governmental entities, 
officially established accounting principles consist of GASB Statements and 
Interpretations as well as AICPA and FASB pronouncements specifically made 
applicable to state and local governmental entities by GASB Statements or 
Interpretations. (Appendix G [paragraph 1.48] of this chapter discusses SAS 
No. 69 and the hierarchy of sources of GAAP for governmental entities.) GASB 
Statements No. 20 and No. 29, The Use o f Not-for-Profit Accounting and 
Financial Reporting Principles by Governmental Entities, provide guidance on 
the applicability of FASB and AICPA pronouncements to proprietary activities 
of government, such as governmental health care enterprises that use enter­
prise fund accounting and financial reporting. Footnote 1 of this chapter 
discusses the guidance in GASB Statement No. 20.
1.40 GASB Statement No. 29 provides that proprietary activities that 
apply the provisions of paragraph 7 of GASB Statement No. 20 should apply 
only those “new” (issued after November 30, 1989) FASB Statements and 
Interpretations that are developed for business enterprises, rather than those 
whose provisions are limited to not-for-profit organizations or address issues 
primarily concerning such organizations (such as FASB Statements No. 116, 
No. 117, No. 124, and No. 136).
* FASB Statement No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of 
FASB Statement No. 13, and Technical Corrections, among other matters, rescinds FASB Statement 
No. 4, Reporting Gains and Losses from Extinguishment of Debt, and amends APB Opinion No. 30, 
Reporting the Results of Operations—Reporting the Effects of Disposal of a Segment of a Business, and 
Extraordinary, Unusual and Infrequently Occurring Events and Transactions, to reflect the rescission 
and to make technical corrections. The provisions of FASB Statement No. 145 related to the 
rescission of FASB Statement No. 4 shall be applied in fiscal years beginning after May 15, 2002, with 
early application encouraged. The FASB Statement No. 145 technical corrections are effective for 
financial statements issued on or after May 15, 2002, with early application encouraged.
** FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, is 
effective for financial statements issued for fiscal years beginning after December 15, 2001, and 
interim periods within those fiscal years, with early application encouraged.
*** Governmental health care entities that are required to adopt, or that have elected early 
implementation of GASB Statement No. 34 and related pronouncements should refer to appendix F 
to this Guide.
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1.41 Paragraph 33 in the “Basis for Conclusions” of GASB Statement No. 
20 also provides that AICPA pronouncements issued after November 30, 1989 
and not specifically made applicable to governmental entities should be applied 
using the same logic used in the application of FASB standards. That is, AICPA 
pronouncements that do not conflict with or contradict GASB pronouncements 
should be applied on an “all or none” basis and constitute level “b” in the GAAP 
hierarchy. (See appendix G [paragraph 1.48] of this chapter.) Many of the 
AICPA pronouncements issued after November 30, 1989 provide guidance on 
specialized industries, including this Guide. However, users of this Guide 
should note the provisions of SOP 94-6, Disclosure of Certain Significant Risks 
and Uncertainties, discussed in paragraph 8.30 of this Guide.
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Appendix A—Financial Reporting Pronouncements 
That Specifically Exempt Not-for-Profit Organizations 
From Their Application
Note regarding effective dates of pronouncements and the applicability of
FASB Statement No. 141, Business Combinations, and FASB Statement No.
142, Goodwill and Other Intangible Assets:
•  FASB Statement No. 141, among other matters, amends APB Opinion 
No. 28 and FASB Statement No. 128. FASB Statement No. 141 applies 
to business combinations initiated after June 30, 2001 and prescribes 
the use of the purchase method for those business combinations. FASB 
Statement No. 141, however, does not apply to certain combinations, 
including a combination involving two or more not-for-profit organiza­
tions, or the acquisition of a for-profit business entity by a not-for-profit 
organization. For those combinations, pronouncements that are 
amended by FASB Statement No. 141 should be applied as though FASB 
Statement No. 141 had not amended them, and this appendix does not 
reflect those amendments.
•  The provisions of FASB Statement No. 142 shall be applied in fiscal years 
beginning after December 15, 2001, to all goodwill and other intangible 
assets recognized in an entity’s statement of financial position at the 
beginning of that fiscal year. Early application is permitted in certain 
circumstances. Certain provisions of FASB Statement No. 142 shall be 
applied to goodwill and other acquired intangible assets for which the 
acquisition date is after June 30, 2001, even if  an entity has not adopted 
FASB Statement No. 142 in its entirety. The provisions of FASB 
Statement No. 141 and FASB Statement No. 142 should not be applied 
to goodwill and intangible assets arising from a combination between 
two or more not-for-profit organizations or acquired in the acquisition of 
a for-profit business entity by a not-for-profit organization until the 
FASB completes its project on those types of combinations and 
acquisitions. Thus, the guidance in APB Opinion Nos. 16 and 17 remains 
in effect for such assets. In addition, when applying APB Opinion Nos.
16 and 17, not-for-profit organizations should continue to apply the 
amendments to those Opinions found in other literature even though 
that other literature may have been superseded by FASB Statement 
Nos. 141, 142, and 144. For example, when applying APB Opinion No.
17, not-for-profit organizations should continue to apply the amend­
ments to that Opinion found in FASB Statement No. 121, even though 
that Statement was superseded by FASB Statement No. 144. Readers 
should be alert to the issuance of a final Standard on combinations of 
not-for-profit organizations.
•  FASB Statement No. 144, Accounting for the Impairment or Disposal of 
Long-Lived Assets, is effective for financial statements issued for fiscal 
years beginning after December 15, 2001, and interim periods within 
those fiscal years, with early application encouraged.
(continued)
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•  FASB Statement No. 145, Rescission of FASB Statements No. 4, 44, and 
64, Amendment of FASB Statement No. 13, and Technical Corrections, 
among other matters, amends certain pronouncements, including APB 
Opinion No. 28, and FASB Statement Nos. 115, 128, and 141, to make 
technical corrections. These technical corrections are effective for finan­
cial statements issued on or after May 15, 2002, with early application 
encouraged.
•  FASB Statement No. 147, Acquisitions o f Certain Financial Institutions. 
The provisions of paragraph 5 are effective for acquisitions for which the 
date of acquisition is on or after October 1, 2002. The provisions of 
paragraph 6 are effective on October 1, 2002. Transition provisions for 
previously recognized unidentifiable intangible assets in paragraphs 8 
through 14 are effective October 1, 2002, with earlier application 
permitted.
•  FASB Statement No. 148, Accounting for Stock-Based Compensation— 
Transition and Disclosure. The amendment to APB Opinion No. 28 is 
effective for financial reports containing condensed financial statements 
for interim periods beginning after December 15, 2002. Early application 
is encouraged.________________________________________________________
Other References, if Any * Status of Other References______ Pronouncement_______
APB Opinion 18, The Equity 
Method of Accounting for 
Investments in Common 
Stock, as amended by APB  
Opinions 23 and 30 and 
FASB Statement Nos. 13, 58, 
94, 115, 128, 142, and 144, 
and including FASB Interpre­
tation No. 35CON
APB Opinion 28, Interim 
Financial Reporting, as 
amended by FASB Statement 
Nos. 3, 95, 109, 128, 130, 131, 
135, 144, 145, and 148, and 
including FASB Interpreta­
tion No, 18**
FASB Statement No. 3, 
Reporting Accounting 
Changes in Interim Financial 
Statements, as amended by 
FASB Statement No. 135
FASB Statement No. 89, 
Financial Reporting and 
Changing Prices, as amended 
by FASB Statement Nos.
109, 135, and 139
FASB Statement No. 115, 
Accounting for Certain Invest­
ments in Debt and Equity 
Securities, as amended by 
FASB Statement Nos. 124, 
130, 133, 134, 135, 140, 144, 
and 145
This Guide
None
None
None
FASB Statement No. 124, 
Accounting for Certain 
Investments Held by Not-for- 
Profit Organizations; 
Chapter 4 of this Guide
Chapter 11 of this Guide 
provides guidance concerning 
the equity method of 
accounting for investments 
in common stock
None
None
None
Currently effective
(continued)
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FASB Statement No. 128, None None
Earnings per Share, as 
amended by FASB State­
ment Nos. 135, and 145
FASB Statement No. 130, 
Reporting Comprehensive 
Income, as amended by 
FASB Statement No. 135
FASB Statement No. 131, 
Disclosures about Segments 
of an Enterprise and Related 
Information, as amended by 
FASB Statement No. 135
FASB Statement No. 141, 
Business Combinations, as 
amended by FASB State­
ment Nos. 144, 145, and 147
FASB Interpretation No. 18, 
Accounting for Income Taxes 
in Interim Periods, as 
amended by FASB State­
ment Nos. 71, 109, 111, 135, 
and 144
FASB Interpretation No. 35, 
Criteria for Applying the 
Equity Method of Accounting 
for Investments in Common 
Stock
FASB Statement No. 117
None
Chapter 1 and chapter 11 of 
this Guide
None
Currently effective
None
Currently effective
None
See APB Opinion 18 See APB Opinion 18
* References in this column are provided as a guide to other sources of information about the 
topic covered by the listed pronouncement.
CON On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1—3 and 5 of ARB No. 51, add a sentence to endnote 3 of ARB No. 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65. In July 2002, the FASB released an 
exposure draft of a proposed Interpretation, Consolidation of Certain Special-Purpose Entities, which 
would provide guidance for certain specific situations. After completing its deliberations relating to 
the specific situations, the FASB then will continue its consideration of the broader proposals in the 
1999 exposure draft.
** In June 2001, the FASB released an exposure draft of a proposed FASB Statement, Account­
ing in Interim and Annual Financial Statements for Certain Costs and Activities Related to Property, 
Plant, and Equipment, which among other matters, would amend APB Opinion No. 28, Interim 
Financial Reporting. Readers should be alert to the issuance of a final Standard.
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Appendix B—Financial Reporting Pronouncements 
That, by the Nature of Their Subject Matter, Generally 
Do Not Apply to Not-for-Profit Organizations
Note regarding effective dates of pronouncements and the applicability of 
FASB Statement No. 141, Business Combinations:
•  FASB Statement No. 141, an amendment of FASB Statement No. 123, 
applies to business combinations initiated after June 30, 2001, and 
prescribes the use of the purchase method for those combinations. FASB 
Statement No. 141, however, does not apply to certain combinations, 
including a combination involving two or more not-for-profit organiza­
tions, or the acquisition of a for-profit business entity by a not-for-profit 
organization.
•  FASB Statement No. 144, Accounting for the Impairment or Disposal o f 
Long-Lived Assets, an amendment of FASB Statement No. 123, is 
effective for financial statements issued for fiscal years beginning after 
December 15, 2001, and interim periods within those fiscal years, with 
early application encouraged.
•  FASB Statement No. 148, Accounting for Stock-Based Compensation— 
Transition and Disclosure. The transition guidance and annual disclo­
sure provisions are effective for fiscal years ending after December 15, 
2002, with earlier application permitted in certain circumstances. The 
interim disclosure provisions are effective for financial reports contain­
ing financial statements for interim periods beginning after December 
15, 2002.
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•  APB Opinion 14, Accounting for Convertible Debt and Debt Issued with 
Stock Purchase Warrants
•  APB Opinion 25, Accounting for Stock Issued to Employees, as 
amended by FASB Statement Nos. 109 and 123, and including FASB 
Interpretation Nos. 28, 38, and 44
•  FASB Statement No. 84, Induced Conversions of Convertible Debt
•  FASB Statement No. 123, Accounting for Stock-Based Compensation, 
as amended by FASB Statement Nos. 128, 135, 141, 144, and 148
•  FASB Statement No. 148, Accounting for Stock-Based Compensation— 
Transition and Disclosure
•  FASB Interpretation No. 28, Accounting for Stock Appreciation Rights 
and Other Variable Stock Option or Award Plans, as amended by 
FASB Statement Nos. 123 and 128
•  FASB Interpretation No. 38, Determining the Measurement Date for 
Stock Option, Purchase, and Award Plans Involving Junior Stock, as 
amended by FASB Statement Nos. 123 and 128
•  FASB Interpretation No. 44, Accounting for Certain Transactions 
involving Stock Compensation, as amended by FASB Statement No. 
141
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Whose Application to Not-for-Profit Organizations is 
Subject to Additional FASB or AICPA Guidance
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Note regarding effective dates of pronouncements and the applicability of 
FASB Statement No. 141, Business Combinations:
•  FASB Statement No. 141, among other matters, amends APB Opinion 
No. 29. FASB Statement No. 141 applies to business combinations 
initiated after June 30, 2001 and prescribes the use of the purchase 
method for those business combinations. FASB Statement No. 141, 
however, does not apply to certain combinations, including a combina­
tion involving two or more not-for-profit organizations, or the acquisition 
of a for-profit business entity by a not-for-profit organization. For those 
combinations, pronouncements that are amended by FASB Statement 
No. 141 should be applied as though FASB Statement No. 141 had not 
amended them, and this appendix does not reflect those amendments.
•  FASB Statement No. 144, Accounting for the Impairment or Disposal of 
Long-Lived Assets, is effective for financial statements issued for fiscal 
years beginning after December 15, 2001, and interim periods within 
those fiscal years, with early application encouraged.__________________
Pronouncement Additional Guidance
ARB No. 51, Consolidated Financial 
Statements, as amended by APB Opin­
ions 10, 16, 18, and 23, and FASB State­
ment Nos. 58, 71, 94, 111, 131, and 
144CON
APB Opinion 29, Accounting for Non­
monetary Transactions, as amended by 
FASB Statement Nos. 71, 109, 123, and 144, 
and including FASB Interpretation No. 
30
FASB Statement No. 94, Consolida­
tion o f A ll Majority-Owned Subsidiar­
ies, as amended by FASB Statement 
No. 131 CON
FASB Statement No. 116, Accounting 
for Contributions Received and Con­
tributions Made
This Guide
FASB Statement No. 116 and chap­
ters 5 and 10 of this Guide provide 
accounting guidance for contributions
See ARB No. 51
FASB Statement No. 136, this 
Guide and the AICPA Audit and 
Accounting Guide Not-for-Profit 
Organizations
(continued)
CON On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1-3 and 5 of ARB No. 51, add a sentence to endnote 3 of ARB No. 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65. In July 2002, the FASB released an 
exposure draft of a proposed Interpretation, Consolidation of Certain Special-Purpose Entities, which 
would provide guidance for certain specific situations. After completing its deliberations relating to 
the specific situations, the FASB then will continue its consideration of the broader proposals in the 
1999 exposure draft.
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Pronouncement Additional Guidance
Health Care Organizations
FASB Statement No. 117, Financial 
Statements o f Not-for-Profit Organiza­
tions, as amended by FASB Statement 
Nos. 124, and 144
FASB Statement No. 124, Accounting 
for Certain Investments Held by Not- 
for-Profit Organizations, as amended 
by FASB Statement No. 133, Account­
ing for Derivative Instruments and 
Hedging Activities, as amended by 
FASB Statement No. 138, Accounting 
for Certain Derivative Instruments 
and Certain Hedging Activities
FASB Statement No. 136, Transfers o f 
Assets to a Not-for-Profit Organization 
or Charitable Trust That Raises or 
Holds Contributions for Others, as 
amended by FASB Statement No. 140
FASB Interpretation No. 30, Accounting 
for Involuntary Conversions o f Non­
monetary Assets to Monetary Assets, as 
amended by FASB Statement No. 109
This Guide
This Guide
This Guide and the AICPA Audit and 
Accounting Guide Not-for-Profit Or­
ganizations
See APB Opinion 29
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Appendix D—Financial Reporting Pronouncements 
Pertaining to Specialized Industry Practices of 
Business Enterprises
Note regarding effective dates of pronouncements and the applicability of
FASB Statement No. 141, Business Combinations, and FASB Statement No.
142, Goodwill and Other Intangible Assets:
•  FASB Statement No. 141, among other matters, amends FASB 
Statement Nos. 44, 45, and 72 and FASB Interpretation No. 9. FASB 
Statement No. 141 applies to business combinations initiated after June 
30, 2001 and prescribes the use of the purchase method for those 
business combinations. FASB Statement No. 141, however, does not 
apply to certain combinations, including a combination involving two or 
more not-for-profit organizations, or the acquisition of a for-profit 
business entity by a not-for-profit organization. For those combinations, 
pronouncements that are amended by FASB Statement No. 141 should 
be applied as though FASB Statement No. 141 had not amended them, 
and this appendix does not reflect those amendments.
•  The provisions of FASB Statement No. 142 shall be applied in fiscal years 
beginning after December 15, 2001, to all goodwill and other intangible 
assets recognized in an entity’s statement of financial position at the 
beginning of that fiscal year. Early application is permitted in certain 
circumstances. Certain provisions of FASB Statement No. 142 shall be 
applied to goodwill and other acquired intangible assets for which the 
acquisition date is after June 30, 2001, even if  an entity has not adopted 
FASB Statement No. 142 in its entirety. The provisions of FASB 
Statement No. 141 and FASB Statement No. 142 should not be applied 
to goodwill and intangible assets arising from a combination between 
two or more not-for-profit organizations or acquired in the acquisition of 
a for-profit business entity by a not-for-profit organization until the 
FASB completes its project on those types of combinations and 
acquisitions. Thus, the guidance in APB Opinion Nos. 16 and 17 remains 
in effect for such assets. In addition, when applying APB Opinion Nos.
16 and 17, not-for-profit organizations should continue to apply the 
amendments to those Opinions found in other literature even though 
that other literature may have been superseded by FASB Statement 
Nos. 141, 142, and 144. For example, when applying APB Opinion No.
17, not-for-profit organizations should continue to apply the 
amendments to that Opinion found in FASB Statement No. 121, even 
though that Statement was superseded by FASB Statement No. 144. 
Readers should be alert to the issuance of a final Standard on 
combinations of not-for-profit organizations.
•  FASB Statement No. 143, Accounting for Asset Retirement Obligations, 
is effective for financial statements issued for fiscal years beginning after 
June 15, 2002, with earlier application encouraged.
•  FASB Statement No. 144, Accounting for the Impairment or Disposal of 
Long-Lived Assets, is effective for financial statements issued for fiscal 
years beginning after December 15, 2001, and interim periods within 
those fiscal years, with early application encouraged.
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•  FASB Statement No. 145, Rescission of FASB Statements No. 4, 44, and 
64, Amendment o f FASB Statement No. 13, and Technical Corrections, 
among other matters, rescinds FASB Statement No. 44, and amends 
certain pronouncements, including FASB Statement Nos. 19 and 60, to 
make technical corrections. The rescission of FASB Statement No. 44 
and these technical corrections are effective for financial statements 
issued on or after May 15, 2002, with early application encouraged.
•  FASB Statement No. 147, Acquisitions o f Certain Financial Institutions. 
The provisions of paragraph 5 are effective for acquisitions for which the 
date of acquisition is on or after October 1, 2002. The provisions of 
paragraph 6 are effective on October 1, 2002. Transition provisions for 
previously recognized unidentifiable intangible assets in paragraphs 8 
through 14 are effective October 1, 2002, with earlier application 
permitted.
This appendix includes pronouncements that apply only to entities operating 
in certain industries, generally business enterprises. However, some not-for- 
profit organizations conduct activities in some of those industries and should 
apply the guidance concerning recognition and measurement of assets, liabili­
ties, revenues, expenses, and gains and losses in those pronouncements to the 
transactions unique to those industries. In addition, those not-for-profit organi­
zations should follow the financial statement display guidance in FASB State­
ment No. 117, Financial Statements o f Not-for-Profit Organizations, and this 
Guide, although it may conflict with display that would result from applying 
the guidance in the pronouncements included in this appendix.
•  APB Opinion 12, Omnibus Opinion—1967 (guidance under the head­
ing “Capital Changes”)
•  APB Opinion 13, Amending Paragraph 6 o f APB Opinion No. 9, 
Application to Commercial Banks
•  FASB Statement No. 7, Accounting and Reporting by Development 
Stage Enterprises, as amended by FASB Statement Nos. 71 and 95, 
and including FASB Interpretation No. 7
•  FASB Statement No. 19, Financial Accounting and Reporting by Oil 
and Gas Producing Companies, as amended by FASB Statement Nos.
25, 69, 71, 109, 143, 144, and 145, and including FASB Interpretation 
Nos. 33 and 36
•  FASB Statement No. 25, Suspension o f Certain Accounting Require­
ments for Oil and Gas Producing Companies (an amendment o f FASB 
Statement No. 19), as amended by FASB Statement No. 111
•  FASB Statement No. 35, Accounting and Reporting by Defined Benefit 
Pension Plans, as amended by FASB Statement Nos. 75, 110, and 135
•  FASB Statement No. 44, Accounting for Intangible Assets o f Motor 
Carriers (an amendment o f Chapter 5 of ARB No. 43 and an Interpre­
tation o f APB Opinions 17 and 30), as amended by FASB Statement 
Nos. 109, and 142 (FASB Statement No. 44 was rescinded by FASB 
Statement No. 145)
•  FASB Statement No. 45, Accounting for Franchise Fee Revenue
•  FASB Statement No. 50, Financial Reporting in the Record and Music 
Industry
•  FASB Statement No. 51, Financial Reporting by Cable Television 
Companies, as amended by FASB Statement Nos. 71, 131, 142, and 
144*
AAG-HCO 1.45
Unique Considerations of Health Care Organizations 21
•  FASB Statement No. 60, Accounting and Reporting by Insurance 
Enterprises, as amended by FASB Statement Nos. 91, 97, 109, 113, 
114, 115, 120, 124, 133, 135, 144, and 145, and including FASB 
Interpretation No. 40
•  FASB Statement No. 61, Accounting for Title Plant, as amended by 
FASB Statement No. 144
•  FASB Statement No. 63, Financial Reporting by Broadcasters, as 
amended by FASB Statement No. 139
•  FASB Statement No. 65, Accounting for Certain Mortgage Banking 
Activities, as amended by FASB Statement Nos. 91, 115, 124, 133, 134, 
and 140CON
•  FASB Statement No. 67, Accounting for Costs and Initial Rental 
Operations o f Real Estate Projects, as amended by FASB Statement 
Nos. 111 and 144*
•  FASB Statement No. 69, Disclosures about Oil and Gas Producing 
Activities (an amendment of FASB Statements 19, 25, 33, and 39), as 
amended by FASB Statement Nos. 89, 95, 109, and 131
•  FASB Statement No. 71, Accounting for the Effects of Certain Types of 
Regulation, as amended by FASB Statement Nos. 90, 92, 109, 135, 142, 
and 144
•  FASB Statement No. 72, Accounting for Certain Acquisitions of Banking 
or Thrift Institutions (an amendment of APB Opinion No. 17, an interpre­
tation of APB Opinions 16 and 17, and an amendment of FASB Interpre­
tation No. 9), as amended by FASB Statement Nos. 142 and 147
•  FASB Statement No. 73, Reporting a Change in Accounting for Rail­
road Track Structures (an amendment of APB Opinion No. 20)
•  FASB Statement No. 90, Regulated Enterprises—Accounting for Aban­
donments and Disallowances o f Plant Costs (an amendment of FASB 
Statement No. 71), as amended by FASB Statement Nos. 92 and 109
•  FASB Statement No. 91, Accounting for Nonrefundable Fees and Costs 
Associated with Originating or Acquiring Loans and Initial Direct 
Costs o f Leases (an amendment of FASB Statements No. 13, 60, and 
65 and a rescission of FASB Statement No. 17), as amended by FASB 
Statement Nos. 98, 114, 115, and 124
•  FASB Statement No. 92, Regulated Enterprises—Accounting for 
Phase-in Plans (an amendment o f FASB Statement No. 71)
•  FASB Statement No. 97, Accounting and Reporting by Insurance 
Enterprises for Certain Long-Duration Contracts and for Realized 
Gains and Losses from the Sale o f Investments, as amended by FASB 
Statement Nos. 113, 115, and 120
•  FASB Statement No. 101, Regulated Enterprises—Accounting for the 
Discontinuation o f Application of FASB Statement No. 71, as amended 
by FASB Statement Nos. 109 and 144
•  FASB Statement No. 110, Reporting by Defined Benefit Pension Plans 
of Investment Contracts (an amendment o f FASB Statement No. 35)
•  FASB Statement No. 113, Accounting and Reporting for Reinsurance 
of Short-Duration and Long-Duration Contracts, as amended by FASB 
Statement Nos. 120 and 133, and including FASB Interpretation No. 40
•  FASB Statement No. 120, Accounting and Reporting by Mutual Life 
Insurance Enterprises and by Insurance Enterprises for Certain Long- 
Duration Participating Contracts (an amendment of FASB Statement 
Nos. 60, 97, and 113 and Interpretation No. 40)
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•  FASB Statement No. 134, Accounting for Mortgage-Backed Securities 
Retained after the Securitization o f Mortgage Loans Held for Sale by a 
Mortgage Banking Enterprise (an amendment o f FASB Statement 
No. 65)
•  FASB Statement No. 139, Rescission of FASB Statement No. 53 and 
amendments to FASB Statements No. 63, 89, and 121
•  FASB Statement No. 147, Acquisitions o f Certain Financial Institu­
tions
•  FASB Interpretation No. 7, Applying FASB Statement No. 7 in Finan­
cial Statements o f Established Operating Enterprises
•  FASB Interpretation No. 9, Applying APB Opinions No. 16 and 17 
When a Savings and Loan Association or a Similar Institution Is 
Acquired in a Business Combination Accounted for by the Purchase 
Method, as amended by FASB Statement Nos. 72, 142, and 147
•  FASB Interpretation No. 33, Applying FASB Statement No. 34 to Oil 
and Gas Producing Operations Accounted for by the Full Cost Method
•  FASB Interpretation No. 36, Accounting for Exploratory Wells in 
Progress at the End o f a Period
•  FASB Interpretation No. 40, Applicability of Generally Accepted Ac­
counting Principles to Mutual Life Insurance and Other Enterprises, 
as amended by FASB Statement Nos. 115, 120, and 135
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CON On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1—3 and 5 of ARB No. 51, add a sentence to endnote 3 of ARB No. 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65. In July 2002, the FASB released an 
exposure draft of a proposed Interpretation, Consolidation of Certain Special-Purpose Entities, which 
would provide guidance for certain specific situations. After completing its deliberations relating to 
the specific situations, the FASB then will continue its consideration of the broader proposals in the 
1999 exposure draft.
* In June 2001, the FASB released an exposure draft of a proposed FASB Statement, Accounting 
in Interim and Annual Financial Statements for Certain Costs and Activities Related to Property, 
Plant, and Equipment, which among other matters, would amend FASB Statement No. 51, Financial 
Reporting by Cable Television Companies, and FASB Statement No. 67, Accounting for Costs and 
Initial Rental Operations of Real Estate Projects, and rescind FASB Statement No. 73, Reporting a 
Change in Accounting for Railroad Track Structures. Readers should be alert to the issuance of a final 
Standard.
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Appendix E—Financial Reporting Pronouncements 
Not Subsequently Superseded and Not Included 
in Appendixes A through D of This Chapter
Note regarding effective dates of pronouncements and the applicability of
FASB Statement No. 141, Business Combinations, and FASB Statement No.
142, Goodwill and Other Intangible Assets:
•  FASB Statement No. 141, among other matters, supersedes APB 
Opinion No. 16 and FASB Statement Nos. 10, 38, and 79; and amends 
APB Opinion Nos. 20 and 30, FASB Statement Nos. 15, 16, 68, 87, 95,
106, 109, and 133 and FASB Interpretation Nos. 4 and 21. (The amend­
ment of FASB Statement No. 68 was subsequently deleted by the 
technical corrections in FASB Statement No. 145). FASB Statement No.
141 applies to business combinations initiated after June 30, 2001 and 
prescribes the use of the purchase method for those business combina­
tions. FASB Statement No. 141, however, does not apply to certain 
combinations, including a combination involving two or more not-for- 
profit organizations, or the acquisition of a for-profit business entity by 
a not-for-profit organization. For those combinations, pronouncements 
that are superseded or amended by FASB Statement No. 141 should be 
applied as though FASB Statement No. 141 had not superseded or 
amended them, and this appendix does not reflect those amendments or 
supersessions.
•  The provisions of FASB Statement No. 142 shall be applied in fiscal years 
beginning after December 15, 2001, to all goodwill and other intangible 
assets recognized in an entity’s statement of financial position at the 
beginning of that fiscal year. Early application is permitted in certain 
circumstances. Certain provisions of FASB Statement No. 142 shall be 
applied to goodwill and other acquired intangible assets for which the 
acquisition date is after June 30, 2001, even if  an entity has not adopted 
FASB Statement No. 142 in its entirety. The provisions of FASB 
Statement No. 141 and FASB Statement No. 142 should not be applied 
to goodwill and intangible assets arising from a combination between 
two or more not-for-profit organizations or acquired in the acquisition of 
a for-profit business entity by a not-for-profit organization until the 
FASB completes its project on those types of combinations and 
acquisitions. Thus, the guidance in APB Opinion Nos. 16 and 17 remains 
in effect for such assets. In addition, when applying APB Opinion Nos.
16 and 17, not-for-profit organizations should continue to apply the 
amendments to those Opinions found in other literature even though 
that other literature may have been superseded by FASB Statement 
Nos. 141, 142, and 144. For example, when applying APB Opinion No.
17, not-for-profit organizations should continue to apply the 
amendments to that Opinion found in FASB Statement No. 121 even 
though that Statement was superseded by FASB Statement No. 144. 
Readers should be alert to the issuance of a final Standard on 
combinations of not-for-profit organizations.
•  FASB Statement No. 143, Accounting for Asset Retirement Obligations, 
is effective for financial statements issued for fiscal years beginning after 
June 15, 2002, with earlier application encouraged.____________________
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•  FASB Statement No. 144, Accounting for the Impairment or Disposal of 
Long-Lived Assets, among other matters, supersedes FASB Statement 
No. 121 and is effective for financial statements issued for fiscal years 
beginning after December 15, 2001, and interim periods within those 
fiscal years, with early application encouraged.
•  The provisions of FASB Statement No. 145, Rescission o f FASB 
Statements No. 4, 44, and 64, Amendment o f FASB Statement No. 13, 
and Technical Corrections, related to the rescission of FASB Statement 
No. 4 shall be applied in fiscal years beginning after May 15, 2002, with 
early application encouraged. The provisions in paragraphs 8 and 9(c) of 
FASB Statement No. 145 related to the amendment of FASB Statement 
No. 13 are effective for transactions occurring after May 15, 2002, with 
early application encouraged. All other provisions are effective for 
financial statements issued on or after May 15, 2002, with early 
application encouraged.
•  FASB Statement No. 146, Accounting for Costs Associated With Exit or 
Disposal Activities, is effective for exit or disposal activities initiated 
after December 31, 2002. Early application is encouraged.
•  FASB Statement No. 147, Acquisitions of Certain Financial Institutions. 
The provisions of paragraph 5 are effective for acquisitions for which the 
date of acquisition is on or after October 1, 2002. The provisions of 
paragraph 6 are effective on October 1, 2002. Transition provisions for 
previously recognized unidentifiable intangible assets in paragraphs 8 
through 14 are effective October 1, 2002, with earlier application 
permitted.
•  FASB Interpretation No. 45, Guarantor’s Accounting and Disclosure 
Requirements for Guarantees, Including Indirect Guarantees o f  
Indebtedness o f Others. Initial recognition and initial measurement 
provisions apply on a prospective basis to guarantees issued or modified 
after December 31, 2002, irrespective of the guarantor’s fiscal year-end. 
The disclosure requirements are effective for financial statements of 
interim or annual periods ending after December 15, 2002.
As stated in paragraph 1.27 of this Guide, not-for-profit organizations should 
follow the guidance in effective provisions of ARBs, APB Opinions, and FASB 
Statements and Interpretations, except for specific pronouncements that ex­
plicitly exempt not-for-profit organizations and pronouncements for which this 
Guide provides guidance. This appendix includes pronouncements, not sub­
sequently superseded, that (a) do not exempt not-for-profit organizations from 
their application, (b) by the nature of their subject matter, apply to the kinds 
of transactions not-for-profit organizations engage in, (c) are subject to no 
additional FASB or AICPA guidance, and (d) do not pertain to specialized 
industry practices of business enterprises. Not-for-profit organizations should 
follow the guidance in the effective provisions of the pronouncements included 
in this appendix.
•  ARB No. 43, Restatement and Revision o f Accounting Research Bulle­
tins, as amended by APB Opinions (FASB Statement No. 44 is re­
scinded by FASB Statement No. 145), 6, 9, 10, 16, 17, 20, 21, 25, and
26, and FASB Statement Nos. 5, 6, 44, 52, 78, 94, 109, 111, 115, 123,
131, 133, 135, and 142
•  ARB No. 45, Long-Term Construction-Type Contracts
AAG-HCO 1.46
Unique Considerations of Health Care Organizations 25
•  ARB No. 46, Discontinuance o f Dating Earned Surplus
•  APB Opinion 2, Accounting for the “Investment Credit,” as amended 
by APB Opinion 4 and FASB Statement Nos. 71 and 109
•  APB Opinion 4 (amending Opinion 2), Accounting for the “Investment 
Credit”
•  APB Opinion 6, Status o f Accounting Research Bulletins, as amended 
by APB Opinions 16, 17, and 26, and FASB Statement Nos. 52, 71, 
109, 111, and 135
•  APB Opinion 9, Reporting the Results o f Operations (paragraph 1.38 
of this Guide discusses this pronouncement), as amended by APB 
Opinions 13, 15, 20, and 30, and FASB Statement No. 16
•  APB Opinion 10, Omnibus Opinion—1966, as amended by APB Opin­
ions 12, 14, 16, and 18, and FASB Statement Nos. 111 and 129, and 
including FASB Interpretation Nos. 39 and 41
•  APB Opinion 12, Omnibus Opinion—1967 (except guidance under the 
heading, “Capital Changes”), as amended by APB Opinion 14 and 
FASB Statement Nos. 87, 106, and 111
•  APB Opinion 16, Business Combinations (paragraph 1.36 of this Guide 
discusses this pronouncement), as amended by FASB Statement Nos. 
10, 38, 71, 79, 87, 106, 109, 121, and 135, and including FASB 
Interpretation Nos. 4, 9, and 21CON
•  APB Opinion 17, Intangible Assets, as amended by APB Opinion 30 
and FASB Statement Nos. 2, 71, 72, 109, 121, and 135, and including 
FASB Interpretation No. 9
•  APB Opinion 20, Accounting Changes, as amended by FASB State­
ment Nos. 16, 58, 71, 73, 95, 111, and 128, and including FASB 
Interpretation Nos. 1 and 20*
•  APB Opinion 21, Interest on Receivables and Payables, as amended by 
FASB Statement Nos. 34 and 109
•  APB Opinion 22, Disclosure o f Accounting Policies, as amended by 
FASB Statement Nos. 2, 52, 95, and 111
•  APB Opinion 23, Accounting for Income Taxes—Special Areas, as 
amended by FASB Statement Nos. 60, 71, 94, and 109
•  APB Opinion 26, Early Extinguishment o f Debt (paragraph 1.38 of this 
Guide discusses this pronouncement), as amended by APB Opinion 30 
and FASB Statement Nos. 4, (rescinded by FASB Statement No. 145) 
15, 71, 84, and 140
•  APB Opinion 30, Reporting the Results o f Operations—Reporting the 
Effects of Disposal of a Segment of a Business, and Extraordinary, 
Unusual and Infrequently Occurring Events and Transactions (para­
graph 1.38 of this Guide discusses this pronouncement), as amended 
by FASB Statement Nos. 4 , 16, 60, 97, 101, 109, 128, 144, and 145, and 
including FASB Interpretation No. 27
•  FASB Statement No. 2, Accounting for Research and Development 
Costs, as amended by FASB Statement Nos. 71, 86, and 142, and 
including FASB Interpretation Nos. 4 and 6
•  FASB Statement No. 4, Reporting Gains and Losses from Extinguish­
ment of Debt (an amendment of APB Opinion No. 30) (paragraph 1.38 
of this Guide discusses this pronouncement), as amended by FASB 
Statement Nos. 64 and 71 (FASB Statement No. 4 was rescinded by 
FASB Statement No. 145)
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•  FASB Statement No. 5, Accounting for Contingencies, as amended by 
FASB Statement Nos. 11, 16, 60, 71, 87, 111, 112, 113, 114, and 123, 
and including FASB Interpretation Nos. 14, 34, and 45
•  FASB Statement No. 6, Classification of Short-Term Obligations Ex­
pected to Be Refinanced (an amendment of ARB No. 43, Chapter 3A), 
and including FASB Interpretation No. 8
•  FASB Statement No. 10, Extension of “Grandfather” Provisions for 
Business Combinations (an amendment of APB Opinion No. 16)
•  FASB Statement No. 11, Accounting for Contingencies— Transition 
Method (an amendment of FASB Statement No. 5)
•  FASB Statement No. 13, Accounting for Leases, as amended by FASB 
Statement Nos. 22, 23, 27, 28, 29, 34, 71, 91, 94, 98, 109, 135, 140, and 
145, and including FASB Interpretation Nos. 19, 21, 23, 24, 26, and 27
•  FASB Statement No. 15, Accounting by Debtors and Creditors for 
Troubled Debt Restructurings, as amended by FASB Statement Nos. 71, 
111, 114, 135, 144, and 145CON
•  FASB Statement No. 16, Prior Period Adjustments, as amended by 
FASB Statement Nos. 71 and 109
•  FASB Statement No. 22, Changes in the Provisions of Lease Agree­
ments Resulting from Refundings of Tax-Exempt Debt (an amendment 
of FASB Statement No. 13), as amended by FASB Statement Nos. 71, 
140, and 145
•  FASB Statement No. 23, Inception of the Lease (an amendment of 
FASB Statement No. 13)
•  FASB Statement No. 27, Classification of Renewals or Extensions of 
Existing Sales-Type or Direct Financing Leases (an amendment of 
FASB Statement No. 13)
•  FASB Statement No. 28, Accounting for Sales with Leasebacks (an 
amendment of FASB Statement No. 13), as amended by FASB State­
ment No. 66
•  FASB Statement No. 29, Determining Contingent Rentals (an amend­
ment of FASB Statement No. 13), as amended by FASB Statement No. 98
•  FASB Statement No. 34, Capitalization of Interest Cost, as amended 
by FASB Statement Nos. 42, 58, 62, 71, and 144, and including FASB 
Interpretation No. 33
•  FASB Statement No. 37, Balance Sheet Classification of Deferred 
Income Taxes (an amendment of APB Opinion No. 11), as amended by 
FASB Statement No. 109
•  FASB Statement No. 38, Accounting for Preacquisition Contingencies 
of Purchased Enterprises (an amendment of APB Opinion No. 16), as 
amended by FASB Statement No. 109
•  FASB Statement No. 42, Determining Materiality for Capitalization 
of Interest Cost (an amendment of FASB Statement No. 34)
•  FASB Statement No. 43, Accounting for Compensated Absences, as 
amended by FASB Statement Nos. 71, 112, 123, 135, and 144
•  FASB Statement No. 47, Disclosure of Long-Term Obligations
•  FASB Statement No. 48, Revenue Recognition When Right of Return Exists
•  FASB Statement No. 49, Accounting for Product Financing Arrange­
ments, as amended by FASB Statement No. 71
•  FASB Statement No. 52, Foreign Currency Translation (paragraph
1.38 of this Guide discusses this pronouncement), as amended by 
FASB Statement Nos. 95, 109, 130, 133, 135, and 142, and including 
FASB Interpretation No. 37
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•  FASB Statement No. 57, Related Party Disclosures, as amended by 
FASB Statement Nos. 95 and 109, and including FASB Interpretation 
No. 45CON
•  FASB Statement No. 58, Capitalization of Interest in Financial State­
ments That Include Investments Accounted for by the Equity Method 
(an amendment o f FASB Statement No. 34)
•  FASB Statement No. 62, Capitalization of Interest Cost in Situations 
Involving Certain Tax-Exempt Borrowings and Certain Gifts and 
Grants (an amendment o f FASB Statement No. 34)
•  FASB Statement No. 64, Extinguishments o f Debt Made to Satisfy 
Sinking-Fund Requirements (an amendment o f FASB Statement No. 4) 
(rescinded by FASB Statement No. 145)
•  FASB Statement No. 66, Accounting for Sales o f Real Estate, as 
amended by FASB Statement Nos. 98, 135, and 144
•  FASB Statement No. 68, Research and Development Arrangements, as 
amended by FASB Statement No. 142
•  FASB Statement No. 78, Classification o f Obligations That Are Call­
able by the Creditor (an amendment o f ARB No. 43, Chapter 3A)
•  FASB Statement No. 79, Elimination of Certain Disclosures for Busi­
ness Combinations by Nonpublic Enterprises (an amendment o f APB 
Opinion No. 16)
•  FASB Statement No. 86, Accounting for the Costs o f Computer Soft­
ware to Be Sold, Leased, or Otherwise Marketed
•  FASB Statement No. 87, Employers’ Accounting for Pensions, as 
amended by FASB Statement Nos. 106, 109, 130, 132, and 135
•  FASB Statement No. 88, Employers’ Accounting for Settlements and 
Curtailments of Defined Benefit Pension Plans and for Termination 
Benefits, as amended by FASB Statement Nos. 132 and 144
•  FASB Statement No. 93, Recognition o f Depreciation by Not-for-Profit 
Organizations, as amended by FASB Statement Nos. 99 and 135
•  FASB Statement No. 95, Statement o f Cash Flows, as amended by 
FASB Statement Nos. 102, 104, 117, 133, and 145
•  FASB Statement No. 98, Accounting for Leases:
— Sale-Leaseback Transactions Involving Real Estate
— Sales-Type Leases o f Real Estate
— Definition o f the Lease Term
— Initial Direct Costs of Direct Financing Leases
(an amendment of FASB Statements No. 13, 66, and 91 and a rescis­
sion of FASB Statement No. 26 and Technical Bulletin No. 79-11)
•  FASB Statement No. 99, Deferral o f the Effective Date o f Recognition 
of Depreciation by Not-for-Profit Organizations (an amendment of 
FASB Statement No. 93)
•  FASB Statement No. 102, Statement of Cash Flows—Exemption of 
Certain Enterprises and Classification o f Cash Flows from Certain 
Securities Acquired for Resale (an amendment of FASB Statement No. 
95), as amended by FASB Statement Nos. 115, 135, and 145
•  FASB Statement No. 104, Statement of Cash Flows—Net Reporting of 
Certain Cash Receipts and Cash Payments and Classification of Cash 
Flows from Hedging Transactions (an amendment of FASB Statement 
No. 95)
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•  FASB Statement No. 106, Employers’ Accounting for Postretirement 
Benefits Other Than Pensions, as amended by FASB Statement Nos.
132, 135, and 144
•  FASB Statement No. 107, Disclosures about Fair Value o f Financial 
Instruments, as amended by FASB Statement Nos. 112, 123, 126, 133, 
and 140, and including FASB Interpretation No. 45
•  FASB Statement No. 109, Accounting for Income Taxes (paragraph
1.38 of this Guide discusses this pronouncement), as amended by 
FASB Statement Nos. 115, 123, 130, and 135
•  FASB Statement No. 111, Rescission o f FASB Statement No. 32 and 
Technical Corrections
•  FASB Statement No. 112, Employers’ Accounting for Postemployment 
Benefits (an amendment o f FASB Statements No. 5 and 43), as 
amended by FASB Statement No. 123
•  FASB Statement No. 114, Accounting by Creditors for Impairment of 
a Loan (an amendment of FASB Statements No. 5 and 15), as amended 
by FASB Statement No. 118
•  FASB Statement No. 118, Accounting by Creditors for Impairment of 
a Loan—Income Recognition and Disclosures (an amendment o f FASB 
Statement No. 114)
•  FASB Statement No. 121, Accounting for the Impairment o f Long- 
Lived Assets and for Long-Lived Assets to Be Disposed Of, as amended 
by FASB Statement Nos. 139 and 142 (FASB Statement No. 121 was 
superseded by FASB Statement No. 144)
•  FASB Statement No. 126, Exemption from Certain Required Disclo­
sures about Financial Instruments for Certain Nonpublic Entities, as 
amended by FASB Statement No. 133
•  FASB Statement No. 129, Disclosure o f Information about Capital 
Structure
•  FASB Statement No. 132, Employers’  Disclosures about Pensions and 
Other Postretirement Benefits, as amended by FASB Statement No. 
135
•  FASB Statement No. 133, Accounting for Derivative Instruments and 
Hedging Activities, as amended by FASB Statement Nos. 137, 138,
140, and 145
•  FASB Statement No. 135, Rescission of FASB Statement No. 75 and 
Technical Corrections, as amended by FASB Statement No. 145
•  FASB Statement No. 137, Accounting for Derivative Instruments and 
Hedging Activities—Deferral o f the Effective Date o f FASB Statement 
No. 133
•  FASB Statement No. 138, Accounting for Certain Derivative Instru­
ments and Certain Hedging Activities
•  FASB Statement No. 140, Accounting for Transfers and Servicing o f 
Financial Assets and Extinguishments of Liabilities
•  FASB Statement No. 142, Goodwill and Other Intangible Assets, as 
amended by FASB Statement Nos. 144, 145, and 147
•  FASB Statement No. 143, Accounting for Asset Retirement Obliga­
tions, as amended by FASB Statement No. 144
•  FASB Statement No. 144, Accounting for the Impairment or Disposal 
of Long-Lived Assets, as amended by FASB Statement Nos. 145 and 
147
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•  FASB Statement No. 145, Rescission of FASB Statements No. 4, 44, and 
64, Amendment of FASB Statement No. 13, and Technical Corrections
•  FASB Statement No. 146, Accounting for Costs Associated With Exit 
or Disposal Activities
•  FASB Interpretation No. 1, Accounting Changes Related to the Cost of 
Inventory
•  FASB Interpretation No. 4, Applicability of FASB Statement No. 2 to 
Business Combinations Accounted for by the Purchase Method
•  FASB Interpretation No. 6, Applicability o f FASB Statement No. 2 to 
Computer Software, as amended by FASB Statement No. 86
•  FASB Interpretation No. 8, Classification o f a Short-Term Obligation 
Repaid Prior to Being Replaced by a Long-Term Security
•  FASB Interpretation No. 14, Reasonable Estimation of the Amount of 
a Loss
•  FASB Interpretation No. 19, Lessee Guarantee o f the Residual Value 
of Leased Property
•  FASB Interpretation No. 20, Reporting Accounting Changes under 
AICPA Statements of Position, as amended by FASB Statement No. 111
•  FASB Interpretation No. 21, Accounting for Leases in a Business 
Combination, as amended by FASB Statement No. 145
•  FASB Interpretation No. 23, Leases of Certain Property Owned by a 
Governmental Unit or Authority
•  FASB Interpretation No. 24, Leases Involving Only Part o f a Building
•  FASB Interpretation No. 26, Accounting for Purchase o f a Leased Asset 
by the Lessee during the Term of the Lease
•  FASB Interpretation No. 27, Accounting for a Loss on a Sublease, as 
amended by FASB Statement Nos. 135, and 144
•  FASB Interpretation No. 34, Disclosure o f Indirect Guarantees o f 
Indebtedness of Others (rescinded by FASB Interpretation No. 45)
•  FASB Interpretation No. 37, Accounting for Translation Adjustments 
upon Sale o f Part o f an Investment in a Foreign Entity
•  FASB Interpretation No. 39, Offsetting of Amounts Related to Certain 
Contracts, as amended by FASB Statement Nos. 113, 135, and 144 and 
FASB Interpretation No. 41
•  FASB Interpretation No. 41, Offsetting of Amounts Related to Certain 
Repurchase and Reverse Repurchase Agreements
•  FASB Interpretation No. 43, Real Estate Sales, as amended by FASB 
Statement No. 140
•  FASB Interpretation No. 45, Guarantor’s Accounting and Disclosure 
Requirements for Guarantees, Including Indirect Guarantees of In ­
debtedness of Others
CON On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1-3 and 5 of ARB No. 51, add a sentence to endnote 3 of ARB No. 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65. In July 2002, the FASB released an 
exposure draft of a proposed Interpretation, Consolidation of Certain Special-Purpose Entities, which 
would provide guidance for certain specific situations. After completing its deliberations relating to 
the specific situations, the FASB then will continue its consideration of the broader proposals in the 
1999 exposure draft.
* In June 2001, the FASB released an exposure draft of a proposed FASB Statement, Accounting 
in Interim and Annual Financial Statements for Certain Costs and Activities Related to Property, 
Plant, and Equipment, which among other matters, would amend APB Opinion No. 20, Accounting 
Changes. Readers should be alert to the issuance of a final Standard.
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Appendix F—All Financial Reporting Pronouncements, 
Cross-Referenced by Appendix
Note regarding effective dates of pronouncements and the applicability of
FASB Statement No. 141, Business Combinations, and FASB Statement No.
142, Goodwill and Other Intangible Assets:
•  FASB Statement No. 141 supersedes or amends certain pronouncements 
that are listed in this appendix. FASB Statement No. 141 applies to business 
combinations initiated after June 30, 2001 and prescribes the use of the 
purchase method for those business combinations. FASB Statement No.
141, however, does not apply to certain combinations, including a com­
bination involving two or more not-for-profit organizations, or the 
acquisition of a for-profit business entity by a not-for-profit organization. 
For those combinations, pronouncements that are superseded or 
amended by FASB Statement No. 141 should be applied as though FASB 
Statement No. 141 had not superseded or amended them.
•  The provisions of FASB Statement No. 142 shall be applied in fiscal years 
beginning after December 15, 2001, to all goodwill and other intangible 
assets recognized in an entity’s statement of financial position at the 
beginning of that fiscal year. Early application is permitted in certain 
circumstances. Certain provisions of FASB Statement No. 142 shall be 
applied to goodwill and other acquired intangible assets for which the 
acquisition date is after June 30, 2001, even if  an entity has not adopted 
FASB Statement No. 142 in its entirety. The provisions of FASB 
Statement No. 141 and FASB Statement No. 142 should not be applied 
to goodwill and intangible assets arising from a combination between 
two or more not-for-profit organizations or acquired in the acquisition of 
a for-profit business entity by a not-for-profit organization until the 
FASB completes its project on those types of combinations and 
acquisitions. Thus, the guidance in APB Opinion Nos. 16 and 17 remains 
in effect for such assets. In addition, when applying APB Opinion Nos. 
16 and 17, not-for-profit organizations should continue to apply the 
amendments to those Opinions found in other literature even though 
that other literature may have been superseded by FASB Statement 
Nos. 141, 142, and 144. For example, when applying APB Opinion No. 
17, not-for-profit organizations should continue to apply the amend­
ments to that Opinion found in FASB Statement No. 121, even though 
that Statement was superseded by FASB Statement No. 144. Readers 
should be alert to the issuance of a final Standard on combinations of 
not-for-profit organizations.
•  FASB Statement No. 143, Accounting for Asset Retirement Obligations, 
is effective for financial statements issued for fiscal years beginning after 
June 15, 2002, with earlier application encouraged. Among other 
matters, FASB Statement No. 143 supersedes FASB Statement No. 19.
•  FASB Statement No. 144, Accounting for the Impairment or Disposal of 
Long-Lived Assets, supersedes FASB Statement No. 121 and amends 
certain pronouncements that are listed in this appendix. FASB 
Statement No. 144 is effective for financial statements issued for fiscal 
years beginning after December 15, 2001, and interim periods within 
those fiscal years, with early application encouraged.__________________
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•  The provisions of FASB Statement No. 145, Rescission of FASB 
Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, 
and Technical Corrections, related to the rescission of FASB Statement 
No. 4 shall be applied in fiscal years beginning after May 15, 2002, with 
early application encouraged. The provisions in paragraphs 8 and 9(c) of 
FASB Statement No. 145 related to the amendment of FASB Statement 
No. 13 are effective for transactions occurring after May 15, 2002, with 
early application encouraged. All other provisions are effective for finan­
cial statements issued on or after May 15, 2002, with early application 
encouraged.
•  FASB Statement No. 146, Accounting for Costs Associated With Exit or 
Disposal Activities, is effective for exit or disposal activities initiated 
after December 31, 2002. Early application is encouraged.
•  FASB Statement No. 147, Acquisitions of Certain Financial Institutions. 
The provisions of paragraph 5 are effective for acquisitions for which the 
date of acquisition is on or after October 1, 2002. The provisions of 
paragraph 6 are effective on October 1, 2002. Transition provisions for 
previously recognized unidentifiable intangible assets in paragraphs 8 
through 14 are effective October 1, 2002, with earlier application 
permitted.
•  FASB Statement No. 148, Accounting for Stock-Based Compensation— 
Transition and Disclosure. The transition guidance and annual disclo­
sure provisions are effective for fiscal years ending after December 15, 
2002, with earlier application permitted in certain circumstances. The 
interim disclosure provisions are effective for financial reports 
containing financial statements for interim periods beginning after 
December 15, 2002.
•  FASB Interpretation No. 45, Guarantor’s Accounting and Disclosure 
Requirements for Guarantees, Including Indirect Guarantees of Indebt­
edness o f Others. Initial recognition and initial measurement provisions 
apply on a prospective basis to guarantees issued or modified after 
December 31, 2002, irrespective of the guarantor’s fiscal year-end. The 
disclosure requirements are effective for financial statements of interim 
or annual periods ending after December 15, 2002._____________________
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ARB 1 to ARB 42 Superseded
ARB 43 E
ARB 44 Superseded
ARB 44 (Revised) Superseded
ARB 45 E
ARB 46 E
ARB 47 to ARB 50 Superseded
ARB 51 C
APB Opinion 1 Superseded
APB Opinion 2 E
APB Opinion 3 Superseded
APB Opinion 4 E
APB Opinion 5 Superseded
APB Opinion 6 E
APB Opinions 7 and 8 Superseded
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APB Opinion 9 E
APB Opinion 10 E
APB Opinion 11 Superseded
APB Opinion 12 D, E
APB Opinion 13 D
APB Opinion 14 B
APB Opinion 15 Superseded
APB Opinion 16 E
APB Opinion 17 E
APB Opinion 18 A
APB Opinion 19 Superseded
APB Opinion 20 E
APB Opinion 21 E
APB Opinion 22 E
APB Opinion 23 E
APB Opinion 24 Superseded
APB Opinion 25 B
APB Opinion 26 E
APB Opinion 27 Superseded
APB Opinion 28 A
APB Opinion 29 C
APB Opinion 30 E
APB Opinion 31 Superseded
FASB Statement No. 1 Superseded
FASB Statement No. 2 E
FASB Statement No. 3 A
FASB Statement No. 4 E
FASB Statement No. 5 E
FASB Statement No. 6 E
FASB Statement No. 7 D
FASB Statement Nos. 8 and 9 Superseded
FASB Statement No. 10 E
FASB Statement No. 11 E
FASB Statement No. 12 Superseded
FASB Statement No. 13 E
FASB Statement No. 14 Superseded
FASB Statement No. 15 E
FASB Statement No. 16 E
FASB Statement No. 17 Superseded
FASB Statement No. 18 Superseded
FASB Statement No. 19 D
FASB Statement No. 20 Superseded
FASB Statement No. 21 Superseded
FASB Statement No. 22 E
FASB Statement No. 23 E
FASB Statement No. 24 Superseded
FASB Statement No. 25 D
FASB Statement No. 26 Superseded
FASB Statement No. 27 E
FASB Statement No. 28 E
FASB Statement No. 29 E
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FASB Statement No. 30 Superseded
FASB Statement Nos. 31 to 33 Superseded
FASB Statement No. 34 E
FASB Statement No. 35 D
FASB Statement No. 36 Superseded
FASB Statement No. 37 E
FASB Statement No. 38 E
FASB Statement Nos. 39 to 41 Superseded
FASB Statement No. 42 E
FASB Statement No. 43 E
FASB Statement No. 44 D
FASB Statement No. 45 D
FASB Statement No. 46 Superseded
FASB Statement No. 47 E
FASB Statement No. 48 E
FASB Statement No. 49 E
FASB Statement No. 50 D
FASB Statement No. 51 D
FASB Statement No. 52 E
FASB Statement No. 53 Superseded
FASB Statement Nos. 54 to 56 Superseded
FASB Statement No. 57 E
FASB Statement No. 58 E
FASB Statement No. 59 Superseded
FASB Statement No. 60 D
FASB Statement No. 61 D
FASB Statement No. 62 E
FASB Statement No. 63 D
FASB Statement No. 64 E
FASB Statement No. 65 D
FASB Statement No. 66 E
FASB Statement No. 67 D
FASB Statement No. 68 E
FASB Statement No. 69 D
FASB Statement No. 70 Superseded
FASB Statement No. 71 D
FASB Statement No. 72 D
FASB Statement No. 73 D
FASB Statement No. 74 Superseded
FASB Statement No.. 75 Superseded
FASB Statement No. 76 Superseded
FASB Statement No. 77 Superseded
FASB Statement No. 78 E
FASB Statement No. 79 E
FASB Statement No. 80 Superseded
FASB Statement Nos. 81 to 83 Superseded
FASB Statement No. 84 B
FASB Statement No. 85 Superseded
FASB Statement No. 86 E
FASB Statement No. 87 E
FASB Statement No. 88 E
AAG-HCO 1.47
__________Pronouncement__________  _____ Appendix
34 Health Care Organizations
FASB Statement No. 89 A
FASB Statement No. 90 D
FASB Statement No. 91 D
FASB Statement No. 92 D
FASB Statement No. 93 E
FASB Statement No. 94 C
FASB Statement No. 95 E
FASB Statement No. 96 Superseded
FASB Statement No. 97 D
FASB Statement No. 98 E
FASB Statement No. 99 E
FASB Statement No. 100 Superseded
FASB Statement No. 101 D
FASB Statement No. 102 E
FASB Statement No. 103 Superseded
FASB Statement No. 104 E
FASB Statement No. 105 Superseded
FASB Statement No. 106 E
FASB Statement No. 107 E
FASB Statement No. 108 Superseded
FASB Statement No. 109 E
FASB Statement No. 110 D
FASB Statement No. 111 E
FASB Statement No. 112 E
FASB Statement No. 113 D
FASB Statement No. 114 E
FASB Statement No. 115 A
FASB Statement No. 116 C
FASB Statement No. 117 C
FASB Statement No. 118 E
FASB Statement No. 119 Superseded
FASB Statement No. 120 D
FASB Statement No. 121 E
FASB Statement No. 122 Superseded
FASB Statement No. 123 B
FASB Statement No. 124 C
FASB Statement No. 125 Superseded
FASB Statement No. 126 E
FASB Statement No. 127 Superseded
FASB Statement No. 128 A
FASB Statement No. 129 E
FASB Statement No. 130 A
FASB Statement No. 131 A
FASB Statement No. 132 E
FASB Statement No. 133 E
FASB Statement No. 134 D
FASB Statement No. 135 E
FASB Statement No. 136 C
FASB Statement No. 137 E
FASB Statement No. 138 E
FASB Statement No. 139 D
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FASB Statement No. 140 E
FASB Statement No. 141 A
FASB Statement No. 142 E
FASB Statement No. 143 E
FASB Statement No. 144 E
FASB Statement No. 145 E
FASB Statement No. 146 E
FASB Statement No. 147 D
FASB Statement No. 148 B
FASB Interpretation No. 1 E
FASB Interpretation Nos. 2 and 3 Superseded
FASB Interpretation No. 4 E
FASB Interpretation No. 5 Superseded
FASB Interpretation No. 6 E
FASB Interpretation No. 7 D
FASB Interpretation No. 8 E
FASB Interpretation No. 9 D
FASB Interpretation Nos. 10 to 13 Superseded
FASB Interpretation No. 14 E
FASB Interpretation Nos. 15 to 17 Superseded
FASB Interpretation No. 18 A
FASB Interpretation No. 19 E
FASB Interpretation No. 20 E
FASB Interpretation No. 21 E
FASB Interpretation No. 22 Superseded
FASB Interpretation No. 23 E
FASB Interpretation No. 24 E
FASB Interpretation No. 25 Superseded
FASB Interpretation No. 26 E
FASB Interpretation No. 27 E
FASB Interpretation No. 28 B
FASB Interpretation No. 29 Superseded
FASB Interpretation No. 30 C
FASB Interpretation No. 31 Superseded
FASB Interpretation No. 32 Superseded
FASB Interpretation No. 33 D
FASB Interpretation No. 34 E
FASB Interpretation No. 35 A
FASB Interpretation No. 36 D
FASB Interpretation No. 37 E
FASB Interpretation No. 38 B
FASB Interpretation No. 39 E
FASB Interpretation No. 40 D
FASB Interpretation No. 41 E
FASB Interpretation No. 42 Superseded
FASB Interpretation No. 43 E
FASB Interpretation No. 44 B
FASB Interpretation No. 45 E
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Appendix G—The Hierarchy of GAAP
SAS No. 69, The Meaning o f Present Fairly in Conformity With Generally 
Accepted Accounting Principles, establishes the hierarchy of GAAP.
For financial statements of entities other than governm ental entities, the 
hierarchy is summarized as follows:
Category (a). Rule 203 literature consists of officially established ac­
counting principles, which are FASB Statements and 
Interpretations, APB Opinions, and ARBs.
Category (b). This consists of FASB Technical Bulletins and, i f  clear­
ed by the FASB, AICPA Industry Audit and Account­
ing Guides, and AICPA SOPs.
Category (c). This consists of AICPA AcSEC Practice Bulletins that 
have been cleared by the FASB and consensus positions 
of the FASB EITF.
Category (d). This consists of AICPA accounting interpretations and 
implementation guides (“Qs and As”) published by the 
FASB staff, and practices that are widely recognized 
and prevalent either generally or in the industry.
I f  the accounting treatment of a transaction or event is not specified by Rule 
203 literature, the auditor should consider whether the accounting treatment 
is specified by another source of established accounting principles. I f  an 
established accounting principle from one or more sources in category (b), (c), 
or (d) is relevant to the circumstances, the auditor should be prepared to justify 
a conclusion that another treatment is generally accepted. I f  there is a conflict 
between accounting principles relevant to the circumstances from one or more 
sources in category (b), (c), or (d), the auditor should follow the treatment 
specified by the source in the higher category—for example, follow category (b) 
treatment over category (c)—or be prepared to justify a conclusion that a 
treatment specified by a source in the lower category better presents the 
substance of the transaction in the circumstances.
For financial statements of State and L oca l governm ental entities,1 the 
hierarchy is summarized as follows:
Category (a). Officially established accounting principles, consists 
of GASB Statements and Interpretations, as well as 
AICPA and FASB pronouncements specifically made 
applicable to state and local governmental entities by 
GASB Statements or Interpretations. GASB Statements 
and Interpretations are periodically incorporated in the 
Codification of Governmental Accounting and Finan­
cial Reporting Standards.
1 State and local governmental entities include public benefit corporations and authorities; 
public employee retirement systems; and governmental utilities, hospitals and other health care 
providers, and colleges and universities. SAS No. 91, Federal GAAP Hierarchy, amends SAS No. 69 
to establish a hierarchy for federal governmental entities. Federal health care organizations are not 
included in the scope of this Guide.
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Category (b). This consists of GASB Technical Bulletins and, if spe­
cifically made applicable to state and local governmen­
tal entities by the AICPA and cleared2 by the GASB, 
AICPA Industry Audit and Accounting Guides and 
AICPA SOPs.
Category (c). This consists of AICPA AcSEC Practice Bulletins if 
specifically made applicable to state and local govern­
mental entities and cleared3 by the GASB, as well as 
consensus positions of a group of accountants organ­
ized by the GASB that attempts to reach consensus 
positions on accounting issues applicable to state and 
local governmental entities.4
Category (d). Includes implementation guides (“Qs and As”) publish­
ed by the GASB staff, as well as practices that are widely 
recognized and prevalent in state and local government. 
In the absence of a pronouncement covered by Rule 203 or another source of 
established accounting principles, the auditor of financial statements of state 
and local governmental entities may consider other accounting literature, 
depending on its relevance in the circumstances. Other accounting literature 
includes, for example, GASB Concepts Statements; the pronouncements re­
ferred to in categories (a) through (d) above that relate to other than govern­
mental entities when not specifically made applicable to state and local 
governmental entities either by the GASB or by the organization issuing them; 
FASB Concepts Statements; Federal Accounting Standards Advisory Board 
(FASAB) Statements, Interpretations, Technical Bulletins, and Concepts 
Statements; AICPA Issues Papers; International Accounting Standards of the 
International Accounting Standards Committee; pronouncements of other pro­
fessional associations or regulatory agencies; Technical Information Service 
Inquiries and Replies included in AICPA Technical Practice Aids; and account­
ing textbooks, handbooks, and articles. The appropriateness of other account­
ing literature depends on its relevance to particular circumstances, the 
specificity of the guidance, and the general recognition of the issuer or author 
as an authority. For example, GASB Concepts Statements would normally be 
more influential than other sources in this category.
2 The auditor should assume that such pronouncements specifically made applicable to state and 
local governments have been cleared by the GASB unless the pronouncement indicates otherwise.
3 See footnote 2.
4 As of the date of this Guide, the GASB had not organized such a group.
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Chapter 2 
General Auditing Considerations*
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified in a future 
edition of this Guide to discuss additional auditing guidance and 
incorporate references to certain auditing guidance in the Audit and 
Accounting Guide Audits of State and Local Governments (GASB 34 
Edition), that should be considered by auditors of governmental health 
care entities that are required to adopt, or that have elected early 
implementation of GASB Statement No. 34.
Scope of the Engagement
2.01 SAS No. 83, Establishing an Understanding With the Client, as 
amended by SAS No. 89, Audit Adjustments (AICPA, Professional Stand­
ards, vol. 1, AU sec. 310), provides that, for each audit engagement, the 
independent auditor and the health care organization should establish a 
clear understanding regarding the services to be performed. The under­
standing should include the objectives of the engagement, management’s 
responsibilities, the auditor’s responsibilities, and limitations of the en­
gagement. Such an understanding should be documented in the working 
papers,** preferably through a written communication with the client. I f  the 
auditor believes an understanding with the client has not been established, he 
or she should decline to accept or perform the engagement. In addition to 
reporting on the entity’s basic financial statements, the independent auditor 
may be asked to report on the following special reports: (a) cost-reimbursement 
reports; (b) cost reports related to research grants; (c) reports for contribu­
tors; (d) reports for local, state, or federal authorities; (e) reports related to 
bond indentures and other debt instruments; and (f )  other special-purpose 
reports. The nature, timing, and extent of auditing procedures to be performed 
and the type of reports to be issued are based on the scope of services required 
by the entity.
* SAS No. 96, Audit Documentation (AICPA, Professional Standards, vol. 1, AU secs. 312, 329, 
339, and 341), among other matters, supersedes SAS No. 41, Working Papers (AICPA, Professional 
Standards, vol. 1, AU sec. 339). SAS No. 96 is effective for audits of financial statements for periods 
beginning on or after May 15, 2002. Earlier application is permitted. In this edition of the Guide, the 
terminology “working papers” has not been updated to reflect the terminology “audit documentation” 
used in SAS No. 96. This chapter of the Guide will be modified in a future edition of the Guide to 
reflect the requirements and terminology used in SAS No. 96.
* The AICPA Auditing Standards Board (ASB) has released an exposure draft of seven proposed 
Statements on Auditing Standards (SASs) relating to the auditor’s risk assessment process. Among 
other matters, the proposed SASs would supersede or amend certain SASs, including some of the 
SASs discussed in this chapter of the Guide. Readers should be alert to the issuance of final 
Standards.
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Planning the Audit
2.02 The nature, timing, and extent of planning usually vary with the size 
and complexity of the entity, as well as with the independent auditor’s experience 
with the entity and with the industry. SAS No. 22, Planning and Supervision 
(AICPA, Professional Standards, vol. 1, AU sec. 311), contains guidance on 
planning an audit in accordance with generally accepted auditing standards 
(GAAS).
2.03 The independent auditor’s work in forming an opinion on financial 
statements consists of obtaining and evaluating evidential matter regarding 
management’s assertions. Assertions are representations by management that 
are embodied in the financial statements. They can be either explicit or implicit 
and can be classified according to the following broad categories: existence and 
occurrence, completeness, rights and obligations, valuation and allocation, and 
presentation and disclosure.
2.04 The purpose of specific audit objectives and examples of control 
activities in the auditing sections of the following chapters is to illustrate how 
the independent auditor might obtain an understanding of internal control, 
assess control risk, and perform audit procedures. There is not necessarily a 
one-to-one relationship between audit objectives and procedures. Some proce­
dures may relate to more than one objective. On the other hand, a combination 
of procedures may be needed to achieve a single objective. The illustrations 
are not intended to be all-inclusive or to suggest that specific audit objectives, 
control activities, and audit procedures should be applied. Some of the objec­
tives may not be relevant to a particular entity because of the nature of its 
operations or the absence of certain types of transactions. The absence of one 
or more of the illustrative controls would not necessarily indicate a deficiency 
in internal control. The auditor performs procedures that are responsive to the 
auditor’s risk assessment.
2.05 The illustrations are arranged by broad audit objectives. These 
classifications may be useful in the evaluation process, but the classifications 
are of secondary importance. Some specific objectives may serve to achieve 
more than one broad objective.
2.06 Many of the illustrative control activities are premised on the exist­
ence of certain essential characteristics of internal control (for example, 
authorization of transactions, segregation of duties, documentation, supervi­
sion and review, and timeliness of procedures). To avoid repetition, these 
characteristics have not been emphasized in the illustrations.
Inherent Risk
2.07 In determining the scope of audit procedures to be performed, the 
independent auditor should be aware of certain aspects of the health care 
organization’s operations that are usually subject to higher or lower levels 
of inherent risk. SAS No. 47, Audit Risk and Materiality in Conducting an 
Audit (AICPA, Professional Standards, vol. 1, AU sec. 312),* provides guidance
* SAS No. 96, among other matters, amends SAS No. 47, Audit Risk and Materiality in 
Conducting an Audit (AICPA, Professional Standards, vol. 1, AU sec. 312), to add a requirement to 
SAS No. 47 to document the nature and effect of misstatements that the auditor aggregates as well 
as the auditor’s conclusion as to whether the aggregated misstatements cause the financial state­
ments to be materially misstated. SAS No. 96 is effective for audits of financial statements for periods 
beginning on or after May 15, 2002. Earlier application is permitted. This chapter of the Guide will 
be modified in a future edition of the Guide to reflect the requirements and terminology used in SAS 
No. 96.
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on the consideration of audit risk and materiality when planning and perform­
ing an audit of financial statements. SAS No. 98, Omnibus Statement on 
Auditing Standards—2002 (AICPA, Professional Standards, vol. 1, AU sec. 
312.34—.41), amends the section “Evaluating Audit Findings” of SAS No. 47, to 
clarify the auditor’s responsibility with respect to evaluating auditing adjust­
ments. SOP 00-1, Auditing Health Care Third-Party Revenues and Related 
Receivables, provides guidance to auditors regarding uncertainties inherent in 
health care third-party revenue recognition. SOP 00-1 is included as appendix 
E to this Guide.
2.08 In many health care organizations, certain accounts typically (a) 
will have a low volume of transactions, (b) will consist of transactions that 
are not complex, and (c) do not require the use of significant accounting 
estimates. Accounts such as inventories, marketable securities, assets 
whose use is limited, property and equipment, long-term debt, and equity 
frequently have these characteristics and may allow the auditor to assess 
inherent risk as being at a relatively low level. However, in certain circum­
stances, such as investments in complex derivative financial instruments, 
inherent risk may be higher. The auditor should use professional judgment 
in evaluating the factors relevant to assessments of inherent risk. SAS No. 
92, Auditing Derivative Instruments, Hedging Activities, and Investments in 
Securities (AICPA, Professional Standards, vol. 1, AU sec. 332), among other 
matters, provides guidance to auditors in planning and performing auditing 
procedures for assertions about derivative instruments that are made in an 
entity’s financial statements, and presents examples of factors that affect 
inherent risk for assertions about derivatives. In addition, a companion Audit 
Guide, Auditing Derivative Instruments, Hedging Activities, and Investments 
in Securities, provides practical guidance for implementing SAS No. 92.
2.09 Because of the large monetary amounts and the complexity of deter­
mining health care service revenue and receivables, there are risks associated 
with health care service revenue recognition and the valuation of the related 
receivables. A  significant portion of services usually is paid for by third parties 
such as Medicare, Medicaid, and various health insurance carriers under 
statutory provisions or other arrangements in amounts that can be significantly 
different from, and frequently less than, the entity’s established rates.
2.10 Risks are associated with recognizing the liability for costs incurred 
by providers of prepaid health care services (for example, HMOs) because such 
costs may have been incurred but not yet reported to the providers. It is 
therefore necessary to estimate the liability for those costs. These estimates 
often require a high degree of management judgment. Management must 
consider historical experience as well as the effects of any changes in conditions 
such as seasonality trends and changes in subscriber population and in the 
services and benefits provided.
2.11 Risks also are associated with contingencies for uninsured medical 
malpractice losses and obligations under continuing care contracts. A  high 
degree of management judgment and complex analyses usually are involved in 
evaluating the related financial statement assertions.
2.12 The risk of material misstatements, whether caused by error or 
fraud, and illegal acts by clients is present in all audit engagements. SAS No. 82, 
Consideration of Fraud in a Financial Statement Audit (AICPA, Professional
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Standards, vol. 1, AU sec. 316),* and SAS No. 54, Illegal Acts by Clients 
(AICPA, Professional Standards, vol. 1, AU sec. 317), describe the auditor’s 
responsibilities for detecting these matters in an audit of financial statements. 
They also describe the auditor’s responsibilities for communicating detected 
errors, fraudulent acts, and illegal acts to parties within and external to the 
entity.
2.13 SAS No. 82 states that, in auditing financial statements, the audi­
tor’s interest specifically relates to fraudulent acts that cause a material 
misstatement of the financial statements. Two types of misstatements are 
relevant to the auditor’s consideration of fraud in a financial statement audit: 
misstatements arising from fraudulent financial reporting and misstatements 
arising from misappropriation of assets.
2.14 SAS No. 82 does not change the auditor’s responsibilities for consid­
ering fraud, but it does establish new performance requirements for auditors 
to formally consider and explicitly document their consideration of fraud risk 
factors. Specifically, SAS No. 82—
•  Requires the auditor to specifically assess the risk of material mis­
statement due to fraud on every audit and provides categories of fraud 
risk factors that the auditor should consider in making that assess­
ment. It provides examples of fraud risk factors that, when present, 
might indicate the presence of fraud.
•  Offers guidance on how the auditor may respond to the results of the 
assessment.
•  Reaffirms the requirement that the auditor communicate known in­
stances of fraud to an appropriate level of management and the audit 
committee and, under certain circumstances, appropriate regulators.
•  Provides guidance on the evaluation of test results as they relate to 
the risk of material misstatements due to fraud.
•  Requires the auditor to document evidence of the performance of the 
assessment including risk factors identified as present and the audi­
tor’s response thereto.
Internal Control
2.15 SAS No. 55, Consideration of Internal Control in a Financial State­
ment Audit, as amended by SAS No. 78, Consideration of Internal Control in a 
Financial Statement Audit: An Amendment to SAS No. 55, and SAS No. 94, The 
Effect of Information Technology on the Auditor’s Consideration o f Internal 
Control in a Financial Statement Audit (AICPA, Professional Standards, vol. 1,
* SAS No. 99, Consideration of Fraud in a Financial Statement Audit (AICPA, Professional 
Standards, vol. 1, AU sec. 316), among other matters, supersedes SAS No. 82, Consideration of Fraud 
in a Financial Statement Audit (AICPA, Professional Standards, vol. 1, AU sec. 316A). SAS No. 99 is 
the primary source of authoritative guidance about an auditor’s responsibilities concerning the 
consideration of fraud in a financial statement audit. SAS No. 99 establishes standards and provides 
guidance to auditors in fulfilling their responsibility to plan and perform the audit to obtain 
reasonable assurance about whether the financial statements are free of material misstatement, 
whether caused by error or fraud as stated in SAS No. 1, section 110, Responsibilities and Functions 
of the Independent Auditor (AICPA, Professional Standards, vol. 1, AU sec. 110.02). SAS No. 99 is 
effective for audits of financial statements for periods beginning on or after December 15, 2002. Early 
application of the provisions of SAS No. 99 is permissible. This chapter of the Guide will be modified 
to conform to the requirements in SAS No. 99 in a future edition of the Guide. Also, the AICPA has 
published a nonauthoritative Practice Aid entitled Fraud Detection in a GAAS Audit—SAS No. 99 
Implementation Guide (product no. 006613), that is intended to provide auditors with the most recent 
information related to the implementation of SAS No. 99. This Practice Aid is an Other Auditing 
Publication as defined in SAS No. 95, Generally Accepted Auditing Standards (AICPA, Professional 
Standards, vol. 1, AU sec. 150).
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AU sec. 319), describes the components of internal control and explains how an 
independent auditor should consider internal control in planning and perform­
ing an audit. Internal control is a process—effected by an entity’s board of 
directors, management, and other personnel—designed to provide reasonable 
assurance regarding the achievement of objectives in the following categories: 
(a) reliability of financial reporting, (b) effectiveness and efficiency of opera­
tions, and (c) compliance with applicable laws and regulations. Internal control 
consists of the following five interrelated components:
a. Control environment
b. Risk assessment
c. Control activities
d. Information and communication
e. Monitoring
2.16 The auditor should obtain an understanding of each of the five compo­
nents of internal control sufficient to plan the audit. A sufficient understanding is 
obtained by performing procedures to understand the design of controls relevant 
to an audit of financial statements and whether the controls have been placed in 
operation. In obtaining this understanding, the auditor considers how an entity’s 
use of information technology (IT) and manual procedures may affect controls 
relevant to the audit. IT encompasses automated means of originating, processing, 
storing, and communicating information, and includes recording devices, commu­
nication systems, computer systems, and other electronic devices. The auditor is 
primarily interested in the entity’s use of IT to initiate, record, process, and report 
transactions or other financial data.
2.17 After obtaining an understanding of the components of internal control, 
the independent auditor assesses control risk for the assertions embodied in the 
account balance, transaction class, and disclosure components of the financial 
statements. The independent auditor uses the understanding of internal control 
and the assessed level of control risk in determining the nature, timing, and extent 
of substantive tests for financial statement assertions.
Analytical Procedures
2.18 SAS No. 56, Analytical Procedures (AICPA, Professional Standards, 
vol. 1, AU sec. 329),* provides guidance on the use of analytical procedures and 
requires their use in the planning and overall review stages of all audits. The 
AICPA Audit Guide Analytical Procedures, provides practical guidance to 
auditors on the effective use of analytical procedures. That Audit Guide in­
cludes a discussion of SAS No. 56; concepts and definitions; a series of ques­
tions and answers; and a case study illustrating trend analysis, ratio analysis, 
reasonableness testing, and regression analysis. For planning purposes, these 
procedures should focus on (a) enhancing the independent auditor’s under­
standing of the client’s business and the transactions and events that have 
occurred since the last audit date and (b) identifying areas that may represent 
specific risks relevant to the audit. Thus, the objective of the procedures is to
* SAS No. 96, among other matters, amends SAS No. 56, Analytical Procedures (AICPA, 
Professional Standards, vol. 1, AU sec. 329), to add a requirement that the auditor document certain 
matters when an analytical procedure is used as the principal substantive test of a significant 
financial statement assertion. SAS No. 96 is effective for audits of financial statements for periods 
beginning on or after May 15, 2002. Earlier application is permitted. This chapter of the Guide will 
be modified in a future edition of the Guide to reflect the requirements and terminology used in SAS 
No. 96.
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identify such things as the existence of unusual transactions and events, as 
well as amounts, ratios, and trends that might indicate matters that have 
financial statement and audit planning ramifications. For overall review pur­
poses, these procedures should focus on considering the adequacy of the 
evidence gathered in response to unusual or unexpected balances or relation­
ships. The objective of the procedures is to assist the auditor in assessing the 
conclusions reached and evaluating the overall financial statement presenta­
tion. Analytical procedures also may be used as substantive tests to identify 
potential misstatements. These procedures focus on comparing actual balances 
with expected balances and investigating and evaluating significant differ­
ences from the balances expected.
2.19 Examples of sources of information for developing expectations in­
clude prior-period financial information, budgets, and health care financial 
and statistical ratios. Additional information is available from the Center for 
Healthcare Industry Performance Studies’ (CHIPS) Financial Analysis Service, 
which is published annually, as well as other health care industry associations.
2.20 Following are examples of analytical procedures the independent 
auditor may find useful:
•  Comparison of account balances with budget and prior-period amounts
•  Analysis of changes in revenues during the current period based on 
statistical data (for example, admissions, patient days, visits, and 
professional service procedure counts for laboratory, radiology, and 
surgery) and information concerning price changes
•  Comparison between periods of the number of days of revenue in 
receivables
•  Relationship between periods of the allowance for uncollectible ac­
counts to the balance of patient accounts receivable in the aggregate, 
based on known changes in the accounts receivable’s aging and com­
position by payor
•  Relationship between periods of the liability for claims incurred but 
not reported (IBNR) to the related expense
Accounting Estimates
2.21 In determining the scope of audit procedures to be performed, the 
independent auditor should recognize that certain areas of health care organi­
zation operations require accounting estimates that may be material in the 
preparation and presentation of financial statements. SOP 94-6, Disclosure of 
Certain Significant Risks and Uncertainties,1 requires entities to include in 
their financial statements information about the use of estimates in the 
preparation of financial statements. In addition, if  certain specified disclosure 
criteria are met, the SOP requires entities to include disclosures about certain 
significant estimates in their financial statements. SAS No. 57, Auditing 
Accounting Estimates (AICPA, Professional Standards, vol. 1, AU sec. 342), 
provides guidance on obtaining and evaluating sufficient competent evidential 
matter to support significant accounting estimates in an audit of financial 
statements in accordance with GAAS. SOP 00-1 provides guidance for auditors 
regarding the sufficiency of evidential matter supporting accounting estimates 
recorded for the proper valuation of health care third-party revenues and 
related receivables. SOP 00-1 is included as appendix E to this Guide.
1 SOP 94-6 does not pertain to governmental entities, unless the entity has elected to follow all 
FASB pronouncements under paragraph 7 of GASB Statement No. 20, Accounting and Financial 
Reporting for Proprietary Funds and Other Governmental Entities That Use Proprietary Fund 
Accounting. (See chapter 1, footnote 1.)
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2.22 Although management is responsible for making estimates, the inde­
pendent auditor is responsible for evaluating the reasonableness of estimates and 
should consider appropriate procedures in planning and performing the audit. 
These procedures should include both subjective and objective factors.
2.23 The independent auditor should acquire an understanding of the 
relevance of internal control to the accumulation of data and the preparation 
of accounting estimates. Internal control should also provide for adequate 
review and approval of accounting estimates by appropriate levels of authority.
2.24 Although significant accounting estimates may affect many ele­
ments of a health care organization’s financial statements, they most often 
affect the following:
a. The provision for third-party payor contractual adjustments and 
allowances and the provision for estimated receivables and payables 
for final settlements with those payors
b. The provision for uncollectible accounts
c. Accruals for uninsured medical malpractice claims
d. Accruals for obligations under continuing care contracts
e. Accruals by providers of prepaid health care services for IBNR costs
Individual Practice Associations
2.25 In planning the audit of an individual practice association (IPA), the 
auditor usually considers the following matters:
•  The size of a typical IPA accounting department and business office 
often is not large enough to result in effective segregation of duties. 
However, most IPAs have an active office manager who can exercise 
a high degree of influence and control over the operations.
•  Physician compensation arrangements often use incentives or other 
features with complicated methodologies and formulas.
•  Contracts with managed care plans, often with capitated payment and 
risk pool settlement terms, frequently represent a significant amount 
of revenue for the IPA.
2.26 IPAs with capitated contracts accrue costs when the services are 
rendered, including cost estimates of IBNR claims. The IBNR accrual includes 
an estimate of the costs of services for which the IPA is responsible, including 
referrals outside the IPA. Risk pool settlements should be accrued during the 
contract period based on relevant factors, such as experience to date.
Other Planning Considerations
2.27 In planning the audit, the independent auditor also should consider—
•  Matters relating to the entity’s business and the health care industry.
•  Financial statement items likely to require adjustment.
•  Conditions that might require extension or modification of audit tests 
(such as the existence of related party transactions or the existence of 
uninsured malpractice risks).
•  The entity’s experience with payment denials and other matters 
subject to review by medical review organizations.
•  The nature of reports expected to be rendered. Examples include 
reports on consolidated or consolidating financial statements, reports 
on financial statements filed with the Securities and Exchange Com­
mission (SEC), reports filed with third-party payors or other regula­
tory bodies, and other special reports.
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2.28 Planning procedures usually include reviewing the independent 
auditor’s files relating to the entity and holding discussions with audit person­
nel and the personnel of the entity. Examples of these procedures include the 
following:
•  Review correspondence files, the prior year’s working papers,* perma­
nent files, financial statements, and independent auditors’ reports.
•  Review the minutes of meetings of the governing board of directors 
and board committees.
•  Review the relationship of affiliated organizations to the health care 
organization and determine the extent to which their financial infor­
mation should be included in the financial statements of the entity. 
(See the related discussion in chapter 11.)
•  Review the status of unsettled cost (reimbursement) reports for prior 
periods filed with third-party payors.
•  Discuss matters that may affect the audit with the firm’s personnel 
responsible for any nonaudit services to the entity.
•  Identify situations for which accounting estimates are required and 
relevant factors that may affect those estimates.
•  Inquire about current business developments affecting the entity.
•  Read the current year’s interim financial statements and 10-Q forms.
•  Review periodic reports to third-party payors or other regulatory 
bodies.
•  Discuss the nature, scope, and timing of the engagement with the 
entity’s management, board of directors, or audit committee.
•  Consider the effects of all applicable accounting and auditing pro­
nouncements, particularly recent pronouncements.
•  Coordinate the assistance of entity personnel in data preparation.
•  Determine the extent of involvement, if any, of consultants, special­
ists, and internal auditors.
•  Establish the timing of the audit work.
2.29 The independent auditor may find it helpful to maintain a perma­
nent file that includes copies of the following documents relating to the health 
care organization:**
a. Articles of incorporation
b. Bylaws
c. Chart of accounts
d. Organization chart
e. Specific documents concerning restrictions on donor gifts and bequests
f. Contracts and agreements, including leases, agreements with phy­
sicians, agreements with third-party payors, and agreements with 
affiliated organizations
* SAS No. 96, among other matters, requires that audit documentation should include abstracts 
or copies of significant contracts or agreements that were examined to evaluate the accounting for 
significant transactions. SAS No. 96 also supersedes SAS No. 41, and provides further requirements 
about the content, ownership and confidentiality of audit documentation. SAS No. 96 is effective for 
audits of financial statements for periods beginning on or after May 15, 2002. Earlier application is 
permitted. In this edition of the Guide, the terminology “working papers” has not been updated to 
reflect the terminology “audit documentation” used in SAS No. 96. This chapter of the Guide will be 
modified in a future edition of the Guide to reflect the requirements and terminology used in SAS No. 
96.
** See footnote * in paragraph 2.28.
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g. Description of internal control
h. Loan agreements, bond indentures, and other debt instruments
2.30 The independent auditor should understand the specific cost-finding 
or other rate-setting methods used by third-party payors to determine final 
amounts reimbursable to the health care organization. These payment meth­
ods may require that a health care organization accumulate and report various 
statistical data, such as admissions, discharges, patient days, visits, beds, 
square footage, and pounds of laundry.
2.31 The independent auditor intending to use audit-sampling proce­
dures should refer to SAS No. 39, Audit Sampling (AICPA, Professional 
Standards, vol. 1, AU sec. 350), when planning the work to be done. The AICPA 
Audit Guide Audit Sampling presents recommendations on the application of 
generally accepted auditing standards to audits involving the use of audit 
sampling methods, and guidance on applying audit sampling in accordance 
with SAS No. 39.
2.32 I f  the health care organization has an internal audit function, the 
independent auditor should also refer to SAS No. 65, The Auditor’s Considera­
tion of the Internal Audit Function in an Audit of Financial Statements 
(AICPA, Professional Standards, vol. 1, AU sec. 322).
Transactions Processed by Service Organizations
2.33 Health care organizations may engage outside service organizations 
to perform services that are part of the health care provider’s information 
system. A  service organization’s services are part of an entity’s information 
system if they affect any of the following—
•  The classes of transactions in the entity’s operations that are signifi­
cant to the entity’s financial statements
•  The procedures, both automated and manual, by which the entity’s 
transactions are initiated, recorded, processed, and reported from 
their occurrence to their inclusion in the financial statements
•  The related accounting records, whether electronic or manual, sup­
porting information, and specific accounts in the entity’s financial 
statements involved in initiating, recording, processing and reporting 
the entity’s transactions
•  How the entity’s information system captures other events and condi­
tions that are significant to the financial statements
•  The financial reporting process used to prepare the entity’s financial 
statements, including significant accounting estimates and disclo­
sures
Examples of service organizations used by health care organizations include 
the following:
•  Bank trust departments that invest and service assets for health care 
organizations
•  Service organizations that process payroll
•  Billing entities that prepare reimbursement claims to insurers and 
other third parties
•  Administrators of employee benefit plans who process and pay benefit 
claims and maintain participant records
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2.34 SAS No. 55, as amended by SAS No. 78, and SAS No. 94 states that 
the auditor should obtain an understanding of an entity’s internal control 
sufficient to plan the audit. This understanding may encompass controls 
placed in operation by the health care organization and service organizations 
whose services are part of the health care organization’s information system. 
In planning the audit, such information should be used to—
•  Identify types of potential misstatements.
•  Consider factors that affect the risk of material misstatement.
•  Design tests of controls, when applicable.
•  Design substantive tests.
2.35 SAS No. 70, Service Organizations, as amended (AICPA, Profes­
sional Standards, vol. 1, AU sec. 324), explains the considerations an auditor 
should make in obtaining an understanding of internal control and assessing 
control risk for entities that use a service organization to process transactions. 
The AICPA Audit Guide Service Organizations: Applying SAS No. 70, as 
Amended, provides additional guidance for user auditors engaged to audit the 
financial statements of entities that use service organizations.
2.36 The auditor of a health care organization should determine whether 
the health care organization uses a service organization. Information about the 
nature of the services provided by the service organization and the service 
organization’s controls over those services may be available from sources such 
as user manuals, system overviews, technical manuals, the contract between 
the health care organization and the service organization, and reports by 
service auditors, internal auditors, or regulatory authorities on the service 
organization’s controls.
2.37 After considering the available information, the auditor of the health 
care organization may conclude that he or she has the means to obtain a 
sufficient understanding of internal control to plan the audit. I f  the auditor of 
the health care organization concludes that information is not available to 
obtain a sufficient understanding to plan the audit, he or she may consider 
contacting the service organization, through the health care organization, to 
obtain specific information or request that a service auditor be engaged to 
perform procedures that will supply the necessary information, or the auditor 
of the health care organization may visit the service organization and perform 
such procedures. I f  the auditor of the health care organization is unable to 
obtain sufficient evidence to achieve his or her audit objectives, the auditor of 
the health care organization should qualify his or her opinion or disclaim an 
opinion on the financial statements because of a scope limitation.
2.38 After obtaining an understanding of internal control, the auditor 
may assess control risk at the maximum level for some or all financial state­
ment assertions related to the service organization’s processing because, he or 
she believes controls are unlikely to pertain to an assertion, are unlikely to be 
effective, or because evaluating their effectiveness would be inefficient. Proce­
dures to evaluate operating effectiveness include one or any combination of the 
following:
a. Performing tests of controls over the activities of the service organi­
zation at the health care organization
b. Performing tests of controls at the service organization
c. Obtaining a service auditor’s report that describes the results of tests 
of the operating effectiveness of controls performed by the service 
auditor
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Other Audit Considerations 
Illegal Acts
2.39 The Social Security Act provides for criminal penalties for individu­
als or entities that offer, pay, solicit, or receive remuneration to induce busi­
ness that is reimbursed under Medicare or state health care programs. The 
types of remuneration covered by the Medicare Anti-Kickback Statute include, 
with certain exceptions, kickbacks, bribes, and rebates made directly or indi­
rectly, overtly or covertly, and in cash or in kind. In addition, prohibited 
conduct includes not only remuneration intended to induce referrals or pa­
tients but also remuneration intended to induce the purchasing, leasing, 
ordering, or arranging for any good, facility, service, or item paid for by 
Medicare or state health care programs. In addition, fraudulent activities may 
exist that are unrelated to Medicare or state programs, such as fraudulent 
billing and admitting practices.
2.40 The auditor’s procedures will vary based on his or her assessment of 
the risk of material misstatement resulting from such illegal acts. SAS No. 54 
states that the auditor should plan and perform the audit to provide reasonable 
assurance of detecting illegal acts having a direct and material effect on the 
determination of financial statement amounts. SAS No. 54 also notes that an 
audit in accordance with GAAS does not include audit procedures specifically 
designed to detect illegal acts that have only an indirect effect on the financial 
statements (for example, illegal acts that have a material effect as the result 
of fines or penalties that may be imposed on the entity) and provides guidance 
on the auditor’s responsibilities when specific information concerning the 
possible existence of this type of illegal act comes to the auditor’s attention.
2.41 Examples of laws and regulations that are generally recognized by 
auditors to have a direct and material effect on the determination of amounts 
in financial statements of health care organizations include tax laws affecting 
tax accruals and tax expense as well as Medicare and Medicaid laws directly 
affecting the amount of revenue recognized during the accounting period (such 
as those concerning the submission of bills for fictitious patients).
2.42 Health care organizations also may be affected by many other laws 
and regulations such as those related to Medicare and Medicaid fraud and 
abuse, securities trading, occupational safety and health, food and drug ad­
ministration, environmental protection, equal employment opportunities, and 
price-fixing or other antitrust violations. Generally, these laws and regulations 
relate more to an entity’s operating aspects than to its financial and accounting 
aspects, and their financial statement effect is only indirect. An auditor ordi­
narily does not have sufficient basis for recognizing possible violations of such 
laws and regulations. Their indirect effect is normally the result of the need to 
disclose a contingent liability because of the allegation or determination of 
illegality. For example, patients may be obtained based on illegal arrange­
ments with physicians or other providers. While the direct effects of the 
services rendered may be recorded appropriately, their indirect effects, the 
possible contingent liability for violating Medicare and Medicaid fraud and 
abuse statutes, may not be appropriately disclosed. Even when violations of 
such laws and regulations can have consequences material to the financial 
statements, auditors may not become aware of the existence of the illegal act 
unless he or she is informed by the client, or there is evidence of a governmental 
agency investigation or enforcement proceeding in the records, documents, or 
other information normally inspected in an audit of financial statements.
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2.43 Whether an act is, in fact, illegal is a determination that is normally 
beyond the auditor’s professional competence. The auditor’s training, experi­
ence, and understanding of the client and the industry may provide a basis for 
recognizing that some acts coming to the auditor’s attention may be illegal. 
However, determining whether a particular client act is illegal generally would 
be based on the advice of an informed expert qualified to practice law or may 
have to await final determination by a court of law. For example, determining 
whether admitting a patient or providing a service is medically necessary or 
whether a particular procedure or device was properly approved is not within 
the auditor’s professional competence.
Use of a Specialist
2.44 SAS No. 73, Using the Work of a Specialist (AICPA, Professional 
Standards, vol. 1, AU sec. 336), provides guidance to the auditor who uses the 
work of a specialist in performing the audit of a health care organization’s 
financial statements. Guidance is provided on deciding when to use a special­
ist, the auditor’s responsibilities for evaluating the qualifications and the work 
of the specialist, and using the findings of the specialist. The Statement 
requires the auditor to evaluate the relationship of the specialist to the client 
and states that the auditor should perform additional procedures if  the auditor 
concludes that the objectivity of the specialist may be impaired by such a 
relationship.
Clinical Coding Validations
2.45 Typically, a number of clinicians (e.g., the attending physician, 
consulting physicians, radiologists, pathologists, therapists, and nurses) add 
documentation to a patient’s medical record. Provider personnel generally 
review the medical record and assign a code (ICD-9-CM or CPT-4 code) to the 
record. The provider prepares and submits a bill that includes, among other 
things, the assigned ICD-9-CM or CPT-4 code. The Medicare Fiscal Intermedi­
ary or other third-party payor typically reviews the bill and assigns it a specific 
payment code, such as a Diagnostic Related Group (DRG) number. Payment is 
based on the DRG or other payment code assigned. The provider may check the 
payment code assigned and follow up on any discrepancies identified. However, 
since the assignment of the payment code is made by the third-party payor, 
responsibility for correct assignment rests with that payor.
2.46 Errors can occur throughout this process. Physicians or other clini­
cians may not document the appropriate procedure. Coding personnel may not 
notice or interpret certain items in the medical record correctly. Accordingly, 
an incorrect code may be assigned and an erroneous amount may be paid.
2.47 An auditor ordinarily would not find it necessary to consider the 
process of assigning codes in planning and performing an audit of the 
provider’s financial statements. However, the auditor should be alert for 
indications of potential material misstatements of the financial statements 
resulting indirectly from such matters. For example, the auditor may become 
aware that a retrospective review has been performed or that an investigation 
has been completed or is in process. In such circumstances, the auditor should 
consider whether performance of additional substantive audit procedures is 
necessary to reduce audit risk to an acceptable level.
Going-Concern Considerations
2.48 SAS No. 59, The Auditor’s Consideration of an Entity’s Ability to 
Continue as a Going Concern (AICPA, Professional Standards, vol. 1, AU sec.
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341),* provides guidance to the independent auditor conducting an audit on 
how to evaluate whether there is substantial doubt about the entity’s ability to 
continue as a going concern. Continuation of an entity as a going concern is 
assumed in financial reporting in the absence of significant information to the 
contrary. Ordinarily, information that significantly contradicts the going-con­
cern assumption relates to the entity’s inability to continue to meet its obliga­
tions as they become due without substantial disposition of assets outside the 
ordinary course of business, restructuring of debt, externally forced revision of 
its operations, or similar actions. SAS No. 59 states that the independent 
auditor has a responsibility to evaluate whether there is substantial doubt 
about the entity’s ability to continue as a going concern for a reasonable period 
of time, not to exceed one year beyond the date of the financial statements 
being audited.
2.49 Noncompliance with donor-imposed restrictions should be disclosed 
i f  there is a reasonable possibility that a material contingent liability has been 
incurred at the date of the financial statements or there is at least a reasonable 
possibility that the noncompliance could lead to a material loss of revenue or 
could cause an entity to be unable to continue as a going concern. I f  the 
noncompliance results from an organization’s failure to maintain an appropri­
ate composition of assets in amounts needed to comply with all donor restric­
tions, the amounts and circumstances should be disclosed.
Communication
Communication of Matters Related to Internal Control
2.50 SAS No. 60, Communication of Internal Control Related Matters 
Noted in an Audit (AICPA, Professional Standards, vol. 1, AU sec. 325), 
provides guidance in identifying and reporting conditions related to an entity’s 
internal control that are observed during an audit of the financial statements. 
It is contemplated that the communication generally would be to the audit 
committee or, in organizations that do not have an audit committee, to those 
with an equivalent level of authority and responsibility such as the board of 
directors, the owner in an owner-managed enterprise, or the individuals who 
engaged the independent auditor. Conditions noted by the independent auditor 
that are considered reportable under SAS No. 60 should be reported, preferably 
in writing. I f  information is communicated orally, the independent auditor 
should document the communication by appropriate memoranda or notations 
in the working papers.**
* SAS No. 96, among other matters, amends SAS No. 59, The Auditor’s Consideration of an 
Entity’s Ability to Continue as a Going Concern (AICPA, Professional Standards, vol. 1, AU sec. 341), 
to add a requirement for the auditor to document (a) the conditions or events that led him or her to 
believe that there is substantial doubt about the entity’s ability to continue as a going concern; (b ) the 
work performed in connection with the auditor’s evaluation of management’s plans; (c) the auditor’s 
conclusion as to whether substantial doubt about the entity’s ability to continue as a going concern 
for a reasonable period of time remains or is alleviated; and (d ) the consideration and effect of that 
conclusion on the financial statements, disclosures, and the audit report. SAS No. 96 is effective for 
audits of financial statements for periods beginning on or after May 15, 2002. Earlier application is 
permitted. This chapter of the Guide will be modified in a future edition of the Guide to reflect the 
requirements and terminology used in SAS No. 96.
* SAS No. 96, among other matters, supersedes SAS No. 41. SAS No. 96 is effective for audits 
of financial statements for periods beginning on or after May 15, 2002. Earlier application is 
permitted. In this edition of the Guide, the terminology “working papers” has not been updated to 
reflect the terminology “audit documentation” used in SAS No. 96. This chapter of the Guide will be 
modified in a future edition of the Guide to reflect the requirements and terminology used in SAS No. 
96.
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Communication With Audit Committees
2.51 SAS No. 61, Communication With Audit Committees, as amended by 
SAS No. 89, Audit Adjustments, and SAS No. 90, Audit Committee Communi­
cations (AICPA, Professional Standards, vol. 1, AU sec. 380), establishes a 
requirement for the independent auditor to determine that certain matters 
related to the conduct of an audit are communicated to those with responsibil­
ity for oversight of the financial reporting process. The communications re­
quired by SAS No. 61 are applicable to (a) entities that either have an audit 
committee or otherwise have formally designated oversight of the financial 
reporting process to a group equivalent to an audit committee (such as a 
finance committee or a budget committee) and (b) all SEC engagements as 
defined in SAS No. 61. In addition, communication with the audit committee 
or its equivalent by the independent auditor on certain specified matters when 
they arise in the conduct of an audit is required by other standards, including 
SAS No. 82 * and SAS No. 54.
Management Representations
2.52 SAS No. 85, Management Representations, as amended by SAS No. 
89, Audit Adjustments (AICPA, Professional Standards, vol. 1, AU sec. 333), 
establishes a requirement that an auditor performing an audit in accordance 
with GAAS, obtain written representations from management for all financial 
statements and periods covered by the auditor’s report. The specific written 
representations to be obtained depend on the circumstances of the engagement 
and the nature and basis of presentation of the financial statements. Para­
graph 6 of SAS No. 85, as amended by SAS No. 89,** lists matters ordinarily 
included in management’s representation letter. SAS No. 85, as amended by 
SAS No. 89, includes several examples as well. Appendix A  of the SAS, as 
amended by SAS No. 89, includes an illustrative management representation 
letter, Appendix B provides illustrative wording for additional representations 
that may be appropriate in certain situations, and Appendix C provides an 
illustrative updating management representation letter. Independent auditors 
of health care organizations also might obtain representations, i f  applicable, of 
the following:
•  The health care organization is in compliance with the provisions of 
Internal Revenue Code (IRC) sec. 501(c)(3) and is exempt from federal 
income tax under IRC sec. 501(a), as evidenced by a determination 
letter.
•  Information returns have been filed on a timely basis.
•  Provision has been made, when material, for estimated retroactive 
adjustments by third-party payors under reimbursement agreements.
•  The health care organization is in compliance with bond indentures or 
other debt instruments.
* See footnote ** in paragraph 2.12.
** SAS No. 99, among other matters, amends SAS No. 85, Management Representations (AICPA, 
Professional Standards, vol. 1, AU sec. 333.06 and Appendix A). SAS No. 99 requires the auditor to 
make inquiries of management about fraud. In support of and consistent with these inquiries, the 
amendment to SAS No. 85 revises the guidance for management representations about fraud 
currently found in SAS No. 85. SAS No. 99 is effective for audits of financial statements for periods 
beginning on or after December 15, 2002. Early application of the provisions of SAS No. 99 is 
permissible. This chapter of the Guide will be modified to conform to the requirements in SAS No. 99 
in a future edition of the Guide.
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•  Pending changes in the organizational structure, financing arrange­
ments, or other matters that could have a material effect on the 
financial statements of the entity are properly disclosed.
•  The health care organization is in compliance with contractual agree­
ments, grants, and donor restrictions.
•  The health care organization has maintained an appropriate compo­
sition of assets in amounts needed to comply with all donor restric­
tions.
•  All assets and liabilities under the entity’s control have been included 
in the financial statements.
•  The internal controls over the receipt and recording of contributions 
received are adequate.
•  Reclassifications between net asset classes is proper.
2.53 SOP 00-1 provides the following examples of specific representations 
for receivables, cost reports filed with third parties, and contingencies related 
to health care third-party revenue recognition:
•  Receivables
— Adequate consideration has been given to, and appropriate provi­
sion made for, estimated adjustments to revenue, such as for 
denied claims and changes to diagnosis-related group (DRG) 
assignments.
— Recorded valuation allowances are necessary, appropriate, and 
properly supported.
— All peer review organizations, fiscal intermediary, and third- 
party payor reports and information have been made available.
•  Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports have been 
properly filed.
— Management is responsible for the accuracy and propriety of all 
cost reports filed.
— All costs reflected on such reports are appropriate and allowable 
under applicable reimbursement rules and regulations and are 
patient-related and properly allocated to applicable payors.
— The reimbursement methodologies and principles employed are 
in accordance with applicable rules and regulations.
— Adequate consideration has been given to, and appropriate provi­
sion made for, audit adjustments by intermediaries, third-party 
payors, or other regulatory agencies.
— All items required to be disclosed, including disputed costs that 
are being claimed to establish a basis for a subsequent appeal, 
have been fully disclosed in the cost report.
— Recorded third-party settlements include differences between 
filed (and to be filed) cost reports and calculated settlements, 
which are necessary based on historical experience or new or 
ambiguous regulations that may be subject to differing interpre­
tations. While management believes the entity is entitled to all 
amounts claimed on the cost reports, management also believes 
the amounts of these differences are appropriate.
•  Contingencies
— There are no violations or possible violations of laws or regula­
tions, such as those related to the Medicare and Medicaid antifraud
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and abuse statutes, including but not limited to the Medicare and 
Medicaid Anti-Kickback Statute, Limitations on Certain Physi­
cian Referrals (the Stark law), and the False Claims Act, in any 
jurisdiction, whose effects should be considered for disclosure in 
the financial statements or as a basis for recording a loss contin­
gency other than those disclosed or accrued in the financial 
statements.
— Billings to third-party payors comply in all material respects with 
applicable coding guidelines (for example, ICD-9-CM and CPT-4) 
and laws and regulations (including those dealing with Medicare 
and Medicaid antifraud and abuse), and billings reflect only 
charges for goods and services that were medically necessary; 
properly approved by regulatory bodies (for example, the Food and 
Drug Administration), if required; and properly rendered.
— There have been no communications (oral or written) from regu­
latory agencies, governmental representatives, employees, or oth­
ers concerning investigations or allegations of noncompliance 
with laws and regulations in any jurisdiction (including those 
related to the Medicare and Medicaid antifraud and abuse stat­
utes), deficiencies in financial reporting practices, or other mat­
ters that could have a material adverse effect on the financial 
statements.
Single Audit Act and Related Audit Considerations
2.54 An independent auditor may be engaged to audit the financial 
statements of a health care organization that expends federal awards from a 
governmental agency in accordance with the Single Audit Act Amendments of 
1996 and Office of Management and Budget (OMB) Circular A-133, Audits of 
States, Local Governments, and Non-Profit Organizations. Federal awards may 
take the form of grants, contracts, loans, loan guarantees, property, coopera­
tive agreements, interest subsidies, and insurance or direct appropriations.
2.55 OMB Circular A-133 prescribes policies, procedures, and guidelines 
to implement the Single Audit Act Amendments of 1996 and requires state and 
local governments and not-for-profit organizations that expend total federal 
awards equal to or in excess of $300,000 in a fiscal year to have an audit 
performed in accordance with the Act and OMB Circular A-133.
2.56 Institutions covered by OMB Circular A-133 include not-for-profit 
hospitals and public hospitals and institutions of higher education, and their 
affiliated hospitals, voluntary health and welfare organizations and other 
community-based organizations.3 Medicare payments to a non-federal entity 
for providing patient care services to Medicare eligible individuals are not 
considered federal awards expended under OMB Circular A-133. Medicaid 
payments to a subrecipient for providing patient care services to Medicaid 
eligible individuals are not considered federal awards expended under OMB 
Circular A-133 unless a state requires the funds to be treated as federal awards 
expended because reimbursement is on a cost-reimbursement basis.
3 The Codification of Office of Management and Budget (OMB) Circular A-133 by the U.S. 
Department of Health and Human Services also includes audit requirements for commercial organi­
zations (including for-profit hospitals) that receive federal awards under HHS programs. Generally, 
the organization has two options regarding audits: (1) a financial-related audit of a particular award 
in accordance with Government Auditing Standards, or (2) an audit that meets the requirements of 
OMB Circular A-133. See title 45 of the Code of Federal Regulations (CFR) section 74.26(d) for 
further information.
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2.57 OMB Circular A-110 establishes standard requirements (such as 
insurance, record retention, and banking) for obtaining consistency and uni­
formity among federal agencies in the administration of grants to and agree­
ments with public and private hospitals and other entities. OMB Circular A-87, 
Cost Principles for State and Local Governments, establishes principles and 
standards for determining allowable costs incurred by state and local govern­
ments under grants, contracts, and other agreements. OMB Circular A-21, 
Cost Principles for Educational Institutions, and OMB Circular A-122, Cost 
Principles for Nonprofit Organizations, establish principles and standards for 
determining allowable costs incurred by educational institutions and not-for- 
profit organizations under grants, contracts, and other agreements. Federal 
research and development awards under grants and contracts administered by 
hospitals are exempt from OMB’s cost principles circulars A-87, A-21 and 
A-122, but are subject to requirements provided in the U.S. Department of 
Health and Human Services regulations at 45 CFR part 74, appendix E, 
“Principles for Determining Costs Applicable to Research and Development 
Under Grants and Contracts with Hospitals.”
2.58 SAS No. 74, Compliance Auditing Considerations in Audits of Gov­
ernmental Entities and Recipients of Governmental Financial Assistance 
(AICPA, Professional Standards, vol. 1, AU sec. 801), provides general guid­
ance for audits of governmental entities and entities that receive federal 
awards. The Statement explains the requirements of the financial audit stand­
ards contained in Government Auditing Standards, as amended (the Yellow 
Book) issued by the Comptroller General of the United States and their 
relationship to GAAS. It also provides general guidance on testing compliance 
with requirements applicable to federal awards. The Statement clarifies that 
the entity, rather than the independent auditor, is responsible for arranging 
for audits that meet all applicable requirements and provides guidance on 
communications the auditor should make upon becoming aware that the entity 
may be subject to an audit requirement that may not be satisfied by his or her 
engagement.
2.59 SOP 98-3, Audits of States, Local Governments, and Not-for-Profit 
Organizations Receiving Federal Awards, provides guidance on the auditor’s 
responsibilities when conducting a single audit or program-specific audit in 
accordance with the Single Audit Act Amendments of 1996 and OMB Circular 
A-133.4 It discusses the auditor’s responsibility for considering internal control 
and for performing tests of compliance with applicable laws, regulations, and 
program compliance requirements. Further, it provides reporting guidance 
including examples of the reports required by Government Auditing Standards 
and OMB Circular A-133.
Statutory Reporting Considerations for Managed 
Care Organizations
Risk-based Capital Requirements
2.60 Many managed care organizations (MCO) that bear financial risk 
are regulated by state departments of insurance. The risk-based capital (RBC)
4 SOP 98-3 is updated annually with conforming changes. SOP 98-3 is available in the AICPA 
publication Technical Practice Aids, and is also included as an appendix to the AICPA Audit and 
Accounting Guides, Audits of State and Local Governmental Units (Non-GASB 34 Edition), Audits of 
State and Local Governments (GASB 34 Edition), and Not-for-Profit Organizations. In 2003, SOP 
98-3 will be removed from those industry Guides and will be available in a separate Audit Guide 
Audits of States, Local Governments, and Not-for-Profit Organizations Receiving Federal Awards.
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formula is one of the tools used by regulators to evaluate the financial health 
of regulated entities.
2.61 The National Association of Insurance Commissioners (NAIC) for­
mula for the RBC of managed care organizations became effective in the filing 
of 1998 annual statements. Five principal risk elements to the MCO RBC 
formula are: affiliated investment risk, asset risk, underwriting risk, credit 
risk, and general business risk. Four action levels (in order of increasingly 
stringent level of regulatory response) are: company action level, regulatory 
action level, authorized control level, and mandatory control level. At a mini­
mum, the company action-level event requires the filing with the respective 
state insurance commissioner an RBC plan detailing conditions leading to the 
event and proposals of corrective action. State laws vary as to whether appli­
cable legislation pertaining to compliance with the RBC formula has been passed. 
Additional information can be found on the NAIC Web site at www.naic.org.
Codification of Statutory Accounting Practices for Managed 
Care Organizations
2.62 Generally speaking, regulated insurers have been required by their 
state of domicile to submit annually a set of audited financial statements that were 
prepared using that state’s prescribed or permitted statutory accounting practices. 
These statutory accounting practices are considered to be an “other comprehensive 
basis of accounting” (OCBOA) under SAS No. 62, Special Reports.
2.63 In 1999, the NAIC completed a process to codify statutory accounting 
practices for certain insurance entities (including regulated MCO), resulting in 
a revised Accounting Practices and Procedures Manual effective January 1, 
2001 (the “revised Manual”). This Manual has also been updated on an annual 
basis and a new Accounting Practices and Procedure Manual (Manual) reflect­
ing revisions or additions to SAP is published in March of each year. It is 
expected that most states will require insurers to comply with most, i f  not all, 
provisions of the Manual. States may adopt the Manual in whole, or in part, as 
an element of prescribed statutory accounting practices in those states. If, 
however, the requirements of state laws, regulations, and administrative rules 
differ from guidance provided in the Manual those state laws, regulations, and 
administrative rules will take precedence. Preparers of financial statements 
and auditors should monitor the status of the adoption of the Manual by the 
domiciliary state insurance regulatory authority.
2.64 Practitioners should consider whether going-concern issues exist as 
a result of the financial statement effect of adoption. This includes considera­
tion of the effect on RBC.
2.65 Nine of the Statements of Statutory Accounting Principles (SSAPs) 
included in the revised Manual have been specifically modified or written to address 
issues related to managed care. These include SSAP No. 25, Accounting for and 
Disclosures about Transactions with Affiliates and Other Related Parties, No. 35, 
Guaranty Fund and Other Assessments, No. 47, Uninsured Plans, No. 50, Classi­
fications and Definitions of Insurance or Managed Care Contracts in Force, No. 54, 
Individual and Group Accident and Health Contracts, No. 55, Unpaid Claims, 
Losses and Loss Adjustment Expenses, No. 66, Retrospectively Rated Insurance 
Contracts, No. 73, Health Care Delivery Assets—Supplies, Pharmaceuticals and 
Surgical Supplies, Durable Medical Equipment, Furniture, Medical Equipment and 
Fixtures, and Leasehold Improvements in Health Care Facilities and SSAP No. 84, 
Health Care Receivables. All other SSAPs will apply if applicable to the entity.
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Chapter 3 
Cash and Cash Equivalents
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
Accounting and Financial Reporting
3.01 Cash and cash equivalents should include all cash and highly liquid 
investments that are both (a) readily convertible to cash and (b) so near to 
maturity that they present insignificant risk of changes in value because of 
changes in interest rates, in accordance with paragraph 8 of FASB Statement 
No. 95, Statement of Cash Flows, and paragraph 9 of GASB Statement No. 9, 
Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds and 
Governmental Entities That Use Proprietary Fund Accounting. For fiduciary 
purposes, separate checking or savings accounts may be maintained for re­
stricted donations. Such accounts, however, are not reported on a line separate 
from other cash and cash equivalents because donor restrictions generally 
relate to limitations on the use of net assets rather than on the use of specific 
assets.1 However, cash and claims to cash that (a) are restricted as to with­
drawal or use for other than current operations, (b) are designated for expen­
diture in the acquisition or construction of noncurrent assets, (c) are required 
to be segregated for the liquidation of long-term debts, or (d) are required by a 
donor-imposed restriction that limits their use to long-term purposes are 
reported separately and are excluded from current assets. (See paragraph 
10.10.) Internally designated funds should be reported separately from exter­
nally designated funds either on the face of the balance sheet or in the notes to 
the financial statements. I f  the form of the assets is not evident from the 
description on the balance sheet, the form of the assets should be disclosed in 
the notes to the financial statements. GASB Statement No. 9, paragraph 8, 
provides that a governmental health care enterprise’s statement of cash flows 
should explain the change in all cash and cash equivalents, regardless of any 
restrictions on their use.
Agency Funds
3.02 Health care organizations may receive and hold assets owned by 
others under agency relationships; for example, they may perform billing and 
collection services for physicians. In accepting responsibility for those assets, 
an organization incurs a liability to the principal under the agency relationship 
to return the assets in the future or, i f  authorized, to disburse them to another 
party on behalf of the principal. Such agency funds are reported as unrestricted 
assets.
1 A columnar presentation that highlights the three classes of net assets (that is, permanently 
restricted, temporarily restricted, and unrestricted) is not precluded if the totals for the reporting 
entity as a whole are displayed.
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3.03 In other cases, not-for-profit health care organizations may act as 
agents, trustees, or intermediaries helping donors to make a contribution to 
another entity or individual. When acting in that capacity, those organizations 
do not receive a contribution when they receive the assets, nor do they make a 
contribution when they disburse the assets to the other entity or individual. 
Instead, they act as go-betweens, passing the assets from the donor through 
their organization to the specified entity or individual. FASB Statement No. 
136, Transfers of Assets to a Not-for-Profit Organization or Charitable Trust 
That Raises or Holds Contributions for Others,2 establishes standards for 
transactions in which a donor makes a contribution by transferring assets to a 
recipient organization—a not-for-profit organization or a charitable trust— 
that accepts the assets from the donor and agrees to use the assets on behalf 
of or transfer the assets, their investment return, or both to another entity— 
the beneficiary—named by the donor.3 In general, if a donor specifies a 
beneficiary, the recipient organization should not recognize a contribution. 
(For exceptions, see the discussion of variance power at paragraph 10.05 in this 
Guide and financially interrelated organizations at paragraphs 11.28 through
11.32 in this Guide.) Instead, as discussed in paragraph 11 of FASB Statement 
No. 136, the recipient organization should recognize its liability to the specified 
beneficiary concurrent with its recognition of cash or other financial assets 
received from the donor. Both the asset and the liability recognized should be 
measured at the fair value of the assets received. I f  the assets received from 
the donor are donated materials, supplies, or other nonfinancial assets, the 
recipient organization may choose either to (a) report the receipt of the assets 
as a liability to the beneficiary concurrent with recognition of the assets 
received or (b) not report the transaction at all. The choice is an accounting 
policy that should be applied consistently from period to period. An entity 
should consider the need for disclosure in the notes to the financial statements 
pursuant to APB Opinion No. 22, Disclosure of Accounting Policies, and para­
graph 11 of FASB Statement No. 136. Standards for not-for-profit organiza­
tions that act as agents, trustees, or intermediaries are described further in 
chapters 5 and 6 of the Audit and Accounting Guide Not-for-Profit Organizations.
Disclosures
3.04 I f  the provider has concentrations of credit risk related to financial 
instruments such as certificates of deposit or money market mutual funds, the 
disclosure requirements of FASB Statement No. 107, Disclosures about Fair 
Value of Financial Instruments, as amended by FASB Statement No. 133, 
Accounting for Derivative Instruments and Hedging Activities,4 should be 
followed. Examples of potential exposure to credit risk include funds depos­
ited with a single financial institution in excess of Federal Deposit Insurance
2 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in chapter 1.)
3 FASB Statement No. 136 also establishes standards for transactions that take place in a 
similar manner but are not contributions because the transfers are revocable, repayable, or recipro­
cal. For example, if a resource provider transfers assets to a recipient organization and names itself 
or its affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants 
variance power. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.20, 
11.22 and 11.23 in this Guide. This Guide does not use the word donor in discussing those transac­
tions because they are not contributions.
4 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in 
chapter 1.)
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Corporation (FDIC) limits and investments in obligations that are not insured or 
guaranteed by the government. For governmental health care enterprises, 
GASB Statement No. 3, Deposits with Financial Institutions, Investments (in­
cluding Repurchase Agreements), and Reverse Repurchase Agreements, requires 
certain disclosures about deposits, including credit risk classification of bank 
balances that are not entirely insured.
Auditing
3.05 There are no unique auditing considerations with respect to cash and 
cash equivalents recorded by health care organizations.
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Chapter 4 
Investments
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
Accounting
4.01 This chapter discusses the accounting and reporting for investments 
of health care entities other than (a) equity investments accounted for under 
the equity method or (b) investments in consolidated subsidiaries. Discussions 
pertaining to those two types of investments are included in chapter 11. In 
some cases, nongovernmental health care organizations may transfer assets to 
a not-for-profit organization (such as a community foundation or a financially 
interrelated organization) or a trust for investment and management. Para­
graphs 4.14 and 4.15 discuss a nongovernmental health care organization’s 
reporting of investments held on its behalf by unrelated foundations and trusts 
or by related organizations that are not financially interrelated. Paragraphs 
11.20 through 11.23 and 11.28 through 11.32 discuss the reporting by a 
nongovernmental health care organization of investments held on its behalf by 
financially interrelated organizations.
4.02 The accounting for investments in equity securities that have readily 
determinable fair values and all investments in debt securities is discussed in 
paragraphs 4.03 through 4.13. Other types of investments that are not finan­
cial instruments (such as real estate or certain oil and gas interests) are 
reported at amortized cost and are subject to impairment considerations 
consistent with FASB Statement No. 144, Accounting for the Impairment or 
Disposal of Long-Lived Assets.1,*
Investments in Debt Securities and Certain Equity Securities
4.03 This section discusses the accounting and reporting for investments 
in equity securities that have readily determinable fair values and all invest­
ments in debt securities held by (a) investor-owned entities, (b) not-for-profit 
organizations, and (c) governmental entities.
1 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in 
chapter 1.)
* FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, 
supersedes FASB Statement No. 121, Accounting for the Impairment of Long-Lived Assets and for 
Long-Lived Assets to be Disposed Of. FASB Statement No. 144 is effective for financial statements 
issued for fiscal years beginning after December 15, 2001, and interim periods within those fiscal 
years, with early application encouraged.
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4.04 Investor-owned providers are subject to the accounting and report­
ing requirements of FASB Statement No. 115, Accounting for Certain Invest­
ments in Debt and Equity Securities. FASB Statement No. 115 defines three 
categories into which an enterprise classifies investments. The accounting and 
reporting differ by category. Investments in debt securities that the enterprise 
has the positive intent and ability to hold to maturity are classified as held-to- 
maturity securities and are reported at amortized cost. Debt and equity securi­
ties that are bought and held principally for the purpose of selling them in the 
near term are classified as trading securities and reported at fair value, with 
unrealized holding gains and losses included in income. However, an enter­
prise is not precluded from classifying at acquisition a security it plans to hold 
for a longer period as a trading security. Investments in debt securities that 
are not classified as held-to-maturity or trading and equity securities that are 
not classified as trading are classified as available-for-sale securities and 
reported at fair value, with unrealized holding gains and losses excluded from 
income and reported in a separate component of other comprehensive income 
until realized, except all or a portion of the unrealized holding gain and loss of 
an available-for-sale security that is designated as being hedged in a fair value 
hedge shall be recognized in earnings during the period of the hedge.
4.05 Investor-owned entities should follow the disclosure requirements of 
FASB Statement No. 115, as amended by FASB Statement No. 133, Account­
ing for Derivative Instruments and Hedging Activities.
Not-for-Profit Organizations
4.06 Not-for-profit organizations should report investments in equity 
securities with readily determinable fair values and all debt securities at fair 
value on the balance sheet consistent with FASB Statement No. 124, Account­
ing for Certain Investments Held by Not-for-Profit Organizations. FASB State­
ment No. 124 does not apply to investments in derivative instruments that are 
subject to the requirements of FASB Statement No. 133. FASB Statement No. 
133 establishes accounting and reporting standards for derivative instru­
ments, including certain derivative instruments embedded in other contracts 
and for hedging activities. Investment return, including realized and unreal­
ized gains and losses, should be included as changes in net assets consistent 
with paragraphs 4.07 through 4.10.
4.07 Investment return (including realized and unrealized gains and 
losses) not restricted by donors or by law should be classified as changes in 
unrestricted net assets as follows:
a. Included in the performance indicator (see paragraphs 10.17 and
10.18):
•  Dividend, interest, and other similar investment income
•  Realized gains and losses
•  Unrealized gains and losses on trading securities2
•  Other than temporary impairment losses
b. Excluded from the performance indicator:
•  Unrealized gains and losses on other than trading securities
Investor-Owned Entities
2 Trading securities are defined in FASB Statement No. 115, including any interpretations 
thereof.
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4.08 Except as described in paragraphs 4.09 and 4.10, investment return 
(including realized and unrealized gains and losses) restricted by donors or by 
law, should be classified as changes in temporarily or permanently restricted 
net assets consistent with the applicable restrictions.
4.09 Gains and investment income that are limited to specific uses by 
donor-imposed restrictions may be reported as increases in unrestricted net 
assets if  the restrictions are met in the same reporting period as the gains and 
income are recognized, provided that the organization has a similar policy for 
reporting contributions received, applies the policy consistently from period to 
period, and discloses its accounting policy. The classification of these gains and 
investment income in unrestricted net assets should be consistent with para­
graph 4.07.
4.10 In the absence of donor stipulations or law to the contrary, losses on 
the investments of a donor-restricted endowment fund3 shall reduce temporar­
ily restricted net assets to the extent that donor-imposed temporary restric­
tions on net appreciation of the fund have not been met before the loss occurs. 
Any remaining loss shall reduce unrestricted net assets and shall be excluded 
from the determination of the performance indicator. I f  losses reduce the assets 
of a donor-restricted endowment fund below the level required by the donor 
stipulations or law, gains that restore the fair value of the assets of the 
endowment fund to the required level shall be classified as increases in 
unrestricted net assets and shall be excluded from the determination of the 
performance indicator.
4.11 Not-for-profit organizations should follow the disclosure require­
ments of FASB Statement No. 124.
Governmental Entities
4.12 Governmental health care entities are subject to the accounting and 
reporting requirements of GASB Statement No. 31, Accounting and Financial 
Reporting for Certain Investments and for External Investment Pools. Govern­
mental health care entities should report investments in (a) participating 
interest-earning investment contracts, (b) external investment pools, (c) open- 
ended mutual funds, (d) debt securities, and (e) equity securities, option 
contracts, stock warrants, and stock rights that have readily determinable fair 
values at fair value on the balance sheet. Governmental entities are permitted 
to report certain money market investments and participating interest-earning 
investment contracts at amortized cost, provided that the investment has a 
remaining maturity of one year or less at time of purchase. All investment 
income, including changes in the fair value of investments, shall be recognized 
as nonoperating revenue in the statement of operations. Governmental health 
care entities should follow the disclosure requirements of GASB Statement 
No. 31.
4.13 GASB Statements No. 3, Deposits with Financial Institutions, In­
vestments (Including Repurchase Agreements), and Reverse Repurchase
3 Donors that create endowment funds can require that their gifts be invested in perpetuity or 
for a specified term. Some donors may require that a portion of income, gains, or both be added to the 
gift and invested subject to similar restrictions. It is generally understood that at least the amount of 
the original gift(s) and any required accumulations are not expendable, although the value of the 
investments purchased may occasionally fall below that amount. Future appreciation of the invest­
ments generally restores the value to the required level. In states that have enacted its provisions, 
the Uniform Management of Institutional Funds Act describes “historic dollar value” as the amount 
that is not expendable.
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Agreements, No. 28, Accounting and Financial Reporting for Securities Lending 
Transactions, and GASB Interpretation No. 3, Financial Reporting for Reverse 
Repurchase Agreements, provide guidance on investment-related disclosures 
required by governmental entities as well as accounting for securities lending 
and reverse repurchase agreements.
Transfers of Assets to a Not-for-Profit Organization or 
Charitable Trust for Investment
4.14 I f  a nongovernmental health care organization transfers assets to a 
not-for-profit organization or charitable trust (called a recipient organization) 
that accepts those assets and agrees to use them on behalf of or transfer them, 
their investment return, or both back to the health care organization or its 
affiliate, the transfer is reciprocal and thus is not a contribution (see para­
graphs 4, 17 and 18 of FASB Statement No. 136, Transfers of Assets to a 
Not-for-Profit Organization or Charitable Trust That Raises or Holds Contri­
butions for Others).4 Examples of that type of reciprocal transfer include (a) a 
nongovernmental health care organization transfers assets to a community 
foundation to establish an endowment for the benefit of the nongovernmental 
health care organization (or its affiliate) and (b) a nongovernmental health care 
organization transfers assets to a foundation it creates to hold those assets. 
Paragraphs 17 and 18 of FASB Statement No. 136 describe two types of 
reciprocal transfers, which are:
•  An equity transaction—The nongovernmental health care organiza­
tion (a) specifies itself or its affiliate as the beneficiary, (b) the health 
care organization and the recipient organization are financially inter­
related organizations (paragraph 11.21 discusses financially interre­
lated organizations), and (c) neither the health care organization nor 
its affiliate expects payment of the transferred assets, although pay­
ment of investment return on the transferred assets may be expected. 
(All three criteria must be met.)
•  The nongovernmental health care organization specifies itself or its 
affiliate as the beneficiary and the transfer is not an equity trans­
action. (The three criteria (a), (b), and (c) in the previous bullet are 
not met.)
4.15 I f  the reciprocal transaction is not an equity transaction, the nongov­
ernmental health care organization reports an asset, in exchange for the assets 
transferred, as discussed in paragraph 17 of FASB Statement No. 136. (Ac­
counting for equity transactions is discussed in paragraphs 11.20 through
11.23 of this Guide.) The nongovernmental health care organization should 
disclose the following information for each period for which a statement of 
financial position is presented, in accordance with paragraph 19 of FASB 
Statement No. 136:
•  The identity of the recipient organization to which the transfer was 
made
•  Whether variance power was granted to the recipient organization 
and, i f  so, a description of the terms of the variance power5
4 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in chapter 1).
5 Because of their reciprocal nature, those transfers were presumed by the FASB not to be 
contributions received or made—even if the health care organization granted variance power at the 
time of the transfer. See paragraph 96 of FASB Statement No. 136.
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•  The terms under which amounts will be distributed to the health care 
organization or its affiliate
•  The aggregate amount recognized in the statement of financial posi­
tion for those transfers and whether that amount is recorded as an 
interest in the net assets of the recipient organization or as another 
asset (for example, as a beneficial interest in assets held by others or 
a refundable advance).
Financial Statement Presentation
Entities Subject to FASB Statement No. 115, FASB 
Statement No. 124, or GASB Statement No. 31
4.16 Securities should be reported as either current or noncurrent, as 
appropriate, under the provisions of ARB No. 43, Restatement and Revision of 
Accounting Research Bulletins, Chapter 3A.6
4.17 For cash flow reporting purposes by nongovernmental entities, pur­
chases, sales, and maturities of trading securities should be classified as cash 
flows from operating activities; governmental entities should classify these 
items as investing activities. Cash flows from purchases, sales, and maturities 
of all other securities should be classified as cash flows from investing activi­
ties. I f  investments in debt securities are reported as cash equivalents in 
accordance with FASB Statement No. 95, Statement of Cash Flows, or GASB 
Statement No. 9, Reporting Cash Flows of Proprietary and Nonexpendable 
Trust Funds and Governmental Entities That Use Proprietary Fund Account­
ing, the notes to the financial statements should reconcile the reporting classi­
fications used in the statement of financial position.
4.18 All health care organizations with investments that meet the 
definition of financial instruments set forth in FASB Statement No. 107 are 
subject to the disclosure requirements of FASB Statement No. 107, Disclosures 
about Fair Value of Financial Instruments.7 Organizations with derivative 
instruments that meet the definition of derivative instruments set forth in 
FASB Statement No. 133,* are subject to the disclosure requirements in FASB
6 Chapter 3A of ARB No. 43 indicates in paragraph 4 that “the term current assets is used to 
designate cash and other assets or resources commonly identified as those which are reasonably 
expected to be realized in cash or sold or consumed during the normal operating cycle of the 
business.” That paragraph further indicates that the term also comprehends “marketable securities 
representing the investment of cash available for current operations.” Paragraph 5 indicates that “a 
one-year time period is to be used as a basis for the segregation of current assets in cases where there 
are several operating cycles occurring within a year.” Paragraph 6 says that the “concept of the 
nature of current assets contemplates the exclusion from that classification of .. . cash and claims to 
cash which are restricted as to withdrawal or use for other than current operations, are designated 
for expenditure in the acquisition or construction of noncurrent assets, or are segregated for the 
liquidation of long-term debts.” Cash and cash equivalents of permanent endowment funds held 
temporarily until suitable long-term investment opportunities are identified are included in the 
classification “long-term investments.”
7 Disclosures about the fair value of financial instruments prescribed in FASB Statement No. 
107 are optional for an entity that meets the criteria of FASB Statement No. 126, Exemption from 
Certain Required Disclosures about Financial Instruments for Certain Nonpublic Entities, as 
amended by FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities.
* In May 2002, the FASB released an exposure draft of a proposed FASB Statement, Amend­
ment of Statement 133 on Derivative Instruments and Hedging Activities, to clarify the definition of a 
derivative, as set forth in FASB Statement No. 133, Accounting for Derivative Instruments and 
Hedging Activities. Readers should be alert to the issuance of a final Standard.
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Statement No. 133.8,* Governmental health care entities are also required to 
disclose information about their investments in accordance with GASB State­
ment Nos. 3, 28, and 31, GASB Technical Bulletin No. 87-1, Applying Para­
graph 68 of GASB Statement No. 3, No. 94-1, Disclosures about Derivatives and 
Similar Debt and Investment Transactions, No. 97-1, Classifications of Depos­
its and Investments into Custodial Credit Risk Categories for Certain Bank 
Holding Company Transactions, and GASB Interpretation No. 3.
4.19 The following example illustrates the accounting treatment and 
financial statement presentation for other-than-trading securities of a not-for- 
profit health care organization:
Facts
Other than trading securities are purchased in year 1 at a cost of $100. At the 
end of year 1, the fair value of the securities is $300. In year 2, the securities 
are sold for $400.
Journal Entries
•  Entry at the end of year 1 to adjust the recorded value of the securities 
to fair value:
Valuation allowance 200
Change in net unrealized gains and losses on investments 200
•  Entry at the end of year 2 to record the sale of the securities:
Cash 400
Realized gain 300
Investments 100
Change in net unrealized gains and losses on investments 200 
Valuation allowance - 200
As discussed in paragraph 4.07, unrealized gains and losses on other than 
trading securities are reported in the statement of operations below the per­
formance indicator and realized gains and losses are reported in the statement 
of operations above the performance indicator.
Auditing
4.20 Auditing objectives and procedures for investments of health care 
organizations generally are similar to those of other organizations. SAS No. 92, 
Auditing Derivative Instruments, Hedging Activities, and Investments in Securi­
ties (AICPA, Professional Standards, vol. 1, AU sec. 332), among other matters,
8 FASB Statements No. 107 and No. 133 are not applicable to governmental health care 
enterprises that do not apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in chapter 1.)
* SOP 02-2, Accounting for Derivative Instruments and Hedging Activities by Not-for-Profit 
Health Care Organizations, and Clarification of the Performance Indicator, was issued December 27, 
2002. Among other matters, SOP 02-2 requires not-for-profit health care organizations to provide 
disclosures that are analogous to those required by paragraph 45 of FASB Statement No. 133 for 
for-profit enterprises, including the disclosure of anticipated reclassifications into the performance 
indicator of gains and losses that have been excluded from that measure and reported in accumulated 
derivative gain or loss as of the reporting date. SOP 02-2 applies to not-for-profit health care 
organizations that are within the scope of this Guide. SOP 02-2 does not apply to governmental 
entities that are within the scope of this Guide. The provisions of SOP 02-2 are effective for fiscal 
years beginning after June 15, 2003. Earlier application is encouraged but is permitted only as of the 
beginning of any fiscal quarter that begins after issuance of SOP 02-2. See paragraphs 10 and 11 of 
SOP 02-2 for additional effective date and transition information. This chapter of the Guide will be 
modified to refer to the requirements in SOP 02-2 in a future edition of the Guide.
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provides guidance to auditors in planning and performing auditing procedures 
for assertions about investments in securities that are made in an entity’s 
financial statements. The guidance in SAS No. 92 applies to all debt and equity 
securities. SAS No. 92 uses the definitions of debt security and equity security 
that are in FASB Statement No. 115, but applies to debt and equity securities 
without regard to whether they are subject to the requirements of FASB 
Statement No. 115, such as, for example, assertions about securities accounted 
for under the equity method following the requirements of APB Opinion No. 
18, The Equity Method of Accounting for Investments in Common Stock. A  
companion Audit Guide Auditing Derivative Instruments, Hedging Activities, 
and Investments in Securities, provides practical guidance for implementing 
SAS No. 92. In addition, the independent auditor may need to consider the 
examples of specific auditing objectives, selected control activities, and audit­
ing procedures that are presented in exhibit 4-1.
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Specific Auditing Selected Control Auditing
Objectives Activities Procedures
Health Care Organizations
Financial Statement 
Assertions
Existence and 
completeness; 
rights and 
obligations; and 
valuation
68
Exhibit 4-1
Marketable 
securities are 
fairly stated, 
properly 
classified, 
described, and 
disclosed.
An independent 
trustee manages 
the investments. 
The trustee’s 
reports are 
reviewed by a 
responsible 
employee.
Verify existence
through
confirmation.
Test the valuation 
of equity and debt 
securities not 
intended to be 
held to maturity 
by comparing the 
recorded values 
with the fair 
market values 
reported by the 
trustee or another 
independent 
source. For fair 
value estimates 
obtained from 
third-party 
sources, the 
auditor should 
consider the 
applicability of 
the guidance in 
SAS No. 73, Using 
the Work of a 
Specialist 
(AICPA, 
Professional 
Standards, vol. 1, 
AU sec. 336) or 
SAS No. 70, 
Service 
Organizations 
(AICPA, 
Professional 
Standards, vol. 1, 
AU sec. 324).9
9 Paragraphs 35 through 46 of SAS No. 92, Auditing Derivative Instruments, Hedging Activities, 
and Investments in Securities (AICPA, Professional Standards, vol. 1, AU sec. 332), and paragraphs 
6.16 through 6.38 in the companion Audit Guide Auditing Derivative Instruments, Hedging Activities, 
and Investments in Securities, provide guidance to auditors on audit evidence that may be used to 
support assertions about the fair value of securities. That guidance should be considered in the 
context of specific accounting requirements.
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Financial Statement Specific Auditing
Assertions Objectives
Valuation, rights, 
and obligations
Endowment 
funds are 
properly stated at 
their required 
value and related 
gains and losses 
are properly 
classified.
Selected Control 
Activities
Value of 
endowment 
funds are 
reviewed 
periodically to 
ensure that the 
balance is at its 
required level.
Accuracy and 
completeness
Investment 
income and 
gains/losses are 
recorded in 
accordance with 
donor restrictions.
Review of 
investment 
transactions to 
ensure they are 
recorded in 
compliance with 
donor restrictions.
Presentation and 
disclosure
is based on 
management’s 
intent or ability 
to dispose of 
excess funds that 
are available for 
operations within 
an operating 
cycle.
Securities are
properly
classified.
Classification is 
monitored 
periodically and
Auditing
Procedures
Verified that 
value of 
endowments are 
at required levels 
through 
confirmation.
Review treatment 
of gains and 
losses on
endowment funds 
to ensure that 
they are properly 
classified.
Test the recording 
of selected 
transactions to 
ensure amounts 
are properly 
classified in 
accordance with 
donor restrictions.
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Chapter 5 
Receivables
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
5.01 Receivables may include amounts due for (a) health care services 
from patients, residents, third-party payors, and employers; (b) premiums and 
stop-loss insurance recoveries; (c) intercompany transactions; (d) promises to 
give in future periods (pledges); and (e) amounts due from employees, physi­
cians, or others. All loans, such as loans to physicians, should be evaluated 
periodically for impairment. Loans that are included in the scope of FASB State­
ment No. 114, Accounting by Creditors for Impairments of a Loan,1 should be 
evaluated based on the provisions of that statement. A  loan is impaired when, 
based on current information and events, it is probable that the provider will 
be unable to collect all amounts due, including principal and interest, according 
to the contractual terms of the loan agreement. I f  the provider measures an 
impaired loan using a present value amount, the creditor should calculate that 
present value based on an estimate of the expected future cash flows of the 
impaired loan, discounted at the loan’s effective interest rate.
5.02 Amounts realizable from third-party payors for health care services 
are usually less than the provider’s full established rates for those services. The 
realizable amounts may be determined by (a) contractual agreement with 
others (such as Blue Cross plans, Medicare, Medicaid, or HMOs), (b) legislation 
or regulation (such as workers’ compensation or no-fault insurance), or (c) 
provider policy or practice (such as courtesy discounts to medical staff mem­
bers and employees or other administrative adjustments).
5.03 Revenue and the related receivables for health care services usually 
are recorded in the accounting records on an accrual basis at the provider’s full 
established rates. The provision for contractual adjustments (that is, the 
difference between established rates and third-party payor payments) and 
discounts (that is, the difference between established rates and the amount 
collectible) are recognized on an accrual basis and deducted from gross service 
revenue to determine net service revenue. Contractual adjustments, discounts, 
and an allowance for uncollectibles are recorded to report the receivables for 
health care services at net realizable value. Estimates of contractual adjust­
ments, other adjustments, and the allowance for uncollectibles are reported in 
the period during which the services are provided even though the actual 
amounts may become known at a later date. This later date may be (a) when 
the person is discharged, (b) subsequent to discharge or completion of service,
1 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in 
chapter 1.)
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(c) when the third party is billed, or (d) when payment or partial payment is 
received. As discussed in paragraph 10.03, the provision of charity care does 
not qualify for recognition as receivables or revenue in the financial statements.
5.04 Nongovernmental health care organizations with loans and trade 
receivables should follow the recognition and measurement guidance in para­
graph 8 of Statement of Position (SOP) 01-6, Accounting by Certain Entities 
(Including Entities With Trade Receivables) That Lend to or Finance the 
Activities of Others, to the extent that that guidance is applicable.*
Rate Setting
5.05 The independent auditor should be familiar with the rate-setting 
environment in which the entity operates and the regulations and contractual 
agreements that determine payments to be received for health care services. 
Payment rates established by regulations or contractual agreements may be 
determined either prospectively or retrospectively.
5.06 Prospective rate setting is a method used to set payment rates in 
advance of the delivery of health care services. Such payment rates determine 
what third parties will pay for health care services during the rate period 
(generally one year). Prospective rate setting may result from a contractual 
agreement with a third party, such as a Blue Cross plan, or it may be mandated 
through legislation. The intent of prospective rate setting is to establish 
payment rates before the period to which they will apply and that are not 
subject to change. The independent auditor should be aware, however, that 
some rate-setting methods described as prospective may include provision for 
retrospective adjustments and that some third parties pay prospective rates 
for certain services and retrospective rates for other services.
5.07 Under retrospective rate setting, third parties usually determine an 
interim payment rate and, during the rate period (generally one year), pay the 
health care organization for services rendered using that rate. After the rate 
period has ended, a final settlement is made in accordance with federal or state 
regulations or contractual agreements.
Estimated Final Settlements
5.08 Under a retrospective system, an entity may be entitled to receive 
additional payments or may be required to refund amounts received in excess 
of amounts earned under the system. Although final settlements are not made 
until a subsequent period, they are usually subject to reasonable estimations 
and are reported in the financial statements in the period in which services are 
rendered. Differences between original estimates and subsequent revisions 
(including final settlements) are included in the statement of operations in the 
period in which the revisions are made and disclosed, if material. Those 
differences are not treated as prior period adjustments unless they meet the 
criteria for prior period adjustments as set forth in FASB Statement No. 16, 
Prior Period Adjustments.2
5.09 Rate-setting methods that are described as prospective but provide 
for retrospective adjustments are accounted for as retrospective rate-setting 
systems for the services to which they apply (see paragraph 5.08).
* SOP 01-6 is effective for annual and interim financial statements issued for fiscal years 
beginning after December 15, 2001.
2 Paragraph 37 of SOP 00-1, Auditing Health Care Third-Party Revenues and Related Receiv­
ables, provides a sample disclosure for material differences between an original estimate and 
subsequent revisions. SOP 00-1 is included in appendix E to this Guide.
AAG-HCO 5.04
Receivables 73
State Waiver Contingencies Under Medicare
5.10 Certain states (referred to as waiver states) have received permis­
sion to determine rates of payment for Medicare patients in accordance with a 
statewide rate-setting method different from the method used by the federal 
program. A  condition for Medicare participation in a state waiver program 
typically requires that Medicare expenditures in that state not exceed pre­
scribed limits. I f  Medicare expenditures exceed prescribed limits, the excess, 
depending on the conditions of the waiver, may be recoverable by the federal 
government. FASB Statement No. 5, Accounting for Contingencies, provides 
guidance with respect to accounting for loss contingencies, such as those arising 
under state Medicare waivers. GASB Statement No. 10, Accounting and Fi­
nancial Reporting for Risk Financing and Related Insurance Issues, provides 
guidance with respect to accounting for contingencies by governmental entities.
Premiums and Stop-Loss Insurance Receivables
5.11 Some health care organizations contract to provide comprehensive 
health care services for a fixed period in return for fixed periodic premiums. 
Many of those organizations may transfer a portion of their financial risks 
under the contract to another organization by purchasing stop-loss insurance. 
Receivables of those organizations may include uncollected premiums and 
amounts recoverable from stop-loss insurers reduced by appropriate valuation 
allowances. Chapter 13 provides guidance on applying GAAP for stop-loss 
insurance costs of providers of prepaid health care services. FASB Statement 
No. 113, Accounting and Reporting for Reinsurance of Short-Duration and 
Long-Duration Contracts, also provides guidance on accounting for reinsur­
ance contracts. Governmental entities should comply with the provisions of 
GASB Statement No. 10 which provides different guidance on accounting for 
reinsurance contracts than FASB Statement No. 113.
Promises to Give in Future Periods (Pledges)
5.12 Providers involved in fund-raising campaigns frequently are the 
recipients of promises to give3 with payments due in future periods; pledge 
drives are a common example. FASB Statement No. 116, Accounting for 
Contributions Received and Contributions Made,4 establishes the accounting 
and financial reporting guidance for pledges and similar promises to pay. Provid­
ers may also be the beneficiaries of fund-raising campaigns conducted by others. 
FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization 
or Charitable Trust That Raises or Holds Contributions for Others,5 estab­
lishes standards for transactions in which a donor makes a contribution by 
transferring assets to a recipient organization—a not-for-profit organization or 
a charitable trust—that accepts the assets from the donor and agrees to use the 
assets on behalf of or transfer the assets, their investment return, or both to 
another entity—the beneficiary—named by the donor.6 In general, a nongov-
3 To be recognized in financial statements there must be sufficient evidence in the form of 
verifiable documentation that a promise was made and received (FASB Statement No. 116, para­
graph 6).
4 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in chapter 1.)
5 See footnote 4.
6 FASB Statement No. 136 also establishes standards for transactions that take place in a 
similar manner but are not contributions because the transfers are revocable, repayable, or recipro­
cal. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.20, 11.22, and 11.23 
of this Guide. This Guide does not use the word donor in discussing those transactions because they 
are not contributions.
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emmental health care organization that is specified as a beneficiary recognizes its 
rights to the assets held by a recipient organization as an asset: either a beneficial 
interest or a receivable. (See paragraph 15 of FASB Statement No. 136.) (For 
exceptions, see the discussion of variance power at paragraph 10.05 and financially 
interrelated organizations at paragraphs 11.28 through 11.32 of this Guide.) I f the 
beneficiary has an unconditional right to receive all or a portion of the specified 
cash flows from a charitable trust or other identifiable pool of assets, the benefici­
ary has a beneficial interest. The beneficiary recognizes that beneficial interest as 
an asset and a contribution received, measuring and subsequently remeasuring it 
at fair value, using a valuation technique such as the present value of the 
estimated expected future cash flows. I f the beneficiary has unconditional rights 
to receive the value of the transferred assets at a future date, the beneficiary has 
a receivable that should be recognized in accordance with the provisions of FASB 
Statement No. 116 for unconditional promises to give.
5.13 A  general summary of the provisions of FASB Statement No. 116 for 
promises to give is presented below. Specific guidance is provided in chapter 5 
of the AICPA Audit and Accounting Guide Not-for-Profit Organizations. By 
specifying that they will adhere to future payment dates, donors implicitly 
indicate that their gift is to support activities in each period in which a 
payment is scheduled. Therefore, in any promise to give with payments due in 
future periods, a time restriction is implicit unless the donor explicitly states 
that the gift is to support current activities or other circumstances clearly point 
to that intent.
5.14 Promises to give fall into two broad categories: conditional and 
unconditional. Conditional promises to give depend on the occurrence of a 
specified future and uncertain event (for example, a stipulation that the 
provider must meet a matching requirement) whose occurrence or failure of 
occurrence gives the donor the right of return of the assets or releases the donor 
from the obligation to transfer assets in the future. Conditional promises to 
give are not recognized in financial statements until the conditions on which 
they depend are substantially met (that is, until the period in which the 
conditional promise becomes an unconditional promise). A  transfer of assets in 
partial fulfillment of a conditional promise shall be accounted for as a refund­
able advance (that is, as a liability) until such time as the conditional promise 
becomes unconditional.7
5.15 Unconditional promises to give with payments due in future periods 
should be reported as receivables and as restricted support in the period the 
promise is received (unless explicit donor stipulations or circumstances sur­
rounding the receipt of the promise make clear that the donor intended the 
promise to be used to support activities of the current period). The expiration 
of those restrictions (or the expiration of a portion of the restriction) is recog­
nized as the donor makes the future payment or payments. I f  the promise is to 
be paid in one future payment, the related temporarily restricted net assets 
will be transferred to unrestricted net assets in the period in which the 
payment is received. I f  the donor sets forth a schedule of future payments, a 
transfer from temporarily restricted net assets to unrestricted net assets is made 
in each period a payment is received. I f  other explicit donor restrictions are
7 For accounting purposes, a conditional promise to give is considered unconditional if the 
possibility that the condition will not be met is remote. In the case of ambiguous donor stipulations, 
if a promise contains stipulations that are not clearly unconditional (that is, if the donor’s stipula­
tions are ambiguous), the promise is presumed to be a conditional promise. Additional guidance on 
distinguishing conditional promises from unconditional promises is provided in FASB Statement No. 
116, paragraphs 22 and 23.
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attached to the promise, such as that the gift be used for a specific purpose, the 
expiration of the restriction is recognized in the time period(s) when the 
donor makes the future payment(s) and when the stipulated purpose for 
which the assets were restricted has been fulfilled. In the period (or periods) 
that the restrictions expire, the temporarily restricted net assets (or the 
portion of the temporarily restricted net assets that relate to the particular 
payment installment) are reclassified as unrestricted net assets and reported 
in the statement of operations as net assets released from restriction.
5.16 In the year that unconditional promises to give cash are received, 
they should be measured at the present value8 of their estimated future cash 
flows. (Unconditional promises to give cash that are expected to be collected 
within one year of the financial statement date may be measured at their net 
realizable value.) In determining the estimated future cash flows of uncondi­
tional promises to give cash, not-for-profit organizations should consider when 
the receivable is expected to be collected, the creditworthiness of the other 
parties, the organization’s past collection experience and its policies concerning 
the enforcement of promises to give, and other factors concerning the receiv­
able’s collectibility. I f  the present value of unconditional promises to give cash 
decreases after initial measurement because of decreases in estimated future 
cash flows, the decrease should be recognized in the period(s) in which the 
expectation changes. Such decreases should be reported as expenses or 
losses (bad debt) in the net asset class in which the net assets are repre­
sented.9 Accretion of the discount element of the unconditional promise to give 
is accounted for as contribution income, which increases unrestricted, tempo­
rarily, or permanently restricted net assets, as appropriate.
5.17 With regard to pledges and other promises to pay in future periods, if a 
provider routinely conducts fund drives, an estimate of the future cash flows of a 
portfolio of short-term promises resulting from a mass fund-raising appeal may be 
made based on experience gained from similar appeals in prior years.
5.18 Chapter 5 of the Audit and Accounting Guide Not-for-Profit Organi­
zations provides further guidance regarding accounting for promises to give in 
future periods and for assets held by not-for-profit organizations or charitable 
trusts that raise or hold contributions for others.
5.19 GASB Statement No. 33, Accounting and Financial Reporting for 
Nonexchange Transactions, as amended by GASB Statement No. 36, Recipient 
Reporting for Certain Shared Nonexchange Revenues, provides guidance on 
accounting and reporting contributions to governmental health care entities. 
Promises of cash or other assets that nongovernmental entities, including indi­
viduals, voluntarily make to governments may be referred to in practice as 
“pledges,” “promises to give,” or “promised donations” or by some other term. 
Promised assets may include permanently nonexpendable additions to endow­
ments and other trusts; term endowments; contributions of works of art and 
similar assets to capitalized collections; or other kinds of capital or financial 
assets, with or without purpose restrictions or time requirements. For purposes of 
reporting under GASB Statement No. 33, these are classifed as “voluntary 
nonexchange transactions.” Governmental health care enterprises that receive 
promises to give from nongovernmental entities to provide cash or other assets
8 FASB Statement No. 116 states that present value should be calculated using a discount rate 
commensurate with the risks involved.
9 As discussed in FASB Statement No. 116, all expenses should be reported as decreases in 
unrestricted net assets. Therefore, decreases in contributions because of changes in the estimated 
future cash flows should be reported as losses if they are decreases in temporarily restricted net 
assets or permanently restricted net assets.
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should recognize receivables and revenues (net of estimated uncollectible 
amounts) when all eligibility requirements are met, provided that the promise 
is verifiable and the resources are measurable and probable of collection. 
Transactions that are not recognizable because they are not measureable 
should be disclosed.
5.20 As discussed in GASB Statement No. 33, paragraph 20, eligibility 
requirements comprise one or more of the following:
a. Required characteristics of recipients.
b. Time requirements.
c. Reimbursements.
d. Contingencies.
Detailed guidance on the application of eligibility requirements is provided in 
GASB Statement No. 33, paragraphs 21 through 26.
Financial Statement Presentation 
Accounts Receivable
5.21 Receivables are reported net of an allowance for doubtful accounts. 
Although the aggregate amount of receivables may include balances due from 
patients and third-party payors (including final settlements and appeals), the 
amounts due from third-party payors for retroactive adjustments of items such 
as final settlements or appeals shall be reported separately in the financial 
statements.
5.22 Accounts receivable of health care organizations generally are sub­
ject to the same financial disclosure requirements as other business organiza­
tions.10 Nongovernmental health care organizations with loans and trade 
receivables should follow the presentation and disclosure guidance in para­
graph 13 of SOP 01-6 to the extent that guidance is applicable.* FASB State­
ment No. 107, Disclosures about Fair Value of Financial Instruments,11 sets 
forth disclosure requirements regarding the carrying amount of patient ac­
counts receivable.
5.23 FASB Statement No. 107, Disclosures about Fair Value of Financial 
Instruments, as amended by FASB Statement No. 133, Accounting for Deriva­
tive Instruments and Hedging Activities,12 provides guidance on the required 
disclosures about significant concentrations of credit risk arising from all 
financial instruments, including trade accounts receivable. Concentration of 
credit risk frequently is an issue because most health care organizations 
generally tend to treat patients from their local or surrounding communities. 
Accordingly, disclosure should be made of the primary geographic sources of 
patients. It should be noted that concentration of credit risk may be a signifi­
cant issue in stand-alone financial statements issued for a member hospital of 
a large national multi hospital system but may not be an issue for financial 
statements prepared for the hospital system. When the individual facilities’ 
financial statements are consolidated into statements prepared for the entire 
system, the credit risk is dispersed over a much larger base of health plans,
10 See discussion of SOP 00-1 in paragraph 5.31.
* SOP 01-6 is effective for annual and interim financial statements issued for fiscal years 
beginning after December 15, 2001.
11 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in chapter 1.)
12 See footnote 11.
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patients, and geographies and, therefore, is not as concentrated. Health care 
organizations with significant concentrations of credit risk should comply with 
the disclosure provisions of FASB Statement No. 107, as amended by FASB 
Statement No. 133.
5.24 Off-balance-sheet risk exists when the possible accounting loss from 
a financial instrument is not reflected on the balance sheet. Health care organiza­
tions (most notably hospitals) may enter into arrangements where they will 
finance their patient accounts receivable as a cash flow management strategy. 
Nongovernmental health care organizations should follow the presentation 
and disclosure guidance in paragraph 13 of SOP 01-6 regarding credit losses 
on off-balance-sheet instruments to the extent that guidance is applicable.*
5.25 FASB Statement No. 133, as amended, provides guidance on 
the required disclosures by entities that hold or issue derivative instru­
ments. 13, ** GASB Technical Bulletin 94-1, Disclosures about Derivatives and 
Similar Debt and Investment Transactions, also applies to governmental health 
care enterprises.
Interfund Receivables
5.26 Interfund receivables (or payables) may exist in internal records. 
However, since general-purpose financial statements of not-for-profit health 
care organizations do not classify assets and liabilities into fund groups, 
interfund receivables (or payables) are eliminated. Such interfund balances 
and transactions are different from interfund transactions between a govern­
mental health care enterprise fund and another fund, such as the general fund 
or a special revenue fund of a primary government, when the two funds are 
included in the same financial reporting entity. Governmental health care 
enterprises that are a part of a larger financial reporting entity, such as a city 
or a county, are required to report amounts that are receivable (or payable) to 
other funds or component units of the same financial reporting entity in their 
external financial reports.
Promises to Give in Future Periods (Pledges)
5.27 Contributions receivable should be reported net of an allowance for 
uncollectible amounts. That allowance may be based on the receivable’s age, the 
creditworthiness of the parties, the organization’s past collection experience 
and its policies concerning the enforcement of promises to give, and other 
factors concerning the receivable’s collectibility. After the date of initial meas­
urement, bad debt expense should be reported for the amount of promises to 
give that are expected to be uncollectible (see paragraphs 5.14 and 5.19).
* SOP 01-6 is effective for annual and interim financial statements issued for fiscal years 
beginning after December 15, 2001.
13 See footnote 11.
** SOP 02-2, Accounting for Derivative Instruments and Hedging Activities by Not-for-Profit 
Health Care Organizations, and Clarification of the Performance Indicator, was issued December 27, 
2002. Among other matters, SOP 02-2 requires not-for-profit health care organizations to provide 
disclosures that are analogous to those required by paragraph 45 of FASB Statement No. 133 for 
for-profit enterprises, including the disclosure of anticipated reclassifications into the performance 
indicator of gains and losses that have been excluded from that measure and reported in accumulated 
derivative gain or loss as of the reporting date. SOP 02-2 applies to not-for-profit health care 
organizations that are within the scope of this Guide. SOP 02-2 does not apply to governmental 
entities that are within the scope of this Guide. The provisions of SOP 02-2 are effective for fiscal 
years beginning after June 15, 2003. Earlier application is encouraged but is permitted only as of the 
beginning of any fiscal quarter that begins after issuance of SOP 02-2. See paragraphs 10 and 11 of 
SOP 02-2 for additional effective date and transition information. This chapter of the Guide will be 
modified to refer to the requirements in SOP 02-2 in a future edition of the Guide.
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5.28 Investor owned health care enterprises and not-for-profit health care 
organizations that are recipients of unconditional pledges (promises to give in 
future periods) shall disclose—
a. The amounts of promises receivable in less than one year, in one to 
five years, and in more than five years.
b. The amount of the allowance for uncollectible promises receivable.
5.29 Investor owned health care enterprises and not-for-profit health care 
organizations that are recipients of conditional pledges (promises to give in 
future periods) shall disclose—
a. The total of the amounts promised.
b. A  description and amount for each group of promises having similar 
characteristics, such as amounts of promises conditioned on estab­
lishing new programs, completing a new building, or raising match­
ing gifts by a specified date.
Auditing
5.30 In general, receivables, particularly those arising from health care 
services, are material to the financial position of health care organizations. 
Examples of specific auditing objectives, selected control activities, and audit­
ing procedures that may be considered by the independent auditor as they 
relate to the major components of receivables of health care organizations are 
presented in exhibit 5-1 at the end of this chapter.
5.31 SOP 00-1, Auditing Health Care Third-Party Revenues and Related 
Receivables, provides guidance to auditors in evaluating the reasonableness of 
management’s estimates regarding the proper valuation of health care third- 
party revenues and receivables embodied in the financial statements.
Accounts Receivable Confirmations
5.32 Direct confirmation of amounts due from discharged patients and 
third-party payors may be an appropriate audit procedure for obtaining evi­
dence about the existence and accuracy of amounts due. However, many 
patients whose accounts are expected to be paid by a third-party payor may not 
have received bills, and many third-party payors may be unable to respond to 
confirmation requests on specific account balances. In addition, obtaining 
confirmation of receivables from patients who are not discharged may be 
impracticable because those patients may not know the amount of their 
indebtedness until they are discharged.
5.33 I f  confirmation of amounts due from patients and third-party payors 
is impracticable or determined not to be effective, the independent auditor 
should document this decision in accordance with SAS No. 67, The Confirma­
tion Process (AICPA, Professional Standards, vol. 1, AU sec. 330), and should 
use alternate procedures such as—
•  Performing an analytical procedure or testing the details of sub­
sequent receipts.
•  Reviewing third-party contracts or payment agreements.
•  Comparing billings with documentation in medical records.
•  Reviewing the results of third-party payor audits and, if available, 
peer review organization (PRO) reports.
•  Examining or confirming interim payments with third-party payors.
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Exhibit 5-1
Auditing Considerations
Financial Statement 
Assertions
Specific Auditing 
Objectives
Selected Control 
Activities
Receivables for Health Care Services
Existence Amounts reported Charges are 
in the financial generated 
statements 
represent valid 
receivables, which 
do not include 
charity care 
balances.
automatically 
when services are 
performed.
A  medical record 
is prepared.
Auditing
Procedures
Review and test
subsequent
receipts.
Compare billing 
information to the 
documentation 
contained in the 
medical records.
Procedures 
ensure that 
amounts due 
from third-party 
payors for 
individual 
accounts are 
supported 
properly.
Procedures 
ensure the 
proper recording 
of cash receipts.
Review the 
results of PRO, if  
available, and 
insurance 
company reviews 
for evidence that 
might indicate 
receivables may 
not be realized.
Trace the receipts 
applicable to 
patient accounts 
to the accounts 
receivable records.
Completeness Amounts reported 
in the financial 
statements are 
complete and are
Procedures 
ensure charity 
care balances are 
identified and 
excluded from 
gross receivables.
Procedures 
ensure that (a) 
detailed accounts 
receivable
Review the 
management 
policy for 
determining 
charity care.
Review policy and 
reasonableness of 
charity care 
measurement. 
Compare detailed 
accounts
receivable records 
with control
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Financial Statement
Assertions
Valuation
Specific Auditing Selected Control 
Objectives Activities
calculated and
accumulated
properly.
records are 
compared 
routinely with 
control accounts 
and third-party 
payor logs, (b) 
differences are 
investigated and 
reconciled, and
(c) adjustments, 
i f  necessary, are 
made promptly.
Auditing
Procedures
accounts and 
third-party payor 
logs, and 
investigate 
reconciling items.
Receivables are 
reported in the 
financial
statements at net 
realizable value.
Allowances for 
uncollectibles 
and contractual 
adjustments are 
reviewed 
periodically by 
management to 
ensure that 
receivables are 
reported at 
estimated net 
realizable value.
Review 
third-party 
contracts and 
recompute patient 
receivables.
Examine 
contracts or 
confirm interim 
third-party 
payments with 
third-party payors.
Write-offs and 
allowances for 
uncollectibles are 
identified and 
approved in 
accordance with 
the entity’s 
established policy.
Review and test 
the method used 
to determine the 
allowances for 
uncollectible 
accounts.
Determine that 
patient accounts 
are classified 
appropriately by 
payor (for 
example, 
Medicare or 
self-pay) to 
evaluate 
collectibility.
Test Medicare 
logs for accuracy 
and completeness.
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Financial Statement
Assertions
Presentation and 
disclosure
Estimated Third-Party Settlements
Completeness and 
valuation
Amounts included 
in the financial 
statements are 
accurate and 
complete.
Procedures 
ensure that 
estimated 
third-party 
settlements are 
reasonably
Auditing
Procedures
Test and analyze 
aged accounts 
receivable trial 
balances, 
collection trends, 
delinquent 
accounts, 
subsequent period 
write-offs and 
economic or other 
factors used to 
determine 
allowance for 
uncollectible 
accounts.
Review pledges 
and other 
receivables for 
collectibility.
Determine that 
significant 
contractual 
arrangements 
with third parties 
are disclosed.
Review
correspondence 
from significant 
third-party payors 
related to (a) 
interim payment 
rates applicable to 
periods for which 
final settlements 
have not been 
made and (b) the 
amount of interim 
or final
settlements made 
during the period. 
Test the
reasonableness of 
settlement 
amounts, 
including specific 
and unallocated
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Significant 
contractual 
arrangements 
with third parties 
are disclosed.
Existence Amounts reported 
in the financial 
statements 
represent valid 
receivables and/or 
payables.
Procedures 
ensure that 
estimated 
third-party 
settlements 
are determined 
in accordance 
with the 
reimbursement 
and rate-setting 
methodologies 
applicable to the 
entity.
Specific Auditing 
Objectives
Selected Control 
Activities
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Financial Statement
Assertions
Presentation and 
disclosure
Specific Auditing Selected Control 
Objectives Activities
calculated and 
reported.
Amounts reported 
in the financial 
statements are 
presented 
properly and all
Auditing
Procedures
reserves, in light 
of the payors 
involved, the 
nature of the 
payment 
mechanism, the 
risks associated 
with future 
audits, and other 
relevant factors.
Review
third-party payor 
audit reports and 
adjustments for 
prior years’ cost 
reports or 
settlements to 
consider whether
(a) the effect of 
such adjustments 
has been reported 
properly in the 
financial 
statements and
(b) adjustments of 
a similar nature 
apply to the 
current period.
Obtain a 
representation 
from management 
that provisions for 
estimated 
retroactive 
adjustments by 
third-party payors 
under
reimbursement 
agreements for 
open years are 
adequate.
Determine that 
the tentative 
nature of 
third-party 
settlement
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Financial Statement
Assertions
Specific Auditing Selected Control 
Objectives Activities
required 
disclosures are 
made.
Auditing
Procedures
amounts is 
disclosed properly.
Determine that 
differences 
between original 
estimates and 
subsequent 
revisions 
(including final 
settlements) are 
included in the 
statement of 
operations in the 
period in which 
the revisions are 
made and 
disclosed, if 
material.
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Chapter 6 
Property and Equipment, Supplies, and 
Other Assets
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
Overview
6.01 Health care organizations use various types of property and equip­
ment. Those assets may be material to the financial position of institutional 
health care organizations, such as hospitals and nursing homes. Typical ac­
counts used to record property and equipment transactions are land, land 
improvements, buildings and improvements, leasehold improvements, equip­
ment (fixed and movable), leased property and equipment, accumulated depre­
ciation and amortization, and construction in progress.
6.02 Supplies usually are not material to the financial position of 
health care organizations. However, because of the volume of supply trans­
actions, they may materially affect operations. Supplies typically include 
medical and surgical supplies; pharmaceuticals; linens, uniforms, and gar­
ments; food and other commodities; and housekeeping, maintenance, and 
office supplies.
6.03 Other assets may include prepaid expenses, deposits, and deferred 
expenses. Prepaid costs, such as amounts paid to physicians for future services 
(for example, administering a hospital department or providing community 
services that further the organization’s mission) may be deferred and amor­
tized over the period benefited. Such assets are classified as current or noncur­
rent as appropriate.
Accounting
6.04 Accounting for property and equipment, supplies, and other assets 
of health care organizations is similar to that used by other business organi­
zations.
6.05 Depreciation and amortization of property and equipment are re­
corded in conformity with GAAP. Useful lives assigned to depreciable assets 
should be reasonable, based on the circumstances. The American Hospital 
Association publishes useful guidelines for classifications and estimated useful 
lives for property and equipment used by hospitals. Those guidelines also may 
be useful to other health care organizations. I f  there is a potential that an asset 
is impaired, health care organizations should consider the guidance in FASB
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Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived 
Assets.1, *, **
6.06 The recognition of contribution income related to donated long-lived 
assets (or assets recognized to be acquired with donated funds) is discussed in 
chapter 10 of this Guide.
Financial Statement Presentation
6.07 Financial statement presentation of property and equipment of 
health care organizations is similar to that of other business organizations. 
Property held for investment purposes should be presented as part of invest­
ments. Donor or legal restrictions on the proceeds from the disposition of 
donated property and equipment (or of property and equipment purchased 
with cash restricted for acquisition of long-lived assets) are disclosed.
6.08 Financial statement presentation of supplies and other assets of 
health care organizations is similar to that of other business organizations.
Auditing
6.09 Auditing objectives for property and equipment, supplies, and other 
assets of health care organizations are similar to those in audits of other 
business organizations. The auditor may be able to assess inherent risk for 
these accounts as being relatively low because the transactions therein are 
generally small in number, relatively simple in nature, and do not involve the 
use of complex estimates. The auditor should consider the characteristics of the 
entity and of the transactions occurring during the period when assessing 
inherent risk for these accounts.
6.10 A  health care organization may have access to the use of property 
and equipment under a variety of arrangements. It may (a) own property and 
equipment, (b) rent property and equipment from an independent or related 
organization, (c) use property and equipment provided by a related organiza­
tion (such as a religious order) or by an unrelated organization under an 
affiliation program, or (d) use property and equipment provided by a govern­
ment agency or unit or a government-related hospital district. The inde­
pendent auditor should inquire into (and the financial statements should 
disclose) the nature of any relationship between the health care organization 
and lessors, bailors, or other owners of property. With respect to leases, FASB 
Statement No. 13, Accounting for Leases, as amended and interpreted, pro­
vides accounting guidance.2 GASB Statement No. 13, Accounting for Operat­
ing Leases with Scheduled Rent Increases, provides additional guidance for 
operating leases of governmental health care enterprises.
1 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in 
chapter 1.)
* The GASB has published an exposure draft of a proposed Statement, Accounting and Finan­
cial Reporting for Impairment of Capital Assets and for Insurance Recoveries. Readers should be alert 
to the issuance of a final Standard.
** FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, 
supersedes FASB Statement No. 121, Accounting for the Impairment of Long-Lived Assets and for 
Long-Lived Assets to be Disposed Of. FASB Statement No. 144 is effective for financial statements 
issued for fiscal years beginning after December 15, 2001, and interim periods within those fiscal 
years, with early application encouraged.
2 For governmental health care enterprises, National Council on Governmental Accounting 
(NCGA) Statement No. 5, Accounting and Financial Reporting Principles for Lease Agreements of 
State and Local Governments, requires the application of FASB Statement No. 13 for proprietary 
activities and provides additional guidance on specific matters unique to governmental entities.
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6.11 In evaluating capitalization policies, the independent auditor should  
consider whether interest has been capitalized in accordance with the provisions 
of FASB Statement No. 34, Capitalization of Interest Cost, and related amend­
ments and FASB Statement No. 62, Capitalization of Interest Cost in Situations 
Involving Certain Tax-Exempt Borrowings and Certain Gifts and Grants.
6.12 In evaluating the entity’s depreciation policies, the auditor may wish 
to refer to the American Hospital Association’s Estimated Useful Lives of 
Depreciable Hospital Assets, which is revised periodically and sets forth plant 
asset classifications and the estimated useful lives of depreciable assets. The 
auditor also should be aware that social, economic, and scientific advances in 
the health care industry make obsolescence an important factor to be consid­
ered when evaluating depreciation policies and methods.
6.13 FASB Statement No. 144* requires that health care organizations 
review long-lived assets for impairment whenever events or changes in circum­
stances indicate that the carrying amount of the asset may not be recoverable. 
In considering a health care organization’s application of FASB Statement No. 
144, auditors should obtain an understanding of the policies and procedures 
used by management to determine whether all impaired assets have been 
properly identified. In addition to evaluating the entity’s procedures for iden­
tifying indicators of impairment, the auditor should consider information 
obtained during the audit in determining whether the health care organization 
has identified appropriate indicators of impairment. For example, a change in 
the use of a facility from an acute-care hospital to an ambulatory surgery 
center may require that the asset be reviewed for impairment using the 
method prescribed by FASB Statement No. 144.
6.14 The independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
relating to property and equipment that are presented in exhibit 6-1.
FASB Statement No. 144 supersedes FASB Statement No. 121, and is effective for financial 
statements issued for fiscal years beginning after December 15, 2001, and interim periods within 
those fiscal years, with early application encouraged.
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Exhibit 6-1
Financial Statement 
Assertions
Auditing Considerations
Specific Auditing 
Objectives
Donated Property Equipment
Valuation Donated property 
and equipment is 
reported at fair 
market value at 
the date of 
donation.
Selected Control 
Activities
Procedures 
ensure that the 
donation of 
property and 
equipment is 
known and 
recorded and 
that
documentation 
supports the 
determination of 
the fair market 
value.
Presentation and 
disclosure
Property and Equipment Not Held for Use in Operations
Presentation and 
disclosure
Property and 
equipment not 
used for 
operations is 
reported 
separately.
Property records 
segregate 
property and 
equipment not 
used for 
operating 
purposes.
Management 
regularly 
monitors 
compliance with 
health care 
planning agency 
regulations 
related to 
additions of 
property and 
equipment.
Property and Equipment Additions
Auditing
Procedures
Review the 
documentation 
supporting the 
determination of 
the fair market 
value.
Review material 
donated property 
and equipment 
transactions to 
ensure the 
propriety of the 
reporting.
Determine that 
property held for 
nonoperating 
purposes is 
reported 
separately.
For material new 
construction, 
determine 
compliance with 
health care 
planning agency 
or other
regulatory agency 
requirements.
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The receipt of 
donated property 
and equipment is 
properly reported.
Rights and 
obligations
The appropriate 
health care 
planning agency 
or other
regulatory agency 
approvals, if 
required, have 
been obtained for 
property and 
equipment 
additions.
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Financial Statement Specific Auditing 
Assertions Objectives
Selected Control 
Activities
Additions are 
authorized in the 
capital budget.
Auditing
Procedures
Existence and 
valuation
Recorded 
property and 
equipment are 
owned by the 
entity and are 
carried at the 
appropriate 
amounts.
Inventory of fixed 
assets is taken 
periodically. 
Detailed property 
records
periodically are 
reconciled to the 
recorded 
amounts.
Review a 
summary of 
property and 
equipment (cost 
and accumulated 
depreciation) 
including 
additions, 
deletions, and 
transfers.
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Chapter 7 
Current Liabilities, Tax Considerations, and 
Long-Term Obligations
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
Overview
7.01 Current liabilities may include notes payable to banks; the current 
portion of long-term debt; accounts payable; advances from and amounts 
payable to third-party payors for estimated and final reimbursement settle­
ments; refunds to and deposits from patients and others; deferred revenue; 
accrued salaries and payroll taxes; and other accruals such as pension or 
profit-sharing contributions, compensated absences, and income and other 
taxes. In addition, there may be a current portion of estimated malpractice 
costs and risk-contract recognized losses (see chapter 8).
7.02 Long-term obligations may include notes, mortgages, capital leases, 
bonds, and obligations under continuing care contracts. They also may include 
estimated malpractice cost and risk-contract recognized losses.
Accounting for Current Liabilities
7.03 Accounting for current liabilities of health care organizations is 
similar to that of other business enterprises. Health care organizations are 
usually labor-intensive and provide employees with compensated absences, 
such as for holidays, vacations, and illnesses. Liabilities related to such ab­
sences are accounted for in accordance with FASB Statement No. 43, Account­
ing for Compensated Absences. Governmental health care entities should 
follow the guidance in GASB Statement No. 16, Accounting for Compensated 
Absences.
7.04 Liabilities related to postretirement benefits other than pensions 
should be accounted for in accordance with FASB Statement No. 106, Employ­
ers’ Accounting for Postretirement Benefits Other Than Pensions, and postem­
ployment benefits should be accounted for in accordance with FASB Statement 
No. 112, Employers’ Accounting for Postemployment Benefits. These two pro­
nouncements are not required to be applied by governmental health care 
enterprises. GASB Statement No. 12, Disclosure of Information on Postemploy­
ment Benefits Other Than Pension Benefits by State and Local Governmental 
Employers, however, does require certain disclosures about postemployment 
benefits.
7.05 Governmental health care enterprises sometimes report govern­
ment-mandated or voluntary nonexchange revenues, such as expenditure- 
driven grants. These revenues are recognized when all eligibility requirements
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have been met, as discussed in GASB Statement No. 33, Accounting and 
Financial Reporting for Nonexchange Transactions. In some cases, it may 
become apparent after revenue has been recognized in the financial statements 
that the eligibility requirements are no longer met, for example, because an 
audit of a particular grant program determined that certain expenses did not 
meet purpose restrictions. GASB Statement No. 33 provides that, i f  it is 
probable that the recipient must return all or part of the resources, a liability 
(or reduction of receivables) and an expense should be recognized for the 
amount that the resource provider (grantor) is expected to cancel or reclaim. 
(See paragraphs 5.19, 5.20, 10.05 and 10.12 for further discussion of GASB 
Statement No. 33.)
Tax Considerations for Not-for-Profit Health 
Care Organizations
7.06 Health care organizations that are owned and operated by a state or 
local government are exempt from federal income tax pursuant to IRC sec. 115 
and also are exempt from the federal income tax filing requirements. Such 
organizations are exempt not only from regular federal income tax but also 
from the tax on unrelated business income. I f  a health care entity is owned and 
operated by a separately constituted authority or other legal entity, the entity’s 
management should consider whether such authority or other legal entity is 
organized properly to preserve qualification of the tax exemption pursuant to 
IRC sec. 115. In some cases, state or local governmental entities will secure 
tax-exempt status as an IRC sec. 501(c)(3) organization. I f  such an exemption 
is secured, the entity may become subject to federal income tax and the related 
filing requirements on the same basis as other tax-exempt entities.
Tax-Exempt Entities
7.07 Nongovernmental not-for-profit health care organizations usually 
seek exemption from federal income tax under IRC sec. 501(a). Under IRC sec. 
501(a), entities organized and operated exclusively for religious, charitable, or 
educational purposes, as described in IRC sec. 501(c)(3), are exempt from 
federal income taxes. The following are additional requirements for such 
entities:
a. No part of the entity’s net earnings, either directly or indirectly, 
inures to any private shareholder or individual.
b. No substantial part of the entity’s activities consists of carrying on 
propaganda or otherwise attempting to influence legislation. (IRC 
sec. 501(h) provides a limited exception to the general rule that public 
charities may not incur expenditures to influence legislation.)
c. The entity does not participate in, or intervene in, any political 
campaign on behalf of any candidate for public office.
7.08 The term charitable is used in IRC sec. 501(c)(3) in its generally 
accepted legal sense. Providing health care to the community is considered a 
charitable activity. Therefore, provided a health care entity is not organized or 
operated for the benefit of private interests (such as designated individuals, 
the founder or the founder’s family, shareholders of the entity, or persons 
controlled directly or indirectly by such private interests), it generally would 
qualify as an IRC sec. 501(c)(3) organization.
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7.09 The Internal Revenue Service (IRS) has ruled that in order for a 
nursing home to establish its exemption as a public charitable organization 
under IRC sec. 501(c)(3), it must be operated to meet the primary needs of the 
elderly for housing, health care, and financial security. Operating for financial 
security generally means that an individual will be maintained in residence 
even if such individual can no longer pay residence fees.
Private Inurement
7.10 Under IRC sec. 501(c)(3) no part of the net earnings of the charitable 
organization shall inure to the benefit of any private shareholder or individual.
A  private shareholder or individual refers to a person or persons having a 
private or personal interest in the activities of the organization. The IRS has 
stated that physicians have a personal or private interest in the activities of a 
hospital and could be subject to the private inurement proscription.
Unrelated Business Income Tax
7.11 Although not-for-profit organizations may be exempt from federal 
income tax, they nevertheless may be subject to tax on unrelated business 
income. The objective of the tax on unrelated business is to place such activities 
on the same basis as that of taxable entities. Unrelated business income is the 
income from any regularly carried-on trade or business, the conduct of which 
is not substantially related to the exercise or performance of the organization’s 
tax-exempt purpose or function. The fact that proceeds from an activity are 
used exclusively for the entity’s tax-exempt purpose does not make the activity 
substantially related to its tax-exempt purpose or function. As is the case with 
most tax-related definitions, there are qualifications and exceptions. Some of 
the more significant exclusions from this tax include—
•  An annual specific deduction for certain limited activities.
•  Income from activities of which substantially all the work is performed 
by unpaid volunteers.
•  Income from activities carried on for the convenience of the entity’s 
patients, officers, or employees.
•  Dividends, interest, annuities, royalties, capital gains and losses, and 
rents from real property—with two major exceptions. The first excep­
tion is that income from investments that are debt-financed and 
otherwise not functionally related to the tax-exempt purpose is tax­
able. The second major exception makes taxable the interest, annui­
ties, royalties, and rents received from a controlled (80-percent-owned) 
taxable corporation or partnership unless this entity is engaged in an 
activity that would have been exempt if  it were carried on directly by 
the not-for-profit organization.
Financial Statement Presentation
7.12 Financial reporting and disclosure requirements for current liabili­
ties and long-term obligations of health care organizations are the same as for 
other business organizations. In addition, with respect to CCRCs, the method 
of accounting for advance fees, the method of calculating the obligation to 
provide future services and use of facilities, and the refund policy for refund­
able fees are disclosed in the financial statements. Chapter 14 describes other
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disclosure requirements applicable to CCRCs. Taxable entities have the same 
financial reporting and disclosure requirements as other commercial enter­
prises. Tax-exempt entities should disclose their tax-exempt status.
Long-Term Debt
7.13 Significant sums of money are required to replace and upgrade 
buildings and expand the facilities of health care organizations. As a result, 
health care organizations are dependent on external sources of funds to satisfy 
their capital needs. Many health care organizations finance acquisitions, addi­
tions, and renovations with long-term debt.
7.14 In addition to serving as a financing source for government opera­
tions, tax-exempt debt frequently is issued by state and local governments on 
behalf of nongovernmental organizations (for example, not-for-profit organiza­
tions) to foster private-sector participation in certain desirable community 
activities such as the provision of health care services. Tax-exempt bonds 
usually can be issued to obtain a higher ratio of project financing (up to 100 
percent), a longer maturity period (up to thirty years), and a lower interest cost 
than taxable bonds. The majority of tax-exempt bonds issued by health care 
organizations are revenue bonds, which are bonds secured by a pledge of the 
entity’s revenues. General obligation bonds are secured by the revenues of the 
issuing authority.
Financing Authorities
7.15 Because most providers legally cannot issue tax-exempt revenue 
bonds directly, a significant number of states have enacted legislation permit­
ting health care organizations to borrow funds for capital projects by issuing 
bonds through financing authorities. Financing authorities are authorized to 
issue tax-exempt bonds or other obligations and use the proceeds for the 
benefit of the health care organization. To obtain project financing, a health 
care organization sometimes is required by a financing authority to enter into 
a lease arrangement, a sublease arrangement, or both. At other times, a lease 
or sublease arrangement is not required.
7.16 When a financing authority issues tax-exempt bonds or similar debt 
instruments and uses the proceeds for the benefit of a health care organization, 
the obligation is reported as a liability in the organization’s balance sheet i f  the 
health care organization is responsible for repayment. In some cases, this 
obligation may take the form of a liability arising from a capital lease. I f  a 
health care organization has no obligation to make payments of principal and 
interest on the debt or capital or operating lease payments on related buildings 
or equipment, the organization should not reflect the liability on its balance 
sheet. In such circumstances, proceeds from the bond issue are reported as 
contributions from the sponsoring organization.
Assets Whose Use is Limited
7.17 Among the many provisions normally included in the bond inden­
tures of tax-exempt issues are the requirements to set aside funds annually 
from operations to ensure that bond principal, interest payments, and other 
requirements are met. The treatment of funds established under the terms of 
debt-financing instruments is discussed in paragraphs 1.16 and 1.17.
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Advance Refundings
7.18 In an advance refunding, new debt is issued for the purpose of replacing 
an existing debt issue. Advance refundings enable providers to restructure 
their long-term liabilities, take advantage of reduced interest rates, or termi­
nate restrictive bond covenants. The terms by which the debt may be satisfied 
legally and the related lien released without the debt necessarily being retired 
are spelled out in the debt instrument. Under the Tax Reform Act of 1986, 
bonds issued before January 1, 1986, may be advance refunded only twice. 
Bonds issued on or after that date may be advance refunded only once.
7.19 The accounting, financial reporting, and disclosure requirements for 
advance refundings entered into by health care organizations other than 
governmental entities are described in FASB Statements No. 4, Reporting 
Gains and Losses from Extinguishment of Debt (as amended),* No. 140, Ac­
counting for Transfers and Servicing of Financial Assets and Extinguishments 
of Liabilities, and FASB Interpretation No. 39, Offsetting of Amounts Related 
to Certain Contracts.1 Generally speaking, these entities are required to report 
any gain or loss resulting from an advance refunding as an extraordinary item 
in the financial statements of the period in which the refunding occurred. The 
accounting, financial reporting, and disclosure requirements for advance re­
fundings (and for current refundings) entered into by governmental health 
care entities are set forth in GASB Statements No. 23, Accounting and Finan­
cial Reporting for Refundings of Debt Reported by Proprietary Activities, and 
No. 7, Advance Refundings Resulting in Defeasance of Debt. Generally speak­
ing, governmental entities are required to amortize any gain or loss resulting 
from a current or advance refunding to interest expense over the shorter of the 
life of the new bonds or the remaining life of the old bonds.
7.20 There are several types of advance refundings, including net ad­
vance refundings, full cash advance refundings, and crossover refundings (see 
the Glossary). In a crossover refunding, because the old bonds are not defeased 
until the crossover date, no immediate gain or loss should be recognized. I f  the 
retirement dates of the old debt have been established, the call premium, 
unamortized premium or discount, and initial issue costs should be recognized 
systematically in the income statement over the remaining life of the old debt 
as an adjustment of the cost of borrowing related to the old debt. In addition, 
the income earned on the funds used to consummate the advance refunding 
and the interest expense on both the old and new debts should be recognized 
in the statement of operations. The funds used to consummate the advance
* FASB Statement No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of  
FASB Statement No. 13, and Technical Corrections, among other matters, rescinds FASB Statement 
No. 4, Reporting Gains and Losses from Extinguishment of Debt. The provisions of FASB Statement 
No. 145 related to the rescission of FASB Statement No. 4 shall be applied in fiscal years beginning 
after May 15, 2002, with early application encouraged. This chapter will be modified in a future 
edition of the Guide to reflect the provisions of FASB Statement No. 145.
1 Emerging Issues Task Force (EITF) Issue No. 96-19, Debtor’s Accounting for a Modification or 
Exchange of Debt Instruments, addresses accounting for modifications or exchanges of debt instru­
ments. EITF Issue No. 96-19 requires that (1) an exchange of debt instruments with substantially 
different terms is a debt extinguishment and should be accounted for in accordance with paragraph 
16 of FASB Statement No. 125; and (2) a substantial modification of terms should be accounted for 
like, and reported in the same manner as an extinguishment. Also, transactions involving the 
modification or exchange of debt instruments can only result in gain or loss recognition by the debtor 
if the conditions for extinguishment of debt described in paragraph 16 of FASB Statement No. 125 are 
satisfied or if the consensus in Issue No. 96-19 requires that accounting. FASB Statement No. 140, 
among other matters, replaces FASB Statement No. 125. FASB Statement No. 140 does not change 
the guidance dealing with accounting for extinguishments of liabilities.
AAG-HCO 7.20
96 Health Care Organizations
refunding should be reported as an asset and both the old and new debts should 
be reported as liabilities. The assets and liabilities should not be offset.*
7.21 FASB Statement No. 140 provides accounting and reporting stand­
ards for extinguishments of liabilities. Paragraph 16 of FASB Statement No. 
140 says a debtor should derecognize a liability if and only if  it has been 
extinguished. Paragraph 16 says a liability has been extinguished if  either of 
the following conditions is met:
a. The debtor pays the creditor and is relieved of its obligation for the 
liability. Paying the creditor includes delivery of cash, other financial 
assets, goods, or services or reacquisition by the debtor of its out­
standing debt securities whether the securities are canceled or held 
as so-called treasury bonds.
b. The debtor is legally released from being the primary obligor under 
the liability, either judicially or by the creditor [footnote omitted].
Paragraph 114 of FASB Statement No. 140 provides related guidance.
7.22 Paragraph 17b of FASB Statement No. 140 requires that, i f  an entity 
had debt that was considered to be extinguished by an in-substance defeasance 
under the provisions of FASB Statement No. 76 prior to the effective date of 
FASB Statement No. 125, the entity should provide a general description of the 
transaction and the amount of debt that is considered extinguished at the end 
of the period so long as that debt remains outstanding.
Arbitrage Rebate Liabilities
7.23 Advance refundings involving tax-exempt debt are subject to arbi­
trage rules under the IRC sec. 103(c) and related regulations that, in general, 
prohibit the yield realized from the investment of the proceeds of the new debt 
from exceeding the yield on the debt itself. Compliance with those rules is 
necessary for the interest on the debt to be exempt from federal income tax and, 
possibly, from state and local tax.
7.24 Whenever a provider invests tax-exempt bond proceeds and the 
ultimate yield is higher than the interest rate on the bonds, the provider may 
be subject to an arbitrage rebate liability. The arbitrage determination is made 
as of the date of the issue; however, intentional acts undertaken after the date 
of the issue can disqualify the issue retroactively. The earnings in excess of 
interest expense represent a liability that must be paid to the U.S. Treasury in 
order for the bonds to maintain their tax-exempt status. The arbitrage rebate 
liability may be a substantial amount if the bond proceeds are not spent as 
quickly as planned. For example, this may occur if  a provider encounters a 
delay in a major construction project.
Auditing
7.25 Auditing objectives and procedures for long-term debt issued by 
health care organizations generally are similar to those of other organizations. 
In addition, the independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
that are presented in exhibit 7-1.
* Public companies may also refer to the interpretations in Securities and Exchange Commission 
(SEC) Staff Accounting Bulletin (SAB) No. 94. This SAB expresses the views of the SEC staff regarding 
the period in which a gain or loss is recognized on early extinguishments of debt and the periods over 
which deferred debt issue costs and debt premium or discount should be amortized. SABs represent 
interpretations and practices followed by the staff of the Office of the Chief Accountant and the Division 
of Corporation Finance in administering the disclosure requirements of federal securities laws.
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Exhibit 7-1
Auditing Considerations
Financial Statement 
Assertions
Tax-Exempt Debt
Presentation and 
disclosure
Income Taxes
Rights and 
obligations
Procedures 
ensure that the 
providers 
monitor their 
compliance with 
restrictive debt 
covenants.
Management 
monitors 
compliance with 
applicable tax 
regulations.
Transactions are 
reviewed for 
their effect on tax 
status and tax 
liabilities.
Review the debt 
instruments for 
the presence of 
any restrictive 
debt covenants.
Test compliance 
with restrictive 
debt covenants.
Determine that 
the not-for-profit 
organization has 
obtained a 
determination of 
its tax-exempt 
status.
Inquire if tax 
returns have been 
filed on a timely 
basis.
Determine the 
status of the tax 
returns under 
examination.
Read the prior 
years’ tax returns.
Read the minutes 
and the 
accounting for 
evidence of 
significant 
unrelated 
business activities.
Review for 
reasonableness
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Amounts related 
to tax-exempt 
debt are properly 
classified in the 
financial 
statements and 
related
disclosures are 
adequate.
The not-for-profit 
organization has 
obtained a 
qualifying income 
tax exemption 
from the 
governmental 
authority.
Specific Auditing 
Objectives
Selected Control 
Activities
Auditing
Procedures
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Financial Statement
Assertions
Presentation and 
disclosure
Specific Auditing Selected Control 
Objectives Activities
The entity’s 
tax-exempt status 
and its tax 
contingencies are 
disclosed in the 
notes to the 
financial 
statements.
Auditing
Procedures
the unrelated 
business income 
tax liability.
Determine that 
the entity’s 
tax-exempt status 
is disclosed in the 
notes to the 
financial 
statements.
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Chapter 8 
Commitments and Contingencies
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis —for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
Overview
8.01 Commitments and contingencies may include (a) losses arising from 
litigation, including malpractice and other claims; (b) contingencies related to 
risk contracting; (c) third-party payment and rate-setting programs; (d) con­
struction contract commitments; (e) the Hill-Burton Act obligation to provide 
uncompensated care; (f ) commitments and guarantees that include contractual 
agreements with physicians, specialists, and others who perform services by 
arrangement with health care organizations; and (g) commitments and contin­
gent liabilities related to pension plans, operating leases, purchase commit­
ments, and loan guarantees.
8.02 FASB Statement No. 5, Accounting for Contingencies, as amended 
and interpreted, and FASB Interpretation No. 14, Reasonable Estimation of 
the Amount of a Loss, provide guidance on accounting for contingencies.* FASB 
Statement No. 60, Accounting and Reporting by Insurance Enterprises, dis­
cusses accounting for claims costs, including estimates of costs relating to 
IBNR claims. Governmental health care entities should consider the account­
ing and disclosure requirements of GASB Statement No. 10, Accounting and 
Financial Reporting for Risk Financing and Related Insurance Issues, as 
amended by GASB Statement No. 30, Risk Financing Omnibus, and Interpre­
tation No. 4, Accounting and Financial Reporting for Capitalization Contribu­
tions to Public Entity Risk Pools.
Medical Malpractice Claims
8.03 The extent of risk transfer is key in determining whether a liability 
should be recognized in a provider’s financial statements pertaining to mal­
practice claims. The existence of an insurance policy, by itself, is no assurance 
that the risk of financial loss is transferred.
* FASB Interpretation No. 45, Guarantor’s Accounting and Disclosure Requirements for Guar­
antees, Including Indirect Guarantees of Indebtedness of Others, an interpretation of FASB Statement 
No. 5, Accounting for Contingencies, clarifies the requirements of FASB Statement No. 5 relating to 
the guarantor’s accounting for and disclosures of certain guarantees issued. FASB Interpretation No. 
45 does not apply to certain guarantee contracts, including guarantees issued by an insurance or 
reinsurance company and accounted for under FASB Statement No. 60, Accounting and Reporting by 
Insurance Enterprises. Initial recognition and initial measurement provisions apply on a prospective 
basis to guarantees issued or modified after December 31, 2002, irrespective of the guarantor’s fiscal 
year-end. The disclosure requirements are effective for financial statements of interim or annual 
periods ending after December 15, 2002. This chapter will be modified to refer to the requirements in 
FASB Interpretation No. 45 in a future edition of the Guide.
AAG-HCO 8.03
100 Health Care Organizations
8.04 I f  the entity has purchased a claims-made insurance policy (see 
paragraph 8.13), there is no transfer of risk for claims not reported to the 
insurance carrier within the policy term. With regard to retrospectively rated 
insurance policies (see paragraphs 8.14 and 8.15) and policies by captive 
insurance companies (see paragraphs 8.16 through 8.19), the economic sub­
stance of the terms of the insurance policy may more closely resemble a claims 
funding mechanism than an instrument that transfers risk of loss to an 
external third party. I f  the health care organization has not transferred risk to 
an external third party, it should evaluate its exposure to losses arising from 
malpractice claims and record a liability, if appropriate.
Accruing Malpractice Liabilities
8.05 The ultimate costs of malpractice claims, which include costs associ­
ated with litigating or settling claims, are accrued when the incidents that give 
rise to the claims occur. Estimated losses from asserted and unasserted claims 
are accrued either individually or on a group basis, based on the best estimates 
of the ultimate costs of the claims and the relationship of past reported 
incidents to eventual claims payments. All relevant information, including 
industry experience, the entity’s own historical experience, the entity’s existing 
asserted claims, and reported incidents, is used in estimating the expected 
amount of claims. The accrual includes an estimate of the losses that will result 
from unreported incidents, which are probable of having occurred before the 
end of the reporting period.
8.06 In estimating the probability that unreported incidents have oc­
curred, some health care organizations may develop a range of possible esti­
mates of the number of unreported incidents, including zero. However, the 
greater the volume of a health care organization’s operations, the greater the 
likelihood that the organization’s minimum estimate of the number of probable 
unreported incidents will be greater than zero.
8.07 I f  it is probable that a loss has been incurred and the information 
available indicates the loss is within a range of amounts, the most likely 
amount of loss in the range is accrued. I f  no amount in the range is more likely 
than any other, the minimum amount in the range is accrued. The potential 
additional loss is disclosed if there is at least a reasonable possibility of a loss 
in excess of the amount accrued.
8.08 In estimating losses from malpractice claims, a health care organi­
zation may need to modify data drawn from industry experience so it is 
relevant to developing an estimate that is specific to the organization. Various 
factors (such as the nature of operations, size, and the provider’s past experi­
ence) are considered in assessing comparability. Further, industry data that 
are not current may not be relevant.
8.09 Estimated losses are reviewed and changed, if necessary, at each 
reporting date. The amounts of the changes are recognized currently as addi­
tional expense or as a reduction of expense.
8.10 Accrued unpaid claims and expenses that are expected to be paid 
during the normal operating cycle (generally within one year of the date of the 
financial statements) are classified as current liabilities. All other accrued 
unpaid claims and expenses are classified as noncurrent liabilities.
8.11 A  health care organization discloses its program of medical malprac­
tice insurance coverages and the basis for any related loss accruals. I f  the 
organization cannot estimate losses relating to a particular category of malpractice 
claims (for example, asserted claims, reported incidents, or unreported incidents)
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in accordance with paragraphs 8.03 through 8.10, the potential losses related 
to that category of claims are not accrued. However, the contingency is dis­
closed in the notes to the financial statements, as required by FASB Statement 
No. 5.
8.12 Health care organizations that discount accrued malpractice claims 
should disclose in the notes to the financial statements the carrying amount of 
accrued malpractice claims that are discounted in the financial statements and 
the interest rate or rates used to discount those claims. Also, the FASB has 
issued FASB Concepts Statement No. 7, Using Cash Flow Information and 
Present Value in Accounting Measurements. This Concepts Statement provides 
useful discussion of general principles governing the use of present value, and 
of the objective of present value in accounting measurements. Statements of 
Financial Accounting Concepts are not sources of established accounting prin­
ciples as described in SAS No. 69, The Meaning of Present Fairly in Conformity 
with Generally Accepted Accounting Principles, and, thus, do not amend, 
modify, or justify a change from generally accepted accounting principles 
currently in effect.
Accounting for Claims-Made Insurance Policies and 
Tail Coverage
8.13 A  claims-made insurance policy represents a transfer of risk within 
the policy limits to the insurance carrier for asserted claims and incidents 
reported to the insurance carrier. The policy, however, does not represent a 
transfer of risk for claims and incidents not reported to the insurance carrier 
during the policy period. Consequently, a health care organization that is 
insured under a claims-made insurance policy recognizes the estimated cost of 
those claims and incidents not reported to the insurance carrier, in accordance 
with paragraphs 8.03 through 8.10. This estimation is done unless the health 
care organization has bought tail coverage (see the Glossary) and included the 
cost of the premium as an expense in the financial statements for that period.
Accounting for Retrospectively Rated Premiums
8.14 A  health care organization with a retrospectively rated insurance 
policy whose ultimate premium is based primarily on the health care organi­
zation’s loss experience accounts for the minimum premium as an expense over 
the period of coverage under the policy and accrues estimated losses from 
asserted and unasserted claims in excess of the minimum premium, as indi­
cated in paragraphs 8.03 through 8.10. Such estimated losses, however, are not 
accrued in excess of a stipulated maximum premium. I f  the health care 
organization cannot estimate losses from asserted or unasserted malpractice 
claims, as indicated in paragraphs 8.03 through 8.10, the health care organi­
zation should disclose the existing contingency in the notes to the financial 
statements, as required by FASB Statement No. 5.
8.15 A  health care organization insured under a retrospectively rated 
policy whose ultimate premium is based primarily on the experience of a group 
of health care organizations amortizes the initial premium to expense on a pro 
rata basis over the policy term. The organization also accrues additional 
premiums or refunds on the basis of the group’s experience to date, which 
includes a provision for the ultimate cost of asserted and unasserted claims 
before the financial statement date, whether reported or unreported. The 
health care organization discloses that (a) it is insured under a retrospectively
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rated policy and (b) premiums are accrued based on the ultimate cost of the 
experience to date of a group of organizations. I f  the health care organization 
cannot estimate losses from asserted or unasserted malpractice claims, as 
indicated in paragraphs 8.03 through 8.10, it should disclose the existing 
contingency in the notes to the financial statements, as required by FASB 
Statement No. 5.
Accounting for Medical Malpractice Claims Insured by 
Captive Insurance Companies
8.16 A  majority-owned captive insurance company (for example, a wholly 
owned captive) is consolidated in accordance with FASB Statement No. 94, 
Consolidation of All Majority-Owned Subsidiaries.* Multi provider captives, in 
which the ownership percentage is 50 percent or less, are accounted for in 
accordance with APB Opinion No. 18, The Equity Method of Accounting for 
Investments in Common Stock. (See chapter 11 of the Guide for additional 
discussion of considerations related to consolidation and the use of the equity 
method.)
8.17 A  health care organization insured by an unconsolidated multi 
provider captive insurance company for medical malpractice claims under a 
retrospectively rated insurance policy whose ultimate premium is based pri­
marily on the health care organization’s experience up to a maximum pre­
mium, if any, accounts for such insurance as indicated in paragraph 8.14.
8.18 A  health care organization insured by an unconsolidated multi 
provider captive insurance company for medical malpractice claims under a 
retrospectively rated policy based primarily on the experience of a group of 
health care organizations accounts for such insurance as indicated in para­
graph 8.15. However, the health care organization considers whether the 
economic substance of the multi provider captive insurance company is suffi­
cient to relieve the health care organization from further liability. The health 
care organization should disclose that (a) it is insured under a retrospectively 
rated policy of a multi provider captive insurance company and (b) the premi­
ums are accrued based on the captive insurance company’s experience to date.
8.19 A health care organization that is insured by a multi provider captive 
insurance company discloses in its financial statements that it is insured by 
such a company, and it should disclose its ownership percentage, i f  significant, 
in the captive company as well as the method of accounting for its investment 
in, and the operations of, the captive company. In addition, if the health care 
organization cannot make the necessary estimates of losses from asserted or 
unasserted claims, as indicated in paragraphs 8.03 through 8.10, the health 
care organization discloses the existing contingency in the notes to the finan­
cial statements, as required by FASB Statement No. 5.
Accounting for Trust Funds
8.20 In general, a trust fund, whether legally revocable or irrevocable, is 
included in the financial statements of the health care organization. A  portion of
* On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 15, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and amend APB Opinion No. 18. In July 2002, the FASB released an exposure draft of a proposed 
Interpretation, Consolidation of Certain Special-Purpose Entities, which would provide guidance for 
certain specific situations. After completing its deliberations relating to the specific situations, the 
FASB then will continue its consideration of the broader proposals in the 1999 exposure draft.
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the fund equal to the amount of assets expected to be liquidated to pay 
malpractice claims classified as current liabilities is classified as a current 
asset; the balance of the fund, i f  any, is classified as a noncurrent asset. 
Revenues and administrative expenses of the trust fund are included in the 
statement of operations (see chapter 10). In some circumstances, the foregoing 
may not be possible (for example, if a common trust fund exists for a group of 
health care organizations; i f  the health care organization is part of a common 
municipality risk-financing internal service fund; or i f  the legal, regulatory, or 
indenture restrictions prevent the inclusion of a trust fund in a health care 
organization’s financial statements). In those circumstances, the provisions of 
paragraphs 8.21 and 8.22 apply.
8.21 In general, estimated losses from asserted and unasserted claims are 
accrued and reported, as indicated in paragraphs 8.03 through 8.12. The estimated 
losses are not based on payments to the trust fund. However, accounting for a 
health care organization that participates in a pooled fund depends on the 
extent to which the associated risks and rewards have been transferred to another 
party. An organization that transfers its risk of loss to the common trust fund and 
forfeits its rights to any excess funding should expense its contributions and 
account for its participation in the trust fund based on the type of coverage 
obtained (for example, occurrence basis, claims-made, or retrospectively rated). 
Governmental health care entities that are component units of a state or local 
government reporting entity and that participate in that entity’s risk-financing 
internal service fund should report claims expenses equal to the charges from the 
internal service fund if those charges meet the requirements of paragraphs 65 
through 68 of GASB Statement No. 10.
8.22 The existence of the trust fund and whether it is irrevocable is 
disclosed in the financial statements.
Governmental Health Care Enterprises
8.23 Governmental health care enterprises that are component units of a 
state or local governmental reporting entity and that participate in that 
entity’s risk-financing internal service fund should report claims expenses 
equal to the charges from the internal service fund if those charges meet the 
requirements of paragraphs 65 through 68 of GASB Statement No. 10. A 
governmental health care enterprise that participates in a public entity risk 
pool with transfer or pooling of risk should present its premium or required 
contribution as insurance expense, as discussed in GASB Statement No. 10, 
paragraphs 69 and 70. Enterprises participating in public entity risk pools 
without transfer or pooling of risk should report payments to pools as deposits 
and recognize and measure claims liabilities in accordance with GASB State­
ment No. 10, paragraphs 53 through 58.
Auditing Commitments and Contingencies
8.24 Auditing objectives and procedures for commitments and contingen­
cies generally are similar to those of other organizations. The independent 
auditor may need to consider the specific auditing objectives, selected control 
activities, and auditing procedures presented in exhibit 8-1 at the end of this 
chapter.
Auditing Medical Malpractice Loss Contingencies
8.25 The existence of an insurance policy, by itself, is no assurance that 
malpractice contingencies are assumed by others. The auditor should review
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the insurance contracts and determine the extent of the risk retained by the 
provider. Specific auditing procedures to consider include the following:
•  Determine the type (such as occurrence basis or claims-made) and 
level (per occurrence or in the aggregate) of insurance protection the 
provider has obtained.
•  Determine if the coverage actually transfers the malpractice risks. Is 
the insurance with a related party (for example, a captive insurance 
company)? Does it provide for retrospective premiums or similar 
adjustments?
Once the extent of the risk retained is understood, the auditor will be able to 
determine the nature, extent, and timing of other auditing procedures.
8.26 I f  a health care organization has transferred the risk of loss to a 
financially viable third party by purchasing insurance coverage of sufficient 
limits on an occurrence basis, no additional auditing procedures are neces­
sary. I f  the organization retains all or a portion of the risk through self-in­
surance or has purchased a claims-made policy, the independent auditor 
should perform additional auditing procedures to obtain reasonable assur­
ance that the organization’s accounting for medical malpractice losses is in 
accordance with GAAP.
8.27 The independent auditor should consider the extent to which the 
renewal of a claims-made policy or the purchase of tail coverage after the 
balance-sheet date but prior to the issuance of the financial statements limits 
the entity’s liability exposure as of the balance-sheet date. I f an entity either 
renews a claims-made policy or purchases tail coverage, and the new policy 
covers claims asserted during the new policy term (regardless of when the 
incident occurred), the entity has transferred to the insurer the risk for that 
portion of the entity’s claims that is expected to be reported during the new 
policy term (up to the new policy limits). Accordingly, the entity’s liability for 
the IBNR claims transferred would not exceed the premium on the new policy, 
except for anticipated claims in excess of the new policy limits.
8.28 Management’s intent to renew a claims-made policy is not sufficient 
to constitute a limit on IBNR claims as of the balance-sheet date unless 
management contractually obligates itself for renewal before the issuance date 
of the financial statements and the cost is expensed in the period covered by 
the financial statements. The requirement to renew a claims-made policy or to 
purchase and expense tail coverage applies even if state regulations require 
that renewal of claims-made coverage be offered continually.
8.29 I f  the insured has the unilateral option to purchase tail coverage at 
a premium that may not exceed a stipulated maximum, and the provider 
intends to purchase that coverage, the amount of IBNR loss to be accrued may 
effectively be limited to the maximum tail-coverage premium stated in the 
policy. However, providers in these circumstances that do not intend to pur­
chase tail coverage may not accrue the cost of obtaining that coverage as a 
substitute for the IBNR accrual.
Auditing Accounting Estimates
8.30 Management is responsible for making the accounting estimates 
that are included in the financial statements. Management is also responsible 
for providing proper disclosure of (1) the use of estimates in the preparation of 
financial statements and (2) certain significant estimates (SOP 94-6, Disclosure of
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Certain Significant Risks and Uncertainties).1 The auditor is responsible for 
evaluating the reasonableness of management’s estimates and the adequacy of 
the related disclosures. The auditor does this using one or more of the following 
approaches:
a. Test the process used by management to develop the estimate.
b. Develop an independent expectation of the estimate to corroborate 
the reasonableness of management’s estimate.
c. Review subsequent events or transactions occurring prior to comple­
tion of fieldwork.
8.31 In evaluating management’s estimates of asserted and unasserted 
claims, the auditor should consider factors such as management’s description 
and evaluation of asserted claims and unasserted claims arising from reported 
incidents; the lawyer’s (and, i f  appropriate, the outside risk manager’s) assess­
ment of asserted claims and reported incidents not covered by insurers; and 
the actuary’s evaluations of the aggregate liability covering asserted claims 
and unasserted claims arising from reported and unreported incidents.
8.32 Written assurances should be obtained from management that it has 
disclosed all such matters required to be disclosed by FASB Statement No. 5.
8.33 In evaluating the information provided by legal counsel, it may be 
necessary to supplement the written representations with inquiries if the 
representations are not clear regarding the probability of the litigation out­
come or the potential range of loss.2
8.34 The auditor should consider the frequency of losses due to unre­
ported incidents and the magnitude of prior losses and underlying causes for 
the IBNR claims. I f  there is a basis for an accrual, the auditor should then 
determine whether the entity’s prior history supports the estimation of the 
number of claims and the probable settlement value.
Use of Actuaries and Actuarial Methods
8.35 An actuary may be engaged to provide or review the estimate of the 
medical malpractice loss amount or range of amounts or to assist in developing 
certain factors and assumptions used in estimating the malpractice liability. 
The decision to use an actuary should be based on a consideration of whether 
(a) the estimated claim liability is potentially material to the fair presentation 
of financial statements in conformity with GAAP and (b) special knowledge is 
required to estimate the claim liability.
8.36 I f  an actuary is involved in a substantial way in determining the 
amount of a provider’s malpractice self-insurance liability, the independent 
auditor should follow the requirements of SAS No. 73, Using the Work of a 
Specialist (AICPA, Professional Standards, vol. 1, AU sec. 336). The independent
1 See paragraphs 8.40 through 8.43. SOP 94-6 does not pertain to governmental entities unless 
the entity has elected to follow all FASB pronouncements under paragraph 7 of GASB Statement No. 
20, Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That 
Use Proprietary Fund Accounting. (See footnote 1 in chapter 1.)
2 According to SAS No. 12, Inquiry of a Client’s Lawyer Concerning Litigation, Claims, and 
Assessments (AICPA, Professional Standards, vol. 1, AU sec. 337), a letter of audit inquiry to the 
lawyer handling the claims is the auditor’s primary means of obtaining corroboration of the informa­
tion furnished by management concerning claims made and known incidents for which claims have 
not been made that are either uninsured or in excess of the insurance coverage. Audit inquiry letters 
generally would not be required with respect to reported contingencies that were not considered to 
have a material potential loss. The inability or unwillingness of counsel to evaluate asserted claims 
and or reported incidents would give rise to a modification of the auditor’s opinion.
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auditor should consider the actuary’s professional qualifications, reputation, 
prior experience in estimating malpractice claim losses, and relationship to the 
client. There should be an understanding among the auditor, the client, and 
the actuary of the objectives and scope of the analysis and the methods and 
assumptions used. The independent auditor should be aware of (a) the limita­
tions of assurances in actuarial calculations due to uncertainties and (b) 
restrictions as to the use of the actuarial reports. The independent auditor is 
responsible for determining the adequacy of the actuary’s report for purposes 
of corroborating the representations in the financial statements. The inde­
pendent auditor should perform an appropriate test of the accounting data 
provided by the client to the actuary. Such accounting data may include 
historical claim experience, policy terms (such as coverage, expiration, deduct­
ibles, presence of retrospectively determined premiums, and indemnity limita­
tions), exposure data (such as the number of beds, high-risk medical 
specialties, outpatient visits, and emergency room visits), and information 
about risk management systems, personnel, and procedures.
8.37 An accrual for malpractice losses should be based on estimated 
ultimate losses and costs associated with settling claims. Accruals should not 
be based on recommended funding amounts, which in addition to a provision 
for the actuarially determined liability also includes a provision for (a) credit 
for investment income and (b) a margin for risk of adverse deviation. The 
following are examples of factors to consider and adjustments that may be 
required to convert actuarially determined malpractice funding amounts to an 
appropriate loss accrual to be reported in the financial statements:
•  The risk of adverse deviation is an additional cost factor applied to 
bring a funding requirement to a selected confidence level. This factor 
does not meet the criteria for recognition as a liability in accordance 
with FASB Statement No. 5.
•  An evaluation should be made of the extent and validity of industry 
data when the credibility factor actuarial technique is used. The lower 
the credibility factor, the greater the blending of industry data. This 
may create an unacceptable level of industry data at lower confidence 
levels. Further, a low credibility factor may indicate that provider-spe­
cific data is not sufficient to support the claims liability estimation 
process.
•  A  review of the discounting approach used is necessary to develop the 
required disclosure. The impact on the discounting calculation of any 
other adjustment made to the actuarially determined amounts (such 
as risk of adverse deviation or the credibility of the risk management 
system) has to be evaluated.
•  A  review of the expenses included in the loss estimation process should 
be made. Such expenses include the expense of settlement and litiga­
tion (that is, allocated loss adjustment expenses).
8.38 Limitations on the availability of provider-specific data, lack of a suffi­
cient patient population for claims projection purposes, a very low credibility 
factor, and a variety of other factors may cause the actuary’s estimate of loss to be 
of limited value in developing an estimate of the liability under GAAP.
Risks and Uncertainties
8.39 Uncertainties arise when the evidence available is insufficient for a 
reasonable estimation of the effects of the outcome of a particular future event 
on the current financial statements. Normally, the resolution of the uncertainty is
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prospective, and sufficient evidence cannot be expected to exist at the time of 
the audit. In these situations, it cannot be determined what adjustments, if 
any, to the financial statements may be appropriate. The existence of such an 
uncertainty, i f  material, ordinarily should result in the inclusion of an explana­
tory paragraph in the auditor’s report. In certain circumstances, the possi­
ble effects of the uncertainty on the financial statements may be so pervasive 
that the balance of the financial statements has little meaning. In these cases, 
a disclaimer of opinion may be appropriate.
8.40 SOP 94-6 requires entities to include in their financial statements 
information about—
a. The nature of their operations.
b. Use of estimates in the preparation of financial estimates.
In addition, i f  certain specified disclosure criteria are met, it requires entities 
to include in their financial statements disclosures about—
a. Certain significant estimates.
b. Current vulnerability due to certain concentrations.
8.41 Paragraph 18 of SOP 94-6 gives examples of items that may be based 
on estimates that are particularly sensitive to changes in the near term. 
Examples of similar estimates that may be included in financial statements of 
health care organizations include, but are not limited to, the following:
•  Third-party revenue and related receivables
•  Assets subject to impairment, for example, goodwill
•  Environmental remediation-related obligations
•  Litigation-related contingencies, for example, fraud and abuse actions 
by regulators
•  Estimated risk pool settlements arising from managed care contracting
•  Amounts reported for long-term obligations such as amount reported 
for pensions and postemployment benefits
•  Estimated net proceeds recoverable, the provisions for expected loss 
to be incurred, or both, on disposition of a business or assets
8.42 SOP 00-1 provides guidance to auditors regarding uncertainties 
inherent in health care revenue recognition. Examples of risks unique to the 
government-contracting environment are presented in paragraph 7 of the SOP. 
Also, in the health care environment, it is almost always at least reasonably 
possible that estimates regarding third-party payments could change in the 
near term as a result of one or more future confirming events (for example, 
regulatory action reflecting local or national audit or enforcement initiatives). 
For most entities with significant third-party revenues, the effect of the change 
could be material to the financial statements. Where material exposure exists, 
the uncertainty regarding revenue realization is disclosed in the notes to the 
financial statements.3
8.43 Examples of concentrations that may meet the criteria that require 
disclosure in the financial statements of health care organizations in accord­
ance with paragraph 21 of the SOP include the following:
•  Concentrations in the volume of business transacted with a particular 
payor, supplier, lender, grantor, or contributor
3 A sample disclosure is provided in SOP 00-1 that among other things indicates laws and 
regulations governing the Medicare and Medicaid programs are extremely complex and subject to 
interpretation. As a result, there is at least a reasonable possibility that recorded estimates will 
change by a material amount in the near term. SOP 00-1 is included as appendix E to this Guide.
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•  Concentrations in revenue from particular products, services, or fund­
raising events
•  Concentrations in the available sources of supply of material, labor, or 
services, or of licenses or other rights used in the entity’s operations
•  Concentrations in the market or geographic area in which an entity 
conducts its operations
Evaluating Lawyers' Responses
8.44 Determining the outcome of pending or threatened litigation, claims 
and assessments (including unasserted claims and assessments) normally is 
beyond the auditor’s professional competence. Accordingly, the auditor’s evalu­
ation of the need for disclosures or report modifications is based primarily on 
the opinion of the lawyer handling the matter. The American Bar Association 
(ABA) has adopted a Statement of Policy Regarding Lawyers’ Responses to 
Auditors’ Requests for Information under which lawyers accept certain respon­
sibility for responses to auditors’ inquiries. However, the ABA Statement of 
Policy is not enforceable by the ABA in the same way the AICPA is able to 
enforce its standards under the accounting profession’s Code of Professional 
Conduct. As a result, lawyers’ responses may vary widely.
8.45 Interpretation No. 7 of SAS No. 12, entitled “Assessment of a Law­
yer’s Evaluation of the Outcome of Litigation” (AICPA, Professional Stand­
ards, vol. 1, AU sec. 9337.18-.22) includes the following examples of 
evaluations of litigation, which may be considered to communicate in a suffi­
ciently clear manner a remote likelihood of an unfavorable outcome:
•  “We are of the opinion that this action will not result in any liability 
to the company.”
•  “It is our opinion that the possible liability to the company in this 
proceeding is nominal in amount.”
•  “We believe the company will be able to defend this action successfully.”
•  “We believe that the plaintiff's case against the company is without 
merit.”
•  “Based on the facts known to us, after a full investigation, it is our 
opinion that no liability will be established against the company in 
these suits.”
8.46 On the other hand, the lawyer may use terms, such as meritorious 
defenses, that have different meanings to different lawyers. The Interpretation 
includes the following examples of lawyers’ evaluations that are unclear re­
garding the likelihood of an unfavorable outcome:
•  “This action involves unique characteristics wherein authoritative 
legal precedents do not seem to exist. We believe that the plaintiff will 
have serious problems establishing the company’s liability under the 
act; nevertheless, i f  the plaintiff is successful, the award may be 
substantial.”
•  “It is our opinion that the company will be able to assert meritorious 
 defenses to this action.” (The term “meritorious defenses” indicates
that the company’s defenses will not be summarily dismissed by the 
court; it does not necessarily indicate the lawyer’s opinion that the 
company will prevail.)
•  “We believe the action can be settled for less than the damages 
claimed.”
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•  “We are unable to express an opinion as to the merits of the litigation 
at this time. The company believes there is absolutely no merit to the 
litigation.” (I f the company’s lawyer, with the benefit of all relevant 
information, is unable to conclude that the likelihood of an unfavorable 
outcome is “remote”, it is unlikely that management would be able to 
form a judgment to that effect.)
•  “In our opinion, the company has a substantial chance of prevailing in 
this action.” (A “substantial chance”, a “reasonable opportunity”, or 
similar terms indicate more uncertainty than an opinion that the 
company will prevail.)
8.47 When the lawyer’s response is unclear, the auditor may request a 
conference to clarify the lawyer’s opinion. I f  the response is still unclear or the 
materiality of the uncertainty cannot be determined, the auditor should con­
sider the guidance in paragraphs 29 through 32 of SAS No. 58, Reports on 
Audited Financial Statements, as amended by SAS No. 79, Amendment to 
Statement on Auditing Standards No. 58, Reports on Audited Financial State­
ments (AICPA, Professional Standards, vol. 1, AU sec. 508).
Auditing
8.48 The independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
for commitments and contingencies that are presented in exhibit 8-1.
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Exhibit 8-1
Health Care Organizations
Auditing Considerations
Financial Statement 
Assertions
Specific Auditing 
Objectives
Malpractice Loss Contingencies
Existence and 
occurrence, 
completeness, 
rights and 
obligations, and 
valuation
The liability for 
malpractice 
claims is reported 
properly in the 
balance sheet.
Selected Control 
Activities
Insurance 
coverage is 
reviewed 
regularly, 
including the 
financial viability 
of the insurer.
The risk 
management 
system identifies 
and monitors 
malpractice 
incidents and 
evaluates 
associated losses.
Outside legal 
counsel and 
insurance 
carriers review 
and monitor all 
claims.
The adequacy of
malpractice
accruals is
reviewed
regularly by
management,
including
information
obtained from
qualified
specialists.
Information
supplied to
specialists is
reviewed for
accuracy and
completeness.
Actuarial
assumptions are
Auditing
Procedures
Review the 
amount of 
insurance 
coverage, the type 
of coverage 
(claims-made or 
occurrence), the 
deductible 
provisions, and so 
forth, to 
determine the 
level of risk that 
is retained by the 
entity. Consider 
the financial 
viability of the 
insurance carrier.
Send letters of 
inquiry to 
malpractice 
insurance carriers 
and legal counsel 
(in accordance 
with SAS No. 12).
Review and test 
the method of 
estimating 
accruals (for 
example, review 
actuarial reports 
and prior 
historical loss 
experience).
Determine that 
additional 
premiums 
charged by 
insurers for 
retrospectively 
related policies
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Financial Statement
Assertions
Presentation and 
disclosure
Specific Auditing Selected Control 
Objectives Activities
reviewed for 
compliance with 
GAAP.
Changes in the 
risk management 
system are 
communicated on 
a timely basis.
Commitments and Contingencies
The program of
medical
malpractice
insurance
coverage and the
basis for any loss
accruals are
disclosed
adequately in the
financial
statements.
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Auditing
Procedures
are reported as a 
liability.
Review prior 
estimates and 
historical loss 
experience.
Determine 
whether 
uncertainties 
related to medical 
malpractice 
claims need to be 
disclosed in the 
auditor’s report.
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Net Assets (Equity)
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
Net Assets (Equity) 113
Investor-Owned Health Care Organizations
9.01 The equity accounts of investor-owned health care entities are simi­
lar to those of other investor-owned businesses.
Not-for-Profit and Governmental Health 
Care Organizations
9.02 The balance sheets of not-for-profit health care organizations should 
report separate amounts for each of three classes of net assets:1 (a) perma­
nently restricted net assets, (b) temporarily restricted net assets, and (c) 
unrestricted net assets. This is based on the existence or absence of donor-im­
posed restrictions.
9.03 Unrestricted net assets generally result from revenues from provid­
ing or agreeing to provide health care services, receiving unrestricted contribu­
tions and grants, or receiving dividends or interest from investing in 
income-producing assets minus expenses incurred in providing or agreeing to 
provide health care services, providing other community benefits, and perform­
ing administrative functions. The only limits on the use of unrestricted net 
assets are the broad limits resulting from the nature of the provider’s organi­
zation; the environment in which the organization operates; the purposes 
specified in its articles of incorporation or in its bylaws; or limits resulting from 
contractual agreements with suppliers, creditors, and others entered into in 
the course of business. Information about significant contractual limits, includ­
ing the existence of restrictive debt covenants, generally is provided in the 
notes to the financial statements. Similarly, information about self-imposed 
limits may be provided either on the face of the balance sheet or in the notes to 
the financial statements. Such specifics include information about voluntary 
resolutions by the entity’s governing board to designate a portion of its unre­
stricted net assets for identified purposes (for example, funded depreciation).
9.04 Information about the nature and amounts of different types of 
permanent restrictions or temporary restrictions should be provided either by 
reporting their amounts on the face of the financial statements or by including
1 Though some health care organizations may use other terms, such as equity, this Guide uses 
the term net assets to describe residual interest.
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relevant details in the notes to the financial statements. Separate line items 
may be reported within permanently restricted net assets (or in the notes to 
the financial statements) to distinguish between permanent restrictions for 
holdings of (a) assets, such as land or works of art, donated with stipulations 
that they be used for a specified purpose, be preserved, and not be sold, or (b) 
assets donated with stipulations that they be invested to provide a permanent 
source of income (that is, permanent endowment funds).
9.05 Similarly, separate line items may be reported within temporarily 
restricted net assets (or in the notes to the financial statements) to distinguish 
between temporary restrictions for (a) support of particular operating activi­
ties, (b) investment for a specified term, (c) use in a specified future period, or
(d ) acquisition of long-lived assets. Donors’ temporary restrictions may require 
that resources be used in a later period or after a specified date (time restric­
tions) or that resources be used for a specified purpose (purpose restrictions) or 
both. For example, gifts of cash and other assets with stipulations that they be 
invested to provide a source of income for a specified term and that the income 
be used for a specified purpose are restricted both as to time and purpose.
9.06 Governmental health care entities either report (1) the three classes 
of fund balance or (2) unrestricted (general) and restricted fund balances.
9.07 The nature of the restrictions on donor-restricted resources should 
be disclosed in the financial statements.
Auditing
9.08 The independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
relating to net assets (equity) that are presented in exhibit 9-1.
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Auditing Considerations
Specific Auditing Selected Control Auditing
Objectives Activities Procedures
Financial Statement 
Assertions____
Net Assets (Equity)
Rights and 
obligations
Exhibit 9-1
Resources are 
used and 
accounted for in 
accordance with 
donor and grantor 
restrictions.
Management 
monitors 
compliance with 
these restrictions.
Review the 
minutes of board 
and board 
committee 
meetings for 
evidence of donor 
restrictions.
Determine 
compliance with 
donor and grantor 
restrictions.
Presentation and 
disclosure
Net assets are 
presented and 
disclosed properly 
in the financial 
statements.
Procedures 
ensure proper 
authorization, 
recording, and 
presentation.
Test significant 
net asset 
transactions to 
determine that 
they are properly 
authorized and 
recorded.
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Chapter 10 
Revenue, Expenses, Gains, and Losses
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
Conceptual Framework for Reporting Revenue, 
Expenses, Gains, and Losses
10.01 FASB Concepts Statement No. 6, Elements of Financial State­
ments, provides a useful conceptual framework for preparers of financial 
statements to distinguish among elements of financial statements for purposes 
of display. Additionally, not-for-profit organizations are subject to the require­
ments of FASB Statement No. 117, Financial Statements of Not-for-Profit 
Organizations.1 This chapter draws on the concepts contained in FASB 
Concepts Statement No. 6 and FASB Statement No. 117 in discussing revenue, 
expenses, gains, and losses with respect to health care organizations. Expenses 
are not generally netted against revenues, whereas gains and losses may be 
displayed as net amounts. The application of these concepts to the classifica­
tion of revenue, expenses, gains, and losses in the statement of operations of 
health care organizations is discussed in paragraphs 10.02 through 10.10.
10.02 FASB Concepts Statement No. 6, paragraph 78, defines revenues 
as “inflows or other enhancements of assets of an entity or settlements of its 
liabilities (or a combination of both) from delivering or producing goods, 
rendering services, or other activities that constitute the entity’s ongoing major 
or central operations.” Similarly, paragraph 80 defines expenses as “outflows 
or other using up of assets or incurrences of liabilities (or a combination of both) 
from delivering or producing goods, rendering services, or carrying out other 
activities that constitute the entity’s ongoing major or central operations.”
Distinguishing Charity Care From Bad Debt Expense
10.03 Charity care represents health care services that are provided but 
are never expected to result in cash flows. As a result, charity care does not 
qualify for recognition as receivables or revenue in the financial statements. 
Distinguishing charity care from bad-debt expense requires the exercise of 
judgment. Charity care is provided to a patient with demonstrated inability to 
pay. Each organization establishes its own criteria for charity care consistent 
with its mission statement and financial ability. Only the portion of a patient’s 
account that meets the organization’s charity care criteria is recognized as 
charity. Although it is not necessary for the entity to make this determination
1 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in chapter 1.)
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upon admission or registration of an individual, at some point the entity must 
determine that the individual meets the established criteria for charity care. 
(See paragraph 10.21 for disclosure requirements relating to charity care.)
Revenue
10.04 Revenue usually is recorded when coverage is provided to an en­
rollee or the service is provided to a patient or resident. Revenue is classified 
based on the type of service rendered or contracted to be rendered. Examples 
of revenue include—
• Patient service revenue, which is derived from fees charged for patient 
care. This may be based on diagnosis related group (DRG) payments, 
resource-based relative value scales (RBRVS) payments, per diems, 
discounts, or other fee-for-service arrangements.
•  Premium revenue, which is derived from capitation arrangements.
•  Resident service revenue, which may be related to maintenance fees, 
rental fees, or amortization of advance fees.
10.05 Some not-for-profit health care enterprises may receive relatively 
small amounts of contributions, grants, or tax support. Such amounts, whether 
temporarily restricted, permanently restricted, or unrestricted, are recognized 
as revenue or gains when they are received. Special considerations pertaining 
to revenue recognition of promises to give in future periods (pledges) are 
discussed in chapter 5 and in paragraphs 10.07 through 10.10 in this Guide. 
FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization 
or Charitable Trust That Raises or Holds Contributions for Others,2 estab­
lishes standards for transactions in which a donor makes a contribution by 
transferring assets to a recipient organization—a not-for-profit organization or 
a charitable trust—that accepts the assets from the donor and agrees to use 
the assets on behalf of or transfer the assets, their investment return, or both 
to another entity—the beneficiary—named by the donor.3 If a donor transfers 
assets to an agent, trustee, or intermediary (recipient organization) and speci­
fies a nongovernmental health care organization as the ultimate recipient (the 
specified beneficiary) of the contribution or grant, that specified health care 
organization should recognize its rights to the assets held by a recipient 
organization as an asset and contribution revenue unless the recipient organi­
zation is explicitly granted variance power. (See paragraph 15 of FASB State­
ment No. 136.) Variance power is the unilateral power to redirect the use of the 
transferred assets to an entity or individual other than the specified benefici­
ary. Explicitly grants means that the donor should explicitly refer to the 
recipient organization’s ability to exercise variance power in the instrument 
that transfers the assets. Unilateral power means that the recipient organiza­
tion can override the donor’s instructions without approval from the donor, the 
specified beneficiary, or any other interested party. (See paragraph 12 of FASB 
Statement No. 136.) If the recipient organization is explicitly granted variance 
power, the specified health care organization (beneficiary) should not recognize
2 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1 
in chapter 1.)
3 FASB Statement No. 136 also established standards for transactions that take place in a 
similar manner but are not contributions because the transfers are revocable, repayable, or recipro­
cal. For example, if a resource provider transfers assets to a recipient organization and names itself 
or its affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants 
variance power. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.20,
11.22, and 11.23 of this Guide. This Guide does not use the word donor in discussing those transac­
tions because they are not contributions.
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its potential for future distributions from the assets held by the recipient 
organization. (See paragraph 16 of FASB Statement No. 136.) Those distribu­
tions, if they occur, should be recognized as contributions by the specified 
health care organization (beneficiary) when received or unconditionally prom­
ised. (See further discussion at paragraph 5.11 in this Guide. Also, special 
considerations pertaining to transfers between related entities are discussed 
in paragraphs 10.07, 11.20 through 11.23, and 11.28 through 11.32 in this 
Guide.) Governmental health care enterprises may also receive contributions, 
grants, or tax support. Governmental health care enterprises classify these 
transactions into one of four classes of nonexchange transactions based on their 
principal characteristics, as discussed in GASB Statement No. 33, Accounting 
and Financial Reporting for Nonexchange Transactions, paragraph 7, as 
amended by GASB Statement No. 36, Recipient Reporting for Certain Shared 
Nonexchange Revenues. (GASB Statement No. 33, as amended, applies to 
transactions involving financial and capital resources. GASB Statement No. 
33, as amended, does not apply to other resources, such as contributed serv­
ices.) Transactions that are not recognizable because they are not measurable 
should be disclosed.
10.06 Other revenue, gains, or losses are derived from services other than 
providing health care services or coverage to patients, residents, or enrollees. 
These typically include—
• Interest and dividends from all funds held by a trustee, malpractice 
funds, or other miscellaneous investment activities.
•  Certain realized changes in market values of marketable securities 
(see chapter 4).
•  Fees from educational programs, which include tuition for schools 
(such as nursing) or laboratory and X-ray technology.
•  Rental of health care facility space.
•  Sales of medical and pharmaceutical supplies to employees, physi­
cians, and others.
•  Fees charged for transcripts for lawyers, insurance companies, and 
others.
•  Proceeds from sale of cafeteria meals and guest trays to employees, 
medical staff, and visitors.
•  Proceeds from sale of scrap, used X-ray film, etc.
•  Proceeds from sales at gift shops, snack bars, newsstands, parking 
lots, vending machines, or other service facilities operated by the 
health care organization.
10.07 Interest earned and gains and losses on investments and other 
assets (or liabilities) are reported by not-for-profit organizations as increases 
or decreases in unrestricted net assets, unless their use is temporarily or 
permanently restricted by explicit donor stipulation or by law. Net assets 
released from restriction, such as those related to the fulfillment of time or 
purpose restrictions, should be reported separately in the financial statements 
or disclosed in the notes. Additional guidance on accounting for investments 
can be found in chapter 4. Occasionally, nongovernmental health care organi­
zations may receive funds from (or transfer funds to) a not-for-profit organiza­
tion or a charitable trust. If  the not-for-profit organization is an affiliate, those 
transfers generally are either: (a) an equity transfer, (b) an equity transaction, 
or (c) a loan or advance. Equity transfers are discussed in paragraph 11.19. 
Equity transactions are discussed in paragraphs 11.20 through 11.23. Loans and
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advances to related entities are discussed in paragraph 11.25. In limited circum­
stances, those transfers are contributions. The circumstances in which a distribu­
tion from a not-for-profit organization or charitable trust to an affiliated 
nongovernmental health care organization is a contribution are described in 
paragraphs 11.31 and 11.32. If the not-for-profit organization or charitable 
trust is not an affiliate, the transaction is either (a) an investment transaction, 
(b) a refundable advance, or (c) a contribution. Investment transactions are 
discussed in paragraphs 4.14 and 4.15. The transfer is a refundable advance if 
it is revocable or repayable. The transfer is a contribution only if it meets the 
definition of a contribution in FASB Statement No. 116; that is, it is an 
unconditional, voluntary, nonreciprocal transfer by an entity acting other than 
as an owner.
10.08 Contributions of noncash assets that are not long-lived assets are 
recognized as revenue or gains in the period received and as assets or a 
reduction of liabilities or expenses, depending on the form of the benefits 
received. (For example, a donation of supplies would be reflected as revenue or 
gains and as an increase in inventory or supply expense.) The donations are 
measured at fair value.4 Donations received with no restrictions attached are 
reported as unrestricted support in the statement of operations. Donations 
with explicit donor restrictions attached (other than permanent restrictions) 
are reported as temporarily restricted support. The expiration of these restric­
tions is recognized in the period when the time stipulated by the donor has elapsed, 
when the stipulated purpose for which the asset was restricted has been fulfilled, 
or both. When the restriction expires, the temporarily restricted net assets are 
reclassified to unrestricted net assets and reported in the statement of operations 
as “net assets released from restriction.” Donor-restricted contributions whose 
restrictions are met in the same reporting period may be reported as unrestricted 
support provided that an organization discloses its accounting policy and applies 
the policy consistently from period to period. Donations with explicit donor restric­
tions attached that permanently limit the health care organization’s use of the 
contributed assets (for example, permanent endowments) are reported as in­
creases in permanently restricted net assets.
10.09 Contributions of long-lived assets, including the use of long-lived 
assets such as land, buildings, and equipment, are reported as support or gains 
in the period received. The donation is measured at its fair value. If  the donor 
places no restrictions on the use of the asset, the contribution is reported as 
unrestricted support. Contributions of long-lived assets with explicit donor 
restrictions are reported as temporarily or permanently restricted support. 
The provider reports expirations of donor restrictions when the stipulation is 
fulfilled and the assets are placed in service. At that time, temporarily re­
stricted net assets are reclassified to unrestricted net assets and reported in 
the statement of operations as “net assets released from restriction.” Contribu­
tions of long-lived assets to governmental health care enterprises are reported 
as nonoperating revenues when all eligibility requirements have been met, as 
discussed in paragraph 10.05. Although GASB Statement No. 33 modifies the 
requirements for reporting contribution revenue, that Statement does not 
modify the fund balance section of governmental health care enterprise bal­
ance sheets.
10.10 Donations of cash or other assets that must be used to acquire long- 
lived assets are reported as temporarily restricted support in the period received.
4 Information necessary to estimate the fair value of a donated asset may be obtained from 
various sources as described in FASB Statement No. 116, Accounting for Contributions Received and 
Contributions Made, paragraph 19.
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Expirations of donor restrictions are reported when the acquired long-lived 
assets are placed in service and donor-imposed restrictions are satisfied. The 
temporarily restricted net assets are reclassified to unrestricted net assets and 
reported in the statement of operations as “net assets released from restric­
tion.” For providers that prepare classified balance sheets, assets that are 
restricted by donors for acquisition of long-lived assets (such as cash or contri­
butions receivable) are not included in “cash and cash equivalents” or with 
other “contributions receivable.” Rather, those assets are reported in a sepa­
rate section, such as “assets restricted to investment in property and equip­
ment,” and are sequenced near the “property and equipment” section of the 
balance sheet (see paragraph 3.01).
10.11 The nature and extent of donated services received by health care 
organizations varies and can range from the limited participation of many 
people in fund-raising activities to active participation in the entity’s service 
programs; their values usually are not recorded. Contributed services should 
be reported as contribution revenue and as assets or expenses if the services 
create or enhance a nonfinancial (that is, nonmonetary) asset (for example, 
property and equipment) or meet all of the following criteria:
a. Require specialized skills
b. Are provided by individuals with those skills (such as accounting, 
financial, construction, educational, electrical, legal, medical, and 
other services provided by accountants, investment advisers, con­
tractors, teachers, electricians, lawyers, doctors, and other profes­
sionals and craftspeople)
c. Would typically need to be purchased by the organization if they had 
not been provided by contribution
Additional guidance with regard to the accounting for and the reporting of 
donated services is provided in FASB Statement No. 116.
10.12 Contributions to governmental health care enterprises are gov­
erned by GASB Statement No. 33, discussed in paragraph 10.05. GASB State­
ment No. 33 applies to external transactions involving financial and capital 
resources. Interfund or intra-entity activity—transfers of resources between 
the funds of a single governmental reporting entity or between a primary 
government and its component units—are accounted for as residual equity 
transfers or operating transfers, in accordance with paragraph 105 of NCGA 
Statement No. 1, Governmental Accounting and Financial Reporting Princi­
ples.
10.13 Additional guidance regarding accounting for contributions dis­
cussed above can be found in chapters 5 and 6 of the Audit and Accounting 
Guide Not-for-Profit Organizations, which also addresses the following:
•  Permanent endowments
•  Split-interest agreements
•  Gifts in kind
•  Contributed utilities, facilities, or use of long-lived assets
•  Transfers to a not-for-profit organization or charitable trust that 
raises or holds contributions for others (refer to chapter 5 in the Audit 
and Accounting Guide Not-for-Profit Organizations under the heading 
“Agency Transactions”)
10.14 Foundations, business organizations, and other types of entities 
may provide resources to health care organizations under programs referred to 
as grants, awards, or sponsorships. Those asset transfers are contributions if the
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resource providers receive no value in exchange for the assets transferred or if 
the value received by the resource provider is incidental to the potential public 
benefit from using the assets transferred. For governmental health-care or­
ganizations, these transactions are referred to as nonexchange transactions, 
addressed in GASB Statement No. 33. The asset transfers are exchange or 
exchange-like transactions if the potential public benefit is secondary to the 
resource providers’ potential direct benefits. For example, a research grant 
made by a foundation to a hospital would likely be a contribution if the research 
program is to be planned and carried out by the hospital and the hospital has 
the right to publish the results. If, however, the grant is made by a pharmaceu­
tical manufacturer that provides potential new medications to be tested in the 
hospital’s research facilities and retains the right to any patents or other 
results, the grant would likely be an exchange transaction.
Expenses
10.15 The basis and timing of the recognition of expenses for health care 
organizations generally are the same as for other business enterprises. Ex­
penses arising from nonexchange transactions (such as grants, taxes, and 
contributions) reported by governmental health care enterprises are recog­
nized based on their appropriate class of nonexchange transactions, as dis­
cussed in paragraph 10.05. Not-for-profit organizations report expenses as 
decreases in unrestricted net assets.
10.16 Statement of Position (SOP) 98-2, Accounting for Costs of Activities 
of Not-for-Profit Organizations and Local Governmental Entities That Include 
Fund Raising, provides guidance for not-for-profit and state and local govern­
mental entities (including health care organizations) that conduct fund-raising 
activities with activities related to other functions, such as program activities 
or supporting services (joint activities). This SOP establishes financial ac­
counting standards for accounting for costs of joint activities, and requires 
financial statement disclosures about the nature of the activities for which 
joint costs have been allocated and the amounts of joint costs. SOP 98-2 is 
included as appendix C to this Guide.
Financial Statement Presentation
10.17 The statement of operations for not-for-profit organizations should 
include a performance indicator that reports results of operations.* Because of 
the importance of the performance indicator, it should be clearly labeled with 
a descriptive term such as revenues over expenses, revenues and gains over 
expenses and losses, earned income, or performance earnings. The notes to the 
financial statements should include a description of the nature and composi­
tion of the performance indicator. Not-for-profit organizations should report
* SOP 02-2, Accounting for Derivative Instruments and Hedging Activities by Not-for-Profit 
Health Care Organizations, and Clarification of the Performance Indicator, was issued December 27, 
2002. Among other matters, SOP 02-2 amends paragraph 10.17 in this Guide. The amendments to 
paragraph 10.17 revise the definition of performance indicator, clarifying that the performance 
indicator (earnings measure) reported by not-for-profit health care organizations is analogous to 
income from continuing operations of a for-profit enterprise. SOP 02-2 applies to not-for-profit health 
care organizations that are within the scope of this Guide. SOP 02-2 does not apply to governmental 
entities that are within the scope of this Guide. The provisions of SOP 02-2 are effective for fiscal 
years beginning after June 15, 2003. Earlier application is encouraged but is permitted only as of the 
beginning of any fiscal quarter that begins after issuance of SOP 02-2. See paragraphs 10 and 11 of 
SOP 02-2 for additional effective date and transition information. This chapter of the Guide will be 
modified to conform to the requirements in SOP 02-2 in a future edition of the Guide.
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the performance indicator in a statement that also presents the total changes 
in unrestricted net assets. Other changes in net assets may be presented 
separately or in the same statement.
10.18 Health care organizations should report the following items sepa­
rately from the performance indicator—*
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting 
entity, are controlled by the reporting entity, or are under common 
control with the reporting entity.
c. Receipt of restricted contributions, including temporary restrictions 
(such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions related 
to) long-lived assets.
e. Unrealized gains and losses on investments not restricted by donors 
or by law, except for those investments classified as trading securities 
(see paragraph 4.07).
f. Investment returns restricted by donors or by law (see paragraphs
4.08 through 4.10).
g. Other items that are required by GAAP to be reported separately 
(such as extraordinary items, the effect of discontinued operations, 
the cumulative effect of accounting changes, minimum pension li­
abilities in accordance with paragraph 37 of FASB Statement No. 87, 
Employers’ Accounting for Pensions, or foreign currency translation 
adjustments).5
10.19 Classifying revenues, expenses, gains, and losses within classes of 
net assets does not preclude incorporating additional classifications within the 
performance indicator. For example, within a class or classes of changes in net 
assets, a not-for-profit organization may classify items as operating and non­
operating, expendable and nonexpendable, earned and unearned, recurring 
and nonrecurring, or in other ways. This Guide neither requires nor precludes 
reporting such intermediate measures or subtotals. However, because terms 
such as operating income are used with different meanings, if an intermediate 
measure of operations is reported and its use is not apparent from the details 
provided on the face of the statement, a note to the financial statements should 
describe the nature of the reported measure of operations or the items excluded 
from operations.
10.20 For financial reporting purposes, patient service revenue is re­
ported net of provisions for contractual and other adjustments in the operating 
statement. Significant revenue earned under capitation arrangements is re­
ported separately. The notes to the financial statements disclose the methods
* SOP 02-2 was issued December 27, 2002. Among other matters, SOP 02-2 amends paragraph 
10.18 in this Guide to clarify the guidance in this paragraph regarding items that should be reported 
separately from the performance indicator. See footnote * to paragraph 10.17 in this Guide for a 
discussion of the scope and effective date of SOP 02-2. This chapter of the Guide will be modified to 
conform to the requirements in SOP 02-2 in a future edition of the Guide.
5 Governmental enterprises should report extraordinary items and the effect of discontinued 
operations in the statement of operations immediately preceding net income; the cumulative effect of 
an accounting change should be reported as an adjustment to beginning fund balance in the period of 
the change. Investor-owned enterprises should report extraordinary items, the effect of discontinued 
operations and the cumulative effect of an accounting change in the statement of operations immedi­
ately preceding net income.
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of revenue recognition (for example, policies related to capitation revenue, 
patient service revenue, or contributions). In addition, with regard to contrac­
tual adjustments and third-party settlements, identification and explanation 
of the estimated amounts that are payable or receivable by the entity are 
disclosed.
10.21 As discussed in paragraph 10.03, patient service revenue does not 
include charity care. Management’s policy for providing charity care, as well as 
the level of charity care provided, should be disclosed in the financial state­
ments. Such disclosure generally is made in the notes to the financial state­
ments and is measured based on the provider’s rates, costs, units of service, or 
other statistical measure.
10.22 Expenses may be reported on the face of the financial statements 
using either a natural classification or a functional presentation. Public com­
panies (that is, registrants with the SEC) are required to disclose segment 
information in accordance with FASB Statement No. 131, Disclosure about 
Segments of an Enterprise and Related Information.6 Not-for-profit organiza­
tions that report using a natural classification of expenses are required to 
disclose expenses by functional classification.
10.23 The extent of classification and subclassification of expenses de­
pends on many factors, such as the nature and complexity of the health care 
organization. For example, some entities may present only two categories: (a) 
health services (including inpatient services, outpatient procedures, home 
health services, etc.) and (b) general and administrative. Others may present 
additional distinctions such as physician services, research, and teaching. 
Functional allocations should be based on full cost allocations. If  a not-for- 
profit health care organization includes a ratio of fund-raising expenses to 
amounts raised in its financial statements, it should disclose how that ratio is 
computed (See paragraph 20 of FASB Statement No. 136).
Auditing7
10.24 The independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
to audit revenue, expenses, gains, and losses that are presented in exhibit 10-1.
6 The segment reporting requirements of NCGA Interpretation No. 2, Segment Information for 
Enterprise Funds, apply to governmental health care enterprises.
7 SOP 00-1, Auditing Health Care Third-Party Revenues and Related Receivables, discusses 
matters for auditors to consider in testing third-party revenues and related receivables, and provides 
guidance to auditors regarding the sufficiency of evidential matter and reporting on financial 
statements of health care entities exposed to material uncertainties. SOP 00-1 is included as 
appendix E to this Guide.
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Exhibit 10-1
Financial Statement 
Assertions
Auditing Considerations
Specific Auditing 
Objectives
Selected Control 
Activities
Revenue and Gains for Health Care Services
Existence and 
occurrence, 
completeness, and 
presentation and 
disclosure
Revenue and 
gains are 
reported in the 
proper period 
using the accrual 
basis of 
accounting and 
are classified 
properly by the 
type of service 
rendered.
Procedures help 
ensure that 
revenue is 
accrued as 
services are 
performed or as 
contractual 
obligations are 
satisfied.
Auditing
Procedures
Perform a 
walk-through of 
the revenue 
system.
Compare the 
current period’s 
revenue with 
prior periods’ 
revenue and/or 
budgets and 
obtain
explanations for 
large or unusual 
variances.
In the statement 
of operations, 
revenue from 
health care 
services is 
reported, net of 
contractual 
adjustments and 
other
adjustments, in 
the proper period 
and is classified 
properly.
Management 
establishes and 
monitors controls 
over the 
recognition of 
revenue.
Controls ensure 
that deductions 
from revenue are 
recorded in the 
proper period 
and are classified 
properly.
Contractual and 
other
adjustments are 
authorized, 
controlled, and 
recorded properly.
Consider the 
adequacy of the 
controls over the 
revenue 
recognition 
process.
Review the 
financial 
statements to 
determine that 
revenue is 
reported net of 
contractual 
adjustments and 
other adjustments.
Test contractual
adjustments,
other
adjustments, and 
bad debts to 
determine that 
they are
accounted for both 
in accordance 
with the 
respective 
contracts and the
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Financial Statement
Assertions
Specific Auditing 
Objectives
Selected Control 
Activities
Charity care, 
bad-debt 
writeoffs, and 
courtesy and 
policy discounts 
are authorized, 
controlled, and 
recorded properly.
Auditing
Procedures
entity’s policy. 
Determine that 
specific and 
unallocated 
reserves appear 
reasonable and 
comparable to 
prior year.
Review
third-party payor 
contracts and 
methods of 
payment and test 
the entity’s 
computation of 
estimated 
adjustments to 
revenue as 
required under 
such contracts.
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Chapter 11 
The Reporting Entity and 
Related Organizations
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 and related pronouncements 
in a future edition of this Guide.
Overview
11.01 The FASB is presently studying the concept of the reporting entity 
and issues related to consolidations, application of the equity method of ac­
counting, and accounting for various types of joint ventures. On October 14, 
1995, the FASB released an exposure draft entitled Consolidated Financial 
Statements: Policy and Procedures as part of its project on consolidations and 
related matters.* The conclusions in this chapter will be reconsidered when 
the FASB completes this project, which may affect the definition of control and 
other related matters. The GASB has issued Statement No. 14, The Financial 
Reporting Entity, which addresses these issues for governmental entities. 
GASB Statement No. 14 establishes standards for defining and reporting for 
the financial reporting entity and for reporting its participation in joint ven­
tures.
11.02 Networks among health care organizations, both vertical and hori­
zontal, are being formed continually and new organizational structures are 
being developed. The dynamics of change in the health care industry and their 
impact on evolving organizational structures must be considered in defining 
the reporting entity.
* On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1—3 and 5 of ARB No. 51, add a sentence to endnote 3 of ARB No. 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65. In July 2002, the FASB released an 
exposure draft of a proposed Interpretation, Consolidation of Certain Special-Purpose Entities, which 
would provide guidance for certain specific situations. After completing its deliberations relating to 
the specific situations, the FASB then will continue its consideration of the broader proposals in the 
1999 exposure draft.
** In May 2002, the GASB issued GASB Statement No. 39, Determining Whether Certain 
Organizations Are Component Units, an amendment of GASB Statement No. 14, The Financial 
Reporting Entity. GASB Statement No. 39 clarifies existing accounting guidance, and provides 
additional guidance to determine whether certain organizations for which the primary government is 
not financially accountable should be reported as discretely-presented component units based on the 
nature and significance of their relationship with the primary government. Generally, it requires 
reporting, as a discretely-presented component unit, an organization that raises or holds economic 
resources for the direct benefit of a governmental unit. GASB Statement No. 39 is effective for 
financial statements for periods beginning after June 15, 2003. Earlier application is encouraged. If 
any further conforming changes are identified for this Guide to reflect the issuance of GASB 
Statement No. 39, those changes will be made in a future edition of this Guide.
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11.03 An integrated health care system typically consists of multiple 
related entities, operating both for-profit and not-for-profit organizations. A 
not-for-profit parent corporation may be the sole corporate member or, through 
other means, it may control other entities such as a not-for-profit hospital, a 
not-for-profit medical foundation that contracts with a for-profit physician 
group, or other not-for-profit providers such as a long-term care center, a 
substance abuse center, a surgery center, or an outpatient clinic. The system 
also may own stock in various for-profit ventures such as HMOs or insurance 
companies that may or may not provide patient care. Fund-raising typically is 
accomplished through a separate foundation. Foundations, auxiliaries, guilds, 
and similar organizations frequently assist and, in many instances, are related 
to the health care organization.
11.04 The guidance in this chapter relates to for-profit and not-for-profit 
consolidations of parent-subsidiary relationships, whether through stock own­
ership or other means of control. Other circumstances may exist in the health 
care industry where combined financial statements involving commonly con­
trolled entities are more meaningful than their separate financial statements. 
More specific guidance related to combined financial statements can be found 
in ARB No. 51, Consolidated Financial Statements, paragraphs 22 and 23.1
Financial Reporting*
11.05 Whether the financial statements of a reporting health care organi­
zation and those of one or more other for-profit or not-for-profit entities should 
be consolidated, whether those other entities should be reported using the 
equity method, and the extent of disclosure that should be required (if any) if 
consolidated financial statements are not presented, should be based on the 
nature of the relationship between the entities.
11.06 Health care organizations may be related to one or more other 
entities in numerous ways, including ownership, control, and/or economic 
interest.
11.07 As discussed in paragraphs 11.10 through 11.16, the existence of 
various forms of control and economic interests result in various financial 
reporting. Certain kinds of control result in consolidation (see paragraph 
11.10). Other kinds of control result in consolidation only if coupled with an 
economic interest (see paragraph 11.11). Still other kinds of control result in 
consolidation being permitted but not required, if coupled with an economic 
interest (see paragraph 11.12). The existence of either control or an economic 
interest, but not both, is discussed in paragraph 11.13; disclosures concerning 
restrictions on distributions are discussed in paragraph 11.14; and reporting 
under the equity method of accounting is discussed in paragraph 11.16.
1 In some situations, debt agreements may require combined financial statements of affiliated 
entities, the assets or revenues of which serve as collateral for the related debt (sometimes called an 
“obligated group”). ARB No. 51 applies to those situations. However, if debt or other agreements 
prescribe a financial presentation that varies from GAAP (for example, exclusion of entities otherwise 
required to be consolidated), the auditor should consider SAS No. 62, Special Reports (AICPA, 
Professional Standards, vol. 1, AU sec. 623), for reporting guidance.
* On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1-3 and 5 of ARB No. 51, add a sentence to endnote three of ARB No. 51, and amend 
APB Opinion Nos. 16 and 18 and FASB Statement Nos. 15, 57, and 65. In July 2002, the FASB 
released an exposure draft of a proposed Interpretation, Consolidation of Certain Special-Purpose 
Entities, which would provide guidance for certain specific situations. After completing its 
deliberations relating to the specific situations, the FASB then will continue its consideration of the 
broader proposals in the 1999 exposure draft.
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11.08 Control is the direct or indirect ability to determine the direction of 
management and policies through ownership, contract, or otherwise. However, the 
rights and powers of the controlling entity may vary depending on the legal 
structure of the controlled entity and the nature of control. The majority owner of 
a for-profit entity’s voting stock or the sole corporate member of a not-for-profit 
entity may not only have the ability to determine the direction of the controlled 
entity but also have the proportionate right to (or the responsibility for) operating 
results and a residual interest in the net assets upon dissolution. However, in other 
situations, the rights of the controlling party may be more limited. For example, 
in the case of a sole general partner in a limited partnership, the limited part­
ners—and not the general partner—may be entitled to the net assets upon 
dissolution. Further, the existence of “super-majority" voting rights can entitle the 
holder to disproportionate voting powers, and could affect the determination of the 
“controlling entity.” As a result, whether the financial statements of a controlled 
entity should be consolidated with the reporting entity depends on the nature of 
control and whether an economic interest exists.2
11.09 An economic interest in another entity exists if (a) the other entity 
holds or utilizes significant resources that must be used for the unrestricted or 
restricted purposes of the reporting entity—either directly or indirectly—for 
producing income or providing services or (b) the reporting entity is responsible 
for the liabilities of the other entity. The following are examples of economic 
interests:
•  Other entities solicit funds in the name of, and with the expressed or 
implied approval of, the reporting entity. In addition, substantially all 
of the funds solicited are intended by the contributor or are otherwise 
required to be transferred to the reporting entity or used at its 
discretion or direction.
•  The reporting entity transfers significant resources to another entity 
whose resources are held for the benefit of the reporting entity.
•  The reporting entity assigns certain significant functions to another 
entity.
•  The reporting entity provides or is committed to provide funds for 
another entity or the reporting entity guarantees significant debt of 
another entity.
•  The reporting entity has a right to, or the responsibility for, the 
operating results of another entity. Or, upon dissolution, the reporting 
entity is entitled to the net assets, or is responsible for any deficit, of 
another entity.
11.10 Health care organizations with a controlling financial interest in 
other entities through direct or indirect ownership of a majority voting inter­
est3 in those other entities should consolidate those other entities, unless con­
2 Emerging Issues Task Force (EITF) Issue No. 97-2, Application of FASB Statement No. 94 and 
APB  Opinion No. 16 to Physician Practice Management Entities and Certain Other Entities with 
Contractual Management Arrangements, addresses the issue of consolidation and business combina­
tions among physician practice management entities, and other situations in which one entity 
manages another under similar circumstances and arrangements.
3 Because not-for-profit organizations may exist in various legal forms, ownership of not-for- 
profit organizations may be evidenced in various ways. Examples include corporations issuing stock, 
corporations issuing ownership certificates, membership corporations issuing membership certifi­
cates, joint ventures, and partnerships. A parent corporation typically owns stock in a for-profit 
entity, whereas a sole corporate member holds membership rights in a not-for-profit entity. As it 
relates to health care consolidations, sole corporate membership in a not-for-profit entity is consid­
ered to be equivalent to ownership of a majority voting interest in a for-profit entity, unless the sole 
corporate member’s economic interest in the controlled entity is limited by state law or contractual 
agreement.
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trol does not rest directly or indirectly with the majority owner or sole corporate 
member (for example, if the subsidiary is in legal reorganization or in bank­
ruptcy).4 In such situations consolidation is prohibited, as discussed in para­
graph 2 of ARB No. 51, as amended by FASB Statement No. 94, Consolidation 
of All Majority Owned Subsidiaries and FASB Statement No. 144, Accounting 
for the Impairment or Disposal of Long-Lived Assets.5
11.11 In the case of (a) control through a majority voting interest in the 
board of another entity by means other than ownership or sole corporate 
membership6 and (b) an economic interest in such entities, consolidation is 
required, unless control is likely to be temporary or does not rest with the 
majority owner. In this situation consolidation is prohibited.7
11.12 Control of a separate not-for-profit organization in which the re­
porting entity has an economic interest may take forms other than majority 
ownership or voting interest; for example, control may be through contract or 
affiliation agreement.8 In circumstances such as these, consolidation is 
permitted but not required, unless control is likely to be temporary.9 In this 
situation consolidation is prohibited.10 If the reporting entity controls a sepa­
rate not-for-profit entity through a form other than majority ownership (para­
graph 11.10) or voting interest (paragraph 11.11), has an economic interest in 
that other entity, and consolidated financial statements are not presented, the 
notes to the financial statements should include the following disclosures:
a. Identification of the other entity and the nature of its relationship 
with the reporting entity that results in control
b. Summarized financial data of the other entity, including total assets, 
liabilities, net assets, revenue, and expenses; and resources that are 
held for the benefit of the reporting entity or that are under its control
c. The disclosures set forth in FASB Statement No. 57, Related Party 
Disclosures
4 See footnote 2 in this chapter.
5 FASB Statement No. 144, among other matters, amends ARB No. 51 to eliminate the excep­
tion to consolidation for a subsidiary for which control is likely to be temporary. FASB Statement No. 
144 is effective for financial statements issued for fiscal years beginning after December 15, 2001, and 
interim periods within those fiscal years, with early application encouraged. This Guide has been 
conformed to FASB Statement No. 144 to eliminate the exception to consolidation for a temporarily 
controlled subsidiary in circumstances in which this Guide requires consolidation based on a control­
ling financial interest (paragraph 11.10 of this Guide). No such conforming change to this Guide is 
appropriate in circumstances in which consolidation is required or permitted based on control 
through other than a controlling financial interest (paragraphs 11.11 and 11.12 of this Guide). 
Accordingly, this Guide retains the exception to consolidation for a temporarily controlled subsidiary 
in circumstances in which consolidation is required or permitted based on control through other than 
a controlling financial interest.
6 For purposes of this Guide, a majority voting interest in the board of another entity by means 
other than ownership or sole corporate membership is illustrated by the following example. Entity B 
has a five-member board, and a simple voting majority is required to approve board actions. Entity A 
will have a majority voting interest in the board of entity B if three or more of its board members, 
officers, or employees serve on (or may be appointed at entity A’s discretion to) the board of entity B. 
However, if three of entity A’s board members serve on the board of entity B but entity A does not have 
the ability to require that those members serve on entity B’s board, entity A does not have a majority 
voting interest in the board of entity B.
7 See footnote 5 in this chapter.
8 Evidence of control may include authority to amend articles of incorporation and bylaws or 
authority to approve operating, capital, and construction budgets; capital acquisitions; strategic 
plans, goals, and objectives; and mergers or dissolutions.
9 See footnote 2 in this chapter.
10 See footnote 7 in this chapter.
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11.13 In some cases, one entity may have an economic interest in another 
entity without controlling it (for example, a noncontrolled entity may solicit 
funds in the name of, and with the expressed or implied approval of, the 
reporting entity and substantially all of the funds solicited are intended by the 
contributor to benefit the reporting entity). The existence of control (other than 
through ownership or sole corporate membership) or an economic interest, but 
not both, precludes consolidation but requires the disclosures set forth in FASB 
Statement No. 57.11
11.14 If  consolidated financial statements are presented and they include 
a controlled not-for-profit organization, they should disclose any restrictions 
made by entities outside of the reporting entity on distributions from the 
controlled not-for-profit organization to the reporting entity and any resulting 
unavailability of the net assets of the controlled not-for-profit organization for 
use by the reporting entity.
11.15 When consolidated financial statements are required or permitted, 
a minority interest should be provided if such interest is represented by an 
economic interest whereby the minority interest would share in the operating 
results or residual interest upon dissolution.
11.16 Investments in common stock of for-profit entities in which the 
reporting entity has 50 percent or less of the voting stock in the investee should 
be reported under the equity method in conformity with APB Opinion No. 18, 
The Equity Method of Accounting for Investments in Common Stock, if the 
guidance in that opinion requires use of the equity method. The equity method 
should be followed by an investor whose investment in voting stock gives it the 
ability to exercise significant influence over operating and financial policies of 
an investee. Determining the ability of an investor to exercise significant 
influence is not always clear, and applying judgment is necessary to assess the 
status of each investment. However, to achieve a reasonable degree of uniform­
ity, the ownership of 20 percent or more of the voting stock leads to a presump­
tion that the investor can exercise significant influence and, therefore, the 
investment should be accounted for under the equity method in accordance 
with APB Opinion No. 18. However, this presumption can be overcome in 
certain instances. FASB Interpretation No. 35, Criteria for Applying the Equity 
Method of Accounting for Investments in Common Stock, paragraph 4, provides 
examples of indications that an investor may be unable to exercise significant 
influence. Health care organizations that report investments on the equity 
method should make the financial statement disclosures required by APB 
Opinion No. 18.
11.17 This Guide provides guidance concerning consolidated financial 
statements. Consolidation of a parent or subsidiary organization requires the 
presentation of a single set of amounts for the entire reporting entity. Combi­
nation, as discussed in paragraphs 22 and 23 of ARB No. 51, refers to financial 
statements prepared for organizations between which common control exists 
but for which the parent-subsidiary relationship does not exist. Both consoli­
dation and combination require elimination of interorganization transactions 
and balances. Paragraph 22 of ARB No. 51 states that “there are circum­
stances, however, where combined financial statements (as distinguished from 
consolidated statements) of commonly controlled companies are likely to be 
more meaningful than their separate statements.” This Guide prohibits con­
solidated financial statements in certain circumstances. However, it provides
11 The existence of an economic interest does not necessarily cause the entities to be related 
parties, as defined in FASB Statement No. 57. However, the disclosures required by that statement 
are required under this Guide if an economic interest exists.
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no guidance concerning combined financial statements of commonly controlled 
entities, which may be presented in certain circumstances in conformity with 
the guidance in ARB No. 51.
11.18 Paragraph 15 of FASB Statement No. 94 precludes the use of the 
parent company’s financial statements as the general-purpose financial state­
ments of the primary reporting entity. Similarly, where consolidation is re­
quired, this Guide precludes the issuance of parent company financial 
statements as the general-purpose financial statements of the primary report­
ing entity. However, neither FASB Statement No. 94 nor this Guide discuss 
the use of the parent company’s financial statements as other than the general- 
purpose financial statements for the primary reporting entity.12 GAAP does 
not preclude the issuance of financial statements for the subsidiary only. 
However, care should be taken to include all disclosures required by FASB 
Statement No. 57 and other relevant pronouncements.
Transfers 
Equity Transfers
11.19 Equity transfers are similar to ownership transactions between a 
for-profit parent and its owned subsidiary (for example, additional paid-in 
capital or dividends).13 However, equity transfers can occur only between 
related not-for-profit entities when one controls the other or both are under 
common control. An equity transfer embodies no expectation of repayment, nor 
does the transferor receive anything of immediate economic value (such as a 
financial interest or ownership). Equity transfers are reported separately as 
changes in net assets, are excluded from the performance indicator, and do not 
result in any step-up in basis of the underlying assets transferred. (Certain 
transfers from a foundation to a related nongovernmental health care organi­
zation are discussed in paragraphs 11.31 and 11.32.)
Equity Transactions
11.20 Transfers from a nongovernmental health care organization to a 
not-for-profit organization or charitable trust are equity transactions, as de­
scribed in FASB Statement No. 136, Transfers of Assets to a Not-for-Profit 
Organization or Charitable Trust That Raises or Holds Contributions for 
Others, (see paragraphs 4 and 18), if the transfer meets all of the following 
criteria:
•  A nongovernmental health care organization transfers assets to a 
not-for-profit organization or charitable trust (called a recipient or­
ganization) that accepts those assets and agrees to use them on behalf 
of or transfer them, their investment return, or both back to the health 
care organization or its affiliate.
•  The nongovernmental health care organization and the recipient 
organization are financially interrelated organizations.
•  Neither the nongovernmental health care organization nor its affiliate 
expects payment of the transferred assets, although payment of in­
vestment return on the transferred assets may be expected.
12 Contractual agreements or regulatory provisions may require parent company only financial 
statements. SAS No. 62 provides guidance for reporting on financial presentations to comply with 
contractual agreements or regulatory provisions.
13 Transfers, including residual equity transfers, reported by governmental health care enter­
prises should be reported in accordance with NCGA Statement No. 1, Governmental Accounting and 
Financial Reporting Principles, paragraphs 105 and 106.
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11.21 Paragraph 13 of FASB Statement No. 136 provides that organiza­
tions are financially interrelated if the relationship between them has both of 
the following characteristics: (a) one organization has the ability to influence 
the operating and financial decisions of the other and (b) one organization has 
an ongoing economic interest in the net assets of the other. The ability to 
influence the operating and financial decisions of the other can be demon­
strated in several ways:
а. The organizations are affiliates as defined in FASB Statement No. 57.
b. One organization has considerable representation on the governing 
board of the other organization.
c. The charter or bylaws of one organization limit its activities to those 
that are beneficial to the other organization.
d. An agreement between the organizations allows one organization to 
actively participate in the policymaking processes of the other, such 
as setting organizational priorities, budgets, and management 
compensation.
An ongoing economic interest in the net assets of another is a residual right to 
the other organization’s net assets that results from an ongoing relationship. 
The value of those rights increases or decreases as a result of the investment, 
fundraising, operating, and other activities of the other organization.14
11.22 An equity transaction differs from an equity transfer in that an 
equity transaction, as described in FASB Statement No. 136, involves a finan­
cially interrelated party either as a third party in a transfer from an entity to 
one of its affiliates or as a counterparty in a transfer from an entity to itself. 
An equity transfer, as described in the Guide, is a transaction directly between 
a transferor and a transferee. In addition, an equity transaction is reciprocal; 
the health care organization or its affiliate named as the beneficiary receives 
an ongoing economic interest in the assets held by the recipient organization. 
(See paragraphs 18 and 95 of FASB Statement No. 136). An equity transfer is 
nonreciprocal; there is no expectation of repayment and the transferor does not 
receive a financial interest or ownership. (See paragraph 11.19 of this Guide).
11.23 The reporting of an equity transaction depends upon whether the 
resource provider or its affiliate is the specified beneficiary. As discussed in 
paragraph 18 of FASB Statement No. 136, if the resource provider specifies 
itself as the beneficiary, the resource provider reports an asset—interest in the 
net assets of the recipient organization (or an increase in a previously recog­
nized interest),15 and the recipient organization reports an equity transaction 
as a separate line in its statement of activities. If  the resource provider specifies 
its affiliate as the beneficiary, the resource provider and the recipient organization 
report an equity transaction as separate lines in their statements of activities, and 
the affiliate named as beneficiary reports an interest in the net assets of the 
recipient organization.16 The resource provider should disclose the information
14 Paragraph 104 of FASB Statement No. 136 notes that although most of the relationships 
described in the definition of economic interest in the glossary of SOP 94-3, Reporting of Related 
Entities by Not-for-Profit Organizations, are potentially ongoing economic interests in the net assets 
of the other, some are not. (The guidance in SOP 94-3 is incorporated in paragraph 11.09 of this 
Guide). Only economic interests that are both ongoing and residual interests in the net assets meet 
the criterion of paragraph 13(b) of FASB Statement No. 136.
15 That interest would be eliminated if the beneficiary (resource provider) and the recipient 
organization were included in consolidated financial statements. See footnote 6 to paragraph 15 of 
FASB Statement No. 136.
16 That interest would be eliminated if the beneficiary (affiliate) and the recipient organization 
were included in consolidated financial statements. See footnote 6 to paragraph 15 of FASB State­
ment No. 136.
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described in paragraph 4.15 of this Guide for each period for which a statement 
of financial position is presented.
Other Transfers
11.24 Other transfers may occur among related entities. If the entities are 
consolidated or combined, such transfers are eliminated in consolidation and/or 
combination. I f  the entities are not consolidated or combined (for example, 
in separate subsidiaries or obligated group financial statements),17 the method 
of accounting for such transfers is dictated by the substance of the transaction 
as well as the legal form. For example, certain transfers by a foundation to a 
related nongovernmental health care organization are reported as contribu­
tions, as discussed in paragraphs 11.31 and 11.32. In other situations, pay­
ments may be made for services provided between not-for-profit entities under 
common control, which should be accounted for as revenues and expenses 
depending on the types of services provided.
11.25 A health care organization may loan or advance resources to a 
related entity. If repayment is reasonably assured, a receivable or payable 
should be recorded by the entities. Subsequent to the time a receivable is 
recorded, the ability of the receiving entity to repay the receivable should be 
considered. If the receivable is not to be repaid, or if the receiving entity is 
perceived as unable to repay, it may be accounted for as an equity transfer with 
the transferor reducing net assets and the transferee increasing net assets at 
the date such determination is made (see paragraph 11.19).
11.26 Transfers that result in changes in ownership interest are ac­
counted for as investments in accordance with APB Opinion No. 18 and FASB 
Statement No. 94.
11.27 Assets transferred from one commonly controlled entity to another 
should be recorded by the transferee at the carrying value of the transferring 
entity. This treatment is consistent with the guidance prescribed by appendix 
D of FASB Statement No. 141, Business Combinations*
Related Fund-Raising Organizations
11.28 A related entity may act as an agent, trustee, or intermediary for 
contributions to the reporting entity. FASB Statement No. 136 establishes 
standards for transactions in which a donor makes a contribution by transferring 
assets to a recipient organization—a not-for-profit organization or a charita­
ble trust—that accepts the assets from the donor and agrees to use the assets 
on behalf of or transfer the assets, their investment return, or both to another 
entity—the beneficiary—named by the donor.18,19 Paragraph 68 of FASB State­
17 See paragraph 12.06 for additional discussion regarding obligated group financial state­
ments.
* FASB Statement No. 141, Business Combinations, supersedes AICPA Accounting Interpreta­
tion No. 39 of APB Opinion No. 16, Business Combinations. However, the guidance in that Interpre­
tation, used in past practice to account for transfers of net assets between entities under common 
control, is carried forward without reconsideration in appendix D, Continuing Authoritative Guid­
ance, of FASB Statement No. 141.
18 FASB Statement No. 136 also establishes standards for transactions that take place in a 
similar manner but are not contributions because the transfers are revocable, repayable, or recipro­
cal. For example, if a resource provider transfers assets to a recipient organization and names itself 
or its affiliate as beneficiary, that transaction is reciprocal even if the resource provider grants 
variance power. Those standards and transactions are discussed in paragraphs 4.14, 4.15, 11.20,
11.22, and 11.23 of this Guide. This Guide does not use the word donor in discussing those transac­
tions because they are not contributions.
19 This pronouncement is not applicable to governmental health care enterprises. (See footnote
1 in chapter 1.)
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ment No. 136 states that a donor may specify the beneficiary (a) by name, (b ) 
by stating that all entities that meet a set of donor-defined criteria are 
beneficiaries, or (c) by actions surrounding the transfer that made clear the 
identity of the beneficiary, such as by responding to a request from an organi­
zation that exists to raise assets for the beneficiary. Paragraphs 69 through 72 
and Appendix A of FASB Statement No. 136 provide examples of donor 
stipulations and discuss whether those stipulations specify a beneficiary.
11.29 If a recipient organization and a specified beneficiary are finan­
cially interrelated organizations (as defined in paragraph 13 of FASB State­
ment No. 136 and described in paragraph 11.21 of this Guide) and the recipient 
organization is not a trustee, the recipient organization should recognize the 
fair value of any assets it receives from the donor that are specified by the 
beneficiary as a contribution received, rather than as a liability to the benefi­
ciary, as discussed in paragraph 14 of FASB Statement No. 136. For example, 
a foundation that exists to raise, hold, and invest assets for a specified health 
care organization or for a group of affiliates of which the specified health care 
organization is a member generally is financially interrelated with the organiza­
tion or organizations it supports. A financially interrelated foundation should 
recognize contribution revenue when it receives assets from the donor.20 The 
specified health care organization should recognize its interest in the net assets 
of the foundation (the recipient organization) and adjust that interest for its 
share of the change in net assets of the recipient organization using a method 
similar to the equity method of accounting for investments in common stock 
(see paragraph 15 of FASB Statement No. 136).21
11.30 When measuring its interest in the recipient organization, the 
specified health care organization would include the net assets of the recipient 
organization that are restricted to use by that health care organization. If  the 
recipient organization supports more than one beneficiary and an agreement 
with the recipient organization specifies how unrestricted gifts to the recipient 
organization should be divided between the organizations supported, the speci­
fied health care organization would also include its share of the recipient 
organization’s unrestricted assets, computed in accordance with that agree­
ment. Similarly, if a parent organization controls both the recipient organiza­
tion and the specified health care organization and the parent directed that 
unrestricted gifts would be distributed to affiliates in accordance with a 
specified formula, each affiliate would include in its interest its share of 
unrestricted net assets, computed in accordance with that formula. (See para­
graphs 41 through 45 of FASB Statement No. 136).
11.31 Distributions from a financially interrelated recipient organization 
to a nongovernmental health care organization that it supports are generally 
reported by the health care organization as a reduction of its interest in the 
recipient organization. However, if the distribution is made from net assets that 
are not includable in that interest because the health care organization does 
not have rights to them (that is, the recipient organization can determine to 
whom the assets will be distributed), the health care organization reports a 
contribution from the related recipient organization. For example, assume a 
foundation’s mission is to raise contributions for two financially interrelated 
health care organizations, Hospital A and Hospital B. The foundation receives 
$10,000 in contributions from donors that do not specify which of the two hosp­
20 Foundations that are not providers of health care services are not covered by this Guide and 
should follow the AICPA Audit and Accounting Guide Not-for-Profit Organizations.
21 That interest would be eliminated if the beneficiary and the recipient organization were 
included in consolidated financial statements. See footnote 6 to paragraph 15 of FASB Statement No. 
136.
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itals should benefit from their gifts. There is no agreement between the 
foundation and Hospitals A and B that specifies how gifts to the foundation 
should be divided between the hospitals if the donor does not specify a benefi­
ciary. Hospital A would report contribution revenue for any portion of the 
$10,000 that it receives from the foundation. Likewise, Hospital B would report 
contribution revenue for any portion of the $10,000 that it receives, but neither 
Hospital A nor Hospital B would record an interest in those assets before the 
foundation either distributes them or unconditionally promises them.
11.32 As discussed in paragraphs 11 and 12 of FASB Statement No. 136, 
if the recipient organization and the specified health care organization are not 
financially interrelated organizations as defined in paragraph 13 of FASB 
Statement No. 136 (see paragraph 11.21 in this Guide), and the donor specifies 
a beneficiary, the recipient organization should recognize a liability to the 
specified beneficiary unless the recipient is explicitly granted variance power. 
(See discussion of variance power at paragraph 10.05 of this Guide). If the 
assets received from the donor are donated materials, supplies, or other 
nonfinancial assets, the recipient organization may choose either to (a) report 
the receipt of the assets as a liability to the beneficiary concurrent with 
recognition of the assets received or (b) not to report the transaction at all. The 
choice is an accounting policy that should be applied consistently from period 
to period and disclosed in the notes to the financial statements. The specified 
health care organization recognizes its rights to the assets (financial or nonfi­
nancial) held by a recipient organization as an asset and contribution revenue 
unless the recipient organization is explicitly granted variance power. (See 
further discussion at paragraphs 5.11 and 10.05.) In contrast, if the donor does 
not specify a beneficiary (see further discussion at paragraph 11.28) and the 
foundation and a hospital are under common control, but they are not finan­
cially interrelated, the recipient organization should recognize contribution 
revenue when it receives the gift. The gift should be accounted for as contribu­
tions received by the hospital, consistent with FASB Statement No. 116, 
Accounting for Contributions Received and Contributions Made, and Chapter 
10 of this Guide, provided that the foundation is acting other than as an owner.
11.33 Additional guidance regarding accounting for contributions re­
ceived by agents, trustees, and intermediaries can be found in chapter 5 of the 
Audit and Accounting Guide Not-for-Profit Organizations.
Disclosure
11.34 Significant relationships and transactions not in the ordinary course 
of business with directors, management, medical staff, or other related parties 
(including unconsolidated related organizations) should be disclosed in accordance 
with FASB Statement No. 57. SAS No. 45, Omnibus Statement on Auditing 
Standards—1983, “Related Parties” (AICPA, Professional Standards, vol. 1, AU 
sec. 334), sets forth procedures for the auditor to consider in determining the 
existence of transactions with related parties and identifying them.
11.35 Hospital boards may contract with management companies to operate 
their facilities. Frequently, the management company will employ the admin­
istrator as well as other key personnel. Further, services may be acquired 
from entities related to the management company.22 The auditor should 
evaluate the impact of these arrangements on the hospital’s internal controls 
and disclose related party transactions as required by FASB Statement No. 57.
22 See footnote 2 in this chapter.
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11.36 The reporting and disclosure requirements of the nongovernmental 
health care organization under the circumstances noted in paragraphs 11.10 
through 11.18 are summarized as follows:23
Circumstances Requirements
The entity owns a majority of a 
for-profit entity’s voting stock.
The entity is the sole corporate 
member of a not-for-profit entity. 
(See paragraph 11.10, footnote 3.)
The entity controls another 
through a majority voting interest 
in the board and an economic 
interest exists.
The reporting entity owns 50 
percent or less of the common 
voting stock of an investee and can 
exercise significant influence over 
operating and financial policies.
There have been material 
transactions between the health 
care entity and the related 
organization. (This could be present 
in any of the foregoing 
circumstances.)
An entity has control over another 
not-for-profit organization or has 
an economic interest in the other, 
but not both.
The reporting entity controls a 
separate not-for-profit entity 
through a form other than majority 
ownership or voting interest and 
has an economic interest in that 
other entity.
Consolidate unless control does not 
rest with the majority owner or the 
interest is limited by state law or 
contractual agreement.
Consolidate unless control does not 
rest with the majority owner or the 
sole corporate member’s interest is 
limited by state law or contractual 
agreement.
Consolidate unless control is likely 
to be temporary or does not rest 
with the majority owner or the sole 
corporate member; or the interest 
is limited by state law or 
contractual agreement.
The investment should be 
accounted for under the equity 
method in accordance with APB 
Opinion No. 18.
In the notes to the financial 
statements (a) disclose the 
existence and nature of the 
relationship and (b) describe and 
quantify the transactions.
In the notes to the financial 
statements (a) disclose the 
existence and nature of the 
relationship and (b) describe and 
quantify the transactions. 
Consolidation is prohibited.
Consolidation permitted but not 
required. If consolidated 
statements are not presented, the 
notes to the financial statements 
should disclose (a) the 
identification of the other entity 
and the nature of its relationship 
with the reporting entity, (b) 
summarized financial data of the 
other entity, and (c) the disclosures 
set forth in FASB Statement No. 57.
23 See footnote 5 in this chapter.
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11.37 As discussed in paragraph 11.02, the dynamics of change in the 
health care industry have resulted in increased business combinations as new 
organizational structures are being formed. FASB Statement No. 141 ad­
dresses financial accounting and reporting for business combinations. FASB 
Statement No. 141 applies to business combinations initiated after June 30, 
2001 and prescribes the use of the purchase method for those business combi­
nations.* FASB Statement No. 141, however, does not apply to certain combi­
nations, including a combination involving two or more not-for-profit 
organizations, or the acquisition of a for-profit business by a not-for-profit 
organization. For those combinations, the guidance in APB Opinion Nos. 16 
and 17 still apply and APB Opinion No. 16 provides a useful framework when 
evaluating similar transactions entered into by not-for-profit health care busi­
ness organizations.** A list of possible factors to be considered when evaluating 
these transactions in relation to APB Opinion No. 16 is summarized as follows:
Business Combinations
Circumstances Accounting and Disclosure Guidance
Monetary consideration received or 
paid, change in legal title to assets, 
and/or assumption of liabilities.
Change in control (for example, 
change in sole corporate member).
This is similar to a purchase under 
APB Opinion No. 16.24
This is similar to a pooling of 
interests transaction under APB 
Opinion No. 16. No step-up in basis.
See paragraphs 1.36 and 1.37 for additional guidance regarding the application 
of APB Opinion No. 16 to not-for-profit organizations. Also see footnote * in the 
section “APB Opinion No. 16, Business Combinations” in chapter 1 in this Guide 
regarding pronouncements that were superseded by FASB Statement No. 141, 
including APB Opinion No. 16.
Auditing
11.38 The independent auditor may need to consider the examples of 
specific auditing objectives, control activities, and auditing procedures for 
related party organizations, balances, and transactions that are presented in 
exhibit 11-1.
* FASB Statement No. 141 supersedes APB Opinion No. 16. If FASB Statement No. 141 has not 
been adopted, see APB Opinion No. 16 for guidance concerning business combinations.
* The FASB has on its agenda a project on accounting for combinations of not-for-profit 
organizations. Readers should be alert to the issuance of a final Standard.
24 FASB Statement No. 141 supersedes AICPA Accounting Interpretation No. 39 of APB Opinion 
No. 16. Appendix D of FASB Statement No. 141 carries forward without reconsideration guidance in 
APB Opinion No. 16 and an interpretation that has been used in past practice to account for transfers 
of net assets or exchanges of shares between entities under common control. Paragraph D12 of FASB 
Statement No. 141 discusses the accounting for a transfer of assets or exchange of shares between 
entities under common control.
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Exhibit 11-1
Auditing Considerations
Financial Statement Specific Auditing 
Assertions Objectives
Selected Control 
Activities
Reporting Entity and Related Organizations 
Existence and
occurrence, 
completeness, and 
presentation and 
disclosure
The reporting 
entity is 
appropriate.
Procedures 
ensure that 
investees, 
affiliates, and 
other related 
entities are 
accounted for 
appropriately.
Auditing
Procedures
Review the 
articles of 
incorporation, 
bylaws, and 
minutes of 
directors’ 
meetings, 
shareholder lists, 
and filings with 
regulatory 
authorities to 
determine the 
existence of 
related parties.
Obtain
representations 
from management 
as to whether all 
investees, 
affiliates, and 
related entities 
have been 
accounted for 
properly or 
disclosed.
Relationships and 
transactions with 
related
organizations are 
identified and 
disclosed, if 
appropriate, 
because of 
economic
Procedures 
ensure that 
conflict-of-interest 
policies,
procedures, and 
disclosure 
requirements are 
met.
Review
transactions with 
investees, 
affiliates, and 
other related 
entities to 
determine that 
they are reported 
properly.
Test significant 
related party 
transactions as 
follows:
•  Determine 
substance.
•  Examine
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Financial Statement
Assertions
Presentation and 
disclosure
Specific Auditing Selected Control 
Objectives Activities
dependence of the 
entity.
Related party 
transactions and 
organizations are 
reported properly.
documents 
(invoices, 
contracts, and 
agreements).
•  Determine the 
basis of pricing.
•  Determine the 
collectibility of 
receivables and 
advances.
Review related 
party transactions 
for completeness 
b y -
•  Considering 
previously 
identified 
transactions or 
relationships.
•  Reviewing the 
minutes of 
directors’ and 
other meetings.
•  Discussing 
related-party 
transactions 
with entity 
personnel.
•  Reviewing 
unusual 
transactions.
•  Reviewing the 
responses to 
related party 
(conflict-of- 
interest) 
questionnaires.
Review the 
presentation and 
disclosure of 
related party 
information for 
completeness.
Auditing
Procedures
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Chapter 12 
Independent Auditor's Reports
Note: Governmental health care entities that are required to adopt, or 
that have elected early implementation of GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for 
State and Local Governments, and related pronouncements should refer 
to appendix F of this Guide. This chapter will be modified in a future 
edition of this Guide to discuss additional auditing guidance and 
incorporate references to certain auditing guidance in the Audit and 
Accounting Guide Audits of State and Local Governments (GASB 34 
Edition), that should be considered by auditors of governmental health 
care entities that are required to adopt, or that have elected early 
implementation of GASB Statement No. 34.___________________________
Overview
12.01 The guidance in SAS No. 58, Reports on Audited Financial State­
ments, as amended (AICPA, Professional Standards, vol. 1, AU sec. 508), 
applies to audit reports on the financial statements of health care organiza­
tions. Such a report may contain an unqualified opinion, an unqualified opin­
ion with an explanatory paragraph, a qualified opinion, a disclaimer of opinion, 
or an adverse opinion. The facts and circumstances of each particular audit 
govern the appropriate form of the report.1 Report examples appearing in this 
chapter illustrate the form of certain auditor’s reports issued by the independent 
auditor in auditing the financial statements of a health care organization.
Unqualified Opinion
12.02 The independent auditor’s standard report states that the financial 
statements present fairly, in all material respects, an entity’s financial posi­
tion, results of operations, changes in net assets, and cash flows in conformity 
with GAAP. The opinion should include an identification of the United States 
of America as the country of origin of those accounting principles. This conclu­
sion may be expressed only when the independent auditor has formed such an 
opinion on the basis of an audit performed in accordance with GAAS and an 
identification of the United States of America as the country of origin of those 
standards. An example of the independent auditor’s standard report is pre­
sented in exhibit 12-1 at the end of this chapter.
Qualified Opinion
12.03 SAS No. 58 states that certain circumstances may require a quali­
fied opinion. A qualified opinion states that except for the effects of the matter 
to which the qualification relates, the financial statements present fairly, in all 
material respects, the financial position, results of operations, and cash flows 
in conformity with GAAP. Such an opinion is expressed when—
1 SAS No. 79, Amendment to Statement on Auditing Standards No. 58, Reports on Audited 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 508), amends SAS No. 58 to 
eliminate the requirement that when certain criteria are met, the auditor add an uncertainties 
explanatory paragraph to the auditor’s report. It also clarifies and reorganizes the guidance in SAS 
No. 58 concerning emphasis paragraphs, uncertainties, and disclaimers of opinion.
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a. There is a lack of sufficient competent evidential matter or there are 
restrictions on the scope of the audit that have led the independent 
auditor to conclude that an unqualified opinion cannot be expressed 
and the independent auditor has concluded not to disclaim an opinion 
(see exhibit 12-2).
b. The independent auditor believes, on the basis of the audit, that the 
financial statements contain a departure from GAAP, the effect of 
which is material, and has concluded not to express an adverse 
opinion (see exhibit 12-3).
Additional Information
12.04 SAS No. 29, Reporting on Information Accompanying the Basic Finan­
cial Statements in Auditor-Submitted Documents (AICPA, Professional Stand­
ards, vol. 1, AU sec. 551), contains useful guidance on reporting on additional 
information. The information covered by SAS No. 29 is presented to accompany 
the basic financial statements in an independent auditor-submitted document and 
is not considered necessary for a fair presentation of financial position, results of 
operations, changes in net assets, and cash flows in conformity with GAAP. Such 
information includes additional details or explanations of items in, or related to, 
the basic financial statements, consolidating/combining information, historical 
summaries of items extracted from the basic financial statements, statistical data, 
and other material, some of which may be from sources outside the accounting 
system or outside the health care organization.
12.05 With respect to supplementary and other information, guidance is 
contained in SAS No. 8, Other Information in Documents Containing Audited 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 550), 
and SAS No. 52, Omnibus Statement on Auditing Standards—1987, “Required 
Supplementary Information” (AICPA, Professional Standards, vol. 1, AU sec. 
558). Among other changes, SAS No. 52 amends SAS No. 29 regarding required 
supplementary information. SAS No. 8 (AICPA, Professional Standards, vol. 
1, AU sec. 550.07), SAS No. 29 (AICPA, Professional Standards, vol. 1, AU secs.
551.12 and .15), and SAS No. 52 (AICPA, Professional Standards, vol. 1, AU 
secs. 558.08 and .10), were also amended by SAS No. 98, Omnibus Statement 
on Auditing Standards—2002, to address the appropriate reporting for supple­
mentary information and other information. The amendments to SAS No. 8 
and SAS No. 52, among other matters, clarify that an auditor may issue a 
report providing an opinion, in relation to the basic financial statements taken 
as a whole, on supplementary information and other information that has been 
subjected to the auditing procedures applied in the audit of those basic finan­
cial statements. The amendments to SAS No. 29, among other matters, clarify 
the reporting guidance with respect to required supplementary information in 
an auditor-submitted document. In addition, SAS No. 42, Reporting on Con­
densed Financial Statements and Selected Financial Data (AICPA, Profes­
sional Standards, vol. 1, AU sec. 552), contains guidance on reporting in a 
client-prepared document when condensed financial statements or selected 
financial data are presented by a public entity.
Special Reports
12.06 If a health care organization is required to follow reporting require­
ments of a regulatory agency, to report under a cash receipts and disburse­
ments basis of accounting, or to report on another comprehensive basis of 
accounting other than GAAP, the auditor should follow the guidance in SAS No.
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62, Special Reports (AICPA, Professional Standards, vol. 1, AU sec. 623). SAS 
No. 62 also provides reporting guidance when reporting on specified elements, 
accounts, or items of a financial statement; compliance with aspects of contrac­
tual agreements or regulatory requirements related to audited financial state­
ments; financial presentations to comply with contractual agreements or 
regulatory provisions; and financial information presented in prescribed forms 
(see exhibit 12-4). Accountants’ reports on regulatory basis financial state­
ments generally are prescribed by professional standards as restricted-use 
reports as described in SAS No. 87, Restricting the Use of an Auditor’s Report 
(AICPA, Professional Standards, vol. 1, AU sec. 532). Where obligated group 
financial statements exclude entities that are required under GAAP to be 
consolidated in order to comply with loan agreements, the accountants’ report 
should restrict the use to specified parties (see exhibit 12-4).2 Use should be 
restricted to the company and other parties to the agreement. Health care 
providers that receive federal financial assistance should also refer to SOP
98-3, Audits of States, Local Governments, and Not-for-Profit Organizations 
Receiving Federal Awards.
2 Obligated group is a term used to denote a group of entities, sometimes a parent corporation 
and several of its subsidiaries, that is liable for the repayment of obligations, such as tax-exempt 
bonds.
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Exhibit 12-1
Health Care Organizations
Unqualified Opinion—Comparative Financial Statements
Independent Auditor’s Report
To the Board of Trustees 
XYZ Health Care Organization
We have audited the accompanying balance sheets of XYZ Health Care Organi­
zation as of September 30, 20X2, and 20X1, and the related statements of 
operations, changes in net assets, and cash flows for the years then ended. 
These financial statements are the responsibility of XYZ Health Care Organi­
zation’s management. Our responsibility is to express an opinion on these 
financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally 
accepted in the United States of America. These standards require that we plan 
and perform the audit to obtain reasonable assurance about whether the 
financial statements are free of material misstatement. An audit includes 
examining, on a test basis, evidence supporting the amounts and disclosures 
in the financial statements. An audit also includes assessing the accounting 
principles used and significant estimates made by management, as well as 
evaluating the overall financial statement presentation. We believe that our 
audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all 
material respects, the financial position of XYZ Health Care Organization as 
of September 30, 20X2, and 20X1, and the results of its operations, changes in 
net assets, and cash flows for the years then ended in conformity with account­
ing principles generally accepted in the United States of America.
[Signature]
[Date]
AAG-HCO 12.06
Independent Auditor's Reports 145
Exhibit 12-2
Qualified Opinion—Scope Limitation
Independent Auditor’s Report
To the Board of Trustees 
XYZ Health Care Organization
[Include same first paragraph as the standard report—see exhibit 12-1]
Except as discussed in the following paragraph, we conducted our audits in 
accordance with auditing standards generally accepted in the United States of 
America. Those standards require that we plan and perform the audit to obtain 
reasonable assurance about whether the financial statements are free of 
material misstatement. An audit includes examining, on a test basis, evidence 
supporting the amounts and disclosures in the financial statements. An audit 
also includes assessing the accounting principles used and significant esti­
mates made by management, as well as evaluating the overall financial 
statement presentation. We believe that our audits provide a reasonable basis 
for our opinion.
We were unable to obtain audited financial statements supporting XYZ’s 
investment in an affiliate stated at $XXX,XXX and $XXX,XXX at September
30, 20X2, and 20X1, respectively, or its equity in earnings of that affiliate of 
$XXX,XXX and $XXX,XXX, which is included in the statement of operations 
for the years then ended as described in Note X to the financial statements; nor 
were we able to satisfy ourselves as to the carrying value of the investment in 
the affiliate or the equity in its earnings by other auditing procedures.
In our opinion, except for the effects of such adjustments, if any, as might have 
been determined to be necessary had we been able to examine evidence 
regarding the affiliate investment and earnings, the financial statements 
referred to in the first paragraph present fairly, in all material respects, the 
financial position of XYZ Health Care Organization as of September 30, 20X2, 
and 20X1, and the results of its operations, changes in net assets, and cash 
flows for the years then ended in conformity with accounting principles gener­
ally accepted in the United States of America.
[Signature]
[Date]
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Exhibit 12-3
Health Care Organizations
Qualified Opinion—Departure From 
Generally Accepted Accounting Principles 
That Have a Material Effect on the Financial Statements
Independent Auditor’s Report
To the Board of Trustees 
XYZ Health Care Organization
[Include same first and second paragraphs as the 
standard report—see exhibit 12-1]
XYZ Health Care Organization has excluded, from property and debt in the 
accompanying balance sheets, certain lease obligations that, in our opinion, 
should be capitalized to conform with accounting principles generally accepted 
in the United States of America. If  these lease obligations were capitalized, 
property would be increased by $XXX,XXX and $XXX,XXX, long-term debt 
would be increased by $XXX,XXX and $XXX,XXX, and unrestricted net assets 
would be increased by $XXX,XXX and $XXX,XXX as of September 31, 20X2, 
and 20X1, respectively. In addition, earnings would be increased by $XXX,XXX 
and $XXX,XXX, respectively, for the years then ended.
In our opinion, except for the effects of not capitalizing certain lease obligations 
as discussed in the preceding paragraph, the financial statements referred to 
in the first paragraph present fairly, in all material respects, the financial 
position of XYZ Health Care Organization as of September 30, 20X2, and 20X1, 
and the results of its operations, changes in net assets, and cash flows for the 
years then ended in conformity with accounting principles generally accepted 
in the United States of America.
[Signature]
[Date]
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Report on Financial Statements Prepared Pursuant to a 
Master Trust Indenture That Results in a Presentation Not 
in Conformity With Generally Accepted Accounting Principles 
or Other Comprehensive Basis of Accounting
Independent Auditor’s Report
To the Board of Directors 
Sample Health Care Corporation
We have audited the accompanying special-purpose combined balance sheets 
of the Obligated Group (as defined in the Master Trust Indenture dated 
December X, 20X0, between Sample Health Care Corporation and Any Bank 
as Trustee) of Sample Health Care Corporation and Affiliates as of December
31, 20X2, and 20X1, and the related special-purpose combined statements of 
operations, changes in net assets, and cash flows for the years then ended. 
These financial statements are the responsibility of management. Our respon­
sibility is to express an opinion on these financial statements based on our 
audits.
We conducted our audits in accordance with auditing standards generally 
accepted in the United States of America. Those standards require that we plan 
and perform the audit to obtain reasonable assurance about whether the 
financial statements are free of material misstatement. An audit includes 
examining, on a test basis, evidence supporting the amounts and disclosures 
in the financial statements. An audit also includes assessing the accounting 
principles used and significant estimates made by management, as well as 
evaluating the overall financial statement presentation. We believe that our 
audits provide a reasonable basis for our opinion.
As described in Note 1, these special-purpose financial statements were pre­
pared in accordance with the accounting requirements set forth in the Master 
Trust Indenture and are not intended to be a presentation in conformity with 
generally accepted accounting principles.
In our opinion, the special-purpose financial statements of the Obligated Group 
as of and for the years ended December 31, 20X2, and 20X1, are fairly presented, 
in all material respects, on the basis of accounting described in Note 1.
This report is intended solely for the information and use of the board of 
directors and management of Sample Health Care Corporation, the Trustee 
under the Master Trust Indenture, and bondholders, and is not intended to be 
and should not be used by anyone other than these specified parties.
[Signature]
[Date]
Exhibit 12-4
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Corporate Compliance Programs
12.07 SOP 99-1, Guidance to Practitioners in Conducting and Reporting 
on an Agreed-Upon Procedures Engagement to Assist Management in Evaluat­
ing the Effectiveness of Its Corporate Compliance Program, provides guidance 
to practitioners in conducting and reporting on an agreed-upon procedures 
engagement performed pursuant to the AICPA Statements on Standards for 
Attestation Engagements to assist a health care provider in evaluating the 
effectiveness of its corporate compliance program consistent with the require­
ments of a Corporate Integrity Agreement entered into with the Office of the 
Inspector General of the U.S. Department of Health and Human Services. SOP
99-1 is included as appendix D to this Guide.
148 Health Care Organizations
AAG-HCO 12.07
Prepaid Health Care Services 149
Chapter 13 
Financial Accounting and Reporting by 
Providers of Prepaid Health Care Services
Overview
13.01 This chapter provides guidance on applying GAAP to providers of 
prepaid health care services for the accounting and reporting of health care 
costs, contract losses (premium deficiencies), stop-loss insurance (reinsur­
ance), and contract acquisition costs.
Accounting for Health Care Costs
13.02 Health care costs should be accrued as services are rendered, 
including estimates of the costs of services rendered but not yet reported. 
Furthermore, if a provider of prepaid health care services is obligated to render 
services to specific members beyond the premium period due to provisions in 
the contract or regulatory requirements, the costs of such services to be 
incurred also should be accrued currently. Costs that will be incurred after a 
contract is terminated, such as guaranteed salaries, rent, and depreciation, net 
of any anticipated revenues, should be accrued when it is determined that a 
contract with a sponsoring employer or other group will be terminated.*
13.03 Amounts payable to hospitals, physicians, or other health care 
providers under risk-retention, bonus, or similar programs should be accrued 
during the contract period based on relevant factors, such as experience to 
date.
13.04 The basis for accruing health care costs and significant business 
and contractual arrangements with hospitals, physicians, or other associated 
entities should be disclosed in the notes to the financial statements.
Accounting for Loss Contracts
13.05 A prepaid health care provider enters into contracts to provide 
members with specified health care services for specified periods in return for 
fixed periodic premiums. The premium revenue is expected to cover health care 
costs and other costs over the terms of the contracts. Only in unusual circum­
stances would a provider be able to increase premiums on contracts in force to 
cover expected losses. A provider may be able to control or reduce future health 
care delivery costs to avoid anticipated losses, but the ability to avoid losses 
under existing contracts may be difficult to measure or to demonstrate. Asso­
ciated entities such as hospitals, medical groups, and individual practice 
associations (IPAs) may enter into similar contracts with prepaid health care 
providers in which they agree to deliver identified health care services to the 
providers’ members for specified periods in return for fixed fees.
* FASB Statement No. 146, Accounting for Costs Associated With Exit or Disposal Activities, 
addresses financial accounting and reporting for costs associated with exit or disposal activities. 
Paragraphs 14 through 16 of FASB Statement No. 146 provide additional guidance for applying the 
recognition and measurement provisions of FASB Statement No. 146 to contract termination costs. 
FASB Statement No. 146 also includes disclosure requirements. FASB Statement No. 146 is effective 
for exit or disposal activities initiated after December 31, 2002. Early application is encouraged. This 
chapter of the Guide will be modified to conform to the requirements in FASB Statement No. 146 in 
a future edition of the Guide.
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13.06 FASB Statement No. 5, Accounting for Contingencies, states that a 
loss should be accrued in financial statements when it is probable that a loss 
has been incurred and the amount of the loss can be reasonably estimated. 
Accordingly, losses should be recognized when it is probable that expected 
future health care costs and maintenance costs under a group of existing 
contracts will exceed anticipated future premiums and stop-loss insurance 
recoveries on those contracts. The estimated future health care costs and 
maintenance costs to be considered in determining whether a loss has been 
incurred should include fixed and variable, direct and allocable indirect costs. 
Contracts should be grouped in a manner consistent with the provider’s 
method of establishing premium rates, for example, by community rating 
practices, geographical area, or statutory requirements, to determine whether 
a loss has been incurred.
Accounting for Stop-Loss Insurance
13.07 In stop-loss insurance, prepaid health care providers or associated 
entities transfer portions of their financial risks to other companies. A provider 
typically contracts to recover health care costs in excess of stated amounts 
during the contract periods.
13.08 Stop-loss insurance premiums should be included in reported 
health care costs. Stop-loss insurance recoveries should be reported as reduc­
tions of related health care costs. Receivables representing amounts recover­
able from insurers should be reported as assets, reduced by appropriate 
valuation allowances. In addition, the nature, amounts, and effects of signifi­
cant stop-loss insurance contracts should be disclosed.
Accounting for Contract Acquisition Costs
13.09 Many prepaid health care providers incur costs that vary with, and 
are primarily related to, the marketing of subscriber contracts and member 
enrollment. These costs, sometimes referred to as acquisition costs, consist 
mainly of commissions paid to agents or brokers and incentive compensation 
based on new enrollments. Commissions and incentive compensation may be 
paid when the contracts are written, at later dates, or over the terms of the 
contracts as premiums are received. Some providers incur additional costs 
directly related to the acquisition of specific contracts, such as the costs of 
specialized brochures, marketing, and advertising. Providers also incur costs 
that are related to the acquisition of new members but that do not relate to 
specific contracts and are not considered acquisition costs. These costs include 
salaries of the marketing director and staff, general marketing brochures, and 
general advertising and promotion expenses.
13.10 Although there is theoretical support for deferring certain acquisi­
tion costs, acquisition costs of providers of prepaid health care services—other 
than costs of advertising—should be expensed as incurred.1 Advertising costs 
should be accounted for in conformity with the guidance in SOP 93-7, Reporting 
on Advertising Costs.2
1 In accordance with existing practice, as mandated by SOP 89-5, Financial Accounting and 
Reporting by Providers of Prepaid Health Care Services. Although SOP 89-5 has been superseded 
with the issuance of this Audit and Accounting Guide, its provisions have been adopted in this 
chapter.
2 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See chapter 1, 
footnote 1.)
AAG-HCO 13.06
Continuing Care Retirement Communities 151
Chapter 14 
Financial Accounting and Reporting by 
Continuing Care Retirement Communities
Overview
14.01 This chapter provides guidance on applying GAAP to continuing 
care retirement communities (CCRCs) for refundable and nonrefundable ad­
vance fees, for obligations to provide future services and the use of facilities to 
current residents, and for the costs of acquiring initial care contracts.1
14.02 The United States has over one thousand CCRCs. Most CCRCs are 
operated by not-for-profit organizations, and many are affiliated with religious 
organizations.
14.03 CCRC facilities may be independent or they may be affiliated with 
other health care facilities. They usually provide less intensive care than do 
hospitals. They generally supply required continuous nursing service or appro­
priate assistance to residents who have a wide range of medical conditions and 
needs.
14.04 Some states regulate CCRCs, although most states currently do 
not. There is, however, a growing trend toward regulation in this rapidly 
developing industry. States that do require some form of regulation specify 
that the CCRCs be certified by a state authority, such as a department of 
insurance or a department of social services. In addition, some states mandate 
that escrow or reserve funds be maintained for the protection of residents.
Types of Contracts
14.05 CCRCs use three basic types of contracts. They include all-inclusive 
(type A), modified (type B), and fee-for-service (type C) contracts.
Type A  Contracts
14.06 An all-inclusive continuing-care contract includes residential facili­
ties, meals, and other amenities. It also provides long-term nursing care for 
little or no increase in periodic fees, except to cover normal operating costs and 
inflation.
Type B Contracts
14.07 A modified continuing-care contract also includes residential facili­
ties, meals, and other amenities. However, only a specified amount of long­
term nursing care is provided for little or no increase in periodic fees, except to
1 The provisions of this chapter do not apply to governmental health care enterprises, unless the 
entity has elected to follow all FASB pronouncements under paragraph 7 of GASB Statement No. 20, 
Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That 
Use Proprietary Fund Accounting. (See chapter 1, footnote 1.)
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cover normal operating costs and inflation. After the specified amount of 
nursing care is used, residents pay either a discounted rate or the full per diem 
rates for required nursing care.
Type C Contracts
14.08 A fee-for-service continuing-care contract includes residential fa­
cilities, meals, and other amenities as well as emergency and infirmary nurs­
ing care. Access to long-term nursing care is guaranteed, but it may be required 
at full per diem rates.
Types of Living Accommodations
14.09 CCRCs offer different types of living accommodations to residents, 
such as single or shared apartment units or individual homes. They also 
provide a variety of amenities, including social, recreational, dining, and 
laundry services.
14.10 CCRCs may provide long-term nursing-care services, either at the 
same location or, by agreement, with another facility. Residents are trans­
ferred to or from a nursing center as medical care is required. As the health of 
a resident declines, he or she may be transferred permanently to a nursing 
center.
Fees and Payment Methods
14.11 Continuing-care contracts contain a number of different ap­
proaches to providing delivery of services. Contract provisions, for example, 
may stipulate the amount of the advance fee, whether periodic fees will be 
required, and, if so, whether they can be adjusted. In addition, contracts 
generally do the following: detail the future services that will be provided to 
residents; explain how a resident will be charged for services; describe the 
CCRC’s refund policies and the formula for calculating the amount of the 
refund, which may be simple or complex; and describe the obligations of the 
CCRC and the resident if a contract is terminated or a residential unit is 
reoccupied.
14.12 A CCRC may require several different payment methods for serv­
ices and the use of facilities. Paragraphs 14.13 through 14.19 discuss three of 
the most prevalent methods.
Advance Fee Only
14.13 Under this method, a resident pays an advance fee in return for 
future services and the use of facilities. Such services generally include CCRC 
housing-related services (for example, meals, laundry, housekeeping, and so­
cial services) and health care. These services usually are provided to the 
resident for the remainder of his or her life or until the contract is terminated. 
Additional periodic fees are not paid, regardless of how long a resident lives or 
if the resident requires more services than anticipated. Generally, the resident 
receives no ownership interest in the facility.
Advance Fee With Periodic Fees
14.14 Under this method, a resident pays an advance fee and periodic fees 
for services and the use of facilities. Such periodic fees may be fixed, or they 
may be subject to adjustment for increases in operating costs or inflation or for 
other economic reasons.
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Periodic Fees Only
14.15 Under this method, a resident pays a fee at periodic intervals for 
services and the use of the facilities provided by the CCRC. Such fees may be 
either fixed or adjustable.
14.16 An advance fee may be met by transferring a resident’s personal 
assets (which may include rights to future income) or by paying a lump sum of 
cash to the CCRC.
14.17 Advance fees received for future services may be refunded at the 
occurrence of some future event, such as death, withdrawal from the CCRC, 
termination of the contract, or reoccupancy of a residential unit. The amount 
of the refund generally is based on contractual provisions or statutory require­
ments.
14.18 Many continuing-care contracts are similar to annuity contracts. 
Under those contracts, the CCRC assumes the risks associated with (a) esti­
mating the amount of the advance fee and other fees to be paid by a resident 
and (b) determining whether such fees will be sufficient to cover the cost of 
providing a resident’s required services and the use of facilities. For some 
contracts, residents may share the future costs without limit.
14.19 The CCRC has an obligation to provide future services for the 
length of the contract or the life of the resident. In certain circumstances, this 
obligation continues regardless of whether advance fees or periodic fees are 
sufficient to meet the costs of providing services to a resident.
Accounting for Refundable Advance Fees
14.20 Payment of an advance fee generally is required before a resident 
acquires a right to reside in an apartment or residential unit for life. A portion 
of advance fees may be refundable by rescission within a legally set time period 
or if a certain future event occurs, such as the death or withdrawal of a resident 
or termination of the contract. Some refunds are paid only if a residential unit 
is reoccupied.
14.21 CCRC refund policies vary either by region or according to statu­
tory requirements, but generally the amount of the refund is based on provi­
sions specified in a contract. For example, some contracts require a refund of 
the advance fee, less a reasonable processing fee. Amounts refunded may be 
based on a fixed amount or percentage, an amount that declines to a fixed 
amount over time, an amount that declines to zero, or an amount based on the 
resale amount. Refunds may be contingent on vacating the unit, resale of the 
unit, or passage of a fixed period of time if the unit is not resold.
14.22 The estimated amount of advance fees that is expected to be re­
funded to current residents under the terms of the contracts should be ac­
counted for and reported as a liability. The estimated amount should be based 
on the individual facility’s own experience or, if records are not available, on 
the experience of comparable facilities. The remaining amount of advance fees 
should be accounted for as deferred revenue within the liability section of the 
balance sheet. Adjustments to the estimated liability should be accounted for 
as deferred revenue and amortized together with nonrefundable advance fees 
as discussed in paragraph 14.23. The gross amount of contractual refund 
obligations under existing contracts and the CCRC’s refund policy should be 
disclosed in the notes to the financial statements. Amounts refunded should be 
disclosed in the statement of cash flows as a financing transaction.
AAG-HCO 14.22
154 Health Care Organizations
14.23 The deferred revenue should be amortized to income over future 
periods based on the estimated life of the resident or on the contract term, if 
shorter. The period of amortization should be adjusted annually based on the 
actuarially determined, estimated, remaining life expectancy of each individ­
ual or on the joint and last survivor life expectancy of each pair of residents 
occupying the same unit. The straight-line method should be used to amortize 
deferred revenue except in certain circumstances when costs are expected to 
increase at a significantly higher rate than future revenues in the later years 
of residence. In those situations, deferred revenue may be amortized to income 
using a method that reflects the disproportionate ratio between the costs of the 
expected services and the expected revenues. The amortized amount should 
not exceed the amount available to the CCRC under state regulations, contract 
provisions, or management policy. Unamortized deferred revenue from nonre­
fundable advance fees should be recorded as revenue upon a resident’s death 
or the termination of the contract. The method of amortization should be 
disclosed in the notes to the financial statements.
Accounting for Fees Refundable to Residents 
Only From Reoccupancy Proceeds of a Contract 
Holder's Unit
14.24 Some contracts between a CCRC and a resident stipulate that all 
or a portion of the advance fee may be refundable if the contract holder’s unit 
is reoccupied by another person. The source of money for the payment is from 
the proceeds of the advance fees collected by the CCRC from the next resident 
of the reoccupied unit. The terms governing how the proceeds from the next 
resident are to be paid to the previous resident vary from contract to contract. 
In effect, the CCRC acts as if it were an agent for present and future residents.
14.25 The portion of the fees that will be paid to current residents or their 
designees, only to the extent of the proceeds of reoccupancy of a contract 
holder’s unit, should be accounted for as deferred revenue, provided that legal 
and management policy and practice support the withholding of refunds under 
this condition. Similar amounts received from new residents in excess of the 
amount to be paid to previous residents or their designees also should be 
deferred. The deferred revenue should be amortized to income over future 
periods based on the remaining useful life of the facility. The basis and method 
of amortization should be consistent with the method for calculating deprecia­
tion and should be disclosed in the notes to the financial statements.
Accounting for Nonrefundable Advance Fees
14.26 Under provisions of continuing-care contracts entered into by a 
CCRC and residents, nonrefundable advance fees represent payment for fu­
ture services and should be accounted for as deferred revenue. If a CCRC has 
sufficient historical experience and relevant statistical data about life expec­
tancies, it should consider that information when determining the remaining 
life of residents. A CCRC with insufficient historical experience or reliable 
actuarial data may use relevant data of similar communities within that area, 
relevant national industry statistics, or other appropriate data. Nonrefundable 
advance fees should be amortized in the manner discussed in paragraph 14.23.
14.27 The application of the conclusions in paragraphs 14.25 and 14.26 is 
presented in exhibit 14-1 at the end of this chapter.
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Accounting for the Obligation to Provide Future 
Services and the Use of Facilities to Current Residents
14.28 A CCRC expects to provide services and the use of facilities to 
individuals over their remaining lives under continuing-care contract agree­
ments. The nature and extent of such services depend on such variables as the 
individual’s age, health, sex, and economic status upon entering the CCRC. 
Thus, the CCRC assumes a risk in estimating the cost of future services and 
the use of facilities. Although many CCRCs are allowed contractually to 
increase periodic fees, some contracts may restrict increases in periodic fees 
and require continuing services without additional compensation. If the ad­
vance fees and periodic fees charged are insufficient to meet the costs of 
providing future services and the use of facilities, the CCRC has a liability to 
provide future services and the use of facilities that is equal to the estimated 
cost of providing future services and the use of facilities (defined as amounts 
that are expected to be incurred to provide services and the use of facilities to 
individuals over their remaining lives under continuing care contracts, includ­
ing resident-care, dietary, health care, facility, interest, depreciation, and 
amortization costs) in excess of the related anticipated revenues. The liability 
is based on actuarial assumptions (such as mortality and morbidity rates), on 
estimates of future costs and revenues, and on the specific CCRC’s historical 
experience and statistical data.
14.29 The obligation to provide future services and the use of facilities to 
current residents should be calculated annually in order to determine whether 
a liability should be reported in the financial statements. The liability related 
to continuing-care contracts is the present value of future net cash flows, minus 
the balance of unamortized deferred revenue, plus depreciation of facilities to 
be charged related to the contracts, plus unamortized costs of acquiring the 
related initial continuing-care contracts, if applicable. The calculation should 
be made by grouping contracts by type, such as all contracts with a limit on 
annual increases in fees, contracts with unlimited fee increases, and so forth.
14.30 Cash inflows include revenue contractually committed to support 
the residents and inflows resulting from monthly fees including anticipated 
increases in accordance with contract terms. This includes third-party pay­
ments, contractually or statutorily committed investment income from services 
related to CCRC activities, contributions pledged by donors to support CCRC 
activities, and the volume of deferred nonrefundable advance fees. Cash out­
flows are composed of operating expenses, including interest expense and 
excluding selling, and general and administrative expenses. Anticipated cost 
increases affecting these operating expenses should be considered in determin­
ing cash outflows. The expected inflation rate as well as other factors should 
be considered in determining the discount rate. In calculating the liability, the 
specific CCRC’s historical experience or statistical data relating to the residents’ 
life spans should be used. The life spans used should be the same as those used 
to amortize deferred revenue (see paragraph 14.23). For a new CCRC, either 
relevant data of similar communities in the area or relevant national industry 
statistics may be used if they are deemed to be representative.
14.31 A CCRC should disclose in its notes to the financial statements (1) 
the carrying amount of the liability to provide future services and the use of 
facilities related to continuing-care contracts that is presented at present value 
in the financial statements (if not separately disclosed in the balance sheet) 
and (2) the interest rate used to discount that liability. Also, the FASB has
AAG-HCO 14.31
156 Health Care Organizations
issued FASB Concepts Statement No. 7, Using Cash Flow Information and 
Present Value in Accounting Measurements. This Concepts Statement provides 
useful discussion of general principles governing the use of present value, and 
of the objective of present value in accounting measurements. Statements of 
Financial Accounting Concepts are not sources of established accounting prin­
ciples as described in SAS No. 69, The Meaning of Present Fairly in Conformity 
with Generally Accepted Accounting Principles, and, thus, do not amend, 
modify, or justify a change from generally accepted accounting principles 
currently in effect.
14.32 The application of the conclusions in paragraph 14.30 is presented 
in exhibit 14-2 at the end of this chapter.
Accounting for the Costs of Acquiring Initial 
Continuing-Care Contracts
14.33 Advertising costs incurred in connection with acquiring initial con­
tinuing-care contracts should be accounted for in conformity with the guidance 
in SOP 93-7, Reporting on Advertising Costs. Start-up costs should be expensed 
as incurred in accordance with SOP 98-5, Reporting on the Costs of Start-Up 
Activities. However, costs of acquiring initial continuing-care contracts that are 
within the scope of FASB Statement No. 67, Accounting for Costs and Initial 
Rental Operations of Real Estate Projects, should be expensed or capitalized in 
accordance with that Statement. Capitalized costs should be amortized to 
expenses on a straight-line basis over the average expected remaining lives of 
the residents under the contract or the contract term, if shorter. The costs of 
acquiring continuing-care contracts after a CCRC is substantially occupied or 
one year following completion should be expensed when incurred.2
Financial Statements
14.34 A complete set of illustrative financial statements for a CCRC is 
included in appendix A.
14.35 The notes to the financial statements for each year presented 
should include—
•  A description of the CCRC and the nature of the related continuing- 
care contracts entered into by the CCRC.
•  The statutory escrow or similar requirements.
•  The refund policy of the CCRC and the general amount of refund 
obligation under the existing contracts.
•  The interest rate used to discount the liability to provide future services.
Auditing
14.36 When auditing a CCRC, the independent auditor may need to 
consider the examples of specific auditing objectives, selected control activities, 
and auditing procedures that are presented in exhibit 14-3 at the end of this 
chapter.
2 In accordance with existing practice, as mandated by SOP 90-8, Financial Accounting and 
Reporting by Continuing Care Retirement Communities. Although SOP 90-8 is superseded with the 
issuance of this Audit and Accounting Guide, its provisions have been adopted in this chapter.
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Accounting for Refundable and Nonrefundable Advance Fees
Assumptions:
а. The unit is occupied for twenty years.
b. The facility has an estimated thirty-year life.
c. The resident is admitted on the first day of the year indicated and 
dies on the last day of year indicated.
d. The estimated remaining life expectancy is taken from an appropri­
ate actuarial table.
e. The cost of providing future services is expected to be incurred 
equally over the remaining life.
Example:
___________ Advance Fees____________
Refunded to
Year Entry Nonrefundable Refundable the Previous
Admitted Dies Resident Age Total 25% 75% Occupant*
1 4 A 68 $100,000 $25,000 $ 75,000 —
5 8 B 82 120,000 30,000 90,000 $75,000
9 13 C 79 150,000 37,500 112,500 90,000
14 — D 80 130,000 32,500 97,500 97,500
Amortization of Nonrefundable Advance Fees:
Unamortized Estimated 
Deferred Remaining 
Resident A  Revenue Life (in Years) Income
Year 1 $25,000 12.1 = $ 2,066
2 22,934 11.5 = 1,994
3 20,940 11.1 = 1,886
4 19,054 10.6 = 1,798
Unamortized deferred revenue
recognized upon the death of the resident 17,256
Total $25,000
* Per contact, the amount is limited to 75% of proceeds of reoccupancy up to amount originally 
paid by previous occupant.
Amortization of Advance Fees Refundable to Residents 
$75,000/30 years = $2,500 per year for years 1 through 4 
15,000/26 years = $577 additional or $3,077 per year for years 5 through 8
22,500/22 years = $1,023 additional or $4,100 per year for years 9 through next change in occupancy
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Unamortized Estimated 
Deferred Remaining 
Resident B  Revenue Life (in Years) Income
Year 5 $30,000 6.1 = $4,918
6 25,082 5.8 = 4,324
7 20,758 5.5 = 3,774
8 16,984 5.3 = 3,205
Unamortized deferred revenue
recognized upon the death of the resident 13,779
Total $30,000
Unamortized 
Deferred 
Resident C  Revenue
Year 9 
10 
11 
12 
13
$37,500
32,143
27,346
23,073
19,290
Estimated 
Remaining 
Life (in Years)
7.0 =
6.7 =
6.4 =
6.1 =
5.8 =
Income
$ 5,357 
4,797 
4,273 
3,783 
3,324
Unamortized deferred revenue
recognized upon the death of the resident 15,966
Total $37,500
Resident D
Unamortized
Deferred
Revenue
Estimated 
Remaining 
Life (in Years) Income
Year 14 $32,500 6.7 = $4,851
15 27,649 6.4 = 4,321
16 23,328 6.1 = 3,824
17 19,504 5.8 = 3,363
18 16,141 5.5 = 2,935
19 13,206 5.3 = 2,492
20 10,714 5.1 = 2,100
Amortization continues until the death of the resident.
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Accounting for the Obligation to Provide Future Services 
and the Use of Facilities to Current Residents
Assumptions:
a. All residents pay a $ 50,000 fee, which is refundable less 2 percent 
per month for the first 36 months. After that period, none of the fee 
is refundable. The CCRC opened on 1/1/X4. (See exhibit 14-1 for an 
illustration of how to compute refundable and deferred revenue.)
b. An additional periodic fee of $1,000 is payable monthly with a 5 
percent increase annually.
c. The unamortized (deferred) costs of acquiring related initial con­
tracts on 12/31/X6 are assumed to be $17,000.
d. The unamortized deferred revenue on 12/31/X6 is assumed to be 
$27,027.
Present value of net cash flow on 12/31/X6:
Cash inflows:
Estimated
Remaining Life Estimated Cash Inflows
Resident
(in Months) 
on 12 / 31/X6 19X7 19X8 19X9 20X0
A 36 $12,000 $12,600 $13,230 —
B 22 12,000 10,500 — —
C 27 12,000 12,600 3,308 —
D 38 12,000 12,600 13,230 $2,315
Estimated cash inflows $48,000 $48,300 $29,768 $2,315
Cash outflows:
Estimated 
Remaining Life Estimated Cash Outflows
Resident
(in Months) 
on 12/ 31/X6 19X7 19X8 19X9 20X0
A 36 $10,000 $12,000 $15,000 —
B 22 15,000 11,000 — —
C 27 14,000 17,000 5,000 —
D 38 8,000 12,000 14,000 $4,000
Estimated cash outflows $47,000 $52,000 $34,000 $4,000
Recapitulation 19X7 19X8 19X9 20X0
Cash inflows $ 48,000 $ 48,300 $ 29,768 $ 2,315
Cash outflows (47,000) (52,000) (34,000) (4,000)
$ 1,000 $ (3,700) $ (4,232) $(1,685)
Present value of net cash flows discounted at 10 percent $(7,137)
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Depreciation of facilities to be charged to current residents:
Original cost of facility $17,000,000
Cost of facility allocable to revenue-producing service 
areas $(2,000,000)
Cost of facility to be allocated to residents (including 
common areas) $15,000,000
Useful life 40 years
Annual depreciation using straight-line method $ 375,000
Number of residents expected to occupy the facility 200
Annual depreciation per resident $ 1,875
Monthly depreciation per resident $ 156
Resident
Estimated 
Remaining Life 
(in Months) 
on 12/31 /X6 19X7 19X8 19X9 20X0
A 36 $1,875 $1,875 $1,875 —
B 22 1,875 1,560 — —
C 27 1,875 1,875 468 —
D 38 1,875 1,875 1,875 $ 312
Yearly estimated depreciation of 
facilities to be charged to current 
residents $7,500 $7,185 $4,218 $ 312
Total estimated depreciation of the use of facilities to be
charged to the current residents $19,215
Liability for providing future services and the use of facilities to current resi­
dents:
Present value of future net cash outflows $ 7,137
Minus:
Unamortized deferred revenue on 12/31/X6 (27,027)
Plus:
Depreciation to be charged to current residents 19,215
Unamortized costs of acquiring initial
contracts— see assumption c above 17,000*
Liability for providing future services and the use of 
facilities to current residents on 12/31/X6 $16,325
* These numbers are for illustrative purposes only and no inference has been made as to the 
recoverability of the $17,000.
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Financial Statement Specific Auditing Selected Control 
Assertions Objectives Activities
Continuing Care Retirement Communities
Continuing Care Retirement Communities
Exhibit 14-3
Existence, 
completeness, and 
presentation and 
maturity
Liabilities 
relating to 
refundable fee 
arrangements are 
accounted for and 
reported properly.
Written
documentation is 
prepared for 
refundable fee 
arrangements.
161
Auditing
Procedures
Review the 
refundable fee 
arrangements 
regarding 
stipulations for 
repayments and 
determine that 
such
arrangements are 
classified and 
disclosed properly 
in the financial 
statements.
Liabilities are 
accounted for and 
reported properly.
All liabilities are
classified,
described, and
disclosed
properly in the
financial
statements.
Management 
monitors 
compliance with 
restrictive 
covenants.
Compare the 
account balances 
with the prior 
periods’ balance 
and the 
amortization 
schedules.
Confirm any 
significant new 
obligations.
Deferred Revenue
Completeness, 
rights and 
obligations, and 
presentation and 
disclosure
Deferred revenue 
and the obligation 
to provide future 
services to, and 
the use of 
facilities by, 
current residents 
of CCRCs are 
recognized and 
reported properly.
Procedures 
ensure that 
amounts received 
as advance fees 
are recognized in 
the proper period 
and that the 
obligation to 
provide future 
services and the 
use of facilities is 
reported.
Written
documentation is
Test the 
procedures 
related to the 
recognition of 
advance fees and 
determine that 
the obligation to 
provide future 
services and the 
use of facilities is 
properly reported.
Review the 
refundable fee
Long-Term Obligations
Existence, Liabilities
completeness, and relating to
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Financial Statement
Assertions
presentation and 
maturity
Specific Auditing 
Objectives
refundable fee 
arrangements are 
accounted for and 
reported properly.
Selected Control 
Activities
prepared for 
refundable fee 
arrangements.
Auditing
Procedures
arrangements 
regarding 
stipulations for 
repayments and 
determine that 
such
arrangements are 
classified and 
disclosed properly 
in the financial 
statements.
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Appendix A 
Illustrative Financial Statements
The following illustrative financial statements illustrate the applications of 
the reporting practices discussed in this guide. Specific types of health care 
organizations have been selected to illustrate a wide diversity of reporting 
practices. It is not intended that these illustrations represent either the only 
types of disclosure nor the only statement formats that would be appropriate.
For example, the reporting of revenue, expenses, gains, and losses vary depend­
ing on the relationship of the underlying transaction to the entity’s operations. 
More or less detail should appear either in the financial statements or in the 
notes to the financial statements, depending on the circumstances.
Governmental health care entities are required to follow the accounting and 
reporting requirements of the GASB. GASB pronouncements may require govern­
mental health care entities to present information beyond or different from that 
presented by not-for-profit and investor-owned entities. For example, GASB State­
ment No. 3, Deposits with Financial Institutions, Investments (including Repur­
chase Agreements), and Reverse Repurchase Agreements, requires governmental 
entities to make certain disclosures about the credit and market risks of their 
investments. GASB Statement No. 27, Accounting for Pensions by State and Local 
Governmental Employers, requires certain accounting for and disclosures about 
pension benefits provided to employees of governmental health care entities. GASB 
Statement No. 9, Reporting Cash Flows of Proprietary and Nonexpendable Trust 
Funds and Governmental Entities That Use Proprietary Fund Accounting, requires 
governmental health care entities to present a statement of cash flows using a 
format that differs in some respects from that required by FASB Statement No.
95, Statement of Cash Flows, and that requires the reporting of cash flow informa­
tion on both restricted and unrestricted funds. GASB Statement No. 12, Disclosure 
of Information on Postemployment Benefits Other Than Pension Benefits by State 
and Local Governmental Employers, requires certain disclosures about other 
postemployment benefits (OPEB) provided to employees of governmental health 
care entities. GASB Statement No. 12 also provides that governmental health care 
entities are not required to change their recognition and measurement of OPEB 
to comply with FASB Statement No. 106, Accounting for Postretirement Benefits 
Other Than Pensions, or FASB Statement No. 112, Employer’s Accounting for 
Postemployment Benefits. In June 1999, the GASB issued Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for State and 
Local Governments, as part of its governmental financial reporting model project. 
GASB Statement No. 34 establishes new financial reporting requirements for state 
and local governments, and amends or supersedes various existing GASB and 
NCGA Statements and Interpretations. Because they are not yet effective for 
certain governmental health care entities, the requirements of GASB Statement 
No. 34 and related pronouncements are discussed in appendix F to this Guide. 
Management’s discussion and analysis, basic financial statements, and notes to 
financial statements prepared in conformity with GASB Statement No. 34 and 
related pronouncements are provided in appendix F to this Guide. The effective 
dates of GASB Statement No. 34 are discussed in paragraph 1.11. This appendix 
A to the Guide will be modified to conform to the requirements of GASB Statement 
No. 34 and related pronouncements in a future edition of this Guide.
Other GASB pronouncements may also have implications for governmental 
health care entities. For example, GASB Statement No. 13, Accounting for
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Operating Leases with Scheduled Rent Increases (paragraph 6.10), may affect 
the accounting for and financial reporting of certain lease transactions. Dis­
cussed elsewhere in this Audit and Accounting Guide are GASB Statement No.
7, Advance Refundings Resulting in Defeasance of Debt (paragraph 7.19), GASB 
Statement No. 10, Accounting and Financial Reporting for Risk Financing and 
Related Insurance Issues (paragraph 8.02), GASB Statement No. 14, The 
Financial Reporting Entity (paragraph 11.01), GASB Statement No. 16, Ac­
counting for Compensated Absences (paragraph 7.03), GASB Statement No. 20, 
Accounting and Financial Reporting for Proprietary Funds and Other Govern­
mental Entities That Use Proprietary Fund Accounting (chapter 1, footnote 1), 
GASB Statement No. 23, Accounting and Financial Reporting for Refundings 
of Debt Reported by Proprietary Activities (paragraph 7.19), GASB Statement 
No. 28, Accounting and Financial Reporting for Securities Lending Transac­
tions (paragraph 4.13), GASB Statement No. 29, The Use of Not-for-Profit 
Accounting and Financial Reporting Principles by Governmental Entities 
(chapter 1, footnote 1), GASB Statement No. 30, Risk Financing Omnibus 
(paragraph 8.02), GASB Statement No. 31, Accounting and Financial Report­
ing for Certain Investments and for External Investment Pools (paragraph 4.12), 
GASB Statement No. 33, Accounting and Financial Reporting for Nonexchange 
Transactions, as amended by GASB Statement No. 36, Recipient Reporting for 
Certain Shared Nonexchange Revenues, (paragraphs 5.19, 5.20, 7.05, 10.05, and 
10.12), GASB Interpretation No. 3, Financial Reporting for Reverse Repurchase 
Agreements (paragraph 4.13), GASB Interpretation No. 4, Accounting and 
Financial Reporting for Capitalization Contributions to Public Entity Risk 
Pools (paragraph 8.02), and GASB Technical Bulletin 94-1, Disclosures about 
Derivatives and Similar Debt and Investment Transactions (paragraph 4.16).
These illustrative financial statements are not intended to include items that 
should be accounted for under the requirements of FASB Statement No. 133, 
Accounting for Derivative Instruments and Hedging Activities, as amended, and 
do not reflect the requirements of FASB Statement No. 133. FASB Statement 
No. 133, among other matters, amends the disclosure requirements for securi­
ties in FASB Statement No. 115, Accounting for Certain Investments in Debt 
and Equity Securities (see paragraph 534 of FASB Statement No. 133). In 
reporting disclosures about investments in securities, investor-owned entities 
should comply primarily with the requirements of paragraphs 6,17, 19, 20, 21, 
and 22 of FASB Statement No. 115, as amended. Other disclosure requirements 
for investments in securities may also be applicable. Practitioners should refer 
to FASB Statement No. 133, as amended, for guidance on reporting derivative 
instruments and hedging activities.
This appendix contains illustrative financial statements for the following types 
of health care organizations:
1. Not-for-profit hospital
2. Governmental hospital authority (pre-GASB statement No. 34)
3. Nursing home
4. Continuing care retirement community (CCRC)
5. Home health agency
6. Health maintenance organization (HMO)
7. Ambulatory care organization
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NOT-FOR-PROFIT HOSPITAL
Sample Not-for-Profit Hospital 
Balance Sheets 
December 31, 20X7 and 20X6 
(in thousands)
20X7
Assets
Current assets:
Cash and cash equivalents 
Short-term investments 
Assets limited as to use 
Patient accounts receivable, net of 
allowance for doubtful accounts of $2,500 
in 20X7 and $2,400 in 20X6 
Other current assets
Total current assets
Interest in net assets of Sample Hospital 
Foundation* 
Assets limited as to use:
Internally designated for capital acquisition 
Held by trustee
Less amount required to meet current 
obligations
$ 4,758 
15,836 
970
15,100
2,670
39,334
510
12,000
6,949
18,949
(970)
17,979
20X6
$ 5,877 
10,740 
1,300
14,194
2,856
34,967
462
12,500
7,341
19,841
(1,300)
18,541
(continued )
* These illustrative financial statements include a presentation of an interest in the net assets 
of a financially interrelated foundation that is based on the particular fact pattern described in Note 
12 to the illustrative financial statements and the following additional facts:
• Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital Foun­
dation to such an extent that it can determine the timing and amount of distributions from 
the Foundation. Thus, it is inappropriate for the Hospital to imply a time restriction on amounts 
held by the Foundation.
• Contributions to Foundation are restricted by donors for property acquisitions. Those restrictions 
have been met by the Hospital even though the net assets remain at the Foundation. Thus, 
the net assets related to the interest in the Foundation are classified as unrestricted in the 
Hospital’s financial statements.
• The Hospital’s policy is to report restricted revenues as unrestricted if the restriction is met 
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted to 
property acquisitions, this presentation shows the change in that interest reported separately from the 
performance indicator, in the spirit of the guidance in paragraph 10.18 for contributions restricted to 
property acquisitions. Readers should be aware that FASB Statement No. 136 is silent on this 
classification. The AICPA is considering addressing the classification of the change in interest in a 
financially interrelated organization and related issues in Technical Practice Aids (TPAs). TPAs are 
nonauthoritative and are not sources of established accounting principles as described in SAS No. 69, The 
Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles.
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Sample Not-for-Profit Hospital 
Balance Sheets 
(continued) 
December 31, 20X7 and 20X6 
(in thousands)
20X7
Long-term investments 4,680 
Long-term investments restricted for capital
acquisition 320
Property and equipment, net 51,038
Other assets 1,185
Total assets $115,046
Liabilities and Net Assets
Current liabilities:
Current portion of long-term debt $ 1,470
Accounts payable and accrued expenses 5,818
Estimated third-party payor settlements 2,143
Other current liabilities 1,969
Total current liabilities 11,400
Long-term debt, net of current portion 23,144
Other liabilities 3,953
Total liabilities 38,497
Net assets:
Unrestricted 70,846
Temporarily restricted 2,115
Permanently restricted 3,588
Total net assets 76,549
Total liabilities and net assets $115,046
See accompanying notes to financial statements.
20X6
4,680
520
50,492
908
$110,570
$ 1,750 
5,382 
1,942 
2,114
11,188
24,014
3,166
38,368
66,199
2,470
3,533
72,202
$110,570
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Sample Not-for-Profit Hospital 
Statements of Operations 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
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20 X 7  20X6
Unrestricted revenues, gains and other support:
$85,156 $78,942Net patient service revenue
Premium revenue 11,150 10,950
Other revenue 2,601 5,212
Net assets released from restrictions used for operations 300
Total revenues, gains and other support 99,207 95,104
Expenses:
88,521 80,585Operating expenses
Depreciation and amortization 4,782 4,280
Interest 1,752 1,825
Provision for bad debts 1,000 1,300
Other 2,000 1,300
Total expenses 98,055 89,290
Operating income 1,152 5,814
Other income:
Investment income 3,900 3,025
Excess of revenues over expenses 5,052 8,839
Change in net unrealized gains and losses on other
than trading securities 300 375
Net assets released from restrictions used for purchase
of property and equipment 200
Change in interest in net assets of Sample
Hospital Foundation* 283 536
Transfers to parent (688) (3,051)
Increase in unrestricted net assets, before extraordinary item 5,147 6,699
Extraordinary loss from extinguishment of debt (500)
Increase in unrestricted net assets $ 4,647 $ 6,699
See accompanying notes to financial statements.
* These illustrative financial statements include a presentation of an interest in the net assets 
of a financially interrelated foundation that is based on the particular fact pattern described in Note 
12 to the illustrative financial statements and the following additional facts:
• Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital Foun­
dation to such an extent that it can determine the timing and amount of distributions from 
the Foundation. Thus, it is inappropriate for the Hospital to imply a time restriction on amounts 
held by the Foundation.
• Contributions to Foundation are restricted by donors for property acquisitions. Those restrictions 
have been met by the Hospital even though the net assets remain at the Foundation. Thus, 
the net assets related to the interest in the Foundation are classified as unrestricted in the 
Hospital’s financial statements.
• The Hospital’s policy is to report restricted revenues as unrestricted if the restriction is met 
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted to 
property acquisitions, this presentation shows the change in that interest reported separately from the 
performance indicator, in the spirit of the guidance in paragraph 10.18 for contributions restricted to 
property acquisitions. Readers should be aware that FASB Statement No. 136 is silent on this 
classification. The AICPA is considering addressing the classification of the change in interest in a 
financially interrelated organization and related issues in Technical Practice Aids (TPAs). TPAs are 
nonauthoritative and are not sources of established accounting principles as described in SAS No. 69, The 
Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles.
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FORMAT B
Sample Not-for-Profit Hospital 
Statements of Operations 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Unrestricted revenues, gains and other support:
Net patient service revenue $ 85,156 $78,942
Premium revenue 11,150 10,950
Other, primarily investment income 6,501 8,237
Net assets released from restrictions used for operations 300
Total revenues, gains and other support 103,107 98,129
Expenses:
Salaries and benefits 53,900 49,938
Medical supplies and drugs 26,532 22,121
Insurance 8,089 8,526
Depreciation and amortization 4,782 4,280
Interest 1,752 1,825
Allowance for bad debts 1,000 1,300
Other 2,000 1,300
Total expenses 98,055 89,290
Excess of revenues, gains, and other support over expenses 5,052 8,839
Change in net unrealized gains and losses on
other than trading securities 300 375
Net assets released from restrictions used for
purchase of property and equipment 200
Change in interest in net assets of Sample
Hospital Foundation* 283 536
Transfers to parent (688) (3,051)
Increase in unrestricted net assets, before
extraordinary item 5,147 6,699
Extraordinary loss from extinguishment of debt (500)
Increase in unrestricted net assets $ 4,647 $ 6,699
See accompanying notes to financial statements.
These illustrative financial statements include a presentation of an interest in the net assets 
of a financially interrelated foundation that is based on the particular fact pattern described in Note 
12 to the illustrative financial statements and the following additional facts:
• Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital Foun­
dation to such an extent that it can determine the timing and amount of distributions from 
the Foundation. Thus, it is inappropriate for the Hospital to imply a time restriction on amounts 
held by the Foundation.
• Contributions to Foundation are restricted by donors for property acquisitions. Those restrictions 
have been met by the Hospital even though the net assets remain at the Foundation. Thus, 
the net assets related to the interest in the Foundation are classified as unrestricted in the 
Hospital’s financial statements.
• The Hospital’s policy is to report restricted revenues as unrestricted if the restriction is met 
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted to 
property acquisitions, this presentation shows the change in that interest reported separately from the 
performance indicator, in the spirit of the guidance in paragraph 10.18 for contributions restricted to 
property acquisitions. Readers should be aware that FASB Statement No. 136 is silent on this 
classification. The AICPA is considering addressing the classification of the change in interest in a 
financially interrelated organization and related issues in Technical Practice Aids (TPAs). TPAs are 
nonauthoritative and are not sources of established accounting principles as described in SAS No. 69, The 
Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles.
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Sample Not-for-Profit Hospital 
Statements of Changes in Net Assets 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Unrestricted net assets:
Excess of revenues over expenses $ 5,052 $ 8,839
Net unrealized gains on investments, other
than trading securities 300 375
Change in interest in net assets of Sample
Hospital Foundation* 283 536
Transfers to parent (688) (3,051)
Net assets released from restrictions used for
purchase of property and equipment 200
Increase in unrestricted net assets before
extraordinary item 5,147 6,699
Extraordinary loss from extinguishment of debt (500)
Increase in unrestricted net assets 4,647 6,699
Temporarily restricted net assets:
Contributions for charity care 140 996
Net realized and unrealized gains on investments 5 8
Net assets released from restrictions (500)
Increase (decrease) in temporarily restricted net assets (355) 1,004
Permanently restricted net assets:
Contributions for endowment funds 50 411
Net realized and unrealized gains on investments 5 2
Increase in permanently restricted net assets 55 413
Increase in net assets 4,347 8,116
Net assets, beginning of year 72,202 64,086
Net assets, end of year $76,549 $72,202
See accompanying notes to financial statements.
* These illustrative financial statements include a presentation of an interest in the net assets 
of a financially interrelated foundation that is based on the particular fact pattern described in Note
12 to the illustrative financial statements and the following additional facts:
• Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital Foun­
dation to such an extent that it can determine the timing and amount of distributions from 
the Foundation. Thus, it is inappropriate for the Hospital to imply a time restriction on amounts 
held by the Foundation.
• Contributions to Foundation are restricted by donors for property acquisitions. Those restrictions 
have been met by the Hospital even though the net assets remain at the Foundation. Thus, 
the net assets related to the interest in the Foundation are classified as unrestricted in the 
Hospital’s financial statements.
• The Hospital’s policy is to report restricted revenues as unrestricted if the restriction is met 
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted to 
property acquisitions, this presentation shows the change in that interest reported separately from the 
performance indicator, in the spirit of the guidance in paragraph 10.18 for contributions restricted to 
property acquisitions. Readers should be aware that FASB Statement No. 136 is silent on this 
classification. The AICPA is considering addressing the classification of the change in interest in a 
financially interrelated organization and related issues in Technical Practice Aids (TPAs). TPAs are 
nonauthoritative and are not sources of established accounting principles as described in SAS No. 69, The 
Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles.
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Sample Not-for-Profit Hospital 
Statements of Cash Flows (Indirect Method) 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Cash flows from operating activities:
Change in net assets $ 4,347 $ 8,116
Adjustments to reconcile change in net assets to net 
cash provided by operating activities:
Extraordinary loss from extinguishment of debt 500
Depreciation and amortization 4,782 4,280
Net realized and unrealized gains on investments,
other than trading (450) (575)
Undistributed portion of change in interest in net
assets of Sample Hospital Foundation (48) (51)
Transfers to parent 688 3,051
Allowance for bad debts 1,000 1,300
Restricted contributions and investment
income received (290) (413)
(Increase) decrease in:
Patient accounts receivable (1,906) (2,036)
Trading securities 215
Other current assets 186 (2,481)
Other assets (277) (190)
Increase (decrease) in:
Accounts payable and accrued expenses 436 679
Estimated third-party payor settlements 201 305
Other current liabilities (145) (257)
Other liabilities 787 (128)
Net cash provided by operating activities 10,026 11,600
Cash flows from investing activities:
Purchase of investments (3,769) (2,150)
Capital expenditures (4,728) (5,860)
Net cash used in investing activities (8,497) (8,010)
Cash flows from financing activities:
Transfers to parent (688) (3,051)
Proceeds from restricted contributions and
restricted investment income 290 413
Payments on long-term debt (24,700) (804)
Payments on capital lease obligations (150) (100)
Proceeds from issuance of long-term debt 22,600 500
Net cash used in financing activities (2,648) (3,042)
Net (decrease) increase in cash and cash equivalents (1,119) 548
Cash and cash equivalents, beginning of year 5,877 5,329
Cash and cash equivalents, end of year $ 4,758 $ 5,877
AAG-HCO APP A
Illustrative Financial Statements 171
Supplemental Disclosures of Cash Flow Information:
The Hospital entered into capital lease obligations in the amount of $600,000 
for new equipment in 20X7.
Cash paid for interest (net of amount capitalized) in 20X7 and 20X6 was 
$1,780,000 and $1,856,000, respectively.
See accompanying notes to financial statements.
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Sample Not-for-Profit Hospital 
Notes to Financial Statements 
December 31, 20X7 and 20X6
1. Description of Organization and Summary of Significant Accounting 
Policies1
Organization. The Sample Not-for-Profit Hospital (the Hospital), located in Tulsa, 
Oklahoma, is a not-for-profit acute care hospital. The Hospital provides inpatient, 
outpatient and emergency care services for residents of northeastern Oklahoma. 
Admitting physicians are primarily practitioners in the local area. The Hospital was 
incorporated in Oklahoma in 20X1 and is affiliated with the Sample Health System.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include certain in­
vestments in highly liquid debt instruments with original maturities of three 
months or less.
The Hospital routinely invests its surplus operating funds in money market 
mutual funds. These funds generally invest in highly liquid U.S. government 
and agency obligations.
Investments. Investments in equity securities with readily determinable fair 
values and all investments in debt securities are measured at fair value in the 
balance sheet. Investment income or loss (including realized gains and losses 
on investments, interest and dividends) is included in the excess of revenues 
over expenses unless the income or loss is restricted by donor or law. Unrealized 
gains and losses on investments are excluded from the excess of revenues over 
expenses unless the investments are trading securities.
Assets limited as to use. Assets limited as to use primarily include assets held 
by trustees under indenture agreements and designated assets set aside by the 
Board of Trustees for future capital improvements, over which the Board 
retains control and may at its discretion subsequently use for other purposes. 
Amounts required to meet current liabilities of the Hospital have been reclas­
sified in the balance sheet at December 31, 20X7 and 20X6.
Property and equipment. Property and equipment acquisitions are recorded at 
cost. Depreciation is provided over the estimated useful life of each class of 
depreciable asset and is computed using the straight-line method. Equipment 
under capital lease obligations is amortized on the straight-line method over the 
shorter period of the lease term or the estimated usefu l life of the equipment. Such 
amortization is included in depreciation and amortization in the financial state­
ments. Interest cost incurred on borrowed funds during the period of construction 
of capital assets is capitalized as a component of the cost of acquiring those assets.
Gifts of long-lived assets such as land, buildings, or equipment are reported 
as unrestricted support, and are excluded from the excess of revenues over 
expenses, unless explicit donor stipulations specify how the donated assets
1 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade 
Receivables) That Lend to or Finance the Activities o f Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts. SOP 01-6 is effective for annual and interim financial 
statements issued for fiscal years beginning after December 15, 2001.
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must be used. Gifts of long-lived assets with explicit restrictions that specify 
how the assets are to be used and gifts of cash or other assets that must be used 
to acquire long-lived assets are reported as restricted support. Absent explicit 
donor stipulations about how long those long-lived assets must be maintained, 
expirations of donor restrictions are reported when the donated or acquired 
long-lived assets are placed in service.
Temporarily and permanently restricted net assets. Temporarily restricted 
net assets are those whose use by the Hospital has been limited by donors to a 
specific time period or purpose. Permanently restricted net assets have been 
restricted by donors to be maintained by the Hospital in perpetuity.
Excess of revenues over expenses. The statement of operations includes excess 
of revenues over expenses. Changes in unrestricted net assets which are excluded 
from excess of revenues over expenses, consistent with industry practice, include 
unrealized gains and losses on investments other than trading securities, perma­
nent transfers of assets to and from affiliates for other than goods and services, and 
contributions of long-lived assets (including assets acquired using contributions 
which by donor restriction were to be used for the purposes of acquiring such assets).
Net patient service revenue. The Hospital has agreements with third-party 
payors that provide for payments to the Hospital at amounts different from its 
established rates. Payment arrangements include prospectively determined 
rates per discharge, reimbursed costs, discounted charges, and per diem pay­
ments. Net patient service revenue is reported at the estimated net realizable 
amounts from patients, third-party payors, and others for services rendered, 
including estimated retroactive adjustments under reimbursement agree­
ments with third-party payors. Retroactive adjustments are accrued on an 
estimated basis in the period the related services are rendered and adjusted in 
future periods as final settlements are determined.
Premium revenue. The Hospital has agreements with various Health Main­
tenance Organizations (HMOs) to provide medical services to subscribing par­
ticipants. Under these agreements, the Hospital receives monthly capitation 
payments based on the number of each HMO’s participants, regardless of 
services actually performed by the Hospital. In addition, the HMOs make 
fee-for-service payments to the Hospital for certain covered services based upon 
discounted fee schedules.
Charity care. The Hospital provides care to patients who meet certain 
criteria under its charity care policy without charge or at amounts less than its 
established rates. Because the Hospital does not pursue collection of amounts 
determined to qualify as charity care, they are not reported as revenue.
Donor-restricted gifts. Unconditional promises to give cash and other assets 
to the Hospital are reported at fair value at the date the promise is received. 
Conditional promises to give and indications of intentions to give are reported 
at fair value at the date the gift is received. The gifts are reported as either 
temporarily or permanently restricted support if they are received with donor 
stipulations that limit the use of the donated assets. When a donor restriction 
expires, that is, when a stipulated time restriction ends or purpose restriction 
is accomplished, temporarily restricted net assets are reclassified as unre­
stricted net assets and reported in the statement of operations as net assets 
released from restrictions. Donor-restricted contributions whose restrictions 
are met within the same year as received are reported as unrestricted contri­
butions in the accompanying financial statements.
Estimated malpractice costs. The provision for estimated medical malprac­
tice claims includes estimates of the ultimate costs for both reported claims and 
claims incurred but not reported.
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Income taxes. The Hospital is a not-for-profit corporation and has been 
recognized as tax-exempt pursuant to Sec. 501(c)(3) of the Internal Revenue Code.
2. Net Patient Service Revenue
The Hospital has agreements with third-party payors that provide for pay­
ments to the Hospital at amounts different from its established rates. A 
summary of the payment arrangements with major third-party payors follows:
•  Medicare. Inpatient acute care services and outpatient services ren­
dered to Medicare program beneficiaries are paid at prospectively deter­
mined rates. These rates vary according to a patient classification system 
that is based on clinical, diagnostic, and other factors. Inpatient nonacute 
services and defined capital and medical education costs related to 
Medicare beneficiaries are paid based on a cost reimbursement method­
ology. The Hospital is reimbursed for cost reimbursable items at a 
tentative rate with final settlement determined after submission of 
annual cost reports by the Hospital and audits thereof by the Medicare 
fiscal intermediary. Beginning in 20X3, the Hospital claimed Medicare 
payments based on an interpretation of certain “disproportionate share” 
rules. The intermediary disagreed and declined to pay the excess reim­
bursement claimed under that interpretation. Through 1996, the Hospi­
tal has not included the claimed excess in net patient revenues pending 
resolution of the matter. In 20X7, the intermediary accepted the claims 
and paid the outstanding claims, including $950,000 applicable to 20X6 
and $300,000 applicable to 20X5 and prior, which has been included in 
20X7 net revenues.
•  Medicaid. Inpatient and outpatient services rendered to Medicaid 
program beneficiaries are reimbursed under a cost reimbursement 
methodology. The Hospital is reimbursed at a tentative rate with final 
settlement determined after submission of annual cost reports by the 
Hospital and audits thereof by the Medicaid fiscal intermediary.
Revenue from the Medicare and Medicaid programs accounted for approxi­
mately XX percent and XX percent, respectively, of the Hospital’s net patient 
revenue for the year ended 20X7, and XX percent and XX percent, respectively, 
of the Hospital’s net patient revenue, for the year ended 20X6. Laws and 
regulations governing the Medicare and Medicaid programs are extremely 
complex and subject to interpretation. As a result, there is at least a reasonable 
possibility that recorded estimates will change by a material amount in the 
near term. The 20X6 net patient service revenue increased approximately 
$XXX due to removal of allowances previously estimated that are no longer 
necessary as a result of final settlements and years that are no longer subject 
to audits, reviews, and investigations. The 20X7 net patient service revenue 
decreased approximately $XXX due to prior-year retroactive adjustments in 
excess of amounts previously estimated.
The Hospital also has entered into payment agreements with certain com­
mercial insurance carriers, health maintenance organizations, and preferred 
provider organizations. The basis for payment to the Hospital under these 
agreements includes prospectively determined rates per discharge, discounts 
from established charges, and prospectively determined daily rates.
3. Investm ents
Assets Limited as to Use
The composition of assets limited as to use at December 31, 20X7 and 20X6, 
is set forth in the following table. Investments are stated at fair value.
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20X7 20X6
Internally designated for capital acquisition: 
Cash
U.S. Treasury obligations 
Interest receivable
Held by trustee under indenture agreement: 
Cash and short-term investments 
U.S. Treasury obligation 
Interest receivable
Other Investments
$ 545,000 $ 350,000
11,435,000 12,115,000
20,000 35,000
12,000,000 12,500,000
352,000 260,000
6,505,000 7,007,000
92,000 74,000
6,949,000 7,341,000
$18,949,000 $19,841,000
Other investments, stated at fair value, at December 31, 20X7 and 20X6, 
include:
20X7 20X6
Trading:
U.S. Corporate Bonds $ 1,260,000 $ 1,475,000
Other:
U.S. Treasury obligations $19,266,000 $14,233,000
Interest receivable 310,000 232,000
20,836,000 15,940,000
Less:
Long-term investments 4,680,000 4,680,000
Long-term investments restricted for capital 
acquisitions 320,000 520,000
Short-term investments $15,836,000 $10,740,000
Investment income and gains for assets limited as to use, cash equivalents, 
and other investments are comprised of the following for the years ending 
December 31, 20X7 and 20X6:
20X7 20X6
Income:
Interest income $3,585,000 $2,725,000
Realized gains on sales of securities 150,000 200,000
Unrealized gains on trading securities 165,000 100,000
$3,900,000 $3,025,000
Other Changes in Unrestricted Net Assets:
Unrealized gains on other than trading
securities $ 300,000 $ 375,000
4. Property and Equipment
A summary of property and equipment at December 31, 20X7 and 20X6, 
follows:
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20X7 20X6
Land $ 3,000,000 $ 3,000,000
Land improvements 472,000 472,000
Buildings and improvements 46,852,000 46,636,000
Equipment 29,190,000 26,260,000
Equipment under capital lease obligations 2,851,000 2,752,000
82,365,000 79,120,000
Less accumulated depreciation and
amortization 34,928,000 30,661,000
47,437,000 48,459,000
Construction in progress 3,601,000 2,033,000
Property and equipment, net $51,038,000 $50,492,000
Depreciation expense for the years ended December 31, 20X7 and 20X6 
amounted to approximately $4,782,000 and $4,280,000. Accumulated amorti­
zation for equipment under capital lease obligations was $689,000 and $453,000 
at December 31, 20X7 and 20X6, respectively. Construction contracts of ap­
proximately $7,885,000 exist for the remodeling of Hospital facilities. At 
December 31, 20X7, the remaining commitment on these contracts approxi­
mated $4,625,000.
5. Long-Term Debt
A summary of long-term debt and capital lease obligations at December 31, 
20X7 and 20X6, follows:
20X7 20X6
7.25 percent 20X7 Tax-Exempt Revenue 
Bonds, principal maturing in varying annual 
amounts, due November 1, 20XX, 
collateralized by a pledge of the Hospital’s 
gross receipts $21,479,000
8.50 percent 20X2 Tax-Exempt Revenue 
Bonds, principal maturing in varying annual
amounts, due June 1, 20XX $22,016,000
7.75 percent mortgage loan, principal 
maturing in varying annual amounts, due 
January 20XX, collateralized by a mortgage 
on certain property and equipment
7.75 percent note payable, payable in monthly 
installments of $12,000, including interest, 
due March 20XX, unsecured
Capital lease obligations, at varying rates of 
imputed interest from 6.8 percent to 9.3 
percent collateralized by leased equipment
Less current portion
2,010,000 2,127,000
125,000 671,000
1,000,000 950,000
24,614,000 25,764,000
1,470,000 1,750,000
$23,144,000 $24,014,000
Under the terms of the 20X7 and 20X2 revenue bond indentures, the Hospital is 
required to maintain certain deposits with a trustee. Such deposits are included 
with assets limited as to use. The revenue note indenture also places limits on the 
incurrence of additional borrowings and requires that the Hospital satisfy certain 
measures of financial performance as long as the notes are outstanding.
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Year Ending Long-Term Capital Leases
December 31, Debt Obligations
20X8
20X9
20Y0
20Y1
20Y2
Thereafter
$ 970,000
912,000
983,000 
1,060,000 
1,143,000
18,546,000
$ 550,000 
260,000 
260,000 
45,000
Less amount representing interest 
under capital leases obligations
$23,614,000 1,115,000
115,000
$1,000,000
A summary of interest cost and investment income on borrowed funds held 
by the trustee under the 20X7 and 20X2 revenue bond indentures during the 
years ended December 31, 20X7 and 20X6, follows:
20X7 20X6
Interest cost: 
Capitalized 
Charged to operations
$ 740,000 
1,752,000
$ 700,000 
1,825,000
Total $2,492,000 $2,525,000
Investment income: 
Capitalized
Credited to other revenue
$ 505,000 
330,000
$ 663,000 
386,000
Total $ 835,000 $1,049,000
6. T em porarily  an d  P erm an en tly  R estr ic ted  N et A ssets
Temporarily restricted net assets are available for the following purposes or 
periods at December 31, 20X7 and 20X6:
20X7 20X6
Health care services 
Purchase of equipment 
Indigent care 
Health education 
For periods after December 31, 20X9
$ 320,000
840,000
350,000
605,000
$ 520,000
950,000
400,000
600,000
$2,115,000 $2,470,000
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Permanently restricted net assets at December 31, 20X7 and 20X6, are
restricted to:
20X7 20X6
Investments to be held in perpetuity, the 
income from which is expendable to support 
health care services (reported as operating 
income) $2,973,000 $2,923,000
Endowment requiring income to be added to 
original gift until fund value is $1,500,000 615,000 610,000
$3,588,000 $3,533,000
During 20X7, net assets were released from donor restrictions by incurring 
expenses satisfying the restricted purposes of indigent care and health care 
education in the amounts of $250,000 and $50,000, respectively.
7. M edical M alpractice C laim s
The Hospital purchases professional and general liability insurance to cover 
medical malpractice claims. There are known claims and incidents that may 
result in the assertion of additional claims, as well as claims from unknown 
incidents that may be asserted arising from services provided to patients. The 
Hospital has employed independent actuaries to estimate the ultimate costs, if 
any, of the settlement of such claims. Accrued malpractice losses have been 
discounted at 7 percent and in management’s opinion provide an adequate 
reserve for loss contingencies.
On March 15, 20X7, a patient filed a suit against the Hospital for malpractice 
during care received as an inpatient. The Hospital believes it has meritorious 
defenses against the suit; however, the ultimate resolution of the matter could 
result in a loss. The patient has claimed $16 million in actual damages. Under 
state law, punitive damages are determined at trial. The Hospital maintains 
insurance coverage for malpractice claims. The coverage does not include 
punitive damages awards. Trial is scheduled to occur within the next year.
8. P en sio n  an d  O ther P o stre tirem en t B en efit P la n s1
The Hospital has a defined benefit pension plan covering substantially all of 
its employees. The plan benefits are based on years of service and the employ­
ees’ compensation during the last five years of covered employment. Contribu­
tions are intended to provide not only for benefits attributed to service to date 
but also for those expected to be earned in the future.
[The following paragraph is encouraged but not required.]
The Hospital also sponsors two defined benefit postretirement plans that 
cover both salaried and nonsalaried employees. One plan provides medical and 
dental benefits, and the other provides for the payment of life insurance 
premiums. The postretirement health care plan is contributory, with retiree 
contributions adjusted annually; the life insurance plan is noncontributory. The
1 FASB Statement No. 132, Employers’ Disclosures about Pensions and Other Postretirement 
Benefits, an amendment of FASB Statement Nos. 87, 88, and 106, permits reduced disclosures for 
nonpublic entities. This note to the financial statements illustrates the financial statement disclo­
sures about pension and postretirement benefit plans for a public entity. Readers should refer to 
FASB Statement No. 132 when considering disclosure requirements for nonpublic entities.
AAG-HCO APP A
Illustrative Financial Statements 179
accounting for the health care plan anticipates future cost-sharing changes to 
the written plan that are consistent with the Hospital’s expressed intent to 
increase retiree contributions each year to 50 percent of the excess of the 
expected general inflation rate over 6 percent. Beginning in 20X7, the Hospital 
adopted a funding policy for its postretirement health care plan similar to its 
funding policy for its life insurance plan—an amount equal to a level percentage 
of the employees’ salaries is contributed to the plan annually. For 20X7, that 
percentage was 4.25, and the aggregate contribution for both plans was 
$34,000.
The following table sets forth the changes in benefit obligations, changes in 
plan assets and components of net periodic benefit cost for both the pension 
plan and the other postretirement benefit plans:
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Change in benefit obligation:
Benefit obligation at beginning $ 9,710 $ 9,700 $585 $500
of year
Service cost 905 770 14 15
Interest cost 700 650 50 44
Plan participants’ contributions 34 34
Actuarial gain (20) (7)
Benefits paid (375) (1,410) (66) (8)
Benefit obligation at end of year 10,920 9,710 610 585
Change in plan assets:
Fair value of plan assets at
beginning of year 9,800 9,610 89 40
Actual return on plan assets 759 810 4 4
Employer contribution 866 790 39 19
Plan participants’ contributions 34 34
Benefits paid (375) (1,410) (66) (8)
Fair value of plan assets at end
of year 11,050 9,800 100 89
Funded status 130 90 (510) (496)
Unrecognized net actuarial gain (30) (40) (30) (40)
Unrecognized prior service cost 50 55 16 19
Unrecognized transition obligation 445 470
Unrecognized transition asset (15) (20)
Prepaid (accrued) benefit cost $ 135 $ 85 $ (79) $ (47)
Weighted-average assumptions as of
December 31:
Discount rate 7.00% 7.00% 7.00% 7.00%
Expected return on plan assets 8.00% 8.00% 6.60% 6.60%
Rate of compensation increase 6.00% 6.00%
For measurement purposes, a 7 percent annual rate of increase in the per capita 
cost of covered health care benefits was assumed for 20X8. The rate was 
assumed to decrease gradually to 5 percent over the next five years.
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Pension Benefits Other Benefits
Components of net periodic 
benefit cost:
20X7 20X6 20X7 20X6
Service cost $905 $ 770 $14 $15
Interest cost 700 650 50 44
Expected return on plan assets (784) (769) (6) (3)
Amortization of prior service cost 5 7 3 2
Recognized net actuarial (gain) 
Amortization of transition 
obligation
(5) (2) (15)
25
(1)
25
Amortization of transition asset (5) (1)
Net periodic benefit cost $816 $655 $71 $82
Assumed health care cost trend rates have a significant effect on the amounts 
reported for the health care plans. A one-percentage-point change in assumed 
health care cost trend rates would have the following effects:
1-Percentage- 1-Percentage-
Point Increase Point Decrease
Effect on total of service and interest
cost components $13 $(11)
Effect on postretirement benefit obligation 73 (67)
9. Concentrations o f Credit Risk
The Hospital grants credit without collateral to its patients, most of whom 
are local residents and are insured under third-party payor agreements. The 
mix of receivables from patients and third-party payors at December 31, 20X7 
and 20X6, was as follows:
20X7 20X6
Medicare 51% 53%
Medicaid 17 14
Blue Cross 18 17
Other third-party payors 7 9
Patients 7 7
100% 100%
10. Commitments and Contingencies
Operating leases. The Hospital leases various equipment and facilities under 
operating leases expiring at various dates through April 20Y2. Total rental 
expense in 20X7 and 20X6 for all operating leases was approximately $859,000 
and $770,000, respectively.
The following is a schedule by year of future minimum lease payments under 
operating leases as of December 31, 20X7, that have initial or remaining lease 
terms in excess of one year.
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Year Ending 
December 31, Amount
20X8 
20X9 
20Y0 
20Y1 
20Y2
$517,000
506,000
459,000
375,000
343,000
Litigation. The Hospital is involved in litigation and regulatory investigations 
arising in the course of business. After consultation with legal counsel, manage­
ment estimates that these matters will be resolved without material adverse effect 
on the Hospital’s future financial position or results from operations.
Allowance for doubtful accounts. Beginning in 20X5, the Hospital has provided 
care under an agreement with Associated HMO. The HMO currently owes the 
Hospital $950,000, substantially all of which is overdue. The Hospital has notified 
the HMO that further services under the contract cannot be provided without 
payment on the outstanding balance. The HMO has assured the Hospital that 
additional funds are being obtained in order to pay the overdue balance and 
continue service under the agreement, however, if the HMO is unable to make 
payments, additional allowances for bad debts would need to be accrued.
11. Extraordinary Loss
In 20X7, the Hospital advance refunded its 20X2 Revenue Bonds in the 
amount of $22 million by issuing 20X7 Revenue Bonds. As a result of this 
transaction, an extraordinary loss totaling $500,000 was recorded. As of De­
cember 31, 20X7, $21 million of advance refunded bonds, which are considered 
extinguished, remain outstanding.
12. Related Party Transactions
During the years ended December 31, 20X7 and 20X6, the Hospital contributed 
capital to Sample Health System, an affiliate with some board members in common 
with the Hospital, in the amounts of $688,000 and $3,051,000, respectively.
The Sample Hospital Foundation (the Foundation), which is controlled by 
Sample Health System, was established to solicit contributions from the general 
public solely for the funding of capital acquisitions by the Hospital. Funds are 
distributed to the Hospital as determined by the Foundation’s Board of Directors. 
A summary of the foundation’s assets, liabilities, net assets, results of operations, 
and changes in net assets follows. The Hospital’s interest in the net assets of the 
Foundation is reported as a non-current asset in the balance sheets.
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At December 31, 
20X7 20X6
Assets, principally cash and cash equivalents $521,000 $472,000
Liabilities 11,000 10,000
Unrestricted net assets 510,000 462,000
Total liabilities and net assets $521,000 $472,000
Support and revenue $269,000 $535,000
Expenses
Distributions to Sample Hospital for property
acquisitions 235,000 485,000
Other 13,000 16,000
Total expenses 248,000 501,000
Excess of support and revenue over expenses 21,000 34,000
Other changes in net assets 27,000 17,000
Unrestricted net assets, beginning of year 462,000 411,000
Unrestricted net assets, end of year $510,000 $462,000
Liabilities include $10,000 payable at the end of each year to Sample Hospital. 
These amounts were paid after the end of each year.
13. Functional Expenses
The Hospital provides general health care services to residents within its 
geographic location. Expenses related to providing these services are as follows 
(in thousands):
At December 31, 
20X7 20X6
$86,000 $78,647 
12,055 10,643
$98,055 $89,290
14. Fair Value o f F inancial Instrum ents
The following methods and assumptions were used by the Hospital in esti­
mating the fair value of its financial instruments:
Cash and cash equivalents: The carrying amount reported in the 
balance sheet for cash and cash equivalents approximates its fair value.
Investments: Fair values, which are the amounts reported in the 
balance sheet, are based on quoted market prices, if  available, or 
estimated using quoted market prices for similar securities.
Assets limited as to use: These assets consist primarily of cash and 
short-term investm ents and interest receivable. The carrying 
amount reported in the balance sheet is fair value.
Accounts payable and accrued expenses: The carrying amount re­
ported in the balance sheet for accounts payable and accrued ex­
penses approximates its fair value.
Estimated third-party payor settlements: The carrying amount re­
ported in the balance sheet for estimated third-party payor settle­
ments approximates its fair value.
Health care services 
General and administrative
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Long-term debt: Fair values of the Hospital’s revenue notes are 
based on current traded value. The fair value of the Hospital’s 
remaining long-term debt is estimated using discounted cash flow 
analyses, based on the Hospital’s current incremental borrowing 
rates for similar types of borrowing arrangements.
The carrying amounts and fair values of the Hospital’s financial instru­
ments at December 31 , 20X7 and 20X6, are as follows (In thousands):
20X7 20X6
Carrying Carrying
Amount Fair Value Amount Fair Value
Cash and cash
equivalents $ 4,758 $ 4,758 $ 5,877 $ 5,877
Short-term investments 15,836 15,836 10,740 10,740
Assets limited as to use 18,949 18,949 19,841 19,841
Long-term investments 4,680 4,680 4,680 4,680
Long-term investments
restricted for capital
acquisition 320 320 520 520
Accounts payable and
accrued expenses 5,818 5,818 5,382 5,382
Estimated third-party
payor settlements 2,143 2,143 1,942 1,942
Long-term debt 24,614 23,980 25,764 24,918
15. Prom ises to Contribute
At December 31, 20X7, the Hospital had received $1,500,000 of conditional 
promises to contribute to the building of a new facility for outpatient services. 
These contributions will be recorded as temporarily restricted support when 
received. The Hospital had no material outstanding unconditional promises of 
support at December 31, 20X7.
16. Charity Care
The amount of charges foregone for services and supplies furnished under the 
Hospital’s charity care policy aggregated approximately $4,500,000 and 
$4,100,000 in 20X7 and 20X6, respectively.
17. Subsequent Event
On February 9, 20X8, the Hospital signed a contract in the amount of 
$1,050,000 for the purchase of certain real estate.
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ILLUSTRATIVE FINANCIAL STATEMENTS 
FOR A GOVERNMENTAL HOSPITAL AUTHORITY 
PRE-GASB STATEMENT NO. 34*
Sample Governmental Hospital Authority 
Balance Sheets— Restricted and Unrestricted Funds 
December 31, 20X7 and 20X6 
(in thousands)
A ssets
20X7 20X6
Current assets:
Cash and cash equivalents $ 7,136 $ 7,557
Short-term investments 1,961 2,049
Assets limited as to use 825 1,105
Patient accounts receivable, net of
estimated uncollectibles of $2,125 in 20X7
and $2,040 in 20X6 19,834 16,727
Supplies and other current assets 2,270 2,428
Total current assets 32,026 29,866
Assets limited as to use:
Internally designated 21,000 20,600
Held by trustees 3,858 3,103
24,858 23,703
Less amount required to meet current obligations (825) (1,105)
24,033 22,598
Property and equipment, net 43,382 42,918
Other assets 1,441 1,165
Total assets $100,882 $96,547
L ia b ilities  an d  F u n d  B a lan ce
Current liabilities:
Current maturities of long-term debt $ 1,250 $ 1,488
Accounts payable and accrued expenses 4,945 4,575
Estimated third-party payor settlements 1,822 1,651
Other current liabilities 1,673 1,797
Total current liabilities 9,690 9,511
Long-term debt, net of current maturities 19,672 20,412
Other liabilities 3,361 2,690
Total liabilities 32,723 32,613
Fund balance:
Unrestricted 63,311 58,831
Restricted 4,848 5,103
Total fund balance 68,159 63,934
Total liabilities and fund balance $100,882 $96,547
See accompanying notes to financial statements.
* Because GASB Statement No. 34 is effective in three annual phases for financial statements 
for periods beginning after June 15, 2001, its requirements are not integrated into this Guide but are 
discussed in appendix F. The financial statements and notes presented in this illustration are based 
on pre-GASB Statement No. 34 requirements. Appendix F presents illustrative management’s 
discussion and analysis, basic financial statements, and notes to financial statements prepared in  
accordance with GASB Statement No. 34 and related pronouncements. This appendix A to the Guide 
will be modified to conform to the requirem ents o f GASB Statem ent No. 34 and related 
pronouncements in a future edition of this Guide.
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Sample Governmental Hospital Authority 
Statements of Operations— Unrestricted Funds 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Revenue:
Net patient service revenue $54,864 $60,292
Ad valorem taxes 23,895 15,309
Other 3,416 3,248
Total revenue 82,175 78,849
Expenses:
Salaries and benefits 46,845 43,235
Medical supplies and drugs 12,746 7,986
Insurance  7,030 7,382
Other supplies 10,314 11,166
Provision for bad debts 859 938
Depreciation and amortization 4,065 3,638
Interest 1,489 1,552
Total expenses 83,348 75,897
Operating income (loss) (1,173) 2,952
Nonoperating income
Investment income 5,653 5,304
Excess of revenues over expenses $ 4,480 $ 8,256
See accompanying notes to financial statements.
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Sample Governmental Hospital Authority 
Statements of Changes in Fund Balances 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
Unrestricted 
$50,575
8,256
8,256
58,831
4,480
4,480 
$63,311
accompanying notes to financial statements.
Fund balance, January 1, 20X6
Excess of revenues over expenses 
Unexpended research grants 
Endowment funds
Fund balance, December 31, 20X6
Excess of revenues over expenses 
Unexpended research grants 
Amounts released from restrictions
Fund balance, December 31, 20X7
Restricted
$3,899
853
351
1,204
5,103
170
(425)
(255)
$4,848
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Sample Governmental Hospital Authority 
Statements of Cash Flows— Restricted and 
Unrestricted Funds (Indirect Method) 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
20X7
Cash flows from operating activities:
Operating income (loss) $ (1,173)
Interest expense considered capital
financing activity 1,489
Ad valorem taxes considered financing
activity (23,895)
Adjustments to reconcile operating income
to net cash provided by operating activities:
Depreciation and amortization 4,065
Provision for bad debts 859
Changes in:
Patient accounts receivable (3,966)
Supplies and other current assets 158
Other assets (276)
Accounts payable, accrued expenses, and
other current liabilities 246
Estimated third-party payor settlements 171
Other liabilities 671
Net cash provided by operating activities (21,651)
Cash flows from noncapital financing 
activities:
Net proceeds from contributions restricted 
for specific expenditure 
Ad valorem taxes 
Other
Net cash provided by noncapital financing 
activities 23,640
170
23,895
(425)
20X6
$ 2,952 
1,552 
(15,309)
3,638
938
(2,909)
100
(225)
(235)
241
(9,257)
853
15,309
266
16,428 
(continued)
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Sample Governmental Hospital Authority 
Statements of Cash Flows— Restricted and 
Unrestricted Funds (Indirect Method) 
(continued)
December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Cash flows from capital and related financing 
activities:
Principal paid on long-term debt (1,488) (1,896)
Interest paid on long-term debt (1,489) (1,552)
Purchase of property and equipment (4,019) (4,111)
Net cash used by capital and related 
financing activities (6,996) (7,559)
Cash flows from investing activities:
Interest and dividends on investments 2,737 2,124
Purchases of investments (1,045) (289)
Proceeds from sale of investments 2,327 683
Net cash provided by investing activities 4,019 2,518
Net increase (decrease) in cash and cash 
equivalents (988) 2,130
Cash and cash equivalents, beginning of year 9,101 6,971
Cash and cash equivalents, end of year $8,113 $9,101
Reconciliation of cash and cash equivalents to 
the balance sheets:
Cash and cash equivalents in current assets 7,136 7,557
Cash and cash equivalents in assets limited 
as to use
Held by trustee for self-insurance 474 473
Held by trustee under debt indenture 503 1,071
Total cash and cash equivalents $8,113 $9,101
Supplemental Disclosures of Cash Flow Information:
The Authority entered into capital lease obligations of $510,000 for new 
equipment in 20X7.
See accompanying notes to financial statements.
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Sample Governmental Hospital Authority 
Notes to Financial Statements*
1. D escrip tion  o f R eporting E ntity  and Sum m ary o f S ign ifican t 
A ccounting P o lic ies
Reporting entity. The Sample Hospital Authority (the Authority) is a public 
corporation. It was created on January 1, 20XX, by the Board of County 
Commissioners of Feeling County, Illinois, to operate, control, and manage all 
matters concerning the county’s health care functions. The Board of County 
Commissioners appoints the Board of Trustee members of the Authority, and 
the Authority may not issue debt without the county’s approval. For this reason, 
the Authority is considered to be a component unit of Feeling County, Illinois, 
and is included as a discretely presented component unit in the general purpose 
financial statements of the county.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Proprietary fund accounting. The A uthority u tilizes the proprietary fund 
method of accounting whereby revenue and expenses are recognized on 
the accrual basis. Substantially  all revenues and expenses are subject to 
accrual.
Costs of borrowing. Interest cost incurred on borrowed funds during the 
period of construction of capital assets is capitalized as a component of the cost 
of acquiring those assets.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instrum ents with an original maturity of three months 
or less.
Ad valorem taxes. The Authority received approximately 29 percent in 20X7 
and 19 percent in 20X6 of its financial support from ad valorem taxes. These 
funds were used as follows:
20X7 20X6
Percentage used to support operations 26% 16%
Percentage used for debt service on general
obligation bonds 3% 3%
Current taxes are received beginning in October of each year and become 
delinquent after January 31 of the following year. Taxes are reported as 
revenues in the period for which they are levied.
Accounting standards. Pursuant to Governmental Accounting Standards 
Board (GASB) Statement No. 20, Accounting and Financial Reporting for 
Proprietary Funds and Other Governmental Entities That Use Proprietary Fund 
Accounting, the Authority has elected to apply the provisions of all relevant 
pronouncements of the Financial Accounting Standards Board (FASB), includ­
ing those issued after November 3 0 , 1989, that do not conflict with or contradict 
GASB pronouncements.
* Includes only disclosures unique to a governmental hospital.
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Risk management. The Authority is exposed to various risks of loss from torts; 
theft of, damage to, and destruction of assets; business interruption; errors and 
omissions; employee injuries and illnesses; natural disasters; and employee health, 
dental, and accident benefits. Commercial insurance coverage is purchased for 
claims arising from such matters. Settled claims have not exceeded this commercial 
coverage in any of the three preceding years. The Authority is self-insured for 
medical malpractice claims and judgments, as discussed in Note 14.
Investments in debt and equity securities. Investments in debt and equity 
securities are carried at fair value except for investments in debt securities with 
maturities of less than one year at the time of purchase. These investments are 
reported at amortized cost, which approximates fair value. Interest, dividends, 
and gains and losses, both realized and unrealized, on investments in debt and 
equity securities are included in nonoperating income when earned.
2. R estricted Fund Balance
Temporarily restricted fund balance is available for the following purposes:
20X7 20X6
Program A activities:
Purchase of equipment $ 404 $ 321
Research 553 683
General 46 63
Program B activities:
Purchase of equipment 235 235
General 79 110
Program C activities:
General 206 400
Buildings and equipment 94 72
Annuity trust agreements 44 65
For periods after December 31, 20X7 and
20X6 184 151
Total temporarily restricted fund balance $1,845 $2,100
Permanently restricted fund balance as of December 31, 20X7 and 20X6, is 
restricted to investment in perpetuity, the income from which is expendable to 
support:
20X7 20X6
$ 158 $ 158
176 176
423 423
854 854
1,611 1,611 
Endowment requiring income to be added to
original gift until fund’s value is $2,125 1,392 1,392
Total permanently restricted fund balance 3,003 3,003
Total temporarily and permanently
restricted fund balance $4,848 $5,103
Program A activities 
Program B activities 
Program C activities 
Any activities of the Authority
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3. D onor R estr ic tio n s R eleased
Fund balance was released from donor restrictions by incurring expenses 
satisfying the restricted purposes or by occurrence of other events specified by 
donors:
20X7
Purpose restrictions accomplished:
Program A expenses $168
Program B expenses 31
Program C expenses 206
405
Time restrictions expired:
Passage of specified time 20
Total restrictions released $425
4. C harity  Care
Charges excluded from revenue under the Authority’s charity care policy were 
$5,100 and $4,845 for 20X7 and 20X6, respectively.
5. A ssets L im ited  as to  U se
Assets limited as to use that are required for obligations classified as 
current liabilities are reported in current assets. The composition of assets 
lim ited as to use at December 31, 20X7 and 20X6, is set forth in the following
table.
20X7 20X6
Internally designated for capital acquisitions $21,000 $20,600
Held by trustees 1,245 923
Under indenture agreement 2,613 2,180
Total $24,858 $23,703
6. B ank  D ep o sits  and  In vestm en ts
Statutes authorize the Authority to invest in obligations of the U.S. Treasury, 
agencies, and instrumentalities, commercial paper rated A-1 by Standard & 
Poor’s Corporation or P-1 by Moody’s Commercial Paper Record, bankers’ 
acceptances. At December 3 1 , 20X7 and 20X6, the Authority had bank balances 
as follows:
20X7 20X6
Insured (FDIC) or collateralized with 
securities held by the Authority $3,687 $5,677
Collateralized by securities held by the 
pledging financial institution’s trust
department in the Authority’s name 1,153 300
Total $4,840 $5,977
Carrying Value $5,021 $6,539
192 Health Care Organizations
As discussed in Note 1, the Authority’s investments generally are carried at 
fair value. All securities are held in the Authority’s name by a custodial bank 
that is the agent of the Authority. At December 31, 20X7 and 20X6, the 
Authority’s investments consisted of the following:
20X7 20X6
U.S. Treasury Obligations $21,771 $20,039
U.S. Government Agency Securities 5,048 5,713
$26,819 $25,752
The Authority’s bylaws require that investm ents be made only in U.S. 
government obligations and that all bank balances be insured or collateral­
ized by U.S. government securities held by the Authority’s third-party agent 
or the pledging financial institution’s trust department in the name of the 
Authority.
7. Long-Term Debt
A summary of long-term debt, including capital lease obligations, at Decem­
ber 31, 20X7 and 20X6, follows:
20X7 20X6
7.25 percent Revenue Notes, due November
1, 20YY, collateralized by a pledge of the
Authority’s gross receipts $18,257 $18,714
9.25 percent mortgage loan, due January 
20XX, collateralized by a mortgage on 
property and equipment with a depreciated 
cost of $1,530 at December 31, 20X7
9.75 percent note payable, due March 20XX, 
unsecured
Total long-term debt
Less current maturities of long-term debt
Long-term debt net of current maturities
Capital lease obligations, at varying rates of 
imputed interest from 9.8 percent to 12.3 
percent collateralized by leased equipment 
with cost of $1,275 at December 31, 20X7
Less current portion of capital lease 
obligations
Capital lease obligations, excluding current 
portion
1,709 1,808
106 570
20,072 21,092
825 1,020
$19,247 $20,072
$ 850 $ 808
425 468
$ 425 $ 340
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Under the terms of the Revenue Note Indenture, the Authority is required to 
maintain certain deposits with a trustee. Such deposits are included with assets 
limited as to use in the financial statements. The Revenue Note Indenture also 
places limits oh the incurrence of additional borrowings and requires that the 
Authority satisfy certain measures of financial performance as long as the notes 
are outstanding.
Scheduled principal repayments on long-term debt and payments on capital 
lease obligations for the next five years are as follows:
Year Ending Long-Term Capital Lease
December 31, Debt Obligations
20X8 $ 825 $506
20X9 775 221
20Y0 836 221
20Y1 900 —
20Y2 972 —
Thereafter 15,764 —
$20,072 948
Less amount representing interest on
capital lease obligations 98
Total $850
A summary of interest cost and investment income on borrowed funds held 
by the trustee under the Revenue Note Indenture during the years ended 20X7 
and 20X6 follows:
20X7 20X6
Interest cost:
Capitalized $ 629 $ 628
Charged to operations 1,489 1,552
Total $2,118 $2,180
Investment income:
Capitalized $ 429 $ 564
Credited to other revenue 280 328
Total $ 709 $ 892
8. Pension  Plan
Plan description. Sample Hospital Pension Plan (SHPP) provides retirement 
and disability benefits, annual cost-of-living adjustments, and death benefits 
to plan members and beneficiaries. SHPP is affiliated with County Employees 
Pension Plan (CEPP), an agent multiple-employer pension plan administered 
by the Illinois Retirement System. Article 39 of the Regulations of the State of 
Illinois assigns the authority to establish and amend the benefit provisions of 
the plans that participate in CEPP to the respective employer entities; for 
CEPP, that authority rests with the County of Feeling, Illinois. The Illinois 
Retirement System issues a publicly available financial report that includes 
financial statements and required supplementary information for SHPP. That 
report may be obtained by writing to Illinois Retirement System, State Gov­
ernment Lane, Anytown, USA 01000 or by calling 1-800-555-PLAN.
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Funding policy. The contribution requirements of plan members and the 
Authority are established and may be amended by the CEPP Board of Trustees. 
Plan members are required to contribute 7.8 percent of their annual covered 
salary. The Authority is required to contribute at an actuarially determined 
rate; the current rate is 11.9 percent of annual covered payroll.
Annual pension cost and net pension obligation. The Authority’s annual 
pension cost and net pension obligation to SHPP for the current year were as follows:
20X7
Annual required contribution $2 6
Interest on net pension obligation 3
Adjustment to annual required contribution (3)
Annual pension cost 26
Contributions made (12)
Increase (decrease) in net pension obligation 14
Net pension obligation beginning of year 66
Net pension obligation, end of year $ 8 0
The annual required contribution for the current year was determined as part 
of the December 31, 20X6, actuarial valuation using the entry age actuarial 
cost method. The actuarial assumptions included (a) 7.5% investm ent rate of 
return (net of administrative expenses) and (b) projected salary increases 
ranging from 5.5% to 9.5% per year. Both (a) and (b) included an inflation 
component of 5.5%. The actuarial assumptions also include a 2% per year 
cost-of-living adjustment. The actuarial value of assets was determined using 
techniques that smooth the effects of short-term volatility in the market value 
of investments over a four-year period. The unfunded actuarial accrued liability 
is being amortized as a level percentage of projected payroll on an open basis. 
The remaining amortization period at December 31, 20X6, was 23 years.
Three-Year Trend Information
Fiscal Annual Percentage Net
Year Pension of APC Pension
Ending Cost (APC) Contributed Obligation
12/31/X5 $20 94% $49
12/31/X6 23 68 65
12/31/X7 26 46 80
(The preparer of the financial statements should consider the need for 
required supplementary information (RSI) as required by GASB Statement No. 
27, Accounting for Pensions by State and Local Governmental Employers, 
paragraph 22.)
9. Postretirem ent Plan  
In addition to the pension benefits described above, the Authority provides 
postretirement health care benefits, in accordance with the Authority’s bylaws, 
to all employees who retire from the Authority on or after attaining age 60 with 
at least 15 years of service. Currently 250 retirees meet these eligibility 
requirements. The Authority reimburses 75 percent of the amount of validated 
claims for medical, dental, and hospitalization costs incurred by pre-Medicare 
retirees and their dependents. The Authority also reimburses a fixed amount of 
$25 per month for a Medicare supplement for each retiree eligible for Medicare.
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Expenditures for postretirement health care benefits are recognized as retirees 
report claims and include a provision for estimated claims incurred but not yet 
reported to the Authority. During the year, expenditures of $764 were recog­
nized for postretirement health care. Approximately $64 of the $128 increase 
in expenditures over the previous year was caused by the addition of dental 
benefits, effective July 1, 20X7.
Other disclosures that may be required include the following:
10. P rop erty , P lan t, an d  E quipm ent*
11. O ff-B alance-Sheet R isk  and C on cen tration  o f  C redit Risk*
12. F a ir  V alue o f  F in a n cia l Instrum ents*
13. C om m itm ents and  C on tin g en cies  *, #
14. O p eratin g  Leases*
15. S u b seq u en t Events*
#  Requirements for disclosures about claims and judgments and risk financing by governmental 
health care enterprises are provided in GASB Statement No. 10, Accounting and Financial Report­
ing for Risk Financing and Related Insurance Issues, and are not illustrated here.
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for a not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NURSING HOME
Sample For-Profit Nursing Home, Inc.
Balance Sheets 
December 31, 20X5 and 20X4
20X5 20X4
A ssets
Current assets:
Cash and cash equivalents $ 95,000 $ 129,000
Investments 150,000
Assets limited as to use 50,000 50,000
Patient accounts receivable, net of allowance 
for doubtful accounts of $6,700 in 20X5 and
$5,300 in 20X4 162,000 152,000
Estimated third-party payor settlements 71,000 62,000
Interest receivable 7,000
Supplies 47,000 43,000
Prepaid expenses 3,000 2,000
Deferred tax asset 12,000 14,000
Total current assets 597,000 452,000
Assets limited as to use, net of amount required
for current liabilities 173,000 150,000
Property and equipment:
Land 205,000 205,000
Land improvements 37,000 32,000
Buildings 1,399,000 1,399,000
Furniture, fixtures, and equipment 228,000 189,000
1,869,000 1,825,000
Less accumulated depreciation 210,000 141,000
Property and equipment, net 1,659,000 1,684,000
Other assets 150,000 127,000
Total assets $2,579,000 $2,413,000 
(continued)
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Sample For-Profit Nursing Home, Inc. 
Balance Sheets
(continued) 
December 31, 20X5 and 20X4
20X5 20X4
L iab ilities and  S h areh o ld ers’ E q u ity
Current liabilities:
Current maturities of long-term debt $ 50,000 $ 50,000
Accounts payable 78,000 52,000
Accrued expenses 175,000 188,000
Deposits from patients 50,000 45,000
Other current liabilities 74,000 15,000
Total current liabilities 427,000 350,000
Deferred tax liability 6,000 14,000
Long-term debt, net of current maturities 1,700,000 1,750,000
Shareholders’ equity:
Common stock, $20 par value; authorized 
5,000 shares; issued and outstanding
3,500 shares 70,000 70,000
Retained earnings 376,000 229,000
Total shareholders’ equity 446,000 299,000
Total liabilities and shareholders’ equity $2,579,000 $2,413,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc. 
Statements of Income and Retained Earnings 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue:
Net patient service revenue $2,163,000 $1,949,000
Other revenue 67,000 22,000
Interest on investments held by trustee 13,000 7,000
Total revenue 2,243,000 1,978,000
Expenses:
Salaries and benefits 969,000 919,000
Medical supplies and drugs 511,000 499,000
Insurance and other 216,000 176,000
Provision for bad debts 92,000 83,000
Depreciation 69,000 57,000
Interest 164,000 172,000
Total expenses 2,021,000 1,906,000
Operating income 222,000 72,000
Nonoperating income:
Other interest income 5,000
Income before provision for income taxes 227,000 72,000
Provision for income taxes 80,000 29,000
Net income 147,000 43,000
Retained earnings, beginning of year 229,000 186,000
Retained earnings, end of year $ 376,000 $ 229,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc. 
Statements of Cash Flows 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities: 
Cash received from residents and
third-party payors $2,019,000 $1,796,000
Cash received from others 67,000 22,000
Cash paid to employees and suppliers (1,679,000) (1,495,000)
Interest and dividends received 10,000 10,000
Interest paid (160,000) (170,000)
Taxes paid (29,000) (30,000)
Deposits received from patients 35,000 15,000
Deposits refunded to patients (30,000) (20,000)
Net cash provided by operating activities 233,000 128,000
Cash flows from investing activities:
Purchase of investments (150,000)
Proceeds from sale of property 2,000
Capital expenditures (44,000) (79,000)
Purchase of assets limited as to use (23,000)
Net cash used in investing activities (217,000) (77,000)
Cash flows from financing activities:
Repayment of long-term debt (50,000) (50,000)
Net cash used in financing activities (50,000) (50,000)
Net increase (decrease) in cash and cash
equivalents (34,000) 1,000
Cash and cash equivalents, beginning of year 129,000 128,000
Cash and cash equivalents, end of year $ 95,000 $ 129,000
(continued)
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Sample For-Profit Nursing Home, Inc. 
Statements of Cash Flows 
(continued) 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Reconciliation of net income to net cash 
provided by operating activities:
Net income $147,000 $43,000
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation 69,000 57,000
Provision for bad debts 92,000 83,000
Loss on sale of property — 11,000
Change in deferred income taxes (6,000) (14,000)
(Increase) decrease in:
Patient accounts receivable (102,000) (41,000)
Other current assets (21,000) (15,000)
Estimated third-party payor settlements (9,000) (10,000)
Interest receivable (7,000) (3,000)
Other assets (7,000) (10,000)
Increase (decrease) in:
Accounts payable and accrued expenses 13,000 43,000
Deposits from patients 5,000 (5,000)
Other current liabilities 59,000 (11,000)
Net cash provided by operating activities $233,000 $128,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc. 
Notes to Financial Statements 
December 31, 20X5 and 20X4
1. D escription of Organization and Summary o f Significant Account­
ing  Policies2
Organization. The Sample Nursing Home, Inc. (the Company) was incorpo­
rated in New State in 20X1 and operates a 128-bed nursing home in Abacus, 
New State. A summary of the Company’s significant accounting policies follows:
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less, excluding amounts whose use is limited by note indenture.
Investments. Investments in debt instruments, including assets limited as 
to use, are classified as held-to-maturity because the Company has the positive 
intent and ability to hold the securities until maturity. Held-to-maturity 
securities are carried at cost adjusted for amortization of premiums and 
accretion of discounts.
Assets limited as to use. Assets deposited with a trustee under terms of the 
note indenture and assets set aside by the Board of Directors for capital 
improvements are classified as assets limited as to use. Amounts required to 
meet current liabilities have been reclassified in the balance sheet.
Property and equipment. Property and equipment are recorded at cost. 
Depreciation is calculated on the straight-line method over the estimated useful 
lives of depreciable assets.
Bond issuance costs. Costs incurred in issuing the Series 20X1 bonds are 
being amortized based on the effective interest method.
Net patient service revenue. Net patient service revenue is reported at the 
estimated net realizable amounts from residents, third-party payors, and 
others for service rendered.
Revenue under third-party payor agreements is subject to audit and retroac­
tive adjustment. Provisions for estimated third-party payor settlements are 
provided in the period the related services are rendered. Differences between 
the estimated amounts accrued and interim and final settlements are reported 
in operations in the year of settlement.
Income taxes. The provisions for income taxes are based on amounts esti­
mated to be currently payable and those deferred because of temporary differ­
ences between the financial statement and tax bases of assets and liabilities. 
These differences consist principally of bad debts and depreciation.
2 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade 
Receivables) That Lend to or Finance the Activities o f Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts. SOP 01-6 is effective for annual and interim financial 
statements issued for fiscal years beginning after December 15, 2001.
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2. A ssets L im ited  as to  U se
Assets limited as to use include:
Assets held by trustee under the Series 20X1 note indenture 
agreement at December 31, 20X5 and 20X4.
20X5 20X4
U.S. Government obligations 
Cash
Accrued interest income
$150,000
24,000
2,000
$130,000
21,000
2,000
Internally designated by the Board of 
Directors for capital improvements
176,000 153,000
Certificate of deposit 
Accrued interest
$ 45,000 
2,000
$ 45,000 
2,000
47,000 47,000
$223,000 $200,000
3. In vestm en ts
4. Long-Term  D ebt
Long-term debt at December 31, 20X5 and 20X4, was as follows:
20X5 20X4
9.5 percent bonds payable to the City of 
Abacus, maturing $50,000 annually through 
November 1, 20YY, with a final maturity of 
$1 million on November 1, 20YY 
Less current maturities
$1,750,000
50,000
$1,800,000
50,000
$1,700,000 $1,750,000
The notes are collateralized by a first-mortgage lien on all property and 
equipment of the Company and a security interest in all of its receipts. The note 
indenture requires the maintenance of certain deposits with a trustee, which 
are included in assets limited as to use.
Future maturities of long-term debt as of December 31, 20X5, follow:
Year Ending December 31, Amount
20X6 $ 50,000
20X7 50,000
20X8 50,000
20X9 50,000
20Y0 50,000
Thereafter 1,500,000
Total $1,750,000
In reporting disclosures about investments in securities, entities should comply primarily with 
the requirements of paragraphs 6, 17, 19, 20, 21, and 22 of FASB Statement No. 115, as amended. 
Other disclosure requirements may also be applicable.
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5. Incom e T axes
The provisions for income taxes are as follows:
20X5 20X4
Current:
Federal $72,000 $15,000
State 2,000 _______
Total current 74,000 15,000
Deferred:
Federal 6,000 13,000
State _______  1,000
Total deferred 6,000 14,000
Total provision for income taxes $80,000 $29,000
Deferred income taxes are provided for the temporary differences between 
the financial reporting basis and the tax basis of the Company’s assets and 
liabilities.
For the years ended December 31, 20X5 and 20X4, the effective tax rate 
approximated the statutory rate of 34 percent and 40 percent, respectively.
The net current and noncurrent components of deferred income taxes recog­
nized in the balance sheet at December 31, 20X5 and 20X4, follows:
20X5 20X4
Net current assets $12,000 $14,000
Net noncurrent liabilities 6,000 14,000
$ 6,000 $ 0
Management has determined that no valuation allowance related to deferred 
tax assets is necessary at December 31, 20X5 and 20X4, respectively.
6. C on cen tration  in  S ta te  M edica id  Program
The Company has 100 of its 128 beds designated for care of patients under 
the state’s Medicaid program. The current funding of that program is 90 days 
behind filed claims. The current state budget has no provision for reducing that 
lag and, while the proposed budget for 20X6 includes additional funding, there 
is no assurance that the final budget will include the needed additional funds.
7. T hird  P arty  R ate A djustm ents and  R even u e
Revenue from the Medicaid program accounted for approximately XX percent 
for the year ended 20X5, and XX percent for the year ended 20X4, of the 
Company’s net patient revenue. Laws and regulations governing the Medicaid 
program are extremely complex and subject to interpretation. As a result, there 
is at least a reasonable possibility that recorded estimates will change by a 
material amount in the near term. The 20X5 net patient service revenue 
increased approximately $XXX due to removal of allowances previously esti­
mated that are no longer necessary as a result of final settlements and years 
that are no longer subject to audits, reviews, and investigations. The 20X4 net 
patient service revenue decreased approximately $XXX due to prior-year ret­
roactive adjustments in excess of amounts previously estimated.
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* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A CONTINUING 
CARE RETIREMENT COMMUNITY
Sample Not-for-Profit Continuing Care Retirement Community 
Balance Sheets 
December 31, 20X5 and 20X4
20X5 20X4
A ssets
Current assets:
Cash $ 375,000 $ 330,000
Assets limited as to use 265,000 170,000
Accounts receivable, net of allowance for 
doubtful accounts of $4,000 in 20X5 and
$5,000 in 20X4 187,000 197,000
Supplies 40,000 21,000
Prepaid expenses 115,000 73,000
Total current assets 982,000 791,000
Assets limited as to use, net of amount
required for current liabilities 1,865,000 1,583,000
Property and equipment, net 14,893,000 15,280,000
Deferred financing costs, net of accumulated 
amortization of $28,000 in 20X5 and $21,000
in 20X4 83,000 90,000
Total assets $17,823,000 $17,744,000
L iab ilities and  N et A ssets
Liabilities:
Current maturities of long-term debt $ 90,000 $ 77,000
Accounts payable 180,000 174,000
Accrued expenses 161,000 178,000
Deposits on unoccupied units 22,000 40,000
Total current liabilities 453,000 469,000
Long-term debt, less current maturities 8,871,000 8,935,000
Refundable fees 59,000 144,000
Estimated obligation to provide future 
services, in excess of amounts received or to
be received 88,000 100,000
Deferred revenue from advance fees 6,304,000 6,585,000
Total liabilities 15,775,000 16,233,000
Net assets:
Unrestricted 1,286,000 833,000
Temporarily restricted 311,000 294,000
Permanently restricted 451,000 384,000
Total net assets 2,048,000 1,511,000
Total liabilities and net assets $17,823,000 $17,744,000
See accompanying notes to financial statements.
AAG-HCO APP A
206 Health Care Organizations
Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Operations 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Resident services, including amortization of 
advance fees of $935,000 in 20X5 and
$915,000 in 20X4 $3,946,000 $3,152,000
Patient revenue from nonresidents 249,000 275,000
Change in obligation to provide future
services 12,000 (82,000)
Contributions 54,000 39,000
Net assets released from restrictions used for
operations 24,000 50,000
Investment income 29,000 30,000
Other 75,000 68,000
Total revenue, gains, and other support 4,389,000 3,532,000
Expenses:
Salaries and benefits 1,708,000 1,250,000
Medical supplies and drugs 543,000 742,000
Insurance 291,000 311,000
Depreciation 452,000 447,000
Interest 967,000  955,000
Total expenses 3,961,000 3,705,000
Operating income (loss) 428,000 (173,000)
Net assets released from restriction—purchase
of equipment 25,000 45,000
Increase (decrease) in unrestricted net
assets $ 453,000 $ (128,000)
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Changes in Net Assets 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Unrestricted net assets:
Operating income (loss) $ 428,000 $ (173,000)
Net assets released from 
restriction—purchase of equipment 25,000 45,000
Increase (decrease) in unrestricted net 
assets 453,000 (128,000)
Temporarily restricted net assets: 
Contributions 40,000 15,000
Net assets released from restrictions used 
for operations (24,000) (50,000)
Net assets released from 
restriction—purchase of equipment (25,000) (45,000)
Investment income 26,000 15,000
Increase (decrease) in temporarily 
restricted net assets 17,000 (65,000)
Permanently restricted net assets: 
Contributions 67,000 52,000
Increase in permanently restricted net 
assets 67,000 52,000
Increase (decrease) in net assets 537,000 (141,000)
Net assets, beginning of year 1,511,000 1,652,000
Net assets, end of year $2,048,000 $1,511,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Cash Flows 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities: 
Cash received from residents and
third-party payors $ 3,252,000 $ 2,341,000
Advance fees received 654,000 857,000
Other receipts from operations 75,000 68,000
Investment income received 68,000 53,000
Contributions received 51,000 44,000
Cash paid to employees and suppliers (2,576,000) (2,040,000)
Interest paid (950,000) (945,000)
N et cash provided by operating activities 574,000 378,000
Cash flows from investing activities:
Purchase of property and equipment (65,000) (250,000)
Purchase of assets limited as to use (377,000) 229,000
Net cash used in investing activities (442,000) (21,000)
Cash flows from financing activities:
Permanently restricted funds received 67,000 52,000
Refunds of deposits and refundable fees (103,000) (52,000)
Proceeds from issuance of long-term debt 26,000
Principal payments of long-term debt (77,000) (307,000)
Net cash used in financing activities (87,000) (307,000)
Net increase in cash 45,000 50,000
Cash, beginning of year 330,000 280,000
Cash, end of year $ 375,000 $ 330,000
(continued)
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Cash Flows 
(continued) 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets $ 537,000 $(141,000)
Adjustments to reconcile change in net assets
to net cash provided by operating activities:
Advance fees received 654,000 857,000
Restricted net assets received (67,000) (52,000)
Amortization of advance fees (935,000) (915,000)
Loss (gain) on obligation to provide future
services (12,000) 82,000
Depreciation 452,000 447,000
Amortization of deferred financing costs 7,000 34,000
Provision for bad debts 3,000 3,000
(Increase) decrease in:
Accounts receivable 7,000 (33,000)
Other assets (61,000) (4,000)
Increase (decrease) in:
Accounts payable and accrued expenses (11,000) 100,000
Net cash provided by operating
activities $ 574,000 $ 378,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Notes to Financial Statements3 
December 31, 20X5 and 20X4
1. D escription o f O rganization and Summary o f S ign ificant A ccount­
in g  P olicies*,4
Organization. The Sample Continuing Care Retirement Community (the 
CCRC) is a nonprofit organization that principally provides housing, health 
care, and other related services to residents through the operation of a retire­
ment facility containing 249 apartments and a 78-bed health care facility 
located in Evergreen Park, Illinois. The CCRC was incorporated in Illinois in 
20X1. A summary of significant accounting policies follows.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Investments. Investments, which consist of U.S. Treasury obligations, are 
measured at fair value in the balance sheet. Investment income (including 
realized gains and losses on investments, interest, and dividends) is included 
in operating income (loss) unless restricted by donor or law. Unrealized gains 
and losses on investments, if  any, are excluded from operating income (loss).
Deferred financing costs. Deferred financing costs are amortized using the 
effective interest method over the term of the related financing agreement.
Advance fees. Fees paid by a resident upon entering into a continuing care 
contract, net of the portion thereof that is refundable to the resident, are 
recorded as deferred revenue and are amortized to income using the straight- 
line method over the estimated remaining life expectancy of the resident.
Obligation to provide future services. The CCRC annually calculates the 
present value of the net cost of future services and the use of facilities to be provided 
to current residents and compares that amount with the balance of deferred 
revenue from advance fees. If the present value of the net cost of future services 
and the use of facilities exceeds the deferred revenue from advance fees, a liability 
is recorded (obligation to provide future services and use of facilities) with the 
corresponding charge to income. The obligation is discounted at 9 percent, based 
on the expected long-term rate of return on government obligations.
Donor restrictions. The CCRC reports gifts of cash and other assets as restricted 
support if they are received with donor stipulations that limit the use of the donated 
assets. When a donor restriction expires (that is, when a stipulated time restriction 
ends or a purpose restriction is accomplished), temporarily restricted net assets are
3 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue 
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences 
between an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is 
included in appendix E to this Guide.
* Does not include all disclosures common to all health care entities.
4 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade 
Receivables) That Lend to or Finance the Activities o f Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts. SOP 01-6 is effective for annual and interim financial 
statements issued for fiscal years beginning after December 15, 2001.
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reclassified as unrestricted net assets and reported in the statement of opera­
tions as net assets released from restrictions. Donor-restricted contributions 
whose restrictions are met within the same year as received are reflected as 
unrestricted contributions in the accompanying financial statements.
The CCRC reports gifts of property and equipment (or other long-lived assets) 
as unrestricted support unless explicit donor stipulations specify how the 
donated assets must be used. Gifts of long-lived assets with explicit restrictions 
that specify how the assets are to be used and gifts of cash or other assets that 
must be used to acquire long-lived assets are reported as restricted support. 
Absent explicit donor stipulations about how long those long-lived assets must 
be maintained, the CCRC reports expirations of donor restrictions when the 
donated or acquired long-lived assets are placed in service.
Income taxes. The CCRC has been recognized by the Internal Revenue 
Service as a not-for-profit corporation as described in Sec. 501(c)(3) of the 
Internal Revenue Code (IRC) and is exempt from federal income taxes pursuant 
to Sec. 501(a) of the IRC.
Property and equipment. Property and equipment are stated at cost. Donated 
property is recorded at its estimated fair value at the date of receipt. Deprecia­
tion is computed on the straight-line method based on the following estimated 
useful lives:
Land improvements 20 years
Buildings and improvements 40 years
Furniture and equipment 5—15 years
Operating income (loss). The statement of operations includes operating in­
come (loss). Changes in unrestricted net assets which are excluded from operating 
income (loss), consistent with industry practice, include unrealized gains and losses 
on investments other than trading securities, permanent transfers of assets to and 
from affiliates for other than goods and services, and contributions of long-lived 
assets (including assets acquired using contributions which by donor restriction 
were to be used for the purposes of acquiring such assets).
2. Property and Equipment
A summary of property and equipment at December 31, 20X5 and 20X4, 
follows:
20X5 20X4
Land $ 557,000 $ 557,000
Land improvements 205,000 203,000
Buildings and improvements 14,573,000 14,564,000
Furniture and equipment 752,000 698,000
16,087,000 16,022,000
Less: accumulated depreciation (1,194,000) (742,000)
$14,893,000 $15,280,000
3. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:
20X5 20X4
Purchase of equipment $169,000 $152,000
Charity care 142,000 142,000
$311,000 $294,000
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Net assets were released from donor restrictions by incurring expenses 
satisfying the restricted purposes or by occurrence of other events specified by 
donors:
20X5 20X4
Charity care $24,000 $50,000
Purchase of equipment $25,000 $45,000
4. P erm an en tly  R estr ic ted  N et A ssets
Permanently restricted net assets are restricted to investment in perpetuity, 
the income from which is expendable to support:
20X5 20X4
Charity care $168,000 $168,000
Community activities 283,000 216,000
$451,000 $384,000
5. Long-Term  D ebt
Long-term debt at December 31, 20X5 and 20X4, is as follows:
20X5 20X4
10.75 percent mortgage note payable $8,901,000 $8,965,000
Notes payable to bank—unsecured 34,000 14,000
Other 26,000 33,000
8,961,000 9,012,000
Less current maturities 90,000 77,000
$8,871,000 $8,935,000
The mortgage note is payable in consecutive monthly installments of principal 
and interest of $85,425 to May 20XX. The note is collateralized by a first 
mortgage on property and equipment with a depreciated cost at December 31, 
20X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, the CCRC established an initial 
debt service reserve fund of $1,000,000 at April 15, 20X3. All resident fees 
received thereafter, net of resident fee refunds and debt service payments not 
to exceed $300,000 annually in the first four years and $200,000 annually 
thereafter, are to be added to the debt service reserve fund until the total sum 
of $2,050,000 is accumulated. Since June 1 , 20X4, the CCRC has been required 
to deliver to the trustee $5,500 per month to establish maintenance reserves 
until the aggregate of such payments equals a residential unit reserve and a 
health care center reserve of $240,000 and $90,000, respectively. At December 
31, 20X5 and 20X4, the trustee held investments aggregating $2,130,000 and 
$1,753,000, respectively. Such amount has been classified as assets limited as 
to use.
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Scheduled annual principal maturities of long-term debt for the next five 
years are as follows:
Year Ending December 31. Amount
20X6 $ 90,000
20X7 90,000
20X8 95,000
20X9 105,000
20Y0 105,000
i. C lassifica tion  o f  E xp en ses
20X5 20X4
Program activities 3,368,000 3,135,000
General and administrative 593,000 570,000
$3,961,000 $3,705,000
7. A ssets L im ited  as to  Use*
8. R isks and  U n certa in tie s  D isclosures*
9. P en sio n  Plan*
10. P ostre tirem en t Benefits*
11. F a ir  V alu es o f  F in a n cia l Instrum ents*
12. C on cen tration s o f  C redit Risk*
13. Investm ents*
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
AAG-HCO APP A
214 Health Care Organizations
ILLUSTRATIVE FINANCIAL STATEMENTS FOR A HOME HEALTH AGENCY
Sample Not-for-Profit Home Health Agency 
Balance Sheets
December 31, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $ 74,000 $ 41,000
Investments 147,000 137,000
Accounts receivable, net of allowance for 
doubtful accounts of $61,000 in 20X5 and 
$30,000 in 20X4 752,000 476,000
Other receivables 27,000 22,000
Total current assets 1,000,000 676,000
Investments 100,000 100,000
Equipment:
Medical and office equipment 56,000 39,000
Vehicles 50,000 37,000
106,000 76,000
Less accumulated depreciation (45,000) (24,000)
Equipment, net 61,000 52,000
Deferred finance charges, net of accumulated 
amortization of $15,000 in 20X5 and $10,000 
in 20X4 20,000 25,000
Total assets $1,181,000 $853,000
Liabilities and Net Assets
Current liabilities:
Current maturities of long-term debt $ 13,000 $ 13,000
Accounts payable 40,000 21,000
Accrued payroll and vacation costs 496,000 352,000
Estimated third-party payor settlements 28,000 31,000
Advances from third-party payors 70,000 66,000
Total current liabilities 647,000 483,000
Long-term debt, less current maturities 105,000 118,000
Total liabilities 752,000 601,000
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N e t  a s s e t s :
Unrestricted 330,000 167,000
Temporarily restricted 9,000 5,000
Permanently restricted 90,000 80,000
Total net assets 429,000 252,000
Total liabilities and net assets $1,181,000 $853,000
See accompanying notes to financial statements.
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FORMAT A
Sample Not-for-Profit Home Health Agency 
Statements of Operations 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Investment income 13,000 6,000
Other revenue 27,000 32,000
Total revenue, gains, and other support 4,092,000 2,747,000
Expenses:
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Excess of revenue over expenses and change in
unrestricted net assets $ 163,000 $ 99,000
See accompanying notes to financial statements.
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FORMAT B 
Sample Not-for-Profit Home Health Agency 
Statements of Operations 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Other revenue 27,000 32,000
Total revenue, gains, and other support 4,079,000 2,741,000
Expenses:
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Operating income 150,000 93,000
Other income:
Investment income 13,000 6,000
Excess of revenue over expenses and change in
unrestricted net assets $ 163,000 $ 99,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency 
Statements of Changes in Net Assets 
Years Ended December 31, 20X5 and 20X4
20X5
Unrestricted net assets:
Excess of revenue over expenses $163,000
Increase in unrestricted net assets 163,000
Temporarily restricted net assets:
Contributions 9,000
Net assets released from restrictions (5,000)
Increase in temporarily restricted net 
assets 4,000
Permanently restricted net assets:
Contributions 10,000
Increase in permanently restricted net 
assets 10,000
Increase in net assets 177,000
Net assets, beginning of year 252,000
Net assets, end of year $429,000
See accompanying notes to financial statements.
20X4
$ 99,000 
99,000
5,000
5,000
6,000
6,000
110,000
142,000
$252,000
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Sample Not-for-Profit Home Health Agency 
Statements of Cash Flows 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities:
Cash received from patients and
third-party payors $3,721,000 $2,542,000
Other receipts from operations 22,000 32,000
Cash paid to employees and suppliers (3,679,000) (2,541,000)
Interest paid (11,000) (14,000)
Nonoperating revenue 23,000 22,000
Net cash provided by operating activities 76,000 41,000
Cash flows from investing activities:
Purchase of equipment (30,000) (19,000)
Purchase of investments (10,000) (15,000)
Net cash used in investing activities (40,000) (34,000)
Cash flows from financing activities: 
Proceeds from contributions restricted for:
Endowment 10,000 6,000
Other financing activities:
Payment of long-term debt (13,000) —
Net cash provided by (used in) financing
activities (3,000) 6,000
Net increase in cash and cash equivalents 33,000 13,000
Cash and cash equivalents, beginning of year 41,000 28,000
Cash and cash equivalents, end of year $ 74,000 $ 41,000
(continued)
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Sample Not-for-Profit Home Health Agency 
Statements of Cash Flows 
(continued) 
Years Ended December 31, 20X5 and 20X4
20X5
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets $177,000
Adjustments to reconcile change in net assets 
to net cash provided by operating activities:
Increase in permanently restricted net 
assets (10,000)
Provision for bad debts 46,000
Depreciation 21,000
Amortization of deferred financing charges 5,000
(Increase) decrease in:
Accounts receivable (322,000)
Other receivables (5,000)
Increase (decrease) in:
Accounts payable, accrued payroll, and 
vacation costs 163,000
Estimated third-party payor settlements 1,000
Net cash provided by operating activities $ 76,000
See accompanying notes to financial statements.
20X4
$110,000
(6,000)
21,000
15,000
5,000
(150,000)
4 ,000
38,000
4,000
$ 41,000
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Sample Not-for-Profit Home Health Agency 
Notes to Financial Statements 
Years Ended December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Accounting 
Policies5
Organization. The Sample Home Health Agency (the Agency) was incorpo­
rated in 20X0 in New State as a not-for-profit corporation. The Agency provides 
health and supportive services to individuals at their homes, primarily in the 
New State area.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in 
highly liquid debt instruments with an original maturity of three months or less.
Investments. Investments, which consist of U.S. Treasury obligations, are 
measured at fair value in the balance sheet. Investment income (including 
realized gains and losses on investments, interest and dividends) is included 
in excess of revenues over expenses unless restricted by donor or law. Unreal­
ized gains and losses on investments, if any, are excluded from excess of 
revenues over expenses.
Equipment. Equipment is recorded at cost. Depreciation is computed using 
the straight-line method over the estimated useful lives of the assets.
Deferred financing costs. Deferred financing costs are being amortized using 
the effective interest method over the term of the related financing agreement.
Donor restrictions. The Agency reports gifts of cash and other assets as 
restricted support if  they are received with donor stipulations that limit the 
use of the donated assets. When a donor restriction expires, that is, when a 
stipulated time restriction ends or purpose restriction is accomplished, tempo­
rarily restricted net assets are reclassified as unrestricted net assets and 
reported in the statement of operations as net assets released from restrictions. 
When long-lived assets are placed in service, thus satisfying purpose restric­
tions, the amount is included as a change in net assets, restricted and unre­
stricted. Donor-restricted contributions whose restrictions are met within the 
same year as received are reflected as unrestricted contributions in the accom­
panying financial statements.
The Agency reports gifts of equipment (or other long-lived assets) as unre­
stricted support unless explicit donor stipulations specify how the donated 
assets must be used. Gifts of long-lived assets with explicit restrictions that 
specify how the assets are to be used and gifts of cash or other assets that must 
be used to acquire long-lived assets are reported as restricted support. Absent 
explicit donor stipulations about how long those long-lived assets must be 
maintained, the Agency reports expirations of donor restrictions when the 
donated or acquired long-lived assets are placed in service.
5 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade 
Receivables) That Lend to or Finance the Activities o f Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts. SOP 01-6 is effective for annual and interim financial 
statements issued for fiscal years beginning after December 15, 2001.
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Net patient service revenue. Net patient service revenue represents the 
estimated net realizable amounts from patients, third-party payors, and others 
for services rendered.
Charity care. The Agency has a policy of providing charity care to patients 
who are unable to pay. Such patients are identified based on financial information 
obtained from the patient and subsequent analysis. Since the Agency does not 
expect payment, estimated charges for charity care are not included in revenue.
Income taxes. The Agency has been recognized by the Internal Revenue 
Service as a not-for-profit corporation as described in Sec. 501(c)(3) of the 
Internal Revenue Code (IRC) and is exempt from federal income taxes on 
related income pursuant to Sec. 501(a) of the IRC.
Excess of revenue over expenses. The statement of operations includes excess 
of revenue over expenses. Changes in unrestricted net assets which are excluded 
from excess of revenue over expenses, consistent with industry practice, include 
unrealized gains and losses on investments other than trading securities, 
permanent transfers of assets to and from affiliates for other than goods and 
services, and contributions of long-lived assets (including assets acquired using 
contributions which by donor restriction were to be used for the purposes of 
acquiring such assets).
2. Temporarily R estricted Net A ssets
Temporarily restricted net assets are available for the following purposes:
20X5 20X4
Charity care $ — $5,000
Purchase of equipment 9,000 —
$9,000 $5,000
Net assets were released from donor restrictions by incurring expenses 
satisfying the restricted purposes or by occurrence of other events specified by 
donors:
20X5 20X4
Charity care expenditures $5,000 $ —
3. Perm anently R estricted Net Assets
Permanently restricted net assets are restricted in perpetuity, the income 
from which is expendable to support:
20X5
Program A activities $10,000
Any activities of the Agency 80,000
$90,000
4. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 20X5 and 37 percent in 20X4 of net patient 
service revenue was derived under federal and state third-party reimburse­
ment programs. These revenues are based, in part, on cost reimbursement 
principles and are subject to audit and retroactive adjustment by the respective 
third-party fiscal intermediaries. Laws and regulations governing these pro­
grams are extremely complex and subject to interpretation. As a result, there 
is at least a reasonable possibility that recorded estimates will change by a 
material amount in the near term. The 20X5 net patient service revenue 
increased approximately $XXX due to removal of allowances previously estimated
20X4
$ _
80,000
$80,000
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that are no longer necessary as a result of final settlements and years that are 
no longer subject to audits, reviews, and investigations. The 20X4 net patient 
service revenue decreased approximately $XXX due to prior-year retroactive 
adjustments in excess of amounts previously estimated.
5. In tern a lly -D esign ated  A ssets
The Board of Directors has designated investments aggregating $100,000 to 
be used for future major capital improvements. Those assets are classified in 
the balance sheet as long-term investments.
6. Long-Term  D ebt
Long-term debt at December 31, 20X5 and 20X4, is as follows:
20X5 20X4
Note payable to bank, interest at 15 percent, 
payable in monthly installments of $2,200 per 
month, including interest, collateralized by
equipment with a depreciated cost of $42,000 $118,000 $131,000 
Less current maturities 13,000 13,000
$105,000 $118,000
Scheduled maturities of long-term debt at December 31, 20X5, are as follows:
Year Ending December 31, Amount
20X6 $ 13,000
20X7 13,000
20X8 13,000
20X9 13,000
20Y0 13,000
Thereafter 53,000
Total $118,000
7. C lassifica tion  o f  E x p en ses
______________ Program _______________  General an d
Total A B C  A dm in istra tive
E xpenses incurred  
for the year 
ended December 
31, 20X5, were 
for:
Salaries and
benefits $2,714,000 $1,363,000 $699,000 $363,000 $289,000
M edical supplies 
and drugs 1,042,000 511,000 246,000 285,000
Insurance and 
other 90,000 58,000 32,000
Provision for bad 
debts 46,000 16,000 30,000
Depreciation 21,000 5,000 16,000
Interest 16,000 10,000 3,000 3,000
Total expenses $3,929,000 $1,963,000 $978,000 $648,000 $340,000
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____________ Program_____________  General and
Total A B C  Administrat ive
Expenses incurred 
for the year 
ended December 
31, 20X4, were 
for:
Salaries and
benefits $1,835,000 $ 915,000 $463,000 $216,000 $241,000
Medical supplies 
and drugs 675,000 335,000 211,000 129,000
Insurance and 
other 83,000 64,000 19,000
Provision for bad 
debts 21,000 21,000
Depreciation 15,000 6,000 9,000
Interest 19,000 12,000 5,000 2,000
Total expenses $2,648,000 $1,353,000 $679,000 $345,000 $271,000
(The preparer of the financial statements may wish to include a brief descrip­
tion of the types of programs.)
8. C harity  Care
Charity care represented approximately 3 percent and 4 percent of visits in 
20X5 and 20X4, respectively.
9. R isk s an d  U n certa in tie s  D isclosures*
10. P en sio n  Plan*
11. P o stretirem en t Benefits*
12. F air  V alue o f  F in a n cia l Statem ents*
13. C on cen tration s o f  C redit Risk*
14. Investm ents*
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A 
HEALTH MAINTENANCE ORGANIZATION
Sample Not-for-Profit Health Maintenance Organization 
Balance Sheets 
June 30, 20X5 and 20X4
20X5 20X4
A ssets
Current assets:
Cash and cash equivalents $2,937,000 $1,021,000
Premiums receivable, net of allowance for
doubtful accounts of $36,000 in 20X5 and
$42,000 in 20X4 358,000 407,000
Other receivables 263,000 261,000
Supplies 190,000 184,000
Prepaid expenses 197,000 99,000
Total current assets 3,945,000 1,972,000
Property and equipment, net 5,756,000 5,626,000
State guaranty fund deposit 150,000 150,000
Debt issuance costs, net of accumulated
amortization of $42,000 in 20X5 and $39,000
in 20X4 18,000 21,000
Total assets $9,869,000 $7,769,000
L ia b ilities  an d  N et A ssets
Current liabilities:
Unsecured 12 percent note payable to a bank $ — $ 44,000
Current maturities of long-term debt 241,000 109,000
Accounts payable—medical services 2,245,000 1,471,000
Other accounts payable and accrued expenses 829,000 661,000
Unearned premium revenue 141,000 202,000
Total current liabilities 3,456,000 2,487,000
Long-term debt, less current maturities 4,295,000 2,382,000
Total liabilities 7,751,000 4,869,000
Net assets—unrestricted 2,118,000 2,900,000
Total liabilities and net assets $9,869,000 $7,769,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization 
Statements of Operations and Changes in Net Assets 
Years Ended June 30, 20X5 and 20X4
20X5 20X4
Revenue:
Premiums earned $27,682,000 $22,500,000
Coinsurance 689,000 500,000
Interest and other income 242,000 100,000
Total revenue 28,613,000 23,100,000
Expenses:
Salaries and benefits 16,154,000 13,328,000
Medical supplies and drugs 8,507,000 5,988,000
Insurance 3,963,000 2,463,000
Provision for bad debts 19,000 20,000
Depreciation 367,000 336,000
Interest 385,000 375,000
Total expenses 29,395,000 22,510,000
Operating income (loss) (782,000) 590,000
Net assets, beginning of year 2,900,000 2,310,000
Net assets, end of year $ 2,118,000 $ 2,900,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization 
Statements of Cash Flows 
Years Ended June 30, 20X5 and 20X4
_  20X5 20X4
Cash flows from operating activities:
Cash received from premiums, stop-loss 
insurance recoveries, and coinsurance 
Cash paid to employees and to providers of 
health care services 
Interest and other income received 
Interest paid
Net cash provided by operating activities
Cash flows from investing activities:
Capital expenditures
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from long-term debt 
Principal payments on long-term debt 
Principal payments on note payable
Net cash provided by (used in) financing 
activities
Net increase in cash and cash equivalents 
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
$28,969,000 $24,410,000
(28,405,000) (22,818,000)
230,000 90,000
(382,000) (372,000)
412,000 1,310,000
(497,000) (121,000)
(497,000) (121,000)
2,300,000 _
(255,000) (1,000,000)
(44,000) —
2,001,000 (1,000,000)
1,916,000 189,000
1,021,000 832,000
$ 2,937,000 $ 1,021,000
(continued)
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Sample Not-for-Profit Health Maintenance Organization 
Statements of Cash Flows 
(continued) 
Years Ended June 30, 20X5 and 20X4
20X5 20X4
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets $(782,000) $ 590,000
Adjustments to reconcile change in net 
assets to net cash provided by operating 
activities:
Depreciation and amortization 370,000 339,000
Provision for bad debts 19,000 20,000
(Increase) decrease in:
Premiums receivables 30,000 64,000
Other current assets 230,000 (93,000)
Increase (decrease) in:
Accounts payable—medical services 774,000 335,000
Other accounts payable and accrued
expenses (168,000) (60,000)
Unearned premium revenue (61,000) 115,000
Net cash provided by operating activities $ 412,000 $1,310,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization 
Notes to Financial Statements6 
June 30, 20X5 and 20X4
1. Organization
The Sample Health Maintenance Organization (the HMO) was incorporated 
in 20X0 in New State as a not-for-profit corporation for the purpose of providing 
comprehensive health care services on a prepaid basis and for the purpose of 
establishing and operating organized health maintenance and health care 
delivery systems.
The HMO has been determined to be a qualified health maintenance organi­
zation under Title XIII of the Public Health Service Act.
2. Summary of Significant A ccounting Policies7
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in 
highly liquid debt instruments with an original maturity of three months or less.
Supplies. Inventories of drugs and other supplies are stated at the lower of 
cost (first-in, first-out) or market.
Property and equipment. Property and equipment are recorded at cost. 
Maintenance and repairs are charged to expense, and betterments are capital­
ized. Property and equipment costing approximately $700,000 was financed by 
health maintenance organization initial development grants received in 20X1 
and 20X2 from the U.S. Department of Health and Human Services (HHS). 
This property will be owned by the HMO as long as the equipment and facilities 
are used for projects related to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated 
useful lives of the related assets as follows:
Building 40 years
Improvements 20-25 years
Data processing and laboratory 
equipment and automobiles 3-7  years
Medical equipment 10 years
Office equipment 5-10 years
Amortization of debt issuance costs. Debt issuance costs are deferred and 
amortized using the effective interest method over the term of the related debt.
Health care service cost recognition. The HMO contracts with various health 
care providers for the provision of certain medical care services to its members.
6 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue 
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences 
between an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is 
included in appendix E to this Guide.
7 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade 
Receivables) That Lend to or Finance the Activities o f Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts. SOP 01-6 is effective for annual and interim financial 
statements issued for fiscal years beginning after December 15, 2001.
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The HMO compensates these providers on a capitation basis. As part of a cost 
control incentive program, the HMO retains up to 20 percent of the capitation 
as a risk-sharing fund. In the event of hospital utilization in excess of budget, 
those providers bear the risk to the extent of 15 percent of the capitation fee. 
Operating expenses include all amounts incurred by the HMO under the 
aforementioned contracts.
The cost of other health care services provided or contracted for is accrued in 
the period in which it is provided to a member based in part on estimates, 
including an accrual for medical services provided but not reported to the HMO.
Premiums revenue. Membership contracts are on a yearly basis subject to 
cancellation by the employer group or the HMO upon 30 days written notice. 
Premiums are due monthly and are recognized as revenue during the period in 
which the HMO is obligated to provide services to members.
Reinsurance (stop-loss insurance). Reinsurance premiums are reported as 
health care costs, and reinsurance recoveries are reported as a reduction of 
related health care costs.
Federal income tax. The HMO is exempt from federal income taxes under 
Sec. 501(c)(4) of the Internal Revenue Code; accordingly, no provision for 
federal income taxes has been made in the accompanying financial statements.
3. Property and Equipment
Property and equipment at June 3 0 , 20X5 and 20X4, consists of the following:
20X5 20X4
Land $ 300,000 $ 300,000
Buildings and improvements 5,473,000 5,459,000
Furniture and equipment 1,786,000 1,303,000
7,559,000 7,062,000
Less accumulated depreciation (1,803,000) (1,436,000)
$5,756,000 $5,626,000
4. Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost of 
$4,943,000. A summary of long-term debt at June 30, 20X5 a nd 20X4, follows.
20X5 20X4
HHS loan, interest at 7.5 percent, payable in 
monthly installments of $50,000, including
interest $2,020,000 $ 111,000
HHS loan, interest at 9.25 percent, payable 
in monthly installments of $10,000,
including interest 1,658,000 1,694,000
Secured equipment loans, payable in 
monthly installments of $15,000, including
interest 858,000 686,000
4,536,000 2,491,000 
Less current maturities 241,000 109,000
$4,295,000 $2 ,382,000
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Year Ending December 31, Amount
20X6 $ 241,000
20X7 259,000
20X8 280,000
20X9 800,000
20Y0 2,956,000
$4,536,000
5. State Guarantee Fund Deposit
In August 20X4 the state in which the HMO is domiciled enacted legislation 
specifically governing HMOs. Under this legislation, the corporation is required 
to maintain a deposit of $150,000 with the director of the division of insurance 
of the state.
6. Employee Retirement Plan
The HMO has a contributory defined contribution retirement plan covering 
substantially all employees. Expense determined in accordance with the plan 
formula (4 percent to 10 percent of eligible covered compensation) was $354,000 
and $275,000 for the years ended June 30, 20X5 and 20X4, respectively.
7. Stop-Loss Insurance
The HMO entered into a stop-loss insurance agreement with an insurance 
company to limit its losses on individual claims. Under the terms of this 
agreement, the insurance company will reimburse the HMO approximately 25 
percent of the cost of each member’s annual hospital services, in excess of a 
$1,000 deductible, up to a lifetime limitation of $500,000 per member. In the 
event the HMO ceases operations, (a) plan benefits will continue for members 
who are confined in an acute care hospital on the date of insolvency until their 
discharge, and (b) plan benefits will continue for any other member until the 
end of the contract period for which premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are 
included in insurance expense (Note 9) in 20X5 and 20X4, respectively. Ap­
proximately $600,000 and $400,000 in stop-loss insurance recoveries are de­
ducted from insurance expense in 20X5 and 20X4, respectively.
Included in other receivables is approximately $50,000 recoverable from 
insurers.
8. Malpractice Claims
Malpractice claims have been asserted against the HMO by various claim­
ants. The claims are in various stages of processing, and some may ultimately 
be brought to trial. In the opinion of counsel, the outcome of these actions will 
not have a significant effect on the financial position or the operating income 
of the HMO. Incidents occurring through June 30, 20X5, may result in the 
assertion of additional claims. Other claims may be asserted arising from past 
services provided. Management believes that these claims, if asserted, would 
be settled within the limits of insurance coverage.
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9. C lassification o f Expenses
20X5 20X4
Program activities 26,921,000 20,909,000
General and administrative 2,474,000 1,601,000
$29,395,000 $22,510,000
10. R isks and U ncertainties Disclosures*
11. Pension  Plan*
12. Postretirem ent Benefits*
13. Fair Value o f F inancial Instruments*
14. C oncentrations o f Credit Risk*
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR AN 
AMBULATORY CARE ORGANIZATION 
Sample Not-for-Profit Ambulatory Care, Inc. 
Balance Sheets 
December 31, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash $ 65,000 $ 76,000
Patient accounts receivable, net of allowance
for doubtful accounts of $15,000 in 20X5 and
$5,000 in 20X4 290,000 278,000
Estimated retroactive
adjustments—third-party payors 19,000 32,000
Accounts receivable—other 13,000 8,000
Supplies 21,000 18,000
Prepaid expenses and deposits 5,000 9,000
Total current assets 413,000 421,000
Property and equipment, at cost:
Land 100,000 100,000
Land improvements 322,000 322,000
Buildings 682,000 682,000
Equipment 1,390,000 1,389,000
2,494,000 2,493,000
Less accumulated depreciation 217,000 100,000
Property and equipment, net 2,277,000 2,393,000
Other assets:
Advances receivable 14,000 5,000
Total assets $2,704,000 $2,819,000
Liabilities and Net Assets
Current liabilities:
Notes payable $ 138,000 $ 144,000
Accounts payable 52,000 87,000
Accrued payroll, benefits, and taxes 33,000 22,000
Estimated retroactive
adjustments—third-party payors 30,000 24,000
Financing advance from third-party payors — 1,000
Total current liabilities 253,000 278,000
Net assets—unrestricted 2,451,000 2,541,000
Total liabilities and net assets $2,704,000 $2,819,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Ambulatory Care, Inc. 
Statements of Operations and Changes 
in Net Assets 
Years Ended December 31, 20X5 and 20X4
Revenue and gains:
Net patient service revenue 
Other
Total revenue and gains
Expenses:
Salaries and benefits 
Medical supplies and drugs 
Insurance
Provision for bad debts
Depreciation
Interest
Total expenses
Operating loss
Net assets, beginning of year 
Net assets, end of year
20X5 20X4
$ 860,000 $ 357,000
29,000 15,000
889,000 372,000
485,000 243,000
189,000 66,000
154,000 98,000
14,000 4,000
117,000 100,000
20,000 18,000
979,000 529,000
(90,000) (157,000)
2,541,000 2,698,000
$2,451,000 $2,541,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Ambulatory Care, Inc. 
Statements of Cash Flows 
Years Ended December 31, 20X5 and 20X4
20X5
Cash flows from operating activities:
Cash received from patients and third-party
payors $866,000
Cash received from others 21,000
Interest received 3,000
Interest paid (15,000)
Cash paid to employees and suppliers (870,000)
Net cash provided by (used in) operating
activities 5,000
Cash flows from investing activities:
Purchase of equipment (1,000)
Advances made to XYZ Affiliate (9,000)
Net cash used in investing activities (10,000)
Cash flows from financing activities:
Proceeds from notes payable —
Payments on notes payable (6,000)
Net cash provided by (used in) financing
activities (6,000)
Net increase (decrease) in cash (11,000)
Cash, beginning of year 76,000
Cash, end of year $ 65,000
20X4
$368,000
6,000
11,000
(16,000)
(432,000)
(63,000)
(4,000)
(5,000)
(9,000) 
144,000
144,000 
72,000 
4,000 
$ 76,000
(continued)
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Sample Not-for-Profit Ambulatory Care, Inc. 
Statements of Cash Flows 
(continued) 
Years Ended December 31, 20X5 and 20X4
20X5
Reconciliation of change in net assets to net 
cash provided by (used in) operating 
activities:
Change in net assets $ (90,000)
Adjustments to reconcile change in net assets 
to net cash provided by (used in) operating 
activities:
Depreciation 117,000
Provision for bad debts 14,000
(Increase) decrease in:
Patient accounts receivable (12,000)
Other current assets 1,000
Increase (decrease) in:
Accounts payable and accrued payroll, 
benefits, and taxes (24,000)
Other current liabilities (1,000)
Net cash provided by (used in) operating 
activities $ 5,000
See accompanying notes to financial statements.
20X4
$(157,000)
100,000
4,000
(19,000)
(2 ,000)
10,000
1,000
$ (63,000)
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Sample Not-for-Profit Ambulatory Care, Inc. 
Notes to Financial Statements 
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Accounting 
Policies8
Organization. Ambulatory Care, Inc. was incorporated on September 7, 
20X3, in New State, to operate an ambulatory care health facility to treat or 
prevent injury and disease, to provide funds or to expend funds to further the 
treatment or prevention of injury or disease, and to develop and participate in 
activities designed to promote the general health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and 
GHI Hospital—entered into a members’ agreement to develop this ambulatory 
care center. In accordance with this agreement, each hospital contributed 
capital of $947,000 to Ambulatory Care, Inc. Ambulatory Care, Inc. began 
operations in October 20X3.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Supplies. Supplies are stated at the lower of cost (first-in, first-out) or net 
realizable value.
Depreciation. Depreciation of property and equipment is computed on the 
straight-line method over the estimated lives of depreciable assets.
Third-party contractual adjustments. Retroactively calculated third-party 
contractual adjustments are accrued on an estimated basis in the period the 
related services are rendered. Net patient service revenue is adjusted as 
required in subsequent periods based on final settlements.
Net patient service revenue. Patient service revenue is reported at the esti­
mated net realizable amounts from patients, third-party payors, and others for 
services rendered.
Charity care. Ambulatory Care, Inc. has a policy of providing charity care to 
patients who are unable to pay. Such patients are identified and related charges 
are estimated, based on financial information obtained from the patient and 
subsequent analysis. Since management does not expect payment for charity 
care, the estimated charges are excluded from revenue.
Income taxes. Ambulatory Care, Inc. has been recognized by the Internal 
Revenue Service as a not-for-profit corporation as described in Sec. 501(c)(3) of 
the Internal Revenue Code (IRC) and is exempt from federal income taxes on 
related income pursuant to Sec. 501(a) of the IRC.
8 Paragraph 13 of SOP 01-6, Accounting by Certain Entities (Including Entities With Trade 
Receivables) That Lend to or Finance the Activities o f Others, provides guidance on disclosures that 
should be included in the summary of significant accounting policies, including accounting policies for 
loans, trade receivables, and doubtful accounts. SOP 01-6 is effective for annual and interim financial 
statements issued for fiscal years beginning after December 15, 2001.
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2. Advances Receivable*
In May 20X4, Ambulatory Care, Inc. entered into a five-year agreement with 
XYZ Affiliates (XYZ). Under this agreement, XYZ is to provide emergency 
medical services as well as charge and bill each patient treated at Ambulatory 
Care, Inc. Ambulatory Care, Inc. has guaranteed that XYZ will collect at least 
$18,000 per month during the term of this agreement. In any month in which 
XYZ does not collect the minimum guarantee, Ambulatory Care, Inc. advances 
funds to XYZ to cover the deficiency. Such advances are to be repaid to the 
extent XYZ’s net cash collections exceed the minimum guarantee amount. 
Management estimates that the advances will be fully recovered in 20X8.
3. Related-Party Transactions
During 20X3, Ambulatory Care, Inc. entered into a contract with one of the 
member hospitals (the managing hospital) for the management of the business 
and affairs of Ambulatory Care, Inc. Under this agreement, Ambulatory Care, 
Inc. pays $4,000 per month to the managing hospital. The agreement with the 
managing hospital was to remain in effect through December 31, 20X5, but has 
been extended on a month-to-month basis.
In addition, during 20X4 each hospital loaned $48,000 to Ambulatory Care, 
Inc. in the form of promissory notes at an interest rate of prime rate plus 1 
percent (effective rates of 10 percent and 9 percent in 20X5 and 20X4, respec­
tively). Of the total $144,000 liability, $48,000 is payable on demand after 
November 28, 20X5, to one member hospital, with the remaining portion 
($96,000) payable on demand after December 8, 20X5, to the other two member 
hospitals. During 20X5, Ambulatory Care, Inc. paid $2,000 to each member 
hospital, thereby reducing the obligation to $138,000.
4. Revenue From Contracting Agencies
Ambulatory Care, Inc. participates as a provider of health care services to Blue 
Cross, Medicare, and County Indigent Plan patients. Reimbursement for covered 
services is based on tentative payment rates. Final reimbursement is determined 
after submission of annual cost reports and audits thereof by the fiscal intermedi­
aries. Provisions for estimated reimbursement adjustments are reported in the 
financial statements in the period that the services are rendered.
Revenue from the Medicare program accounted for approximately XX percent 
for the year ended 20X5, and XX percent for the year ended 20X4, of Ambulatory 
Care, Inc.’s net patient revenue. Laws and regulations governing the Medicare 
program are extremely complex and subject to interpretation. As a result, there 
is at least a reasonable possibility that recorded estimates will change by a 
material amount in the near term. The 20X5 net patient service revenue 
increased approximately $XXX due to removal of allowances previously esti­
mated that are no longer necessary as a result of final settlements and years 
that are no longer subject to audits, reviews, and investigations. The 20X4 net 
patient service revenue decreased approximately $XXX due to prior-year ret­
roactive adjustments in excess of amounts previously estimated.
* FASB Interpretation No. 45, Guarantor’s Accounting and Disclosure Requirements for Guar­
antees, Including Indirect Guarantees of Indebtedness of Others, elaborates on the disclosures to be 
made by a guarantor in its financial statements about its obligations under certain guarantees that 
it has issued. That Interpretation also clarifies that a guarantor is required to recognize, at the 
inception of certain guarantees, a liability for the fair value of the obligation undertaken in issuing 
the guarantee. Initial recognition and initial measurement provisions apply on a prospective basis to 
certain guarantees issued or modified after December 31, 2002, irrespective of the guarantor’s fiscal 
year-end. The disclosure requirements are effective for financial statements of interim or annual 
periods ending after December 15, 2002. Conforming changes identified for these illustrative finan­
cial statements in appendix A of this Guide to reflect the issuance of FASB Interpretation No. 45 will 
be made in a future edition of this Guide.
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5. Charity Care
Ambulatory Care, Inc. has a policy of providing charity care to indigent 
patients in emergency situations. These services, which are excluded from 
revenues, amounted to $27,000 and $13,000 in 20X5 and 20X4, respectively, 
when measured at Ambulatory Care, Inc.’s established rates.
6. Classification of Expenses
Program
Total B
Expenses incurred 
for the year 
ended December 
31, 20X5, were 
for:
Salaries and
General and 
Administrative
benefits $485,000 $216,000 $102,000 $121,000 $46,000
Medical supplies
and drugs 189,000 98,000 43,000 48,000 —
Insurance 154,000 79,000 45,000 14,000 16,000
Provision for bad
debts 14,000 9,000 — 5,000 —
Depreciation 117,000 100,000 — 17,000 —
Interest 20,000 9,000 — 11,000
Total expenses $979,000 $511,000 $190,000 $205,000 $73,000
Program General and
Total A B C
Expenses incurred
for the year
ended December
31, 20X4, were
for:
Salaries and
benefits $243,000 $111,000 $46,000 $ 57,000 $29,000
Medical supplies
and drugs 66,000 31,000 15,000 20,000 —
Insurance 98,000 45,000 19,000 26,000 8,000
Provision for
bad debts 4,000 — 4,000 — —
Depreciation 100,000 56,000 — 44,000 —
Interest 18,000 7,000 — 11,000
Total expenses $529,000 $250,000 $84,000 $147,000 $48,000
(The preparer of the financial statements may wish to include a brief descrip­
tion of the types of programs.)
7. Risks and Uncertainties Disclosures*
8. Pension Plan*
9. Postretirement Benefits*
10. Fair Value of Financial Instruments*
11. Concentrations of Credit Risk*
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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Appendix B 
Background Information and Basis 
for Conclusions
1. This appendix provides background information and discusses the 
comments received on the April 14, 1995 exposure draft that preceded this 
Audit and Accounting Guide (Guide)— Proposed Audit and Accounting Guide 
Health Care Organizations and the basis for key conclusions in this Guide.
Background Information
2. In 1989, the AICPA Health Care Committee (“the Committee”) com­
pleted a total rewrite of the guide. Since then, conforming changes have been 
made to update the guide for newly issued technical pronouncements. In June 
1993, the FASB issued FASB Statement No. 116, Accounting for Contributions 
Received and Contributions Made (“Contributions”), and FASB Statement No. 
117, Financial Statements of Not-for-Profit Organizations (“Display”). These 
Statements provide broad standards and introduce new concepts for which 
there is no detailed implementation guidance. FASB Statement No. 117 per­
mits the AICPA to provide more specific reporting guidance. Specifically, 
paragraph 3 of FASB Statement No. 117 states:
"Within the parameters of the Statement, the AICPA or another appropriate 
body, following the process described in AICPA Statement of Auditing Stand­
ards (SAS) No. 69, The Meaning of Present Fairly in Conformity With Generally 
Accepted Accounting Principles in the Independent Auditor’s Report, may  
provide more specific reporting guidance for certain not-for-profit organiza­
tions."
The Guide provides this guidance as it relates to providers of health care 
services.
3. In April 1995, the Committee released an exposure draft of a proposed 
Audit and Accounting Guide Health Care Organizations (ED) for public com­
ment. The committees received 40 comment letters on the ED. The committees 
redeliberated the issues based on the comments received. This appendix dis­
cusses the key issues in the ED and comments received on those issues, as well 
as the basis for AcSEC’s conclusions on those and certain other issues.
Basis for Conclusions
Contributions and Display
4. FASB Statements No. 116 and No. 117 allow more flexibility in finan­
cial reporting than currently exists within the health care industry. The most 
prominent flexibility relates to the elimination of the requirements to present 
a classified balance sheet and income statement as compared to the statement 
of activities.
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5. FASB Statements No. 116 and No. 117 apply to all not-for-profit 
enterprises, regardless of whether or not the entity is a business enterprise. 
The majority of tax-exempt health care organizations, however, operate as 
business enterprises (i.e., are essentially self-sustaining from fees charged for 
goods and services). The Committee believes that the uniformity and useful­
ness of financial reporting for business enterprise organizations would be 
enhanced if the implementation guidance for FASB Statements No. 116 and 
No. 117 were consistent with the objectives of business enterprise financial 
reporting. The Committee points to the provisions in FASB Concept Statement 
No. 4, paragraph 8, which clearly supports the use of business enterprise 
financial reporting objectives for those organizations:
"Some organizations have no ownership interest but are essentially self-sus­
taining from fees they charge for goods and services. Examples are those private 
nonprofit hospitals...that may receive relatively small amounts of contributions 
and grants, but finance their capital needs largely from the proceeds of debt 
issues and their operating needs largely from service charges rather than from 
private philanthropy or governmental grants. As a result, assessments of 
amounts, timing, and uncertainty of cash flows become the dominate interest 
of their creditors and other resource providers and profitability becomes an 
important indicator of performance. Consequently, the objectives of Concepts 
Statement 1 may be more appropriate for those organizations."
6. Based on the theoretical support provided in FASB Concepts State­
ment No. 4, as well as the FASB allowance for more specific guidance (see 
paragraph 2 of this appendix), chapter 1 of the Guide defines four types of 
operating structures that are found within the industry: (1) not-for-profit 
business-oriented organizations, (2) investor-owned health care enterprises, 
(3) governmental health care organizations, and (4) not-for-profit, nonbusi­
ness-oriented organizations. This Guide provides specific reporting guidance 
for not-for-profit business-oriented organizations, investor-owned enterprises 
and governmental entities. (Not-for-profit nonbusiness organizations follow 
guidance for not-for-profit entities provided in the Audit and Accounting Guide 
Not-for-Profit Organizations.) The Guide recommends that these entities pro­
vide a classified balance sheet and a statement of operations. The Guide also 
encourages natural class reporting on the face of the financial statements, with 
disclosure of functional details in the footnotes.
7. A number of respondents to the ED were concerned that because the 
exposure draft of the Guide did not require an entity to distinguish between 
operating activities and nonoperating activities that such distinctions were no 
longer permissible. In response to these concerns, the Guide was clarified to 
incorporate paragraph 23 of FASB Statement No. 117. This paragraph specifi­
cally allows additional classifications within a statement of operations. Like 
FASB Statement No. 117, however, the Guide neither requires nor precludes 
such classifications.
Assets Whose Use is Limited
8. Several comments were received on the ED requesting specific guid­
ance to allow internally designated funds to be disclosed on the face of the 
financial statements. In response to these comments, the Committee clarified 
the Guide to require cash and claims to cash that meet one of the following 
criteria to be reported separately and excluded from current assets:
a. restricted as to withdrawal or use for other than current operations,
b. designated for expenditure in the acquisition or construction of 
noncurrent assets,
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c. required to be segregated for the liquidation of long-term debts, or
d. required by a donor-imposed restriction that limits their use to 
long-term purposes.
Consistent with comments received from a rating agency, the Guide requires 
internally designated funds to be reported separately from externally desig­
nated funds either in the notes to or on the face of the financial statements. The 
Committee believes this separation is beneficial due to the degree of control an 
organization maintains over internally designated funds.
Investments
9. Chapter 4, as presented in the Exposure Draft, was re-drafted to 
conform with the provisions of FASB Statement No. 124, Certain Investments 
Held by Not-For-Profit Organizations. This Standard requires fair value ac­
counting for marketable equity and debt securities. The majority of respon­
dents to the ED favored an income recognition approach similar to FASB 
Statement No. 115, Accounting for Certain Investments in Debt and Equity 
Securities. They believe such an approach is essential because it would foster 
greater consistency among not-for-profit and for-profit entities. Accordingly, 
an approach similar to FASB Statement No. 115 (i.e., the differentiation of 
trading securities vs. available-for-sale securities) was incorporated into the 
Guide. (The FASB specifically prohibited the use of a held-to-maturity category 
by not-for-profit organizations.)
Accounting for Donor-Imposed Restricted Contributions on 
Long-Lived Assets
10. The majority of comments received on accounting for donor-imposed 
restrictions on contributions of long-lived assets concurred with the Health 
Care Committee’s conclusion that the expiration of donor imposed restrictions 
on long-lived assets should be recognized when the asset is placed in service 
(rather than as depreciated as permitted by FASB Statement No. 116). Other 
respondents disagreed with the Health Care Committee’s position for various 
reasons. After considering each comment on the issue, the Committee con­
cluded that it would maintain the position set forth in the ED. The Committee 
believes this approach is easier to implement, it provides for uniformity in 
reporting within the industry and, because the donations are excluded from 
operating results, an appropriate matching of revenues and expenses occurs.
Use of a Performance Indicator
11. The Guide stresses the importance of the performance indicator and, 
in an effort to ensure consistency within the industry, provides specific guid­
ance on what the performance indicator should represent. This guidance is 
consistent with performance criteria historically used in the health care indus­
try, to the extent allowed under the provisions of FASB Statement No. 117. 
Specifically, the Guide states that health care organizations should report the 
results of their operations separately from—
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting 
entity, are controlled by the reporting entity, or are under common 
control with the reporting entity.
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c. Receipt of restricted contributions, including temporary restrictions 
(such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions related 
to) long-lived assets.
e. Unrealized gains and losses on investments not restricted by donors 
or by law, except for those investments classified as trading securi­
ties.
f. Investment returns restricted by donors or by law.
g. Other items that are required by GAAP to be reported separately 
(such as extraordinary items, the effect of discontinued operations, 
or the cumulative effect of accounting changes).1
12. In its deliberations, the FASB discussed the use of the word net 
income to describe the performance indicator of not-for-profit health care 
organizations. The Board concluded that the term net income is an inappropri­
ate term to describe the performance indicator of a not-for-profit organization 
and that descriptive terms such as revenues over expenses, revenues and gains 
over expenses and losses, earned income or performance earnings would be more 
appropriate. Accordingly, this guide requires the use of such descriptive terms 
instead of net income to describe the performance indicator of not-for-profit 
organizations.
Definition of a Governmental Entity
13. Subsequent to the release of the ED, the FASB and the GASB agreed 
on the definition of a governmental entity. Paragraph 1.02 of the Guide 
incorporates that definition.
Effective Date
14. Several comment letters were received expressing concern about the 
effective date of the Guide. In response to these comments, the Committee 
revised the effective date to fiscal years beginning after June 15, 1996, with 
earlier application permitted.
Status of Audit and Accounting Guides in the 
GAAP Hierarchy
15. In several instances the Guide provides more specific reporting re­
quirements than FASB Statements No. 116 and No. 117 (see paragraphs 4 
through 6, 8, 10, and 11). In the deliberation of the Guide, the question has 
arisen regarding the status of the guide in the GAAP hierarchy, given the fact 
that AICPA Audit and Accounting Guides are “Level B” GAAP while FASB 
Statements are “Level A ”. In discussing the issue the Committee and the 
Accounting Standards Executive Committee referred to paragraph 49 of FASB 
Statement No. 117, which states that the AICPA:
“may provide more specific reporting guidance for certain not-for profit organi­
zations. SAS 69 requires that an entity adopt cleared AICPA Industry Audit
and Accounting Guides, and cleared AICPA Statements of Position that become
1 Governmental enterprises should report extraordinary items and the effect of discontinued 
operations in the statement of operations immediately preceding net income; the cumulative effect of 
an accounting change should be reported as an adjustment to beginning fund balance in the period of 
the change. Investor-owned enterprises should report extraordinary items, the effect of discontinued 
operations and the cumulative effect of an accounting change in the statement of operations immedi­
ately preceding net income.
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effective after March 15, 1992. As used in SAS 69, cleared means that the FASB 
has indicated that it does not object to the issuance of the proposed pronounce­
ment.”
The FASB has indicated that it does not object to the more specific reporting 
requirements contained in this guide for health care organizations.
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Appendix C
Statement of 98-2
Position
Accounting for Costs of 
Activities of Not-for-Profit 
Organizations and State and 
Local Governmental Entities 
That Include Fund Raising
March 11, 1998
Amendment to
AICPA Audit and Accounting Guides 
Health Care Organizations,
Not-for-Profit Organizations, and
Audits of State and Local Governmental Units
Issued by the Accounting 
Standards Executive Committee
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NOTE
Statements of Position on accounting issues present the conclusions 
of at least two-thirds of the Accounting Standards Executive Com­
mittee, which is the senior technical body of the Institute authorized 
to speak for the Institute in the areas of financial accounting and 
reporting. Statement on Auditing Standards No. 69, The Meaning of 
Present Fairly in Conformity With Generally Accepted Accounting 
Principles, identifies AICPA Statements of Position that have been 
cleared by either the Financial Accounting Standards Board (for 
financial statements of nongovernmental entities) or the Govern­
mental Accounting Standards Board (for financial statements of 
state and local governmental entities), as sources of established 
accounting principles in category b of the hierarchy of generally 
accepted accounting principles that it establishes. AICPA members 
should consider the accounting principles in this Statement of Posi­
tion if  a different accounting treatment of a transaction or event is 
not specified by a pronouncement covered by Rule 203 of the AICPA 
Code of Professional Conduct. In such circumstances, the accounting 
treatment specified by this Statement of Position should be used, or 
the member should be prepared to justify a conclusion that another 
treatment better presents the substance of the transaction in the 
circumstances.
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SUMMARY
This Statement of Position (SOP) applies to all nongovernmental not-for-profit 
organizations (NPOs) and all state and local governmental entities that solicit 
contributions.
This SOP requires—
•  I f  the criteria of purpose, audience, and content as defined in this SOP 
are met, the costs of joint activities that are identifiable with a 
particular function should be charged to that function and joint costs 
should be allocated between fund raising and the appropriate program 
or management and general function.
•  I f  any of the criteria of purpose, audience, and content are not met, all 
costs of the activity should be reported as fund-raising costs, including 
costs that otherwise might be considered program or management and 
general costs if  they had been incurred in a different activity, subject 
to the exception in the following sentence. Costs of goods or services 
provided in exchange transactions that are part of joint activities, such 
as costs of direct donor benefits of a special event (for example, a meal), 
should not be reported as fund raising.
•  Certain financial statement disclosures if  joint costs are allocated.
•  Some commonly used and acceptable allocation methods are described 
and illustrated although no methods are prescribed or prohibited.
This SOP amends existing guidance in AICPA Audit and Accounting Guides 
Health Care Organizations, Not-for-Profit Organizations (which was issued in 
August 1996 and supersedes SOP 87-2, Accounting for Joint Costs of Informa­
tional Materials and Activities of Not-for-Profit Organizations That Include a 
Fund-Raising Appeal, because the provisions of SOP 87-2 are incorporated into 
the Guide), and Audits of State and Local Governmental Units.
This SOP is effective for financial statements for years beginning on or after 
December 15, 1998. Earlier application is encouraged in fiscal years for which 
financial statements have not been issued. I f  comparative financial statements 
are presented, retroactive application is permitted but not required.
AAG-HCO APP C
Statement of Position 98-2 249
FOREWORD
The accounting guidance contained in this document has been cleared by the 
Financial Accounting Standards Board (FASB) and the Governmental Account­
ing Standards Board (GASB). The procedure for clearing accounting guidance 
in documents issued by the Accounting Standards Executive Committee (Ac­
SEC) involves the FASB and the GASB reviewing and discussing in public 
board meetings (1) a prospectus for a project to develop a document, (2) a 
proposed exposure draft that has been approved by at least ten of AcSEC’s 
fifteen members, and (3) a proposed final document that has been approved by 
at least ten of AcSEC’s fifteen members. The document is cleared if  at least five 
of the seven FASB members and three of the five GASB members do not object 
to AcSEC undertaking the project, issuing the proposed exposure draft or, after 
considering the input received by AcSEC as a result of the issuance of the 
exposure draft, issuing the final document.*
The criteria applied by the FASB and the GASB in their review of proposed 
projects and proposed documents include the following:
1. The proposal does not conflict with current or proposed accounting 
requirements, unless it is a limited circumstance, usually in special­
ized industry accounting, and the proposal adequately justifies the 
departure.
2. The proposal will result in an improvement in practice.
3. The AICPA demonstrates the need for the proposal.
4. The benefits of the proposal are expected to exceed the costs of 
applying it.
In many situations, prior to clearance, the FASB and the GASB will propose 
suggestions, many of which are included in the documents.
* This document was cleared prior to July 1, 1997. In July 1997, the GASB increased to seven 
members. Documents considered by the GASB after July 1, 1997 are cleared if at least four of the 
seven GASB members do not object.
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Accounting for Costs of Activities of 
Not-for-Profit Organizations and 
State and Local Governmental Entities 
That Include Fund Raising
Introduction
1. Some nongovernmental not-for-profit organizations (NPOs) and 
some state and local governmental entities,1 such as governmental colleges 
and universities and governmental health care providers, solicit support 
through a variety of fund-raising activities.2 These activities include direct 
mail, telephone solicitation, door-to-door canvassing, telethons, special events, 
and others. Sometimes fund-raising activities are conducted with activities 
related to other functions, such as program activities or supporting services, 
such as management and general activities.3,* Sometimes fund-raising 
activities include components that would otherwise be associated with pro­
gram or supporting services, but in fact support fund raising.
1 This Statement of Position (SOP) uses the term entity to refer to both nongovernmental 
not-for-profit organizations (NPOs) and state and local governments.
2 Terms that appear in the Glossary are set in boldface type the first time they appear.
3 The functional classifications of fund raising, program, and management and general are 
discussed throughout this SOP for purposes of illustrating how the guidance in this SOP would be 
applied by entities that use those functional classifications. Some entities have a functional structure 
that does not include fund raising, program, or management and general, or that includes other 
functional classifications, such as membership development. This SOP is not intended to require 
reporting the functional classifications of fund raising, program, and management and general. In 
circumstances in which entities that have a functional structure that includes other functional 
classifications conduct joint activities, all costs of those joint activities should be charged to fund 
raising (or the category in which fund raising is reported—see the following two parenthetical 
sentences), unless the purpose, audience, and content of those joint activities are appropriate for 
achieving those other functions. (An example of an entity that reports fund raising in a category other 
than fund raising is a state and local governmental entity applying the accounting and financial 
reporting principles in the AICPA Industry Audit Guide Audits o f Colleges and Universities, as 
amended by SOP 74-8. As discussed in paragraph D-5 of this SOP, those entities are required to 
report fund raising as part of the “institutional support” function.)
* The AICPA Audit and Accounting Guides Audits o f Colleges and Universities, Audits o f  
Voluntary Health and Welfare Organizations, and Audits o f Certain Nonprofit Organizations were 
superseded by the 1996 edition of the AICPA Audit and Accounting Guide Not-for-Profit Organiza­
tions. However, because the accounting guidance contained in these Guides remained applicable to 
certain governmental entities (pursuant to the provisions of GASB Statement Nos. 15, Governmental 
College and University Accounting and Financial Reporting Models, and 29, The Use o f Not-for-Profit 
Accounting and Financial Reporting Principles by Governmental Entities), the AICPA continued to 
make these Guides available for sale.
With the recent issuance of GASB Statement Nos. 34, Basic Financial Statements—and Management’s 
Discussion and Analysis—for State and Local Governments, and 35, Basic Financial Statements—and 
Management’s Discussion and Analysis—for Public Colleges and Universities, which supersede the 
effect of GASB Statement Nos. 15 and 29, it is no longer necessary for the AICPA to continue selling 
these Guides.
Accordingly, Audits o f Colleges and Universities, Audits o f Voluntary Health and Welfare Organiza­
tions, and Audits o f Certain Nonprofit Organizations will no longer be included as part of this 
loose-leaf publication.
Once the phased-in effective dates of the GASB Statements have occurred, the accounting guidance 
in these Guides will no longer be applicable to any governmental entities. Please note that the Guides 
have not been updated since 1994. Therefore, if you already have a Guide, and choose to continue 
using it until the phase-in period is complete, you must consider guidance issued since they were last 
updated.
AAG-HCO APP C
252 Health Care Organizations
2. External users of financial statements—including contributors, credi­
tors, accreditation agencies, and regulators—want assurance that fund-raising 
costs, as well as program costs and management and general costs, are stated 
fairly.
3. In 1987, the AICPA issued Statement of Position (SOP) 87-2, Account­
ing for Joint Costs of Informational Materials and Activities of Not-for-Profit 
Organizations That Include a Fund-Raising Appeal.4 SOP 87-2 required that 
all circumstances concerning informational materials and activities that in­
clude a fund-raising appeal be considered in accounting for joint costs of those 
materials and activities and that certain criteria be applied in determining 
whether joint costs of those materials and activities should be charged to fund 
raising or allocated to program or management and general. Those criteria 
include requiring verifiable indications of the reasons for conducting the activ­
ity, such as the content, audience, and action, i f  any, requested of the partici­
pant, as well as other corroborating evidence. Further, SOP 87-2 required that 
all joint costs of those materials and activities be charged to fund raising unless 
the appeal is designed to motivate its audience to action other than providing 
financial support to the organization.
4. The provisions of SOP 87-2 have been difficult to implement and have 
been applied inconsistently in practice. (Appendix B, “Background,” discusses 
this further.)
5. This SOP establishes financial accounting standards for accounting for 
costs of joint activities. In addition, this SOP requires financial statement 
disclosures about the nature of the activities for which joint costs have been 
allocated and the amounts of joint costs. Appendix F provides explanations and 
illustrations of some acceptable allocation methods.
Scope
6. This SOP applies to all nongovernmental NPOs and all state and local 
governmental entities that solicit contributions.
Conclusions
Accounting for Joint Activities
7. I f  the criteria of purpose, audience, and content are met, the costs of a 
joint activity that are identifiable with a particular function should be 
charged to that function and joint costs should be allocated between fund 
raising and the appropriate program or management and general function. I f 
any of the criteria are not met, all costs of the joint activity should be reported
4 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit Organiza­
tions. The Guide supersedes SOP 87-2, Accounting for Joint Costs o f Informational Materials and 
Activities o f Not-for-Profit Organizations That Include a Fund-Raising Appeal, because the provi­
sions of SOP 87-2 are incorporated into paragraphs 13.36 to 13.45 of Not-for-Profit Organizations. 
Not-for-Profit Organizations applies to all nongovernmental NPOs other than those required to 
follow the Audit and Accounting Guide Health Care Organizations. The discussion in this SOP of SOP 
87-2 refers to both SOP 87-2 and the guidance included in paragraphs 13.36 to 13.45 of Not-for-Profit 
Organizations. Also, SOP 87-2 was not applicable to entities that are within the scope of Governmen­
tal Accounting Standards Board (GASB) Statement No. 29, The Use o f Not-for-Profit Accounting and 
Financial Reporting Principles by Governmental Entities.
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as fund-raising costs, including costs that otherwise might be considered 
program or management and general costs if they had been incurred in a 
different activity, subject to the exception in the following sentence. Costs of 
goods or services provided in exchange transactions that are part of joint 
activities, such as costs of direct donor benefits of a special event (for example, 
a meal), should not be reported as fund raising.
Purpose
8. The purpose criterion is met if  the purpose of the joint activity includes 
accomplishing program or management and general functions. (Paragraphs 9 
and 10 provide guidance that should be considered in determining whether the 
purpose criterion is met. Paragraph 9 provides guidance pertaining to program 
functions only. Paragraph 10 provides guidance pertaining to both program 
and management and general functions.)
9. Program functions. To accomplish program functions, the activity 
should call for specific action by the audience that will help accomplish the 
entity’s mission. For purposes of applying the guidance in this SOP, the 
following are examples of activities that do and do not call for specific action by 
the audience that will help accomplish the entity’s mission:
•  An entity’s mission includes improving individuals’ physical health. 
For that entity, motivating the audience to take specific action that 
will improve their physical health is a call for specific action by the 
audience that will help accomplish the entity’s mission. An example 
of an activity that motivates the audience to take specific action that 
will improve their physical health is sending the audience a brochure that 
urges them to stop smoking and suggests specific methods, instructions, 
references, and resources that may be used to stop smoking.
•  An entity’s mission includes educating individuals in areas other than 
the causes, conditions, needs, or concerns that the entity’s programs 
are designed to address (referred to hereafter in this SOP as “causes”). 
For that entity, educating the audience in areas other than causes or 
motivating the audience to otherwise engage in specific activities that 
will educate them in areas other than causes is a call for specific action 
by the audience that will help accomplish the entity’s mission. Exam­
ples of entities whose mission includes educating individuals in areas 
other than causes are universities and possibly other entities. An 
example of an activity motivating individuals to engage in education in 
areas other than causes is a university inviting individuals to attend a 
lecture or class in which the individuals will learn about the solar system.
•  Educating the audience about causes or motivating the audience to 
otherwise engage in specific activities that will educate them about 
causes is not a call for specific action by the audience that will help 
accomplish the entity’s mission. Such activities are considered in 
support of fund raising. (However, some educational activities that 
might otherwise be considered as educating the audience about causes 
may implicitly call for specific action by the audience that will help 
accomplish the entity’s mission. For example, activities that educate 
the audience about environmental problems caused by not recycling 
implicitly call for that audience to increase recycling. I f  the need for 
and benefits of the specific action are clearly evident from the educa­
tional message, the message is considered to include an implicit call 
for specific action by the audience that will help accomplish the entity’s 
mission.)
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•  Asking the audience to make contributions is not a call for specific 
action by the audience that will help accomplish the entity’s mission.
I f  the activity calls for specific action by the audience that will help accomplish 
the entity’s mission, the guidance in paragraph 10 should also be considered in 
determining whether the purpose criterion is met.
10. Program and management and general functions. The following fac­
tors should be considered, in the order in which they are listed,5 to determine 
whether the purpose criterion is met:
a. Whether compensation or fees for performing the activity are based 
on contributions raised. The purpose criterion is not met if a major­
ity of compensation or fees for any party’s performance of any 
component of the discrete joint activity varies based on contribu­
tions raised for that discrete joint activity.6, 7
b. Whether a similar program or management and general activity is 
conducted separately and on a similar or greater scale. The pur­
pose criterion is met if  either of the following two conditions is met:
(1) Condition 1:
— The program component of the joint activity calls for 
specific action by the recipient that will help accomplish 
the entity’s mission and
— A  similar program component is conducted without the 
fund-raising component using the same medium and on 
a scale that is similar to or greater than the scale on which 
it is conducted with the fund raising.8
(2) Condition 2:
A management and general activity that is similar to the man­
agement and general component of the joint activity being ac­
counted for is conducted without the fund-raising component 
using the same medium and on a scale that is similar to or 
greater than the scale on which it is conducted with the fund 
raising.
5 In considering the guidance in paragraph 10, the factor in paragraph 10a (the compensation 
or fees test) is the preeminent guidance. I f  the factor in paragraph 10a is not determinative, the factor 
in paragraph 10b (whether a similar program or management and general activity is conducted 
separately and on a similar or greater scale) should be considered. If the factor in paragraph 10b is 
not determinative, the factor in paragraph 10c (other evidence) should be considered.
6 Some compensation contracts provide that compensation for performing the activity is based 
on a factor other than contributions raised, but not to exceed a specified portion of contributions 
raised. For example, a contract may provide that compensation for performing the activity is $10 per 
contact hour, but not to exceed 60 percent of contributions raised. In such circumstances, compensa­
tion is not considered based on amounts raised, unless the stated maximum percentage is met. In 
circumstances in which it is not yet known whether the stated maximum percentage is met, 
compensation is not considered based on amounts raised, unless it is probable that the stated 
maximum percentage will be met.
7 The compensation or fees test is a negative test in that it either (a) results in failing the 
purpose criterion or (b) is not determinative of whether the purpose criterion is met. Therefore, if the 
activity fails the purpose criterion based on this factor (the compensation or fees test), the activity 
fails the purpose criterion and the factor in paragraph 10b should not be considered. If the purpose 
criterion is not failed based on this factor, this factor is not determinative of whether the purpose 
criterion is met and the factor in paragraph 10b should be considered.
8 Determining the scale on which an activity is conducted may be a subjective determination. 
Factors to consider in determining the scale on which an activity is conducted may include dollars 
spent, the size of the audience reached, and the degree to which the characteristics of the audience 
are similar to the characteristics of the audience of the activity being evaluated.
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I f  the purpose criterion is met based on the factor in paragraph 10b, 
the factor in paragraph 10c should not be considered.
c. Other evidence. I f  the factors in paragraph 10a or 10b do not deter­
mine whether the purpose criterion is met, other evidence may 
determine whether the criterion is met. All available evidence, both 
positive and negative, should be considered to determine whether, 
based on the weight of that evidence, the purpose criterion is met.
11. The following are examples of indicators that provide evidence for 
determining whether the purpose criterion is met:
a. Evidence that the purpose criterion may be met includes—
•  Measuring program results and accomplishments of the activity. 
The facts may indicate that the purpose criterion is met if  the 
entity measures program results and accomplishments of the 
activity (other than measuring the extent to which the public 
was educated about causes).
•  Medium. The facts may indicate that the purpose criterion is 
met if the program component of the joint activity calls for 
specific action by the recipient that will help accomplish the 
entity’s mission and if  the entity conducts the program compo­
nent without a significant fund-raising component in a different 
medium. Also, the facts may indicate that the purpose criterion 
is met if  the entity conducts the management and general 
component of the joint activity without a significant fund-raising 
component in a different medium.
b. Evidence that the purpose criterion may not be met includes—
•  Evaluation or compensation. The facts may indicate that the 
purpose criterion is not met if (a) the evaluation of any party’s 
performance of any component of the discrete joint activity 
varies based on contributions raised for that discrete joint activ­
ity or (b) some, but less than a majority, of compensation or fees 
for any party’s performance of any component of the discrete 
joint activity varies based on contributions raised for that dis­
crete joint activity.
c. Evidence that the purpose criterion may be either met or not met 
includes—
•  Evaluation of measured results of the activity. The entity may 
have a process to evaluate measured program results and accom­
plishments of the activity (other than measuring the extent to 
which the public was educated about causes). I f  the entity has 
such a process, in evaluating the effectiveness of the joint activ­
ity, the entity may place significantly greater weight on the 
activity’s effectiveness in accomplishing program goals or may 
place significantly greater weight on the activity’s effectiveness 
in raising contributions. The former may indicate that the pur­
pose criterion is met. The latter may indicate that the purpose 
criterion is not met.
•  Qualifications. The qualifications and duties of those perform­
ing the joint activity should be considered.
— I f  a third party, such as a consultant or contractor, per­
forms part or all of the joint activity, such as producing 
brochures or making telephone calls, the third party’s 
experience and the range of services provided to the entity
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should be considered in determining whether the third 
party is performing fund-raising, program (other than 
educating the public about causes), or management and 
general activities on behalf of the entity.
— I f  the entity’s employees perform part or all of the joint 
activity, the full range of their job duties should be consid­
ered in determining whether those employees are perform­
ing fund-raising, program (other than educating the public 
about causes), or management and general activities on 
behalf of the entity. For example, (a) employees who are 
not members of the fund-raising department and (b) em­
ployees who are members of the fund-raising department 
but who perform non-fund-raising activities are more 
likely to perform activities that include program or man­
agement and general functions than are employees who 
otherwise devote significant time to fund raising.
•  Tangible evidence of intent. Tangible evidence indicating the
intended purpose of the joint activity should be considered.
Examples of such tangible evidence include
— The entity’s written mission statement, as stated in its 
fund-raising activities, bylaws, or annual report.
— Minutes of board of directors’, committees’, or other meetings.
— Restrictions imposed by donors (who are not related par­
ties) on gifts intended to fund the joint activity.
— Long-range plans or operating policies.
— Written instructions to other entities, such as script writ­
ers, consultants, or list brokers, concerning the purpose of 
the joint activity, audience to be targeted, or method of 
conducting the joint activity.
— Internal management memoranda.
Audience
12. A  rebuttable presumption exists that the audience criterion is not met 
i f  the audience includes prior donors or is otherwise selected based on its ability 
or likelihood to contribute to the entity. That presumption can be overcome if 
the audience is also selected for one or more of the reasons in paragraph 13a, 
13b, or 13c. In determining whether that presumption is overcome, entities 
should consider the extent to which the audience is selected based on its ability 
or likelihood to contribute to the entity and contrast that with the extent to 
which it is selected for one or more of the reasons in paragraph 13a, 13b, or 13c. 
For example, i f  the audience’s ability or likelihood to contribute is a significant 
factor in its selection and it has a need for the action related to the program 
component of the joint activity, but having that need is an insignificant factor 
in its selection, the presumption would not be overcome.
13. In circumstances in which the audience includes no prior donors and 
is not otherwise selected based on its ability or likelihood to contribute to the 
entity, the audience criterion is met if  the audience is selected for one or more 
of the following reasons:
a. The audience’s need to use or reasonable potential for use of the 
specific action called for by the program component of the joint activity
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b. The audience’s ability to take specific action to assist the entity in 
meeting the goals of the program component of the joint activity
c. The entity is required to direct the management and general compo­
nent of the joint activity to the particular audience or the audience 
has reasonable potential for use of the management and general 
component
Content
14. The content criterion is met if  the joint activity supports program or 
management and general functions, as follows:
a. Program. The joint activity calls for specific action by the recipient 
that will help accomplish the entity’s mission. I f  the need for and 
benefits of the action are not clearly evident, information describing 
the action and explaining the need for and benefits of the action is 
provided.
b. Management and general. The joint activity fulfills one or more of 
the entity’s management and general responsibilities through a 
component of the joint activity.9
15. Information identifying and describing the entity, causes, or how the 
contributions provided will be used is considered in support of fund raising.
Allocation Methods
16. The cost allocation methodology used should be rational and system­
atic, it should result in an allocation of joint costs that is reasonable, and it 
should be applied consistently given similar facts and circumstances.
Incidental Activities
17. Some fund-raising activities conducted in conjunction with program 
or management and general activities are incidental to such program or 
management and general activities. For example, an entity may conduct a 
fund-raising activity by including a generic message, “Contributions to Organi­
zation X may be sent to [address]” on a small area of a message that would 
otherwise be considered a program or management and general activity based 
on its purpose, audience, and content. That fund-raising activity likely would 
be considered incidental to the program or management and general activity 
being conducted. Similarly, entities may conduct program or management and 
general activities in conjunction with fund-raising activities that are incidental 
to such fund-raising activities. For example, an entity may conduct a program 
activity by including a generic program message such as “Continue to pray for 
[a particular cause]” on a small area of a message that would otherwise be 
considered fund raising based on its purpose, audience, and content. That 
program activity would likely be considered incidental to the fund-raising 
activity being conducted. Similarly, an entity may conduct a management and 
general activity by including a brief management and general message—“We
9 Some states or other regulatory bodies require that certain disclosures be included when 
soliciting contributions. For purposes of applying the guidance in this SOP, communications that 
include such required disclosures are considered fund-raising activities and are not considered 
management and general activities.
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recently changed our phone number. Our new number is 123-4567”—on a 
small area of a message that would otherwise be considered a program or 
fund-raising activity based on its purpose, audience, and content. That man­
agement and general activity would likely be considered incidental to the 
program or fund-raising activity being conducted. In circumstances in which a 
fund-raising, program, or management and general activity is conducted in 
conjunction with another activity and is incidental to that other activity, and 
the conditions in this SOP for allocation are met, joint costs are permitted but 
not required to be allocated and may therefore be charged to the functional 
classification related to the activity that is not the incidental activity. However, 
in circumstances in which the program or management and general activities 
are incidental to the fund-raising activities, it is unlikely that the conditions 
required by this SOP to permit allocation of joint costs would be met.
Disclosures
18. Entities that allocate joint costs should disclose the following in the 
notes to their financial statements:
a. The types of activities for which joint costs have been incurred
b. A  statement that such costs have been allocated
c. The total amount allocated during the period and the portion allo­
cated to each functional expense category
19. This SOP encourages, but does not require, that the amount of joint 
costs for each kind of joint activity be disclosed, i f practical.
Effective Date
20. This SOP is effective for financial statements for years beginning on 
or after December 15, 1998. Earlier application is encouraged in fiscal years for 
which financial statements have not been issued. I f  comparative financial 
statements are presented, retroactive application is permitted but not required.
The provisions of this Statement of Position need 
_______ not be applied to immaterial items._______
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APPENDIX A
Accounting for Joint Activities10
10 N ote: This flowchart sum m arizes certain guidance in th is SOP and is not intended as a 
substitu te  for the  SOP.
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APPENDIX B 
Background
B.1. As stated in paragraph 4, the provisions of Statement of Position 
(SOP) 87-2, Accounting for Joint Costs of Informational Materials and Activities 
of Not-for-Profit Organizations That Include a Fund-Raising Appeal, have been 
difficult to implement and applied inconsistently in practice. That difficulty has 
been due in part to the following:
•  The second sentence of paragraph 1 of SOP 87-2 stated that “some 
of the costs incurred by such organizations are clearly identifiable 
with fundraising, such as the cost of fund-raising consulting serv­
ices.” It is unclear whether activities that would otherwise be 
considered program activities should be characterized as program 
activities i f  they are performed or overseen by professional fund 
raisers. Also, it is unclear whether activities would be reported 
differently (for example, as program rather than fund raising) 
depending on whether the fund-raising consultant is compensated 
by a predetermined fee or by some other method, such as a percent­
age of contributions raised.
•  SOP 87-2 was unclear about whether allocation of costs to fund­
raising expense is required i f  the activity for which the costs were 
incurred would not have been undertaken without the fund-raising 
component.
•  SOP 87-2 defined joint costs through examples, and it is therefore 
unclear what kinds of costs were covered by SOP 87-2. For example, 
it is unclear whether salaries and indirect costs can be joint costs.
•  Some believe the guidance in SOP 87-2 was inadequate to determine 
whether joint activities, such as those that request contributions and 
also list the warning signs of a disease, are designed to motivate their 
audiences to action other than to provide contributions to the entity. 
It is unclear what attributes the targeted audience should possess in 
order to conclude that a program function is being conducted.
B.2. In 1992, the Accounting Standards Executive Committee (AcSEC) 
undertook a project to supersede SOP 87-2, to provide clearer guidance than 
that provided by SOP 87-2, as well as to provide guidance that would improve 
on the guidance in SOP 87-2. In September 1993, AcSEC released an exposure 
draft of a proposed SOP, Accounting for Costs of Materials and Activities of 
Not-for-Profit Organizations and State and Local Governmental Entities That 
Include a Fund-Raising Appeal, for public comment. AcSEC received more than 
300 comment letters on the exposure draft. AcSEC redeliberated the issues 
based on the comments received.
B.3. In 1996, after redeliberating the issues based on the comments re­
ceived and making certain revisions to the draft SOP, AcSEC conducted a field 
test of the draft SOP. The objectives of the field test were to determine whether 
the provisions of the draft SOP were sufficiently clear and definitive to generate 
consistent and comparable application of the SOP. Based on the field test 
results, AcSEC concluded that the provisions of the draft SOP, with certain 
revisions, were sufficiently clear and definitive to generate consistent and 
comparable application of the SOP.
B.4. Some respondents who commented on the exposure draft, as well as 
some interested parties who followed the project through its due process sub­
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sequent to the exposure draft, commented that the SOP should be reexposed 
for public comment. Reasons cited include:
•  Approximately three years had passed between the end of the com­
ment period and AcSEC’s decision to issue the SOP.
•  AcSEC made significant revisions to the SOP subsequent to releasing 
the exposure draft for comment.
Considering whether a proposed standard should be reexposed for public 
comment is inherently a subjective process. Factors that AcSEC considered 
include—
•  The significance of changes made to the exposure draft and whether 
those changes result in guidance that the public did not have an 
opportunity to consider.
•  Whether the scope was revised in such a way that affected entities did 
not have an opportunity to comment.
•  New information about or changes in the nature of the transactions 
being considered, practice, or other factors.
AcSEC believes that the length of time between exposure and final issuance is 
not pertinent to whether the SOP should be reexposed for public comment.
B.5. Based on consideration of the factors identified, AcSEC believes that 
the SOP should not be reexposed for public comment. AcSEC notes that 
although the SOP has been revised based on comments received on the expo­
sure draft, those revisions do not change the overall model in the SOP. Those 
revisions were made primarily to clarify the SOP and improve its operational­
ity. Further, AcSEC believes that the project received a high level of attention 
from interested parties. AcSEC provided working drafts to interested parties 
and those parties provided input throughout the process, up to and including 
the Financial Accounting Standard Board’s and the Governmental Accounting 
Standards Board’s clearance of the SOP for issuance.
B.6. Appendix C discusses the key issues in the exposure draft and com­
ments received on those issues, as well as the basis for AcSEC’s conclusions on 
those and certain other issues.
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APPENDIX C 
Basis for Conclusions
C.1. This section discusses considerations that were deemed significant by 
members of the Accounting Standards Executive Committee (AcSEC) in reach­
ing the conclusions in this Statement of Position (SOP). It includes reasons for 
accepting certain views and rejecting others. Individual AcSEC members gave 
greater weight to some factors than to others.
Overall Framework
C.2. This SOP uses the model in SOP 87-2, Accounting for Joint Costs of 
Informational Materials and Activities of Not-for-Profit Organizations That 
Include a Fund-Raising Appeal, as a starting point and clarifies guidance that 
was unclear, provides more detailed guidance, revises some guidance, and 
expands the scope of costs covered to include all costs of joint activities. The 
model established by SOP 87-2 was to account for joint costs as fund raising 
unless an entity could demonstrate that a program or management and general 
function had been conducted. SOP 87-2 used verifiable indications of the 
reasons for conducting the activity, such as content, audience, the action 
requested, i f  any, and other corroborating evidence as a basis for determining 
whether a program or management and general function had been conducted.
C.3. On an overall basis, the majority of respondents who commented on 
the September 1993 exposure draft of a proposed SOP, Accounting for Costs of 
Materials and Activities of Not-for-Profit Organizations and State and Local 
Governmental Entities That Include a Fund-Raising Appeal, opposed it, for 
various reasons, including the following:
•  The guidance in SOP 87-2 is operational, results in sound financial 
reporting, and should be retained.
•  The guidance in SOP 87-2 should be retained but clarified.
•  The guidance proposed in the exposure draft should be revised. (Some 
commented that it overstates fund raising; others commented that it 
understates fund raising.)
C.4. AcSEC concluded that it supports the model in the exposure draft, 
subject to certain revisions. AcSEC believes that this SOP provides clear, 
detailed accounting guidance that, when applied, will increase comparability 
of financial statements. Those statements will also include more meaningful 
disclosures without incurring increased costs.
C.5. Some respondents commented that the model in the exposure draft 
would adversely affect entities both financially and operationally. Various 
reasons were given, including the following:
•  It would inhibit the ability of entities, particularly small entities and 
entities that raise contributions through direct solicitations, to gener­
ate the necessary revenue to perform their program services.
•  Most entities would not meet the criteria in this SOP for reporting 
costs of joint activities as program or management and general, 
because they must combine their mission statements, public informa­
tion and education, and fund-raising appeals due to a lack of resources. 
Some noted that this may result in unsatisfactory ratings from public 
watchdog groups.
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AcSEC did not find these arguments compelling. This SOP provides accounting 
guidance; it provides no guidance concerning how entities should undertake 
their activities. Also, this SOP does not prohibit allocation merely because 
activities carrying out different functions are combined. In fact, this SOP 
provides guidance for reporting costs as program or management and general 
in circumstances in which those activities are combined with fund-raising. 
Moreover, actions taken by financial statement users are not the direct result 
of the requirements of this SOP. Rather, those actions may result from more 
relevant and useful information on which to base decisions.
C.6. Some respondents commented that the exposure draft is biased to­
ward reporting expenses as fund raising. AcSEC believes that determining 
whether the costs of joint activities should be classified as program, manage­
ment and general, or fund raising sometimes is difficult, and such distinctions 
sometimes are subject to a high degree of judgment. AcSEC believes that 
external financial statement users focus on and have perceptions about 
amounts reported as program, management and general, and fund raising. 
That focus and those perceptions provide incentives for entities to report 
expenses as program or management and general rather than fund raising. 
Therefore, in circumstances in which joint activities are conducted, a presump­
tion exists that expenses should be reported as fund raising rather than as 
program or management and general. The criteria in this SOP provide guidance 
for entities to overcome that presumption.
Accounting for Joint Activities
C.7. This SOP requires that if any of the criteria of purpose, audience, and 
content are not met, all costs of the activity should be reported as fund raising, 
including costs that otherwise might be considered program or management 
and general costs if they had been incurred in a different activity, subject to the 
exception in the following sentence. Costs of goods or services provided in 
exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event (for example, a meal), should not be reported 
as fund raising. (This SOP expands on the model established by SOP 87-2 by 
including all costs of joint activities other than costs of goods or services 
provided in exchange transactions, rather than merely joint costs.) AcSEC 
believes that the criteria of purpose, audience, and content are each relevant 
in determining whether a joint activity should be reported as fund raising, 
program, or management and general because each provides significant evi­
dence about the benefits expected to be obtained by undertaking the activity.
C.8. Some respondents commented that reporting costs that otherwise 
might be considered program or management and general costs if  they had been 
incurred in a different activity as fund raising is misleading and that the scope 
of the SOP should include only joint costs of joint activities. Some commented 
that reporting costs that otherwise might be considered program or manage­
ment and general costs if  they had been incurred in a different activity as fund 
raising conflicts with Financial Accounting Standards Board (FASB) State­
ment of Financial Accounting Standards No. 117, Financial Statements of 
Not-for-Profit Organizations, which defines fund raising, program, and man­
agement and general and requires not-for-profit organizations (NPOs) to report 
information about expenses using those functional classifications.
C.9. AcSEC believes that the purpose for which costs other than joint 
costs are incurred may be fund raising, program, or management and general,
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depending on the context in which they are used in the activity undertaken. 
For example, a program-related pamphlet may be sent to an audience in need 
of the program. In that context, the pamphlet is used for program purposes. 
However, in order to demonstrate to potential donors that the entity’s programs 
are worthwhile, that same pamphlet may be sent to an audience that is likely 
to contribute, but that has no need or reasonable potential for use of the 
program. In that context, the pamphlet is used for fund raising. AcSEC believes 
this broader scope will result in more comparability and more meaningful 
financial reporting by covering all costs of activities that include fund raising 
and by assigning those costs to the function for which they are incurred, 
consistent with the guidance in Statement No. 117.
C.10. AcSEC believes that costs of goods or services provided in exchange 
transactions should not be charged to fund raising because those costs are 
incurred in exchange for revenues other than contributions.
Criteria of Purpose, Audience, and Content 
Call For Action
C.11. The definition of program in FASB Statement No. 117 includes 
public education. As noted in paragraph C.6, AcSEC believes that in circum­
stances in which joint activities are conducted, a presumption exists that 
expenses should be reported as fund raising rather than as program or man­
agement and general. AcSEC believes that in order to overcome that presump­
tion, it is not enough that (a) the purpose of the activity include educating the 
public about causes, (b) the audience has a need or reasonable potential for use 
of any educational component of the activity pertaining to causes, or (c) the 
audience has the ability to assist the entity in meeting the goals of the program 
component of the activity by becoming educated about causes. Therefore, 
AcSEC concluded that for purposes of this SOP, in order to conclude that the 
criteria of purpose, audience, and content are met program activities are 
required to call for specific action by the recipient (other than becoming 
educated about causes) that will help accomplish the entity’s mission. As 
discussed in paragraph 9, in certain circumstances educational activities may 
call for specific action by the recipient that will help accomplish the entity’s 
mission.
Purpose
C.12. AcSEC believes meeting the purpose criterion demonstrates that the 
purpose of the activity includes accomplishing program or management and 
general functions. Inherent in the notion of a joint activity is that the activity 
has elements of more than one function. Accordingly, the purpose criterion 
provides guidance for determining whether the purpose of the activity includes 
accomplishing program or management and general functions in addition to 
fund raising.
Compensation and Evaluation Tests
C.13. The exposure draft proposed that all costs of the joint activity should 
be charged to fund raising if  (a) substantially all compensation or fees for 
performing the activity are based on amounts raised or (b) the evaluation of the 
party performing the activity is based on amounts raised. Some respondents 
commented that basing the method of compensation or evaluating the performance
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of the party performing the activity based on contributions raised should 
not lead to the conclusion that all costs of the activity should be charged to 
fund raising. Others commented that the method of compensation is unre­
lated to whether the purpose criterion is met. The reasons given included 
the following:
•  It is counterintuitive to imply that those performing multipurpose 
activities that include fund raising would not be compensated or 
evaluated based on amounts raised.
•  Such guidance would create a bias toward entities that use employees 
to raise contributions and against entities that hire professional fund 
raisers and public relations firms and is therefore not neutral.
Some respondents gave examples of circumstances in which substantially all 
compensation is based on contributions raised and asserted that the activity 
was nevertheless a program activity. In each of those examples, AcSEC consid­
ered all the facts presented and concluded that the activity was fund raising.
C.14. AcSEC continues to support the spirit of the proposed guidance, 
because AcSEC believes that basing a majority of compensation on funds raised 
is persuasive evidence that the activity is a fund-raising activity. Nevertheless, 
AcSEC believes that the proposed guidance was unclear and would be difficult 
to implement, primarily because of the broad definition of “based on contribu­
tions raised” included in the glossary of the exposure draft. In connection with 
that issue, AcSEC was concerned that any joint activities performed by a 
fund-raising department or by individuals whose duties include fund raising, 
such as executive officers of small NPOs who are employed based on their 
ability to raise contributions, would be required to be reported as fund raising 
because the compensation of the parties performing those activities is based on 
amounts raised. Also, AcSEC had concerns that it would be difficult to deter­
mine whether fixed contract amounts were negotiated based on expected 
contributions. Therefore, AcSEC concluded that the compensation test should 
be revised to provide that the purpose criterion is not met if  a majority of 
compensation or fees for any party’s performance of any component of the 
discrete joint activity varies based on contributions raised for that discrete joint 
activity. AcSEC believes that guidance is sound and is operational.
C.15. AcSEC believes that the guidance in paragraph 10a is not biased 
against entities that hire professional fund raisers, because it applies to the 
entity’s employees as well as professional fund raisers. For example, if a 
majority of an employee’s compensation or fees for performing a component of 
a discrete joint activity varies based on contributions raised for that discrete 
joint activity, the purpose criterion is not met.
Similar Function-Similar Medium Test
C.16. Some respondents misinterpreted the exposure draft as providing 
that, in order to meet the purpose criterion, the program or management and 
general activity must be conducted without the fund-raising component, using 
the same medium and on a scale that is similar to or greater than the program 
or management and general component of the activity being accounted for. That 
was not a requirement proposed by the exposure draft. The exposure draft 
proposed that meeting that condition would result in meeting the purpose 
criterion. Failing the criterion merely leads to consideration of other evidence, 
such as the indicators in paragraph 11. AcSEC has revised the SOP to state 
this more clearly.
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C.17. The compensation test and the similar function-similar medium 
test may not always be determinative because the attributes that they con­
sider may not be present. Therefore, this SOP includes indicators that should 
be considered in circumstances in which the compensation test and the similar 
function-similar medium test are not determinative. The nature of those 
indicators is such that they may be present in varying degrees. Therefore, all 
available evidence, both positive and negative, should be considered to deter­
mine whether, based on the weight of that evidence, the purpose criterion is 
met.
Audience
C.18. The exposure draft proposed that if the audience for the materials or 
activities is selected principally on its ability or likelihood to contribute, the 
audience criterion is not met and all the costs of the activity should be charged 
to fund raising. Further, the exposure draft proposed that if the audience is 
selected principally based on its need for the program or because it can assist 
the entity in meeting its program goals other than by financial support provided 
to the entity, the audience criterion is met. Some respondents commented that 
that audience criterion is too narrow, because it is based on the principal reason 
for selecting the audience. They asserted that for some activities no principal 
reason exists for selecting an audience; entities select the audience for those 
activities for multiple reasons, such as both the audience’s ability to contribute 
and its ability to help meet program goals. Some commented that for some 
activities, entities select audiences that have provided past financial support 
because, by providing financial support, those audiences have expressed an 
interest in the program.
C.19. AcSEC believes that meeting the audience criterion should demon­
strate that the audience is selected because it is a suitable audience for 
accomplishing the activity’s program or management and general functions. 
Therefore, the reasons for selecting the audience should be consistent with the 
program or management and general content of the activity. However, AcSEC 
believes it is inherent in the notion of joint activities that the activity has 
elements of more than one function, including fund raising, and acknowledges 
that it may be difficult to determine the principal reason for selecting the 
audience. Accordingly, AcSEC concluded that if the audience includes prior 
donors or is otherwise selected based on its ability or likelihood to contribute, 
a rebuttable presumption should exist that the audience was selected to raise 
funds. AcSEC believes that the reasons for selecting the audience that can 
overcome that presumption, which are included in paragraph 13 of this SOP, 
demonstrate that the audience is selected because it is a suitable audience for 
accomplishing the activity’s program or management and general functions 
based on the program or management and general content of the activity.
Content
C.20. AcSEC believes that meeting the content criterion demonstrates that 
the content of the activity supports program or management and general 
functions. AcSEC believes that accounting guidance should not impose value 
judgments about whether the entity’s mission, programs, and responsibilities 
are worthwhile. Therefore, whether the content criterion is met depends on the 
relationship of the content to the entity’s mission, programs, and management 
and general responsibilities.
Other Evidence
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C.21. Paragraph 14 provides that, to meet the content criterion, program 
activities should call for specific action by the recipient that will help accom­
plish the entity’s mission. The exposure draft proposed that slogans, general 
calls to prayer, and general calls to protest do not meet the content criterion; 
some respondents disagreed. AcSEC concluded that this SOP should be silent 
concerning whether slogans, general calls to prayer, and general calls to protest 
are calls to action that meet the content criterion. AcSEC believes that deter­
mining whether those items are calls to action that meet the content criterion 
requires judgments based on the particular facts and circumstances.
C.22. Some respondents commented that educating the public about 
causes without calling for specific action should satisfy the content criterion. 
They noted that this is particularly relevant for NPOs subject to Internal 
Revenue Code (IRC) Section 501(c)4, because those NPOs are involved in 
legislative reform. Also, some noted that it may be the entity’s mission or goal 
to educate the public about causes. They believe that, in those cases, the NPO’s 
program is to educate the public about causes without necessarily calling for 
specific action by the recipient.
C.23. As discussed in paragraph C.11, AcSEC concluded that education 
that does not motivate the audience to action is in fact done in support of fund 
raising. However, this SOP acknowledges that some educational messages 
motivate the audience to specific action, and those messages meet the content 
criterion. AcSEC believes that that provision will result in the activities of some 
NPOs subject to IRC Section 501(c)4 (and some other entities, whose mission 
or goal is to educate the public) meeting the content criterion.
C.24. Paragraph 13c provides that one way that the audience criterion is 
met is i f  the entity is required to direct the management and general component 
of the activity to the particular audience. Further, as discussed in paragraph
D.13, in Discussion of Conclusions, an audience that includes prior donors and 
is selected because the entity is required to send them certain information to 
comply with requirements of the Internal Revenue Service (IRS) is an example 
of an audience that is selected because the entity is required to direct the 
management and general component of the activity to that audience. Para­
graph 146 provides that one way that the content criterion is met is i f  the 
activity fulfills one or more of the entity’s management and general responsi­
bilities through a component of the joint activity. However, footnote 9 to 
paragraph 146 provides that disclosures made when soliciting contributions to 
comply with requirements of states or other regulatory bodies are considered 
fund-raising activities, and are not considered management and general activi­
ties. AcSEC considered whether it is inconsistent to conclude both that (a) 
activities conducted to comply with requirements of regulatory bodies concern­
ing contributions that have been received are management and general activi­
ties, and that (b) activities conducted to comply with requirements of regulatory 
bodies concerning soliciting contributions are fund-raising activities. AcSEC 
believes that those provisions are not inconsistent. AcSEC believes there is a 
distinction between (a) requirements that must be met as a result of receiving 
contributions and (b) requirements that must be met in order to solicit contri­
butions. AcSEC believes that activities that are undertaken as a result of 
receiving contributions are management and general activities while activities 
that are undertaken in order to solicit contributions are fund-raising activities.
Incidental Activities
C.25. Many entities conduct fund-raising activities in conjunction with 
program or management and general activities that are incidental to such program
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or management and general activities. Similarly, entities may conduct program 
or management and general activities in conjunction with fund-raising activi­
ties that are incidental to such fund-raising activities. Such efforts may be a 
practical and efficient means for entities to conduct activities, although the 
principal purpose of the activity may be to fulfill either fund-raising, program, 
or management and general functions. The exposure draft proposed that 
incidental activities need not be considered in applying this SOP. Some respon­
dents disagreed with that guidance, while others commented that it was 
confusing. AcSEC continues to support that guidance. AcSEC believes that 
guidance is necessary to avoid requiring complex allocations in circumstances 
in which the criteria of purpose, audience, and content are met but the activity 
is overwhelmingly either fund raising, program, or management and general.
Allocation Methods
C.26. Respondents had various comments concerning allocation methods, 
including the following:
•  The SOP should focus on allocation methods rather than on circum­
stances in which entities should allocate.
•  The SOP should prescribe allocation methods.
•  The approach taken in the SOP—discussing, rather than requiring or 
prohibiting allocation methods—is sound.
•  Certain allocation methods should be prohibited.
•  The SOP should set maximum allocation percentages.
AcSEC believes that no particular allocation method or methods are necessarily 
more desirable than other methods in all circumstances. Therefore, this SOP 
neither prescribes nor prohibits any particular allocation methods. AcSEC 
believes entities should apply the allocation methods that result in the most 
reasonable cost allocations for their activities. Appendix F of this SOP illus­
trates several allocation methods, any one of which may result in a reasonable 
or unreasonable allocation of costs in particular circumstances. The methods 
illustrated are not the only acceptable methods. However, AcSEC believes that 
the methods illustrated in this SOP are among those most likely to result in 
meaningful cost allocations.
C.27. Accounting Principles Board (APB) Opinion No. 20, Accounting 
Changes, states in paragraph 7 that “the term accounting principle includes 
‘not only accounting principles and practices but also the methods of applying 
them.’” APB Opinion 20 also states in paragraphs 15 and 16 that
. . .  In the preparation of financial statements there is a presumption that an 
accounting principle once adopted should not be changed in accounting for 
events and transactions of a similar type . . . .  The presumption that an entity 
should not change an accounting principle may be overcome only if the enter­
prise justifies the use of an alternative acceptable accounting principle [alloca­
tion method] on the basis that it is preferable.
A change in cost allocation methodology may be a change in accounting 
principle for entities covered by this SOP. Accordingly, paragraph 16 of this 
SOP provides that the cost allocation methodology used should be applied 
consistently, given similar facts and circumstances.
Disclosures
C.28. Respondents made various comments concerning the required and 
encouraged disclosures, including recommendations for additional disclosures
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and recommendations that certain disclosures be deleted. AcSEC was not 
persuaded that the costs of the other disclosures recommended by respondents 
are justified by their benefits. AcSEC believes that, with the exception of one 
disclosure, the disclosures prescribed by the exposure draft provide relevant 
information about the kinds of activities for which joint costs have been 
incurred and the manner in which those costs are reported in the financial 
statements. In considering disclosures proposed by the exposure draft about 
the allocation method, AcSEC observed that there are no requirements to 
disclose methods of allocating other expenses and questioned the utility of 
disclosing the allocation method in this circumstance. AcSEC concluded that 
the requirement to disclose the allocation method should be deleted.
C.29. Paragraph 19 encourages, but does not require, certain disclosures. 
AcSEC believes those disclosures provide useful information but that they 
should be encouraged rather than required because the costs of making them 
may not be justified by the benefits in all cases.
Effective Date
C.30. Some respondents commented that the effective date should be 
deferred. AcSEC believes that the accounting systems required to implement 
this SOP are already in place and that implementation should be relatively 
straightforward. However, AcSEC acknowledges that some entities may 
change their operations based on the reporting that would result from this SOP. 
Therefore, AcSEC concluded that this SOP should be effective for financial 
statements for years beginning on or after December 15, 1998.
Cost-Benefit
C.31. Some respondents commented that the guidance would increase 
record keeping costs. AcSEC believes that implementing this SOP will not 
significantly increase record keeping costs, which are primarily the costs of 
documenting reasons for undertaking joint activities. Further, AcSEC believes 
that the costs of making the disclosures required by this SOP should be 
minimal, because entities should already have the information that is required 
to be disclosed. AcSEC believes that implementing this SOP will result in more 
relevant, meaningful, and comparable financial reporting and that the cost of 
implementing this SOP will be justified by its benefits.
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APPENDIX D
Discussion of Conclusions 
Scope
D.1. This Statement of Position (SOP) applies only to costs of joint activi­
ties. It does not address allocations of costs in other circumstances.
Reporting Models and Related Requirements
D.2. Paragraph 26 of Financial Accounting Standards Board (FASB) 
Statement of Financial Accounting Standards No. 117, Financial Statements 
of Not-for-Profit Organizations, specifies that a statement of activities or notes 
to the financial statements should provide information about expenses reported 
by their functional classification, such as major classes of program services 
and supporting activities. Paragraph 13.35 of the AICPA Audit and Account­
ing Guide Not-for-Profit Organizations provides that the financial statements 
of not-for-profit organizations (NPOs) should disclose the total fund-raising 
expenses.
D.3. Governmental Accounting Standards Board (GASB) Statement No. 
29, The Use of Not-for-Profit Accounting and Financial Reporting Principles by 
Governmental Entities, provides that governmental entities should not change 
their accounting and financial reporting to apply the provisions of FASB 
Statements No. 116, Accounting for Contributions Received and Contributions 
Made, and No. 117. GASB Statement No. 29 permits governmental entities that 
have applied the accounting and financial reporting principles in SOP 78-10, 
Accounting Principles and Reporting Practices for Certain Nonprofit Organiza­
tions, or in the AICPA Industry Audit Guide Audits of Voluntary Health and 
Welfare Organizations* (modified by all applicable FASB pronouncements 
issued through November 30, 1989, and by most applicable GASB pronounce­
ments) to continue to do so, pending GASB pronouncements on the accounting 
and financial reporting model for governmental entities. Alternatively, those 
governmental entities are permitted to change to the current governmental 
financial reporting model.
* The AICPA Audit and Accounting Guides Audits o f Colleges and Universities, Audits of 
Voluntary Health and Welfare Organizations, and Audits o f Certain Nonprofit Organizations were 
superseded by the 1996 edition of the AICPA Audit and Accounting Guide Not-for-Profit Organiza­
tions. However, because the accounting guidance contained in these Guides remained applicable to 
certain governmental entities (pursuant to the provisions of GASB Statement Nos. 15, Governmental 
College and University Accounting and Financial Reporting Models, and 29, The Use o f Not-for-Profit 
Accounting and Financial Reporting Principles by Governmental Entities), the AICPA continued to 
make these Guides available for sale.
With the recent issuance of GASB Statement Nos. 34, Basic Financial Statements—and Management’s 
Discussion and Analysis—for State and Local Governments, and 35, Basic Financial Statements—and 
Management’s Discussion and Analysis—for Public Colleges and Universities, which supersede the 
effect of GASB Statement Nos. 15 and 29, it is no longer necessary for the AICPA to continue selling 
these Guides.
Accordingly, Audits o f Colleges and Universities, Audits o f Voluntary Health and Welfare Organiza­
tions, and Audits o f Certain Nonprofit Organizations will no longer be included as part of this 
loose-leaf publication.
Once the phased-in effective dates of the GASB Statements have occurred, the accounting guidance 
in these Guides will no longer be applicable to any governmental entities. Please note that the Guides 
have not been updated since 1994. Therefore, if you already have a Guide, and choose to continue 
using it until the phase-in period is complete, you must consider guidance issued since they were last 
updated.
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D.4. GASB Statement No. 15, Governmental College and University Ac­
counting and Financial Reporting Models, requires governmental colleges and 
universities to use one of two accounting and financial reporting models. One 
model, referred to as the “AICPA College Guide Model,” encompasses the 
accounting and financial reporting guidance in the 1973 AICPA Industry Audit 
Guide Audits of Colleges and Universities, as amended by SOP 74-8, Financial 
Accounting and Reporting by Colleges and Universities, and as modified by 
applicable FASB pronouncements issued through November 30, 1989, and all 
applicable GASB pronouncements. (The other model, referred to as the “Gov­
ernmental Model,” is based on the pronouncements of the National Council on 
Governmental Accounting [NCGA] and the GASB.)
D.5. For state and local governmental entities, some are required to report 
expenses by function using the functional classifications of program, manage­
ment and general, and fund raising. Other state and local governmental 
entities that report expenses or expenditures by function have a functional 
structure that does not include fund raising, program, or management and 
general. Still other state and local governmental entities do not report expenses 
or expenditures by function. Examples of those various reporting requirements 
are as follows:
•  Entities applying the accounting and financial reporting principles in 
the AICPA Industry Audit Guide Audits of Voluntary Health and 
Welfare Organizations,* as well as those that follow SOP 78-10 and 
that receive significant amounts of contributions from the public, are 
required to report separately the costs of the fund-raising, program, 
and management and general functions.
•  Entities applying the accounting and financial reporting principles in 
the AICPA Industry Audit Guide Audits of Colleges and Universities,* 
as amended by SOP 74-8, are required to report fund raising as part 
of the “institutional support” function.
D.6. As discussed in footnote 3 to paragraph 1 of this SOP, this SOP is not 
intended to require reporting the functional classifications of fund raising, 
program, and management and general. Rather, those functional classifica­
tions are discussed throughout this SOP for purposes of illustrating how the 
guidance in this SOP would be applied by entities that use those functional 
classifications. Entities that do not use the functional classifications of fund
* The AICPA Audit and Accounting Guides Audits o f Colleges and Universities, Audits of 
Voluntary Health and Welfare Organizations, and Audits o f Certain Nonprofit Organizations were 
superseded by the 1996 edition of the AICPA Audit and Accounting Guide Not-for-Profit Organiza­
tions. However, because the accounting guidance contained in these Guides remained applicable to 
certain governmental entities (pursuant to the provisions of GASB Statement Nos. 15, Governmental 
College and University Accounting and Financial Reporting Models, and 29, The Use o f Not-for-Profit 
Accounting and Financial Reporting Principles by Governmental Entities), the AICPA continued to 
make these Guides available for sale.
With the recent issuance of GASB Statement Nos. 34, Basic Financial Statements—and Management’s 
Discussion and Analysis—for State and Local Governments, and 35, Basic Financial Statements—and 
Management’s Discussion and Analysis—for Public Colleges and Universities, which supersede the 
effect of GASB Statement Nos. 15 and 29, it is no longer necessary for the AICPA to continue selling 
these Guides.
Accordingly, Audits o f Colleges and Universities, Audits o f Voluntary Health and Welfare Organiza­
tions, and Audits o f Certain Nonprofit Organizations will no longer be included as part of this 
loose-leaf publication.
Once the phased-in effective dates of the GASB Statements have occurred, the accounting guidance 
in these Guides will no longer be applicable to any governmental entities. Please note that the Guides 
have not been updated since 1994. Therefore, if you already have a Guide, and choose to continue 
using it until the phase-in period is complete, you must consider guidance issued since they were last 
updated.
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raising, program, and management and general should apply the guidance in 
this SOP for purposes of accounting for joint activities, using their reporting 
model. For example, some entities may conduct membership-development 
activities. As discussed in the Glossary of this SOP, if there are no significant 
benefits or duties connected with membership, the substance of the member­
ship-development activities may, in fact, be fund raising. In such circum­
stances, the costs of those activities should be charged to fund raising. To the 
extent that member benefits are received, membership is an exchange trans­
action. In circumstances in which membership development is in part soliciting 
revenues from exchange transactions and in part soliciting contributions and 
the purpose, audience, and content of the activity are appropriate for achieving 
membership development, joint costs should be allocated between fund raising 
and the exchange transaction.
Assigning Costs of Joint Activities
D.7. Paragraph 7 provides: “I f  the criteria of purpose, audience, and con­
tent are met, the costs of a joint activity that are identifiable with a particular 
function should be charged to that function and joint costs should be allocated 
between fund raising and the appropriate program or management and general 
function. I f  any of the criteria are not met, all costs of the joint activity should 
be reported as fund-raising costs, including costs that otherwise might be 
considered program or management and general costs if they had been incurred 
in a different activity. . . .” For example, i f  the criteria are met, the costs of 
materials that accomplish program goals and that are unrelated to fund 
raising, such as the costs of a program-related pamphlet included in a joint 
activity, should be charged to program, while joint costs, such as postage, should 
be allocated between fund raising and program. However, if the pamphlet is 
used in fund-raising packets and the criteria are not met, the costs of the 
pamphlets used in the fund-raising packets, as well as the joint costs, should 
be charged to fund raising. (I f  some pamphlets are used in program activities 
that include no fund raising, the cost of the pamphlets used in those separate 
program activities that include no fund raising should be charged to program.)
Educational Activities
D.8. Some entities have missions that include educating the public (stu­
dents) in areas other than causes. Paragraph 9 provides that, for those entities, 
educating the audience in areas other than causes or motivating the audience 
to engage in specific activities, such as attending a lecture or class, that will 
educate them in areas other than causes is considered a call for specific action 
by the recipients that will help accomplish the entity’s mission. Educating the 
audience about causes or motivating the audience to engage in specific activi­
ties that will educate them about causes without educating them in other 
subjects is not considered a call for specific action by the audience that will help 
accomplish the entity’s mission. An example of a lecture or class that will 
educate students in an area other than causes is a lecture on the nesting habits 
of the bald eagle, given by the Save the Bald Eagle Society, an NPO whose 
mission is to save the bald eagle from extinction and educate the public about 
the bald eagle. An example of a lecture or class that will address particular 
causes is a lecture by the Bald Eagle Society on the potential extinction of bald 
eagles and the need to raise contributions to prevent their extinction. For 
purposes of applying the guidance in this SOP, motivating the audience to 
attend a lecture on the nesting habits of the bald eagle is a call for specific action
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that will help accomplish the entity’s mission. I f  the lecture merely addresses 
the potential extinction of bald eagles and the need to raise contributions to 
prevent their extinction, without addressing the nesting habits of the bald 
eagle, motivating the audience to attend the lecture is not considered a call for 
specific action by the recipient that will help accomplish the entity’s mission.
D.9. AcSEC notes that most transactions in which a student attends a 
lecture or class are exchange transactions and are not joint activities. Such 
transactions are joint activities only if  the activity includes fund raising.
Audience
D.10. Paragraph 12 provides that a rebuttable presumption exists that the 
audience criterion is not met if  the audience includes prior donors or is 
otherwise selected based on its ability or likelihood to contribute to the entity. 
That presumption can be overcome i f  the audience is also selected for the 
program or management and general reasons specified in paragraph 13. 
Further, paragraph 12 provides that in determining whether that presumption 
is overcome, entities should consider the extent to which the audience is 
selected based on its ability or likelihood to contribute to the entity and contrast 
that with the extent to which it is selected for the reasons that may overcome 
that presumption. Some organizations conduct joint activities that are special 
events, such as symposia, dinners, dances, and theater parties, in which the 
attendee receives a direct benefit (for example, a meal or theater ticket) and 
for which the admission price includes a contribution. For example, it may cost 
$500 to attend a dinner with a fair value of $50. In that case, the audience is 
required to make a $450 contribution in order to attend. In circumstances in 
which the audience is required to make a contribution to participate in a joint 
activity, such as attending a special event, the audience’s ability or likelihood 
to contribute is a significant factor in its selection. Therefore, in circumstances 
in which the audience is required to make a contribution to participate in a joint 
activity, the extent to which the audience is selected for the program or manage­
ment and general reasons in paragraph 13 must be overwhelmingly signifi­
cant in order to rebut the presumption that the audience criterion is not met.
D.11. The source of the names and the characteristics of the audience 
should be considered in determining the reason for selecting the audience. 
Some entities use lists compiled by others to reach new audiences. The source 
of such lists may indicate the purpose or purposes for which they were selected. 
For example, lists acquired from entities with similar or related programs are 
more likely to meet the audience criterion than are lists acquired from entities 
with dissimilar or unrelated programs. Also, the characteristics of those on the 
lists may indicate the purpose or purposes for which they were selected. For 
example, a list based on a consumer profile of those who buy environmentally 
friendly products may be useful to an entity whose mission addresses environ­
mental concerns and could therefore indicate that the audience was selected 
for its ability to take action to assist the entity in meeting program goals. 
However, a list based on net worth would indicate that the audience was 
selected based on its ability or likelihood to contribute, unless there was a 
correlation between net worth and the program or management and general 
components of the activity.
D.12. Some audiences may be selected because they have an interest in or 
affinity to the program. For example, homeowners may have an interest in the 
homeless because they are sympathetic to the plight of the homeless. Never­
theless, including homeowners in the audience of a program activity to provide
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services to the homeless would not meet the audience criterion, because they 
do not have a need or reasonable potential for use of services to the homeless.
D.13. Paragraph 13c provides that the audience criterion is met if the 
entity is required to direct the management and general component of the joint 
activity to the particular audience or the audience has reasonable potential for 
use of the management and general component. An example of a joint activity 
in which the audience is selected because the entity is required to direct the 
management and general component of the joint activity to the particular 
audience is an activity in which the entity sends a written acknowledgment or 
other information to comply with requirements of the Internal Revenue Service 
to prior donors and includes a request for contributions. An example of a joint 
activity in which the audience is selected because the audience has reasonable 
potential for use of the management and general component is an activity in 
which the entity sends its annual report to prior donors and includes a request 
for contributions.
Content
D.14. Paragraph 14 provides that, to meet the content criterion, program 
activities should call for specific action by the recipient that will help accom­
plish the entity’s mission. As discussed in the Glossary, the action should 
benefit the recipient or society. Examples of actions that benefit the recipient 
(such as by improving the recipient’s physical, mental, emotional, or spiritual 
health and well-being) or society (such as by addressing societal problems) 
include the following:
а. Actions that benefit the recipient:
•  Stop smoking. Specific methods, instructions, references, and 
resources should be suggested.
•  Do not use alcohol or drugs. Specific methods, instructions, 
references, and resources should be suggested.
b. Actions that benefit society:
•  Write or call. The party to communicate with and the subject 
matter to be communicated should be specified.
•  Complete and return the enclosed questionnaire. The results of 
the questionnaire should help the entity achieve its mission. For 
example, i f  the entity discards the questionnaire, it does not help 
the entity achieve its mission.
•  Boycott. The particular product or company to be boycotted 
should be specified.
D.15. Paragraph 146 provides that to meet the content criterion, manage­
ment and general functions are required to fulfill one or more of the entity’s 
management and general responsibilities through a component of the joint 
activity. Some states or other regulatory bodies require that certain disclosures 
be included when soliciting contributions. Paragraph 14, footnote 9, of this SOP 
provides that for purposes of applying the guidance in this SOP, communica­
tions that include such required disclosures are considered fund-raising activi­
ties and are not considered management and general activities. Some examples 
of such disclosures include the following:
•  Information filed with the attorney general concerning this charitable 
solicitation may be obtained from the attorney general of [the state] by 
calling 123-4567. Registration with the attorney general does not 
imply endorsement.
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•  A  copy of the registration and financial information may be obtained 
from the Division of Consumer Services by calling toll-free, within [the 
state], 1-800-123-4567. Registration does not imply endorsement, ap­
proval, or recommendation by [the state].
•  Information about the cost of postage and copying, and other informa­
tion required to be filed under [the state] law, can be obtained by calling 
123-4567.
•  The organization’s latest annual report can be obtained by calling 
123-4567.
Allocation Methods
D.16. Paragraph 16 of this SOP states, “The cost allocation methodology 
used should be rational and systematic, it should result in an allocation of joint 
costs that is reasonable, and it should be applied consistently given similar facts 
and circumstances.” The allocation of joint costs should be based on the degree 
to which costs were incurred for the functions to which the costs are allocated 
(that is, program, management and general, or fund raising). For purposes of 
determining whether the allocation methodology for a particular joint activity 
should be consistent with methodologies used for other particular joint activi­
ties, facts and circumstances that may be considered include factors related to 
the content and relative costs of the components of the activity. The audience 
should not be considered in determining whether the facts and circumstances 
are similar for purposes of determining whether the allocation methodology for 
a particular joint activity should be consistent with methodologies used for 
other particular joint activities.
Practicability of Measuring Joint Costs
D.17. The Glossary of this SOP includes a definition of joint costs. Some 
costs, such as utilities, rent, and insurance, commonly referred to as indirect 
costs, may be joint costs. For example, the telephone bill for a department that, 
among other things, prepares materials that include both fund-raising and 
program components may commonly be referred to as an indirect cost. Such 
telephone bills may also be joint costs. However, for some entities, it is 
impracticable to measure and allocate the portion of the costs that are joint 
costs. Considerations about which joint costs should be measured and allocated, 
such as considerations about materiality and the costs and benefits of develop­
ing and providing the information, are the same as considerations about cost 
allocations in other circumstances.
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APPENDIX E
Illustrations of Applying the Criteria of Purpose, 
Audience, and Content to Determine Whether a 
Program or Management and General Activity 
Has Been Conducted
Illustration 1 
Facts
E.1. Entity A ’s mission is to prevent drug abuse. Entity A ’s annual report 
states that one of its objectives in fulfilling that mission is to assist parents in 
preventing their children from abusing drugs.
E.2. Entity A  mails informational materials to the parents of all junior high 
school students explaining the prevalence and dangers of drug abuse. The 
materials encourage parents to counsel children about the dangers of drug 
abuse and inform them about how to detect drug abuse. The mailing includes 
a request for contributions. Entity A  conducts other activities informing the 
public about the dangers of drug abuse and encouraging parents to counsel 
their children about drug abuse that do not include requests for contributions 
and that are conducted in different media. Entity A ’s executive director is 
involved in the development of the informational materials as well as the 
request for contributions. The executive director’s annual compensation in­
cludes a significant bonus if  total annual contributions exceed a predetermined 
amount.
Conclusion
E.3. The purpose, audience, and content criteria are met, and the joint costs 
should be allocated.
E.4. The activity calls for specific action by the recipient (encouraging parents 
to counsel children about the dangers of drug abuse and informing them about 
how to detect drug abuse) that will help accomplish the entity’s mission. There­
fore, the guidance in paragraph 10 should be considered. Neither of the factors 
in paragraph 10a or 10b is determinative of whether the purpose criterion is 
met. (Although Entity A ’s executive director’s annual compensation varies 
based on annual contributions, the executive director’s compensation does not 
vary based on contributions raised for this discrete joint activity.) Therefore, 
other evidence, such as the indicators in paragraph 11, should be considered. 
The purpose criterion is met based on the other evidence, because (a) the 
program component of this activity calls for specific action by the recipient 
(encouraging parents to counsel children about the dangers of drug abuse) that 
will help accomplish the entity’s mission, and it otherwise conducts the program 
activity in this illustration without a request for contributions, and (b) perform­
ing such programs helps accomplish Entity A’s mission. (Note that had Entity 
A  conducted the activity using the same medium on a scale that is similar to 
or greater than the scale on which it is conducted with the request for contri­
butions, the purpose criterion would have been met under paragraph 10b.)
E.5. The audience criterion is met because the audience (parents of junior 
high school students) is selected based on its need to use or reasonable potential 
for use of the action called for by the program component.
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E.6. The content criterion is met because the activity calls for specific 
action by the recipient (encouraging parents to counsel children about the 
dangers of drug abuse and informing them about how to detect drug abuse) that 
will help accomplish the entity’s mission (assisting parents in preventing their 
children from abusing drugs), and it explains the need for and benefits of the 
action (the prevalence and dangers of drug abuse).
Illustration 2 
Facts
E.7. Entity B’s mission is to reduce the incidence of illness from ABC 
disease, which afflicts a broad segment of the population. One of Entity B’s 
objectives in fulfilling that mission is to inform the public about the effects and 
early warning signs of the disease and specific action that should be taken to 
prevent the disease.
E.8. Entity B maintains a list of its prior donors and sends them donor 
renewal mailings. The mailings include messages about the effects and early 
warning signs of the disease and specific action that should be taken to prevent 
it. That information is also sent to a similar-sized audience but without the 
request for contributions. Also, Entity B believes that recent donors are more 
likely to contribute than nondonors or donors who have not contributed re­
cently. Prior donors are deleted from the mailing list if they have not contrib­
uted to Entity B recently, and new donors are added to the list. There is no 
evidence of a correlation between recent contributions and participation in the 
program component of the activity. Also, the prior donors’ need to use or 
reasonable potential for use of the messages about the effects and early warning 
signs of the disease and specific action that should be taken to prevent it is an 
insignificant factor in their selection.
Conclusion
E.9. The purpose and content criteria are met. The audience criterion is 
not met.11 All costs, including those that might otherwise be considered 
program or management and general costs if  they had been incurred in a 
different activity, should be charged to fund raising.
E.10. The activity calls for specific action by the recipient (action that 
should be taken to prevent ABC disease) that will help accomplish the entity’s 
mission. Therefore, the guidance in paragraph 10 should be considered. The 
purpose criterion is met because (a) the program component of the activity 
calls for specific action by the recipient that will help accomplish the entity’s 
mission (to reduce the incidence of illness from the disease), and (b) the program 
is also conducted using the same medium on a scale that is similar to or 
greater than the scale on which it is conducted with the request for contri­
butions (a similar mailing is done without the request for contributions, to a 
similar-sized audience).
11 Paragraph 7 of this SOP provides that all costs of joint activities, except for costs o f goods or 
services provided in exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event (for example, a meal), should be charged to fund raising if any of the 
criteria of purpose, audience, or content are not met. Accordingly, if one or more criteria are not met, 
the other criteria need not be considered. However, the illustrations in this Appendix provide 
conclusions about whether each of the criteria would be met in circumstances in which one or more 
criteria are not met in order to provide further guidance.
AAG-HCO APP C
Statement of Position 98-2 279
E.11. The audience criterion is not met. The rebuttable presumption that 
the audience criterion is not met because the audience includes prior donors is 
not overcome in this illustration. Although the audience has a need to use or 
reasonable potential for use of the program component, that was an insignifi­
cant factor in its selection.
E.12. The content criterion is met because the activity calls for specific 
action by the recipient (actions to prevent ABC disease) that will help accom­
plish the entity’s mission (to reduce the incidence of ABC disease), and it 
explains the need for and benefits of the action (to prevent ABC disease).
Illustration 3 
Facts
E.13. Entity C’s mission is to reduce the incidence of illness from ABC 
disease, which afflicts a broad segment of the population. One of Entity C’s 
objectives in fulfilling that mission is to increase governmental funding for 
research about ABC disease.
E.14. Entity C maintains a list of its prior donors and its employees call 
them on the telephone reminding them of the effects of ABC disease, asking for 
contributions, and encouraging them to contact their elected officials to urge 
increased governmental funding for research about ABC disease. The callers 
are educated about ABC, do not otherwise perform fund-raising functions, and 
are not compensated or evaluated based on contributions raised. Entity C’s 
research indicates that recent donors are likely to contact their elected officials 
about such funding while nonrecent donors are not. Prior donors are deleted 
from the calling list i f  they have not contributed to Entity C recently, and new 
donors are added to the list.
Conclusion
E.15. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated.
E.16. The activity calls for specific action by the recipient (contacting 
elected officials concerning funding for research about ABC disease) that will 
help accomplish the entity’s mission. Therefore, the guidance in paragraph 10 
should be considered. Neither of the factors in paragraph 10a or 10b is 
determinative of whether the purpose criterion is met. Therefore, other evi­
dence, such as the indicators in paragraph 11, should be considered. The 
purpose criterion is met based on the other evidence, because (a) the qualifica­
tions and duties of the personnel performing the activity indicate that it is a 
program activity (the callers are educated about ABC and do not otherwise 
perform fund-raising functions), (b) the method of compensation for performing 
the activity does not indicate that it is a fund-raising activity (the employees 
are not compensated or evaluated based on contributions raised), and (c) 
performing such programs helps accomplish Entity C’s mission.
E.17. The audience criterion is met because the audience (recent donors) 
is selected based on its ability to assist Entity C in meeting the goals of the 
program component of the activity (recent donors are likely to contact their 
elected officials about such funding while nonrecent donors are not).
E.18. The content criterion is met because the activity calls for specific 
action by the recipient (contacting elected officials concerning funding for re­
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search about ABC disease) that will help accomplish the entity’s mission (to 
reduce the incidence of ABC disease), and it explains the need for and benefits 
of the action (to prevent ABC disease).
Illustration 4 
Facts
E.19. Entity D’s mission is to improve the quality of life for senior citizens. 
One of Entity D’s objectives included in that mission is to increase the physical 
activity of senior citizens. One of Entity D’s programs to attain that objective 
is to send representatives to speak to groups about the importance of exercise 
and to conduct exercise classes.
E.20. Entity D mails a brochure on the importance of exercise that 
encourages exercise in later years to residents over the age of sixty-five in three 
zip code areas. The last two pages of the four-page brochure include a perforated 
contribution remittance form on which Entity D explains its program and 
makes an appeal for contributions. The content of the first two pages of the 
brochure is primarily educational; it explains how seniors can undertake a 
self-supervised exercise program and encourages them to undertake such a 
program. In addition, Entity D includes a second brochure on various exercise 
techniques that can be used by those undertaking an exercise program.
E.21. The brochures are distributed to educate people in this age group 
about the importance of exercising, to help them exercise properly, and to raise 
contributions for Entity D. These objectives are documented in a letter to the 
public relations firm that developed the brochures. The audience is selected 
based on age, without regard to ability to contribute. Entity D believes that 
most of the recipients would benefit from the information about exercise.
Conclusion
E.22. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated. (Note that the costs of the second brochure should be 
charged to program because all the costs of the brochure are identifiable with 
the program function.)
E.23. The activity calls for specific action by the recipient (exercising) that 
will help accomplish the entity’s mission. Therefore, the guidance in paragraph 
10 should be considered. Neither of the factors in paragraph 10a or 10b is 
determinative of whether the purpose criterion is met. Therefore, other evi­
dence, such as the indicators in paragraph 11, should be considered. The 
purpose criterion is met based on the other evidence, because (a) performing 
such programs helps accomplish Entity D’s mission, and (b) the objectives of 
the program are documented in a letter to the public relations firm that 
developed the brochure.
E.24. The audience criterion is met because the audience (residents over 
sixty-five in certain zip codes) is selected based on its need to use or reasonable 
potential for use of the action called for by the program component.
E.25. The content criterion is met because the activity calls for specific 
action by the recipient (exercising) that will help accomplish the entity’s mission 
(increasing the physical activity of senior citizens), and the need for and benefits 
of the action are clearly evident (explains the importance of exercising).
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E.26. The facts are the same as those in Illustration 4, except that Entity 
E employs a fund-raising consultant to develop the first brochure and pays that 
consultant 30 percent of contributions raised.
Conclusion
E.27. The content and audience criteria are met. The purpose crite­
rion is not met, however, because a majority of compensation or fees for the 
fund- raising consultant varies based on contributions raised for this dis­
crete joint activity (the fund-raising consultant is paid 30 percent of contri­
butions raised). All costs should be charged to fund raising, including the 
costs of the second brochure and any other costs that otherwise might be 
considered program or management and general costs i f  they had been 
incurred in a different activity.
Illustration 6 
Facts
E.28. Entity F’s mission is to protect the environment. One of Entity F’s 
objectives included in that mission is to take action that will increase the 
portion of waste recycled by the public.
E.29. Entity F conducts a door-to-door canvass of a community that recy­
cles a low portion of its waste. The purpose of the activity is to help increase 
recycling by educating the community about environmental problems created 
by not recycling, and to raise contributions. Based on the information commu­
nicated by the canvassers, the need for and benefits of the action are clearly 
evident. The ability or likelihood of the residents to contribute is not a basis for 
communities selected, and all neighborhoods in the geographic area are covered 
if their recycling falls below a predetermined rate. The canvassers are selected 
from individuals who are well-informed about the organization’s environ­
mental concerns and programs and who previously participated as volunteers 
in program activities such as answering environmental questions directed to 
the organization and developing program activities designed to influence leg­
islators to take actions addressing those concerns. The canvassers have not 
previously participated in fund-raising activities.
Conclusion
E.30. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated.
E.31. The activity calls for specific action by the recipient (implicitly—to 
help increase recycling) that will help accomplish the entity’s mission. There­
fore, the guidance in paragraph 10 should be considered. Neither of the factors 
in paragraph 10a or 10b is determinative of whether the purpose criterion is 
met. Therefore, other evidence, such as the indicators in paragraph 11, should 
be considered. The purpose criterion is met based on the other evidence, because 
(a) the qualifications and duties of the personnel performing the activity 
indicate that it is a program activity (the canvassers are selected from individu­
als who are well-informed about the organization’s environmental concerns and
Illustration 5
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programs and who previously participated as volunteers in program activities 
such as answering environmental questions directed to the organization and 
developing program activities designed to influence legislators to take actions 
addressing those concerns), and (b) performing such programs helps accom­
plish Entity F’s mission (to protect the environment).
E.32. The audience criterion is met because the audience (neighborhoods 
whose recycling falls below a predetermined rate) is selected based on its need 
to use or reasonable potential for use of the action called for by the program 
component.
E.33. The content criterion is met because the activity calls for specific 
action by the recipient (implicitly—to help increase recycling) that will help 
accomplish the entity’s mission (to protect the environment), and the need for 
and benefits of the action are clearly evident (increased recycling will help 
alleviate environmental problems).
Illustration 7 
Facts
E.34. Entity G’s mission is to provide summer camps for economically 
disadvantaged youths. Educating the families of ineligible youths about the 
camps is not one of the program objectives included in that mission.
E.35. Entity G conducts a door-to-door solicitation campaign for its camp 
programs. In the campaign, volunteers with canisters visit homes in middle- 
class neighborhoods to collect contributions. Entity G believes that people in 
those neighborhoods would not need the camp’s programs but may contribute. 
The volunteers explain the camp’s programs, including why the disadvantaged 
children benefit from the program, and distribute leaflets to the residents 
regardless of whether they contribute to the camp. The leaflets describe the 
camp, its activities, who can attend, and the benefits to attendees. Requests for 
contributions are not included in the leaflets.
Conclusion
E.36. The purpose, audience, and content criteria are not met. All costs 
should be charged to fund raising.
E.37. The activity does not include a call for specific action because it only 
educates the audience about causes (describing the camp, its activities, who 
can attend, and the benefits to attendees). Therefore, the purpose criterion is 
not met.
E.38. The audience criterion is not met, because the audience is selected 
based on its ability or likelihood to contribute, rather than based on (a) its need 
to use or reasonable potential for use of the action called for by the program 
component, or (b) its ability to take action to assist the entity in meeting the 
goals of the program component of the activity. (Entity G believes that people 
in those neighborhoods would not need the camp’s programs but may contribute.)
E.39. The content criterion is not met because the activity does not call for 
specific action by the recipient. (The content educates the audience about 
causes that the program is designed to address without calling for specific 
action.)
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E.40. Entity H ’s mission is to educate the public about lifesaving tech­
niques in order to increase the number of lives saved. One of Entity H’s 
objectives in fulfilling that mission, as stated in the minutes of the board’s 
meetings, is to produce and show television broadcasts including information 
about lifesaving techniques.
E.41. Entity H conducts an annual national telethon to raise contributions 
and to reach the American public with lifesaving educational messages, such 
as summary instructions concerning dealing with certain life-threatening 
situations. Based on the information communicated by the messages, the need 
for and benefits of the action are clearly evident. The broadcast includes 
segments describing Entity H’s services. Entity H broadcasts the telethon to 
the entire country, not merely to areas selected on the basis of giving potential 
or prior fund raising results. Also, Entity H uses national television broadcasts 
devoted entirely to lifesaving educational messages to conduct program activi­
ties without fund raising.
Conclusion
E.42. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated.
E.43. The activity calls for specific action by the recipient (implicitly—to 
save lives) that will help accomplish the entity’s mission. Therefore, the 
guidance in paragraph 10 should be considered. The purpose criterion is met 
because (a) the program component of the activity calls for specific action by 
the recipient that will help accomplish Entity H’s mission (to save lives by 
educating the public), and (b) a similar program activity is conducted without 
the fund raising using the same medium and on a scale that is similar to or 
greater than the scale on which it is conducted with the appeal (Entity H uses 
national television broadcasts devoted entirely to lifesaving educational mes­
sages to conduct program activities without fund raising).
E.44. The audience criterion is met because the audience (a broad segment 
of the population) is selected based on its need to use or reasonable potential 
for use of the action called for by the program activity.
E.45. The content criterion is met because the activity calls for specific 
action by the recipient (implicitly—to save lives) that will help accomplish the 
entity’s mission (to save lives by educating the public), and the need for and 
benefits of the action are clearly evident (saving lives is desirable).
Illustration 9
Facts
E.46. Entity I’s mission is to provide food, clothing, and medical care to 
children in developing countries.
E.47. Entity I conducts television broadcasts in the United States that 
describe its programs, show the needy children, and end with appeals for 
contributions. Entity I’s operating policies and internal management memo­
randa state that these programs are designed to educate the public about the
Illustration 8
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needs of children in developing countries and to raise contributions. The 
employees producing the programs are trained in audiovisual production and 
are familiar with Entity I ’s programs. Also, the executive producer is paid 
$25,000 for this activity, with a $5,000 bonus if the activity raises over 
$ 1,000,000.
Conclusion
E.48. The purpose, audience, and content criteria are not met. All costs 
should be charged to fund raising.
E.49. The activity does not include a call for specific action because it only 
educates the audience about causes (describing its programs and showing the 
needy children). Therefore, the purpose criterion is not met. (Also, note that if 
the factor in paragraph 10a were considered, it would not be determinative of 
whether the purpose criterion is met. Although the executive producer will be 
paid $5,000 if the activity raises over $1,000,000, that amount would not be a 
majority of the executive producer’s total compensation for this activity, be­
cause $5,000 would not be a majority of the executive producer’s total compen­
sation of $30,000 for this activity. Also, note that i f  other evidence, such as the 
indicators in paragraph 11, were considered, the purpose criterion would not 
be met based on the other evidence. Although the qualifications and duties of 
the personnel performing the activity indicate that the employees producing 
the program are familiar with Entity I ’s programs, the facts that some, but less 
than a majority, of the executive producer’s compensation varies based on 
contributions raised, and that the operating policies and internal management 
memoranda state that these programs are designed to educate the public about 
the needs of children in developing countries [with no call for specific action by 
recipients] and to raise contributions, indicate that the purpose is fund raising.)
E.50. The audience criterion is not met because the audience is selected 
based on its ability or likelihood to contribute, rather than based on (a) its need 
to use or reasonable potential for use of the action called for by the program 
component, or (b) its ability to take action to assist the entity in meeting the 
goals of the program component of the activity. (The audience is a broad 
segment of the population of a country that is not in need of or has no reasonable 
potential for use of the program activity.)
E.51. The content criterion is not met because the activity does not call for 
specific action by the recipient that will help accomplish the entity’s mission. 
(The content educates the audience about the causes without calling for specific 
action.)
Illustration 10 
Facts
E.52. Entity J is a university that distributes its annual report, which 
includes reports on mission accomplishments, to those who have made signifi­
cant contributions over the previous year, its board of trustees, and its employ­
ees. The annual report is primarily prepared by management and general 
personnel, such as the accounting department and executive staff. The activity 
is coordinated by the public relations department. Internal management 
memoranda indicate that the purpose of the annual report is to report on how 
management discharged its stewardship responsibilities, including the univer­
sity’s overall performance, goals, financial position, cash flows, and results of
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operations. Included in the package containing the annual report are requests 
for contributions and donor reply cards.
Conclusion
E.53. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated.
E.54. The activity has elements of management and general functions. 
Therefore, no call for specific action is required. Neither of the factors in 
paragraph 10a or 10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph 11, should be 
considered. The purpose criterion is met based on the other evidence, because 
(a) the employees performing the activity are not members of the fund-raising 
department and perform other non-fund-raising activities and (b) internal 
management memoranda indicate that the purpose of the annual report is to 
fulfill one of the university’s management and general responsibilities.
E.55. The audience criterion is met because the audience is selected based 
on its reasonable potential for use of the management and general component. 
Although the activity is directed primarily at those who have previously made 
significant contributions, the audience was selected based on its presumed 
interest in Entity J’s annual report (prior donors who have made significant 
contributions are likely to have an interest in matters discussed in the annual 
report).
E.56. The content criterion is met because the activity (distributing annual 
reports) fulfills one of the entity’s management and general responsibilities 
(reporting concerning management’s fulfillment of its stewardship function).
Illustration 11 
Facts
E.57. Entity K is an NPO. In accordance with internal management 
memoranda documenting its policies requiring it to comply with Internal 
Revenue Service (IRS) regulations, it mails prior donors who have made quid 
pro quo payments in excess of $75 documentation required by the IRS. The 
documentation is included on a perforated piece of paper. The information 
above the perforation line pertains to the documentation required by the IRS. 
The information below the perforation line includes a request for contributions 
and may be used as a donor reply card.
Conclusion
E.58. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated. (Note that the costs of the information below the 
perforation line are identifiable with fund raising and therefore should be 
charged to fund raising.)
E.59. The activity has elements of management and general functions. 
Therefore, no call for specific action is required. Neither of the factors in 
paragraph 10a or 10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph 11, should be 
considered. The purpose criterion is met based on the other evidence, because 
internal management memoranda indicate that the purpose of the activity is 
to fulfill one of Entity K’s management and general responsibilities.
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E.60. The audience criterion is met because the entity is required to direct 
the management and general component of the activity to the particular 
audience. Although the activity is directed at those who have previously 
contributed, the audience was selected based on its need for the documentation.
E.61. The content criterion is met because the activity (sending documen­
tation required by the IRS) fulfills one of the entity’s management and general 
responsibilities (complying with IRS regulations).
Illustration 12 
Facts
E.62. Entity L is an animal rights organization. It mails a package of 
material to individuals included in lists rented from various environmental and 
other organizations that support causes that Entity L believes are congruent 
with its own. In addition to donor response cards and return envelopes, the 
package includes (a) materials urging recipients to contact their legislators and 
urge the legislators to support legislation to protect those rights, and (b) 
postcards addressed to legislators urging support for legislation restricting the 
use of animal testing for cosmetic products. The mail campaign is part of an 
overall strategy that includes magazine advertisements and the distribution of 
similar materials at various community events, some of which are undertaken 
without fund-raising appeals. The advertising and community events reach 
audiences similar in size and demographics to the audience reached by the 
mailing.
Conclusion
E.63. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated.
E.64. The activity calls for specific action by the recipient (mailing post­
cards to legislators urging support for legislation restricting the use of animal 
testing for cosmetic products) that will help accomplish the entity’s mission. 
Therefore, the guidance in paragraph 10 should be considered. Neither of the 
factors in paragraph 10a or 10b is determinative of whether the purpose 
criterion is met. Therefore, other evidence, such as the indicators in paragraph
11, should be considered. The purpose criterion is met based on the other 
evidence, because (a) the program component of this activity calls for specific 
action by the recipient that will help accomplish the entity’s mission, and it 
otherwise conducts the program activity in this illustration without a request 
for contributions, and (b) performing such programs helps accomplish Entity 
L ’s mission.
E.65. The audience criterion is met because the audience (individuals 
included in lists rented from various environmental and other organizations 
that support causes that Entity L believes are congruent with its own) is 
selected based on its ability to take action to assist the entity in meeting the 
goals of the program component of the activity.
E.66. The content criterion is met because the activity calls for specific 
action by the recipient (mailing postcards to legislators urging support for 
legislation restricting the use of animal testing for cosmetic products) that will 
help accomplish the entity’s mission (to protect animal rights), and the need 
for and benefits of the action are clearly evident (to protect animal rights).
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E.67. Entity M is a performing arts organization whose mission is to make 
the arts available to residents in its area. Entity M charges a fee for attending 
performances and sends advertisements, including subscription forms, for the 
performances to residents in its area. These advertisements include a return 
envelope with a request for contributions. Entity M evaluates the effectiveness 
of the advertising based on the number of subscriptions sold as well as 
contributions received. In performing that evaluation, Entity M places more 
weight on the number of subscriptions sold than on the contributions received. 
Also, Entity M advertises the performances on local television and radio without 
a request for contributions but on a smaller scale than the mail advertising.
Conclusion
E.68. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated.
E.69. The activity calls for specific action by the recipient (attending the 
performances) that will help accomplish the entity’s mission. Therefore, the 
guidance in paragraph 10 should be considered. Neither of the factors in 
paragraph 10a or 10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph 11, should be 
considered. The purpose criterion is met based on the other evidence, because
(a) the entity measures program results and accomplishments of the joint 
activity and in evaluating the effectiveness of the activity, the entity places 
significantly greater weight on the activity’s effectiveness in accomplishing 
program goals than on the activity’s effectiveness in raising contributions 
(Entity M evaluates the effectiveness of the advertising based on the number 
of subscriptions sold as well as contributions received and places more weight 
on the number of subscriptions sold than on the contributions received), (b) it 
otherwise conducts the program activity without a request for contributions, 
and (c) performing such programs helps accomplish Entity M ’s mission (to 
make the arts available to residents in its area).
E.70. The audience criterion is met because the audience (a broad segment 
of the population in Entity M ’s area) is selected based on its need to use or 
reasonable potential for use of the action called for by the program component.
E.71. The content criterion is met because the activity calls for specific 
action by the recipient (attending the performances) that will help accomplish 
the entity’s mission (making the arts available to area residents), and the need 
for and benefits of the action are clearly evident (attending the performance is 
a positive cultural experience). (Note that the purchase of subscriptions is an 
exchange transaction and, therefore, is not a contribution.)
Illustration 14
Facts
E.72. Entity N is a university whose mission is to educate the public 
(students) in various academic pursuits. Entity N ’s political science department 
holds a special lecture series in which prominent world leaders speak about 
current events. The speakers command relatively high fees and, in order to 
cover costs and make a modest profit, the university sets a relatively expensive 
fee to attend. However, the tickets are priced at the fair value of the lecture
Illustration 13
Facts
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and no portion of the ticket purchase price is a contribution. Entity N advertises 
the lectures by sending invitations to prior attendees and to prior donors who 
have contributed significant amounts, and by placing advertisements in local 
newspapers read by the general public. At some of the lectures, including the 
lecture being considered in this illustration, deans and other faculty members 
of Entity N solicit significant contributions from attendees. Other lectures in 
the series are conducted on a scale similar to the scale of the lecture in this 
illustration without requesting contributions. Entity N ’s records indicate that 
historically 75 percent of the attendees have attended prior lectures. O f the 75 
percent who have attended prior lectures, 15 percent have made prior contri­
butions to Entity N. Of the 15 percent who have made prior contributions to 
Entity N, 5 percent have made contributions in response to solicitations made 
at the events. (Therefore, one-half of one percent of attendees make contribu­
tions in response to solicitations made at the events. However, those contribu­
tions are significant.) Overall, the audience’s ability or likelihood to contribute 
is an insignificant factor in its selection. Entity N evaluates the effectiveness 
of the activity based on the number of tickets sold, as well as contributions 
received. In performing that evaluation, Entity N places more weight on the 
number of tickets sold than on the contributions received.
Conclusion
E.73. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated.
E.74. The activity calls for specific action by the recipient (attending the 
lecture) that will help accomplish the entity’s mission. Therefore, the guidance 
in paragraph 10 should be considered. The purpose criterion is met because (a) 
the program component of the activity calls for specific action by the recipient 
that will help accomplish the entity’s mission (educating the public [students] 
in various academic pursuits), and (b) the program is also conducted using the 
same medium on a scale that is similar to or greater than the scale on which it 
is conducted with the request for contributions (other lectures in the series are 
conducted on a scale similar to the scale of the lecture in this illustration 
without requesting contributions).
E.75. The audience criterion is met. The rebuttable presumption that the 
audience criterion is not met because the audience includes prior donors is 
overcome in this illustration because the audience (those who have shown prior 
interest in the lecture series, prior donors, a broad segment of the population 
in Entity N ’s area, and those attending the lecture) is also selected for its 
reasonable potential for use of the program component (attending the lecture). 
Although the audience may make significant contributions, that was an insig­
nificant factor in its selection.
E.76. The content criterion is met because the activity calls for specific 
action by the recipient (attending the lecture) that will help accomplish the 
entity’s mission (educating the public [students] in various academic pursuits), 
and the need for and benefits of the action are clearly evident (attending the 
lecture is a positive educational experience). (Note that the purchase of the 
tickets is an exchange transaction and, therefore, is not a contribution. As 
discussed in paragraph 7 of this SOP, costs of goods or services provided in 
exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event, should not be reported as fund raising.12)
12 Paragraphs 13.22 to 13.27 of the Audit and Accounting Guide Not-for-Profit Organizations 
provide guidance concerning reporting special events.
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E.77. Entity O is a university whose mission is to educate the public 
(students) in various academic pursuits. Entity O’s political science department 
holds a special lecture series in which prominent world leaders speak about 
current events. Admission is priced at $250, which is above the $50 fair value 
of the lecture and, therefore, $200 of the admission price is a contribution. 
Therefore, the audience’s likelihood to contribute to the entity is a significant 
factor in its selection. Entity O advertises the lectures by sending invitations 
to prior attendees and to prior donors who have contributed significant 
amounts, and by placing advertisements in local newspapers read by the 
general public. Entity O presents similar lectures that are priced at the fair 
value of those lectures.
Conclusion
E.78. The purpose and content criteria are met. The audience criterion is 
not met. All costs, including those that might otherwise be considered program 
or management and general costs if  they had been incurred in a different 
activity, except for the costs of the direct donor benefit (the lecture), should be 
charged to fund raising.
E.79. The activity calls for specific action by the recipient (attending the 
lecture) that will help accomplish the entity’s mission. Therefore, the guidance 
in paragraph 10 should be considered. The purpose criterion is met because (a) 
the program component of the activity calls for specific action by the recipient 
that will help accomplish the entity’s mission (educating the public [students] 
in various academic pursuits), and (b) the program is also conducted using the 
same medium on a scale that is similar to or greater than the scale on which it 
is conducted with the request for contributions (other lectures in the series are 
conducted on a scale similar to the scale of the lecture in this illustration 
without including a contribution in the admission price.)
E.80. The audience criterion is not met. The rebuttable presumption that 
the audience criterion is not met because the audience is selected based on its 
likelihood to contribute to the entity is not overcome in this illustration. The 
fact that the $250 admission price includes a $200 contribution leads to the 
conclusion that the audience’s ability or likelihood to contribute is an over­
whelmingly significant factor in its selection, whereas there is no evidence that 
the extent to which the audience is selected for its need to use or reasonable 
potential for use of the action called for by the program component (attending 
the lecture) is overwhelmingly significant.
E.81. The content criterion is met because the activity calls for specific 
action by the recipient (attending the lecture) that will help accomplish the 
entity’s mission (educating the public [students] in various academic pursuits), 
and the need for and benefits of the action are clearly evident (attending the 
lecture is a positive educational experience). (Note that the purchase of the 
tickets is an exchange transaction and, therefore, is not a contribution. As 
discussed in paragraph 7 of this SOP, costs of goods or services provided in 
exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event, should not be reported as fund raising.13)
Illustration 15
Facts
13 Paragraphs 13.22 to 13.27 of the Audit and Accounting Guide Not-for-Profit Organizations 
provide guidance concerning reporting special events.
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E.82. Entity P’s mission is to reduce the incidence of illness from ABC 
disease, which primarily afflicts people over sixty-five years of age. One of 
Entity P’s objectives in fulfilling that mission is to have all persons over 
sixty-five screened for ABC disease.
E.83. Entity P rents space at events attended primarily by people over 
sixty-five years of age and conducts free screening for ABC disease. Entity P ’s 
employees, who are educated about ABC disease and screening procedures and 
do not otherwise perform fund-raising functions, educate interested parties 
about the effects of ABC disease and the ease and benefits of screening for it. 
Entity P also solicits contributions at the events. The effectiveness of the 
activity is evaluated primarily based on how many screening tests are per­
formed, and only minimally based on contributions raised. The employees are 
not compensated or evaluated based on contributions raised.
Conclusion
E.84. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated.
E.85. The activity calls for specific action by the recipient (being screened 
for ABC disease) that will help accomplish the entity’s mission. Therefore, the 
guidance in paragraph 10 should be considered. Neither of the factors in 
paragraph 10a or 10b is determinative of whether the purpose criterion is met. 
Therefore, other evidence, such as the indicators in paragraph 11, should be 
considered. The purpose criterion is met based on the other evidence, because
(а) a process exists to evaluate measured program results and accomplishments 
and in evaluating the effectiveness of the joint activity, the entity places 
significantly greater weight on the activity’s effectiveness in accomplishing 
program goals than on the activity’s effectiveness in raising contributions 
(Entity P evaluates the effectiveness of the activity based on the number of 
screening tests conducted as well as contributions received and places more 
weight on the number of tests conducted than on the contributions received);
(b) the qualifications and duties of the personnel performing the activity 
indicate that it is a program activity (the employees are educated about ABC 
disease and the testing procedures and do not otherwise perform fund-raising 
functions); (c) the method of compensation for performing the activity does not 
indicate that it is a fund-raising activity (the employees are not compensated 
or evaluated based on contributions raised); and (d) performing such programs 
helps accomplish Entity P ’s mission (to prevent ABC disease).
E.86. The audience criterion is met because the audience (people over 
sixty-five years of age) is selected based on its need to use or reasonable 
potential for use of the action called for by the program component.
E.87. The content criterion is met because the activity calls for specific 
action by the recipient (being screened for ABC disease) that will help accom­
plish the entity’s mission (to reduce the incidence of ABC disease), and it 
explains the need for and benefits of the action (to prevent ABC disease).
Illustration 17 
Facts
E.88. Entity Q’s mission is to provide cultural and educational television 
programming to residents in its area. Entity Q owns a public television station
Illustration 16
Facts
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and holds a membership drive in which it solicits new members. The drive is 
conducted by station employees and consists of solicitations that are shown 
during long breaks between the station’s regularly scheduled programs. Entity 
Q’s internal management memoranda state that these drives are designed to 
raise contributions. Entity Q evaluates the effectiveness of the activity based 
on the amount of contributions received. Entity Q shows the programs on a 
similar scale, without the request for contributions. The audience is members 
of the general public who watch the programs shown during the drive. Station 
member benefits are given to those who contribute and consist of tokens of 
appreciation with a nominal value.
Conclusion
E.89. The purpose, audience, and content criteria are met, and the joint 
costs should be allocated. (Note that there would be few, if any, joint costs. Costs 
associated with the fund-raising activities, such as costs of airtime, would be 
separately identifiable from costs of the program activities, such as licensing 
costs for a particular television program. Also, note that because no significant 
benefits or duties are associated with membership, member dues are contribu­
tions. Therefore, the substance of the membership-development activities is, in 
fact, fund raising.)
E.90. The activity calls for specific action by the recipient (watching the 
television program) that will help accomplish the entity’s mission. Therefore, 
the guidance in paragraph 10 should be considered. The purpose criterion is 
met because (a) the program component of the activity calls for specific action 
by the recipient that will help accomplish the entity’s mission, and (b) the 
program is also conducted using the same medium on a scale that is similar to 
or greater than the scale on which it is conducted with the request for contri­
butions (Entity Q shows the television programs on a similar scale, without the 
request for contributions).
E.91. The audience criterion is met. The rebuttable presumption that the 
audience criterion is not met because the audience is selected based on its 
likelihood to contribute is overcome in this illustration because the audience 
(members of the general public who watch the television programs shown 
during the drive) is also selected for its reasonable potential for use of the 
program component (watching the television programs). Although the audience 
may make contributions, that was an insignificant factor in its selection.
E.92. The content criterion is met because the activity calls for specific 
action by the recipient (watching the television programs) that will help 
accomplish the entity’s mission (providing cultural and educational television 
programming to residents in its area), and the need for and benefits of the action 
are clearly evident (watching the programs is a positive cultural and educa­
tional experience).
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APPENDIX F
Illustrations of Allocation Methods
F.1. Some commonly used cost allocation methods follow.
Physical Units Method
F.2. Joint costs are allocated to materials and activities in proportion to 
the number of units of output that can be attributed to each of the materials 
and activities. Examples of units of output are lines, square inches, and physical 
content measures. This method assumes that the benefits received by the 
fund-raising, program, or management and general component of the materials 
or activity from the joint costs incurred are directly proportional to the lines, 
square inches, or other physical output measures attributed to each component 
of the activity. This method may result in an unreasonable allocation of joint 
costs if  the units of output, for example, line counts, do not reflect the degree 
to which costs are incurred for the joint activity. Use of the physical units 
method may also result in an unreasonable allocation if  the physical units 
cannot be clearly ascribed to fund raising, program, or management and 
general. For example, direct mail and telephone solicitations sometimes in­
clude content that is not identifiable with fund raising, program, or manage­
ment and general; or the physical units of such content are inseparable.
Illustration
F.3. Assume a direct mail campaign is used to conduct programs of the 
entity and to solicit contributions to support the entity and its programs. 
Further, assume that the appeal meets the criteria for allocation of joint costs 
to more than one function.
F.4. The letter and reply card include a total of one hundred lines. Forty- 
five lines pertain to program because they include a call for action by the 
recipient that will help accomplish the entity’s mission, while fifty-five lines 
pertain to the fund-raising appeal. Accordingly, 45 percent of the costs are 
allocated to program and 55 percent to fund-raising.
Relative Direct Cost Method
F.5. Joint costs are allocated to each of the components on the basis of 
their respective direct costs. Direct costs are those costs that are incurred in 
connection with the multipurpose materials or activity and that are specifi­
cally identifiable with a function (program, fund raising, or management and 
general). This method may result in an unreasonable allocation of joint costs 
if the joint costs of the materials and activity are not incurred in approximately 
the same proportion and for the same reasons as the direct costs of the 
materials and activity. For example, i f  a relatively costly booklet informing 
the reader about the entity’s mission (including a call for action by the 
recipient that will help accomplish the entity’s mission) is included with a 
relatively inexpensive fund-raising letter, the allocation of joint costs based 
on the cost of these pieces may be unreasonable, particularly i f  the booklet 
and letter weigh approximately the same and therefore contribute equally to 
the postage costs.
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F.6. The costs of a direct mail campaign that can be specifically identified 
with program services are the costs of separate program materials and a 
postcard which calls for specific action by the recipient that will help accomplish 
the entity’s mission. They total $20,000. The direct costs of the fund-raising 
component of the direct mail campaign consist of the costs to develop and 
produce the fund-raising letter. They total $80,000. Joint costs associated with 
the direct mail campaign total $40,000 and would be allocated as follows under 
the relative direct cost method:
Program $20,000/$100,000 X $40,000 = $8,000
Fund raising $80,000/$100,000 X $40,000 = $32,000
Stand-Alone Joint-Cost-Allocation Method
F.7. Joint costs are allocated to each component of the activity based on a 
ratio that uses estimates of costs of items included in joint costs that would 
have been incurred had the components been conducted independently. The 
numerator of the ratio is the cost (of items included in joint costs) of conducting 
a single component independently; the denominator is the cost (of items 
included in joint costs) of conducting all components independently. This 
method assumes that efforts for each component in the stand-alone situation 
are proportionate to the efforts actually undertaken in the joint cost situation. 
This method may result in an unreasonable allocation because it ignores the 
effect of each function, which is performed jointly with other functions, on other 
such functions. For example, the programmatic impact of a direct mail cam­
paign or a telemarketing phone message may be significantly lessened when 
performed in conjunction with a fund-raising appeal.
Illustration
F.8. Assume that the joint costs associated with a direct mail campaign 
including both program and fund-raising components are the costs of station­
ery, postage, and envelopes at a total of $100,000. The costs of stationery, 
postage, and envelopes to produce and distribute each component separately 
would have been $90,000 for the program component and $70,000 for the 
fund-raising component. Under the stand-alone joint-cost-allocation method, 
the $100,000 in joint costs would be allocated as follows: $90,000/$ 160,000 X 
$100,000 = $56,250 to program services and $70,000/$160,000 X $100,000 = 
$43,750 to fund raising.
Illustration
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APPENDIX G
Illustrations of Disclosures
G.1. The disclosures discussed in paragraphs 18 and 19 are illustrated 
below. Alternative 1 reports the required and encouraged information in 
narrative format. Alternative 2 reports that information in tabular format, as 
well as information concerning joint costs incurred for each kind of activity by 
functional classification, which is neither required nor encouraged, but which 
is not prohibited.
Alternative 1
Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included requests for 
contributions, as well as program and management and general components. 
Those activities included direct mail campaigns, special events, and a telethon.
The costs of conducting those activities included a total of $310,000 of joint 
costs, which are not specifically attributable to particular components of the 
activities (joint costs). [N o te  to reader: The following sentence is encouraged 
but not required.] Joint costs for each kind of activity were $50,000, $150,000, 
and $110,000 respectively. These joint costs were allocated as follows:
Fund raising $180,000
Program A  80,000
Program B 40,000
Management and general 10,000
Total $310,000
Alternative 2
Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included appeals for con­
tributions and incurred joint costs of $310,000. These activities included direct 
mail campaigns, special events, and a telethon. Joint costs were allocated as 
follows:
Direct
Mail
Special
Events Telethon Total
Fund raising $40,000 $50,000 $90,000 $180,000
Program A 10,000 65,000 5,000 80,000
Program B 25,000 15,000 40,000
Management and 
general 10,000 10,000
Total $50,000 $150,000 $110,000 $310,000
[N ote  to reader: Shading is used to highlight information that is neither 
required nor encouraged, but which is not prohibited. However, entities may 
prefer to disclose it. Disclosing the total joint costs for each kind o f activity 
($50,000, $150,000, and $110,000) is encouraged but not required.]
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APPENDIX H 
Contrast of Guidance in This SOP With the Guidance 
in SOP 87-214, *
This SOP
Applies to all entities that solicit 
contributions, including state and 
local governments.
Covers all costs of joint activities. 
(Costs that otherwise might be con­
sidered program or management 
and general costs if they had been
SOP 87-2
Applied to entities that follow the 
AICPA Industry Audit Guide Audits 
of Voluntary Health and Welfare 
Organizations* or SOP 78-10. (SOP 
87-2 was not applicable to entities 
that are within the scope of Govern­
mental Accounting Standards Board 
Statement No. 29, The Use of Not- 
for-Profit Accounting and Financial 
Reporting Principles by Governmen­
tal Entities.)
Covers only joint costs of joint 
activities.
(continued)
14 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit 
Organizations, which superseded Statement of Position (SOP) 87-2, Accounting for Joint Costs of 
Informational Materials and Activities of Not-for-Profit Organizations That Include a Fund-Raising 
Appeal, because the guidance in SOP 87-2 is incorporated into paragraphs 13.36 to 13.45 of the 
Guide. Also, Not-for-Profit Organizations superseded the AICPA Industry Audit Guide Audits of 
Voluntary Health and Welfare Organizations and SOP 78-10. Not-for-Profit Organizations applies to 
all nongovernmental not-for-profit organizations other than those required to follow the Audit and 
Accounting Guide Health Care Organizations. Therefore, incorporating the guidance in SOP 87-2 into 
Not-for-Profit Organizations broadened the scope of the guidance previously included in SOP 87-2 to 
all not-for-profit organizations other than those required to follow Health Care Organizations. The 
discussion in this SOP of SOP 87-2 refers to both SOP 87-2 and the guidance included in paragraphs 
13.36 to 13.45 of Not-for-Profit Organizations, except that the guidance in Not-for-Profit 
Organizations applies to all not-for-profit organizations other than those required to follow Health 
Care Organizations.
* The AICPA Audit and Accounting Guides Audits of Colleges and Universities, Audits of 
Voluntary Health and Welfare Organizations, and Audits of Certain Nonprofit Organizations were 
superseded by the 1996 edition of the AICPA Audit and Accounting Guide Not-for-Profit 
Organizations. However, because the accounting guidance contained in these Guides remained 
applicable to certain governmental entities (pursuant to the provisions of GASB Statement Nos. 15, 
Governmental College and University Accounting and Financial Reporting Models, and 29, The Use 
of Not-for-Profit Accounting and Financial Reporting Principles by Governmental Entities), the 
AICPA continued to make these Guides available for sale.
With the recent issuance of GASB Statement Nos. 34, Basic Financial Statements— and Management’s 
Discussion and Analysis—for State and Local Governments, and 35, Basic Financial Statements—and 
Management’s Discussion and Analysis—for Public Colleges and Universities, which supersede the 
effect of GASB Statement Nos. 15 and 29, it is no longer necessary for the AICPA to continue selling 
these Guides.
Accordingly, Audits of Colleges and Universities, Audits of Voluntary Health and Welfare 
Organizations, and Audits of Certain Nonprofit Organizations will no longer be included as part of 
this loose-leaf publication.
Once the phased-in effective dates of the GASB Statements have occurred, the accounting guidance 
in these Guides will no longer be applicable to any governmental entities. Please note that the Guides 
have not been updated since 1994. Therefore, if you already have a Guide, and choose to continue 
using it until the phase-in period is complete, you must consider guidance issued since they were last 
updated.
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incurred in a different activity, ex­
cept for costs of goods or services 
provided in exchange transactions 
that are part of joint activities, such 
as costs of direct donor benefits of a 
special event [for example, a meal], 
should be charged to fund raising 
unless the criteria in the SOP are 
met.)
Criteria of purpose, audience, and 
content should all be met in order to 
charge costs of the activity to pro­
gram or management and general.
Neither prescribes nor prohibits any 
allocation methods. Includes a dis­
cussion to help users determine 
whether an allocation is reasonable, 
and provides some illustrations.
Requires note disclosures about the 
types of activities for which joint 
costs have been incurred, amounts 
allocated during the period, and 
amounts allocated to each functional 
expense or expenditure category.
This SOP SO P  87-2
Unclear concerning whether all 
criteria should be met in order to 
charge costs of the activity to pro­
gram or management and general.
Neither prescribes nor prohibits any 
allocation methods. No illustrations 
are provided.
Requires less extensive note disclo­
sures: total amount allocated during 
the period and amounts allocated to 
each functional expense category.
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Effects on Other Guidance
I .1. For nongovernmental organizations, this Statement of Position (SOP) 
amends the AICPA Audit and Accounting Guide Health Care Organizations 
and paragraphs 13.36 to 13.45 of the AICPA Audit and Accounting Guide 
Not-for-Profit Organizations.
I .2. Also, this SOP amends the AICPA Audit and Accounting Guide Not- 
for-Profit Organizations to clarify that costs of goods or services provided in 
exchange transactions that are part of joint activities, such as costs of direct 
donor benefits of a special event (for example, a meal), should not be reported 
as fund-raising. In particular, paragraphs 13.22, 13.24, and 13.25 of Not-for- 
Profit Organizations are amended as follows:
13.22 Some organizations conduct joint activities* that are special events, 
including special social and educational events (such as symposia, dinners, 
dances, and theater parties) in which the attendee receives a direct benefit (for 
example, a meal or theater ticket). FASB Statement No. 117 requires the 
reporting of the gross amounts of revenues and expenses from special events 
and other fund-raising activities that are ongoing major or central activities, 
but permits (but does not require) reporting net amounts if the receipts and 
related costs result from special events that are peripheral or incidental 
activities.
* See the sections of this Guide that provide guidance concerning accounting 
for the costs of joint activities.
13.24 For example, assume that an organization has a special event that is 
an ongoing and major activity with a ticket price of $100. Assume that the 
activity does not meet the audience criterion in SOP 98-2, Accounting for Costs 
of Activities of Not-for-Profit Organizations and State and Local Governmental 
Entities That Include Fund Raising, and, therefore, all costs of the activity, 
other than the direct donor benefits, should be reported as fund raising. The 
event includes a dinner that costs the organization $25 and that has a fair value 
of $30. (Chapter 5, “Contributions Received and Agency Transactions,” of this 
Guide, discusses the appropriate reporting if the meal or other items of value 
are donated to the organization for resale.) In addition, the organization incurs 
other direct costs of the event in connection with promoting and conducting the 
event, including incremental direct costs incurred in transactions with inde­
pendent third parties and the payroll and payroll-related costs for the activities 
of employees who are directly associated with, and devote time to, the event. 
Those other direct costs, which include (a ) $5 that otherwise might be consid­
ered management and general costs if they had been incurred in a different 
activity, and (b ) fund-raising costs of $10, are unrelated to the direct benefits 
to donors and, accordingly, should not be included as costs of benefits to donors. 
In addition, the organization has the following transactions, which are unre­
lated to the special event: unrestricted contributions of $200, program expenses 
of $60, management and general expenses of $20, and fund-raising expenses 
of $20.
13.25 Some ways in which the organization could display the results of the 
special event as part of its statement of activities are illustrated as follows:
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Illustration 1
Changes in unrestricted net assets:
Contributions $200
Special event revenue 100
Less: Costs of direct benefits to donors (25)
Net revenues from special events 75
Contributions and net revenues from
special events 275 
Other expenses:
Program 60
Management and general 20
Fund raising 35
Total other expenses 115
Increase in unrestricted net assets $160
Illustration 2
Changes in unrestricted net assets:
Revenues:
Contributions $200
Special event revenue 100
Total revenues 300 
Expenses:
Program 60
Costs of direct benefits to donors 25
Management and general 20
Fund raising 35
Total expenses 140
Increase in unrestricted net assets $160
Illustration 3
Changes in unrestricted net asset:
Contributions $270
Dinner sales 30
Less: Costs of direct benefits to donors (25)
Gross profit on special events  5
Contributions and net revenues from
special events 275 
Other expenses:
Program 60
Management and general 20
Fund raising 35
Total other expenses 115
Increase in unrestricted net assets $160
I .3. For governmental entities that have applied the accounting and finan­
cial reporting principles in SOP 78-10, Accounting Principles and Reporting 
Practices for Certain Nonprofit Organizations, or the AICPA Industry Audit
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Guide Audits of Voluntary Health and Welfare Organizations* (modified by all 
applicable Financial Accounting Standards Board [FASB] pronouncements 
issued through November 30, 1989, and by most applicable Governmental 
Accounting Standards Board [GASB] pronouncements) in conformity with 
GASB Statement No. 29, The Use of Not-for-Profit Accounting and Financial 
Reporting Principles by Governmental Entities, this SOP amends the principles— 
based on SOP 78-10 and Audits of Voluntary Health and Welfare Organiza­
tions,* as modified—that those entities apply. For governmental entities that 
have applied the accounting and financial reporting principles in the 1973 
AICPA Industry Audit Guide Audits of Colleges and Universities, as amended 
by SOP 74-8, Financial Accounting and Reporting by Colleges and Universities, 
and as modified by applicable FASB pronouncements issued through Novem­
ber 30, 1989, and all applicable GASB pronouncements in conformity with 
GASB Statement No. 15, Governmental College and University Accounting and 
Financial Reporting Models, this SOP amends the principles—based on Audits 
of Colleges and Universities,* as amended and modified—that those entities 
apply. For other governmental organizations, this SOP amends the Audit and 
Accounting Guide Audits of State and Local Governmental Units.
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* The AICPA Audit and Accounting Guides Audits of Colleges and Universities, Audits of 
Voluntary Health and Welfare Organizations, and Audits of Certain Nonprofit Organizations were 
superseded by the 1996 edition of the AICPA Audit and Accounting Guide Not-for-Profit Organiza­
tions. However, because the accounting guidance contained in these Guides remained applicable to 
certain governmental entities (pursuant to the provisions of GASB Statement Nos. 15, Governmental 
College and University Accounting and Financial Reporting Models, and 29, The Use of Not-for-Profit 
Accounting and Financial Reporting Principles by Governmental Entities), the AICPA continued to 
make these Guides available for sale.
With the recent issuance of GASB Statement Nos. 34, Basic Financial Statements— and Management’s 
Discussion and Analysis—for State and Local Governments, and 35, Basic Financial Statements—and 
Management’s Discussion and Analysis—for Public Colleges and Universities, which supersede the 
effect of GASB Statement Nos. 15 and 29, it is no longer necessary for the AICPA to continue selling 
these Guides.
Accordingly, Audits of Colleges and Universities, Audits of Voluntary Health and Welfare Organiza­
tions, and Audits of Certain Nonprofit Organizations will no longer be included as part of this 
loose-leaf publication.
Once the phased-in effective dates of the GASB Statements have occurred, the accounting guidance 
in these Guides will no longer be applicable to any governmental entities. Please note that the Guides 
have not been updated since 1994. Therefore, if you already have a Guide, and choose to continue 
using it until the phase-in period is complete, you must consider guidance issued since they were last 
updated.
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Glossary
Activities. Activities are efforts to accomplish specific objectives. Some activi­
ties include producing and distributing materials. For example, if an entity 
undertakes a mass mailing that includes a letter and a pamphlet, produc­
ing and distributing the letter and pamphlet are part of the activity. Other 
activities may include no materials, such as an annual dinner or a radio 
commercial.
Compensation or fees. Reciprocal transfers of cash or other assets in ex­
change for services performed.
Contributions. Contributions are unconditional transfers of cash or other 
assets to an entity or a settlement or cancellation of its liabilities in a 
voluntary nonreciprocal transfer by another entity acting other than as an 
owner.
Costs of joint activities. Costs of joint activities are costs incurred for a joint 
activity. Costs of joint activities may include joint costs and costs other 
than joint costs. Costs other than joint costs are costs that are identifiable 
with a particular function, such as fund raising, program, management 
and general, and cost of sales. For example, some costs incurred for 
printing, paper, professional fees, and salaries to produce donor cards are 
not joint costs, although they may be incurred in connection with conduct­
ing joint activities.
Fund-raising activities. Fund-raising activities are activities undertaken to 
induce potential donors to contribute money, securities, services, materi­
als, facilities, other assets, or time. They include publicizing and conduct­
ing fund-raising campaigns; maintaining donor mailing lists; conducting 
special fund-raising events; preparing and distributing fund-raising manu­
als, instructions, and other materials; and conducting other activities 
involved with soliciting contributions from individuals, foundations, gov­
ernments, and others.
Help accomplish the entity’s mission. Actions that help accomplish the en­
tity’s mission are actions that either benefit the recipient (such as by 
improving the recipient’s physical, mental, emotional, or spiritual health 
and well-being) or benefit society (by addressing societal problems).
Joint activity. A joint activity is an activity that is part of the fund-raising 
function and has elements of one or more other functions, such as program, 
management and general, membership development, or any other func­
tional category used by the entity.
Joint costs. Joint costs are the costs of conducting joint activities that are not 
identifiable with a particular component of the activity. For example, the 
cost of postage for a letter that includes both fund-raising and program 
components is a joint cost. Joint costs may include the costs of salaries, 
contract labor, consultants, professional fees, paper, printing, postage, 
event advertising, telephones, airtime, and facility rentals.
Management and general activities. Management and general activities 
are those that are not identifiable with a single program, fund-raising 
activity, or membership-development activity but that are indispensable 
to the conduct of those activities and to an organization’s existence. They
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include oversight, business management, general recordkeeping, budget­
ing, financing, soliciting revenue from exchange transactions, such as 
government contracts and related administrative activities, and all man­
agement and administration except for direct conduct of program services 
or fund-raising activities. Disseminating information to inform the public 
of the organization’s “stewardship” of contributed funds, announcements 
concerning appointments, and the annual report, among other activities, 
are management and general activities, as are soliciting funds other than 
contributions, including exchange transactions (whether program-related 
or not).
Medium. A medium is a means of mass communication, such as direct mail, 
direct response advertising, or television.
Membership-development activities. Membership-development activities 
include soliciting for prospective members and membership dues, member­
ship relations, and similar activities. I f  there are no significant benefits or 
duties connected with membership, however, the substance of member­
ship-development activities may, in fact, be fund-raising.
Program activities. Program activities are the activities that result in goods 
or services being distributed to beneficiaries, customers, or members that 
fulfill the purposes or mission for which the organization exists. Those 
services are the major purpose for and the major output of the organization 
and often relate to several major programs. For example, a large university 
may have programs for student instruction, research, and patient care, 
among others. Similarly, a health and welfare organization may have 
programs for health and family services, research, disaster relief, and 
public education, among others.
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Statement of 99-1
Position
Guidance to Practitioners in 
Conducting and Reporting on 
an Agreed-Upon Procedures 
Engagement to Assist 
Management in Evaluating the 
Effectiveness of Its Corporate 
Compliance Program
May 21 , 1999
Issued Under the Authority of the 
Audit Standards Board
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NOTE
This Statement of Position presents the recommendations of the 
AICPA Health Care Pilot Task Force regarding the application of 
Statements on Standards for Attestation Engagements to agreed- 
upon procedures attestation engagements performed to assist a 
health care provider in evaluating the effectiveness of its corporate 
compliance program consistent with the requirements of a Corporate 
Integrity Agreement entered into with the Office of Inspector General 
of the U.S. Department of Health and Human Services. The Auditing 
Standards Board has found the recommendations in this Statement 
of Position to be consistent with existing standards covered by Rule 
202 of the AICPA Code of Professional Conduct. AICPA members 
should be prepared to justify departures from the recommendations 
in this Statement of Position.
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SUMMARY
This Statement of Position (SOP) provides guidance to practitioners in conduct­
ing and reporting on an agreed-upon procedures engagement performed pur­
suant to the AICPA Statements on Standards for Attestation Engagements to 
assist a health care provider in evaluating the effectiveness of its corporate 
compliance program consistent with the requirements of a Corporate Integrity 
Agreement (CIA) entered into with the Office of Inspector General (OIG) of the 
U.S. Department of Health and Human Services. CIAs are specific to the entity 
involved; consequently, users of this SOP should be familiar with the specific 
requirements of the entity’s CIA.
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Guidance to Practitioners in Conducting and 
Reporting on an Agreed-Upon Procedures 
Engagement to Assist Management in 
Evaluating the Effectiveness of Its 
Corporate Compliance Program
Introduction and Background
1. Within the past several years, the health care industry has experienced 
a significant increase in the number and magnitude of allegations of fraud and 
abuse involving federal health care programs (for example, Medicare and 
Medicaid) and private health care insurance. These allegations have triggered 
regulatory scrutiny, litigation, significant monetary settlements, and negative 
publicity related to—among other things—coding and billing practices, patient 
referrals, cost reporting, quality of care, and clinical practices. Typically, as 
part of the global resolution of these allegations, the entity enters into a 
Corporate Integrity Agreement (CIA) with the Office of Inspector General 
(OIG) of the U.S. Department of Health and Human Services. Such agreements 
require that management annually report on its compliance with the terms of 
the CIA and that there be an assessment of the entity’s compliance with the 
CIA. This assessment includes a billing analysis, which may be performed 
by an independent review organization (such as a practitioner or consult­
ant) or the provider (if permitted by the OIG), and an agreed-upon proce­
dures engagement.
2. This SOP provides guidance to practitioners in conducting and report­
ing on an agreed-upon procedures engagement performed pursuant to the 
American Institute of Certified Public Accountants (AICPA) Statements on 
Standards for Attestation Engagements (SSAEs) to assist an entity in evalu­
ating the effectiveness of its corporate compliance program consistent with the 
requirements of a CIA.1 The terms of a CIA are unique to the entity; 
consequently, users of this SOP need to be familiar with the actual CIA and 
its requirements.
3. This SOP applies to agreed-upon procedures engagements to assist in 
evaluating an entity’s compliance for a specified period. Such engagements 
should follow the AICPA attestation standards, including SSAE No. 1, Attesta­
tion Standards (AICPA, Professional Standards, vol. 1, AT sec. 100); SSAE No.
3, Compliance Attestation (AICPA, Professional Standards, vol. 1, AT sec. 500); 
and SSAE No. A, Agreed-Upon Procedures Engagements (AICPA, Professional 
Standards, vol. 1, AT sec. 600). The engagement should be conducted in 
accordance with standards established by the AICPA, including the criteria set 
forth in this SOP. However, this SOP is not intended to provide all the required
1 The practitioner also might be engaged to assist in other areas beyond an agreed-upon 
procedures engagement such as providing consulting services in connection with evaluating the 
company’s billing practices, policies, and procedures as required by the CIA or in implementing, 
assessing, and reporting on voluntarily adopted compliance programs. In addition, the practitioner 
may assist in preparing an entity’s self-disclosure reports to federal health agencies related to billing 
errors and other compliance matters. Similarly, practitioners may be involved in an entity’s prepara­
tion of government-required (but not CIA-imposed) compliance reporting (for example, contract 
requirements for Medicare part C) beyond an agreed-upon procedures engagement.
AAG-HCO APP D
308 Health Care Organizations
criteria set forth in individual CIAs, nor all the applicable standards estab­
lished by the AICPA. Additionally, the SOP contains some guidance that may 
be applied in evaluating an organization’s corporate compliance program, even 
though the program was not imposed by a CIA.
Overview of a Typical Corporate Integrity Agreement
4. A CIA is an agreement between a health care provider and the OIG in 
conjunction with a global settlement of a fraud investigation. Such an agree­
ment typically seeks to establish a compliance program within the health care 
provider (for example, hospital, clinical lab, physician group) that will promote 
compliance with the requirements of Medicare, Medicaid, and all other federal 
health care programs.
5. CIAs are case-specific. Their terms are tailored to address the organ­
izational and operating deficiencies related to providing and billing for health 
care services that have been identified by the OIG, the entity, or others. Detailed 
compliance requirements are imposed as a condition for continued participa­
tion in federal health care programs. A sample CIA, provided by the OIG and 
intended to identify potential requirements, is included in appendix A, “Sam­
ple Corporate Integrity Agreement.” Typical agreements cover five years and 
require the entity to address the following areas:
•  Appointment of a compliance officer and establishment of a compli­
ance committee
•  Establishment of a code of conduct
•  Establishment of policies and procedures regarding the compliance 
program
•  Development of an information and education program as to CIA 
requirements, compliance program and code of conduct
•  Annual assessment of billing policies, procedures, and practices
•  Establishment of a confidential disclosure program
• Prohibition of employment of excluded or convicted persons
•  Notification to OIG of investigation or legal proceedings
•  Reporting of credible evidence of misconduct
•  Notifications to OIG of new provider locations
•  Provision of implementation and annual reports
•  Proper notification and submission of required reports
•  Granting of OIG access to documents and individuals to conduct 
assessments
•  Documentation of record retention requirements
•  Awareness of disclosure criteria
•  Agreement to comply with certain default provisions, penalties, and 
remedies
•  Review of rights as to dispute resolution
•  Review of effective and binding agreement clauses
Conditions for Engagement Performance
6. A practitioner may perform an agreed-upon procedures engagement 
related to management’s compliance with a CIA if all of the conditions specified 
in SSAE No. 4 (AT sec. 600.10) and SSAE No. 3 (AT sec. 500.09-.11) are met.
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7. As discussed more fully in the SSAEs noted in paragraph 6, manage­
ment’s assertions as to its compliance must be capable of evaluation against 
reasonable criteria that either have been established by a recognized body or 
are stated in or attached to the practitioner’s report in a sufficiently clear and 
comprehensive manner. Generally, to avoid confusion, management’s asser­
tions, which are based on the specific terms of its CIA, should be attached to 
the practitioner’s report. If the entity is not subject to a CIA, management may 
develop its assertions using the model CIA. A sample based on the model CIA, 
which is not meant to be all-inclusive, is included as appendix B, “Sample 
Statement of Management’s Assertions.”
Establishing an Understanding With the Client
8. The practitioner should document the understanding in the working 
papers, preferably through a written communication with the client, such as 
an engagement letter. Appendix C, “Sample Engagement Letter,” contains a 
sample engagement letter that may be used for this kind of engagement.
Users' Responsibilities
9. Users typically would be the management of the health care provider 
and the OIG. Management is responsible for ensuring that the entity complies 
with the requirements of the CIA. That responsibility encompasses (a) identi­
fying applicable compliance requirements, (b) establishing and maintaining 
internal control policies and procedures to provide reasonable assurance that 
the entity complies with those requirements, (c) evaluating and monitoring the 
entity’s compliance, and (d) preparing reports that satisfy legal, regulatory, or 
contractual requirements. Management’s evaluation may include documenta­
tion such as accounting or statistical data, policy manuals, accounting manu­
als, narrative memoranda, procedural write-ups, flowcharts, completed 
questionnaires, internal auditors’ reports, and other special studies or analy­
ses. The form and extent of documentation will vary depending on the nature 
of the compliance requirements and the size and complexity of the entity. 
Management may engage the practitioner to gather information to assist it in 
evaluating the entity’s compliance. Regardless of the procedures performed by 
the practitioner, management must accept responsibility for its assertions and 
must not base such assertions solely on the practitioner’s procedures.
10. Specified users are responsible for the sufficiency (nature, timing, and 
extent) of the agreed-upon procedures because they best understand their own 
needs. The specified users assume the risk that such procedures might be 
insufficient for their purposes. In addition, the specified users assume the risk 
that they might misunderstand or otherwise inappropriately use findings 
properly reported by the practitioner.
Practitioner's Responsibilities
11. The objective of the practitioner’s agreed-upon procedures is to pre­
sent specific findings to assist users in evaluating an entity’s compliance with 
the requirements specified in the CIA. (See appendix D, “Sample Procedures.”)
12. The practitioner’s procedures generally may be as limited or extensive 
as the specified users desire, as long as the specified users agree upon the 
procedures performed or to be performed and take responsibility for the 
sufficiency of the agreed-upon procedures for their purposes.
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13. To satisfy the requirements that the practitioner and the specified 
users agree upon the procedures performed or to be performed and that the 
specified users take responsibility for the sufficiency of the agreed-upon proce­
dures for their purposes, ordinarily the practitioner should communicate di­
rectly with and obtain affirmative acknowledgment from each of the specified 
users. For the purposes of these engagements, an effective way to obtain this 
agreement ordinarily is to distribute a draft of the report, detailing the proce­
dures, that is expected to be issued to the OIG with a request for any comments 
it may have.
14. To avoid possible misunderstandings, the practitioner should circu­
late the draft with a legend stating that these are the procedures expected to 
be performed, and unless informed otherwise, the practitioner assumes that 
there are no additional procedures that he or she is expected to perform. A 
legend such as the following might be used.
This draft is furnished solely for the purpose of indicating the form of report that 
we would expect to be able to furnish pursuant to the request by Management of 
[Provider] for our performance of limited procedures relating to [Provider’s] 
compliance with the Corporate Integrity Agreement with the Office of Inspector 
General (OIG) of the U.S. Department of Heath and Human Services. Based on 
our discussions with [Provider], it is our understanding that the procedures 
outlined in this draft report are those we are expected to follow. Unless informed 
otherwise within ninety (90) days of this transmittal, we shall assume that there 
are no additional procedures that we are expected to follow. The text of the 
definitive report will depend, of course, on the results of the procedures.
Involvement of a Specialist2
15. The practitioner’s education and experience enable him or her to be 
knowledgeable about business matters in general, but he or she is not expected 
to have the expertise of a person trained for or qualified to engage in the 
practice of another profession or occupation. In certain circumstances, it may 
be appropriate to involve a specialist to assist the practitioner in the perform­
ance of one or more procedures. The following are examples:
•  An attorney might provide assistance concerning the application of 
laws, regulations, or rules to a client’s situation.
•  A medical specialist might provide assistance in understanding the 
characteristics of diagnosis codes documented in patient medical records.
16. The practitioner and the specified users should agree to the involve­
ment of a specialist in assisting a practitioner in the performance of an 
agreed-upon procedures engagement. This agreement may be reached when 
obtaining agreement on the procedures performed or to be performed and 
acknowledgment of responsibility for the sufficiency of the procedures, as 
discussed previously. The practitioner’s report should describe the nature of 
the assistance provided by the specialist.
17. A practitioner may agree to apply procedures to the report or work 
product of a specialist that does not constitute assistance by the specialist to 
the practitioner in an agreed-upon procedures engagement. For example, the 
practitioner may make reference to information contained in a report of a 
specialist in describing an agreed-upon procedure. However, it is inappropriate
2 A specialist is a person (or firm) possessing special skill or knowledge in a particular field other 
than the attest function. As used herein, a specialist does not include a person employed by the. 
practitioner’s firm who participates in the attestation engagement.
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for the practitioner to agree to merely read the specialist’s report solely to 
describe or repeat the findings, or to take responsibility for all or a portion of 
any procedures performed by a specialist or the specialist’s work product.
Internal Auditors and Other Personnel3
18. The agreed-upon procedures to be enumerated or referred to in the 
practitioner’s report are to be performed entirely by the practitioner except as 
discussed in paragraphs 15-17 of this SOP. However, internal auditors or 
other personnel may prepare schedules, accumulate data, perform an internal 
assessment of management’s compliance, or provide other information for the 
practitioner’s use in performing the agreed-upon procedures.
19. A practitioner may agree to perform procedures on information docu­
mented in the working papers of internal auditors. For example, the practi­
tioner may agree to—
•  Repeat all or some of the procedures.
•  Determine whether the internal auditors’ working papers contain 
documentation of procedures performed and whether the findings 
documented in the working papers are presented in a report by the 
internal auditors.
20. However, it is inappropriate for the practitioner to—
•  Agree to merely read the internal auditor’s report solely to describe or 
repeat its findings.
•  Take responsibility for all or a portion of any procedures performed by 
internal auditors by reporting those findings as the practitioner’s own.
•  Report in any manner that implies shared responsibility for the 
procedures with the internal auditors.
Planning the Engagement
21. Planning an agreed-upon procedures engagement involves working 
with the users to develop an overall strategy for the expected conduct and scope 
of the engagement. To develop such a strategy, practitioners should have 
adequate technical training and proficiency in the attestation standards and 
have adequate knowledge in health care regulatory matters to enable them to 
sufficiently understand the events, transactions, and practices that, in their 
judgment, have a significant effect on the presentation of the assertions.
Working Papers
22. The practitioner should prepare and maintain working papers in 
connection with an engagement under the attestation standards; such working 
papers should be appropriate to the circumstances and the practitioner’s needs 
on the engagement to which they apply.
23. Concern over access to the practitioner’s working papers might cause 
some clients to inquire about working paper requirements. In situations where 
the practitioner is requested to not maintain copies of certain client documen­
tation, or to not prepare and maintain documentation similar to client documents,
3 SAS No. 65, The Auditor’s Consideration of the Internal Audit Function in an Audit of 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 322), does not apply to 
agreed-upon procedures engagements.
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the practitioner may refer to the Auditing Interpretation, “The Auditor’s 
Consideration of the Completeness Assertion” (AICPA, Professional Stand­
ards, vol. 1, AU sec. 9326.06-.17), for guidance. See the Attest Interpretation, 
“Providing Access to or Photocopies of Working Papers to a Regulator” (AICPA, 
Professional Standards, vol. 1, AT sec. 9100.58), for guidance related to provid­
ing access to or photocopies of working papers to a regulator in connection with 
work performed on an attestation engagement.
Management's Representations
24. The practitioner should obtain written representation from manage­
ment on various matters including the following:
a. Acknowledging management’s responsibility for complying with the 
CIA
b. Acknowledging management’s responsibility for establishing and 
maintaining effective internal control over compliance
c. Stating that management has performed an evaluation of the entity’s 
compliance with CIA-specified requirements
d. Stating management’s assertions about the entity’s compliance with 
all aspects of the CIA, including the specific issues that gave rise to 
the CIA4
e. Stating that management has disclosed to the practitioner all known 
noncompliance with the CIA
f. Stating that management has made available all documentation 
relating to compliance with the CIA
g. Stating management’s interpretation of any compliance require­
ments that have varying interpretations
h. Stating that management has disclosed any communication from 
regulatory agencies, internal auditors, legal counsel, and other par­
ties concerning matters regarding the design, implementation, and 
monitoring of the policies and procedures in place, including commu­
nication received between the end of the reporting period and the 
date of the practitioner’s report (the date of signature)
i. Stating that management has disclosed any known noncompliance 
occurring subsequent to the end of the reporting period
j. Describing any related material fraud or abuse, other fraud, abuse 
or illegal acts that, whether or not material, involve management or 
other employees who have a significant role in the entity’s design, 
implementation, and monitoring of the policies and procedures in 
place upon which compliance is based
4 Depending on the circumstances, representations in the following areas might be appropriate.
• Violations or possible violations of laws or regulations, such as those related to the Medicare 
and Medicaid antifraud and abuse statutes
• Compliance of third-party billings with applicable coding guidelines (for example, ICD-9-CM, 
CPT) and laws and regulations (including medical necessity, proper approvals, and proper 
rendering of care)
• Proper filing of all required Medicare, Medicaid, and similar reports under the applicable 
reimbursement rules and regulations (including nature of costs—allowable, patient-related, 
properly allocated, in accordance with applicable rules and regulations, properly adjusted to 
reflect prior audit adjustments) and adequacy of disclosures (including disputed costs)
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k. Stating that management has disclosed to the practitioners, orally 
or in writing, information about past noncompliance issues covered 
in the settlement agreement that gave rise to the CIA and the related 
corrective measures taken to support compliance in those areas
Management’s refusal to furnish all appropriate written representations con­
stitutes a limitation on the scope of the engagement sufficient to require 
withdrawal from the engagement.
Reporting Considerations
25. A practitioner should present the results of applying agreed-upon 
procedures to the specific subject matter in the form of findings. The practi­
tioner should not provide negative assurance about whether the assertion is 
fairly stated in accordance with established or stated criteria. For example, the 
practitioner should not include a statement that “nothing came to my attention 
that caused me to believe that the assertion is not fairly stated in accordance 
with (established or stated) criteria.”
26. The practitioner should report all findings from the application of the 
agreed-upon procedures. The concept of materiality does not apply to findings 
to be reported in an agreed-upon procedures engagement unless the definition 
of materiality is agreed to by the specified users. Any agreed-upon materiality 
limits should be described in the practitioner’s report.
27. The practitioner has no obligation to perform procedures beyond the 
agreed-upon procedures. However, if noncompliance related to management’s 
assertion comes to the practitioner’s attention by other means, such informa­
tion ordinarily should be included in his or her report.
28. The practitioner may become aware of noncompliance related to 
management’s assertion that occurs subsequent to the reporting period but 
before the date of the practitioner’s report. The practitioner should consider 
including information regarding such noncompliance in his or her report. 
However, the practitioner has no responsibility to perform procedures to detect 
such noncompliance other than obtaining management’s representation about 
noncompliance in the subsequent period.
29. The practitioner should follow the reporting guidance in SSAE No. 4 
(AT sec. 600.33—.38). A sample report is included in appendix E, “Sample 
Report.”
30. Evaluating compliance with certain requirements may require inter­
pretation of the laws, regulations, rules, contracts, or other agreements that 
establish those requirements. In such situations, the practitioner should con­
sider whether he or she is provided with the reasonable criteria required to 
evaluate an assertion under the third general attestation standard. If these 
interpretations are significant, the practitioner may include a paragraph stat­
ing the description and the source of interpretations made by the entity’s 
management. An example of such a paragraph, which should precede the 
procedures and findings paragraph(s), follows:
We have been informed that, under [name of entity’s] interpretation of [identify
the compliance requirement], [explain the nature and source of the relevant
interpretation].
31. The date of completion of the agreed-upon procedures should be used 
as the date of the practitioner’s report.
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Appendix A
Sample Corporate Integrity Agreement 
Between the Office of Inspector General 
of the Department of Health and 
Human Services and [Provider]
I. Preamble
[Provider] (“[Provider]”) hereby enters into this Corporate Integrity Agree­
ment (“CIA”) with the Office of Inspector General (“OIG”) of the United States 
Department of Health and Human Services (“HHS”) to ensure compliance by 
its employees with the requirements of Medicare, Medicaid and all other 
Federal health care programs (as defined in 42 U.S.C. 1320a-7b(f)) (hereinafter 
collectively referred to as the “Federal health care programs”). [Provider’s] 
compliance with the terms and conditions in this CIA shall constitute an 
element of [Provider’s] present responsibility with regard to participation in 
the Federal health care programs. Contemporaneously with this CIA, 
[Provider] is entering into a Settlement Agreement with the United States, and 
this CIA is incorporated by reference into the Settlement Agreement.
II. Term of the CIA
The period of the compliance obligations assumed by [Provider] under this 
CIA shall be 5 years from the effective date of this CIA (unless otherwise 
specified). The effective date of this CIA will be the date on which the final 
signatory of this CIA executes this CIA (the “effective date”).*
III. Corporate Integrity Obligations
[Provider] shall establish a compliance program that includes the following 
elements:
A. Compliance Officer
Within ninety (90) days after the effective date of this CIA, [Provider] 
shall appoint an individual to serve as Compliance Officer, who shall 
be responsible for developing and implementing policies, procedures, 
and practices designed to ensure compliance with the requirements 
set forth in this CIA and with the requirements of the Federal health 
care programs. The Compliance Officer shall be a member of senior 
management of [Provider], shall make regular (at least quarterly) 
reports regarding compliance matters directly to the CEO and/or to 
the Board of Directors of [Provider] and shall be authorized to report 
to the Board of Directors at any time. The Compliance Officer shall 
be responsible for monitoring the day-to-day activities engaged in by 
[Provider] to further its compliance objectives as well as any report­
ing obligations created under this CIA. In the event a new Compli­
ance Officer is appointed during the term of this CIA, [Provider] shall 
notify the OIG, in writing, within fifteen (15) days of such a change.
* Source: Office of the Inspector General of the United States Department of Health and 
Human Services.
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[Provider] shall also appoint a Compliance Committee within ninety 
(90) days after the effective date of this CIA. The Compliance Com­
mittee shall, at a minimum, include the Compliance Officer and any 
other appropriate officers as necessary to meet the requirements of 
this CIA within the provider’s corporate structure (e.g., senior execu­
tives of each major department, such as billing, clinical, human 
resources, audit, and operations). The Compliance Officer shall chair 
the Compliance Committee and the Committee shall support the 
Compliance Officer in fulfilling his/her responsibilities.
B. Written Standards
1. Code of Conduct. Within ninety (90) days of the effective date of 
this CIA, [Provider] shall establish a Code of Conduct. The Code of 
Conduct shall be distributed to all employees within ninety (90) days 
of the effective date of this CIA. [Provider] shall make the promotion 
of, and adherence to, the Code of Conduct an element in evaluating 
the performance of managers, supervisors, and all other employees. 
The Code of Conduct shall, at a minimum, set forth:
a. [Provider’s] commitment to full compliance with all stat­
utes, regulations, and guidelines applicable to Federal 
health care programs, including its commitment to pre­
pare and submit accurate billings consistent with Federal 
health care program regulations and procedures or in­
structions otherwise communicated by the Health Care 
Financing Administration (“HCFA”) (or other appropriate 
regulatory agencies) and/or its agents;
b. [Provider’s] requirement that all of its employees shall be 
expected to comply with all statutes, regulations, and 
guidelines applicable to Federal health care programs and 
with [Provider’s] own policies and procedures (including 
the requirements of this CIA);
c. the requirement that all of [Provider’s] employees shall be 
expected to report suspected violations of any statute, 
regulation, or guideline applicable to Federal health care 
programs or with [Provider’s] own policies and procedures;
d. the possible consequences to both [Provider] and to any 
employee of failure to comply with all statutes, regula­
tions, and guidelines applicable to Federal health care 
programs and with [Provider’s] own policies and proce­
dures or of failure to report such non-compliance; and
e. the right of all employees to use the confidential disclosure 
program, as well as [Provider’s] commitment to confiden­
tiality and non-retaliation with respect to disclosures.
Within ninety (90) days of the effective date of the CIA, each 
employee shall certify, in writing, that he or she has received, 
read, understands, and will abide by [Provider’s] Code of Conduct. 
New employees shall receive the Code of Conduct and shall 
complete the required certification within two (2) weeks after the 
commencement of their employment or within ninety (90) days of 
the effective date of the CIA, whichever is later.
[Provider] will annually review the Code of Conduct and will make 
any necessary revisions. These revisions shall be distributed within
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thirty (30) days of initiating such a change. Employees shall 
certify on an annual basis that they have received, read, under­
stand and will abide by the Code of Conduct.
2. Policies and Procedures. Within ninety (90) days of the effective 
date of this CIA, [Provider] shall develop and initiate implemen­
tation of written Policies and Procedures regarding the operation 
of [Provider’s] compliance program and its compliance with all 
federal and state health care statutes, regulations, and guide­
lines, including the requirements of the Federal health care pro­
grams. At a minimum, the Policies and Procedures shall 
specifically address [insert language relevant to allegations in the 
case]. In addition, the Policies and Procedures shall include disci­
plinary guidelines and methods for employees to make disclosures 
or otherwise report on compliance issues to [Provider] manage­
ment through the Confidential Disclosure Program required by 
section III.E. [Provider] shall assess and update as necessary the 
Policies and Procedures at least annually and more frequently, as 
appropriate. A summary of the Policies and Procedures will be 
provided to OIG in the Implementation Report. The Policies and 
Procedures will be available to OIG upon request.
Within ninety (90) days of the effective date of the CIA, the 
relevant portions of the Policies and Procedures shall be distrib­
uted to all appropriate employees. Compliance staff or supervisors 
should be available to explain any and all policies and procedures.
C. Training and Education
1. General Training. Within ninety (90) days of the effective date 
of this CIA, [Provider] shall provide at least two (2) hours of 
training to each employee. This general training shall explain 
[Provider’s]:
a. Corporate Integrity Agreement requirements;
b. Compliance Program (including the Policies and Proce­
dures as they pertain to general compliance issues); and
c. Code of Conduct.
These training materials shall be made available to the OIG, upon 
request.
New employees shall receive the general training described above 
within thirty (30) days of the beginning of their employment or 
within ninety (90) days after the effective date of this CIA, which­
ever is later. Each year, every employee shall receive such general 
training on an annual basis.
2. Specific Training. Within ninety (90) days of the effective date of 
this CIA, each employee who is involved directly or indirectly in 
the delivery of patient care and/or in the preparation or submis­
sion of claims for reimbursement for such care (including, but not 
limited to, coding and billing) for any Federal health care pro­
grams shall receive at least [insert number of training hours] 
hours of training in addition to the general training required 
above. This training shall include a discussion of:
a. the submission of accurate bills for services rendered to 
Medicare and/or Medicaid patients;
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b. policies, procedures and other requirements applicable to 
the documentation of medical records;
c. the personal obligation of each individual involved in the 
billing process to ensure that such billings are accurate;
d. applicable reimbursement rules and statutes;
e. the legal sanctions for improper billings; and
f. examples of proper and improper billing practices.
These training materials shall be made available to OIG, upon 
request. Persons providing the training must be knowledgeable 
about the subject area.
Affected new employees shall receive this training within thirty 
(30) days of the beginning of their employment or within ninety 
(90) days of the effective date of this CIA, whichever is later. If a 
new employee has any responsibility for the delivery of patient 
care, the preparation or submission of claims and/or the assign­
ment of procedure codes prior to completing this specific training, 
a [Provider] employee who has completed the substantive training 
shall review all of the untrained person’s work regarding the 
assignment of billing codes.
Each year, every employee shall receive such specific training on 
an annual basis.
3. Certification. Each employee shall certify, in writing, that he or 
she has attended the required training. The certification shall 
specify the type of training received and the date received. The 
Compliance Officer shall retain the certifications, along with 
specific course materials. These shall be made available to OIG 
upon request.
D. Review Procedures
[Provider] shall retain an entity, such as an accounting, auditing or 
consulting firm (hereinafter “Independent Review Organization”), to 
perform review procedures to assist [Provider] in assessing the 
adequacy of its billing and compliance practices pursuant to this CIA. 
This shall be an annual requirement and shall cover a twelve (12) 
month period. The Independent Review Organization must have 
expertise in the billing, coding, reporting and other requirements of 
the Federal health care programs from which [Provider] seeks reim­
bursement. The Independent Review Organization must be retained 
to conduct the assessment of the first year within ninety (90) days of 
the effective date of this CIA. For purposes of complying with this 
review procedures requirement, the OIG at its discretion, may per­
mit the [Provider] to utilize internal auditors to perform the re- 
view(s). In such case, the [Provider] will engage the Independent 
Review Organization to verify the propriety of the internal auditors’ 
methods and accuracy of their results. The [Provider] will request 
the Independent Review Organization to produce a report on its 
findings which report shall be included in the Annual Report to the 
OIG.
The Independent Review Organization (or the [Provider], if permit­
ted by the OIG, as set forth above) will conduct two separate engage­
ments. One will be an analysis of [Provider’s] billing to the Federal 
health care programs to assist the [Provider] and OIG in determining
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compliance with all applicable statutes, regulations, and direc­
tives/guidance (“billing engagement”). The second engagement will 
assist the [Provider] and OIG in determining whether [Provider] is 
in compliance with this CIA (“compliance engagement”).
1. Billing Engagement. The billing engagement shall consist of a 
review of a statistically valid sample of claims for the relevant 
period. The sample size shall be determined through the use of a 
probe sample.1 At a minimum, the full sample must be within a 
ninety (90) percent confidence level and a precision of twenty-five 
(25) percent. The probe sample must contain at least thirty (30) 
sample units and cannot be used as part of the full sample. Both 
the probe sample and the sample must be selected through ran­
dom numbers. [Provider] shall use OIG’s Office of Audit Services 
Statistical Sampling Software, also known as “RAT-STATS”, 
which is available through the Internet at www.hhs.gov/progorg 
/ratstat.html.
Each annual billing engagement analysis shall include the follow­
ing components in its methodology:
a. Billing Engagement Objective: Provide a statement stat­
ing clearly the objective intended to be achieved by the 
billing engagement and the procedure or combination of 
procedures that will be applied to achieve the objective.
b. Billing Engagement Population: Identify the population, 
which is the group about which information is needed. 
Explain the methodology used to develop the population 
and provide the basis for this determination.
c. Sources of Data: Provide a full description of the source of 
the information upon which the billing engagement con­
clusions will be based, including the legal or other stand­
ards applied, documents relied upon, payment data, 
and/or any contractual obligations.
d. Sampling Unit: Define the sampling unit, which is any of 
the designated elements that comprise the population of 
interest.
e. Sampling Frame: Identify the sampling frame, which is 
the totality of the sampling units from which the sample 
will be selected.
As part of the billing engagement:
a. Inquire of management as to the procedures and controls 
affecting the billing process subject to the annual assess­
ment as specified in the CIA. Document that aspect of the 
billing process (e.g., flow of documents, processing activi-
• ties), and those controls that will be tested in the sample. 
The documentation may consist of flow charts, excerpts 
from policies and procedures manuals, control question­
naires, etc.
b. Report the sample results, including the overall error rate 
and the nature of the errors found (e.g., no documentation, 
inadequate documentation, assignment of incorrect code).
1 Probe sample is defined as a small, random preliminary sample.
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c. Document findings related to [Provider’s] procedures to 
correct inaccurate billings and codings to the Federal 
health care programs and findings regarding the steps 
[Provider] is taking to bring its operations into compliance 
or to correct problems identified by the audit.
2. Agreed-upon Procedures or Compliance Engagement. An Inde­
pendent Review Organization (or the [Provider], if permitted by 
the OIG) shall also conduct an agreed-upon procedures or compli­
ance engagement, which shall assist the users in determining 
whether [Provider’s] program, policies, procedures, and opera­
tions comply with the terms of this CIA. This engagement shall 
include a section by section analysis of the requirements of this 
CIA.
A complete copy of the Independent Review Organization’s billing 
and agreed-upon procedures or compliance engagement shall be 
included in each of [Provider’s] Annual Reports to OIG.
3. Disclosure of Overpayments and Material Deficiencies. If, as a 
result of these engagements, [Provider] or the Independent Re­
view Organization identifies any billing, coding or other policies, 
procedures and/or practices that result in an overpayment, 
[Provider] shall notify the payor (e.g., Medicare fiscal intermedi­
ary or carrier) within 30 days of discovering the deficiency or 
overpayment and take remedial steps within 60 days of discovery 
(or such additional time as may be agreed to by the payor) to 
correct the problem, including preventing the deficiency from 
recurring. The notice to the payor shall include:
a. a statement that the refund is being made pursuant to this 
CIA;
b. a description of the complete circumstances surrounding 
the overpayment;
c. the methodology by which the overpayment was determined;
d. the amount of the overpayment;
e. any claim-specific information used to determine the over­
payment (e.g., beneficiary health insurance number, claim 
number, service date, and payment date);
f. the cost reporting period; and
g. the provider identification number under which the repay­
ment is being made.
If [Provider] determines an overpayment represents a material 
deficiency, contemporaneous with [Provider’s] notification to the 
payor as provided above, [Provider] shall also notify OIG of:
a. a complete description of the material deficiency;
b. amount of overpayment due to the material deficiency;
c. [Provider’s] action(s) to correct and prevent such material 
deficiency from recurring;
d. the payor’s name, address, and contact person where the 
overpayment was sent;
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e. the date of the check and identification number (or elec­
tronic transaction number) on which the overpayment was 
repaid.
For purposes of this CIA, an “overpayment” shall mean the 
amount of money the provider has received in excess of the 
amount due and payable under the Federal health care programs’ 
statutes, regulations or program directives, including carrier and 
intermediary instructions.
For purposes of this CIA, a “material deficiency” shall mean 
anything that involves: (i) a substantial overpayment or improper 
payment relating to the Medicare and/or Medicaid programs; (ii) 
conduct or policies that clearly violate the Medicare and/or Medi­
caid statute, regulations or directives issued by HCFA and/or its 
agents; or (iii) serious quality of care implications for federal 
health care beneficiaries or recipients. A material deficiency may 
be the result of an isolated event or a series of occurrences.
4. Verification/Validation. In the event that the OIG determines 
that it is necessary to conduct an independent review to determine 
whether or the extent to which [Provider] is complying with its 
obligations under this CIA, [Provider] agrees to pay for the rea­
sonable cost of any such review or engagement by the OIG or any 
of its designated agents.
E. Confidential Disclosure Program
Within ninety (90) days after the effective date of this CIA, [Provider] 
shall establish a Confidential Disclosure Program, which must include 
measures (e.g., a toll-free compliance telephone line) to enable employ­
ees, contractors, agents or other individuals to disclose, to the Compli­
ance Officer or some other person who is not in the reporting individual’s 
chain of command, any identified issues or questions associated with 
[Provider’s] policies, practices or procedures with respect to the Federal 
health care program, believed by the individual to be inappropriate. 
[Provider] shall publicize the existence of the hotline (e.g., e-mail to 
employees or post hotline number in prominent common areas).
The Confidential Disclosure Program shall emphasize a non-retribu­
tion, non-retaliation policy, and shall include a reporting mechanism 
for anonymous, confidential communication. Upon receipt of a com­
plaint, the Compliance Officer (or designee) shall gather the infor­
mation in such a way as to elicit all relevant information from the 
individual reporting the alleged misconduct. The Compliance Officer 
(or designee) shall make a preliminary good faith inquiry into the 
allegations set forth in every disclosure to ensure that he or she has 
obtained all of the information necessary to determine whether a 
further review should be conducted. For any disclosure that is suffi­
ciently specific so that it reasonably: (1) permits a determination of 
the appropriateness of the alleged improper practice, and (2) pro­
vides an opportunity for taking corrective action, [Provider] shall 
conduct an internal review of the allegations set forth in such a 
disclosure and ensure that proper follow-up is conducted.
The Compliance Officer shall maintain a confidential disclosure log, 
which shall include a record and summary of each allegation re­
ceived, the status of the respective investigations, and any corrective 
action taken in response to the investigation.
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[Provider] shall not hire or engage as contractors any “Ineligible 
Person.” For purposes of this CIA, an “Ineligible Person” shall be any 
individual or entity who: (i) is currently excluded, suspended, de­
barred or otherwise ineligible to participate in the Federal health 
care programs; or (ii) has been convicted of a criminal offense related 
to the provision of health care items or services and has not been 
reinstated in the Federal health care programs after a period of 
exclusion, suspension, debarment, or ineligibility.
Within ninety (90) days of the effective date of this CIA, [Provider] 
will review its list of current employees and contractors against the 
General Services Administration’s List of Parties Excluded from 
Federal Programs (available through the Internet at 
http://www.amet.gov/epls) and the HHS/OIG Cumulative Sanction 
Report (available through the Internet at http://www.dhhs.gov/pro- 
gorg/oig) to ensure that it is not currently employing or contracting 
with any Ineligible Person. Thereafter, [Provider] will review the list 
once semi-annually to ensure that no current employees or contrac­
tors are or have become Ineligible Persons.
To prevent hiring or contracting with any Ineligible Person, 
[Provider] shall screen all prospective employees and prospective 
contractors prior to engaging their services by (i) requiring appli­
cants to disclose whether they are Ineligible Persons, and (ii) 
reviewing the General Services Administration’s List of Parties 
Excluded from Federal Programs (available through the Internet at 
http://www.arnet.gov/epls) and the HHS/OIG Cumulative Sanction 
Report (available through the Internet at http://www.dhhs.gov/ 
progorg/oig).
If [Provider] has notice that an employee or agent is charged with a 
criminal offense related to any Federal health care program, or is 
suspended or proposed for exclusion during his or her employment 
or contract with [Provider], within 10 days of receiving such notice 
[Provider] will remove such employee from responsibility for, or 
involvement with, [Provider’s] business operations related to the 
Federal health care programs until the resolution of such criminal 
action, suspension, or proposed exclusion. If  [Provider] has notice 
that an employee or agent has become an Ineligible Person, 
[Provider] will remove such person from responsibility for, or involve­
ment with, [Provider’s] business operations related to the Federal 
health care programs and shall remove such person from any position 
for which the person’s salary or the items or services rendered, 
ordered, or prescribed by the person are paid in whole or in part, 
directly or indirectly, by Federal health care programs or otherwise 
with Federal funds at least until such time as the person is reinstated 
into participation in the Federal health care programs.
G. Notification of Proceedings
Within thirty (30) days of discovery, [Provider] shall notify OIG, in 
writing, of any ongoing investigation or legal proceeding conducted 
or brought by a governmental entity or its agents involving an 
allegation that [Provider] has committed a crime or has engaged in 
fraudulent activities or any other knowing misconduct. This notifi­
cation shall include a description of the allegation, the identity of the
F. Ineligible Persons
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investigating or prosecuting agency, and the status of such investi­
gation or legal proceeding. [Provider] shall also provide written 
notice to OIG within thirty (30) days of the resolution of the matter, 
and shall provide OIG with a description of the findings and/or 
results of the proceedings, if any.
H. Reporting
1. Credible evidence of misconduct. I f [Provider] discovers credible 
evidence of misconduct from any source and, after reasonable in­
quiry, has reason to believe that the misconduct may violate criminal, 
civil, or administrative law concerning [Provider’s] practices relating 
to the Federal health care programs, then [Provider] shall 
promptly report the probable violation of law to OIG. Defendants 
shall make this disclosure as soon as practicable, but, not later 
than thirty (30) days after becoming aware of the existence of the 
probable violation. The [Provider’s] report to OIG shall include:
a. the findings concerning the probable violation, including 
the nature and extent of the probable violation;
b. [Provider’s] actions to correct such probable violation; and
c. any further steps it plans to take to address such probable 
violation and prevent it from recurring.
To the extent the misconduct involves an overpayment, the report 
shall include the information listed in section III.D.3 regarding 
material deficiencies.
2. Inappropriate Billing. If [Provider] discovers inappropriate or 
incorrect billing through means other than the Independent Re­
view Organization’s engagement, the provider shall follow proce­
dures in section III.D.3 regarding overpayments and material 
deficiencies.
IV. New Locations
In the event that [Provider] purchases or establishes new business units 
after the effective date of this CIA, [Provider] shall notify OIG of this fact within 
thirty (30) days of the date of purchase or establishment. This notification shall 
include the location of the new operation(s), phone number, fax number, 
Federal health care program provider number(s) (if any), and the corresponding 
payor(s) (contractor specific) that has issued each provider number. All employ­
ees at such locations shall be subject to the requirements in this CIA that apply 
to new employees (e.g., completing certifications and undergoing training).
V. Implementation and Annual Reports
A. Implementation Report
Within one hundred and twenty (120) days after the effective date of 
this CIA, [Provider] shall submit a written report to OIG summariz­
ing the status of its implementation of the requirements of this CIA. 
This Implementation Report shall include:
1. the name, address, phone number and position description of the 
Compliance Officer required by section III.A;
2. the names and positions of the members of the Compliance Com­
mittee required by section III.A;
3. a copy of [Provider’s] Code of Conduct required by section III.B.1;
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4. the summary of the Policies and Procedures required by section
III.B.2;
5. a description of the training programs required by section III.C 
including a description of the targeted audiences and a schedule 
of when the training sessions were held;
6. a certification by the Compliance Officer that:
a. the Policies and Procedures required by section III.B have 
been developed, are being implemented, and have been 
distributed to all pertinent employees;
b. all employees have completed the Code of Conduct certifi­
cation required by section III.B.1; and;
c. all employees have completed the training and executed 
the certification required by section III.C;
7. a description of the confidential disclosure program required by 
section III.E;
8. the identity of the Independent Review Organization(s) and the 
proposed start and completion date of the first audit; and
9. a summary of personnel actions taken pursuant to section III.F.
B. Annual Reports
[Provider] shall submit to OIG an Annual Report with respect to the
status and findings of [Provider’s] compliance activities. The Annual
Reports shall include:
1. any change in the identity or position description of the Compli­
ance Officer and/or members of the Compliance Committee de­
scribed in section III.A;
2. a certification by the Compliance Officer that:
a. all employees have completed the annual Code of Conduct 
certification required by section III.B.1; and
b. all employees have completed the training and executed 
the certification required by section III.C;
3. notification of any changes or amendments to the Policies and 
Procedures required by section III.B and the reasons for such 
changes (e.g., change in contractor policy);
4. a complete copy of the report prepared pursuant to the Inde­
pendent Review Organization’s billing and compliance engage­
ment, including a copy of the methodology used;
5. [Provider’s] response/corrective action plan to any issues raised 
by the Independent Review Organization;
6. a summary of material deficiencies reported throughout the 
course of the previous twelve (12) months pursuant to III.D.3 and
III.H;
7. a report of the aggregate overpayments that have been returned 
to the Federal health care programs that were discovered as a 
direct or indirect result of implementing this CIA. Overpayment 
amounts should be broken down into the following categories: 
Medicare, Medicaid (report each applicable state separately) and 
other Federal health care programs;
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8. a copy of the confidential disclosure log required by section III.E;
9. a description of any personnel action (other than hiring) taken by 
[.Provider] as a result of the obligations in section III.F;
10. a summary describing any ongoing investigation or legal proceed­
ing conducted or brought by a government entity involving an 
allegation that [Provider] has committed a crime or has engaged 
in fraudulent activities, which have been reported pursuant to 
section III.G. The statement shall include a description of the 
allegation, the identity of the investigating or prosecuting agency, 
and the status of such investigation, legal proceeding or requests 
for information;
11. a corrective action plan to address the probable violations of law 
identified in section III.H; and
12. a listing of all of the [Provider’s] locations (including locations and 
mailing addresses), the corresponding name under which each 
location is doing business, the corresponding phone numbers and 
fax numbers, each location’s Federal health care program 
provider identification number(s) and the payor (specific contrac­
tor) that issued each provider identification number.
The first Annual Report shall be received by the OIG no later than 
one year and thirty (30) days after the effective date of this CIA. 
Subsequent Annual Reports shall be submitted no later than the 
anniversary date of the due date of the first Annual Report.
C. Certifications
The Implementation Report and Annual Reports shall include a certi­
fication by the Compliance Officer under penalty of perjury, that: (1) 
[Provider] is in compliance with all of the requirements of this CIA, to 
the best of his or her knowledge; and (2) the Compliance Officer has 
reviewed the Report and has made reasonable inquiry  regarding its 
content and believes that, upon such inquiry, the information is accurate 
and truthful.
VI. Notifications and Submission of Reports
Unless otherwise stated in writing subsequent to the effective date of this 
CIA, all notifications and reports required under this CIA shall be submitted 
to the entities listed below:
OIG: Civil Recoveries Branch—Compliance Unit 
Office of Counsel to the Inspector General 
Office of Inspector General 
U.S. Department of Health and Human Services 
Cohen Building, Room 5527 
330 Independence Avenue, SW 
Washington, DC 20201 
Phone 202-619-2078; Fax 202-205-0604
[Provider]:
[Address and Telephone number of Provider’s Compliance Contact]
VII. OIG Inspection, Audit and Review Rights
In addition to any other rights OIG may have by statute, regulation, or 
contract, OIG or its duly authorized representative(s), may examine 
[Provider’s] books, records, and other documents and supporting materials for
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the purpose of verifying and evaluating: (a) [Provider’s] compliance with the 
terms of this CIA; and (b) [Provider’s] compliance with the requirements of the 
Federal health care programs in which it participates. The documentation 
described above shall be made available by [Provider] to OIG or its duly authorized 
representative(s) at all reasonable times for inspection, audit or reproduction. 
Furthermore, for purposes of this provision, OIG or its duly authorized repre- 
sentative(s) may interview any of [Provider’s] employees who consent to be inter­
viewed at the employee’s place of business during normal business hours or at 
such other place and time as may be mutually agreed upon between the 
employee and OIG. [Provider] agrees to assist OIG in contacting and arranging 
interviews with such employees upon OIG’s request. [Provider’s] employees 
may elect to be interviewed with or without a representative of [Provider] present.
VIII. Document and Record Retention
[Provider] shall maintain for inspection all documents and records relating 
to reimbursement from the Federal health care programs or to compliance with 
this CIA one year longer than the term of this CIA (or longer if otherwise 
required by law).
IX. Disclosures
Subject to HHS’s Freedom of Information Act (“FOIA”) procedures, set forth 
in 45 C.F.R. Part 5, the OIG shall make a reasonable effort to notify [Provider] 
prior to any release by OIG of information submitted by [Provider] pursuant to 
its obligations under this CIA and identified upon submission by [Provider] as 
trade secrets, commercial or financial information and privileged and confidential 
under the FOIA rules. [Provider] shall refrain from identifying any information 
as trade secrets, commercial or financial information and privileged and confi­
dential that does not meet the criteria for exemption from disclosure under FOIA.
X. Breach and Default Provisions
[Provider] is expected to fully and timely comply with all of the obligations 
herein throughout the term of this CIA or other time frames herein agreed to.
A. Stipulated Penalties for Failure to Comply with Certain Obligations
As a contractual remedy, [Provider] and OIG hereby agree that failure 
to comply with certain obligations set forth in this CIA may lead to the 
imposition of the following monetary penalties (hereinafter referred to 
as “Stipulated Penalties”) in accordance with the following provisions.
1. A Stipulated Penalty of $2,500 (which shall begin to accrue on the 
day after the date the obligation became due) for each day, 
beginning 120 days after the effective date of this CIA and con­
cluding at the end of the term of this CIA, [Provider] fails to have 
in place any of the following:
a. a Compliance Officer;
b. a Compliance Committee;
c. a written Code of Conduct;
d. written Policies and Procedures;
e. a training program; and
f. a Confidential Disclosure Program;
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2. A Stipulated Penalty of $2,500 (which shall begin to accrue on the 
day after the date the obligation became due) for each day 
[Provider] fails to meet any of the deadlines to submit the Imple­
mentation Report or the Annual Reports to the OIG.
3. A Stipulated Penalty of $2,000 (which shall begin to accrue on the 
date the failure to comply began) for each day [Provider]:
a. hires or contracts with an Ineligible Person after that 
person has been listed by a federal agency as excluded, 
debarred, suspended or otherwise ineligible for participa­
tion in the Medicare, Medicaid or any other Federal health 
care program (as defined in 42 U.S.C. 1320a7b(f)). This 
Stipulated Penalty shall not be demanded for any time 
period if [Provider] can demonstrate that it did not dis­
cover the person’s exclusion or other ineligibility after 
making a reasonable inquiry (as described in section III.F) 
as to the status of the person;
b. employs or contracts with an Ineligible Person and that 
person: (i) has responsibility for, or involvement with, 
[Provider’s] business operations related to the Federal 
health care programs or (ii) is in a position for which the 
person’s salary or the items or services rendered, ordered, 
or prescribed by the person are paid in whole or in part, 
directly or indirectly, by the Federal health care programs 
or otherwise with Federal funds (this Stipulated Penalty 
shall not be demanded for any time period during which 
[Provider] can demonstrate that it did not discover the 
person’s exclusion or other ineligibility after making a 
reasonable inquiry (as described in III.F) as to the status 
of the person);
c. employs or contracts with a person who: (i) has been 
charged with a criminal offense related to any Federal 
health care program, or (ii) is suspended or proposed for 
exclusion, and that person has responsibility for, or in­
volvement with, [Provider’s] business operations related 
to the Federal health care programs (this Stipulated Pen­
alty shall not be demanded for any time period before 10 
days after [Provider] received notice of the relevant matter 
or after the resolution of the matter).
4. A Stipulated Penalty of $1,500 (which shall begin to accrue on the 
date the [Provider] fails to grant access) for each day [Provider] 
fails to grant access to the information or documentation as 
required in section V of this CIA.
5. A Stipulated Penalty of $1,000 (which shall begin to accrue ten
(10) days after the date that OIG provides notice to [Provider] of 
the failure to comply) for each day [Provider] fails to comply fully 
and adequately with any obligation of this CIA. In its notice to 
[Provider], the OIG shall state the specific grounds for its deter­
mination that the [Provider] has failed to comply fully and ade­
quately with the CIA obligation(s) at issue.
B. Payment of Stipulated Penalties
1. Demand Letter. Upon a finding that [Provider] has failed to 
comply with any of the obligations described in section X.A and
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determining that Stipulated Penalties are appropriate, OIG shall 
notify [Provider] by personal service or certified mail of (a) 
[Provider’s] failure to comply; and (b) the OIG’s exercise of its 
contractual right to demand payment of the Stipulated Penalties 
(this notification is hereinafter referred to as the “Demand Letter”).
Within fifteen (15) days of the date of the Demand Letter, 
[Provider] shall either (a) cure the breach to the OIG’s satisfaction 
and pay the applicable stipulated penalties, or (b) request a 
hearing before an HHS administrative law judge (“ALJ”) to dis­
pute the OIG’s determination of noncompliance, pursuant to the 
agreed-upon provisions set forth below in section X.D. In the event 
[Provider] elects to request an ALJ hearing, the Stipulated Pen­
alties shall continue to accrue until [Provider] cures, to the OIG’s 
satisfaction, the alleged breach in dispute. Failure to respond to 
the Demand Letter in one of these two manners within the allowed 
time period shall be considered a material breach of this CIA and 
shall be grounds for exclusion under section X.C.
2. Timely Written Requests for Extensions. [Provider] may submit a 
timely written request for an extension of time to perform any act 
or file any notification or report required by this CIA. Notwith­
standing any other provision in this section, if OIG grants the 
timely written request with respect to an act, notification, or 
report, Stipulated Penalties for failure to perform the act or file 
the notification or report shall not begin to accrue until one day 
after [Provider] fails to meet the revised deadline as agreed to by 
the OIG-approved extension. Notwithstanding any other provi­
sion in this section, if OIG denies such a timely written request, 
Stipulated Penalties for failure to perform the act or file the 
notification or report shall not begin to accrue until two (2) 
business days after [Provider] receives OIG’s written denial of 
such request. A “timely written request” is defined as a request in 
writing received by OIG at least five (5) business days prior to the 
date by which any act is due to be performed or any notification 
or report is due to be filed.
3. Form of Payment. Payment of the Stipulated Penalties shall be 
made by certified or cashier’s check, payable to “Secretary of the 
Department of Health and Human Services,” and submitted to 
OIG at the address set forth in section VI.
4. Independence from Material Breach Determination. Except as 
otherwise noted, these provisions for payment of Stipulated Pen­
alties shall not affect or otherwise set a standard for the OIG’s 
determination that [Provider] has materially breached this CIA, 
which decision shall be made at the OIG’s discretion and governed 
by the provisions in section X.C, below.
C. Exclusion for Material Breach of this CIA
1. Notice of Material Breach and Intent to Exclude. The parties 
agree that a material breach of this CIA by [Provider] constitutes 
an independent basis for [Provider’s] exclusion from participation 
in the Federal health care programs (as defined in 42 U.S.C. 
1320a7b(f)). Upon a determination by OIG that [Provider] has 
materially breached this CIA and that exclusion should be im­
posed, the OIG shall notify [Provider] by certified mail of (a) 
[Provider’s] material breach; and (b) OIG’s intent to exercise its
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contractual right to impose exclusion (this notification is herein­
after referred to as the “Notice of Material Breach and Intent to 
Exclude”).
2. Opportunity to Cure. [Provider] shall have thirty-five (35) days 
from the date of the Notice of Material Breach and Intent to 
Exclude Letter to demonstrate to the OIG’s satisfaction that:
a. [Provider] is in full compliance with this CIA;
b. the alleged material breach has been cured; or
c. the alleged material breach cannot be cured within the 
35-day period, but that: (i) [Provider] has begun to take 
action to cure the material breach, (ii) [Provider] is pursu­
ing such action with due diligence, and (iii) [Provider] has 
provided to OIG a reasonable timetable for curing the 
material breach.
3. Exclusion Letter. If at the conclusion of the thirty-five (35) day 
period, [Provider] fails to satisfy the requirements of section
X.C.2, OIG may exclude [Provider] from participation in the 
Federal health care programs. OIG will notify [Provider] in writ­
ing of its determination to exclude [Provider] (this letter shall be 
referred to hereinafter as the “Exclusion Letter”). Subject to the 
Dispute Resolution provisions in section X.D, below, the exclusion 
shall go into effect thirty (30) days after the date of the Exclusion 
Letter. The exclusion shall have national effect and will also apply 
to all other federal procurement and non-procurement programs. 
I f  [Provider] is excluded under the provisions of this CIA, 
[Provider] may seek reinstatement pursuant to the provisions at 
42 C.F.R. §§1001.3001-3004.
4. Material Breach. A material breach of this CIA means:
a. a failure by [Provider] to report a material deficiency, take 
corrective action and pay the appropriate refunds, as pro­
vided in section III.D;
b. repeated or flagrant violations of the obligations under 
this CIA, including, but not limited to, the obligations 
addressed in section X.A of this CIA;
c. a failure to respond to a Demand Letter concerning the 
payment of Stipulated Penalties in accordance with sec­
tion X.B above; or
d. a failure to retain and use an Independent Review Organi­
zation for review purposes in accordance with section III.D.
D. Dispute Resolution
1. Review Rights. Upon the OIG’s delivery to [Provider] of its De­
mand Letter or of its Exclusion Letter, and as an agreed-upon 
contractual remedy for the resolution of disputes arising under 
the obligation of this CIA, [Provider] shall be afforded certain 
review rights comparable to the ones that are provided in 42 
U.S.C. §§1320a7(f) and 42 C.F.R. §1005 as if they applied to the 
Stipulated Penalties or exclusion sought pursuant to this CIA. 
Specifically, the OIG’s determination to demand payment of 
Stipulated Penalties or to seek exclusion shall be subject to review
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by an ALJ and, in the event of an appeal, the Departmental Appeals 
Board (“DAB”), in a manner consistent with the provisions in 42
C.F.R. §§1005.2-.21. Notwithstanding the language in 42 C.F.R. 
§1005.2(c), the request for a hearing involving stipulated penalties 
shall be made within fifteen (15) days of the date of the Demand 
Letter and the request for a hearing involving exclusion shall be 
made within thirty (30) days of the date of the Exclusion Letter.
2. Stipulated Penalties Review. Notwithstanding any provision of 
Title 42 of the United States Code or Chapter 42 of the Code of 
Federal Regulations, the only issues in a proceeding for stipulated 
penalties under this CIA shall be (a) whether [Provider] was in full 
and timely compliance with the obligations of this CIA for which the 
OIG demands payment; and (b) the period of noncompliance. 
[Provider] shall have the burden of proving its full and timely 
compliance and the steps taken to cure the noncompliance, if any. If 
the ALJ finds for the OIG with regard to a finding of a breach of this 
CIA and orders [Provider] to pay Stipulated Penalties, such Stipu­
lated Penalties shall become due and payable twenty (20) days after 
the ALJ issues such a decision notwithstanding that [Provider] may 
request review of the ALJ decision by the DAB.
3. Exclusion Review. Notwithstanding any provision of Title 42 of 
the United States Code or Chapter 42 of the Code of Federal 
Regulations, the only issues in a proceeding for exclusion based 
on a material breach of this CIA shall be (a) whether [Provider] 
was in material breach of this CIA; (b) whether such breach was 
continuing on the date of the Exclusion Letter; and (c) the alleged 
material breach cannot be cured within the 35-day period, but that
(i) [Provider] has begun to take action to cure the material breach,
(ii) [Provider] is pursuing such action with due diligence, and (iii) 
[Provider] has provided to OIG a reasonable timetable for curing 
the material breach.
For purposes of the exclusion herein, exclusion shall take effect 
only after an ALJ decision that is favorable to the OIG. [Provider’s] 
election of its contractual right to appeal to the DAB shall not 
abrogate the OIG’s authority to exclude [Provider] upon the issu­
ance of the ALJ’s decision. If the ALJ sustains the determination 
of the OIG and determines that exclusion is authorized, such 
exclusion shall take effect twenty (20) days after the ALJ issues 
such a decision, notwithstanding that [Provider] may request 
review of the ALJ decision by the DAB.
4. Finality of Decision. The review by an ALJ or DAB provided for 
above shall not be considered to be an appeal right arising under 
any statutes or regulations. Consequently, the parties to this CIA 
agree that the DAB’s decision (or the ALJ’s decision if not ap­
pealed) shall be considered final for all purposes under this CIA 
and [Provider] agrees to waive any right it may have to appeal the 
decision administratively, judicially or otherwise seek review by 
any court or other adjudicative forum.
XI. Effective and Binding Agreement
Consistent with the provisions in the Settlement Agreement pursuant to 
which this CIA is entered, and into which this CIA is incorporated, [Provider] 
and OIG agree as follows:
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a. This CIA shall be binding on the successors, assigns and transferees 
of [Provider];
b. This CIA shall become final and binding on the date the final 
signature is obtained on the CIA;
c. Any modifications to this CIA shall be made with the prior written 
consent of the parties to this CIA; and
d. The undersigned [Provider] signatories represent and warrant that 
they are authorized to execute this CIA. The undersigned OIG 
signatory represents that he is signing this CIA in his official capac­
ity and that he is authorized to execute this CIA.
On Behalf of [Provider]
Health Care Organizations
[Date]
[Date]
[Date]
[Please identify all signatories]
ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL 
OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Lewis Moris [Date]
Assistant Inspector General for Legal Affairs 
Office of Inspector General 
U.S. Department of Health and Human Services
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Appendix B 
Sample Statement of Managements Assertions
[Date]
In connection with the Corporate Integrity Agreement (CIA) entered into with 
the Office of the Inspector General of the United States Department of Health 
and Human Services dated [date], we make the following assertions, which are 
true to the best of our knowledge and belief.
Governance
Within 90 days of the date of the CIA, we—
1. Established a Compliance Committee, which meets at least monthly 
and requires a quorum to meet.
2. Appointed to our Compliance Committee members who include at a 
minimum those individuals specified in the CIA.
3. Delegated to the Compliance Committee the authority to implement 
and monitor the CIA, as evidenced by the organization chart or the 
Compliance Committee’s charter.
4. Appointed a compliance officer, who reports directly to the individual 
specified in the CIA.
We appointed a compliance officer who—
1. Has sufficient staff and resources to carry out his or her responsibilities.
2. Actively participates in compliance training.
3. Has authority to conduct full and complete internal investigations 
without restriction.
4. Periodically revises the compliance program to meet changing cir­
cumstances and risks.
Billing Practices, Policies, and Procedures
Although no system of internal controls can provide absolute assurance that 
all bills comply in all respects with Medicare, Medicaid, and other federal 
health care program guidelines, we are not aware of any material weaknesses 
in our billing practices, policies, and procedures. Billings to third-party payors 
comply in all material respects with applicable coding principles and laws and 
regulations (including those dealing with Medicare and Medicaid antifraud and 
abuse) and only reflect charges for goods and services that were medically 
necessary, properly approved by regulatory bodies (e.g., the Food and Drug 
Administration), if required and properly rendered. [Insert other assertions as 
necessary to address matters covered in the CIA.] Any Medicare, Medicaid, and 
other federal health program billing deficiencies that we identified have been 
properly reported to the applicable payor within 60 days of discovery of the 
deficiency.
Corporate Integrity Policy
1. Our policy was developed and implemented within [number] days of 
execution of the CIA.
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2. The policy addresses the Company’s commitment to preparation and 
submission of accurate billings consistent with the standards set 
forth in federal health care program statutes, regulations, proce­
dures and guidelines or as otherwise communicated by Health Care 
Financing Administration (HCFA), its agents or any other agency 
engaged in the administration of the applicable federal health care 
program.
3. The policy addressed the specific issues that gave rise to the settle­
ment, as well as other risk areas identified by the OIG in published 
Fraud Alerts issued through [date].
4. Further details on the development and implementation of our policy 
were provided to the OIG in our letter dated [date].
5. Our policy was distributed to all employees, physicians and inde­
pendent contractors involved in submitting or preparing requests for 
reimbursement.
6. We have prominently displayed a copy of our policy on the Company’s 
premises.
Information and Education Program
As discussed more fully in our letter to the OIG dated [date], we conducted an 
Information and Education Program within [number] days of the CIA. The 
Information and Education Program requires that each officer, employee, agent 
and contractor charged with administering federal health care programs (in­
cluding, but not limited to billers, coders, nurses, physicians, medical records, 
hospital administration and other individuals directly involved in billing fed­
eral health care programs) receive at least [number] hours of training.
The training provided to employees involved in billing, coding, and/or charge 
capture consisted of instructions on submitting accurate bills, the personal 
obligations of each individual to ensure billings are accurate, the nature of 
company-imposed disciplinary actions on individuals who violate company 
policies and/or laws and regulations, applicable federal health care program 
rules, legal sanctions against the company for submission of false or fraudulent 
information, and how to report potential abuses or fraud. The training material 
addresses those issues underlying our settlement with the OIG.
The experience of the trainers is consistent with the topics presented.
Confidential Disclosure Program
Our Confidential Disclosure Program—
1. Was established within [number] days of the CIA.
2. Enables any employee to disclose any practices or billing procedures 
relating to federal health care programs.
3. Provides a toll-free telephone line maintained by the Company, 
which Company representatives have indicated is maintained 
twenty-four hours a day, seven days a week, for the purpose of 
making any disclosures regarding compliance with the Company’s 
Compliance Program, the obligations in the CIA, and Company’s 
overall compliance with federal and state standards.
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4. Includes policies requiring the review of any disclosures to permit a 
determination of the appropriateness of the billing practice alleged 
to be involved and any corrective action to be taken to ensure that 
proper follow-up is conducted.
5. A detailed summary of the communications (including the number 
of disclosures by employees and the dates of such disclosures) con­
cerning billing practices reported as, and found to be, inappropriate 
under the Confidential Disclosure Program, and the results of any 
internal review and the follow-up on such disclosures are summa­
rized in Attachment [title] to our Annual Report.
Excluded Individuals or Entities
Company policy—
1. Prohibits the employment of or contracting with an individual or 
entity that is listed by a federal agency as convicted of abuse or 
excluded, suspended or otherwise ineligible for participation in fed­
eral health care programs.
2. Includes a process to make an inquiry into the status of any potential 
employee or independent contractor.
3. Provides for an annual review of the status of all existing employees 
and contractors to verify whether any individual had been suspended 
or excluded or charged with a criminal offense relating to the provi­
sion of federal health care services.
We are not aware of any individuals employed in contravention of the prohibi­
tions in the CIA.
Record Retention
Our record retention policy is consistent with the requirements of the CIA.
Signed by:
[Chief Executive Officer]
[Chief Financial Officer]
[Corporate Compliance Officer]
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Appendix C 
Sample Engagement Letter
The following is an illustration of a sample engagement letter that may be used 
for this kind of engagement.
[CPA Firm Letterhead]
[Client’s Name and Address]
Dear_____________________ :
This will confirm our understanding of the arrangements for our performance 
of certain agreed-upon procedures in connection with management’s compli­
ance with the terms of the Corporate Integrity Agreement (CIA) with the Office 
of Inspector General (OIG) of the U.S. Department of Health and Human 
Services (HHS) dated [date of CIA] for the period ending [date].
We will perform those procedures enumerated in the attachment to this letter. 
Our responsibility is to carry out these procedures and report our findings. We 
will conduct our engagement in accordance with standards established by the 
American Institute of Certified Public Accountants. Our planned procedures 
were agreed to by management and will be communicated to the OIG for its 
review and are based on the terms specified in the CIA. The sufficiency of these 
procedures is solely the responsibility of the specified users of the report. 
Consequently, it is understood that we make no representation regarding the 
sufficiency of the procedures described in the attachment for the purpose for 
which this report has been requested or for any other purpose.
Management is responsible for the Company’s compliance with all applicable 
laws, regulations, and contracts and agreements, including the CIA. Manage­
ment also is responsible for the design, implementation, and monitoring of the 
policies and procedures upon which compliance is based.
Our engagement to perform agreed-upon procedures is substantially less in 
scope than an examination, the objective of which is the expression of an opinion 
on management’s compliance with the CIA. Accordingly, we will not express 
such an opinion or any other form of assurance thereon.1
Working papers that are prepared in connection with this engagement are the 
property of the independent accountant. The working papers are prepared for 
the purpose of providing the principal support for the independent accountant’s 
report. At the completion of our work, we expect to issue an agreed-upon 
procedures report in the attached form.
1 The independent accountant may wish to include an understanding with the client about any 
limitation or other arrangements regarding liability of the practitioner or the client in the engage­
ment letter. For example, the following might be included in the letter:
Our maximum liability relating to services rendered under this letter (regardless of form of 
action, whether in contract, negligence or otherwise) shall be limited to the charges paid to us 
for the portion of the services or work products giving rise to liability. We will not be liable for 
consequential or punitive damages (including lost profits or savings) even if aware of their 
possible existence.
You will indemnify us against any damage or expense that may result from any third-party 
claim relating to our services or any use by you of any work product, and you will reimburse 
us for all expenses (including counsel fees) as incurred by us in connection with any such claim, 
except to the extent such claim (i) is finally determined to have resulted from our gross negli­
gence or willful misconduct or (ii) is covered by any of the preceding indemnities.
AAG-HCO APP D
Statement of Position 99-1 335
If, however, we are not able to complete all of the specified procedures, we will 
so advise you. At that time, we will discuss with you the form of communication, 
if any, that you desire for our findings. We will ask you to confirm your request 
in writing at that time. If  you request that we delay issuance of our report until 
corrective action is taken that will result in compliance with all aspects of the 
CIA, we will do so only at your written request. Our working papers will be 
retained in accordance with our firm’s working paper retention policy.
The distribution of the independent accountant’s report will be restricted to the 
governing board and management of the Company and the OIG.
Our fees will be billed as work progresses and are based on the amount of time 
required at various levels of responsibility plus actual out-of-pocket expenses. 
Invoices are payable upon presentation. We will notify you immediately of any 
circumstances we encounter that could significantly affect our initial estimate 
of total fees.
We agree that to the extent required by law, we will allow the Comptroller General 
of the United States, HHS, and their duly authorized representatives to have access 
to this engagement letter and our documents and records to the extent necessary 
to verify the nature and amount of costs of the services provided to the Company, 
until the expiration of four years after we have concluded providing services to the 
Company that are performed pursuant to this Engagement Letter. In the event 
the Comptroller General, HHS, or their duly authorized representatives request 
such records, we agree to notify the Company of such request as soon as practicable.
In the event we are requested or authorized by the Company or are required by 
government regulation, subpoena, or other legal process to produce our documents 
or our personnel as witnesses with respect to our engagements for the Company, 
the Company will, so long as we are not a party to the proceeding in which the 
information is sought, reimburse us for our professional time and expenses, as well 
as the fees and expenses of our counsel, incurred in responding to such requests.
If this letter correctly expresses your understanding of this engagement, please 
sign the enclosed copy where indicated and return it to us. We appreciate the 
opportunity to serve you.
Sincerely,______________________________
[Partner’s Signature]
[Firm Name or Firm Representative]
Accepted and agreed to:_________________
[Client Representative’s Signature]
[Title]_________________________________
[Date]_________________________________
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Procedure________________________________________
Governance
1. We read the Company’s corporate minutes and 
organization chart and ascertained that, within 
[number] days of the date of the Corporate Integ­
rity Agreement (CIA), the Company—
a. Established a Compliance Committee, which 
is to meet meets at least monthly and requires 
a quorum to meet.
b. Appointed to its Compliance Committee 
members who include, at a minimum, those 
individuals specified in the CIA.
c. Delegated to the Compliance Committee the 
authority to implement and monitor the CIA, 
as evidenced by the organization chart or the 
Compliance Committee’s charter.
d. Appointed a compliance officer who reports 
directly to the individual specified in the CIA.
2. We interviewed the compliance officer and were 
informed that, in his or her opinion, the Compli­
ance Officer—
a. Has sufficient staff and resources to carry out 
his or her responsibilities.
b. Actively participates in compliance training.
c. Has the authority to conduct full and complete 
internal investigations without restriction.
d. Periodically revises the compliance program 
to meet changing circumstances and risks.
3. We read the OIG notification letter as specified in 
the CIA and noted that the appropriate official 
signed the letter, that it was addressed to the OIG, 
that it covered items (a) through (d) in Step 1, and 
that it was dated within [number of] days of the 
execution of the CIA.
Billing Practices, Policies, and Procedures
The practitioner might be engaged to provide consulting 
services in connection with the evaluation of the Com­
pany’s billing practices, policies, and procedures. I f  so, 
generally no agreed-upon procedures would be per­
formed relating to this area.
Alternatively, if the procedures relating to the Com­
pany’s billing practices, policies, and procedures are 
performed by others such as the Company’s internal 
audit staff, the practitioner performs Steps 4 through 9.
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4. We read the compliance work plan and noted the 
following:
a. The work plan’s stated objectives include the 
determination that billings are accurate and 
complete, for services rendered that have been 
deemed by medical specialists as being 
necessary, and are submitted in accordance 
with federal program guidelines.
b. The work plan sampling methodology sets 
confidence levels consistent with those defined 
in the CIA.
c. The work plan identifies risk areas, as defined 
in the CIA (if applicable), and specifies testing 
procedures by risk area.
d. The work plan specifies that samples are 
taken in risk areas (if applicable) identified by 
the CIA.
e. The work plan includes testing procedures, 
which the practitioner should modify as 
required by the CIA, for the following risks 
areas (if applicable) identified in the CIA:
(1) Clinical documentation, as follows:
(i) No documentation of service
(ii) Insufficient documentation of service
(iii) Improper diagnosis or treatment 
plan giving rise to the provision of a 
medically unnecessary service or 
treatment
(iv) Service or treatment does not conform 
medically with the documented 
diagnosis or treatment plan
(v) Services incorrectly coded
(2) Billing and coding, as follows:
(i) Noncovered or unallowable service
(ii) Duplicate payment
(iii) DRG window error
(iv) Unbundling
(v) Utilization
(vi) Medicare credit balances
[Note to Practitioner: Modify the preceding list as 
required by the CIA.]
5. We selected [quantity] probe samples performed by 
the independent review organization for the 
following risk areas [list risk areas tested]. For the 
probe samples selected, we noted that the—
a. Sample patient billing files were randomly 
selected.
b. Sample size reflected confidence levels 
specified in the CIA.
c. Sample plan describes how missing items (if 
any) would be treated.
Procedure_____________________________________________ Findings
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d. Patient billing files tested were pulled per the 
listing of random numbers and all patient 
billing files were accounted for in the working 
papers.
e. Work plans for the specific sample described 
the risk areas (if applicable) being tested and 
the testing approach/procedures.
f. Working papers noted the completion of each 
work plan step.
g. Working papers contained a summary of 
findings for the sample.
6. We reperformed the work plan steps [list of specific 
steps performed] for the sample patient billing 
files. The reperformance of work plan steps related 
to the medical review of the sample patient billing 
files was performed by the following individuals 
[note the professional qualifications of individuals 
without listing names]. Any exceptions between 
our findings and the Company’s are summarized 
in the Attachment to this report.
7. We read the summary findings of all internal 
compliance reviews that the Company’s Internal 
Audit department indicated it had performed for 
the Company and noted that all material billing 
deficiencies [specify material threshold as defined 
by the Company] noted therein were discussed in 
written communications addressed to the appro­
priate payor (for example, Medicare Part B carrier) 
and were dated within 60 days from the time the 
deficiency occurred.1
8. We inquired of [individual] as to whether the 
Company took remedial steps within [number of] 
days (or such additional time as agreed to by the 
payor) to correct all material billing deficiencies 
noted in Step 7. We were informed that such 
remedial steps had been taken.
9. By reading applicable correspondence, we noted 
that any material billing deficiencies noted in Step 
7 were communicated to the OIG, including 
specific findings relative to the deficiency, the 
Company’s actions taken to correct the deficiency, 
and any further steps the Company plans to take 
to prevent any similar deficiencies from recurring.
1 The CIA provides its own legal definition of a “material deficiency.” Determination of whether 
a billing or other act meets this definition is normally beyond the auditor’s professional competence 
and may have to await final determination by a court of law. Accordingly, to avoid confusion, a 
working definition different from that provided in the CIA (e.g., a specified dollar threshold) may be 
necessary.
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Corporate Integrity Policy
10. We read the Company’s Corporate Integrity Policy 
and noted the following.
a. The policy was developed and implemented 
within [number of] days of execution of the 
CIA.
b. The policy addressed the Company’s commit­
ment to preparation and submission of ac­
curate billings consistent with the standards 
set forth in federal health care program 
statutes, regulations, procedures, and 
guidelines or as otherwise communicated by 
HCFA, its agents, or any other agency 
engaged in the administration of the 
applicable federal health care program.
c. The policy addressed the specific issues that 
gave rise to the settlement, as well as other 
risk areas identified by the OIG in published 
Fraud Alerts issued through [agency].
d. Correspondence addressed to the OIG covered 
the development and implementation of the 
policy.
e. Documentation indicating that the policy was 
distributed to all employees, physicians, and 
independent contractors involved in submit­
ting or preparing requests for reimbursement.
f. The prominent display of a copy of the policy 
on the Company’s premises.
11. We selected a sample of ten employees (involved in 
submitting and preparing requests for reimburse­
ment) and examined written confirmation in the 
employee’s personnel file indicating receipt of a 
copy of the Corporate Integrity Policy.
Information and Education Program
12. We read the Company’s Information and Educa­
tion Program and noted the following.
a. The Information and Education Program 
agenda was dated within [number of] days of 
execution of the CIA.
b. Correspondence covering the development 
and implementation of the Information and 
Education Program was addressed to the OIG.
c. The Information and Education Program re­
quires that each officer, employee, agent, and 
contractor charged with administering federal 
health care programs (including, but not 
limited to billers, coders, nurses, physicians, 
medical records, hospital administration and 
other individuals directly involved in billing 
federal health care programs) receive at least 
[number of] hours of training.
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13. We selected a sample of ten employees involved in 
billing, coding and/or charge capture and ex­
amined sign-in logs of the training classes and 
noted that each had signed indicating that they 
had received at least [number of] hours of training 
as specified in the Information and Education Pro­
gram. We also reviewed tests and surveys com­
pleted by each of the ten trained employees noting 
evidence that they were completed.
14. We inquired as to the training of individuals not 
present during the regularly scheduled training 
programs and were informed that each such indi­
vidual is trained either individually or in a separ­
ate make-up session. We inquired as to the names 
of individuals not initially present and selected one 
such individual and examined that individual’s 
post-training test and survey for completion.
15. We read the course agenda and noted that the 
training provided to employees involved in billing, 
coding, and/or charge capture consisted of 
instructions on submitting accurate bills, the 
personal obligations of each individual to ensure 
billings are accurate, the nature of company- 
imposed disciplinary actions on individuals who 
violate company policies and/or laws and regula­
tions applicable to federal health care program 
rules, legal sanctions against the company for sub­
mission of false or fraudulent information, and 
how to report potential abuses or fraud. We also 
noted that the training material addressed the 
following issues which gave rise to the settlement 
[practitioner list].
16. We inquired of the Corporate Compliance Officer 
as to the qualifications and experience of the train­
ers and were informed that, in the Corporate Com­
pliance Officer’s opinion, they were consistent with 
the topics presented.
17. We noted that the Company’s draft Annual Report 
to the OIG dated [date] addresses certification of 
training.
Confidential Disclosure Program
18. We read documentation of the Company’s Confi­
dential Disclosure Program and noted that it—
a. Includes the printed effective date that was 
within [number of] days of execution of the CIA.
b. Consists of a confidential disclosure program 
enabling any employee to disclose any prac­
tices or billing procedures relating to federal 
health care programs.
Findings
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c. Provides a toll-free telephone line maintained 
by the Company, which Company representa­
tives have indicated is maintained twenty- 
four hours a day, seven days a week, for the 
purpose of making any disclosures regarding 
compliance with the Company’s Compliance 
Program, the obligations in the CIA, and 
Company’s overall compliance with federal 
and state standards.
d. Includes policies requiring the review of any 
disclosures to permit a determination of the 
appropriateness of the billing practice alleged to 
be involved and any corrective action to be taken 
to ensure that proper follow-up is conducted.
19. We made five test calls to the toll-free telephone 
line (hotline) and noted the following.
a. Each call was captured in the hotline logs and 
reported with all other incoming calls.
b. Anonymity is not discouraged.
20. We noted that the Company included in its draft 
Annual Report addressed to OIG dated [date] a 
detailed summary of the communications (includ­
ing the number of disclosures by employees and the 
dates of such disclosures) concerning billing prac­
tices reported as, and found to be, inappropriate 
under the Confidential Disclosure Program, and 
the results of any internal review and the follow-up 
on such disclosures.
21. We observed the display of the Company’s Confiden­
tial Disclosure Program, including notice of the 
availability of its hotline, on the Company’s premises.
Excluded Individuals or Entities
22. We read the Company’s written policy relating to 
dealing with excluded or convicted persons or 
entities and noted that the policy—
a. Prohibits the hiring of or contracting with an 
individual or entity that is listed by a federal 
agency as convicted of abuse or excluded, sus­
pended, or otherwise ineligible for participa­
tion in federal health care programs.
b. Includes a process to make an inquiry into the 
status of any potential employee or indepen­
dent contractor.
c. Provides for a semi-annual review of the 
status of all existing employees and contrac­
tors to verify whether any individual had been 
suspended or excluded or charged with a cri­
minal offense relating to the provision of 
federal health care services.
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23. We selected a sample of ten employees hired over 
the course of the test period as defined in the CIA 
and examined support in the employee’s personnel 
file documenting inquiries made into the status of 
the employee, including documentation of com­
parison to the [source specified in the CIA].
24. We performed the following procedures related to 
the Company’s semi-annual review of employee 
status.
a. Read documentation of the semi-annual re­
view as evidence that a review was performed.
b. Selected and reviewed the lesser of ten or all 
exceptions and determined that such employees 
were removed from responsibility for or involve­
ment with Provider business operations related 
to the Federal health care programs.
c. Examined a notification letter addressed to 
the OIG and dated within 30 days of the em­
ployee’s removal from employment.
d. Inquired of [officer] as to whether he or she 
was aware of any individuals employed in 
contravention of the prohibitions in the CIA. 
If so, we further noted that [indicate specific 
procedures] to confirm that such situation was 
cured within 30 days by [indicate how situa­
tion was cured].
Annual Report
25. We read the Company’s draft Annual Report dated 
[date] and determined that it included the follow­
ing items, to be modified as appropriate, by the 
practitioner:
a. Compliance Program Charter and organiza­
tion chart
b. Amendments to policies
c. Detailed descriptions of reviews and audits
d. Summary of hotline communications
e. Summary of annual review of employees
f. Cross-referencing to items noted in the CIA
Record Retention
26. We read the Company’s record retention policy and 
noted that it was consistent with the requirements 
as outlined in the CIA.
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Sample Report
Independent Accountant’s Report
[Date]
[Sample Health Care Provider]
Office of Inspector General of the U.S. Department of Health and Human 
Services
We have performed the procedures enumerated in the Attachment, which were 
agreed to by Sample Health Care Provider (Company) and the Office of 
Inspector General (OIG) of the U.S. Department of Health and Human Serv­
ices, solely to assist the users in evaluating management’s assertion about 
[name of entity’s] compliance with the Corporate Integrity Agreement (CIA) 
with the OIG dated [date of CIA] for the [period] ending [date], which is included 
as Attachment A to this report. This agreed-upon procedures engagement was 
performed in accordance with standards established by the American Institute 
of Certified Public Accountants. The sufficiency of these procedures is solely 
the responsibility of the specified users of the report. Consequently, we make 
no representation regarding the sufficiency of the procedures described in 
Attachment B either for the purpose for which this report has been requested 
or for any other purpose.
We were not engaged to and did not perform an examination, the objective of 
which would be the expression of an opinion on management’s compliance with 
the CIA. Accordingly, we do not express such an opinion. Had we performed 
additional procedures, other matters might have come to our attention that 
would have been reported to you.
This report is intended solely for the information and use of the Compliance 
Committee and management of the Company and the OIG, and is not intended 
to be and should not be used by anyone other than those specified parties.
[Include as Attachments the CIA and the summary that enumerates procedures 
and findings.]
[Signature]
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NOTE
This Statement of Position presents the recommendations of the 
AICPA Health Care Third-Party Revenue Recognition Task Force 
with regard to auditing financial statement assertions about third- 
party revenues and related receivables of health care entities. The 
Auditing Standards Board has found the recommendations in this 
Statement of Position to be consistent with existing standards cov­
ered by rule 202 of the AICPA Code of Professional Conduct. AICPA 
members should be prepared to justify departures from the recom­
mendations in this Statement of Position.
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SUMMARY
This Statement of Position (SOP) provides guidance to auditors regarding 
uncertainties inherent in health care third-party revenue recognition. It dis­
cusses auditing matters to consider in testing third-party revenues and related 
receivables, and provides guidance regarding the sufficiency of evidential 
matter and reporting on financial statements of health care entities exposed to 
material uncertainties.
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Auditing Health Care Third-Party 
Revenues and Related Receivables
Introduction and Background
1. Most health care providers participate in payment programs that pay 
less than full charges for services rendered. For example, some cost-based 
programs retrospectively determine the final amounts reimbursable for serv­
ices rendered to their beneficiaries based on allowable costs. With increasing 
frequency, even non-cost-based programs (such as the Medicare Prospective 
Payment System) have become subject to retrospective adjustments (for exam­
ple, billing denials and coding changes). Often, such adjustments are not known 
for a considerable period of time after the related services were rendered.
2. The lengthy period of time between rendering services and reaching 
final settlement, compounded further by the complexities and ambiguities of 
reimbursement regulations, makes it difficult to estimate the net patient 
service revenue associated with these programs. This situation has been 
compounded due to the frequency of changes in federal program guidelines.
3. The AICPA Audit and Accounting Guide Health Care Organizations 
(the Guide) requires that patient revenues be reported net of provisions for 
contractual and other adjustments (paragraph 10.20). As a result, patient 
receivables, including amounts due from third-party payors, are also reported 
net of expected contractual and other adjustments. However, amounts ulti­
mately realizable will not be known until some future date, which may be 
several years after the period in which the services were rendered.
4. This SOP provides guidance to auditors regarding uncertainties inher­
ent in health care third-party revenue recognition. It discusses auditing mat­
ters to consider in testing third-party revenue and related receivables, 
including the effects of settlements (both cost-based and non-cost-based third- 
party payment programs), and provides guidance regarding the sufficiency of 
evidential matter and reporting on financial statements of health care entities 
exposed to material uncertainties.
Scope and Applicability
5. This SOP applies to audits of health care organizations falling within 
the scope of the Guide. Its provisions are effective for audits of periods ending 
on or after June 30, 2000. Early application of the provisions of this SOP is 
permitted.
Third-Party Revenues and Related Receivables— 
Inherent Uncertainties
6. Health care entities need to estimate amounts that ultimately will be 
realizable in order for revenues to be fairly stated in accordance with generally 
accepted accounting principles (GAAP). The basis for such estimates may 
range from relatively straightforward calculations using information that is 
readily available to highly complex judgments based on assumptions about 
future decisions.
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7. Entities doing business with governmental payors (for example, Medicare 
and Medicaid) are subject to risks unique to the government-contracting 
environment that are hard to anticipate and quantify and that may vary from 
entity to entity. For example—
•  A health care entity’s revenues may be subject to adjustment as a result 
of examination by government agencies or contractors. The audit proc­
ess and the resolution of significant related matters (including disputes 
based on differing interpretations of the regulations) often are not 
finalized until several years after the services were rendered.
•  Different fiscal intermediaries (entities that contract with the federal 
government to assist in the administration of the Medicare program) 
may interpret governmental regulations differently.
•  Differing opinions on a patient’s principal medical diagnosis, including 
the appropriate sequencing of codes used to submit claims for pay­
ment, can have a significant effect on the payment amount.1
•  Otherwise valid claims may be determined to be nonallowable after 
the fact due to differing opinions on medical necessity.
•  Claims for services rendered may be nonallowable if  they are 
later determined to have been based on inappropriate referrals.2
•  Governmental agencies may make changes in program interpreta­
tions, requirements, or “conditions of participation,” some of which 
may have implications for amounts previously estimated.
8. Such factors often result in retrospective adjustments to interim pay­
ments. Reasonable estimates of such adjustments are central to the third-party 
revenue recognition process in health care, in order to avoid recognizing 
revenue that the provider will not ultimately realize. The delay between 
rendering services and reaching final settlement, as well as the complexities 
and ambiguities of billing and reimbursement regulations, makes it difficult to 
estimate net realizable third-party revenues.
Management's Responsibilities
9. Management is responsible for the fair presentation of its financial 
statements in conformity with GAAP. Management also is responsible for 
adopting sound accounting policies and for establishing and maintaining inter­
nal control that will, among other things, record, process, summarize, and 
report transactions (as well as events and conditions) consistent with manage­
ment’s assertions embodied in the financial statements. Despite the inherent 
uncertainties, management is responsible for estimating the amounts recorded 
in the financial statements and making the required disclosures in accordance 
with GAAP, based on management’s analysis of existing conditions.
1 Historically, the Health Care Financing Administration (HCFA) contracted with Peer Review 
Organizations (PROs) to validate the appropriateness of admissions and the clinical coding from 
which reimbursement was determined. Such reviews were typically performed within ninety days of 
the claim submission date. However, the government has modified its policies with respect to such 
reviews and now analyzes coding errors through other means, including in conjunction with investi­
gations conducted by the Office of the Inspector General (OIG) of the U. S. Department of Health and 
Human Services.
2 Effective January 1, 1995, the Limitation on Certain Physician Referrals law prohibited 
physicians from referring Medicare and Medicaid patients to health care organizations with which 
they had a financial relationship for the furnishing of designated health services. Implementing 
regulations have not yet been adopted as of the date of this publication.
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10. Management’s assertions regarding proper valuation of its revenues 
and receivables are embodied in the financial statements. Management is 
responsible for assuring that revenues are not recognized until their realiza­
tion is reasonably assured. As a result, management makes a reasonable 
estimate of amounts that ultimately will be realized, considering—among 
other things—adjustments associated with regulatory reviews, audits, billing 
reviews, investigations, or other proceedings. Estimates that are significant to 
management’s assertions about revenue include the provision for third-party 
payor contractual adjustments and allowances.
11. Management also is responsible for preparing and certifying cost 
reports submitted to federal and state government agencies in support of 
claims for payment for services rendered to government program beneficiaries.
The Auditor's Responsibilities
12. The auditor’s responsibility is to express an opinion on the financial 
statements taken as a whole. In reaching this opinion, the auditor considers 
the evidence in support of recorded amounts. If amounts are not known with 
certainty, the auditor considers the reasonableness of management’s estimates 
in the present circumstances. The auditor also considers the fairness of the 
presentation and adequacy of the disclosures made by management.
13. In planning the audit, the auditor considers current industry condi­
tions, as well as specific matters affecting the entity.3 Among a number of 
things, the auditor’s procedures typically include an analysis of historical 
results (for example, prior fiscal intermediary audit adjustments and compari­
sons with industry benchmarks and norms) that enable the auditor to better 
assess the risk of material misstatements in the current period. When there 
are heightened risks, the auditor performs more extensive tests covering the 
current period. Exhibit 5-1 of the Guide includes a number of examples of 
procedures that auditors may consider.
14. With respect to auditing third-party revenues, in addition to the usual 
revenue recognition considerations, the auditor considers whether amounts 
ultimately realizable are or should be presently known or are uncertain be­
cause they are dependent on some other future, prospective actions or confirm­
ing events. For example, under a typical fee-for-service contract with a 
commercial payor, if the provider has performed a service for a covered indi­
vidual, the revenue to which the provider is entitled should be determinable at 
the time the service is rendered. On the other hand, if the service was provided 
under a cost-based government contract, the revenue ultimately collectible 
may not be known until certain future events occur (for example, a cost report 
has been submitted and finalized after desk review or audit). In this case, 
management estimates the effect of such potential future adjustments.
15. As stated previously, management is responsible for preparing the 
estimates contained in the financial statements. The auditor evaluates the 
adequacy of the evidence supporting those estimates, reviews the facts sup­
porting management’s judgments, and evaluates the judgments made based on 
conditions existing at the time of the audit. The fact that net revenues recorded 
at the time services are rendered differ materially from amounts that ultimately
3 Risk factors, including ones related to legislative and regulatory matters, are discussed 
annually in the AICPA Audit Risk Alert Health Care Industry Developments.
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are realized does not necessarily mean the audit was not properly planned or 
carried out. Similarly, the fact that future events may differ materially from 
management’s assumptions or estimates does not necessarily mean that man­
agement’s estimates were not valid or the auditor did not follow generally 
accepted auditing standards (GAAS) as described in this SOP with respect to 
auditing estimates.
Evidential Matter
16. The measurement of estimates is inherently uncertain and depends 
on the outcome of future events. Statement on Auditing Standards (SAS) No. 
57, Auditing Accounting Estimates (AICPA, Professional Standards, vol. 1, AU 
sec. 342), and SAS No. 79, Amendment to SAS No. 58, Reports on Audited 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 508) 
provide guidance to the auditor when the valuation of revenues is uncertain, 
pending the outcome of future events. In the current health care environment, 
conclusive evidence concerning amounts ultimately realizable cannot be ex­
pected to exist at the time of the financial statement audit because the 
uncertainty associated with future program audits, administrative reviews, 
billing reviews, regulatory investigations, or other actions will not be resolved 
until sometime in the future.
17. The fact that information related to the effects of future program 
audits, administrative reviews, regulatory investigations, or other actions does 
not exist does not lead to a conclusion that the evidential matter supporting 
management’s assertions is not sufficient to support management’s estimates. 
Rather, the auditor’s judgment regarding the sufficiency of the evidential 
matter is based on the evidential matter that is available or can reasonably be 
expected to be available in the circumstances. If, after considering the existing 
conditions and available evidence, the auditor concludes that sufficient eviden­
tial matter supports management’s assertions about the valuation of revenues 
and receivables, and their presentation and disclosure in the financial state­
ments, an unqualified opinion ordinarily is appropriate.
18. If relevant evidential matter exists that the auditor needs and is 
unable to obtain, the auditor should consider the need to express a qualified 
opinion or to disclaim an opinion because of a scope limitation. For example, if 
an entity has conducted an internal evaluation (for example, of coding or other 
billing matters) under attorney—client privilege and management and its 
legal counsel refuse to respond to the auditor’s inquiries and the auditor 
determines the information is necessary, ordinarily the auditor qualifies his or 
her opinion for a scope limitation.
19. The auditor considers the reasonableness of management’s assump­
tions in light of the entity’s historical experience and the auditor’s knowledge 
of general industry conditions, because the accuracy of management’s assump­
tions will not be known until future events occur. For certain matters, the best 
evidential matter available to the auditor (particularly as it relates to clinical 
and legal interpretations) may be the representations of management and its 
legal counsel, as well as information obtained through reviewing correspon­
dence from regulatory agencies.
20. Pursuant to SAS No. 85, Management Representations (AICPA, 
Professional Standards, vol. 1, AU sec. 333), the auditor should obtain written 
representations from management concerning the absence of violations or 
possible violations of laws or regulations whose effects should be considered for 
disclosure in the financial statements or as a basis for recording a loss contin­
gency. Examples of specific representations include the following:
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•  Receivables
— Adequate consideration has been given to, and appropriate provi­
sion made for, estimated adjustments to revenue, such as for 
denied claims and changes to diagnosis-related group (DRG) 
assignments.
— Recorded valuation allowances are necessary, appropriate, and 
properly supported.
— All peer review organizations, fiscal intermediary, and third- 
party payor reports and information have been made available.
•  Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports have been 
properly filed.
— Management is responsible for the accuracy and propriety of all 
cost reports filed.
— All costs reflected on such reports are appropriate and allowable 
under applicable reimbursement rules and regulations and are 
patient-related and properly allocated to applicable payors.
— The reimbursement methodologies and principles employed are 
in accordance with applicable rules and regulations.
— Adequate consideration has been given to, and appropriate provi­
sion made for, audit adjustments by intermediaries, third-party 
payors, or other regulatory agencies.
— All items required to be disclosed, including disputed costs that 
are being claimed to establish a basis for a subsequent appeal, 
have been fully disclosed in the cost report.
— Recorded third-party settlements include differences between 
filed (and to be filed) cost reports and calculated settlements, 
which are necessary based on historical experience or new or 
ambiguous regulations that may be subject to differing interpre­
tations. While management believes the entity is entitled to all 
amounts claimed on the cost reports, management also believes 
the amounts of these differences are appropriate.
•  Contingencies
— There are no violations or possible violations of laws or regula­
tions, such as those related to the Medicare and Medicaid anti- 
fraud and abuse statutes, including but not limited to the 
Medicare and Medicaid Anti-Kickback Statute, Limitations on 
Certain Physician Referrals (the Stark law), and the False Claims 
Act, in any jurisdiction, whose effects should be considered for 
disclosure in the financial statements or as a basis for recording 
a loss contingency other than those disclosed or accrued in the 
financial statements.
— Billings to third-party payors comply in all material respects with 
applicable coding guidelines (for example, ICD-9-CM and CPT-4) 
and laws and regulations (including those dealing with Medicare 
and Medicaid antifraud and abuse), and billings reflect only 
charges for goods and services that were medically necessary; 
properly approved by regulatory bodies (for example, the Food and 
Drug Administration), if required; and properly rendered.
— There have been no communications (oral or written) from regulatory 
agencies, governmental representatives, employees, or others con­
cerning investigations or allegations of noncompliance with laws
AAG-HCO APP E
354 Health Care Organizations
and regulations in any jurisdiction (including those related to the 
Medicare and Medicaid antifraud and abuse statutes), deficien­
cies in financial reporting practices, or other matters that could 
have a material adverse effect on the financial statements.
21. Management’s refusal to furnish written representations constitutes 
a limitation on the scope of the audit sufficient to preclude an unqualified 
opinion and is ordinarily sufficient to cause an auditor to disclaim an opinion 
or withdraw from the engagement. However, based on the nature of the 
representations not obtained or the circumstances of the refusal, the auditor 
may conclude that a qualified opinion is appropriate.
Potential Departures From GAAP Related to Estimates 
and Uncertainties
22. In addition to examining the evidence in support of management’s 
estimates, the auditor determines that there has not been a departure from 
GAAP with respect to the reporting of those estimates in the financial state­
ments. Such departures generally fall into one of the following categories:
•  Unreasonable accounting estimates
•  Inappropriate accounting principles
•  Inadequate disclosure
Therefore, in order to render an opinion, the auditor’s responsibility is to 
evaluate the reasonableness of management’s estimates based on present 
circumstances and to determine that estimates are reported in accordance with 
GAAP and adequately disclosed.
23. As discussed in SAS No. 31, Evidential Matter (AICPA, Professional 
Standards, vol. 1, AU sec. 326), the auditor’s objective is to obtain sufficient 
competent evidential matter to provide him or her with a reasonable basis for 
forming an opinion. As discussed previously, exhibit 5-1 of the Guide provides 
a number of sample procedures that the auditor might consider in auditing an 
entity’s patient revenues and accounts receivable, including those derived from 
third-party payors. For example, the Guide notes that the auditor might “test 
the reasonableness of settlement amounts, including specific and unallocated 
reserves, in light of the payors involved, the nature of the payment mechanism, 
the risks associated with future audits, and other relevant factors.”4
Unreasonable Accounting Estimates
24. In evaluating the reasonableness of management’s estimates, the 
auditor considers the basis for management’s assumptions regarding the na­
ture of future adjustments and management’s calculations as to the effects of 
such adjustments.5 The auditor cannot determine with certainty whether such 
estimates are right or wrong, because the accuracy of management’s assump­
tions cannot be confirmed until future events occur.
25. Though difficult to predict, it is reasonable for the auditor to expect 
that management has made certain assumptions (either in detail or in the 
aggregate) in developing its estimates regarding conditions likely to result in 
adjustments. The auditor gathers evidence regarding the reasonableness of the
4 See paragraphs 25-28.
5 The lack of such analyses may call into question the reasonableness of recorded amounts.
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estimates (for example, consistency with historical experience and basis of 
management’s underlying assumptions). In evaluating reasonableness, the 
auditor should obtain an understanding of how management developed the 
estimate. Based on that understanding, the auditor should use one or a 
combination of the following approaches:
a. Review and test the process used by management to develop the 
estimate.
b. Develop an independent expectation of the estimate to corroborate 
the reasonableness of management’s estimates.
c. Review subsequent events or transactions occurring prior to comple­
tion of fieldwork (AU sec. 342.10).
26. Since no one accounting estimate can be considered accurate with 
certainty, the auditor recognizes that a difference between an estimated 
amount best supported by the audit evidence and the estimated amount 
included in the financial statements may be reasonable, and such difference 
would not be considered to be a likely misstatement. However, if the auditor 
believes the estimated amount included in the financial statements is unrea­
sonable, he or she should treat the difference between that estimate and the 
closest reasonable estimate in the range as a likely misstatement and aggre­
gate it with other likely misstatements. The auditor also should consider 
whether the difference between estimates best supported by the audit evidence 
and the estimates included in the financial statements, which are individually 
reasonable, indicate a possible bias on the part of the entity’s management. For 
example, if each accounting estimate included in the financial statements was 
individually reasonable, but the effect of the difference between each estimate 
and the estimate best supported by the audit evidence was to increase income, 
the auditor should reconsider the reasonableness of the estimates taken as a 
whole (SAS No. 47, Audit Risk and Materiality in Conducting an Audit 
[AICPA, Professional Standards, vol. 1, AU sec. 312.36]).
27. The auditor recognizes that approaches and estimates will vary from 
entity to entity. Some entities with significant prior experience may attempt 
to quantify the effects of individual potential intermediary or other govern­
mental (for example, the Office of Inspector General and the Department of 
Justice) or private payor adjustments, basing their estimates on very detailed 
calculations and assumptions regarding potential future adjustments. Some 
may prepare cost report6 analyses to estimate the effect of potential adjust­
ments. Others may base their estimates on an analysis of potential adjustments 
in the aggregate, in light of the payors involved; the nature of the payment 
mechanism; the risks associated with future audits; and other relevant factors.
28. Normally, the auditor considers the historical experience of the entity 
(for example, the aggregate amount of prior cost-report adjustments and previous 
regulatory settlements) as well as the risk of potential future adjustments. The
6 Medicare cost reimbursement is based on the application of highly complex technical rules, 
some of which are ambiguous and subject to different interpretations even among Medicare’s fiscal 
intermediaries. It is not uncommon for fiscal intermediaries to reduce claims for reimbursement that 
were based on management’s good faith interpretations of pertinent laws and regulations. Addition­
ally, the Provider Reimbursement Review Board (PRRB) or the courts may be required to resolve 
controversies regarding the application of certain rules. To avoid recognizing revenues before their 
realization is reasonably assured, providers estimate the effects of such potential adjustments. This 
is occasionally done by preparing a cost report based on alternative assumptions to help estimate 
contractual allowances required by generally accepted accounting principles. The existence of re­
serves or a reserve cost report does not by itself mean that a cost report was incorrectly or 
fraudulently filed.
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fact that an entity currently is not subject to a governmental investigation does 
not mean that a recorded valuation allowance for potential billing adjustments 
is not warranted. Nor do these emerging industry trends necessarily indicate 
that an accrual for a specific entity is warranted.
29. In evaluating valuation allowances, the auditor may consider the entity’s 
historical experience and potential future adjustments in the aggregate. For 
example, assume that over the past few years after final cost report audits were 
completed, a hospital’s adjustments averaged 3 percent to 5 percent of total filed 
reimbursable costs. Additionally, the hospital is subject to potential billing adjust­
ments, including errors (for example, violations of the three-day window, dis­
charge and transfer issues, and coding errors). Even though specific incidents are 
not known, it may be reasonable for the hospital to estimate and accrue a valuation 
allowance for such potential future retrospective adjustments, both cost-based and 
non-cost-based. Based on this and other information obtained, the auditor may 
conclude that a valuation allowance for the year under audit of 3 percent to 5 
percent of reimbursable costs plus additional amounts for potential non-cost-based 
program billing errors is reasonable.
30. Amounts that ultimately will be realized by an entity are dependent 
on a number of factors, many of which may be unknown at the time the 
estimate is first made. Further, even if two entities had exactly the same 
clinical and coding experience, amounts that each might realize could vary 
materially due to factors outside of their control (for example, differing appli­
cation of payment rules by fiscal intermediaries, legal interpretations of courts, 
local enforcement initiatives, timeliness of reviews, and quality of documenta­
tion). As a result, because estimates are a matter of judgment and their 
ultimate accuracy depends on the outcome of future events, different entities 
in seemingly similar circumstances may develop materially different esti­
mates. The auditor may conclude that both estimates are reasonable in light 
of the differing assumptions.
Inappropriate Accounting Principles
31. The auditor also determines that estimates are presented in the 
financial statements in accordance with GAAP. If  the auditor believes that the 
accounting principles have not been applied correctly, causing the financial 
statements to be materially misstated, the auditor expresses a qualified or 
adverse opinion.
32. Valuation allowances are recorded so that revenues are not recog­
nized until the revenues are realizable. Valuation allowances are not estab­
lished based on the provisions of Financial Accounting Standards Board 
(FASB) Statement of Financial Accounting Standards No. 5, Accounting for 
Contingencies.
33. The auditor should be alert for valuation allowances not associated 
with any particular program, issue, or time period (for example, cost-report 
year or year the service was rendered). Such a reserve may indicate measure­
ment bias. The auditor also considers the possibility of bias resulting in 
distorted earnings trends over time (for example, building up specific or 
unallocated valuation allowances in profitable years and drawing them down 
in unprofitable years).
Inadequate Disclosure
34. If the auditor concludes that a matter involving a risk or an uncer­
tainty is not adequately disclosed in the financial statements in conformity
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with GAAP, the auditor should express a qualified or adverse opinion. SOP 
94-6, Disclosure of Certain Significant Risks and Uncertainties, provides guid­
ance on the information that reporting entities should disclose regarding risks 
and uncertainties existing as of the date of the financial statements.
35. In the health care environment, it is almost always at least reason­
ably possible that estimates regarding third-party payments could change in 
the near term as a result of one or more future confirming events (for example, 
regulatory actions reflecting local or national audit or enforcement initiatives). 
For most entities with significant third-party revenues, the effect of the change 
could be material to the financial statements. Where material exposure exists, 
the uncertainty regarding revenue realization is disclosed in the notes to the 
financial statements. Because representations from legal counsel are often key 
audit evidence in evaluating the reasonableness of management’s estimates of 
potential future adjustments, the inability of an attorney to form an opinion on 
matters about which he or she has been consulted may be indicative of an 
uncertainty that should be specifically disclosed in the financial statements.
36. Differences between original estimates and subsequent revisions 
might arise due to final settlements, ongoing audits and investigations, or 
passage of time in relation to the statute of limitations. The Guide (paragraph 
5.07) requires that these differences be included in the statement of operations 
in the period in which the revisions are made and disclosed, if material. Such 
differences are not treated as prior period adjustments unless they meet the 
criteria for prior period adjustments as set forth in FASB Statement No. 16, 
Prior Period Adjustments.
37. Disclosures such as the following may be appropriate:
General Hospital (the Hospital) is a (not-for-profit, for-profit, or governmental 
hospital or health care system) located in (City, State). The Hospital provides 
health care services primarily to residents of the region.
Net patient service revenue is reported at estimated net realizable amounts 
from patients, third-party payors, and others for services rendered and includes 
estimated retroactive revenue adjustments due to future audits, reviews, and 
investigations. Retroactive adjustments are considered in the recognition of 
revenue on an estimated basis in the period the related services are rendered, 
and such amounts are adjusted in future periods as adjustments become known 
or as years are no longer subject to such audits, reviews, and investigations.
Revenue from the Medicare and Medicaid programs accounted for approxi­
mately 40 percent and 10 percent, respectively, of the Hospital’s net patient 
revenue for the year ended 1999. Laws and regulations governing the Medicare 
and Medicaid programs are extremely complex and subject to interpretation.
As a result, there is at least a reasonable possibility that recorded estimates 
will change by a material amount in the near term. The 1999 net patient service 
revenue increased approximately $10,000,000 due to removal of allowances 
previously estimated that are no longer necessary as a result of final settle­
ments and years that are no longer subject to audits, reviews, and investiga­
tions. The 1998 net patient service revenue decreased approximately 
$8,000,000 due to prior-year retroactive adjustments in excess of amounts 
previously estimated.
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Appendix 
Other Considerations Related to 
Government Investigations
In recent years, the federal government and many states have aggressively 
increased enforcement efforts under Medicare and Medicaid anti-fraud and 
abuse legislation. Broadening regulatory and legal interpretations have signifi­
cantly increased the risk of penalties for providers; for example, broad inter­
pretations of “false claims” laws are exposing ordinary billing mistakes to 
scrutiny and penalty consideration. In such circumstances, evaluating the 
adequacy of accruals for or disclosure of the potential effects of illegal acts in 
the financial statements of health care organizations is a matter that is likely 
to require a high level of professional judgment.
As previously discussed in this SOP, the far-reaching nature of alleged fraud 
and abuse violations creates an uncertainty with respect to the valuation of 
revenues, because future allegations of illegal acts could, if proven, result in a 
subsequent reduction of revenues. In addition, management makes provisions 
in the financial statements and disclosures for any contingent liabilities asso­
ciated with fines and penalties due to violations of such laws. FASB Statement 
No. 5, Accounting for Contingencies, provides guidance in evaluating contingent 
liabilities, such as fines and penalties under applicable laws and regulations. 
Estimates of potential fines and penalties are not accrued unless their payment 
is probable and reasonably estimable.
The auditor’s expertise is in accounting and auditing matters rather than 
operational, clinical, or legal matters. Accordingly, the auditor’s procedures 
focus on areas that normally are subject to internal controls relevant to 
financial reporting. However, the further that potential illegal acts are removed 
from the events and transactions ordinarily reflected in the financial state­
ments, the less likely the auditor is to become aware of the act, to recognize its 
possible illegality, and to evaluate the effect on the financial statements. For 
example, determining whether a service was medically necessary, obtained 
through a legally appropriate referral, properly performed (including using 
only approved devices, rendered in a quality manner), adequately supervised, 
accurately documented and classified, or rendered and billed by nonsanctioned 
individuals typically is not within the auditor’s professional expertise. As a 
result, an audit in accordance with generally accepted auditing standards 
(GAAS) is not designed to detect such matters.
Further, an audit conducted in accordance with GAAS does not include render­
ing an opinion or any form of assurance on an entity’s compliance with laws 
and regulations.1 Nor does an audit under GAAS include providing any 
assurance on an entity’s billings or cost report. In fact, cost reports typically 
are not prepared and submitted until after the financial statement audit has 
been completed.
Certain audit procedures, although not specifically designed to detect illegal 
acts, may bring possible illegal acts to an auditor’s attention. When a poten­
tially illegal act is detected, the auditor’s responsibilities are addressed in SAS
1 Even when auditors undertake a special engagement designed to attest to compliance with 
certain provisions of laws, regulations, contracts, and grants (for example, an audit in accordance 
with OMB Circular A-133), the auditor’s procedures do not extend to testing compliance with laws 
and regulations related to Medicare and Medicaid fraud and abuse.
AAG-HCO APP E
Statement of Position 00-1 359
No. 54, Illegal Acts by Clients (AICPA, Professional Standards, vol. 1, AU sec. 
317). Disclosure of an illegal act to parties other than the client’s senior 
management and its audit committee or board of directors is not ordinarily part 
of the auditor’s responsibility, and such disclosure would be precluded by the 
auditor’s ethical or legal obligation of confidentiality, unless the matter affects 
the auditor’s opinion on the financial statements.2
2 Statement on Auditing Standards No. 54, Illegal Acts by Clients (AICPA, Professional Stand­
ards, vol. 1, AU sec. 317.23), discusses circumstances in which a duty to notify parties outside the 
client of detected illegal acts may exist.
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Appendix F
GASB Statement No. 34, Basic Financial 
Statements— and Management's Discussion 
and Analysis— for State and Local 
Governments, Reporting Requirements
1. This appendix discusses the accounting and financial reporting require­
ments, as they apply to governmental health care entities within the scope of 
this Guide, of GASB Statement No. 34, Basic Financial Statements—and 
Management’s Discussion and Analysis—for State and Local Governments, as 
amended by these Statements:
•  GASB Statement No. 35, Basic Financial Statements—and Manage­
ment’s Discussion and Analysis—for Public Colleges and Universities
•  GASB Statement No. 37, Basic Financial Statements—and Manage­
ment’s Discussion and Analysis—for State and Local Governments: 
Omnibus
2. This appendix makes various references to implementation guides pub­
lished by the GASB staff. Those implementation guides are category (d) 
guidance in the hierarchy of generally accepted accounting principles (GAAP) 
applicable to state and local governments, as discussed in SAS No. 69, The 
Meaning of Present Fairly in Conformity With Generally Accepted Accounting 
Principles (AICPA, Professional Standards, vol. 1, AU sec. 411). References to 
the guidance in GASB staff implementation guides in this Guide do not elevate 
that guidance to category (b) guidance. Similarly, references in this appendix 
to discussions or examples in the nonauthoritative appendixes of GASB pro­
nouncements or its staff implementation guides do not elevate that guidance 
from “other accounting literature.”
3. As discussed in paragraph 1.11 of this Guide, GASB Statement No. 34, as 
amended, is effective in three annual phases, starting with periods beginning 
after June 15, 2001, so its provisions are not yet in effect for certain govern­
mental health care entities. Because of its phased-in effective dates, the 
chapters and the illustrative financial statements for a governmental hospital 
authority in appendix A in this edition of the Guide have not been modified to 
conform to the requirements of GASB Statement No. 34, as amended. However, 
guidance on its requirements concerning governmental health care entities 
that are included in the scope of this Guide is provided in this appendix. A 
future edition of this Guide will be modified to conform to the requirements of 
GASB Statement No. 34, as amended. The topics in this appendix are organized 
in a manner similar to the organization of topics by chapter in the Guide. The 
related chapter numbers are noted next to the various section headings in this 
appendix.
4. GASB Statement No. 38, Certain Financial Statement Note Disclosures, 
generally has the same effective dates as GASB Statement No. 34 and its 
amendments (although portions of GASB Statement No. 38 may be adopted 
before GASB Statement No. 34). For this reason, the disclosures amended or 
established by GASB Statement No. 38 are also discussed in this appendix.
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GASB Statement No. 34 and Applicability of This 
Guide (Preface to the Guide, Applicability Section)
5. As discussed in the Preface and in paragraph 1.08 in this Guide, the 
applicability of this Guide is limited to the separate financial statements 
issued for governmental health care entities that are either enterprise funds 
of governmental entities or that report using enterprise fund accounting and 
financial reporting requirements. GASB Statement No. 34, paragraph 67, 
replaces the previous definition of enterprise funds in NCGA Statement 1, 
Governmental Accounting and Financial Reporting Principles, with a new 
definition. Based on paragraph 67 of GASB Statement No. 34, any activity 
that charges a fee to external users for goods or services may be reported as 
an enterprise fund. In addition, paragraph 67 requires governments to 
report activities in enterprise funds if any one of the following three criteria 
is met:
a. The activity is financed with debt that is secured solely by a pledge 
of the net revenues from fees and charges of the activity.
b. Laws or regulations require the activity’s costs of providing services, 
including capital costs, to be recovered with fees and charges rather 
than with taxes or similar revenues.
c. The pricing policies of the activity establish fees and charges to 
external users that are designed to recover the activity’s costs of 
providing services, including capital costs.
Paragraph 67 of GASB Statement No. 34 requires that these criteria should be 
applied in the context of the activity’s principal revenue sources.
6. This Guide is not the only industry-specific AICPA Audit and Account­
ing Guide that auditors might have to consider when performing an audit 
of a governmental health care entity. The Audit and Accounting Guide 
Audits of State and Local Governments (GASB 34 Edition), includes govern­
mental health care entities in its scope and was cleared by the GASB. 
Therefore, certain accounting and financial reporting guidance in that 
Guide constitutes category (b ) guidance for governmental health care enti­
ties, and the auditing guidance in that Guide should also be considered 
during an audit of a governmental health care entity that is included in the 
scope of this Guide. In practice, auditors of governmental health care 
entities that issue separate financial statements using enterprise fund 
accounting and reporting may use this Guide as the primary source of 
guidance because this Guide addresses transactions that are unique to or 
prevalent in the health care industry. The Audit and Accounting Guide 
Audits of State and Local Governments (GASB 34 Edition), however, con­
tains information about governmental accounting and financial reporting 
standards and other matters that are unique to or prevalent in government 
and not included in this Guide.1
1 See paragraphs 1.21 and 12.11 through 12.13 in Audits o f State and Local Governments 
(GASB 34 Edition). Audits o f State and Local Governments (GASB 34 Edition), is effective for audits 
of a state or local government’s financial statements for the first fiscal period ending after June 15, 
2003, in which the government does apply, or is required to apply, the provisions of GASB Statement 
No. 34, Basic Financial Statements— and Management’s Discussion and Analysis—for State and 
Local Governments, or No. 35, Basic Financial Statements—and Management’s Discussion and 
Analysis—for Public Colleges and Universities. Earlier application of the Audit and Accounting 
Guide, Audits o f State and Local Governments (GASB 34 Edition), is encouraged if a government 
issues financial statements that apply GASB Statements No. 34 or No. 35 after that Guide was 
issued.
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7. Many governmental health care entities are considered to be special- 
purpose governments as defined in GASB Statement No. 34, paragraph 
134.2 Special-purpose governments are legally separate entities, as that term 
is described in paragraph 15 of GASB Statement No. 14, The Financial 
Reporting Entity. They may be component units of another governmental entity 
or they may be other stand-alone governments. (Both terms component units 
and other stand-alone governments are also defined by GASB Statement No.
14.)3 Because GASB Statement No. 34 is written from the perspective of 
general-purpose governments, paragraph 138 of GASB Statement No. 34 
discusses how those requirements apply to special-purpose governments en­
gaged only in business-type activities, such as certain governmental health care 
entities. Governmental health care entities that are special-purpose govern­
ments engaged only in business-type activities should present only the financial 
statements required for enterprise funds. These financial statements are 
discussed further in paragraph 9 of this appendix.
Overview— Changes Required by GASB Statement No. 
34 (Chapter 1 in the Guide)
8. Briefly, GASB Statement No. 34 and related pronouncements require 
governmental health care entities that are special-purpose governments en­
gaged only in business-type activities to make these changes in their separately 
issued financial reports:
•  Present a management’s discussion and analysis (MD&A) before the 
basic financial statements as required supplementary information 
(RSI).
•  Present a classified statement of net assets/balance sheet.
•  Report three categories of net assets—(1) net assets invested in capital 
assets net of related debt, (2) restricted net assets, and (3) unrestricted 
net assets—instead of fund balance.
•  Apply a new definition of restricted in determining restricted assets 
and restricted net assets.
•  Present a statement of revenues, expenses, and changes in net assets/ 
equity that reports on changes in net assets, including permanent 
endowments. The focus of this statement is to present all changes in 
net assets, not just those that affect net income.
2 GASB Statement No. 34 does not provide guidance on separate reporting by individual 
enterprise funds of a government. Although this appendix is written in terms of special-purpose 
business-type activities that are governmental health care entities, the accounting, financial report­
ing, and auditing considerations are usually equally applicable when the health care activity is 
conducted as a function or program of a general-purpose government and reported in an enterprise 
fund. See footnote 7 to the section heading “Specific Guidance for Special-Purpose Governments” in 
chapter 12 of Audits o f State and Local Governments (GASB 34 Edition). Reporting guidance on 
separate reporting by individual enterprise funds of a government is provided in Audits o f State and 
Local Governments (GASB 34 Edition). See footnote 1 for information about the effective date of that 
Guide.
3 In May 2002, the GASB issued GASB Statement No. 39, Determining Whether Certain 
Organizations Are Component Units, an amendment of GASB Statement No. 14, The Financial 
Reporting Entity. GASB Statement No. 39 may require the reporting of certain hospital foundations 
in the financial statements of governmental health care entities, regardless of whether the founda­
tions follow FASB or GASB standards. GASB Statement No. 39 is effective for financial statements 
for periods beginning after June 15, 2003. Earlier application is encouraged. If any further conform­
ing changes are identified for this Guide to reflect the issuance of GASB Statement No. 39, those 
changes will be made in a future edition of this Guide.
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•  No longer present a separate statement of changes in fund balances. 
These changes are reported in the all-inclusive statement of revenues, 
expenses and changes in net assets/equity.
•  No longer present an amount representing net income/loss. (GASB 
Statement No. 34, however, does not prohibit presenting different 
subtotals within the statement of revenues, expenses, and changes in 
fund net assets. See paragraph 16 of this appendix.)
•  Eliminate reporting of interfund activity as residual equity transfers.
•  Report both operating transfers and residual equity transfers as 
interfund transfers after nonoperating revenues and expenses.
•  Report revenues by major source and separately identify pledged 
revenues.
•  Distinguish between operating and nonoperating revenues and ex­
penses and provide an intermediate total for operating income or loss.
•  Report capital contributions and contributions to term and permanent 
endowments as a component of the all-inclusive statement of reve­
nues, expenses, and changes in net assets.
•  Separately report special items and extraordinary items at the bottom 
of the statement of revenues, expenses, and changes in net assets/ 
equity. (Note that footnote 3 to paragraph 10.18 in this Guide pre­
viously required that governmental enterprises report extraordinary 
items in the statement of operations immediately preceding net income).
•  Report operating cash flows using the direct method in the statement 
of cash flows.
•  Present new note disclosures, including the entity’s policy for defining 
operating revenues and expenses, policy regarding the use of re­
stricted resources, schedules of changes in capital assets and long­
term liabilities, disaggregated information about accounts receivable 
and payable, and short-term debt activity during the year. (Disclosure 
of disaggregated information about accounts receivable and payable 
is required by GASB Statement No. 38.)
•  Present segment information based on a new definition of a segment.
Financial Reporting of Governmental Health Care 
Entities (Chapter 1 in the Guide, Financial Reporting of 
Health Care Organizations Section)
9. GASB Statement No. 34 requires governmental health care entities that 
are special-purpose governments engaged only in business-type activities to 
present three basic financial statements, notes to the financial statements, and 
RSI:4
a. MD&A as RSI.
b. A statement of net assets or balance sheet.
c. A statement of revenues, expenses, and changes in net assets/equity.
d. A statement of cash flows.
e. Notes to financial statements.
f. RSI other than MD&A, as established by GAAP, such as GASB 
Statement No. 27, Accounting for Pensions by State and Local Gov­
ernmental Employers.
4 See footnote 2.
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This appendix presents an illustrative MD&A and basic financial statements 
for a sample governmental hospital authority based on GASB Statement No. 
34, as amended and GASB Statement No. 38.5
Management's Discussion and Analysis
10. GASB Statement No. 34, paragraphs 8 through 11, as amended, estab­
lish eight required elements of MD&A for general-purpose governments. How­
ever, certain of those elements are not applicable to governmental health care 
entities that are special-purpose governments engaged only in business-type 
activities. These governmental health care entities should limit their discus­
sion in MD&A to the elements that are applicable to their entity. Because it is 
RSI, no additional information should be presented within MD&A.
11. Many health care entities that are special-purpose governments engaged 
only in business-type activities present comparative financial statements. 
When comparative financial statements are presented, MD&A should present 
an analysis of both current- and prior-year net assets and changes in them, as 
discussed in the GASB staff document, Guide to Implementation of GASB 
Statement No. 34 on Basic Financial Statements— and Management’s Dis­
cussion and Analysis—for State and Local Governments: Questions and An­
swers (GASB 34 Q&A), item 8.6 Two completely separate MD&As are not 
required.
Measurement Focus and Basis of Accounting
12. GASB Statement No. 34, paragraph 92, requires activities reported using 
enterprise fund accounting and reporting to use the accrual basis of accounting 
and the economic resources measurement focus. GASB Statement No. 34, para­
graphs 93 through 95, make permanent the provisions of GASB Statement No. 20, 
Accounting and Financial Reporting for Proprietary Funds and Other Governmen­
tal Entities That Use Proprietary Fund Accounting. GASB Statement No. 20, as 
amended, requires governmental health care entities that use enterprise fund 
accounting and reporting to apply all GASB pronouncements as well as FASB 
pronouncements issued on or before November 30, 1989 that do not conflict with 
or contradict GASB pronouncements. In addition, those entities may also apply all 
FASB Statements and Interpretations issued after November 30, 1989, except for 
those that conflict with or contradict GASB pronouncements. Only those FASB 
Statements and Interpretations issued after November 30, 1989 that are developed 
for business enterprises should be applied, as discussed in GASB Statement No.
29, The Use of Not-for-Profit Accounting and Financial Reporting Principles by 
Governmental Entities, paragraph 7, as amended. GASB Statement No. 34, para­
graph 115, requires disclosure in the summary of significant accounting policies of 
the policy for applying FASB pronouncements issued after November 30, 1989, to 
business-type activities and to enterprise funds. The requirements in this Guide 
presume that governmental health care entities apply paragraph 7 of GASB 
Statement No. 20.
Statement of Net Assets or Balance Sheet
13. GASB Statement No. 34, paragraphs 97 through 99, provide guidance on 
the statement of net assets or balance sheet. Governmental health care entities
5 There may be situations where governmental health care entities report using multiple 
enterprise funds. Reporting guidance for multiple fund reporting is provided in Audits o f State and 
Local Governments (GASB 34 Edition). See footnote 1 for information about the effective date of that
Guide.
6 See paragraph 2 of this appendix regarding discussions of GASB staff Implementation Guides
in this appendix.
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that are special-purpose governments engaged only in business-type activities 
may use either a balance sheet format—assets equal liabilities plus net assets/ 
equity—or a net assets format—assets less liabilities equal net assets/equity. 
Assets and liabilities are required to be presented in a classified format.7
14. Either term net assets or equity may be used to refer to the difference 
between assets and liabilities. Regardless of the label, net assets/equity is 
required to be reported in three broad components: (1) invested in capital 
assets, net of related debt; (2) restricted, and (3) unrestricted. When permanent 
endowments are reported in restricted net assets, two additional components— 
expendable and nonexpendable are required, as discussed in paragraph 35 of 
GASB Statement No. 34.
15. The term restricted is defined by GASB Statement No. 34, paragraphs
34 and 99. A restriction is a constraint placed on the use of assets or net assets 
that is either externally imposed (such as by creditors through debt covenants) 
or imposed by law through constitutional provisions or enabling legislation. 
Internally designated net assets should be reported as unrestricted net assets 
and should not be displayed separately in the net assets section of the statement 
of net assets/balance sheet, as discussed in paragraph 37 of GASB Statement 
No. 34. (Designated assets, however, may be reported in the statement of net 
assets/balance sheet, as discussed in paragraph 3.01 in this Guide.)
Statement of Revenues, Expenses and Changes in Net 
Assets/Equity
16. The operating statement of governmental health care entities that are 
special-purpose governments engaged only in business-type activities is the state­
ment of revenues, expenses, and changes in net assets/equity. Changes in both 
restricted and unrestricted net assets should be reported in this statement 
using an all inclusive format, illustrated in GASB Statement No. 34, paragraph 
101:
Operating revenues (detailed)
Total operating revenues
Operating expenses (detailed)
Total operating expenses
Operating income (loss)
Nonoperating revenues and expenses (detailed)
Income before other revenues, expenses, gains, losses, and transfers
Capital contributions (grant, developer, and other), additions 
to permanent and term endowments, special and 
extraordinary items (detailed) and transfers
Increase (decrease) in net assets
Net assets—beginning of period
Net assets—end of period
In a change in net assets approach, the increase or decrease in net assets for 
the period and net income are not necessarily the same amount (for example, 
because of capital contributions), as noted in GASB Statement No. 34, paragraph
7 Guidance regarding the classification of certain specific assets or liabilities can be found in the 
chapters of the Guide. For example, see paragraph 4.16 in this Guide regarding the reporting of 
securities as current and noncurrent.
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433. However, GASB Statement No. 34, paragraph 434, indicates that this 
required format does not preclude governments from presenting different 
subtotals before the comprehensive performance measure—increase (decrease) 
in net assets.8
17. As discussed in paragraph 100 and footnote 41 in GASB Statement No.
34, governmental health care entities are required to report revenues (net of 
discounts and allowances) by major source and separately identify revenues 
that provide security for revenue bonds. (See further discussion in paragraph
35 of this appendix). As illustrated in paragraph 16 of this appendix, separate 
subtotals are required for operating revenues, operating expenses and operat­
ing income (loss). Governmental health care entities are required by GASB 
Statement No. 34, paragraph 102, to establish a policy that defines operating 
revenues and expenses that is appropriate to the nature of the activity being 
reported and to disclose that policy in the notes to the financial statements. 
Paragraph 37 of this appendix discusses factors that may be considered in 
establishing that policy.
18. Revenues from capital contributions as well as contributions to the 
principal of permanent and term endowments should be reported after nonop­
erating revenues and expenses, as discussed in GASB Statement No. 34, 
paragraph 100. Income from permanent or term endowments should be re­
corded as nonoperating revenue, as discussed in the GASB staff document 
Guide to Implementation of GASB Statement 34 and Related Pronouncements: 
Questions and Answers (2nd GASB 34 Q&A), item 136.9
19. Governmental health care entities that apply paragraph 7 of GASB 
Statement No. 20 should be aware that the all-inclusive format required by 
GASB Statement No. 34 conflicts with FASB Statement No. 130, Reporting 
Comprehensive Income, as discussed in the 2nd GASB 34 Q&A, item 98.10
Statement of Cash Flows
20. GASB Statement No. 34, paragraph 105, requires governmental health 
care entities that are special-purpose governments engaged only in business- 
type activities to present a statement of cash flows using the direct method, 
discussed in GASB Statement No. 9, Reporting Cash Flows of Proprietary and 
Nonexpendable Trust Funds and Governmental Entities that Use Proprietary 
Fund Accounting, paragraph 31, as amended. A reconciliation of operating 
income (loss) to operating cash flows also should be presented.
General Auditing Considerations (Chapter 2 in 
the Guide)
21. As discussed in paragraph 4 of this appendix, this Guide is not the only 
industry-specific AICPA Audit and Accounting Guide that auditor’s might have 
to consider when performing an audit of a governmental health care entity. The 
Audit and Accounting Guide Audits of State and Local Governments (GASB 34 
Edition), includes governmental health care entities in its scope and the 
auditing guidance in that Guide should also be considered during an audit of a 
governmental health care entity that is included in the scope of this Guide.
8 See paragraph 2 of this appendix regarding discussions of nonauthoritative appendixes to
GASB pronouncements in this appendix.
10 See paragraph 2 of this appendix regarding discussions of GASB staff Implementation 
Guides in this appendix.
9 See paragraph 2 of this appendix regarding discussions of GASB staff Implementation Guides
in this appendix.
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22. Paragraph 2.01 of this Guide discusses the need to establish an under­
standing with the client about the scope of the audit engagement. Chapter 4 in 
the Audit and Accounting Guide Audits of State and Local Governments (GASB 
34 Edition), also discusses the need to establish an understanding with the 
client. That discussion states that the auditor should consider holding a 
preaudit conference with the auditee to discuss the responsibilities of both the 
auditee and the auditor. That discussion also provides a listing of topics for the 
preaudit conference that have elements that are unique to or significant in a 
governmental audit.
23. Paragraph 2.07 of this Guide discusses the guidance on materiality 
provided in SAS No. 47, Audit Risk and Materiality in Conducting an Audit 
(AICPA, Professional Standards, vol. 1, AU sec. 312). The Audit and Accounting 
Guide Audits of State and Local Governments (GASB 34 Edition), provides 
additional guidance on audit materiality determinations, including opinion 
units, as that term is described in the Audit and Accounting Guide Audits of 
State and Local Governments (GASB 34 Edition).
24. Paragraph 2.52 in this Guide discusses management’s representations 
for financial statements. Auditors of governmental health care entities also 
should consider obtaining representations concerning the information provided 
in MD&A, as provided in SAS No. 52, Required Supplementary Information 
(AICPA, Professional Standards, vol. 1, AU sec. 558.07c).
Cash and Cash Equivalents (Chapter 3 in the Guide)
25. Restricted cash and cash equivalents should be reported when restric­
tions (defined in paragraph 15 of this appendix) on the use of those assets 
change the nature or normal understanding of those assets, as discussed in 
GASB Statement No. 34, paragraph 99. For example, cash and investments 
that can only be used to pay debt principal and interest would be reported as 
restricted cash and investments or as cash and investments held by trustee for 
debt service.
Investments (Chapter 4 in the Guide)
26. GASB Statement No. 34, paragraph 121, requires governmental health 
care entities that receive donor-restricted endowments to make certain disclo­
sures about their use of investment income generated by those endowments.
Receivables (Chapter 5 in the Guide)
27. Governmental health care entities that are funds or component units of 
another governmental entity may report receivables (or payables) from other 
funds or from the primary government or other component units. (The term 
primary government is defined in GASB Statement No. 14.) Interfund balances 
are eliminated in the government-wide financial statements of the financial 
reporting entity, when presented.11 Discretely presented component units that 
report amounts receivable (or payable) from the primary government or from 
other component units should report those assets on a separate line from other 
receivables (payables), as discussed in GASB Statement No. 34, paragraph 61.
11 If a governmental health care entity reports using multiple enterprise funds, interfund 
balances are eliminated in the total enterprise fund column.
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Required Disclosures
28. GASB Statement No. 38, paragraph 13, requires governmental health 
care entities to provide details in the notes to their financial statements about 
receivable balances when significant components of those receivables have 
been obscured by aggregation. GASB Statement No. 38, paragraph 14, also 
requires disclosures about interfund balances and transfers.
Property, Equipment, Supplies, and Other Assets 
(Chapter 6 in the Guide)
Required Disclosures
29. GASB Statement No. 34 establishes two capital-asset related-disclosure 
requirements for governmental health care entities. First, paragraph 115e 
requires entities to disclose their policy for capitalizing assets and for estimat­
ing the useful lives of those assets in their summary of significant accounting 
policies. Second, GASB Statement No. 34, paragraphs 116 and 117, require 
certain information to be presented about major classes of capital assets, 
including beginning and ending balances, capital acquisitions, sales or other 
dispositions, current period depreciation expense, and accumulated deprecia­
tion. Capital assets that are not being depreciated should be disclosed sepa­
rately from those that are being depreciated.
Current Liabilities, Tax Considerations, and Long-term 
Liabilities (Chapter 7 in the Guide) and Commitments 
and Contingencies (Chapter 8 in the Guide)
30. GASB Statement No. 34 and GASB Statement No. 38 require certain 
disclosures about current and long-term liabilities, including:
•  GASB Statement No. 38, paragraph 13, requires disclosures about 
accounts payable balances when significant components of those bal­
ances have been obscured by aggregation.
•  GASB Statement No. 38, paragraph 12, requires disclosures about 
short-term debt activity during the year, even if no short-term debt is 
outstanding at year-end. For this purpose, short-term debt consists of 
anticipation notes, use of lines of credit, and similar loans. Disclosures 
should include a schedule of changes in short-term debt as well as a 
discussion of the purposes for which short-term debt was issued.
•  GASB Statement No. 34, paragraphs 116, 119, and 120, require 
information to be presented about both long-term debt, such as bonds 
payable, and about long-term operating liabilities, such as compen­
sated absences and claims and judgments. Required disclosures in­
clude beginning and ending balances, increases, decreases, and the 
portions of each item that are due within one year.
•  GASB Statement No. 38, paragraphs 10 and 11, require disclosure of 
debt service requirements to maturity for each of the five subsequent 
years and in five-year increments thereafter. Principal and interest 
requirements are required to be disclosed separately. Similar require­
ments apply to obligations under capital leases and noncancelable 
operating leases.
•  GASB Statement No. 38, paragraph 9, requires disclosure of actions 
taken to remedy significant violations of finance-related legal or con­
tractual provisions.
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31. The statements of net assets/balance sheets of governmental health care 
entities should report net assets/equity in three components as discussed in 
paragraph 14 of this appendix. The term fund balance should not be reported 
on the face of the statement. (When governmental health care entities first 
apply GASB Statement No. 34, classifying net assets into the three required 
categories should begin by adding together all previously reported fund balance 
amounts. Calculating each of the three required components is described below 
in the following three paragraphs.)
32. As discussed in GASB Statement No. 34, paragraph 33, the net asset 
component, invested in capital assets, net of related debt should be the sum of 
capital assets, net of accumulated depreciation less any debt issued to finance 
those assets. Invested in capital assets, net of related debt should not include 
any restricted resources that must be used to acquire capital assets, (such as 
unexpended debt proceeds, or capital grants and contributions), or debt attrib­
utable to significant amounts of unexpended debt proceeds.
33. Restricted net assets should be reported based on the definition of 
“restricted,” discussed in paragraph 15 of this appendix. As discussed in 
paragraph 98 of GASB Statement No. 34, major categories of restrictions 
should be reported on the face of the statement of net assets/balance sheet, for 
example, net assets restricted for capital acquisitions. As discussed in GASB 34 
Q&A, item 89, unexpended debt proceeds that must be used to acquire or 
construct capital assets and the portion of the debt attributable to the unex­
pended proceeds should be included in restricted net assets. When a governmen­
tal health care entity reports restricted net assets arising from permanent 
endowments, restricted net assets should be reported in two additional compo­
nents—expendable and nonexpendable. As discussed in appendix 4, exercise 3 
in GASB 34 Q&A, no category of restricted net assets can be negative. If 
liabilities that relate to restricted assets exceed those assets, no balance should 
be reported. The negative amount should be reported as a reduction of unre­
stricted net assets.12
34. GASB Statement No. 34, paragraph 98, prohibits governmental entities 
from reporting internal designations in the net assets section of their state­
ments of net assets/balance sheets. Designations are management’s plans for 
the use of resources. They should not be afforded the same status as restrictions.
Revenues, Expenses, Gains, and Losses (Chapter 10 in 
the Guide)
35. GASB Statement No. 34, paragraph 100, requires revenues to be re­
ported by major source, net of discounts and allowances. The amount of 
discounts and allowances may be reported parenthetically on the face of the 
financial statements or in the notes. Revenues should be reported net of the 
increase or decrease in the estimate of uncollectible accounts, as required by 
GASB Statement No. 34, footnote 41 to paragraph 100. Paragraph 10.04 in this 
Guide provides additional discussion on classification of revenue, and examples 
of revenue, including patient service revenue. As discussed in paragraph 10.20 
in this Guide, patient service revenue is reported net of contractual and other 
adjustments in the operating statement.
Net Assets (Equity) (Chapter 9 in the Guide)
12 See paragraph 2 of this appendix regarding discussions of GASB staff Implementation
Guides in this appendix.
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36. Unlike not-for-profit health care entities, the statement of revenues, ex­
penses and changes in net assets/equity does not require disaggregation of trans­
actions based on the types of restrictions that may exist (such as unrestricted, 
temporarily restricted, or permanently restricted revenues). As discussed in GASB 
Statement No. 33, Accounting and Financial Reporting for Nonexchange Transac­
tions, paragraph 14, purpose restrictions on nonexchange revenues (such as grants, 
contributions, and endowments) do not affect when revenues are recognized. 
Rather, resulting net assets should be reported as restricted until the resources 
have been used for the specified purpose (see paragraph 33 of this appendix) or for 
as long as the resource provider requires (for example, for endowments). Disaggre­
gations such as net assets released from restrictions, changes in temporarily 
restricted net assets, and changes in permanently restricted net assets should not be 
reported in either the statement of revenues, expenses, and changes in net 
assets/equity or in the net assets section of the statement of net assets/balance 
sheet of governmental health care entities.
37. Governmental health care entities are required to distinguish between 
operating revenues and expenses and nonoperating revenues and expenses. 
GASB Statement No. 34, paragraph 102, does not establish a definition of 
operating. Rather, governments are required to establish their own policy 
defining operating revenues and expenses that is appropriate to the nature of 
the activity being reported. Once established, an entity’s policy should be 
applied consistently and disclosed in the notes to the financial statements. 
GASB Statement No. 34, paragraph 102, notes that a consideration for deter­
mining which revenues and expenses should be reported as operating is how 
those transactions would be classified in the statement of cash flows. Using this 
approach, transactions that are considered investing, capital and related fi­
nancing, and noncapital financing activities would normally not be reported as 
operating revenues and expenses. This would include investment revenues and 
interest expense as well as most nonexchange transactions, including most 
grants, taxes, and contributions.
38. Contributions of capital assets or of financial resources required to be 
used to acquire capital assets are required to be reported as revenues separately 
after nonoperating revenues and expenses, as illustrated in paragraph 16 of 
this appendix. Contributions to term and permanent endowments should be 
reported in the same manner as capital contributions.
39. GASB Statement No. 34, paragraph 56, defines a special item as a 
significant transaction or other event that is within the control of management 
and that is either unusual in nature or infrequent in occurrence. Special items 
should be reported separately after capital contributions and contributions to 
permanent and term endowments but before extraordinary items, if any.
40. Capital contributions received from other funds of the same financial 
reporting entity should be reported last in the statement of changes as inter­
fund transfers, as discussed in paragraph 101 of GASB Statement No. 34.
Required Disclosures
41. As noted in paragraph 37 of this appendix, governmental health care entities 
should disclose their policy for defining operating revenues and expenses.
42. GASB Statement No. 34, paragraph 122, as amended by GASB State­
ment No. 37, paragraph 17, defines a segment as an identifiable activity (or 
grouping of activities). . .  reported as or within an enterprise fund or an other 
stand-alone entity that:
AAG-HCO APP F
372 Health Care Organizations
•  Has one or more bonds or other debt instruments outstanding with a 
revenue stream pledged in support of that debt, and
• Is required by an external party (such as through a bond indenture) 
to account separately for its assets, liabilities, revenues, and expenses.
GASB Statement No. 34, paragraph 122, details the disclosure required for 
segments.
43. Governmental health care entities that receive restricted resources are 
required to disclose whether, when both restricted and unrestricted resources 
are available, it is their policy to use restricted or unrestricted resources first, 
as discussed in GASB Statement No. 34, paragraph 115(h).
44. GASB Statement No. 34, paragraph 121, requires governmental health 
care entities that receive donor-restricted endowments to make certain disclo­
sures about their use of investment income generated by those endowments.
The Reporting Entity and Related Organizations 
(Chapter 11 in the Guide)
45. GASB Statement No. 34, paragraph 112, eliminated the reporting of 
interfund activity as residual equity transfers. Operating transfers and residual 
equity transfers are reported as interfund transfers after nonoperating revenues 
and expenses.
Independent Auditor's Reports (Chapter 12 in 
the Guide)
46. The Audit and Accounting Guide, Audits of State and Local Governments 
(GASB 34 Edition),13 provides guidance on audit reports for state and local 
governments as well as on assessing materiality (opinion units).
Required Supplementary Information
47. As discussed in paragraph 10 of this appendix, GASB Statement No. 34, 
paragraphs 8 through 11, require presentation of MD&A as RSI. SAS No. 52 
(AICPA, Professional Standards, vol. 1, AU sec. 558.08), as amended, and SAS 
No. 29, Reporting on Information Accompanying the Basic Financial State­
ments in Auditor-Submitted Documents (AICPA, Professional Standards, vol. 
1, AU sec. 551.15), as amended, require auditor reporting on RSI if (a) the 
supplementary information that GAAP requires to be presented in the circum­
stances is omitted; (b) the auditor has concluded that the measurement or 
presentation of the supplementary information departs materially from pre­
scribed guidelines; (c) the auditor is unable to complete the prescribed proce­
dures; or (d ) the auditor is unable to remove substantial doubts about whether 
the supplementary information conforms to prescribed guidelines. SAS No. 52 
(AU sec. 558.08), as amended, provides example language for explanatory 
paragraphs that, except for an explanatory paragraph because all RSI is 
omitted, include a disclaimer on the information.
48. When an auditor-submitted document contains RSI and the conditions 
listed in paragraph 47 of this appendix do not exist, the auditor should (a) 
express an opinion on the information if engaged to examine the information; 
(b) report on such information using the guidance in SAS No. 52 (AU sec. 551.12 
and .14), provided such information has been subjected to the auditing proce­
dures applied in the audit of the basic financial statements; or (c) disclaim an 
opinion on the information.
13 See footnote 1.
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49. When a client-prepared document contains RSI and the conditions listed 
in paragraph 47 of this appendix do not exist, the auditor has no reporting 
requirement but may voluntarily disclaim an opinion on the RSI.14 SAS No. 8, 
Other Information in Documents Containing Audited Financial Statements 
(AICPA, Professional Standards, vol. 1, AU sec. 550.07), as amended, permits 
an auditor to issue a report providing an opinion, in relation to the financial 
statements taken as a whole, when RSI has been subjected to auditing proce­
dures applied in the audit of the basic financial statements.
Illustrative Management's Discussion and Analysis 
and Financial Statements
50. The appendix to this Appendix F presents illustrative management’s 
discussion and analysis, basic financial statements prepared in accordance 
with GASB Statement No. 34 and related pronouncements.
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14 Some auditors voluntarily disclaim an opinion on RSI to inform the report user of the extent 
of auditor responsibility for the information.
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APPENDIX
Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union 
Management’s Discussion and Analysis
Our discussion and analysis of Sample Hospital Authority’s (Authority’s) 
financial performance provides an overview of the Authority’s financial activi­
ties for the fiscal years ended December 31, 20X7 and 20X6. Please read it in 
conjunction with the Authority’s financial statements, which begin on page 
XXX. Unless otherwise indicated, amounts are in thousands.
Financial Highlights
•  The Authority’s net assets increased in each of the past two years with 
a $4,225 or 6.6 percent increase in 20X7 and a $9,460 or 17.4 percent 
increase in 20X6.
•  The Authority reported increased operating losses in both 20X7 
($24,403) and 20X6 ($13,365). Losses in 20X7 increased by $11,038 or 
82.6 percent over the loss reported in 20X6. Operating losses in 20X6 
increased by $4,020 or 43.0 percent.
•  Nonoperating revenues increased by $7,890 or 39.6 percent in 20X7 
compared to 20X6. Nonoperating revenues also increased in 20X6 by 
$1,139 or 6 percent compared to 20X5.
Using This Annual Report
The Authority’s financial statements consist of three statements—a Bal­
ance Sheet; a Statement of Revenues, Expenses, and Changes in Net Assets; 
and a Statement of Cash Flows. These financial statements and related notes 
provide information about the activities of the Authority, including resources 
held by the Authority but restricted for specific purposes by contributors, 
grantors, or enabling legislation.
The Balance Sheet and Statement of Revenues, Expenses, and 
Changes in Net Assets
Our analysis of the Authority finances begins on page XXX. One of the most 
important questions asked about the Authority’s finances is, “Is the Authority 
as a whole better or worse off as a result of the year’s activities?” The Balance 
Sheet and the Statement of Revenues, Expenses, and Changes in Net Assets 
report information about the Authority’s resources and its activities in a way 
that helps answer this question. These statements include all restricted and 
unrestricted assets and all liabilities using the accrual basis of accounting. All 
of the current year’s revenues and expenses are taken into account regardless 
of when cash is received or paid.
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These two statements report the Authority’s net assets and changes in them. 
You can think of the Authority’s net assets—the difference between assets and 
liabilities—as one way to measure the Authority’s financial health, or financial 
position. Over time, increases or decreases in the Authority’s net assets are one 
indicator of whether its financial health is improving or deteriorating. You will 
need to consider other nonfinancial factors, however, such as changes in the 
Authority’s patient base and measures of the quality of service it provides to 
the community, as well as local economic factors to assess the overall health of 
the Authority.
The Statement of Cash Flows
The final required statement is the Statement of Cash Flows. The statement 
reports cash receipts, cash payments, and net changes in cash resulting from 
operations, investing, and financing activities. It provides answers to such 
questions as “Where did cash come from?” “What was cash used for?” and “What 
was the change in cash balance during the reporting period?”
The Authority's Net Assets
The Authority’s net assets are the difference between its assets and liabili­
ties reported in the Balance Sheet on page X. The Authority’s net assets 
increased in each of the past two years by $4,225 (6.6 percent) in 20X7 and 
$9,460 (17.4 percent) in 20X6, as you can see from Table 1.
Table 1: Assets, Liabilities, and Net Assets
20X7 20X6 20X5
Assets:
Current assets $32,382 $30,135 $26,070
Capital assets, net 43,382 42,918 42,445
Other noncurrent assets 25,118 23,494 19,767
Total assets 100,882 96,547 88,282
Liabilities:
Long-term debt outstanding 
Other current and noncurrent 
liabilities
Total liabilities
Net assets:
Invested in capital assets, net of 
related debt 
Restricted for debt service 
Restricted expendable net assets 
Restricted nonexpendable net 
assets 
Unrestricted
Total net assets
20,922 21,900 23,796
11,801 10,713 10,012
32,723 32,613 33,808
22,460
1,945
1,845
3,003
21,018
2,005
2,100
2,919
18,649
2,035
2,075
2,652
38,906 35,892 29,063
$68,159 $63,934 $54,474
A significant component of the change in the Authority’s assets is the 
increase in patient accounts receivable. Although operating revenues decreased 
in 20X7 by $3,445 (5.7 percent), patient accounts receivable, net of estimated 
uncollectible amounts, increased by $3,107 or 18.6 percent in 20X7. In addition,
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patient service revenue decreased by $2,105 in 20X6 compared to 20X5, but 
receivables increased by $2,114 or 14.5 percent. In both cases, the increase in 
accounts receivable is primarily the result of overall slowdowns by health 
insurers in making payments in attempting to cut costs by managing their cash 
flows.
Operating Results and Changes in The Authority's 
Net Assets
In 20X7, the Authority’s net assets increased by $4,225 or 6.6 percent, as 
shown in Table 2. This increase is made up of very different components. And 
it represents a decline of 55.3 percent compared with the increase in net assets 
for 20X6 of $9,460.
Table 2: Operating Results and Changes in Net Assets
20X7 20X6 20X5
Operating Revenues:
Net patient service revenues 
Premium revenues 
Other operating revenues
$43,305
9,876
3,416
$43,736
13,058
3,248
$45,841
12,976
2,910
Total operating revenues 56,597 60,042 61,727
Operating Expenses:
Salaries and benefits 
Medical supplies and drugs 
Depreciation and amortization 
Other operating expenses
46,845
12,746
4,065
17,344
43,235
7,986
3,638
18,548
40,640
6,788
3,508
20,136
Total operating expenses 81,000 73,407 71,072
Operating loss (24,403) (13,365) (9,345)
Nonoperating Revenues and 
Expenses
Property taxes 
Investment income 
Noncapital grants and contributions 
Other nonoperating revenues and 
expenses, net
23,895
5,653
170
(1,914)
15,309
5,304
853
(1,552)
14,875
5,108
510
(1,718)
Total nonoperating 
revenues (expenses) 27,804 19,914 18,775
Excess of revenues over 
expenses before capital grants, 
contributions, and additions to 
permanent endowments 3,401 6,549 9,430
Grants, Contributions, and 
Endowments
Capital grants and contributions 
Additions to permanent endowments
824 2,560
351
1,980
Increase in net assets $ 4,225 $ 9,460 $11,410
Net assets end of year $68,159 $63,934 $ 4,474
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Operating Losses
The first component of the overall change in the Authority’s net assets is its 
operating income (loss)—generally, the difference between net patient service 
and Premium revenues and the expenses incurred to perform those services. 
In each of the past two years, the Authority has reported an operating loss. This 
is consistent with the Authority’s entire operating history. The Authority’s 
hospital operations were begun in 19XX as a municipal hospital, when it was 
agreed that a portion of its costs would be subsidized by property tax revenues, 
making the facility more affordable for the County’s lower income residents. 
However, in each of the past two years, operating losses have increased. Losses 
in 20X7 increased by $11,038 or 82.6 percent higher than the loss reported in 
20X6. Operating losses in 20X6 increased by $4,020 or 43.0 percent.
The primary components of these increased operating losses are:
•  A decrease in premium revenue of $3,182 or 24.4 percent in 20X7. 
(Premium revenues in 20X6 were roughly the same as in the previous 
year.)
•  Increases in salary and benefit costs for the hospital’s employees 
($3,610 or 8.4 percent in 20X7 and $2,595 or 6.4 percent in 20X6).
•  Increases in medical supply and drug costs of $4,760 or 59.6 percent 
in 20X7 and of $1,198 or 17.6 percent in 20X6.
•  An increase in the level of uncompensated care provided. These are 
services provided for which there is no expectation of payment.
Premium revenues from contracts with health maintenance organizations 
decreased in 20X7 primarily because of changes in the fixed amount per 
individual per month (capitation rate) paid by the Acme Health Maintenance 
Group. Acme is the HMO for the County’s largest employer, the XYZ Motor 
Company. The Authority, (with the assistance of the County), negotiated a new 
4-year contract with Acme in 20X6. Those negotiations resulted in a 15 percent 
reduction in capitation rates in 20X7. Under the contract, capitation rates 
increase by 3 percent each year for the next three years. At the same time, the 
Authority (with the County’s approval) agreed to increase its property tax levy 
by 10 percent, as discussed below.
Employee salary and benefits costs increased in 20X6 and again in 20X7 
based on rates established in labor contracts negotiated in 20X5 and 20X6. 
Current labor contracts for all of the Authority’s unionized employees extend 
until 20Y1.
The rate of healthcare inflation has a direct effect on the cost of services 
provided by the Authority. A component of the Authority’s costs are expenses 
for medical supplies and prescription drugs. In 20X5, medical supplies and 
prescription drug costs totaled $6.8 million. In 20X6, they totaled $8.0 million 
or 10.7 percent of total expenses and an increase of 17.6 percent over 20X5. 
And, in 20X7, medical supplies and prescription drug costs totaled $12.7 
million, representing 15.6 percent of total expenses and an increase of 59.6 
percent over 20X6. Some of the major factors contributing to the increased 
medical supply and drug costs include the introduction of new drugs that cannot 
be obtained in generic form, and changes in therapeutic mix. In addition, in 
20X7, the company that the Authority used as its major wholesale drug supplier 
filed for bankruptcy. The Authority negotiated new contracts with other sup­
pliers at substantially higher costs. At its August 20X7 meeting, the Authority’s 
Board of Trustees authorized management to explore other supplier options.
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The Authority sometimes provides care for patients who have little or no 
health insurance or other means of repayment. As discussed, this service to the 
community is consistent with the goals established for the Authority when it 
was established in 19XX. The level of services provided to these patients 
increased by $1,200 in 20X6 compared to 20X5. In 20X7, the costs of uncom­
pensated care increased by $255. Because there is no expectation of repayment, 
charity care is not reported as patient service revenues of the Authority.
Nonoperating Revenues and Expenses
Nonoperating revenues consist primarily of property taxes levied by the 
Authority and interest revenue and investment earnings. During its negotia­
tions with Acme and XYZ, discussed earlier, the Authority agreed—with the 
County’s approval—to increase its property tax levy to County residents by 10 
percent. County voters approved this increase in November 20X6. In addition, 
a 35 percent increase in the sales of new homes in the County in 20X6 and 20X5 
as well as additions of new commercial and manufacturing facilities resulted 
in an increase in the County’s grand list. The grand list is calculated as of July
1 each year and used as the basis for tax levies on January 1. As a result of both 
of these factors, nonoperating tax revenues increased by $8,586 or 56.1 percent 
in 20X7 compared to a $434 (2.9 percent) increase in 20X6.
Grants, Contributions, and Endowments
The Authority receives both capital and operating grants from various state 
and federal agencies for specific programs. These are discussed in detail in Note
2 to the financial statements. Capital and operating grants received in 20X7 
from the State of Union declined due to fiscal/budgetary issues at the state from 
$3,085 in 20X6 ($2,300 capital and $785 operating) to $800 in 20X7 ($650 
capital and $150 operating). Although $1,640 in grants have been budgeted by 
the state for the Authority in 20X8, it is not clear whether monies to fund these 
grants will be appropriated.
The Authority received $351 in permanent endowments in 20X6 from the 
AIA Foundation. Earnings from investing the principal of this endowment must 
be used to support expenditures for Program A research. This is in contrast to 
an increase in state funding of $580 in 20X6 compared to 20X5. The Authority 
has received other permanent endowments in the past. Restrictions established 
by these endowments are detailed in Note 2 to the financial statements.
The Authority's Cash Flows
Changes in the Authority’s cash flows are consistent with changes in 
operating losses and nonoperating revenues and expenses, discussed earlier, 
with one exception. Cash flows used by operating activities increased slightly 
more than operating losses in both 20X7 and 20X6 due to increases in the 
Authority’s patient accounts receivable, discussed earlier.
Capital Asset and Debt Administration 
Capital Assets
At the end of 20X7, the Authority had $43.3 million invested in capital 
assets, net of accumulated depreciation, as detailed in Note 8 to the financial 
statements. In 20X7, the Authority purchased new equipment costing $4,529. 
Of this, $510 was acquired through capital leases. Nearly the same amount— 
$4,111—was spent to acquire new equipment in 20X6. Both of these amounts
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are less than 20X5, when the Authority spent $7,308 for new equipment. The 
Authority has recently found it more economical to lease much of its equipment. 
This allows the Authority to avoid some of the costs of obsolescence caused by 
technological changes.
In August 20X5, the Authority’s Board of Trustees approved a resolution 
setting aside $15 million of its unrestricted net assets for future expansion of 
the hospital and possible addition of a cancer care wing. The Board of Trustees 
held a special meeting in September 20X7 to reconsider the feasibility of the 
project and held initial meetings with several local architectural firms in 
January 20X8. No decisions have been reached as of the date of this annual 
report.
Debt
At year-end, the Authority had $20.9 in revenue notes, mortgage loans, and 
capital lease obligations outstanding. Except for capital leases of $510 initiated 
in 20X7, the Authority issued no new debt in 20X7 or 20X6. The Authority’s 
formal debt issuances—revenue notes—cannot be issued without approval of 
the Feeling County Board of Commissioners. The amount of debt issued is 
subject to limitations that apply to the County and its component units as a 
whole. There have been no changes in the Authority’s debt ratings in the past 
two years.
Other Economic Factors
The County’s largest employer, the XYZ Motor Company, has a number of 
operating plants throughout the country. In late 20X5, XYZ announced that it 
would close its plant in New City, Ohio and move the majority of that plant’s 
operations (including up to 2,000 full-time employees) to its Feeling County 
plant. Work on that move began in May 20X6.
Contacting The Authority's Financial Management
This financial report is designed to provide our patients, suppliers, taxpay­
ers, and creditors with a general overview of the Authority’s finances and to 
show the Authority’s accountability for the money it receives. If you have 
questions about this report or need additional financial information, contact 
the Authority Controller’s Office, at Sample Hospital Authority, 92 Third 
Street, Anytown, UN 01000.
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ILLUSTRATIVE FINANCIAL STATEMENTS 
FOR A GOVERNMENTAL HOSPITAL AUTHORITY
Based on GASB Statement No. 34, as amended
Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union 
Balance SheetsA 
December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Assets
Current assets:
Cash and cash equivalents $ 7,136 $ 7,557
Short-term investments 3,142 3,423
Patient accounts receivable, net of estimated
uncollectibles of $2,125 (20X7) and $2,040
(20X6) 19,834 16,727
Supplies and other current assets 2,270 2,428
Total current assets 32,382 30,135
Noncurrent cash and investments:
Internally designated for capital acquisitions 15,000 15,000
Other long-term investments 2,605 1,327
Held by trustee for debt service 1,945 2,005
Restricted by contributors and grantors for
capital acquisitions and research 1,124 1,078
Principal of permanent endowments 3,003 2,919
Delinquent property taxes 385 229
Capital Assets:
Land 3,590 3,590
Depreciable capital assets, net of accumulated
depreciation 39,792 39,328
Total capital assets, net of accumulated
depreciation 43,382 42,918
Other assets 1,056 936
Total assets $100,882 $96,547
(continued)
A As discussed in paragraph 13 of this appendix, either a balance sheet or a statement of net 
assets format may be used.
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20X7 20X6
Liabilities and Net Assets
Current liabilities:
Current maturities of long-term debt $ 1,250 $ 1,488
Accounts payable and accrued expenses 4,945 4,575
Estimated third-party payor settlements 1,822 1,651
Other current liabilities 1,673 1,797
Total current liabilities 9,690 9,511
Long-term debt, net of current maturities 19,672 20,412
Other long-term liabilities 3,361 2,690
Total liabilities 32,723 32,613
Net Assets;B
Invested in capital assets net of related debt 
Restricted:
22,460 21,018
For debt service 1,945 2,005
Expendable for capital acquisitions 733 628
Expendable for research 781 899
Expendable for specific operating activities 331 573
Nonexpendable permanent endowments 3,003 2,919
Unrestricted 38,906 35,892
Total net assets 68,159 63,934
Total liabilities and net assets 
See accompanying notes to financial statements.
$100,882 $96,547
B As discussed in paragraph 14 of this appendix, either “net assets” or “equity” may be used as 
the label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority 
A Component Unit of Feeling County State of Union 
Statements of Revenues, Expenses, and Changes in Net AssetsC 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
Based on GASB Statement No. 34, as amended
20X7 20X6
Operating revenues:
Net patient service revenue (net of provision 
for bad debts of $859 in 20X7 and $938 in 20X6) $43,305 $43,736
Premium revenue 9,876 13,058
Other 3,416 3,248
Total operating revenues 56,597 60,042
Operating expenses: 
Salaries and benefits 46,845 43,235
Medical supplies and drugs 12,746 7,986
Insurance 7,030 7,382
Other supplies 10,314 11,166
Depreciation and amortization 4,065 3,638
Total operating expenses 81,000 74,407
Operating loss (24,403) (13,365)
Nonoperating revenues (expenses): 
Property taxes 23,895 15,309
Investment income 5,653 5,304
Interest expense (1,489) (1,552)
Noncapital grants and contributions 170 853
Other (425) —
Total nonoperating revenues (expenses) 27,804 19,914
Excess of revenues over expenses before 
capital grants, contributions, and 
additions to permanent endowments 3,401 6,549
Capital grants and contributions 824 2,560
Additions to permanent endowments — 351
Increase in net assets 4,225 9,460
Net assets beginning of the year 63,934 54,474
Net assets end of the year $68,159 $63,934
See accompanying notes to financial statements.
c As discussed in paragraph 16 of this appendix, GASB Statement No. 34, paragraph 101, 
requires proprietary funds and special purpose governments engaged only in business-type activities 
to present an operating statement that uses an “all-inclusive” format, presenting all changes in both 
restricted and unrestricted net assets and presenting a final total, “Increase (decrease) in net 
assets/equity.” As discussed in paragraph 14 of this appendix, governmental healthcare entities may 
use either the term “net assets” or “equity” as a label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union 
Statements of Cash Flows 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
Based on GASB Statement No. 34, as amended
20X7
Cash flows from operating activities:
Receipts from and on behalf of patients $50,074
Payments to suppliers and contractors (30,029)
Payments to employees (46,955)
Other receipts and payments, net 4,591
Net cash provided by operating activities (22,319)
Cash flows from noncapital financing 
activities:
Property taxes 20,739
Noncapital grants and contributions 170
Contributions to permanent endowments —
Other (425)
Net cash provided by noncapital financing
activities 20,484
Cash flows from capital and related 
financing activities:
Capital grants and contributions 824
Property taxes restricted to capital acquisitions 3,000
Principal paid on long-term debt (1,488)
Interest paid on long-term debt (1,489)
Purchase of capital assets (4,019)
Net cash used by capital and related
financing activities (3,172)
Cash flows from investing activities:
Interest and dividends on investments 2,737
Purchases of investments (1,045)
Proceeds from sale of investments 2,327
Net cash provided by investing activities 4,019
Net increase (decrease) in cash and cash
equivalents (988)
20X6
$54,680
(26,634)
(43,460)
3,597
(11,817)
12,224
853
351
13,428
2,560
3,000
(1,896)
(1,552)
(4,111)
(1,999)
2,124
(289)
683
2,518
2,130
(continued)
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20X7 20X6
Cash and cash equivalents, beginning of year 9,101 6,971
Cash and cash equivalents, end of year $ 8,113 $ 9,101
Reconciliation of cash and cash equivalents to 
the statement of net assets:
Cash and cash equivalents in current assets 7,136 7,557
Restricted cash and cash equivalents 977 1,544
Total cash and cash equivalents $ 8,113 $ 9,101
Reconciliation of operating income (loss) to net 
cash provided (used) by operating activities:
Operating loss ($24,403) ($13,365)
Adjustments to reconcile operating income to 
net cash flows used in operating activities:
Depreciation and amortization 4,065 3,638
Provision for bad debts 859 938
Changes in:
Patient accounts receivable (3,966) (2,909)
Supplies and other current assets 158 100
Other assets (120) —
Accounts payable, accrued expenses, and
other current liabilities 246 (225)
Estimated third-party payor settlements 171 (235)
Other liabilities related to operating activities 671 241
Net cash used in operating activities ($22,319) ($11,817)
Noncash Investing, Capital, and Financing Activities:
The Authority entered into capital lease obligations of $510,000 for new 
equipment in 20X7.
The Authority held investments at December 31, 20X7 with a fair value of 
$XXX. During 20X7, the net increase in the fair value of these investments 
was $XXX.
See accompanying notes to financial statements.
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Sample Governmental Hospital Authority 
A Component Unit of Feeling County, State of Union 
Notes to Financial StatementsD 
December 31, 20X7 and 20X6 
(in thousands)
1. Description of Reporting Entity and Summary of Significant 
Accounting Policies
Reporting entity. The Sample Hospital Authority (the Authority) is a public 
corporation. It was created on January 1, 19XX, by the Board o f County 
Commissioners of Feeling County, State of Union, to operate, control, and 
manage all matters concerning the County’s health care functions. The Board 
of County Commissioners appoints the Board of Trustee members of the 
Authority, and the Authority may not issue debt or levy taxes without the 
county’s approval. For this reason, the Authority is considered to be a compo­
nent unit of Feeling County and is included as a discretely presented component 
unit in the basic financial statements of the County.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Enterprise fund accounting. The Authority uses enterprise fund accounting. 
Revenues and expenses are recognized on the accrual basis using the economic 
resources measurement focus. Based on Governmental Accounting Standards 
Board (GASB) Statement No. 20, Accounting and Financial Reporting for 
Proprietary Funds and Other Governmental Entities That Use Proprietary 
Fund Accounting, as amended, the Authority has elected to apply the provisions 
of all relevant pronouncements of the Financial Accounting Standards Board 
(FASB), including those issued after November 30, 1989, that do not conflict 
with or contradict GASB pronouncements.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less.
Capital assets. The Authority’s capital assets are reported at historical cost. 
Contributed capital assets are reported at their estimated fair value at the time 
of their donation. All capital assets other than land are depreciated or amor­
tized (in the case of capital leases) using the straight-line method of deprecia­
tion using these asset lives:
Land improvements 15 to 20 years
Buildings and building improvements 20 to 40 years 
Equipment, computers, and furniture 3 to 7 years
Costs of borrowing. Except for capital assets acquired through gifts, contri­
butions, or capital grants, interest cost on borrowed funds during the period of
D The notes to the financial statements in these illustrative financial statements generally 
include only disclosures unique to a governmental hospital. The disclosures regarding the accounting 
policies for the use of estimates and cost of borrowing in note 1; and charity care in note 5 are not 
unique to a governmental hospital. Also, the notes to the financial statements include disclosures 
that are not required.
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construction of capital assets is capitalized as a component of the cost of 
acquiring those assets. None of the Authority’s interest cost was capitalized in 
either 20X7 or 20X6.
Property taxes. The Authority received approximately 29 percent in 20X7 
and 19 percent in 20X6 of its financial support from property taxes. These funds 
were used as follows:
Property taxes are devied by the County on the Authority’s behalf on January 
1 and are intended to finance the Authority’s activities of the same calendar 
year. Amounts levied are based on assessed property values as of the preceding 
July 1. The property tax calendar includes these dates:
Property taxes are considered delinquent on the day following each payment 
due date.
Grants and contributions. From time to time, the Authority receives grants 
from Feeling County and the State of Union as well as contributions from 
individuals and private organizations. Revenues from grants and contributions 
(including contributions of capital assets) are recognized when all eligibility 
requirements, including time requirements are met. Grants and contributions 
may be restricted for either specific operating purposes or for capital purposes. 
Amounts that are unrestricted or that are restricted to a specific operating 
purpose are reported as nonoperating revenues. Amounts restricted to capital 
acquisitions are reported after nonoperating revenues and expenses.
Endowments. Endowments are provided to the Authority on a voluntary 
basis by individuals and private organizations. Permanent endowments require 
that the principal or corpus of the endowment be retained in perpetuity. If a 
donor has not provided specific instructions, Union state law permits the 
Authority’s Board of Trustees to authorize for expenditure the net appreciation 
of the investments of endowment funds, as discussed in Note 2.
Restricted resources. When the Authority has both restricted and unre­
stricted resources available to finance a particular program, it is the Authority’s 
policy to use restricted resources before unrestricted resources.
Net assets. Net assets of the Authority are classified in four components. Net 
assets invested in capital assets net of related debt consist of capital assets net 
of accumulated depreciation and reduced by the current balances of any 
outstanding borrowings used to finance the purchase or construction of those 
assets. Restricted expendable net assets are noncapital net assets that must be 
used for a particular purpose, as specified by creditors, grantors, or contributors 
external to the Authority, including amounts deposited with trustees as re­
quired by revenue bond indentures, discussed in Note 8. Restricted nonexpend­
able net assets equal the principal portion of permanent endowments. 
Unrestricted net assets are remaining net assets that do not meet the definition 
of invested in capital assets net of related debt or restricted.
20X7 20X6
Used to support operations 
Levied for debt service
$20,895 $12,309 
3,000 3,000
Levy date 
Lien date 
Tax bill mailed
First installment payment due 
Second installment payment due
January 1 
January 1 
January 20
February 15 
July 15
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Operating revenues and expenses. The Authority’s statement of revenues, 
expenses and changes in net assets distinguishes between operating and 
nonoperating revenues and expenses. Operating revenues result from ex­
change transactions associated with providing health care services—the 
Authority’s principal activity. Nonexchange revenues, including taxes, grants, 
and contributions received for purposes other than capital asset acquisition, 
are reported as nonoperating revenues. Operating expenses are all expenses 
incurred to provide health care services, other than financing costs.
Compensated absences. The Authority’s employees earn vacation days at 
varying rates depending on years of service. Vacation time does not accumulate. 
Generally, any days not used at year-end expire. Employees also earn sick leave 
benefits based on varying rates depending on years of service. Employees may 
accumulate sick leave up to a specified maximum. Employees are not paid for 
accumulated sick leave if they leave before retirement. However, employees 
who retire from the Authority may convert accumulated sick leave to termina­
tion payments at varying rates, depending on the employee’s contract. The 
estimated amount of sick leave payable as termination payments is reported 
as a noncurrent liability in both 20X7 and 20X6.
Risk management. The Authority is exposed to various risks of loss from 
torts; theft of, damage to, and destruction of assets; business interruption; 
errors and omissions; employee injuries and illnesses; natural disasters; medi­
cal malpractice; and employee health, dental, and accident benefits. Commer­
cial insurance coverage is purchased for claims arising from such matters. 
Settled claims have not exceeded this commercial coverage in any of the three 
preceding years.
Investments in debt and equity securities. Investments in debt and equity 
securities are reported at fair value except for short-term highly liquid invest­
ments that have a remaining maturity at the time they are purchased of one 
year or less. These investments are carried at amortized cost. Interest, divi­
dends, and gains and losses, both realized and unrealized, on investments in 
debt and equity securities are included in nonoperating revenue when earned.
2. Endowments and Restricted Net Assets
Restricted, expendable net assets are available for the following purposes:
20X7 20X6
Program A activities:
Purchase of equipment $ 404 $ 321
Research 553 683
General 46 63
Program B activities:
Purchase of equipment 235 235
Research 184 151
General 79 110
Program C activities:
General 206 400
Buildings and equipment 94 72
Research 44 65
Total expendable, restricted net assets $1,845 $2,100
Unless the contributor provides specific instructions, Union state law permits 
the Authority Board of Trustees to authorize for expenditure the net appre­
ciation (realized and unrealized) of the investments in its endowments. When
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administering its power to spend net appreciation, the Board of Trustees is 
required to consider the Authority’s “long- and short-term needs, present 
and anticipated financial requirements, expected total return on its invest­
ments, price-level trends, and general economic conditions.” Any net appre­
ciation that is spent is required to be spent for the purposes designated by 
the contributor.
The Board of Trustees chooses to spend only a portion of the investment 
income (including changes in the value of investments) each year. Under the 
policy established by the Board, 5 percent of the average market value of 
endowment investments at the end of the previous three years has been 
authorized for expenditure. The Authority retains the remaining amount, if 
any, to be used in future years when the amount computed using the spending 
policy exceeds investment income. At December 31, 20X7 and 20X6, net 
appreciation of $864 and $953, respectively, is available to be spent, of which 
$402 and $682, respectively, is reported as restricted expendable net assets, 
and the balance is in unrestricted net assets.
Restricted nonexpendable net assets as of December 31, 20X7 and 20X6, 
represent the principal amounts of permanent endowments, restricted to 
investment in perpetuity. Investment earnings from the Authority’s permanent 
endowments are expendable to support these programs as established by the 
contributor:
20X7 20X6
Program A activities $ 158 $ 158
Program B activities 176 176
Program C activities 423 423
Any activities of the Authority 854 854
1,611 1,611
Endowment requiring income to be 
added to original gift until the fund’s
value is $2,125 1,392 1,308
Total restricted nonexpendable net assets 3,003 2,919
3. Designated Net Assets
Of the $40,851 and $37,897 of unrestricted net assets reported in 20X7 and 
20X6, respectively, $15,000 has been designated by the Authority’s Board of 
Trustees for capital acquisitions. Designated funds remain under the control 
of the Board of Trustees, which may at its discretion later use the funds for 
other purposes.
4. Deposits and Investments
State law requires collateralization of all deposits with federal depository 
insurance and other acceptable collateral in specific amounts. The Authority’s 
bylaws require that all bank balances be insured or collateralized by U.S. 
government securities held by the pledging financial institution’s trust depart­
ment in the name of the Authority.
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At December 31, 20X7 and 20X6, the Authority had bank balances as follows:
20X7 20X6
Insured (FDIC) $3,687 $5,677
Collateralized by securities held by the 
pledging financial institution’s trust
department in the Authority’s name 1,153 300
Uninsured, uncollateralized or collateralized 
by securities held by the pledging 
institution or by its trust department or
agent in other than the Authority’s name — —
Total $4,840 $5,977
Carrying amount $5,021 $6,539
Statutes authorize the Authority to invest in obligations of the U.S. Treasury, 
agencies, and instrumentalities, commercial paper rated A-1 by Standard & 
Poor’s Corporation or P-1 by Moody’s Commercial Paper Record, and bankers’ 
acceptances. However, the Authority’s bylaws require that investments be 
made only in U.S. government obligations held by the Authority’s third-party 
agent.
The Authority’s investments generally are reported at fair value, as discussed 
in Note 1. At December 31, 20X7 and 20X6, the Authority’s investments 
consisted of the following, all of which were held in the Authority’s name by a 
custodial bank that is an agent of the Authority:
20X7 20X6
U.S. Treasury Obligations $21,774 $20,039
U.S. Government Agency Securities 7,160 6,731
$28,934 $26,770
The carrying amounts of deposits and investments shown above are included
in the Authority’s balance sheets as follows:
20X7 20X6
Carrying amount
Deposits $ 5,021 $ 6,539
Investments 28,934 26,770
$33,955 $33,309
Included in the following balance sheet captions
Cash and cash equivalents $ 7,136 $ 7,557
Short-term investments 3,142 3,423
Noncurrent cash and investments:
Other long-term investments 2,605 1,327
Restricted by contributors and grantors for
capital acquisitions and research 1,124 1,078
Internally designated for capital acquisitions 15,000 15,000
Held by trustee for debt service 1,945 2,005
Principal of permanent endowments 3,003 2,919
$33,955 $33,309
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5. Charity Care
Charges excluded from revenue under the Authority’s charity care policy were 
$7,100 and $6,845 for 20X7 and 20X6, respectively.
6. Accounts Receivable and Payable
Patient accounts receivable and accounts payable (including accrued ex­
penses) reported as current assets and liabilities by the Authority at December
31, 20X7 and 20X6 consisted of these amounts:
Patient Accounts Receivable
Receivable from patients and their 
insurance carriers 
Receivable from Medicare 
Receivable from Medicaid
Total patient accounts receivable
Less allowance for uncollectibles amounts
Patient accounts receivable, net
20X7
$13,976
4,286
3,697
21,959
2,125
20X6
$11,868
3,002
3,897
18,767
2,040
$19,834 $16,727
Accounts Payable and Accrued Expenses
20X7 20X6
Payable to employees (including payroll taxes) $2,437 $1,970 
Payable to suppliers 2,481 2,591
Other 27 14
Total accounts payable and accrued 
expenses
7. Capital Assets
Capital asset additions, retirements, and balances for the years ended De­
cember 31, 20X7 and 20X6 were as follows:
$4,945 $4,575
Balance 
December 31, 
20X6 Additions
Retire­
ments
Balance 
December 31, 
20X7
LandE $ 3,590 $ 3,590
Land improvements 
Buildings and
645 17 — 662
improvements 29,265 965 (810) 29,420
Equipment 30,375 3,547 (1,860) 32,062
Totals at historical cost 
Less accumulated 
depreciation for:
$63,875 $4,529 ($2,670) $65,734
Land improvements 
Buildings and
(291) (65) --- (356)
improvements (5,352) (582) 810 (5,124)
Equipment 
Total accumulated
(15,314) (3,418) 1,860 (16,872)
depreciation (20,957) (4,065) 2,670 (22,352)
Capital assets, net $42,918 $ 464 $ 0 $43,382
E When present, construction-in-progress should be reported in a separate line in this schedule. 
(See GASB 34 Q&A, item 233). See paragraph 2 in this appendix regarding references to GASB staff 
Implementation Guides. Also, GASB Statement No. 34, paragraph 20, requires non-depreciable 
capital assets to be shown separately on the face of the balance sheet when these balances are 
significant.
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Balance 
December 31, 
20X5
Land
Land improvements 
Buildings and 
improvements 
Equipment
Totals at historical cost 
Less accumulated 
depreciation for:
Land improvements 
Buildings and 
improvements 
Equipment 
Total accumulated 
depreciation 
Capital assets, net
$ 3,590 —
608 112
29,187 78
26,710 3,921
$60,095 $4,111
(309) (57)
 (4,826) (526)
(12,515) (3,055)
(17,650) (3,638)
$42,445 $ 473
— $ 3,590 
(75) 645
—  29,265 
(256) 30,375
($331) $63,875
75 (291)
—  (5,352)
256 (15,314)
331 (20,957)
$ 0 $42,918
8. Long-Term Debt and Other Noncurrent Liabilities
A schedule of changes in the Authority’s noncurrent liabilities for 20X7 and 
20X6 follows:
Bonds and 
Notes Payable: 
Revenue notes 
Mortgage loan 
Note payable 
Total long-term 
debt
Capital lease 
obligations 
Other 
Liabilities: 
Compensated 
absences 
Net pension 
obligation 
Total other 
liabilities 
Total
noncurrent
liabilities
Balance 
December 31, 
20X6
$18,714
1,808
570
21,092
808
2,625
_____ 65
2,690
$24,590
Additions Reductions
($457)
(99)
(464)
510
662
15
677
(1,020)
(468)
(6 )
(6)
Balance 
December 31, 
20X7
$18,257
1,709
106
20,072
850
$1,187 ($1,494)
3,281
_____ 80
3,361
$24,283
Amounts 
Due Within 
One Year
$620
99
106
825
425
See 
Note 9
$1,250
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Balance
December 31,
20X5 Additions
Bonds and
Notes Payable:
Revenue notes 19,568 —
Mortgage loan 1,907 —
Note payable 1,045 —
Total long-term
debt 22,520 _
Capital lease
obligations 1,276 —
Other
Liabilities:
Compensated
absences 2,400 236
Net pension
obligation 49 16
Total other
liabilities 2,449 252
Total
noncurrent
liabilities $26,245 $ 252
Balance Amounts
December 31, Due Within
Reductions 20X6 One Year
(854) 18,714 457
(99) 1,808 99
(475) 570 464
(1,428) 21,092 1,020
(468) 808 468
(11) 2,625 —
See
—  65 Note 9 
____ (11) 2,690 -
($1,907) $24,590 $1,488
Long-term debt. The terms and due dates of the Authority’s long-term debt, 
including capital lease obligations, at December 31, 20X7 and 20X6, follow:
•  7.25 percent Revenue Notes, due November 1, 20Z7, collateralized by 
a pledge of the Authority’s gross receipts. Thus all operating and 
nonoperating revenues of the authority are similarly pledged.
•  9.25 percent mortgage loan, due January 20Y4, collateralized by a 
mortgage on property and equipment with a depreciated cost of $1,530 
at December 31, 20X7
•  9.75 percent note payable, due March 20X8, unsecured
•  Capital lease obligations, at varying rates of imputed interest from 9.8 
percent to 12.3 percent collateralized by leased equipment with cost 
of $1,275 at December 31, 20X7
Under the terms of the Revenue Note Indenture, the Authority is required to 
maintain certain deposits with a trustee. Such deposits are included with 
restricted cash and investments in the balance sheet. The Revenue Note 
Indenture also places limits on the incurrence of additional borrowings and 
requires that the Authority satisfy certain measures of financial performance 
as long as the notes are outstanding.
Scheduled principal and interest repayments on long-term debt and pay­
ments on capital lease obligations are as follows:
______Long-term Debt______ Capital Lease Obligations
Year Ending
December 31: Principal Interest Principal Interest
20X8 $ 825 $ 553 $425 $58
20X9 775 487 213 27
20Y0 836 465 212 13
20Y1 900 448
20Y2 972 432
20Y3 to 20Y7 5,764 1,769
20Y8 to 20Z2 4,824 1,492
20Z3 to 20Z7 5,176 1,116
Total $20,072 $6,762 $850 $98
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9. Pension PlanF
Plan description. Sample Hospital Pension Plan (SHPP) provides retirement 
and disability benefits, annual cost-of-living adjustments, and death benefits 
to plan members and beneficiaries. SHPP is affiliated with County Employees 
Pension Plan (CEPP), an agent multiple-employer pension plan administered 
by the Union Retirement System. Article 39 of the Regulations of the State of 
Union assigns the authority to establish and amend the benefit provisions of 
the plans that participate in CEPP to the respective employer entities; for 
CEPP, that authority rests with the County of Feeling, Union. The Union 
Retirement System issues a publicly available financial report that includes 
financial statements and required supplementary information for SHPP. That 
report may be obtained by writing to Union Retirement System, State Govern­
ment Lane, Anytown, Union 01000 or by calling 1-800-555-PLAN.
Funding policy. The contribution requirements of plan members and the 
Authority are established and may be amended by the CEPP Board of Trustees. 
Plan members are required to contribute 7.8 percent of their annual covered 
salary. The Authority is required to contribute at an actuarially determined 
rate; the current rate for both 20X7 and 20X6 is 11.9 percent of annual covered 
payroll.
Annual pension cost and net pension obligation. The Authority’s annual 
pension cost and net pension obligation to SHPP for 20X7 and 20X6 were as 
follows:
20X7 20X6
Annual required contribution $26 $23
Interest on net pension obligation 3 2
Adjustment to annual required contribution (3) (2)
Annual pension cost 26 23
Contributions made (11) (7)
Increase (decrease) in net pension obligation 15 16
Net pension obligation, beginning of year 65 49
Net pension obligation, end of year $80 $65
The annual required contribution for the current year was determined as part 
of the December 31, 20X6, actuarial valuation using the entry age actuarial 
cost method. The actuarial assumptions included (a) 7.5 percent investment 
rate of return (net of administrative expenses) and (b) projected salary in­
creases ranging from 5.5 percent to 9.5 percent per year. Both (a) and (b ) 
included an inflation component of 5.5 percent. The actuarial assumptions also 
include a 2 percent per year cost-of-living adjustment. The actuarial value of 
assets was determined using techniques that smooth the effects of short-term 
volatility in the market value of investments over a four-year period. The same 
actuarial assumptions were used to determine the actuarial required contribu­
tions for 20X6. The unfunded actuarial accrued liability is being amortized as 
a level percentage of projected payroll on an open basis. The remaining 
amortization period at December 31, 20X6, was 23 years.
F The preparer of the financial statements should consider the need for required supplementary 
information (RSI) as required by GASB Statement No. 27, Accounting for Pensions by State and Local 
Governmental Employers, paragraph 22.
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Three-Year Trend Information
Annual Percentage Net
Fiscal Year Pension Cost of APC  Pension
Ending__________(APC)________Contributed_____ Obligation
12/31/X5 $20 94% $49
12/31/X6 23 30 65
12/31/X7 26 42 80
10. Postretirement Plan
In addition to the pension benefits described above, the Authority provides 
postretirement health care benefits, in accordance with the Authority’s bylaws, 
to all employees who retire from the Authority on or after attaining age 60 with 
at least 15 years of service. Currently 250 retirees (245 in 20X6) meet these 
eligibility requirements. The Authority reimburses 75 percent of the amount 
of validated claims for medical, dental, and hospitalization costs incurred by 
pre-Medicare retirees and their dependents. The Authority also reimburses a 
fixed amount of $25 per month for a Medicare supplement for each retiree 
eligible for Medicare. Expenses for postretirement health care benefits are 
recognized as retirees report claims and include a provision for estimated 
claims incurred but not yet reported to the Authority. Expenses of $764 were 
recognized for postretirement health care in 20X7; expenses recognized in 20X6 
were $636. Approximately $64 of the $128 increase in expenses over the 
previous year was caused by the addition of dental benefits, effective July 1, 
20X7.
11. Commitments under Noncancelable Operating Leases
The Authority is committed under various noncancelable operating leases, all 
of which are for equipment and computers. These expire in various years 
through 20Y9. Future minimum operating lease payments are as follows:
Year ending December 31:
20X8 $3,109
20X9 2,898
20Y0 2,795
20Y1 2,780
20Y2 2,575
20Y3-20Y7 4,215
20Y8-20Y9 1,065
Total $19,437
NOTE—Although not presented in these sample illustrative financial state­
ments, other disclosures required by GASB pronouncements may be applicable, 
including the following:
•  Short-term debt (GASB Statement No. 38, paragraph 12)
•  Interfund balances and transfers (GASB Statement No. 38, paragraph
14, when a governmental health care entity reports multiple enter­
prise funds or is reported as an enterprise fund of a general purpose 
government. See Appendix F, footnote 5.)
•  Segment information (GASB Statement No. 34. paragraphs 122 and 
123, as amended by GASB Statement No. 37, paragraph 17)
•  Violations of finance-related legal or contractual provisions (GASB 
Statement No. 38, paragraph 9)
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•  Risk financing (Requirements for disclosures about claims and judg­
ments and risk financing by governmental health care entities that 
retain a portion of risk for claims and judgments (including malprac­
tice claims and judgments) are provided in GASB Statement No. 10, 
Accounting and Financial Reporting for Risk Financing and Related 
Insurance Issues, as amended). Additionally, GASB Statement No. 34, 
paragraph 119 requires disclosure of certain information about the 
long-term portion of accrued claims and judgments, if applicable.
Other required disclosures, which may be applicable, and that would be similar 
to the disclosures contained in the notes to the sample illustrative financial 
statements for a not-for-profit hospital, are not repeated here. They include the 
following:
•  Off-Balance Sheet Risk and Concentration of Credit Risk
•  Fair Value of Financial Instruments
•  Commitments and Contingencies
•  Subsequent Events
•  Net patient service revenue
•  Related party transactions
•  Description of Reporting Entity and Summary of Significant Account­
ing Policies—Supplies, Net Patient Service Revenue, Charity Care, 
Premium Revenue
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Appendix G 
Information Sources
Further information on matters addressed in this Guide is available through 
various publications and services listed in the table that follows. Many non­
government and some government publications and services involve a charge 
or membership requirement.
Fax services allow users to follow voice cues and request that selected 
documents be sent by fax machine. Some fax services require the user to call 
from the handset of the fax machine, others allow the user to call from any 
phone. Most fax services offer an index document, which lists titles and other 
information describing available documents.
Electronic bulletin board services and web sites allow users to read, copy, and 
exchange information electronically. Most are available using a modem and 
standard communications software. Some bulletin board services are also 
available using one or more Internet protocols.
Recorded announcements allow users to listen to announcements about a 
variety of recent or scheduled actions or meetings.
All telephone numbers listed are voice lines, unless otherwise designated as 
fax (f) or data (d) lines. Required modem speeds, expressed in bauds per second 
(bps), are listed for data lines.
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Appendix H 
Schedule of Changes Made to Health 
Care Organizations
As o f May 2003
Beginning May 2001, all schedules of changes reflect only current year activity 
for improved clarity.
Reference 
Preface
Chapter 1
Paragraph 1.01 
(footnote 1)
Paragraph 1.07 Deleted.
(footnote *)
Paragraph 1.09 Revised to reflect the issuance of GASB Statement
Nos. 37 and 38.
Paragraph 1.10 Revised to clarify guidance.
Paragraph 1.11 Revised to reflect the issuance of GASB Statement No.
38.
Paragraph 1.25 Deleted.
(footnote *)
Paragraph 1.36 Footnote * replaced.
(heading)
Paragraph 1.38 Revised to reflect the issuance of FASB Statement Nos.
144 and 145; Former footnotes ** and *** redesignated 
as footnotes * and **, respectively, and replaced. 
Paragraph 1.39 Former footnote * redesignated as footnote *** and
(heading) replaced.
Paragraph 1.40 Revised to clarify guidance.
Paragraph 1.42 Revised to reflect the issuance of FASB Statement Nos.
141, 142, 144, 145, 147, and 148; Footnote CON revised 
to reflect the issuance of an exposure draft of a pro­
posed FASB Intrepretation; Footnote ** replaced. 
Paragraph 1.43 Revised to reflect the issuance of FASB Statement Nos.
141, 144, and 148.
Paragraph 1.44 Revised to reflect the issuance of FASB Statement Nos.
141 and 144; Footnote CON revised to reflect the issuance 
of an exposure draft of a proposed FASB Interpreta­
tion; Footnote * deleted.
Change
Revised to reflect the issuance of GASB Statement No. 
34 and related pronouncements and the Codification 
of Office of Management and Budget Circular A-133; 
Footnotes 3 and 4 added to reflect the Codification of 
Office of Management and Budget Circular A-133 and 
the conversion of SOP 98-3 to an Audit Guide of the 
same title, respectively; Subsequent footnotes 
renumbered.
Note added to reflect the issuance of GASB Statement 
No. 34 and related pronouncements.
Revised to clarify guidance.
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Paragraph 1.45
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Paragraph 1.46
Paragraph 1.47
Paragraph 1.48 
Chapter 2 (title)
Paragraph 2.01 
(footnote **) 
Paragraph 2.07
Paragraph 2.08 
Paragraph 2.12 
(footnote *) 
Paragraph 2.14 
(footnote *) 
Paragraphs 2.15, 
2.16, and 2.17 
Paragraph 2.18
Paragraph 2.28 
(footnote *) 
Paragraph 2.29 
(footnote **) 
Paragraphs 2.31, 
2.33, and 2.34 
Paragraph 2.34 
(footnote *) 
Paragraph 2.35
Paragraphs 2.48, 
2.50, 2.51, and 
2.52 (footnotes * 
and **) 
Paragraph 2.56
Paragraph 2.57
Change
Revised to reflect the issuance of FASB Statement Nos. 
141, 142, 143, 144, 145, and 147; Footnote CON revised 
to reflect the issuance of an exposure draft of a pro­
posed FASB Interpretation; Footnote * added.
Revised to reflect the issuance of FASB Statement Nos. 
141, 142, 143, 144, 145, 146, and 147, and FASB Inter­
pretation No. 45; Footnote COM deleted; Footnote 
CON revised to reflect the issuance of an exposure 
draft of a proposed FASB Interpretation; Footnote * 
replaced.
Revised to reflect the issuance of FASB Statement Nos. 
141, 142, 143, 144, 145, 146, 147, and 148, and FASB 
Interpretation No. 45; Footnotes * and ** deleted. 
Revised to clarify guidance.
Footnote * added; Note added to reflect the issuance of 
GASB Statement No. 34 and related pronouncements. 
Added.
Health Care Organizations
Revised to reflect the issuance of SAS No. 98; Footnote
* added.
Revised to clarify guidance; Footnote * deleted. 
Added.
Deleted.
Revised to clarify guidance; Footnote * deleted.
Revised to reflect the issuance of the Audit Guide 
Analytical Procedures; Footnote * added.
Added.
Added.
Revised to clarify guidance.
Deleted.
Revised to reflect the issuance of the Audit Guide Service 
Organizations: Applying SAS No. 70, as Amended. 
Added.
Revised to clarify guidance; Footnote 3 added to reflect 
the Codification of Office of Management and Budget 
Circular A-133 requirements.
Revised to reflect OMB cost principles circulars.
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Reference
Paragraph 2.59 
(footnote *)
Paragraphs 2.62, 
2.63, 2.64, and 2.65 
Chapter 3
Paragraph 3.01 
(footnote *) 
Paragraph 3.03
Paragraph 3.04 
(footnote *) 
Chapter 4
Paragraph 4.01 
Paragraph 4.02
Paragraph 4.12 
(heading) 
Paragraph 4.14
Paragraph 4.15 
(footnote *) 
Paragraph 4.16 
(heading) 
Paragraph 4.18
Paragraph 4.20 
Paragraph 4.20 
(exhibit 4.1) 
Chapter 5
Paragraph 5.04
Renumbered 
paragraphs 
5.10 and 5.11 
(footnotes *) 
Renumbered 
paragraph 5.12 
Renumbered 
paragraph 5.19 
(former footnote 9) 
Renumbered 
paragraphs 5.22 
and 5.24
Change
Redesignated as footnote 4 and revised to reflect the 
conversion of SOP 98-3 to an Audit Guide of the same 
title.
Revised to clarify guidance.
Note added to reflect the issuance of GASB Statement 
No. 34 and related pronouncements.
Deleted.
Revised (and footnote 2 added and renumbered foot­
note 3 revised) to clarify guidance; Subsequent foot­
notes renumbered.
Deleted.
Note added to reflect the issuance of GASB Statement 
No. 34 and related pronouncements.
Revised to clarify guidance.
Revised to reflect the issuance of FASB Statement No. 
144; Footnote * replaced.
Footnote * deleted.
Revised (and footnote 4 added) to clarify guidance; 
Subsequent footnotes renumbered.
Redesignated as footnote 5; Subsequent footnotes 
further renumbered.
Footnote * deleted.
Footnote ** redesignated as footnote 7; Subsequent 
footnotes further renumbered; Footnote * added. 
Revised to clarify guidance; Footnote * deleted. 
Redesignated as exhibit 4-1; Revised (and footnote 9 
added) to clarify guidance.
Note added to reflect the issuance of GASB Statement 
No. 34 and related pronouncements.
Added to reflect the issuance of SOP 01-6; Subsequent 
paragraphs renumbered; Footnote * added.
Deleted.
Revised (and footnote 5 added) to to clarify guidance; 
Subsequent footnotes renumbered.
Deleted; Subsequent footnotes further renumbered.
Revised to reflect the issuance of SOP 01-6; Footnotes
* added.
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Renumbered 
paragraph 5.25 
(footnote **) 
Renumbered 
paragraph 5.26 
(footnote *) 
Renumbered 
paragraph 5.34 
(exhibit 5.1) 
Chapter 6 (title)
Paragraph 6.05
Paragraph 6.10 
(footnote *) 
Paragraph 6.13
Exhibit 6.1 
Chapter 7
Paragraph 7.03 
(footnote *) 
Paragraph 7.19
Paragraphs 7.21 
and 7.22 (footnotes 
** and ***)
Exhibit 7.1 
Chapter 8
Paragraph 8.02 
(footnote *) 
Paragraph 8.16 
Paragraphs 8.21 
and 8.23 (heading) 
Paragraph 8.27 
Exhibit 8.1 
Chapter 9
Paragraph 9.02 
(heading)
Exhibit 9.1 
Chapter 10
Paragraph 10.05 
(footnotes 2 and 3)
Reference Change
Added.
Deleted.
Redesignated as exhibit 5-1 and revised to reflect the 
issuance of SOP 00-1.
Footnote * deleted; Note added to reflect the issuance 
of GASB Statement No. 34 and related pronounce­
ments.
Revised to reflect the issuance of FASB Statement No. 
144; Footnote * added; Footnote ** replaced.
Deleted.
Revised to reflect the issuance of FASB Statement No. 
144; Footnote * replaced.
Redesignated as exhibit 6-1.
Note added to reflect the issuance of GASB Statement 
No. 34 and related pronouncements.
Deleted.
Footnote * replaced; Footnote 1 revised to clarify gui­
dance; Footnote ** deleted.
Deleted.
Redesignated as exhibit 7-1.
Note added to reflect the issuance of GASB Statement 
No. 34 and related pronouncements.
Replaced.
Revised to clarify guidance; Footnote * revised. 
Footnotes * deleted.
Revised to reflect the issuance of SAS No. 98. 
Redesignated as exhibit 8-1.
Note added to reflect the issuance of GASB Statement 
No. 34 and related pronouncements.
Footnote * deleted.
Redesignated as exhibit 9-1.
Note added to reflect the issuance of GASB Statement 
No. 34 and related pronouncements.
Added to to clarify guidance; Subsequent footnotes 
renumbered.
AAG-HCO APP H
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Reference
Paragraph 10.09 
Paragraph 10.12 
(footnote *) 
Paragraph 10.17 
(footnote *) 
Paragraph 10.18
Paragraph 10.22 
(renumbered 
footnote 6) 
Exhibit 10.1 
Chapter 11
Paragraph 11.01
Paragraph 11.05 
(heading) 
Paragraph 11.10
Paragraphs 11.11 
and 11.12
Paragraph 11.19 
(renumbered 
footnote 13) 
Paragraphs 11.21 
and 11.23
Paragraph 11.27
Paragraph 11.28
Paragraph 11.29 
Paragraph 11.36
Paragraph 11.37 
(and renumbered 
footnote 24) 
Exhibit 11.1 
Chapter 12 (title)
Paragraph 12.05 
Paragraph 12.06
Change
Revised to clarify guidance.
Deleted.
Added.
Footnote * added; Renumbered footnote 5 revised to 
reflect the issuance of SOP 02-2.
Revised to clarify guidance.
Redesignated as exhibit 10-1.
Note added to reflect the issuance of GASB Statement 
No. 34 and related pronouncements.
Revised to reflect the issuance of GASB Statement No. 
39; Footnote * revised; Footnote ** replaced.
Footnote * revised.
Revised (and footnote 5 added) to reflect the issuance 
of FASB Statement No. 144; Subsequent footnotes 
renumbered.
Revised (and footnotes 7 and 10 added, respectively) to 
reflect the issuance of FASB Statement No. 144; 
Subsequent footnotes further renumbered.
Revised to clarify guidance.
Footnotes *, **, and *** redesignated as 14, 15, and 16, 
respectively; Subsequent footnotes further renum­
bered.
Revised to reflect the issuance of FASB Statement No. 
141; Footnote * replaced.
Footnote ** redesignated as footnote 18 and revised to 
clarify guidance; Footnote 19 added to clarify guidance; 
Subsequent footnotes further renumbered.
Footnotes * and ** redesignated as footnotes 20 and 
21; Subsequent footnotes further renumbered. 
Revised (and footnote 23 added) to reflect the issuance 
of FASB Statement No. 144; Subsequent footnote fur­
ther renumbered.
Revised to reflect the issuance of FASB Statement No. 
141; Footnote * replaced; Footnote ** added.
Redesignated as exhibit 11-1.
Footnote * deleted; Note added to reflect the issuance 
of GASB Statement No. 34 and related pronounce­
ments.
Revised to reflect the issuance of SAS No. 98.
Revised to clarify guidance; Footnote * deleted.
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Exhibits 12.1, 12.2, 
and 12.3
Exhibit 12.4
Paragraph 13.02 
(footnote *)
Exhibits 14.1, 14.2, 
and 14.3
Appendix A
Reference
Appendix F
Relettered 
Appendix G
AAG-HCO APP H
Change
Redesignated as exhibits 12-1, 12-2, and 12-3, respec­
tively.
Redesignated as exhibit 12-4 and revised to clarify 
guidance.
Added.
Redesignated as exhibits 14-1, 14-2, and 14-3, respec­
tively.
Revised to clarify guidance; Sample Not-for-Profit 
Hospital Notes to Financial Statements: Footnote 1 
revised to reflect the issuance of SOP 01-6; Note 2: 
Revised to clarify guidance; ILLUSTRATIVE F INAN ­
CIAL STATEMENTS FOR A  G OVERNM ENTAL  
HOSPITAL AUTHORITY PRE-GASB STATEMENT  
No. 34: Footnote * replaced; Sample Governmental 
Hospital Authority Notes to Financial Statements: 
Footnote ** deleted; Sample For-Profit Nursing Home 
Inc. Notes to Financial Statements: Footnote 2 revised 
to reflect the issuance of SOP 01-6; Note 7: added to 
clarify guidance; Subsequent Notes renumbered; 
Sample Not-For-Profit Continuing Care Retirement 
Community Notes to Financial Statements: Footnote 4 
added to reflect the issuance of SOP 01-6; Subsequent 
footnotes renumbered; Sample Not-For-Profit Home 
Health Agency Notes to Financial Statements: Revised 
to clarify guidance; Renumbered footnote 5 revised to 
reflect the issuance of SOP 01-6; Sample Not-For- 
Profit Health Maintenance Organization Notes to 
Financial Statements: Footnote 7 added to reflect the 
issuance of SOP 01-6; Subsequent footnote further 
renumbered; Sample Not-For-Profit Ambulatory Care 
Inc. Notes to Financial Statements: Revised to clarify 
guidance; Renumbered footnote 8 revised to reflect the 
issuance of SOP 01-6; Note 2: Footnote * added; Note 
4: Revised to clarify guidance.
Added to reflect the issuance of GASB Statement No. 
34 and related pronouncements, and the issuance of 
the Audit and Accounting Guide Audits of State and 
Local Governments (GASB 34 Edition); Subsequent 
appendixes relettered.
Updated.
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acquisition costs. Marketing costs that are (a) directly related to the acquisi­
tion of specific subscriber contracts and member enrollment and (b) incre­
mental to general marketing activities.
acute care. Inpatient general routine care provided to patients who are in a 
phase of illness that does not require the concentrated and continuous 
observation and treatment provided in intensive-care units.
advance fee. A payment required to be made by a continuing care retirement 
community (CCRC) resident prior to, or at the time of, admission to the 
CCRC for future services and the use of facilities specified in a contract 
that remains in effect for as long as the resident resides in the CCRC.
advance refunding. A transaction in which refunding debt is issued to pay 
the refunded debt at a specified future date(s), with the proceeds placed in 
trust or otherwise restricted to pay the refunded debt.
affiliate. A party that, directly or indirectly through one or more intermediar­
ies, controls, is controlled by, or is under common control with an enterprise 
(FASB Statement No. 57, Related Party Disclosures, paragraph 24(a))
agent. An entity that acts for and on behalf of another. A recipient organization 
acts as an agent for and on behalf of a donor if it receives assets from the 
donor and agrees to use those assets on behalf of or transfer those assets, 
the return on investment of those assets, or both to a specified beneficiary. 
A recipient organization acts as an agent for and on behalf of a beneficiary 
if it agrees to solicit assets from potential donors specifically for the 
beneficiary’s use and to distribute those assets to the beneficiary. A 
recipient organization also acts as an agent if a beneficiary can compel the 
organization to make distributions on its behalf. (FASB Statement No. 136, 
Transfers of Assets to a Not-for-Profit Organization or Charitable Trust 
That Raises or Holds Contributions for Others, paragraph 10)
allocated loss adjustment expense (ALAE). Claim expense that can be as­
signed to individual claims (for example, attorney’s fees, claim adjusting 
service fees, or court costs).
ambulatory care organization. A partnership, association, corporation, or 
other legal entity organized to deliver health care services to patients that 
come or are brought to a health care facility for a purpose other than 
admission as an inpatient (for example, emergency room services, clinic 
services, or outpatient surgery).
ancillary services. Services performed for diagnostic or therapeutic purposes. 
Ancillary services generally are those special services for which charges in 
addition to routine charges customarily are made (for example, laboratory, 
radiology, surgical, or other services).
anticipated revenues. Amounts including third-party payments (for exam­
ple, those from Blue Cross), contractually or statutorily committed invest­
ment income from sources related to the activities of a continuing care 
retirement community (CCRC), contributions pledged by donors to support 
CCRC activities, periodic fees expected to be collected, or the balance of 
deferred nonrefundable advance fees.
asserted claim. A claim made against a health care organization by or on 
behalf of a patient alleging improper professional service.
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assets limited as to use. Assets that are segregated and limited either by the 
Board or management (for example, designated for expenditure in the 
acquisition of property and equipment or for the liquidation of long-term 
debt) or by outside third parties other than a donor or grantor (for example, 
funds under bond agreements or malpractice arrangements) as to how the 
assets may be used.
associated entity. An individual practice association, hospital, medical group, 
or similar health care organization that contracts with a prepaid health 
care provider to provide health care services. 
bad-debt expense. The current period charge for actual or expected doubtful 
accounts resulting from the extension of credit. 
capitation fee. A fixed amount per individual that is paid periodically (usually 
monthly) to a provider as compensation for providing comprehensive 
health care services for the period. The fee is set by contract between a 
prepaid health care plan and the provider. These contracts are generally 
with medical groups, independent practice associations (IPAs), hospitals, 
and other similar providers. Capitation fees may be determined actuarially 
or negotiated based on expected costs to be incurred. 
charity care. Health care services that never were expected to result in cash 
inflows. Charity care results from a provider’s policy to provide health care 
services free of charge to individuals who meet certain financial criteria. 
claims-made insurance policy. A policy that covers only malpractice claims 
reported to the insurance carrier during the policy term, regardless of the 
date of the incident giving rise to the claim. 
clinic. A freestanding facility or part of another health care organization used 
for diagnosis and treatment of outpatients. 
commercial paper. Short-term, unsecured promissory notes that represent a 
flexible and low-cost form of short-term financing. Taxable commercial 
paper is sold on a discount basis, rather than on an interest-bearing basis, 
with the discount determined by the maturity of the notes, the creditwor­
thiness of the issuer or its credit support, and general market demand. The 
primary risk is the variable interest rate exposure. Issuance often requires 
some form of credit enhancement or liquidity support. 
comprehensive medical plan (CMP). A health plan option that may be avail­
able to Medicare beneficiaries and provides a more limited range of services 
than health maintenance organizations but includes physician services, 
laboratory, radiology, emergency, preventive, and inpatient services. A 
CMP assumes the financial risk for the provision of services and for 
out-of-area coverage. 
conditional promise to give. A promise to give that depends on the occur­
rence of a specified future or uncertain event to bind the promisor.
continuing-care contract. An agreement between a resident and a CCRC 
specifying the services and facilities to be provided by the CCRC to a 
resident over an established period of time (usually the remaining life of 
the resident).
continuing care retirement community (CCRC). A legal entity sponsoring 
or guaranteeing residential facilities, meals, and health care services for a 
community of retired persons who may reside in apartments, other living 
units, or in some cases a nursing center. (Also referred to as a residential 
care facility or a life-care retirement community.) 
contract period. The period (typically one year) for which premium rates are 
fixed by contract.
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contractual adjustments. The differences between revenue at established 
rates and the amounts realizable from third-party payors under contrac­
tual agreements.
contribution. An unconditional transfer of cash or other assets to an entity or 
a settlement or cancellation of its liabilities in a voluntary nonreciprocal 
transfer by another entity acting other than as an owner.
costs of acquiring initial continuing-care contracts. Costs incurred to origi­
nate a contract that result from and are essential to the acquisition of the 
initial contracts and are incurred through the date of substantial occupancy 
but no later than one year from the date of completion of construction.
These costs include—
• The costs of processing the contract, such as evaluating the prospective 
resident’s financial condition; evaluating and recording guarantees, collat­
eral, and other security arrangements; negotiating contract terms; prepar­
ing and processing contract documents; and closing the transaction.
•  The costs from activities in connection with soliciting potential initial 
residents (such as model units and their furnishings, sales brochures, 
semipermanent signs, tours, grand openings, and sales salaries). 
These costs do not include advertising, interest, administrative costs, 
rent, depreciation, or any other occupancy or equipment costs.
•  The portion of an employee’s compensation and benefits that relates 
to the initial contract acquisitions.
courtesy and policy discounts. The differences between revenue recorded at 
established rates and amounts realizable for services provided to specific 
individuals such as employees, medical staff, and clergy.
credibility. A measure of the statistical significance of a provider’s own data, 
dependent on its stability and volume in relation to the stability and 
volume of the industry data. Actuaries use credibility to blend an estimate 
from a provider’s own experience with a broader estimate based on the 
experience of similar institutions. A provider’s own experience may be 
assigned a credibility weight less than 100 percent due to year-to-year 
volatility. Such volatility is often a function of the size of the provider. 
Large providers generally have less volatility than small providers. In such 
an instance, a broader and more stable body of experience of similar 
providers would be used to supplement the specific provider’s experience.
credit enhancement. Typically, a bank letter of credit that guarantees investors 
will receive principal and interest in the event of an issuer default. A line of 
credit provides liquidity support to an issuer but does not provide a guarantee 
of the repayment of principal and interest in the event of issuer default. The 
liquidity support provides a loan to issuers in the event the issuer is unable to 
place large amounts of maturing commercial paper with investors.
crossover refunding (also called a delayed defeasance). A type of advance 
refunding in which the old debt is not immediately replaced. The proceeds 
from the new debt, additional cash deposits (if any), and the income earned 
on the related investments are sufficient to pay the principal and any call 
premium of the old debt and the interest on the new debt until the date of 
crossover. Until the crossover, the proceeds from the new debt serve as 
collateral for that debt. The old debt is serviced by the entity until the date 
of crossover, at which time the proceeds from the new debt are used to retire 
the old debt and the entity becomes obligated to service the new debt. The 
old debt remains as a liability on the issuer’s books until the crossover, 
when it is called in accordance with the call provisions of its indenture.
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deductions from revenue. Reductions in gross revenue arising from contrac­
tual adjustments, courtesy and policy discounts, or other adjustments and 
deductions.
defeasance. Legal satisfaction of refunded debt without the debt necessarily 
being retired.
development factor. A computed factor used to project future changes in 
estimated losses from the date of the occurrence of the incident to the 
date-of-claim payment resulting from inflation, claimed cost growth, in­
dustry trends, and court awards. The development factor can be applied to 
incurred losses, paid losses, claim counts, and average values.
diagnosis-related group (DRG). A patient classification scheme that catego­
rizes patients who are related medically with respect to primary and 
secondary diagnosis, age, or complications.
donor-imposed condition. A donor stipulation that specifies a future and 
uncertain event whose occurrence or failure to occur gives the promisor a 
right of return of the assets it has transferred or releases the promisor from 
its obligation to transfer its assets.
donor-imposed restriction. A donor stipulation that specifies the use for a 
contributed asset that is more specific than broad limits resulting from the 
nature of the organization, the environment in which it operates, and the 
purposes specified in its articles of incorporation or bylaws of comparable 
documents for an unincorporated association. A restriction on an organi­
zation’s use of the asset contributed may be temporary or permanent.
endowment fund. An established fund of cash, securities, or other assets used 
to provide income for the maintenance of a not-for-profit organization. The 
use of the assets of the fund may be permanently restricted, temporarily 
restricted, or unrestricted. Endowment funds generally are established by 
donor-restricted gifts and bequests to provide a permanent endowment (to 
provide a permanent source of income) or a term endowment (to provide 
income for a specific period). The principal of a permanent endowment 
must be maintained permanently, that is, not used up, expended, or 
otherwise exhausted—and is classified as permanently restricted net 
assets. The principal of a term endowment must be maintained for a 
specified term and is classified as temporarily restricted net assets. An 
organization’s governing board may earmark a portion of its unrestricted 
net assets as a board-designated endowment (sometimes called funds 
functioning as endowment or quasi-endowment funds) to be invested to 
provide income for a long but unspecified period. The principal of a 
board-designated endowment, which results from an internal designation, 
is not donor restricted and is classified as unrestricted net assets.
enrollee. An individual who is a subscriber or an eligible dependent of a 
subscriber in a prepaid health care plan.
estimated costs of future services. Amounts that are expected to be incurred 
to provide services and the use of facilities to individuals over their 
remaining lives under continuing-care contracts. Examples include resi­
dent care, dietary, health care, facility, general and administrative, inter­
est, depreciation, and amortization costs.
exposure. The amount of potential claim risk. The basis for reflecting differ­
ences in the claim potential among providers’ bases for charging insurance 
premiums or allocating member contributions to a captive. Exposure bases 
for hospital professional liability include number of occupied beds, outpa­
tient visits, emergency room visits, and number of residents by specialty.
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floating rate note (FRN). A debt instrument that allows issuers to borrow at 
a floating short-term rate with a long-term stated maturity without some 
of the risks traditionally associated with commercial paper. The investor 
is subject to principal risk to the degree the issuer’s credit deteriorates or 
investor demand for FRNs decreases. Most health care issuers of FRNs 
require credit enhancement and a bank liquidity facility in conjunction 
with an FRN program.
functional classification. A method of grouping expenses according to the 
purpose for which costs are incurred. The primary functional classifica­
tions are program services and supporting activities.
fund. A self-contained accounting entity set up to account for a specific activity 
or project.
gross service revenues. All revenues from the provision of health care serv­
ices excluding charity care.
health care services. Services provided to individuals related to the diagnosis 
or treatment of physical or mental illness.
health maintenance organization (HMO). A generic group of medical care 
entities organized to provide defined health care services to members in 
return for fixed, periodic premiums (usually paid monthly) that are paid 
in advance.
home health agency. An agency organized to provide health and supportive 
services in a person’s home. These services may include nursing, nutri­
tional, and therapeutic aid (such as physical therapy and dialysis) and the 
rental, as well as sale of medical equipment.
increased limit factor. The relationship between losses limited to a per- 
occurrence limit at which the provider’s own experience is meaningful to 
losses limited to the provider’s total retained limit per occurrence.
incremental costs. Costs that vary with and are directly attributable to 
changes in business, such as an additional employer or HMO contract. 
Fixed costs such as building depreciation or general overhead that do not 
change with the addition or loss of a contract are not incremental costs.
incurred but not reported (IBNR) costs. Costs associated with health care 
services incurred during a financial reporting period but not reported to 
the health care organization until after the financial reporting date.
indenture. An agreement between two or more persons specifying the recip­
rocal rights and duties of the parties under a contract (such as a lease, 
mortgage, or contract between bondholders and the issuer of the bond).
individual practice association (IPA). A partnership, association, corpora­
tion, or other legal entity organized to provide or arrange for the delivery 
of health care services to members of a prepaid health care plan and 
nonmember patients. In return, the IPA receives either a capitation fee or 
a specified fee for services rendered.
inpatient. Under most circumstances, a patient who is provided with room, 
board, and general nursing service and is expected to remain in the health 
care facility at least overnight and occupy a bed.
in-substance defeasance. A form of advance refunding in which the debtor 
places into an irrevocable trust an amount of assets estimated to be 
sufficient to satisfy all future principal and interest payments of a specific 
obligation. In such cases, the debt is not considered extinguished because 
the debtor is not legally released from being the primary obligor.
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integrated delivery system. A provider or group of providers that is organ­
ized to deliver and finance acute and preventive health care services. An 
integrated delivery system generally will provide (or arrange to provide) a 
complete continuum of health care services (inpatient acute care, ambula­
tory care, outpatient surgery, home health care, including long-term care) 
to an enrolled population, generally for fixed prepaid fees called premiums.
interest rate swaps. An agreement to exchange interest payments without 
actually exchanging the underlying principal. The two parties each agree 
to make interest payments based on the calculation formula for the other’s 
debt. Swaps can be used for a variety of purposes, such as to reduce the 
overall cost of borrowing, lock in forward rates, reduce interest rate risk, 
or adjust the ratio of variable and fixed-rate debt liabilities. Interest rate 
swaps do not change the amount or type of debt outstanding, but they do 
affect the issuer’s debt portfolio and risk profile.
intermediary. An entity that acts as a facilitator for the transfer of assets 
between a potential donor and a potential beneficiary (donee) but is neither 
an agent or trustee nor a donee and donor as contemplated by FASB Statement 
No. 116, Accounting for Contributions Received and Contributions Made. 
( FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organi­
zation or Charitable Trust That Raises or Holds Contributions for Others, 
paragraph 8)
intermediate care facility (ICF). A facility that provides care to individuals 
whose mental or physical conditions require services that are above the 
level of room and board and that can be made available only through 
institutional facilities. The care provided at an ICF does not require 
hospitals or skilled nursing facilities.
maintenance costs. Costs associated with maintaining enrollment records 
and processing premium collections and payments.
margin for risk of adverse deviation. Actuarially determined estimate of 
the additional funding requirement to obtain a specific confidence level 
that losses will not exceed the amount paid into the self-insurance fund. 
Margins are determined using statistical simulation techniques.
medical group. An association of physicians and other licensed health care 
professionals organized on a group basis to practice medicine.
medium-term notes. An intermediate-term security offered on a continuous 
basis providing flexibility for an issuer to vary the amount of outstanding 
notes as its funding requirements change. The broad range of possible 
maturities enables an issuer to borrow at the most attractive yield at the 
time of each issuance. They can be issued domestically or abroad.
member. An individual who is enrolled as a subscriber or as an eligible 
dependent of a subscriber in a prepaid health care plan.
multiprovider captive. An insurance company owned by two or more health 
care organizations that underwrites malpractice insurance for its owners.
natural classification. A method of classifying expenditures according to the 
nature of the expense such as salaries and wages, employee benefits, 
supplies, and purchased services.
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net advance refunding. A type of advance refunding in which the proceeds 
from the new debt, additional cash deposits (if any) and the income earned 
on the related investments are sufficient to pay the interest, principal, and 
call premium on the old debt. After the advance refunding, the old debt is 
serviced by the investments in trust and the new debt is serviced by the 
entity.
net service revenue. Gross service revenue less provisions for contractual 
adjustments with third-party payors.
nonexchange transaction. An external transaction in which a government 
gives (or receives) value without directly receiving (or giving) equal value 
in exchange.
nonfinancial assets. Nonmonetary assets such as inventories or property, 
plant, and equipment.
not-for-profit organization. An entity that possesses the following charac­
teristics that distinguish it from a business enterprise: (a) contributions of 
significant amounts of resources from resource providers that do not expect 
commensurate or proportionate pecuniary return, (b ) operating purposes 
other than to provide goods or services at a profit, and (c) absence of 
ownership interests like those of business enterprises. Not-for-profit or­
ganizations possess these characteristics in varying degrees.
nursing center. A facility that provides nursing care to residents with a 
variety of needs or medical conditions. A nursing center may be a compo­
nent of a continuing care retirement community. (Also called a health 
center, skilled-nursing facility, intermediate-care facility, continuing-care 
facility, or basic-care home.)
occurrence-basis policy. A policy that covers claims resulting from incidents 
that occur during the policy term, regardless of when the claims are 
reported to the insurance carrier.
outliers. In referring to the Medicare Prospective Payment System, additional 
payments that are made for cases that either have unusually long lengths 
of stay or have charges in excess of the cost outlier threshold.
outpatient. A patient who is not confined overnight in a health care institu­
tion.
peer review organization (PRO). Under federal statutory provision, PROs 
are required in each state to monitor hospital activity under the prospec­
tive payment system. Each hospital must contract with a PRO, which will 
review (a) the validity of diagnostic information, which establishes the 
diagnosis-related group; (b ) the appropriateness of admissions; (c) the 
appropriateness of care to outliers; and (d ) the adequacy of care provided.
periodic fees. Amounts paid to a continuing care retirement community by a 
resident at periodic intervals for continuing-care services. Such fees may 
be fixed or adjustable. (Also called maintenance fees or monthly fees.)
periodic interim payment (PIP). A plan under which the health care organi­
zation receives cash payments from a third-party payor (usually Medicare) 
in constant amounts periodically.
permanent restriction. A donor-imposed restriction that stipulates that re­
sources be maintained permanently but permits the organization to use up 
or expend part or all of the income (or other economic benefits) derived 
from the donated assets.
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permanently restricted net assets. The part of the net assets of a not-for- 
profit organization resulting from (a) contributions and other inflows of 
assets whose use by the organization is limited by donor-imposed stipula­
tions that neither expire by the passage of time nor can be fulfilled or 
otherwise removed by the actions of the organization, (b ) other asset 
enhancements and diminishments subject to the same kind of stipulations, 
and (c) reclassification from (or to) other classes of net assets as a conse­
quence of donor-imposed stipulations.
premium. The consideration paid for providing contract coverage. (Also called 
a subscriber fee.)
premium period. The period to which a premium payment applies (generally 
one month) that entitles a member to health care services according to the 
contract provisions.
prepaid health care plan. A plan in which the provider is compensated in 
advance by the sponsoring organization. The sponsoring organization pays 
or compensates the provider based on either a fixed sum or a per-enrollee 
amount. Prepaid health care plans include health maintenance organiza­
tions, preferred provider organizations, eye care plans, dental care plans, 
and similar plans. Under such plans, the financial risk of delivering the 
health care is transferred to the provider of services.
prepaid health care services. Any form of health care service provided to a 
member in exchange for a scheduled payment (or payments) established 
before care is provided, regardless of the level of service subsequently 
provided.
prevailing charge. A charge that falls within the range of charges most 
frequently used in a locality for a particular service or procedure.
primary care. Care that is rendered in an ambulatory fashion, such as in an 
emergency room, an outpatient clinic, or other outpatient department.
prospective payment system (PPS). Medicare payment made at a predeter­
mined, specific rate for each Medicare discharge, based on the patient’s 
diagnosis. Each discharge is classified according to a series of diagnosis- 
related groups. (See also diagnosis-related group.)
provider. A person or entity that undertakes to provide health care services.
providers of prepaid health care services (prepaid health care providers).
Organizations that provide or arrange for the delivery of health care 
services in accordance with the terms and provisions of a prepaid health 
care plan. Providers assume the financial risk of the cost of delivering 
health care services in excess of preestablished fixed premiums. However, 
some or all of the financial risk may be contractually transferred to other 
providers (affiliated entities) or by purchasing stop-loss insurance. Other 
providers of prepaid health care services may include comprehensive 
medical plans, physicians groups (for example, independent practice asso­
ciations), and hospitals.
refundable advance fees. The portion of an advance fee that is payable to a 
resident of a continuing care retirement community or the resident’s 
estate.
refunded debt. Debt for which payment at a specified future date has been 
provided by the issuance of refunding debt.
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refunding debt. Debt issued to provide funds to pay for refunded debt at a 
specified future date.
reported incident. An occurrence identified by a health care organization as 
one in which improper professional service may be alleged at a future time 
that would result in a malpractice claim.
retrospectively rated insurance policy. An insurance policy with a premium 
that is adjustable based on the experience of the insured health care 
organization or group of health care organizations during the policy term.
risk contract. A contract between a provider of health care services and a 
prepaid health care plan that exposes the provider to the uncertainty of 
financial gain or loss by obligating the provider to provide specified health 
care services to enrollees of the plan for a negotiated price, which may be 
an amount per case, service, or day. The price may vary based on the 
volume of services furnished during the contract period.
secondary care. Care that is rendered to inpatients in hospitals that offer 
short-term, acute-care services of either a general or a specialized nature.
self-insurance. That portion of risk or loss assumed by a health care organi­
zation. There is no external insurance coverage.
skilled nursing facilities (SNF). These facilities provide services on a daily, 
inpatient basis. The services provided by an SNF are ordered by a physi­
cian and require the skilled services of technical or professional personnel.
stop-loss (or reinsurance) insurance. A contract in which a company agrees 
to indemnify providers for certain health care costs incurred by members.
subscriber. The person who is responsible for the payment of premiums or 
whose employment is the basis for eligibility for membership in a prepaid 
health care plan.
tail coverage. Insurance designed to cover malpractice claims incurred before, 
but reported after, cancellation or expiration of a claims-made insurance 
policy.
taxable variable rate demand notes. Issuers may call the notes on any 
monthly interest payment date, which provides issuers the opportunity to 
refinance short-term obligations with long-term bonds if market conditions 
make this alternative attractive.
temporarily restricted net assets. The part of the net assets of a not-for- 
profit organization resulting (a) from contributions and other inflows of 
assets whose use by the organization is limited by donor-imposed stipula­
tions that either expire with the passage of time or can be fulfilled and 
removed by actions of the organization pursuant to those stipulations, (b) 
from other asset enhancements and diminishments subject to the same 
kinds of stipulations, or (c) from reclassification to (or from) other classes 
of net assets as a consequence of donor-imposed stipulations, their expira­
tion by passage of time, or their fulfillment and removal by actions of the 
organization pursuant to those stipulations.
tertiary care. Care that is rendered in hospitals that possess the personnel, 
equipment, and expertise to handle complex cases.
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third-party payor. Any agency (such as Blue Cross, Medicare, or commercial 
insurance companies) that contracts with health care organizations and 
patients to pay for the care of covered patients.
trend factor. A factor used in actuarial methodology to adjust ultimate losses 
from historical experience periods to the loss cost levels of the projection 
period, due to the impact of economic, jurisdictional, and social changes 
affecting hospital professional liability loss costs.
trust fund. A fund established with an outside entity to be used for a specific 
purpose, such as to pay malpractice claims and related expenses as they 
arise.
trustee. An entity that has a duty to hold and manage assets for the benefit 
of a specified beneficiary in accordance with a charitable trust agreement. 
(FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organi­
zation or Charitable Trust That Raises or Holds Contributions for Others, 
paragraph 9)
ultimate cost. Total claims payments, including costs associated with litigat­
ing or setting claims.
unasserted claim. A medical malpractice claim that has not been asserted 
formally against a health care provider by or on behalf of a patient alleging 
improper professional service. It may relate to either reported incidents or 
to unreported incidents.
unreported incident. An occurrence in which improper professional service 
may have been administered by a health care provider, which may result 
in a malpractice claim of which the provider is not yet aware.
unrestricted net assets. The part of net assets of a not-for-profit organization 
that is neither permanently restricted nor temporarily restricted by donor- 
imposed stipulations.
voluntary health and welfare organizations. Organizations formed for the 
purpose of performing voluntary services for various segments of society. 
They are tax-exempt (organized for the benefit of the public), supported by 
the public, and operated on a not-for-profit basis. Most voluntary health 
and welfare organizations concentrate their efforts and expend their re­
sources in an attempt to solve health and welfare problems of society and, 
in many cases, those of specific individuals. As a group, voluntary health 
and welfare organizations include not-for-profit organizations that derive 
their revenue primarily from voluntary contributions from the general 
public to be used for general or specific purposes connected with health, 
welfare, or community services.
wholly owned captive. An insurance company subsidiary of a health care 
organization that provides malpractice insurance primarily to its parent 
corporation.
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For additional copies of the Health Care Organizations Audit & Accounting Guide 
or to automatically receive an annual update —  immediately upon its release 
- call 1-888-777-7077.
Additional Health Care Organizations Publications
Health Care Organizations Audit Risk Alert (ARA)
Find out about current economic, regulatory and professional developments before you 
perform your audit engagement. This ARA will make your audit planning process more efficient 
by giving you concise, relevant information that shows you how current developments may 
impact your clients and your audits.
2002/03 (022343) AICPA Member $20; Nonmember $25
Checklists and Illustrative Financial Statements for Health Care Organizations
Developed by the AlCPA’s staff, this practice aid is an invaluable tool to both preparers and audi­
tors of health care organizations financial statements. This checklist has been updated to reflect 
recent AICPA and FASB pronouncements.
2003  (009023) AICPA Member $32; Nonmember $40
Audit and Accounting Guides —  2003 Industry Guides
With conforming changes as of May 1, 2003.
Each —  AICPA Member $45; Nonmember $56.25
• Audits of Agricultural Producers and Agricultural Cooperatives (012683)
• Audits of Airlines (012693)
• Brokers and Dealers in Securities (012703)
• Audits of Casinos (012713)
• Common Interest Realty Associations (012573)
• Construction Contractors (012583)
• Depository and Lending Institutions: Banks and Savings Institutions, Credit Unions, 
Finance Companies, and Mortgage Companies (012733)
• Audits of Employee Benefit Plans (as of March 1, 2003) (012593)
• Audits of Entities With Oil and Gas Producing Activities (012653)
• Federal Government Contractors (012603)
• Health Care Organizations (012613)
• Audits of Investment Companies (012623)
• Life & Health Insurance Entities (012633)
• Not-for-Profit Organizations (012643)
• Audits of Property and Liability Insurance Cos. (012673)
• Audits of State and Local Governmental Units (Non-GASB 34 Edition) (012563)
• Audits of State and Local Governments (GASB 34 Edition) (012663)
• Audits of States, Local Governments, and Not-for-Profit Organizations Receiving 
Federal Awards (012743)
Audit and Accounting Guides —  General Guides
Each —  AICPA Member $45; Nonmember $56.25
• Analytical Procedures (2001) (012541)
• Audit Sampling (2001) (012530)
• Auditing Derivative Instruments, Hedging Activities, and Investments 
in Securities (2001) (012520)
• Auditing Revenue in Certain Industries (2001) (012510)
• Consideration of Internal Control in a Financial Statement Audit (1996) (012451)
• Personal Financial Statements (2003) (012753)
• Prospective Financial Information (2003) (012723)
Service Organizations: Applying SAS No. 70, as Amended (2002) (012772)
Use of Real Estate Appraisal Information (1997) (013159)
To order call the AICPA at 1-888-777-7077, or fax to 1-800-362-5066 
or log on to www.cpa2biz.com
Prices do not include sales tax or shipping & handling. Prices may be subject to change without notice.
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